Citrus Sinensis ID: 005017
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 719 | 2.2.26 [Sep-21-2011] | |||||||
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.830 | 0.975 | 0.519 | 1e-173 | |
| Q8S8Y8 | 567 | Probable serine/threonine | yes | no | 0.575 | 0.730 | 0.627 | 1e-157 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.581 | 0.750 | 0.614 | 1e-153 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.603 | 0.770 | 0.619 | 1e-149 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.568 | 0.780 | 0.632 | 1e-144 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.566 | 0.578 | 0.553 | 1e-136 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.566 | 0.578 | 0.553 | 1e-136 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.585 | 0.601 | 0.530 | 1e-134 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.536 | 0.748 | 0.547 | 1e-133 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.571 | 0.661 | 0.545 | 1e-131 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 609 bits (1571), Expect = e-173, Method: Compositional matrix adjust.
Identities = 339/653 (51%), Positives = 429/653 (65%), Gaps = 56/653 (8%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
D++ VE DP+ RY+RY+EVLG+GA KTVYKAFDE GIEVAWS+V+ID+V+Q P +L++L
Sbjct: 12 DAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNLERL 71
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
YSEVHLLKSLK +NV+KFY WVDD+KKT+N+ITELFTSG+LRQYR+KH VD+K IKNW
Sbjct: 72 YSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAIKNW 131
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
ARQ+L GL YLH+H PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA M P A+SVIGTP
Sbjct: 132 ARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRAKSVIGTP 191
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPYSEC N AQIFKKV+ G+KPA+LAK+
Sbjct: 192 EFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAALAKI 251
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSG 365
+ Q K FI+KCLVPASERLSAK+LL+DPFL +N + K P K + + +
Sbjct: 252 TNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSS--VLVGTKFPSSLPKSVDVSLEA 309
Query: 366 PSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRI 425
MD+D++ + + STC ++ G PH VLEF R +KN E +L G K DD SVSL LRI
Sbjct: 310 L-HMDVDTN-ESMCTSTCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLVLRI 367
Query: 426 ADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPS 485
AD G RNIHFLFYLDSDTA+SVA EMVEQL+LAD DV FIA+FID LI+ L+PG +
Sbjct: 368 ADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVPGQQLM 427
Query: 486 YDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAP 545
D A+ S +G + S PSE +V G + + +P
Sbjct: 428 ND-----AVMSTSSESKMGESEHVITSQQH------PSELTHDYVLVEGMMHSKEANASP 476
Query: 546 AQG-ENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVD-DTSTKNDKASEFSDYSTDR 603
+ ++L + GG SS SDI V D S+K+ S+Y D
Sbjct: 477 SDYIDSLLNATNLGG-------------PNSSEGSDISVQLDGSSKS-----LSEYGVDE 518
Query: 604 SYKDL--NGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLT 661
Y+ L Y +LG C+ S + ++Q + S + + +S+T
Sbjct: 519 -YRTLECGAYKGTDKLG------CR--HPLSNGSSNFAIFQMDQASHHSELVIGASVSIT 569
Query: 662 SSYSSLSLTGKDVDELKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKK 714
++ D L E+ IEAQYE WF+EL++M+EEALE +RK+W+ K
Sbjct: 570 ----------ENRDVLNGELGLIEAQYEQWFRELTRMREEALEGARKKWLPDK 612
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 555 bits (1429), Expect = e-157, Method: Compositional matrix adjust.
Identities = 274/437 (62%), Positives = 333/437 (76%), Gaps = 23/437 (5%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
EPPD + +E DP+ RY+RY EV+GKGAFKTVYKAFDE GIEVAW++V+IDDVLQ P
Sbjct: 12 EPPDPE--VLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPN 69
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
L++LYSEV LLKSLK +N+++FY SW+DDK KTVN+ITELFTSG+LR YRKKH+ V++K
Sbjct: 70 CLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMK 129
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240
+KNWARQIL GL YLH PPIIHRDLKCDNIF+NGNHGEVKIGDLGLA M+Q A+S
Sbjct: 130 AVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKS 189
Query: 241 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
VIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF+YPY ECKN AQI+KKV+SGIKPA
Sbjct: 190 VIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPA 249
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLP-------- 352
SL++V DP++K FIEKCL+PASERLSAK+LL DPFLQ+ + +PL LP
Sbjct: 250 SLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPKEG 307
Query: 353 ---IQSLKMLRLPMSGPS---SMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNE 406
+ L P + PS S+D+D D +L T S+N C +E +R + N
Sbjct: 308 AFGDRCLMSEGPPTTRPSKTLSIDLDEDS---NLPIVTFSDNSGSRC--IEVRRAKRGNF 362
Query: 407 FRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAF 466
F L+G +ND+ SVSL LRI D +GRVRNIHFLFY + DTA V+ EMVEQL+L D +V F
Sbjct: 363 FVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTF 422
Query: 467 IAEFIDYLIMKLLPGWK 483
IAE ID L++ ++P WK
Sbjct: 423 IAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 541 bits (1395), Expect = e-153, Method: Compositional matrix adjust.
Identities = 269/438 (61%), Positives = 331/438 (75%), Gaps = 20/438 (4%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
EPPD + +E DP+ RY+RY EV+GKGA KTV+K FDE GIEVAW++V+IDD+LQ
Sbjct: 9 AIVEPPDPE--VLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQ 66
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV 177
P L++LYSEV LLKSLK N+++FY SW+DDK KTVN+ITELFTSG+LRQYRKKH+ V
Sbjct: 67 SPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKV 126
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237
++K +K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGNHGEVKIGDLGLA M+Q
Sbjct: 127 NMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQAN 186
Query: 238 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297
A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTFEYPY EC+N AQI+KKV+SGI
Sbjct: 187 AKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGI 246
Query: 298 KPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE----NQKEPICDPLKLPI 353
KPASL+KV DP++ FIEKCL+PASERLSA++LL D FL V N P+ D + +P
Sbjct: 247 KPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD-IVMPK 305
Query: 354 QSLKMLRLPMS-GPS-------SMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNN 405
+ R MS GP SM++D D +L SNN +C +E +R + N
Sbjct: 306 EGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLPIVISSNNSGTNC--IEVRRAKRGN 360
Query: 406 EFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVA 465
F L+G +ND+ SVSL LRI D +GRVRNIHFLF+ + DTA +V+ EMVEQL+L D +V
Sbjct: 361 FFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVK 420
Query: 466 FIAEFIDYLIMKLLPGWK 483
FIAE ID L++ L+P WK
Sbjct: 421 FIAELIDVLLVNLIPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1366), Expect = e-149, Method: Compositional matrix adjust.
Identities = 274/442 (61%), Positives = 332/442 (75%), Gaps = 8/442 (1%)
Query: 54 SGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
SG LG + ++DF EKDPSGRY+RYD+VLG+GAFKTVYKAFDE GIEVAW+ V I+
Sbjct: 5 SGFLGQISSME-EADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIE 63
Query: 114 DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K KT+NMITELFTSG+LR YRKK
Sbjct: 64 DVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKK 123
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
H+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA +
Sbjct: 124 HRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVL 183
Query: 234 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPY+EC+N AQI+KKV
Sbjct: 184 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKV 243
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 353
TS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KDPFL + K+ L
Sbjct: 244 TSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSA--LLASSS 301
Query: 354 QSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTK 413
S K +R P MD+D + + SN P +E QR+ +N EFRLRG +
Sbjct: 302 TSSKYVRPPQLEHLPMDVDHNENK-----SVSSNEDYPWSQTIELQRIAENKEFRLRGER 356
Query: 414 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 473
+DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EMVE+L L +V IA+ ID
Sbjct: 357 SDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDD 416
Query: 474 LIMKLLPGWKPSYDYSSSGALS 495
IM+LL S+ +S L+
Sbjct: 417 FIMQLLSDRTSSHHNQNSPRLT 438
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 263/416 (63%), Positives = 316/416 (75%), Gaps = 7/416 (1%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
++DFV+KDP+GRY+RY++VLG+GAFKTVYKAFDE GIEVAW+ + I+DVLQ+PG L +L
Sbjct: 3 EADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRL 62
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
YSEVHLL SLK DN++K + SWVDD K++NMITELFTSG+L YRKKH+ VD K I NW
Sbjct: 63 YSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNW 122
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
ARQIL GL YLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA MQQPTARSVIGTP
Sbjct: 123 ARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTP 182
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPY EC+N AQI+KKVTSGIKP SL+KV
Sbjct: 183 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKV 242
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSG 365
+DPQ+K FIEKCL+PA R +A +LLKD L V+ K+ + K P
Sbjct: 243 DDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASS--NTTFKPAMPPQCE 300
Query: 366 PSSMDIDSDYKQLSLSTCTESNNGSPHCPVL---EFQRMHKNNEFRLRGTKNDDTSVSLT 422
MD++ K S+S C+ S S C +L E QR+ ++ EF+L G + DD + S+
Sbjct: 301 YRPMDVEYK-KNTSVSICS-SAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVAASMA 358
Query: 423 LRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKL 478
LRIA SSG+ R + F F L +DTA +V GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 359 LRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 242/437 (55%), Positives = 307/437 (70%), Gaps = 30/437 (6%)
Query: 68 DFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS 127
++ E DP+GRY RY++VLGKGA KTVY+AFDE+ G+EVAW++VK+ D LQ P DL++LY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
E+HLLK+LK N++KFY SWVD ++ +N ITE+FTSG LRQYR+KH V+I +K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
QIL GL+YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA +++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 248 MAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
MAPE+YEEEYNELVDIYSFGMC+LEMVTFEYPYSEC +P QI+KKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 308 PQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP----- 362
P ++ F+EKCL AS RLSA++LLKDPFLQV++ + P + LR P
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHA 312
Query: 363 ------MSGPSSMDIDSDYKQLSLSTCTESN---------NGSPHCPVLEFQRMHKNNEF 407
MS S ID D C + + NG P+ N +
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPL-------GNVDI 365
Query: 408 RLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFI 467
++G K++D S+ L LRIAD+ G VRNI+F F +++DTALSVA EMV +LD+ DH+V I
Sbjct: 366 TIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRI 425
Query: 468 AEFIDYLIMKLLPGWKP 484
AE ID + L+P W+P
Sbjct: 426 AEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-136, Method: Compositional matrix adjust.
Identities = 242/437 (55%), Positives = 307/437 (70%), Gaps = 30/437 (6%)
Query: 68 DFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS 127
++ E DP+GRY RY++VLGKGA KTVY+AFDE+ G+EVAW++VK+ D LQ P DL++LY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
E+HLLK+LK N++KFY SWVD ++ +N ITE+FTSG LRQYR+KH V+I +K+W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
QIL GL+YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA +++ A +GTPEF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 248 MAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
MAPE+YEEEYNELVDIYSFGMC+LEMVTFEYPYSEC +P QI+KKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 308 PQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP----- 362
P ++ F+EKCL AS RLSA++LLKDPFLQV++ + P + LR P
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHA 312
Query: 363 ------MSGPSSMDIDSDYKQLSLSTCTESN---------NGSPHCPVLEFQRMHKNNEF 407
MS S ID D C + + NG P+ N +
Sbjct: 313 YSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPL-------GNVDI 365
Query: 408 RLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFI 467
++G K++D S+ L LRIAD+ G VRNI+F F +++DTALSVA EMV +LD+ DH+V I
Sbjct: 366 TIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRI 425
Query: 468 AEFIDYLIMKLLPGWKP 484
AE ID + L+P W+P
Sbjct: 426 AEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 245/462 (53%), Positives = 312/462 (67%), Gaps = 41/462 (8%)
Query: 67 SDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLY 126
S+FVE DP+GRY RY+EVLGKGA KTVY+AFDE+ GIEVAW++VK+ D LQ P DL++LY
Sbjct: 12 SEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLY 71
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
E+HLLK+LK N++KFY SWVD + +N +TELFTSG LRQYR +HK V+I+ +K+W
Sbjct: 72 CEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWC 131
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA +++ A +GTPE
Sbjct: 132 RQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPE 191
Query: 247 FMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306
FMAPE+YEE YNELVDIYSFGMCILEMVTF+YPYSEC +PAQI+KKV SG KP +L KV
Sbjct: 192 FMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVK 251
Query: 307 DPQIKGFIEKCLVPASERLSAKDLLKDPFLQVEN-------------------QKEPICD 347
DP++K FIEKCL S R+SA++LL DPFL++++ Q + D
Sbjct: 252 DPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPD 311
Query: 348 PLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS--LSTCTESNNGSPHCPVLEFQRMH--- 402
P S + R +G + S +Q S ++ E NG + P E + H
Sbjct: 312 YYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPA-ETEETHGIE 370
Query: 403 ----KNN------------EFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTA 446
+NN + ++G + DD + L LRIAD GRVRNI+F F +++DTA
Sbjct: 371 LFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTA 430
Query: 447 LSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDY 488
LSVA EMV +LD+ DH V IA ID I L+P W+P ++
Sbjct: 431 LSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRPGPEF 472
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1222), Expect = e-133, Method: Compositional matrix adjust.
Identities = 232/424 (54%), Positives = 298/424 (70%), Gaps = 38/424 (8%)
Query: 64 DADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ 123
+++ +FVE DP+GRY RY EVLGKGAFK VY+AFD+ GIEVAW++VK+DD DL
Sbjct: 7 NSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLD 66
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
+LYSEVHLLK+LK +++KFY SW+D + T+N+ITE+FTSGNLRQYRKKHK VD++ +K
Sbjct: 67 RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVI 242
W+RQIL GLVYLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA + + +A SVI
Sbjct: 127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186
Query: 243 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
GTPEFMAPELYEE+YN LVDIY+FGMC+LE+VTFEYPYSEC N AQI++KVTSGIKPA+L
Sbjct: 187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246
Query: 303 AKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP 362
V DPQ++ FIEKC+ S+RLSAK+LL DPFL+
Sbjct: 247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKC------------------------ 282
Query: 363 MSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLT 422
YK+ + + + NG +++ + + G + D ++ L
Sbjct: 283 ------------YKENTENVSSHKENGYNGNGIVDKLSDSEVGLLTVEGQRKDLNTIFLK 330
Query: 423 LRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLA-DHDVAFIAEFIDYLIMKLLPG 481
LRI DS G++RNIHF F +++DT+ SVA EMVE+LDL D D++ IA+ ID I +P
Sbjct: 331 LRITDSKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPD 390
Query: 482 WKPS 485
W PS
Sbjct: 391 WTPS 394
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1206), Expect = e-131, Method: Compositional matrix adjust.
Identities = 234/429 (54%), Positives = 301/429 (70%), Gaps = 18/429 (4%)
Query: 64 DADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ 123
D + +F E DP+ RY RY EVLGKGAFKTVYKAFD+ G+EVAW+++K+ D+L+ DL+
Sbjct: 13 DTEPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLE 72
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
+L SEV LLK+LK N++KFY SW+D K +N ITE+FTSG LRQYR KHK VD++ +K
Sbjct: 73 RLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALK 132
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVI 242
W+RQIL GLVYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA + +A S+I
Sbjct: 133 KWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSII 192
Query: 243 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
GTPEFMAPELY+EEYNELVDIY+FGMC+LE+VTFEYPY EC N AQI+KKV+ G KP+SL
Sbjct: 193 GTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSL 252
Query: 303 AKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS-LKMLRL 361
AK+ DP+++ FIEKC+ AS+RLSA++LL DPFL+ + +K + P+QS K
Sbjct: 253 AKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK------IFYPLQSNTKASDG 306
Query: 362 PMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNE--------FRLRGTK 413
S SSM D S++ + + + P + +H + +
Sbjct: 307 AGSSNSSMGYKYDRDASSMAIREHTGSFAEEHPSDRY--IHSTMDPQAAAGRIITVESQM 364
Query: 414 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 473
D ++ L LRIADS+G +NIHF F +++DT++SVA EMV QLDL D DV IAE ID
Sbjct: 365 KDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDA 424
Query: 474 LIMKLLPGW 482
I +P W
Sbjct: 425 EIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 719 | ||||||
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.920 | 0.955 | 0.656 | 0.0 | |
| 351721887 | 710 | with no lysine kinase 6 [Glycine max] gi | 0.961 | 0.973 | 0.592 | 0.0 | |
| 356560001 | 723 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.970 | 0.965 | 0.588 | 0.0 | |
| 449433018 | 663 | PREDICTED: probable serine/threonine-pro | 0.904 | 0.980 | 0.657 | 0.0 | |
| 449478217 | 713 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.892 | 0.900 | 0.642 | 0.0 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.847 | 0.974 | 0.633 | 0.0 | |
| 297745505 | 591 | unnamed protein product [Vitis vinifera] | 0.757 | 0.922 | 0.574 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.859 | 0.958 | 0.565 | 0.0 | |
| 224127975 | 425 | predicted protein [Populus trichocarpa] | 0.588 | 0.995 | 0.778 | 0.0 | |
| 255555709 | 585 | kinase, putative [Ricinus communis] gi|2 | 0.791 | 0.972 | 0.555 | 0.0 |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/676 (65%), Positives = 520/676 (76%), Gaps = 14/676 (2%)
Query: 54 SGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
+G EPPDA DFVE DP+ RYVRYDEVLGKGAFKTVYK FDE GIEVAW++V+I
Sbjct: 16 NGTYSALEPPDAKGDFVETDPTSRYVRYDEVLGKGAFKTVYKGFDEVDGIEVAWNQVRIA 75
Query: 114 DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
DVL+ P DL+KL+SEVHLL+SLK +N+++ SWVDDKKKT+NMITELFTSGNLRQYRKK
Sbjct: 76 DVLRSPKDLEKLHSEVHLLRSLKHENIMELCNSWVDDKKKTINMITELFTSGNLRQYRKK 135
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
HKNVD+K IKNWARQIL GLVYLH HNPPIIHRDLKCDNIFVNG++G VKIGDLGLAI M
Sbjct: 136 HKNVDMKAIKNWARQILQGLVYLHGHNPPIIHRDLKCDNIFVNGHNGVVKIGDLGLAIIM 195
Query: 234 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
QQPTA SVIGTPEFMA ELYEEEYNEL+DIYSFGMC+LEMVTFEYPYSEC+NPAQI+KKV
Sbjct: 196 QQPTATSVIGTPEFMATELYEEEYNELIDIYSFGMCMLEMVTFEYPYSECRNPAQIYKKV 255
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 353
TSGIKPASL V+DPQ+K FI KCLVPASERLSAK+LLKDPFLQ +N EP+ DPL LP
Sbjct: 256 TSGIKPASLGNVSDPQVKEFILKCLVPASERLSAKELLKDPFLQPQNLVEPVRDPLLLPN 315
Query: 354 QSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTK 413
Q K SGP SMDID+DYKQ+S STCT SNN PV E+QR HKN F+L+G +
Sbjct: 316 QYPKSSSATKSGPLSMDIDADYKQISSSTCTGSNNEGTRFPVPEYQREHKNKVFKLKGKE 375
Query: 414 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 473
+DD SVSLTLRIADSSGRV NIHFLFYLDSDTALSVA EMV+QL+LADHDVAFIAEFID+
Sbjct: 376 SDDNSVSLTLRIADSSGRVWNIHFLFYLDSDTALSVASEMVDQLELADHDVAFIAEFIDH 435
Query: 474 LIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVS 533
LIMKL PGWK S +YS + SFY+ S L N S PWD++ V S+ V+Q+ +S
Sbjct: 436 LIMKLSPGWKLSSNYSLNELTSFYTASAALEN---SVACPWDSVLTTVLSQPAVEQEALS 492
Query: 534 GPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQESQSSVASDIFVDDTST 588
G T P + A N +DN G SSPS +EDQ+SQ+S S+I V+D S+
Sbjct: 493 GMTTTPPEGSLQADDFNYNDNRDGAVFHINYHSSPSFGYMEDQDSQTSGVSEILVEDVSS 552
Query: 589 KNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSK 648
K+D+ SE DY+TD + K LNGY SE EL D Y KL+ N S GE I + + K S+
Sbjct: 553 KDDRISELPDYNTDGNCKYLNGYTSEPELRD-SYSLRKLERNDSGVGECIPMNENAKVSE 611
Query: 649 LTFPNLSTV----LSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYEHWFQELSKMKEEAL 703
FP LS +SS SSL L GK +D ELK+E+DAIEAQY++WF++LS+ +EEAL
Sbjct: 612 TPFPKLSGAPNDMSMTSSSSSSLYLVGKSMDTELKLELDAIEAQYQNWFRDLSRRREEAL 671
Query: 704 EASRKRWMAKKRLPVN 719
E+++KRW AKK+LPV+
Sbjct: 672 ESTKKRWTAKKKLPVH 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721887|ref|NP_001235945.1| with no lysine kinase 6 [Glycine max] gi|225348641|gb|ACN87282.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2113), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/732 (59%), Positives = 525/732 (71%), Gaps = 41/732 (5%)
Query: 1 MPLPFEIGGIRFLLDCLRIILRLQTSPFHPQFLKTKN-IKPII----AVFFLVAVWFLSG 55
MP+P +G IRFLL + P FL + + + PI+ AV L V S
Sbjct: 1 MPIPAAVG-IRFLLRSV------------PTFLHSNHELGPILMNSGAVLALPPV---SN 44
Query: 56 MLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVY------KAFDEFAGIEVAWSR 109
+ T EP D + DFVEKDP+GRY+R +E+LG+GAFKTVY + FDE GIEVAW++
Sbjct: 45 VFRTREPHDFEDDFVEKDPTGRYIRNNEILGRGAFKTVYDSDAYYRGFDEVDGIEVAWNQ 104
Query: 110 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 169
VKID ++ DL KLYSEV+LLKSLK +N++KFY SW+DDKKKTVNMITELFTSGNLRQ
Sbjct: 105 VKIDGLMHSVDDLAKLYSEVNLLKSLKHENIIKFYDSWIDDKKKTVNMITELFTSGNLRQ 164
Query: 170 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
YRKKHK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNIFVNGN GEVKIGDLGL
Sbjct: 165 YRKKHKYVEMKAIKGWARQILHGLVYLHSHKPPIIHRDLKCDNIFVNGNQGEVKIGDLGL 224
Query: 230 AIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 289
AI MQQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEMVT EYPYSEC+NPAQI
Sbjct: 225 AIVMQQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEMVTLEYPYSECQNPAQI 284
Query: 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPL 349
FKKVTSGIKPASL KV+DPQ+K FIEKCLVPASERLSA +LLKDPFLQVEN K+PI PL
Sbjct: 285 FKKVTSGIKPASLNKVSDPQLKDFIEKCLVPASERLSADELLKDPFLQVENPKDPILYPL 344
Query: 350 KLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRL 409
+ P ++L+ SG SMD+DSDYK S+S +ESN +PHCP+ E QR +KNN+FRL
Sbjct: 345 QPPSRTLRAYSFK-SGSLSMDMDSDYKPFSMSIYSESNQENPHCPIFEVQRTYKNNKFRL 403
Query: 410 RGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAE 469
+GTKND SVSLTLRIAD+ GRVRNIHFLFY D+DTA+SVA EMVE L+LADHDV FIAE
Sbjct: 404 KGTKNDVNSVSLTLRIADTCGRVRNIHFLFYPDTDTAVSVATEMVEHLELADHDVDFIAE 463
Query: 470 FIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQ 529
IDYLIMKLLP WKPS D+ S G LS Y + +G+T PW ++ +PSE V+ Q
Sbjct: 464 LIDYLIMKLLPWWKPSPDHCSCGELSPYCTNI---DGQTLMAWPWGSVSTSIPSELVIGQ 520
Query: 530 DVVSGPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLEDQESQSSVASDIFVDD 585
D SG P +D ++ ++ A G +S SL KLED+ SQ S AS++ +++
Sbjct: 521 DGFSGSDTTPKEDFVVSENSSVSKIANNATFEGDCNSSSLVKLEDRYSQGSRASEMIIEN 580
Query: 586 TSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVK 645
TS KND + +D S EL D+ +++CKLQ GE +++ +F K
Sbjct: 581 TSMKNDNCHDSND-----DLSSKCFSSSMSELRDVYFEDCKLQQTEYCVGEGVVINEFPK 635
Query: 646 NSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYEHWFQELSKMKEEALE 704
NS V +L SS S +S T +D+D LK ++D IEA Y+HW EL++M EALE
Sbjct: 636 NSGSVLGTSINVENLASSCSYVSSTEEDIDLGLKFKLDEIEAHYQHWIDELNEMMLEALE 695
Query: 705 ASRKRWMAKKRL 716
++R+RWMAKK+L
Sbjct: 696 STRRRWMAKKKL 707
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560001|ref|XP_003548284.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/731 (58%), Positives = 524/731 (71%), Gaps = 33/731 (4%)
Query: 7 IGGIRFLLDCLRIILR-------LQTSPFHPQFLKTKNIKPIIAVFFLVAVWFLSGMLGT 59
+ GIRFLL + L +Q + + ++ + AV L V S + T
Sbjct: 6 VVGIRFLLRSVPTFLHSNHKLGPIQXAQINKNTKRSNFLMNSGAVLALPPV---SNVFRT 62
Query: 60 AEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVY------KAFDEFAGIEVAWSRVKID 113
EP D + DFVEKDP+GRY+RY+E+LG+GAFKTVY + FDE GIEVAW++VKID
Sbjct: 63 REPHDFEDDFVEKDPTGRYIRYNEILGRGAFKTVYDSDAYYRGFDEVDGIEVAWNQVKID 122
Query: 114 DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
++ DL KLYSEV+LLKSLK +N++KFY SW+DDK+KTVNMITELFTSGNLR YRKK
Sbjct: 123 GLMHSVDDLAKLYSEVNLLKSLKHENIIKFYDSWIDDKQKTVNMITELFTSGNLRLYRKK 182
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
HK V++K IK WARQILHGLVYLHSH PPIIHRDLKCDNIFVNGN GEVKIGDLGLA+ M
Sbjct: 183 HKYVEMKAIKGWARQILHGLVYLHSHRPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAVVM 242
Query: 234 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
QQPTA+SVIGTPEFMAPELYEE Y ELVDIYSFGMCILEMVT EYPYSECKNPAQIFKKV
Sbjct: 243 QQPTAQSVIGTPEFMAPELYEEAYTELVDIYSFGMCILEMVTLEYPYSECKNPAQIFKKV 302
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 353
TSGIKPASL KV+DPQ+K FIEKCLVPASERLSA++LLKDPFLQVEN K+PI PL+ P
Sbjct: 303 TSGIKPASLNKVSDPQLKEFIEKCLVPASERLSAEELLKDPFLQVENPKDPILYPLQPPS 362
Query: 354 QSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTK 413
++L+ SG SMD+DSD K S+S C+ESN +PHCPV E QR + +EFRL+GTK
Sbjct: 363 RTLRAYSFK-SGSLSMDMDSDCKPFSMSICSESNQENPHCPVFEVQRTNNKHEFRLKGTK 421
Query: 414 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 473
NDD SVSLTLRIAD+ GRVRNIHFLFYLD+DTA+SVA EMVE L+LADHDV FIAE IDY
Sbjct: 422 NDDNSVSLTLRIADTCGRVRNIHFLFYLDTDTAVSVATEMVEHLELADHDVDFIAELIDY 481
Query: 474 LIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVS 533
LIMKLLP WKPS D+ S G LS YS + I G PW ++ +PSE + QD S
Sbjct: 482 LIMKLLPWWKPSPDHFSCGELSPYSTN-IDGQW------PWGSVLTSIPSELAIDQDGFS 534
Query: 534 GPTRNPSQDLAPAQGENLHDNAGG----GGISSPSLAKLEDQESQSSVASDIFVDDTSTK 589
G P +D ++ ++ N G +S SL KLED+ SQ S AS++ V++TS K
Sbjct: 535 GSDTTPKEDFVASEKSSVSKNDSNATFEGDCNSSSLVKLEDRYSQGSRASEMIVENTSMK 594
Query: 590 NDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKL 649
ND D + D S + L+ +SELE+G +++CKLQ GE +++ +F KNS
Sbjct: 595 NDNC---HDSNADVSSESLSNSMSELEIGGAYFEDCKLQPAEYCSGEGVVINEFPKNSGS 651
Query: 650 TFPNLSTVLSLTSSYSSLSLTGKDVD--ELKMEIDAIEAQYEHWFQELSKMKEEALEASR 707
V + T+S S +S T +D+ EL+ ++D IEA Y+HW EL KM EAL+++R
Sbjct: 652 VLGTSINVENPTNSCSYVSSTEEDIIDLELQFKLDEIEAHYQHWIDELKKMMLEALDSTR 711
Query: 708 KRWMAKKRLPV 718
+ W+AKK+L V
Sbjct: 712 RSWVAKKKLAV 722
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433018|ref|XP_004134295.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/666 (65%), Positives = 507/666 (76%), Gaps = 16/666 (2%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
E PD + EKDP+GRYVRYDE+LG+GAFKTVYKAFDE GIEVAW++V+ID LQ P
Sbjct: 2 ESPD---NAAEKDPTGRYVRYDEILGRGAFKTVYKAFDEVDGIEVAWNQVRIDGFLQSPE 58
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
DL+KLYSEVHLLKSLK +N++KFY SWVDDKKKTVNMITELFTSG+LRQYRKKHK+VD+K
Sbjct: 59 DLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKHVDMK 118
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240
IKNWARQIL GLVYLHSH+PPIIHRDLK DNIF+NGNHGEVKIGDLGLAI MQQPTARS
Sbjct: 119 AIKNWARQILRGLVYLHSHDPPIIHRDLKGDNIFINGNHGEVKIGDLGLAIVMQQPTARS 178
Query: 241 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
VIGTPEFMAPELYEEEYNELVD+YSFGMC+LEMVTFEYPYSECKNPAQIF+KVTSGIKPA
Sbjct: 179 VIGTPEFMAPELYEEEYNELVDVYSFGMCMLEMVTFEYPYSECKNPAQIFRKVTSGIKPA 238
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
SLAKV+DP+ FI KCLVP ERLSAK+LLKD FLQVEN KE +PL+L Q K +
Sbjct: 239 SLAKVSDPRTMEFINKCLVPVHERLSAKELLKDSFLQVENPKESARNPLQLSNQVSKSIN 298
Query: 361 LPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVS 420
LP SGP SMDID D K SLST ESN+GSP PV+EFQ M+KNNEFRLRG KNDD SV+
Sbjct: 299 LPKSGPISMDIDIDQKIHSLSTYAESNSGSPRFPVVEFQTMNKNNEFRLRGNKNDDNSVA 358
Query: 421 LTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLP 480
LTLRIADS+GRVRNIHF FYLDSDTALSVA EM EQL+L +HDV FIAEFID+LI KL+P
Sbjct: 359 LTLRIADSNGRVRNIHFTFYLDSDTALSVAAEMAEQLELINHDVDFIAEFIDFLITKLIP 418
Query: 481 GWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPS 540
WKP YSS+G LS +S P L + K+S S W ++ G + +V QD+ SG
Sbjct: 419 EWKPLSVYSSNGELSLFSAPPFLKSAKSSIGSAWGSILTG-SHDGLVAQDISSGLGCGTQ 477
Query: 541 QDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASE 595
+D ++ + + G I SSPSLA ED S +S A ++ VDD STK+ K +
Sbjct: 478 KDCLQSEEDGWTTDISAGHIFDTCPSSPSLANFEDLNSHASFALELLVDDCSTKSAKVFD 537
Query: 596 FSDYSTDRSYKDLNGYVSELELGDLCY-DECKLQGNYSEDGEDILLYQFVKNSKLTFP-- 652
S+ D S K + ++ELE Y E K Q N + G + F KNS ++ P
Sbjct: 538 CSN--IDGSSKGSSWSIAELEHHGSSYVVEDKFQRNVGDVGIFTPMDYFAKNSVVSMPAP 595
Query: 653 -NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYEHWFQELSKMKEEALEASRKRW 710
S V+SLTSS SSLSLT KD+D ELKMEIDAIE Y F ELS+M+EEALEA+R+RW
Sbjct: 596 SEASNVMSLTSSCSSLSLTDKDLDAELKMEIDAIETHYRQLFDELSRMREEALEATRRRW 655
Query: 711 MAKKRL 716
+AKK+L
Sbjct: 656 IAKKKL 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478217|ref|XP_004155253.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/674 (64%), Positives = 502/674 (74%), Gaps = 32/674 (4%)
Query: 53 LSGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI 112
+S + G+ E PD + EKDP+GRYVRYDE+LG+GAFKTVYKAFDE GIEVAW++V+I
Sbjct: 60 ISALFGSMESPD---NAAEKDPTGRYVRYDEILGRGAFKTVYKAFDEVDGIEVAWNQVRI 116
Query: 113 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK 172
D LQ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKKKTVNMITELFTSG+LRQYRK
Sbjct: 117 DGFLQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRK 176
Query: 173 KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232
KHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DNIF+NGNHGEVKIGDLGLAI
Sbjct: 177 KHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNIFINGNHGEVKIGDLGLAIV 236
Query: 233 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292
MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEMVTFEYPYSECKNPAQIF+K
Sbjct: 237 MQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEMVTFEYPYSECKNPAQIFRK 296
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLP 352
VTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLKD FLQVEN KE +PL+L
Sbjct: 297 VTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKDSFLQVENPKESARNPLQLS 356
Query: 353 IQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGT 412
Q K + LP SGP SMDID D K SLST ESN+GSP PV+EFQ M+KNNEFRLRG
Sbjct: 357 NQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRFPVVEFQTMNKNNEFRLRGN 416
Query: 413 KNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFID 472
KNDD SV+LTLRIADS+GRVRNIHF YLDSDTALSVA EM EQL+L +HDV FIAEFID
Sbjct: 417 KNDDNSVALTLRIADSNGRVRNIHFTXYLDSDTALSVAAEMAEQLELINHDVDFIAEFID 476
Query: 473 YLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVV 532
+LI KL+P WKP YSS+G L S W ++ G + +V QD+
Sbjct: 477 FLITKLIPEWKPLSVYSSNGELR----------------SAWGSILTG-SHDGLVAQDIS 519
Query: 533 SGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKLEDQESQSSVASDIFVDDTS 587
SG +D ++ + + G I SSPSLA ED S +S A ++ VDD S
Sbjct: 520 SGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLANFEDLNSHASFALELLVDDCS 579
Query: 588 TKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECKLQGNYSEDGEDILLYQFVKN 646
TK+ K + S+ D S K + ++ELE Y E K Q N + G + F KN
Sbjct: 580 TKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDKFQRNVGDVGIFTPMDYFAKN 637
Query: 647 SKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDAIEAQYEHWFQELSKMKEEA 702
S ++ P S V+SLTSS SSLSLT KD+D ELKMEIDAIE Y F ELS+M+EEA
Sbjct: 638 SVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEIDAIETHYRQLFDELSRMREEA 697
Query: 703 LEASRKRWMAKKRL 716
LEA+R+RW+AKK+L
Sbjct: 698 LEATRRRWIAKKKL 711
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/660 (63%), Positives = 490/660 (74%), Gaps = 51/660 (7%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
++ +VEKDP+GRYVR+ E+LGKGAFKTVYKAFDE GIE+AW++VKIDDVL+ P DL+KL
Sbjct: 9 EAAYVEKDPTGRYVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKL 68
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
YSEVHLLKSLK +N++KFY SWVDDKKKTVNMITELFTSG+LRQYRKKHKNVD+K IKNW
Sbjct: 69 YSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYRKKHKNVDMKAIKNW 128
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
ARQ+L GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI MQQPTARSVIGTP
Sbjct: 129 ARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTP 188
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELYEEEYNELVDIYSFGMC+LEMVTFEYPY+ECKNPAQI+KKVTSGIKPASL KV
Sbjct: 189 EFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIKPASLCKV 248
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSG 365
D QIK FI KCL PASERL AK+LLKDPF Q EN KEPI PL+LP +S K + L SG
Sbjct: 249 TDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKSIILSKSG 308
Query: 366 PSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRI 425
P SMDID D+ QLS ST TE NNGSP PVLEFQRM+K++EFRLR K +D S+SLTLR
Sbjct: 309 PFSMDIDPDHPQLSSSTSTE-NNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRT 367
Query: 426 ADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPS 485
DS G V+NIHF F LD+DT SV GEMVEQL+LA+H+VAFIA+FIDY+IM+LLPGWKP
Sbjct: 368 VDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPP 427
Query: 486 YDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAP 545
D GA S + P+LGNG
Sbjct: 428 RDDPLGGARSPNAEPPVLGNG--------------------------------------- 448
Query: 546 AQGENLHDN--AGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDR 603
N HD + G G SSP+LA EDQ+S +S D S KNDK F DY+
Sbjct: 449 ----NNHDCTISHGDGNSSPNLANAEDQDSLASAGLVTLTVDASKKNDKTVGFGDYNIGG 504
Query: 604 SYKDLN-GYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSL-T 661
+YK N G+ SE E D +++ KLQ N S E + +F K++ L+F +LS + ++ +
Sbjct: 505 NYKGSNGGHASEQESRDPYHEDYKLQRNNSSIEEFTPMNKFQKSTVLSFDDLSGLSNVRS 564
Query: 662 SSYSSLSLTGKDVDE---LKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKRLPV 718
+ S SL+ D+D+ LK E+DAI+ QY+HWFQELS+M+ EALEA++KRWM KK+L V
Sbjct: 565 LTCSCSSLSLADIDQDPGLKQELDAIDLQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745505|emb|CBI40585.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/668 (57%), Positives = 444/668 (66%), Gaps = 123/668 (18%)
Query: 52 FLSGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVK 111
F G++ + ++ +VEKDP+GRYVR+ E+LGKGAFKTVYKAFDE GIE+AW++VK
Sbjct: 3 FRHGLVMQGAEDEDEAAYVEKDPTGRYVRFKEILGKGAFKTVYKAFDEVDGIEIAWNQVK 62
Query: 112 IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR 171
IDDVL+ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKKKTVNMITELFTSG+LRQYR
Sbjct: 63 IDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKKTVNMITELFTSGSLRQYR 122
Query: 172 KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231
KKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI
Sbjct: 123 KKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 182
Query: 232 AMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291
MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTFEYPY+ECKNPAQI+K
Sbjct: 183 VMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYK 242
Query: 292 KVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKL 351
KVTSGIKPASL KV D QIK FI KCL PASERL AK+LLKDPF Q EN KEPI
Sbjct: 243 KVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPI------ 296
Query: 352 PIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRG 411
R+P+ P PVLEFQRM+K++EFRLR
Sbjct: 297 --------RVPL--------------------------HPDFPVLEFQRMYKSSEFRLRA 322
Query: 412 TKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFI 471
K +D S+SLTLR DS G V+NIHF F LD+DT SV GEMVEQL+LA+H+VAFIA+FI
Sbjct: 323 KKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFI 382
Query: 472 DYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDV 531
DY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 383 DYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG------------------------- 417
Query: 532 VSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTK 589
N HD + G G SSP+LA EDQ+S +S D S K
Sbjct: 418 ------------------NNHDCTISHGDGNSSPNLANAEDQDSLASAGLVTLTVDASKK 459
Query: 590 NDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSK 648
NDK F DY+ +YK N G+ SE E D +++ KLQ N S +D
Sbjct: 460 NDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQRNNSNIDQD----------- 508
Query: 649 LTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYEHWFQELSKMKEEALEASRK 708
P LK E+DAI+ QY+HWFQELS+M+ EALEA++K
Sbjct: 509 ---PG-----------------------LKQELDAIDLQYQHWFQELSRMRVEALEATKK 542
Query: 709 RWMAKKRL 716
RWM KK+L
Sbjct: 543 RWMTKKKL 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/663 (56%), Positives = 462/663 (69%), Gaps = 45/663 (6%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
DSDF EKDP+GRYVRY+E LGKGAFKTVYKAFDE GIEVAW +V+I+D+LQ P L++L
Sbjct: 10 DSDFEEKDPTGRYVRYNEFLGKGAFKTVYKAFDEVDGIEVAWGQVEIEDLLQSPQQLERL 69
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
YSEVHLLKSLK DN++KFY SWVDD KT+N+ITELFTSG+LRQYRKKHKNVD+K IKNW
Sbjct: 70 YSEVHLLKSLKHDNIIKFYNSWVDDTNKTINLITELFTSGSLRQYRKKHKNVDLKAIKNW 129
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
A+QIL GL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAI MQQPTARSVIGTP
Sbjct: 130 AKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 189
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELYEEEYNELVDIYSFGMCILE+VT EYPY+ECKNPAQI+KKV+SGIKPASL KV
Sbjct: 190 EFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIKPASLGKV 249
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKL--PIQSL----KML 359
+DPQ+K FIEKCLVPAS RLSA++LLKD F EN KEP+ + + + +QS ++
Sbjct: 250 SDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSSNFMPNLM 309
Query: 360 RLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSV 419
LP MD+D +YK+LS+ST +S +G+PH L+F+R +KNN F+LRG K DD S+
Sbjct: 310 NLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGEKIDDNSI 369
Query: 420 SLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLL 479
S+TL IAD GR +NIHF FYLDSDTALS+AGEMVEQLDL + DVA IAE ID +I +L+
Sbjct: 370 SMTLHIADPCGRAKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAELIDVMISELV 429
Query: 480 PGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNP 539
P WKP+++ GA S S +L NG TS P D+ A S+ V + ++S
Sbjct: 430 PTWKPAFESMLCGANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSD-AVTEHLISLSANGE 488
Query: 540 SQDLAPAQGENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSD- 598
Q + G+S+ +D + +S A+DI +D+ E SD
Sbjct: 489 EQSTV---------ESALSGMST------KDDATVASDANDI--KSLECPDDECYEASDR 531
Query: 599 --YSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKN---SKLTFPN 653
++ DR D + E + GN GE + + F K+ S + +
Sbjct: 532 CCFNGDRQVLDHER-----------HKEGRYNGNI---GEPVAMNGFTKDWEISCIESCS 577
Query: 654 LSTVLSLTSSYSSLSLTGKD-VDELKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMA 712
+ SS SLSL KD DELK+E+D I+ QY FQEL +M+EEA+E ++ RW+
Sbjct: 578 GMSNSLSLSSICSLSLADKDPSDELKLEVDTIDTQYHQCFQELLRMREEAIEKAKNRWIT 637
Query: 713 KKR 715
K R
Sbjct: 638 KSR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127975|ref|XP_002320210.1| predicted protein [Populus trichocarpa] gi|222860983|gb|EEE98525.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 660 bits (1703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/424 (77%), Positives = 367/424 (86%), Gaps = 1/424 (0%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
EP DA +D VEKDP+GRYVRYD+VLGKGAFKTVY+AFDE GIEVAW++V+IDDVL+ P
Sbjct: 2 EPSDAGADLVEKDPTGRYVRYDDVLGKGAFKTVYRAFDEVDGIEVAWNQVRIDDVLRSPE 61
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
D +KLYSEV+LL+SL+ +N++KF SWVDDK KT+NMITELFTSGNLRQYR+KH+N+DIK
Sbjct: 62 DFEKLYSEVYLLRSLRHENIIKFSNSWVDDKNKTINMITELFTSGNLRQYRRKHRNIDIK 121
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240
IKNWARQIL GLVYLH H+PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI MQ PTA+S
Sbjct: 122 AIKNWARQILRGLVYLHGHSPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQNPTAKS 181
Query: 241 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
VIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VT YPYSEC+N AQI+KKVTSGIKPA
Sbjct: 182 VIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCNYPYSECRNAAQIYKKVTSGIKPA 241
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQ-KEPICDPLKLPIQSLKML 359
SL V + QIK FIEKCL+PASERLSAK+LLK PFLQ+E E ICDPL +P Q L
Sbjct: 242 SLKTVGNTQIKEFIEKCLLPASERLSAKELLKHPFLQLEIPILEQICDPLPVPDQFPISL 301
Query: 360 RLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSV 419
LP SGP MD+D D KQLS STCT SNNGSP PVLE+QR HKNNEF L+G KNDD S
Sbjct: 302 SLPKSGPLFMDMDIDEKQLSESTCTGSNNGSPKSPVLEYQRAHKNNEFGLKGMKNDDNSA 361
Query: 420 SLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLL 479
SLTLRI+D GRVRNIHF+FYLDSDTA+SVA EMVEQL+LADHDVAFIAE ID LI+KLL
Sbjct: 362 SLTLRISDLGGRVRNIHFIFYLDSDTAISVASEMVEQLELADHDVAFIAELIDSLIVKLL 421
Query: 480 PGWK 483
PGWK
Sbjct: 422 PGWK 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/663 (55%), Positives = 441/663 (66%), Gaps = 94/663 (14%)
Query: 64 DADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ 123
D DS+F EKDP+GRYVRYDEVLGKGAFKTVYKAFDE GIEVAW++V ++DVLQ P L+
Sbjct: 8 DDDSEFEEKDPTGRYVRYDEVLGKGAFKTVYKAFDEINGIEVAWNQVSVEDVLQSPDQLE 67
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
+LYSEVHLLKSLK +N++KFY SWVDD KT+NMITELFTSG+LR+YRKKHKNVDIK IK
Sbjct: 68 RLYSEVHLLKSLKHENIMKFYNSWVDDNNKTINMITELFTSGSLRKYRKKHKNVDIKAIK 127
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243
NWARQIL GL YLHSHNPPIIHRDLKCDN+FVNGN+GEVKIGDLGLA MQQPTARSVIG
Sbjct: 128 NWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTARSVIG 187
Query: 244 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
TPEFMAPELYEEEYNELVDIYSFGMCILEMVT EYPYSECKNPAQI+KKVTSGIKPASL
Sbjct: 188 TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIKPASLC 247
Query: 304 KVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPM 363
KVNDP +K FIEKC+VPAS RL A +LLKDPFL EN KE + L LP LK +
Sbjct: 248 KVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQVSRGQ 307
Query: 364 SGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTL 423
S MDIDS++K+LS+ +CT+S + S H EFQR+ NEFRLRG KNDD ++SLTL
Sbjct: 308 SESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNTISLTL 367
Query: 424 RIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 483
RI D G V+NIHF FYLDSDT LS+A EMVEQLDL++ DVA IAE ID LI+KL+P
Sbjct: 368 RIVDRCGGVKNIHFTFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALILKLVPHL- 426
Query: 484 PSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDL 543
S SG+ S S P+ + + + K D +
Sbjct: 427 -----SQSGSTS-------------SMPNGFSELHNDATFKVASKHDFL----------- 457
Query: 544 APAQGENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVD-------DTSTKNDKASEF 596
LA L+ QE+Q S+ S++ + D ST S
Sbjct: 458 --------------------PLADLKGQETQDSLLSELSTELPLTVASDASTNKPLGS-- 495
Query: 597 SDYSTDRSYKDLNGYVSELELGDLCYDECKLQGNYSEDGEDILLY-QFVKNSKLTFPNLS 655
SDY+ D N Y E G ++ G+ Y ++ K+S+ P
Sbjct: 496 SDYTI-----DFNTY----EFG----------SDFMMHGDGTFKYGKYTKHSEKHLP--- 533
Query: 656 TVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKR 715
S G+ D+LK+E+DAI+ QY F+ELS M+EEA+E ++K+W+ +K+
Sbjct: 534 ------------SAKGEVQDDLKLELDAIDMQYNQCFRELSMMREEAIENAKKKWITRKK 581
Query: 716 LPV 718
+P
Sbjct: 582 VPA 584
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 719 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.641 | 0.818 | 0.596 | 8.1e-153 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.579 | 0.735 | 0.631 | 2.5e-147 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.568 | 0.780 | 0.629 | 6.9e-145 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.577 | 0.745 | 0.618 | 3.4e-143 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.385 | 0.395 | 0.679 | 8.1e-125 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.381 | 0.531 | 0.690 | 7.2e-124 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.593 | 0.867 | 0.520 | 2.8e-114 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.470 | 0.615 | 0.551 | 3.9e-110 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.375 | 0.472 | 0.638 | 6.5e-106 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.378 | 0.866 | 0.594 | 1.8e-87 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1398 (497.2 bits), Expect = 8.1e-153, Sum P(2) = 8.1e-153
Identities = 281/471 (59%), Positives = 344/471 (73%)
Query: 54 SGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
SG LG + ++DF EKDPSGRY+RYD+VLG+GAFKTVYKAFDE GIEVAW+ V I+
Sbjct: 5 SGFLGQISSME-EADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIE 63
Query: 114 DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K KT+NMITELFTSG+LR YRKK
Sbjct: 64 DVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKK 123
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
H+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA +
Sbjct: 124 HRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVL 183
Query: 234 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPY+EC+N AQI+KKV
Sbjct: 184 QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKV 243
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 353
TS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KDPFL + K+ L
Sbjct: 244 TSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LASSS 301
Query: 354 QSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTK 413
S K +R P MD+D + + S+S SN P +E QR+ +N EFRLRG +
Sbjct: 302 TSSKYVRPPQLEHLPMDVDHNENK-SVS----SNEDYPWSQTIELQRIAENKEFRLRGER 356
Query: 414 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 473
+DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EMVE+L L +V IA+ ID
Sbjct: 357 SDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDD 416
Query: 474 LIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSPWDAMGAGVPSE 524
IM+LL S+ +S L+ N +T +A G + S+
Sbjct: 417 FIMQLLSDRTSSHHNQNSPRLTHEDHEA--ANQQTVNSKDEEAAGQSMKSD 465
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1392 (495.1 bits), Expect = 2.5e-147, Sum P(2) = 2.5e-147
Identities = 274/434 (63%), Positives = 334/434 (76%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
EPPD + +E DP+ RY+RY EV+GKGAFKTVYKAFDE GIEVAW++V+IDDVLQ P
Sbjct: 12 EPPDPE--VLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSPN 69
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
L++LYSEV LLKSLK +N+++FY SW+DDK KTVN+ITELFTSG+LR YRKKH+ V++K
Sbjct: 70 CLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMK 129
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240
+KNWARQIL GL YLH PPIIHRDLKCDNIF+NGNHGEVKIGDLGLA M+Q A+S
Sbjct: 130 AVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKS 189
Query: 241 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
VIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTF+YPY ECKN AQI+KKV+SGIKPA
Sbjct: 190 VIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPA 249
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE----NQKEPICDPLKLPIQSL 356
SL++V DP++K FIEKCL+PASERLSAK+LL DPFLQ+ N P+ D + +P +
Sbjct: 250 SLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPD-IVMPKEGA 308
Query: 357 KMLRLPMS-GP------SSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFRL 409
R MS GP ++ ID D + +L T S+N C +E +R + N F L
Sbjct: 309 FGDRCLMSEGPPTTRPSKTLSIDLD-EDSNLPIVTFSDNSGSRC--IEVRRAKRGNFFVL 365
Query: 410 RGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAE 469
+G +ND+ SVSL LRI D +GRVRNIHFLFY + DTA V+ EMVEQL+L D +V FIAE
Sbjct: 366 KGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAE 425
Query: 470 FIDYLIMKLLPGWK 483
ID L++ ++P WK
Sbjct: 426 LIDILLVNMIPTWK 439
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 6.9e-145, Sum P(2) = 6.9e-145
Identities = 262/416 (62%), Positives = 317/416 (76%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
++DFV+KDP+GRY+RY++VLG+GAFKTVYKAFDE GIEVAW+ + I+DVLQ+PG L +L
Sbjct: 3 EADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRL 62
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
YSEVHLL SLK DN++K + SWVDD K++NMITELFTSG+L YRKKH+ VD K I NW
Sbjct: 63 YSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNW 122
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
ARQIL GL YLHS PP+IHRDLKCDNIFVNGN G+VKIGDLGLA MQQPTARSVIGTP
Sbjct: 123 ARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTP 182
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPY EC+N AQI+KKVTSGIKP SL+KV
Sbjct: 183 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKV 242
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSG 365
+DPQ+K FIEKCL+PA R +A +LLKD L V+ K+ + K P
Sbjct: 243 DDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNT--TFKPAMPPQCE 300
Query: 366 PSSMDIDSDYKQLSLSTCTESNNGSPHCPVL---EFQRMHKNNEFRLRGTKNDDTSVSLT 422
MD++ K S+S C+ + + S C +L E QR+ ++ EF+L G + DD + S+
Sbjct: 301 YRPMDVEYK-KNTSVSICSSAKS-SQECALLQTMEVQRVAESTEFKLSGERRDDVAASMA 358
Query: 423 LRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKL 478
LRIA SSG+ R + F F L +DTA +V GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 359 LRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1354 (481.7 bits), Expect = 3.4e-143, Sum P(2) = 3.4e-143
Identities = 269/435 (61%), Positives = 331/435 (76%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
EPPD + +E DP+ RY+RY EV+GKGA KTV+K FDE GIEVAW++V+IDD+LQ P
Sbjct: 12 EPPDPE--VLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPD 69
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
L++LYSEV LLKSLK N+++FY SW+DDK KTVN+ITELFTSG+LRQYRKKH+ V++K
Sbjct: 70 CLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMK 129
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240
+K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGNHGEVKIGDLGLA M+Q A+S
Sbjct: 130 AVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKS 189
Query: 241 VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
VIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVTFEYPY EC+N AQI+KKV+SGIKPA
Sbjct: 190 VIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPA 249
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE----NQKEPICDPLKLPIQSL 356
SL+KV DP++ FIEKCL+PASERLSA++LL D FL V N P+ D + +P +
Sbjct: 250 SLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPD-IVMPKEGS 308
Query: 357 KMLRLPMS-GPS-------SMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFR 408
R MS GP SM++D D +L SNN +C +E +R + N F
Sbjct: 309 FGERCLMSEGPPNARNRTMSMNLDEDN---NLPIVISSNNSGTNC--IEVRRAKRGNFFV 363
Query: 409 LRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIA 468
L+G +ND+ SVSL LRI D +GRVRNIHFLF+ + DTA +V+ EMVEQL+L D +V FIA
Sbjct: 364 LKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIA 423
Query: 469 EFIDYLIMKLLPGWK 483
E ID L++ L+P WK
Sbjct: 424 ELIDVLLVNLIPNWK 438
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
Identities = 189/278 (67%), Positives = 231/278 (83%)
Query: 63 PDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
PD S+FVE DP+GRY RY+EVLGKGA KTVY+AFDE+ GIEVAW++VK+ D LQ P DL
Sbjct: 9 PDY-SEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 182
++LY E+HLLK+LK N++KFY SWVD + +N +TELFTSG LRQYR +HK V+I+ +
Sbjct: 68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 242
K+W RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA +++ A +
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCV 187
Query: 243 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
GTPEFMAPE+YEE YNELVDIYSFGMCILEMVTF+YPYSEC +PAQI+KKV SG KP +L
Sbjct: 188 GTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDAL 247
Query: 303 AKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVEN 340
KV DP++K FIEKCL S R+SA++LL DPFL++++
Sbjct: 248 YKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDD 285
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 7.2e-124, Sum P(2) = 7.2e-124
Identities = 190/275 (69%), Positives = 233/275 (84%)
Query: 64 DADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ 123
+++ +FVE DP+GRY RY EVLGKGAFK VY+AFD+ GIEVAW++VK+DD DL
Sbjct: 7 NSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDLD 66
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
+LYSEVHLLK+LK +++KFY SW+D + T+N+ITE+FTSGNLRQYRKKHK VD++ +K
Sbjct: 67 RLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALK 126
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVI 242
W+RQIL GLVYLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA + + +A SVI
Sbjct: 127 KWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVI 186
Query: 243 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
GTPEFMAPELYEE+YN LVDIY+FGMC+LE+VTFEYPYSEC N AQI++KVTSGIKPA+L
Sbjct: 187 GTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAAL 246
Query: 303 AKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQ 337
V DPQ++ FIEKC+ S+RLSAK+LL DPFL+
Sbjct: 247 LNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLK 281
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 229/440 (52%), Positives = 298/440 (67%)
Query: 56 MLGTAEPPDAD-SDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD 114
M+ ++D S++VE DP+GRY RY+EVLGKG+ KTVY+ FDE+ GIEVAW++VK+ D
Sbjct: 1 MMNNLSHLESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYD 60
Query: 115 VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH 174
LQ P +L++LY E+HLLK+LK +++KFY SWVD + +N +TE+FTSG LRQYR KH
Sbjct: 61 FLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKH 120
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
K V+I+ +KNW RQIL GL YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA +Q
Sbjct: 121 KRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQ 180
Query: 235 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294
A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVTF+YPYSEC +PAQI+K+V
Sbjct: 181 HSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVI 240
Query: 295 SGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQV-ENQKEPICDPLKLPI 353
SG KP L KV DP+++GFIEKCL S RLSA +LL D FL + E+ + L
Sbjct: 241 SGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLID 300
Query: 354 QSLKMLRLPMSGPS-SMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNE------ 406
++ LR P S S Y Q + S +LEFQ E
Sbjct: 301 EAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFG 360
Query: 407 ---FRLRGTKNDD-TSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADH 462
++G + D+ + L L+ + G VRNI+F F +++DTA+SVA EMVE+L++ D
Sbjct: 361 SVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDR 420
Query: 463 DVAFIAEFIDYLIMKLLPGW 482
DV IA ID I L+P W
Sbjct: 421 DVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 3.9e-110, Sum P(2) = 3.9e-110
Identities = 189/343 (55%), Positives = 247/343 (72%)
Query: 69 FVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE 128
+VE DPSGRY R+ EVLGKGA KTVYKAFD+ G+EVAW++VK+++V + P LQ+LYSE
Sbjct: 15 YVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSE 74
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 188
VHLLK+L ++++++ SW+D ++T N ITELFTSG LR+YR+K++ VDI+ IK+WARQ
Sbjct: 75 VHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQ 134
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEF 247
IL+GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA ++ A SVIGTPEF
Sbjct: 135 ILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEF 194
Query: 248 MAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
MAPELYEE+YNELVDIYSFGMC+LEM+T EYPYSEC NPAQI+KKVTSG P S +
Sbjct: 195 MAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQH 254
Query: 308 PQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPS 367
+ + F+ KCL S RL AK+LL DPFL ++++ + +LP Q L + L +G
Sbjct: 255 TEAQRFVGKCLETVSRRLPAKELLADPFLAATDERD-LAPLFRLP-QQLAIQNLAANGTV 312
Query: 368 SMDIDS--DYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEFR 408
+ S D + + + T N H L+ Q + + R
Sbjct: 313 VEHLPSTTDPTRTTDMSITGKMNSEDHTIFLQVQILDGDGHMR 355
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 945 (337.7 bits), Expect = 6.5e-106, Sum P(2) = 6.5e-106
Identities = 173/271 (63%), Positives = 219/271 (80%)
Query: 67 SDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLY 126
+++VE DP+GRY R+ E+LG+GA KTVYKA DE GIEVAWS+VK+ +VL+ DLQ+LY
Sbjct: 7 AEYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLY 66
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
SEVHLL +L ++++FY SW+D T+N ITELFTSG LRQY+ K+ +DI+ IK+WA
Sbjct: 67 SEVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWA 126
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTP 245
RQIL GLVYLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA ++ +A S+IGTP
Sbjct: 127 RQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTP 186
Query: 246 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305
EFMAPELYEE YNEL+D+YSFGMC LEM+T E+PYSEC +PAQI+KKV G P + +V
Sbjct: 187 EFMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRV 246
Query: 306 NDPQIKGFIEKCLVPASERLSAKDLLKDPFL 336
D + + FI KCLV AS+R+SAK+LL+DPFL
Sbjct: 247 GDIEAQRFIGKCLVSASKRVSAKELLQDPFL 277
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
Identities = 163/274 (59%), Positives = 210/274 (76%)
Query: 64 DADSD-FVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
D DS+ FVE DP+GRY RY E+LG GA K VY+AFD+ GIEVAW++VK+ P
Sbjct: 15 DKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMT 74
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 182
++LYSEV LLK+LK+ N++ YK W D++ T+N ITE+ TSGNLR+YRKKH++V ++ +
Sbjct: 75 ERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRAL 134
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV 241
K W++QIL GL YLH+H+P IIHRDL C NIFVNGN G+VKIGDLGLA I + A S+
Sbjct: 135 KKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSI 194
Query: 242 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 301
+GTPEFMAPELYEE Y E+VDIYS+GMC+LE+V+ E PYSEC + A+I+K+V+ G+KP +
Sbjct: 195 LGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEA 254
Query: 302 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 335
L KVNDP+ K FIEKC+ R SA +LL DPF
Sbjct: 255 LNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5191 | 0.8303 | 0.9754 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 719 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-64 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-54 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-40 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-37 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-37 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-34 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-25 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 9e-66
Identities = 89/259 (34%), Positives = 139/259 (53%), Gaps = 14/259 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG+G+F VY A D+ G VA +K+ ++ D +++ E+ +LK LK N+V+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVA---IKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
Y + D+ K + ++ E G+L KK + + + RQIL L YLHS
Sbjct: 62 LYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPE-LYEEEYNEL 260
I+HRDLK +NI ++ G VK+ D GLA + + +GTPE+MAPE L + Y +
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 261 VDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCL 318
VDI+S G IL E++T + P+ ++FKK+ P + + P+ K I K L
Sbjct: 177 VDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 319 VP-ASERLSAKDLLKDPFL 336
V +RL+A++ L+ PF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 97/261 (37%), Positives = 146/261 (55%), Gaps = 13/261 (4%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
E+LG+G+F +VY A D+ G +A VK ++ +L+ L E+ +L SL+ N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMA---VKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
++Y S D++K T+N+ E + G+L KK + VI+ + RQIL GL YLHS+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EE 256
I+HRD+K NI V+ + G VK+ D G A + SV GTP +MAPE+ EE
Sbjct: 122 -IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 257 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
Y DI+S G ++EM T + P+SE NP K+ S +P + + + K F+ K
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239
Query: 317 CLVP-ASERLSAKDLLKDPFL 336
CL +R +A +LL+ PFL
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-55
Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 16/263 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G+F TVYKA + G VA +K + Q E+ +L+ L N+V+
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
++ D + ++ E G+L Y + + K A QIL GL YLHS+
Sbjct: 63 LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE--LYEEEYN 258
IIHRDLK +NI ++ +G VKI D GLA + + + +GTP +MAPE L Y
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI--KGFI 314
VD++S G+ + E++T + P+S Q + +++ K + K I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 315 EKCLVP-ASERLSAKDLLKDPFL 336
+KCL S+R +A+++L+ P+
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 77/256 (30%), Positives = 123/256 (48%), Gaps = 47/256 (18%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG+G F TVY A D+ G +VA +KI L++L E+ +LK L N+VK Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVA---IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
+ D+ + ++ E G+L+ ++ + I QIL GL YLHS+ I
Sbjct: 58 GVFEDEN--HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYEE--EYNE 259
IHRDLK +NI ++ ++G+VK+ D GL+ + ++++GTP +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319
DI+S G+ + E+ P++K I K L
Sbjct: 174 KSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199
Query: 320 P-ASERLSAKDLLKDP 334
+R SAK++L+
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 96/288 (33%), Positives = 151/288 (52%), Gaps = 25/288 (8%)
Query: 60 AEPPDADSDFVEK-DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
E A D V + DP Y E +G+GA VYKA D G EVA ++++
Sbjct: 2 EELKAALKDIVSEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRK---- 56
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKH 174
+ + + +E+ ++K K N+V +Y S++ + ++ E G+L Q +
Sbjct: 57 -QNKELIINEILIMKDCKHPNIVDYYDSYLVGD--ELWVVMEYMDGGSLTDIITQNFVRM 113
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 232
I + R++L GL YLHS N +IHRD+K DNI ++ + G VK+ D G A +
Sbjct: 114 NEPQIAYV---CREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQLT 167
Query: 233 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IF 290
++ SV+GTP +MAPE+ + ++Y VDI+S G+ +EM E PY + P + +F
Sbjct: 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALF 226
Query: 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
T GI P + P+ K F+ KCLV +R SA++LL+ PFL+
Sbjct: 227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 88/265 (33%), Positives = 140/265 (52%), Gaps = 19/265 (7%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
E +GKG F VYKA + G EVA +K+ L+ +K+ +E+ +LK K
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVA---IKVIK-LESKEKKEKIINEIQILKKCKH 56
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV----DIKVIKNWARQILHGL 193
N+VK+Y S++ + + ++ E + G+L+ K I + +++L GL
Sbjct: 57 PNIVKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGL 111
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE- 251
YLHS+ IIHRD+K NI + + GEVK+ D GL+ + AR +++GTP +MAPE
Sbjct: 112 EYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
+ + Y+ DI+S G+ +E+ + PYSE +FK T+G + + K
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228
Query: 312 GFIEKCLVPASE-RLSAKDLLKDPF 335
F++KCL E R +A+ LLK PF
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 4e-47
Identities = 89/262 (33%), Positives = 139/262 (53%), Gaps = 17/262 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVV 141
E+LG G+F +VY+ + G A V + D Q +++L E+ LL L+ N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
++ + ++ + + EL G+L + KK+ + VI+ + RQIL GL YLH N
Sbjct: 66 QYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELY--EEEYN 258
+HRD+K NI V+ N G VK+ D G+A ++ A+S G+P +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDPQIKGFIE 315
DI+S G +LEM T + P+S+ + A +FK S P L+ + K FI
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFIL 236
Query: 316 KCL-VPASERLSAKDLLKDPFL 336
KCL S R +A +LL+ PF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 77/268 (28%), Positives = 137/268 (51%), Gaps = 18/268 (6%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+Y + +GKG+F VY + G + + + + + +EV +LK L
Sbjct: 1 KYEII-KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLN 57
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI----KVIKNWARQILHG 192
N++K+Y+S+ + K + ++ E G+L Q KK K + I +W Q+
Sbjct: 58 HPNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAP 250
L YLHS I+HRD+K NIF+ N G VK+GD G++ + A++V+GTP +++P
Sbjct: 116 LKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
EL + + YN DI+S G + E+ T ++P+ E +N ++ K+ G P ++ + +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYPPIPSQYSS-E 230
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFL 336
++ + L ER S +L+ PF+
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 79/261 (30%), Positives = 136/261 (52%), Gaps = 15/261 (5%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
VLG+G+ VYK + G A ++ +D + ++L E+ L+S + VVK
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCESPYVVKC 64
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPP 202
Y ++ K+ ++++ E G+L KK + V+ ARQIL GL YLH+ +
Sbjct: 65 YGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-- 120
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNE 259
IIHRD+K N+ +N GEVKI D G++ ++ + +GT +M+PE + E Y+
Sbjct: 121 IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 260 LVDIYSFGMCILEMVTFEYPYS--ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317
DI+S G+ +LE ++P+ + ++ + + G P+ A+ P+ + FI C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 318 LVP-ASERLSAKDLLKDPFLQ 337
L +R SA +LL+ PF++
Sbjct: 240 LQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 83/258 (32%), Positives = 136/258 (52%), Gaps = 13/258 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+++G+GAF VYK + G VA ++ ++ + + L+ + E+ LLK+LK N+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVK 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ S ++ +I E +G+LRQ KK ++ + Q+L GL YLH
Sbjct: 64 YIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-- 119
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNE 259
+IHRD+K NI + G VK+ D G+A + SV+GTP +MAPE+ E +
Sbjct: 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319
DI+S G ++E++T PY + A +F+ V P L + P++K F+ +C
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQ 236
Query: 320 P-ASERLSAKDLLKDPFL 336
+ R +AK LLK P++
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 32/268 (11%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
E LG+G++ +VYKA + G VA V ++ DLQ++ E+ +LK +V
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIV 61
Query: 142 KFYKSWVDDKKKTVNMITELFTSGN----LRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
K+Y S+ K + ++ E +G+ ++ K +I I Q L GL YLH
Sbjct: 62 KYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI---LYQTLKGLEYLH 116
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEE 255
S+ IHRD+K NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E
Sbjct: 117 SNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 256 E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVND--PQ 309
YN DI+S G+ +EM + PYS+ IF I P +L+ P+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPE 228
Query: 310 IKGFIEKCLV-PASERLSAKDLLKDPFL 336
F++KCLV ER SA LL+ PF+
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 88/264 (33%), Positives = 142/264 (53%), Gaps = 14/264 (5%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDD 138
R ++LG+GAF VY +D G E+A +V D D + ++ L E+ LLK+L+ +
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V++Y DD+ ++ M E G+++ K + + V + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDDETLSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELY 253
+ I+HRD+K NI + G VK+GD G + I +SV GTP +M+PE+
Sbjct: 123 NM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 254 E-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
E Y D++S G ++EM+T + P++E + A IFK T P + V P +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARN 238
Query: 313 FIEKCLV-PASERLSAKDLLKDPF 335
F+ + V A +R SA++LL+ F
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 4e-39
Identities = 89/266 (33%), Positives = 147/266 (55%), Gaps = 11/266 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDD 138
R ++LG+GAF VY +D G E+A +V+ D + + ++ L E+ LLK+L+ +
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V++Y D +KT+ + E G+++ K + + V + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELY 253
+ I+HRD+K NI + + G VK+GD G + I M RSV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 254 E-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
E Y D++S G ++EM+T + P++E + A IFK T P + +++ +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARD 240
Query: 313 FIEKCLVPASERLSAKDLLKDPFLQV 338
F+ V A R SA++LL+ PF Q+
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 91/265 (34%), Positives = 144/265 (54%), Gaps = 21/265 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G G F VY A + G +A ++I D P ++++ E+ +L+ LK N+VK+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
V +K V + E + G L + + + +D VI+ + Q+L GL YLHSH I+
Sbjct: 66 GVEVHREK--VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELY----E 254
HRD+K NIF++ N G +K+GD G A+ ++ T S+ GTP +MAPE+
Sbjct: 122 HRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGF 313
+ + DI+S G +LEM T + P+SE N QI V +G KP + P+ K F
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 314 IEKCLV--PASERLSAKDLLKDPFL 336
+++CL P +R +A +LL+ PF+
Sbjct: 241 LDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 81/265 (30%), Positives = 139/265 (52%), Gaps = 16/265 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +GKG+F TV K + G + W +ID + Q+L SEV++L+ LK N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+Y +D +T+ ++ E G+L ++ +K+ K ++ + I Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 199 HNPP---IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-L 252
+ P ++HRDLK NIF++ N+ VK+GD GLA + + A++ +GTP +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
Y+E DI+S G I E+ P+ +N Q+ K+ G + ++
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR-RIPYRYSSELNE 240
Query: 313 FIEKCL-VPASERLSAKDLLKDPFL 336
I+ L V +R S ++LL+ P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 88/293 (30%), Positives = 142/293 (48%), Gaps = 29/293 (9%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+ E +GKG+F VYKA D+ VA +K+ D+ + +++ + E+ L +
Sbjct: 2 LFTLL-ECIGKGSFGEVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
+ K+Y S++ K + M E G+ K K +D I R++L GL YL
Sbjct: 58 SPYITKYYGSFLKGSKLWIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYL 114
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY- 253
H IHRD+K NI ++ G+VK+ D G++ + ++ + +GTP +MAPE+
Sbjct: 115 HEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVN-DPQ 309
+ Y+E DI+S G+ +E+ E P S+ +P +V I P SL
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKP 226
Query: 310 IKGFIEKCLV--PASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
K F+ CL P ER SAK+LLK F ++ K+ L L I+ +K +
Sbjct: 227 FKDFVSLCLNKDPK-ERPSAKELLKHKF--IKKAKKT--SYLTLLIERIKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 6e-37
Identities = 87/265 (32%), Positives = 145/265 (54%), Gaps = 11/265 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDD 138
R ++LG+GAF VY +D G E+A +V+ D + + ++ L E+ LLK+L +
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V++Y D ++T+++ E G+++ K + + V + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELY 253
+ I+HRD+K NI + + G VK+GD G + I + +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 254 E-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
E Y DI+S G ++EM+T + P++E + A IFK T P V+D +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRD 240
Query: 313 FIEKCLVPASERLSAKDLLKDPFLQ 337
F+++ V A R SA +LL+ F+
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 3e-36
Identities = 88/263 (33%), Positives = 144/263 (54%), Gaps = 11/263 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDD 138
R ++LG+GAF VY +D G E+A +V D D + ++ L E+ LLK+L+ D
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V++Y D ++K +++ E G+++ K + + V + + RQIL G+ YLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELY 253
+ I+HRD+K NI + + G VK+GD G + I M +SV GTP +M+PE+
Sbjct: 125 NM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 254 E-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
E Y D++S ++EM+T + P++E + A IFK T KP V+D +
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 313 FIEKCLVPASERLSAKDLLKDPF 335
F+++ V R +A+ LL+ PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 76/244 (31%), Positives = 129/244 (52%), Gaps = 14/244 (5%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+GKG F VYKA G VA +V+I +++ Q E+ LLK L NV+K+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
S++++ + +N++ EL +G+L + ++K+ + + + I + Q+ L ++HS
Sbjct: 69 ASFIENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEY 257
I+HRD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 258 NELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
N DI+S G + EM + P Y + N + KK+ P A +++ + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 317 CLVP 320
C+ P
Sbjct: 244 CINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 48/290 (16%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG+G + VYKA D+ G VA ++++D+ + G E+ LLK LK N+VK
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVK 62
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
++K + ++ E + +L++Y K+ + +IK+ Q+L GL Y HSH
Sbjct: 63 LLDVIHTERK--LYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPELY--EE 255
I+HRDLK NI +N + G +K+ D GLA I ++ T V T + APE+ +
Sbjct: 119 -ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSK 174
Query: 256 EYNELVDIYSFGMCILEMVTF--------------------------EYP-YSECKNPAQ 288
Y+ VDI+S G EM+T +P ++ +
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234
Query: 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 336
F K + DP+ + K L PA +R+SAK+ LK P+
Sbjct: 235 TFPKFP-PKDLEKVLPRLDPEGIDLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 36/273 (13%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ + LG+GAF VYK + +EVA +K D Q +++ E +++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ---QIEEFLREARIMRK 57
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHG 192
L N+VK +++ + ++ E G+L Y +K++ ++ + ++A QI G
Sbjct: 58 LDHPNIVKLL-GVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMA 249
+ YL S N IHRDL N V N VKI D GL+ + V G +MA
Sbjct: 116 MEYLESKN--FIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PA 300
PE L E ++ D++SFG+ + E+ T E PY N A++ + + G + P
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPP 231
Query: 301 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
L K+ + +C +R + +L++
Sbjct: 232 ELYKL--------MLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 83/270 (30%), Positives = 128/270 (47%), Gaps = 27/270 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
EV+G GA VY A +VA +K D+ + + +L EV + NVVK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLR---QYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+Y S+V + + M + G+L + +D +I +++L GL YLHS+
Sbjct: 64 YYTSFVVGDELWLVM--PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS------VIGTPEFMAPELY 253
IHRD+K NI + G G VKI D G++ ++ R+ +GTP +MAPE+
Sbjct: 122 G--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 254 EEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-----AKVN 306
E+ Y+ DI+SFG+ +E+ T PYS+ P ++ P SL K
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-DPPSLETGADYKKY 236
Query: 307 DPQIKGFIEKCLVP-ASERLSAKDLLKDPF 335
+ I CL S+R +A++LLK F
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 97/280 (34%), Positives = 137/280 (48%), Gaps = 31/280 (11%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH 130
E D +G V VLGKG + VY A D + +A + D +Q L+ E+
Sbjct: 6 EYDENGERV----VLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIA 57
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIK--VIKNWAR 187
L LK N+V++ S D + + E G+L R K + I + +
Sbjct: 58 LHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 245
QIL GL YLH + I+HRD+K DN+ VN G VKI D G + +A P + GT
Sbjct: 116 QILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 246 EFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFK----KVTSGI 297
++MAPE+ ++ Y DI+S G I+EM T + P+ E P A +FK K+ I
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 298 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
P SL+ + K FI +C P +R SA DLL+DPFL
Sbjct: 234 -PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 41/275 (14%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHL 131
+ + LG+GAF VYK +EVA VK L+ +++ E +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VK---TLKEDASEQQIEEFLREARI 54
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQIL 190
++ L NVVK +++ ++ E G+L Y RK + + + ++A QI
Sbjct: 55 MRKLDHPNVVKLL-GVCTEEEPLY-IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIA 112
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---F 247
G+ YL S N IHRDL N V N VKI D GL+ + G +
Sbjct: 113 RGMEYLESKN--FIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 248 MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK------- 298
MAPE L E ++ D++SFG+ + E+ T E PY N ++ + + +G +
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNC 228
Query: 299 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
P L + + +C +R + +L++
Sbjct: 229 PPELYDL--------MLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 22/230 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ + LG+GAF VYK E +VA +K + + ++ E ++K
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE---EREEFLEEASIMKK 57
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGL 193
L N+V+ V + + + ++TE G+L + +KH + +K + A QI G+
Sbjct: 58 LSHPNIVRLLG--VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF-----M 248
YL S N +HRDL N V N VKI D GL+ + M
Sbjct: 116 EYLESKN--FVHRDLAARNCLVTEN-LVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWM 171
Query: 249 APELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
APE ++ ++ D++SFG+ + E+ T E PY N ++ + + G
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 48/287 (16%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS---EVHLLKSLKDD- 138
+++G+G+F TV A ++ E A +KI D QL +K+ E +L L
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYA---IKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHP 62
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
++K Y ++ D++ + + E +G L QY +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------------------QQP 236
IIHRDLK +NI ++ + +KI D G A + +
Sbjct: 121 KG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 237 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 294
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N F+K+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQKIL 235
Query: 295 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKD----LLKDPF 335
S P K IEK LV P +RL + L PF
Sbjct: 236 KL--EYSFPPNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 73/260 (28%), Positives = 137/260 (52%), Gaps = 15/260 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+GKG+F V+K + A ++ + + + + ++ E +L L +++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAIDEARVLAKLDSSYIIR 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR--QILHGLVYLHSHN 200
+Y+S++D K +N++ E +G+L + K + + + W QIL GL +LHS
Sbjct: 64 YYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-Y 257
I+HRD+K N+F++ VKIGDLG+A + T A +++GTP +++PEL E++ Y
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317
NE D+++ G+ + E T ++P+ + N + K+ G+ P + Q+ I++C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVSQMYS-QQLAQLIDQC 236
Query: 318 L-VPASERLSAKDLLKDPFL 336
L +R LL++P L
Sbjct: 237 LTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 88/276 (31%), Positives = 136/276 (49%), Gaps = 35/276 (12%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVH 130
Y R E++G+GA+ VY+ G VA +KI DDV D+Q+ EV
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVA---LKIINLDTPDDDV----SDIQR---EVA 51
Query: 131 LLKSLKDD---NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
LL L+ N+ K+Y S++ + +I E G++R K + K I R
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIR 108
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTP 245
++L L Y+H +IHRD+K NI V N G VK+ D G+A + Q +++ + +GTP
Sbjct: 109 EVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTP 165
Query: 246 EFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
+MAPE+ E Y+ DI+S G+ I EM T PYS+ + + + P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLIPKSKPPRLED 224
Query: 304 KVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQ 337
++ F+ CL P ERLSA++LLK +++
Sbjct: 225 NGYSKLLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 76/260 (29%), Positives = 126/260 (48%), Gaps = 19/260 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS--EVHLLKSLKDDNVVK 142
LGKG++ +VYK A V L ++ + E+ +L S+ N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVD----LGSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKN-VDIKVIKNWARQILHGLVYLHS 198
+ ++++D K + M E G+L + RKK + + + I Q+L GL LH
Sbjct: 64 YKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-Y 257
I+HRDLK NI + N VKIGDLG++ +++ A++ IGTP +MAPE+++ Y
Sbjct: 122 QK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317
+ DI+S G + EM TF P+ E ++ + KV G P + + ++ FI
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRSM 236
Query: 318 LVP-ASERLSAKDLLKDPFL 336
L R + +L P +
Sbjct: 237 LQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 81/352 (23%), Positives = 131/352 (37%), Gaps = 37/352 (10%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-D 138
R LG+G+F VY A D VA + + ++++ E+ +L SL
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPP 58
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVY 195
N+VK Y + D+ + ++ E G+L KK + QIL L Y
Sbjct: 59 NIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--------QQPTARSVIGTPEF 247
LHS IIHRD+K +NI ++ + VK+ D GLA + + +GTP +
Sbjct: 117 LHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 248 MAPELY----EEEYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPA 300
MAPE+ + DI+S G+ + E++T P+ +Q K + P+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 301 SLAKVN-------DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE--PICDPLK 350
+ ++ ++K L RLS+ L L KE
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 351 LPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMH 402
L++ P ++S S +SN P H
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 80/265 (30%), Positives = 127/265 (47%), Gaps = 23/265 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVV 141
+ +G G + VYKA D G VA +K++ PGD + + E+ +LK + N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIV 63
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQ-YRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
++ S++ K + M E G+L+ Y+ + I R+ L GL YLH
Sbjct: 64 AYFGSYLRRDKLWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE-- 256
IHRD+K NI + G+VK+ D G++ + A+ S IGTP +MAPE+ E
Sbjct: 122 --KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 257 --YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVN--DPQIK 311
Y+ DI++ G+ +E+ + P + +P + +F S P L P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWSPVFH 237
Query: 312 GFIEKCLVPA-SERLSAKDLLKDPF 335
FI+KCL +R +A LL+ PF
Sbjct: 238 DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 85/267 (31%), Positives = 132/267 (49%), Gaps = 20/267 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNV 140
EVLGKGA+ TVY G +A +V++D +VL + +KL EV LLKSLK N+
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
V++ + +DD T+++ E G++ + + V + +QIL G+ YLH++
Sbjct: 65 VQYLGTCLDD--NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM------QQPTARSVIGTPEFMAPEL 252
++HRD+K +N+ + N G +K+ D G A +A +S+ GTP +MAPE+
Sbjct: 123 --VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 253 YEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQI 310
E Y DI+S G + EM T + P + A +F + + L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAA 238
Query: 311 KGFIEKCLV-PASERLSAKDLLKDPFL 336
F+ CL ER SA LL+ FL
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 81/275 (29%), Positives = 137/275 (49%), Gaps = 23/275 (8%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG GAF VYKA + G+ A ++I+ +L + E+ +L K N+V Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL----EDFMVEIDILSECKHPNIVGLY 68
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
+++ + K ++ E G L + + + I+ RQ+L L +LHSH +
Sbjct: 69 EAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----- 256
IHRDLK NI + G+VK+ D G++ + + + IGTP +MAPE+ E
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 257 -YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQIKGF 313
Y+ DI+S G+ ++E+ E P+ E NP ++ K+ +P +L + + F
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKS-EPPTLDQPSKWSSSFNDF 241
Query: 314 IEKCLVPASE-RLSAKDLLKDPFLQVENQKEPICD 347
++ CLV + R +A +LLK PF+ ++ + I D
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 82/276 (29%), Positives = 142/276 (51%), Gaps = 31/276 (11%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LY 126
DP + ++ G+G+ V A D+ G +VA ++ DL+K L+
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKM----------DLRKQQRRELLF 64
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
+EV +++ + N+V+ Y S++ + V M E G L H ++ + I
Sbjct: 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIATVC 121
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 244
+L L +LH+ +IHRD+K D+I + + G VK+ D G ++ + P +S++GT
Sbjct: 122 LAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGT 178
Query: 245 PEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-- 301
P +MAPE+ Y VDI+S G+ ++EMV E PY + P Q K++ + P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKN 237
Query: 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336
L KV+ P+++ F+++ LV ++R +A +LL PFL
Sbjct: 238 LHKVS-PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 71/264 (26%), Positives = 125/264 (47%), Gaps = 16/264 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNV 140
+ LG GAF + Y+A D G +A +V + + ++ L E+ L+ L ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
++ + +D N+ E G++ K+ VI N+ Q+L GL YLH +
Sbjct: 66 IRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS------VIGTPEFMAPE-LY 253
IIHRD+K N+ ++ ++I D G A + + ++GT FMAPE L
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYS--ECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
E+Y D++S G I+EM T + P++ + N + K+ S S+ + P ++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 312 GFIEKCL-VPASERLSAKDLLKDP 334
+CL + +R +++LLK P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 66/265 (24%), Positives = 128/265 (48%), Gaps = 30/265 (11%)
Query: 85 LGKGAFKTVYKAFDE-----FAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKD 137
LGKG+F V + +A +K+ + +++ +E ++L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYA--------MKVLKKKKIIKRKEVEHTLTERNILSRINH 52
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+VK + ++ ++K + ++ E G L + K + + +A +I+ L YLH
Sbjct: 53 PFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYE 254
S II+RDLK +NI ++ G +K+ D GLA ++ + + GTPE++APE L
Sbjct: 111 SLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314
+ Y + VD +S G+ + EM+T + P+ ++ +I++K+ P + P+ + I
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLI 224
Query: 315 EKCLVP-ASERL---SAKDLLKDPF 335
L ++RL A+++ PF
Sbjct: 225 SGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 67/269 (24%), Positives = 113/269 (42%), Gaps = 29/269 (10%)
Query: 83 EVLGKGAFKTVYKA-FDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
+ LG+GAF VYK G EVA +K D + + E ++K L N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGHPN 57
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN---------VDIKVIKNWARQIL 190
VV+ +++ ++ E G+L Y +K + + +K + ++A QI
Sbjct: 58 VVRLL-GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPE--- 246
G+ YL S +HRDL N V G VKI D GL+ + R G
Sbjct: 116 KGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 247 FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAK 304
+MAPE L + + D++SFG+ + E+ T PY N ++ + + G +
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKPEY 231
Query: 305 VNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
D ++ + C +R + +L++
Sbjct: 232 CPD-ELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 82/268 (30%), Positives = 142/268 (52%), Gaps = 22/268 (8%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-----LQKLYSEVHLLKSLKDD 138
++G G+F +VY + +G +A +V++ V D L L E+ LLK L+ +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
N+V++ S +D +N+ E G++ + + +++N+ RQIL GL YLH+
Sbjct: 67 NIVQYLGSSLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTAR-SVIGTPEFMAP 250
IIHRD+K NI V+ N G +KI D G++ ++ + AR S+ G+ +MAP
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E+ ++ Y DI+S G ++EM+T ++P+ +C IF K+ P + ++ +
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-E 239
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFL 336
F+EK ++R +A +LLK PFL
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP +Y R++++ G+GA TVY A D G EVA ++ + Q +L + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKEL--IINEILVM 70
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+ K N+V + S++ + V M E G+L + +D I R+ L
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAP 250
L +LHS+ +IHRD+K DNI + G G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 251 ELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDP 308
E+ + Y VDI+S G+ +EMV E PY +NP + ++ T+G +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSA 243
Query: 309 QIKGFIEKCL-VPASERLSAKDLLKDPFLQV 338
+ F+ +CL + +R SAK+LL+ PFL++
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 75/253 (29%), Positives = 135/253 (53%), Gaps = 14/253 (5%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R ++ +G+G F VY+A G+ VA +V+I D++ E+ LLK L N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPN 63
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVY 195
V+K+Y S+++D + +N++ EL +G+L + ++K+ + + K + + Q+ L +
Sbjct: 64 VIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-L 252
+HS ++HRD+K N+F+ G VK+GDLGL + + A S++GTP +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
+E YN DI+S G + EM + P Y + N + KK+ P + +++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 312 GFIEKCLVPASER 324
+ C+ P E+
Sbjct: 239 QLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 17/271 (6%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP +Y RY+++ G+GA TV+ A D G EVA ++ LQ + + +E+ ++
Sbjct: 16 DPKKKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
K LK+ N+V F S++ + V M E G+L + +D I R+ L
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVM--EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAP 250
L +LH++ +IHRD+K DN+ + G G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDP 308
E+ + Y VDI+S G+ +EMV E PY +NP + ++ T+G + P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSP 243
Query: 309 QIKGFIEKCL-VPASERLSAKDLLKDPFLQV 338
+ F+ +CL + +R SAK+LL+ PFL++
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 19/264 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVHLLKSLKDDNVVKF 143
LG G F V + A VK +++ Q+ ++SE +L+ +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKL 58
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
Y+++ D KK + M+ E G L + D + + ++ YLH+ I
Sbjct: 59 YRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--I 114
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE-YNELV 261
I+RDLK +N+ ++ N G VK+ D G A ++ + GTPE++APE+ + Y+ V
Sbjct: 115 IYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 262 DIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK--CL 318
D +S G+ + E++T P+ E +P +I+ + G D K I++
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233
Query: 319 VPASERL-----SAKDLLKDPFLQ 337
P ERL KD+ K +
Sbjct: 234 NPE-ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 45/292 (15%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVH 130
DP+G + EV+G+G + VYKA + G VA +KI D++ D ++ + E +
Sbjct: 2 PDPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDII---EDEEEEIKEEYN 54
Query: 131 LLKSLKD-DNVVKFYKSWVDDKKKTVN------MITELFTSGNLRQYRKKHKNVDIKVIK 183
+L+ + N+ FY +++ KK ++ EL G++ K + ++ +
Sbjct: 55 ILRKYSNHPNIATFYGAFI--KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112
Query: 184 NW----ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
W R+ L GL YLH + +IHRD+K NI + N EVK+ D G++ + R
Sbjct: 113 EWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGR 169
Query: 240 --SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---- 287
+ IGTP +MAPE+ + Y+ D++S G+ +E+ + P + +P
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALF 228
Query: 288 QIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
+I + +K K ND FI +CL+ +R ++LL+ PF+
Sbjct: 229 KIPRNPPPTLKSPENWSKKFND-----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 69/263 (26%), Positives = 130/263 (49%), Gaps = 18/263 (6%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWS--RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
LG G V K G +A R++I++ +Q +++ E+ +L +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-----KQILRELDILHKCNSPYIV 62
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHN 200
FY ++ ++ +++ E G+L + K+ + +++ A +L GL YLH
Sbjct: 63 GFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EK 119
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNE 259
IIHRD+K NI VN + G++K+ D G++ + A++ +GT +MAPE + +Y+
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 260 LVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315
DI+S G+ ++E+ T +PY ++ + + + P + P + F+
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 316 KCLVP-ASERLSAKDLLKDPFLQ 337
CL+ ER S K+LL+ PF++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 87/275 (31%), Positives = 144/275 (52%), Gaps = 25/275 (9%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP +Y R++++ G+GA TVY A D G EVA ++ LQ + + +E+ ++
Sbjct: 16 DPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVM 70
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+ K+ N+V + S++ + V M E G+L + +D I R+ L
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAP 250
L +LHS+ +IHRD+K DNI + G G VK+ D G I +Q +++GTP +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E+ + Y VDI+S G+ +EMV E PY +NP + + + P ++ +P+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP----ELQNPE 239
Query: 310 -----IKGFIEKCL-VPASERLSAKDLLKDPFLQV 338
+ F+ +CL + R SAK+LL+ PFL++
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 72/267 (26%), Positives = 125/267 (46%), Gaps = 22/267 (8%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+ KGA+ V+ A + G A +K D + + ++ +E +L + VVK Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
S+ K + ++ E G+L + ++D V + + +I+ L YLHS+ II
Sbjct: 60 YSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGL--------AIAMQQPTARS--VIGTPEFMAPE-LY 253
HRDLK DNI ++ N G +K+ D GL I + ++GTP+++APE +
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313
+ +++ VD +S G + E + P+ + P +IF+ + +G +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 314 IEKCLVPASE-RL---SAKDLLKDPFL 336
I K LVP E RL S +++ PF
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 69/244 (28%), Positives = 128/244 (52%), Gaps = 14/244 (5%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G F VY+A VA +V+I +++ Q E+ LLK L NV+K+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYL 68
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
S+++D + +N++ EL +G+L Q ++K+ + + + + + Q+ + ++HS
Sbjct: 69 DSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEY 257
++HRD+K N+F+ G VK+GDLGL + + A S++GTP +M+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 258 NELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
N DI+S G + EM + P Y + N + +K+ P + +++ +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 317 CLVP 320
C+ P
Sbjct: 244 CIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSL 135
E++GKG + VY A + G +A +V++ D Q ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQK-DMVKALRSEIETLKDL 65
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
N+V++ + ++ +++ E G++ + + + ++++ + Q+L GL Y
Sbjct: 66 DHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL----AIAMQQPTARSVIGTPEFMAPE 251
LHS I+HRDLK DN+ V+ + G KI D G+ S+ G+ +MAPE
Sbjct: 124 LHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 252 ---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK----KVTSGIKPASLAK 304
Y + Y+ VDI+S G +LEM P+S+ + A +FK + I P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN 240
Query: 305 VNDPQIKGFIEKCLVPASERLSAKDLLKDPF 335
++ + + R +A++LL+ PF
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 91/340 (26%), Positives = 145/340 (42%), Gaps = 74/340 (21%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY+ + +G GA+ V A D+ G +VA KI +V D +++ E+ LL+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 138 DNVVKFYKSWVDDKK---KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
+N++ V ++TEL + +L + K + + I+ + QIL GL
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM------ 248
YLHS N +IHRDLK NI VN N ++KI D GLA + F+
Sbjct: 118 YLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDED-----EKGFLTEYVVT 169
Query: 249 ----APE--LYEEEYNELVDIYSFGMCIL-EMVT----F--------------------- 276
APE L Y + +DI+S G CI E++T F
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 277 -EYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDL 330
+ + + A+ + K L+K+ P+ +EK LV P +R++A +
Sbjct: 229 EDLKFITSEK-ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEA 286
Query: 331 LKDPFLQV--ENQKEPICDPL---------KLPIQSLKML 359
L P+L + + EP+ P +L + LK L
Sbjct: 287 LAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEELKEL 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 88/291 (30%), Positives = 150/291 (51%), Gaps = 33/291 (11%)
Query: 65 ADSDFVEK--------DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL 116
+D + +EK DP +Y R++++ G+GA TVY A D G EVA ++ L
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMN----L 55
Query: 117 QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 176
Q + + +E+ +++ K+ N+V + S++ + V M E G+L +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM--EYLAGGSLTDVVTE-TC 112
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQ 234
+D I R+ L L +LHS+ +IHRD+K DNI + G G VK+ D G I +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPE 169
Query: 235 QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
Q +++GTP +MAPE+ + Y VDI+S G+ +EM+ E PY +NP + +
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLI 228
Query: 294 TSGIKPASLAKVNDPQ-----IKGFIEKCL-VPASERLSAKDLLKDPFLQV 338
+ P ++ +P+ + F+ +CL + +R SAK+LL+ FL++
Sbjct: 229 ATNGTP----ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD------VLQLPGDLQKLYSEVHL 131
Y + ++ G+G + VYKA ++ G VA ++++++ + + E+ L
Sbjct: 1 YEKIAQI-GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI--------REIKL 51
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKNVDIKVIKNWARQ 188
L+ L+ N+V+ + K ++ M+ E +G L K IK + +Q
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQ 108
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS----VIGT 244
+L GL YLHS+ I+HRD+K NI +N N G +K+ D GLA + + VI T
Sbjct: 109 LLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 245 PEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 275
+ PEL Y VD++S G CIL E+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 71/256 (27%), Positives = 133/256 (51%), Gaps = 13/256 (5%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
V+G+GAF V+ + V ++ ++ + + + +E +LK L N++++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEY 64
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNP 201
Y+++++DK + M E G L +Y +K N +D I ++ QIL L ++H+
Sbjct: 65 YENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYE-EEYNE 259
I+HRDLK NI ++ + VKIGD G++ I + A +V+GTP +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL- 318
DI++ G + E+ + + + PA + K+ SG A ++ P ++ I L
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVL-KIMSG-TFAPISDRYSPDLRQLILSMLN 238
Query: 319 VPASERLSAKDLLKDP 334
+ S+R ++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 83/298 (27%), Positives = 127/298 (42%), Gaps = 63/298 (21%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVK-----IDDVLQLPGDLQKLYSEVHLLKSLKD 137
+ LG G F +VY A ++ G VA ++K ++ + L EV L+ L +
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR--------EVKSLRKLNE 56
Query: 138 -DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLV 194
N+VK + + + + + E + GNL Q K K VI++ QIL GL
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-- 251
++H H HRDLK +N+ V+G VKI D GLA ++ +P + T + APE
Sbjct: 114 HIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 252 LYEEEYNELVDIYSFGMCIL-EMVTFE--YP-YSECKNPAQIFKKVT-----------SG 296
L Y+ VDI++ G CI+ E+ T +P SE Q++K + G
Sbjct: 171 LRSTSYSSPVDIWALG-CIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEG 226
Query: 297 IKPASLAKVNDPQIKG----------------FIEKCLV--PASERLSAKDLLKDPFL 336
K AS PQ I+ L P +R +A L+ P+
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK-KRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 66/240 (27%), Positives = 126/240 (52%), Gaps = 19/240 (7%)
Query: 121 DLQK-LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHK 175
DLQK + E+ + KS K +VK+Y +++D+ ++ + E G+L ++ +K+
Sbjct: 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG 100
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+ KV+ A +L GL YLHS IIHRD+K NI + G+VK+ D G++ +
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157
Query: 236 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIFKKV 293
A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ E + P + +
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
Query: 294 TSGIKPASLAKVNDP--------QIKGFIEKCL-VPASERLSAKDLLKDPFLQVENQKEP 344
+ + + ++P + K FI++CL + R + D+L+ P+++ + +K+
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 84/299 (28%), Positives = 130/299 (43%), Gaps = 55/299 (18%)
Query: 81 YDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL----YSEVHLLKS 134
Y+E+ +G+GA+ TVYKA D G VA +V++ P + + E+ LLK
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV------PLSEEGIPLSTLREIALLKQ 54
Query: 135 LKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWA 186
L+ N+V+ D++ + ++ E +L Y K + + IK+
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTP 245
RQ+L G+ +LHSH I+HRDLK NI V + G+VKI D GLA I + SV+ T
Sbjct: 114 RQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTL 170
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTFE---YPYSECKNPAQIFKKV------- 293
+ APE L + Y VD++S G CI E+ SE +IF +
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 294 --------------TSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 336
+ S + ++K L P R+SA + L+ P+
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 1e-24
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP + + +++ GKG+F V+K D VA +KI D+ + +++ + E+ +L
Sbjct: 1 DPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
V K+Y S++ D K + +I E G+ + +D I R+IL G
Sbjct: 57 SQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAP 250
L YLHS IHRD+K N+ ++ HGEVK+ D G+A + Q + +GTP +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E+ ++ Y+ DI+S G+ +E+ E P+SE +P ++ + P + P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEGNYSKP- 228
Query: 310 IKGFIEKCL-VPASERLSAKDLLKDPFL 336
+K F+E CL S R +AK+LLK F+
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 73/218 (33%), Positives = 120/218 (55%), Gaps = 14/218 (6%)
Query: 125 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 184
L++EV +++ + +NVV+ Y S++ + V M E G L H ++ + I
Sbjct: 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIAA 120
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 242
+L L LH+ +IHRD+K D+I + + G VK+ D G ++ + P +S++
Sbjct: 121 VCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 299
GTP +MAPEL Y VDI+S G+ ++EMV E PY + P + K + + P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKL 236
Query: 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336
+L KV+ P +KGF+++ LV ++R +A +LLK PFL
Sbjct: 237 KNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 83/257 (32%), Positives = 136/257 (52%), Gaps = 16/257 (6%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G+ V A ++ +G +VA VK+ D L+ + L++EV +++ + NVV+ Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
KS++ ++ V M E G L + + ++ + I +L L YLHS +I
Sbjct: 85 KSYLVGEELWVLM--EFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQG--VI 139
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELV 261
HRD+K D+I + + G VK+ D G I+ P +S++GTP +MAPE+ Y V
Sbjct: 140 HRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 262 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFIEKCLV- 319
DI+S G+ ++EMV E PY +P Q K++ P A P ++ F+E+ L
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 320 PASERLSAKDLLKDPFL 336
ER +A++LL PFL
Sbjct: 258 EPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 74/270 (27%), Positives = 134/270 (49%), Gaps = 20/270 (7%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
++Y E+LG G TVYKA+ +A + +D ++L +++ SE+ +L
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSP 59
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
++ FY ++ + + +++ TE G+L YRK + V+ A ++ GL YL S
Sbjct: 60 YIIGFYGAFFVENR--ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWS 113
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEY 257
I+HRD+K N+ VN G+VK+ D G++ + A++ +GT +MAPE + E+Y
Sbjct: 114 LK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 258 NELVDIYSFGMCILEMVTFEYPYSEC-KN-----PAQIFKKVTSGIKPASLAKVNDPQIK 311
D++S G+ +E+ +PY + KN P Q+ + + P +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230
Query: 312 GFIEKCL-VPASERLSAKDLLKDPFLQVEN 340
FI +C+ ER + ++L+ PF+ N
Sbjct: 231 HFITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 81/269 (30%), Positives = 132/269 (49%), Gaps = 18/269 (6%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSL 135
RY+ + LGKG+F TVY D+ A E +K V +L P + + E LL L
Sbjct: 1 RYI-LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILH 191
+VKF+ S+++ + +ITE +L + + K + + W Q+L
Sbjct: 60 DHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMA 249
G+ Y+H I+HRDLK NIF+ N +KIGD G++ + A + GTP +M+
Sbjct: 118 GVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308
PE L + Y+ DI+S G + EM + + E +N + ++ G P SL +
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSR 231
Query: 309 QIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
Q+ ++ L S R SA ++L++PF+
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 25/264 (9%)
Query: 84 VLGKGAF--KTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
VLGKGAF T+Y+ ++ V W V + L L +E+ +L L+ N++
Sbjct: 7 VLGKGAFGEATLYRRTED--DSLVVWKEVNLTR-LSEKERRDAL-NEIVILSLLQHPNII 62
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+Y ++DD + M E G L R+K + + +++ + QI+ + Y+H
Sbjct: 63 AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYE-EE 256
I+HRD+K NIF+ G +K+GD G++ + A +V+GTP +M+PEL + +
Sbjct: 121 G--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 257 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE- 315
YN DI++ G + E++T + + + NP + K+ G V I
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY----TPVVSVYSSELISL 232
Query: 316 --KCL-VPASERLSAKDLLKDPFL 336
L +R +A ++L P L
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 23/284 (8%)
Query: 63 PDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
P+ F + DP + E+ G G+F VY A D VA ++ Q
Sbjct: 2 PEIAELFSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKW 59
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF---TSGNLRQYRKKHKNVDI 179
Q + EV L+ L+ N +++ ++ ++ T ++ E S L ++K + V+I
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYCLGSASDILEVHKKPLQEVEI 117
Query: 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
I L GL YLHSH IHRD+K NI + G VK+ D G A ++ P A
Sbjct: 118 AAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSA-SLVSP-AN 169
Query: 240 SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295
S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + ++ +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 296 GIKPASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQ 337
+L+ + + F++ CL +R S+++LLK F+
Sbjct: 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/260 (30%), Positives = 138/260 (53%), Gaps = 18/260 (6%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G+ V A ++ G +VA K+D Q +L L++EV +++ +NVV Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRREL--LFNEVVIMRDYHHENVVDMY 85
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
S++ + V M E G L H ++ + I +L L YLH+ +I
Sbjct: 86 NSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEE-EYNELV 261
HRD+K D+I + + G +K+ D G ++ + P +S++GTP +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 262 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIEKCLV 319
DI+S G+ ++EM+ E PY + P Q +++ + P KV+ ++GF++ LV
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSS-VLRGFLDLMLV 257
Query: 320 -PASERLSAKDLLKDPFLQV 338
S+R +A++LL+ PFL++
Sbjct: 258 REPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 85/297 (28%), Positives = 141/297 (47%), Gaps = 19/297 (6%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
G + P+ F + DP +V E+ G G+F VY A + VA ++ Q
Sbjct: 3 GVVKDPEIADLFYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGK-Q 60
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KN 176
Q + EV L+ LK N +++ ++ + + M L ++ +L + KK +
Sbjct: 61 TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE 120
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
V+I I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A + P
Sbjct: 121 VEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SKSSP 173
Query: 237 TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N
Sbjct: 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH 231
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 347
+ P + +GF++ CL +P ER ++ +LL+ F++ + + D
Sbjct: 232 IAQNDSPTLQSNEWTDSFRGFVDYCLQKIP-QERPASAELLRHDFVRRDRPARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 27/266 (10%)
Query: 84 VLGKGAFKTVY-----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
V+GKGAF V FA + ++ K G ++ + +E +L+ L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYM--NKQKCV----EKGSVRNVLNERRILQELNHP 60
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V + S+ D++ + ++ +L G+LR + + + +K W +I+ L YLHS
Sbjct: 61 FLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELY-EEE 256
IIHRD+K DNI ++ G V I D +A + S GTP +MAPE+ +
Sbjct: 119 KG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 257 YNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIK-PASLAKVNDPQIKG 312
Y+ VD +S G+ E + + PY S K+ T+ + PA+ + I
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 313 FIEKCLVPASERLS--AKDLLKDPFL 336
+E +RL KDL P+
Sbjct: 236 LLE---RDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSL 135
RY + + LG+G + VYKA D+ G VA ++K+ + + G E+ LL+ L
Sbjct: 1 RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL 59
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGL 193
K N++ + K +N++ E F +L + K K++ + IK++ L GL
Sbjct: 60 KHPNIIGLLDVFG--HKSNINLVFE-FMETDLEKVIKD-KSIVLTPADIKSYMLMTLRGL 115
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAP 250
YLHS+ I+HRDLK +N+ + + G +K+ D GLA + P + V+ T + AP
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171
Query: 251 ELY--EEEYNELVDIYSFGMCIL 271
EL Y VD++S G CI
Sbjct: 172 ELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 80/273 (29%), Positives = 134/273 (49%), Gaps = 29/273 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG GAF VYKA ++ G+ A K+ D + +L+ E+ +L S N+VK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA---AKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 145 KSWVDDKKKTVNMITELFTSGN----LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
++ + + ++ E G + + + I+V+ +Q L L YLH +
Sbjct: 69 DAFY--YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV---CKQTLEALNYLHENK 123
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY----- 253
IIHRDLK NI + G++K+ D G++ + R S IGTP +MAPE+
Sbjct: 124 --IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQI 310
+ Y+ D++S G+ ++EM E P+ E NP ++ K+ +P +LA+ + +
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS-EPPTLAQPSRWSSEF 238
Query: 311 KGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 342
K F++KCL R + LL+ PF+ V + K
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 67/238 (28%), Positives = 122/238 (51%), Gaps = 15/238 (6%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G G F V+ D + A + I +V++L Q +++E +LK + +++ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
+ D + + M+ E G L Y + +A +I+ L YLHS I+
Sbjct: 68 WTEHDQR--FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IV 123
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDI 263
+RDLK +NI ++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD
Sbjct: 124 YRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDW 181
Query: 264 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLV 319
++ G+ I EM+ P+ + NP I++K+ +G ++ P L D K I+K LV
Sbjct: 182 WALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 78/267 (29%), Positives = 133/267 (49%), Gaps = 20/267 (7%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLK 136
RY+ + +G+G+F +Y A + + +K D+ ++P + + EV LL +K
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK---SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLV 194
N+V F+ S+ ++ + + M E G+L + + + V I +W QI GL
Sbjct: 58 HPNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPEL 252
H H+ I+HRD+K NIF++ N K+GD G+A + A + +GTP +++PE+
Sbjct: 116 --HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 253 YEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPASLAKVNDPQI 310
+ YN DI+S G + E+ T ++P+ E N Q+ K+ G P S D +
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNFSRD--L 230
Query: 311 KGFIEKCL-VPASERLSAKDLLKDPFL 336
+ I + V +R S +LK PFL
Sbjct: 231 RSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 78/268 (29%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP + + + + GKG+F VYK D VA +KI D+ + +++ + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+ ++Y S++ K + +I E G+ K ++ I R+IL G
Sbjct: 57 SQCDSPYITRYYGSYLKGTK--LWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAP 250
L YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +GTP +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 251 ELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ + P + + P
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP- 228
Query: 310 IKGFIEKCLVPASE-RLSAKDLLKDPFL 336
K F+E CL R +AK+LLK F+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 12/215 (5%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNW 185
E LL LK N+V + +SW + + + ++ G+L K+ K + + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIG 243
QI L YLH + I+HRDLK N+F+ + +K+GDLG+A + Q A ++IG
Sbjct: 108 FVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIG 164
Query: 244 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
TP +M+PEL+ + YN D+++ G C+ EM T ++ ++ + +++ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 303 AKVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPFL 336
K P++ I L E R S K +L+ P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-21
Identities = 81/282 (28%), Positives = 138/282 (48%), Gaps = 31/282 (10%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DP + + + + GKG+F V+K D VA +KI D+ + +++ + E+ +L
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNW 185
V K+Y S++ K + M +L +G +++ I
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------IATM 106
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 243
++IL GL YLHS IHRD+K N+ ++ G+VK+ D G+A + Q + +G
Sbjct: 107 LKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVG 163
Query: 244 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
TP +MAPE+ ++ Y+ DI+S G+ +E+ E P S+ +P ++ + P +L
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPK-NNPPTL 221
Query: 303 AKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQVENQKE 343
K FI+ CL S R +AK+LLK F+ V+N K+
Sbjct: 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI-VKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 43/286 (15%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G + VYKA D+ G VA ++K+ + G + E+ LLK L N++K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
V K + ++ E + + + + + + +IK++ Q+L GL + HSH I+
Sbjct: 65 D--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELY--EEEYNEL 260
HRDLK +N+ +N G +K+ D GLA + T + APEL ++ Y+
Sbjct: 121 HRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 261 VDIYSFGMCIL-EMVTFEYPYSECKN--------------PAQ-IFKKVTS--------- 295
VDI+S G CI E+++ P K+ P ++ K TS
Sbjct: 180 VDIWSVG-CIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 296 ----GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336
G+ L PQ + + L +R++A+ L P+
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 21/227 (9%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
R++++ + LG+G F V + G +VA + Q D ++ E+ +L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEIL 60
Query: 133 KSLKDDNVVKFYKSWVDDK-KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQIL 190
++L +N+VK YK + +++ +I E SG+LR Y ++H+ +++K + ++ QI
Sbjct: 61 RTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPE 246
G+ YL S IHRDL NI V VKI D GLA + + + +P
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 247 F-MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291
F APE L +++ D++SFG+ + E+ F Y PA+ +
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYEL--FTYGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 63/221 (28%), Positives = 117/221 (52%), Gaps = 21/221 (9%)
Query: 83 EVLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+ LG G+F V +K ++ A + +++L ++ + +E +L+S++
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKL-KQVEHVLNEKRILQSIRHP 61
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V Y S+ DD + ++ E G L + +K V + +A Q++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-Y 257
+ I++RDLK +N+ + + G +KI D G A ++ T ++ GTPE++APE+ + Y
Sbjct: 120 LD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPEIILSKGY 175
Query: 258 NELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSG 296
+ VD ++ G+ I EM+ YP + + NP QI++K+ G
Sbjct: 176 GKAVDWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 70/228 (30%), Positives = 120/228 (52%), Gaps = 20/228 (8%)
Query: 77 RYVRYDEVLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
R+++ LG+G F V Y + G +VA +K + DL+K E+ +L
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 60
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH 191
++L +N+VK+ +D + +I E SG+L++Y ++KN +++K +A QI
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF 247
G+ YL S +HRDL N+ V + +VKIGD GL A++ T + + +P F
Sbjct: 121 GMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177
Query: 248 -MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
APE L + ++ D++SFG+ + E++T Y SE +P +F K+
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSES-SPMTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 86 GKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
G+G + VYKA + G E A + K D Q G Q E+ LL+ LK +NVV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQ-----YRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+ +++ K+V ++ + + +L Q + K ++ ++K+ QIL+G+ YLHS
Sbjct: 68 VEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 199 HNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAP 250
+ ++HRDLK NI V G G VKIGDLGLA P V+ T + AP
Sbjct: 127 NW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184
Query: 251 ELY--EEEYNELVDIYSFGMCIL-EMVTFE 277
EL Y + +DI++ G CI E++T E
Sbjct: 185 ELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 66/268 (24%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG G +V K G +A V I + +++ E+ ++ + +V FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR---KQILRELQIMHECRSPYIVSFY 69
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPI 203
+++++ + M E G+L + KK + ++++ A ++ GL YL++ H I
Sbjct: 70 GAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 262
+HRD+K NI VN G++K+ D G++ + A + +GT +M+PE + +Y D
Sbjct: 126 MHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 263 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------KPASLAKVNDPQI-K 311
++S G+ I+E+ ++P++ N + GI P L + P+ +
Sbjct: 185 VWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243
Query: 312 GFIEKCLV-PASERLSAKDLLK-DPFLQ 337
F++ CL+ +ER + + L PF+Q
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 80/276 (28%), Positives = 126/276 (45%), Gaps = 29/276 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG GAF VYKA ++ G A ++ +L+ E+ +L + +VK
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLL 75
Query: 145 KSWVDDKKKTVNMITELFTSGN-----LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
++ D K + MI F G + + + I+VI RQ+L L YLHS
Sbjct: 76 GAFYWDGKLWI-MIE--FCPGGAVDAIMLELDRGLTEPQIQVI---CRQMLEALQYLHSM 129
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE------ 251
IIHRDLK N+ + + G++K+ D G++ + R S IGTP +MAPE
Sbjct: 130 K--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQI 310
+ + Y+ DI+S G+ ++EM E P+ E NP ++ K+ P +
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 311 KGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPI 345
+ F++ L E R SA LL+ PF+ P+
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 76/284 (26%), Positives = 138/284 (48%), Gaps = 32/284 (11%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVH 130
+DP+G + E++G G + VYK G V ++ V+ + GD ++ + E++
Sbjct: 2 RDPAGIF-ELVELVGNGTYGQVYK------GRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 54
Query: 131 LLKSLKDD-NVVKFYKSWVDDKKKTVN----MITELFTSGNLRQYRKKHKNVDIKVIKNW 185
+LK N+ +Y +++ ++ ++ E +G++ K K +K + W
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEW 112
Query: 186 ----ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 239
R+IL GL +LH H +IHRD+K N+ + N EVK+ D G++ + + R
Sbjct: 113 IAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRN 169
Query: 240 SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
+ IGTP +MAPE+ + Y+ D++S G+ +EM P + +P + +
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLI 228
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVPA-SERLSAKDLLKDPFL 336
P +K + + FIE CLV S+R + + L+K PF+
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 50/308 (16%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY ++ +G GAF V A D+ G VA KI P ++ Y E+ LLK L+
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+N++ ++ + + +TEL + R + ++ + I+ + QIL GL Y+H
Sbjct: 69 ENIISLSDIFIS-PLEDIYFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEE 255
S ++HRDLK NI +N N ++KI D GLA +Q P + T + APE L +
Sbjct: 126 SAG--VVHRDLKPSNILINEN-CDLKICDFGLA-RIQDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-------------- 299
+Y+ VDI+S G EM+ + P K+ F +T G P
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240
Query: 300 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEPI 345
+ K DP +EK LV +R+SA + L P+L P
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA------PY 294
Query: 346 CDPLKLPI 353
DP P+
Sbjct: 295 HDPTDEPV 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 84/297 (28%), Positives = 143/297 (48%), Gaps = 19/297 (6%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
G+ + P+ F ++DP + E+ G G+F VY A D VA ++ Q
Sbjct: 7 GSLKDPEIAELFFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGK-Q 64
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KN 176
Q + EV L+ +K N +++ ++ + + M L ++ +L + KK +
Sbjct: 65 SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 124
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
V+I I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A ++ P
Sbjct: 125 VEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SIASP 177
Query: 237 TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292
A S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N
Sbjct: 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH 235
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 347
+ P + + F++ CL +P +R ++++LLK F+ E + + D
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIP-QDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 68/204 (33%), Positives = 114/204 (55%), Gaps = 21/204 (10%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y+ E +G+G + TV+KA + VA RV++DD + G E+ LLK LK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKH 58
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYL 196
N+V+ Y DKK T ++ E + +L++Y + ++D +++K++ Q+L GL +
Sbjct: 59 KNIVRLYDVLHSDKKLT--LVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE- 251
HSHN ++HRDLK N+ +N N GE+K+ D GLA I ++ +A V T + P+
Sbjct: 116 HSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDV 170
Query: 252 -LYEEEYNELVDIYSFGMCIL-EM 273
+ Y+ +D++S G CI E+
Sbjct: 171 LFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 76/269 (28%), Positives = 130/269 (48%), Gaps = 29/269 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWS--RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LGKG + +VYK G+ +A R+++D+ ++ E+ +L +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-----SKFNQIIMELDILHKAVSPYIVD 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYL-HS 198
FY ++ + V M E +G+L + + + V++ ++ GL +L
Sbjct: 64 FYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-- 256
HN IIHRD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE +
Sbjct: 122 HN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 257 -----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQ 309
Y D++S G+ ILEM YPY + A IF ++++ + P +L
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 310 IKGFIEKCL--VPASERLSAKDLLKDPFL 336
+ F+ KCL +P + R + LL+ P+L
Sbjct: 238 AQDFVAKCLNKIP-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 76/261 (29%), Positives = 124/261 (47%), Gaps = 20/261 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKF 143
+G G + VYKA + G A +K++ PG D + E+ ++K K N+V +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
+ S++ K + M E G+L+ + I +R+ L GL YLHS
Sbjct: 72 FGSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----Y 257
+HRD+K NI + N G VK+ D G++ + A+ S IGTP +MAPE+ E Y
Sbjct: 128 MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVN-DPQIKGFIE 315
N+L DI++ G+ +E+ + P + +F S +P L K+ F++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246
Query: 316 KCLVP-ASERLSAKDLLKDPF 335
L +R +A+ LL+ PF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 68 DFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLY 126
D + ++P Y V G G + VYKA + G A +K++ PGD +
Sbjct: 1 DILRRNPQHDYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLE-----PGDDFSLIQ 54
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
E+ ++K K N+V ++ S++ +K + M E G+L+ + I
Sbjct: 55 QEIFMVKECKHCNIVAYFGSYLSREKLWICM--EYCGGGSLQDIYHVTGPLSELQIAYVC 112
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 244
R+ L GL YLHS +HRD+K NI + ++G+VK+ D G+A + A+ S IGT
Sbjct: 113 RETLQGLAYLHSKGK--MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGT 169
Query: 245 PEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
P +MAPE+ E YN+L DI++ G+ +E+ + P + +F S +P
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229
Query: 301 SLAKVN--DPQIKGFIEKCLV------PASERL 325
L F++ L P +ERL
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +G+G + VYKA ++ G VA ++++D + G E+ LLK L N+VK
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLVYLHSHN 200
V + + ++ E F +L+++ I + IK++ Q+L GL + HSH
Sbjct: 64 LLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEE 256
++HRDLK N+ +N G +K+ D GLA A P T + T + APE L +
Sbjct: 121 --VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 257 YNELVDIYSFGMCILEMVT 275
Y+ VDI+S G EMVT
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 85/292 (29%), Positives = 136/292 (46%), Gaps = 19/292 (6%)
Query: 63 PDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
PD F + DP + E+ G G+F VY A D VA ++ Q
Sbjct: 2 PDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKW 59
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 181
Q + EV L+ L+ N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 182 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 241
+ + A L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M A
Sbjct: 120 VTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXF 171
Query: 242 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE 230
Query: 298 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 347
PA + + F++ CL +P +R +++ LLK F+ E I D
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVK----IDDVLQLPGDLQKLYSEVHLLKSLKDD 138
E LG+GA+ V K G +A R++ + +L DL V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC------P 60
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIK--VIKNWARQILHGLVY 195
V FY + ++ V + E+ + + Y+K + K + I ++ A I+ L Y
Sbjct: 61 YTVTFYGALF--REGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPELYE 254
LHS +IHRD+K N+ +N +G+VK+ D G++ + A+++ G +MAPE
Sbjct: 119 LHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 255 EE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E Y+ D++S G+ ++E+ T +PY K P Q K+V P A+ P+
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 342
+ F+ KCL ER + +LL+ PF ++ K
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +G+G + VYKA D+ G VA +++++ + G E+ LLK L N+V+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVR 62
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
+ K + ++ E F +L++Y +D +IK++ Q+L G+ Y HSH
Sbjct: 63 LLDVVHSENK--LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEE 256
++HRDLK N+ ++ G +K+ D GLA A P T + T + APE L +
Sbjct: 120 --VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 257 YNELVDIYSFGMCIL-EMVT 275
Y+ VDI+S G CI EMV
Sbjct: 177 YSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 59/247 (23%), Positives = 108/247 (43%), Gaps = 14/247 (5%)
Query: 87 KGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYK 145
KGAF +VY A G A +K D++ + + +E ++ + V K Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLY- 63
Query: 146 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 205
+ K + ++ E G+ K + K + +++ G+ LH IIH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIH 120
Query: 206 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIY 264
RD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE +++ D +
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 265 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-A 321
S G I E + F YP + P +F + S P + + P+ I + L
Sbjct: 178 SLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 322 SERLSAK 328
++RL A
Sbjct: 237 AKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 132 LKSLKDDN---VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 188
LK L + N +V FY ++ D + ++ M E G+L Q KK + ++ +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 248
+L GL YL I+HRD+K NI VN GE+K+ D G++ + A S +GT +M
Sbjct: 108 VLRGLTYLRE-KHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYM 165
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--SECKNPAQIFKKVTSGIK------- 298
+PE L Y DI+S G+ ++EM YP + K +F + S +
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 299 --------PASLA-------KVNDP-----------QIKGFIEKCLVP-ASERLSAKDLL 331
P +A VN+P + + F++KCL ER K+L
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 332 KDPFLQ 337
K PF++
Sbjct: 286 KHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 74/209 (35%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 79 VRYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
RY + +G GA+ V AFD G +VA K+ Q ++ Y E+ LLK +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMD 72
Query: 137 DDNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+NV+ F + + + V ++T L + +L K K D I+ QIL G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSD-DHIQFLVYQILRG 130
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMA 249
L Y+HS IIHRDLK NI VN + E+KI D GLA + T + G T + A
Sbjct: 131 LKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWYRA 183
Query: 250 PE--LYEEEYNELVDIYSFGMCIL-EMVT 275
PE L YN+ VDI+S G CI+ E++T
Sbjct: 184 PEIMLNWMHYNQTVDIWSVG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG+G + TVYK + G VA + +D P + E+ L+K LK +N+V+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62
Query: 143 FYKSWVDDKKKTVNMITELF--TSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLH 197
+ D T N + +F +L++Y H +D +K++ Q+L G+ + H
Sbjct: 63 LH-----DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LY 253
+ ++HRDLK N+ +N GE+K+ D GLA A P T + + T + AP+ L
Sbjct: 118 ENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 254 EEEYNELVDIYSFGMCIL-EMVT 275
Y+ +DI+S G CI+ EM+T
Sbjct: 175 SRTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 36/286 (12%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+DP+G + EV+G G + VYK G A +K+ DV + + +++ E+++
Sbjct: 12 RDPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTE--DEEEEIKLEINM 65
Query: 132 LKSLKDD-NVVKFYKSWV-------DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
LK N+ +Y +++ DD+ + ++ E +G++ K K +K +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQ---LWLVMEFCGAGSVTDLVKNTKGNALK--E 120
Query: 184 NW----ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
+W R+IL GL +LH+H +IHRD+K N+ + N EVK+ D G++ + + R
Sbjct: 121 DWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGR 177
Query: 240 --SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291
+ IGTP +MAPE+ + Y+ DI+S G+ +EM P + +P +
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALF 236
Query: 292 KVTSGIKPASLAKVNDPQIKGFIEKCLVPAS-ERLSAKDLLKDPFL 336
+ P +K + FIE CLV R S + LLK PF+
Sbjct: 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 84 VLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
VLG GAF TVYK E I VA +K+ P +++ E +++ S+ +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVA---IKVLREETSPKANKEILDEAYVMASVDHPH 70
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHS 198
VV+ + V +IT+L G L Y + HK N+ + + NW QI G+ YL
Sbjct: 71 VVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 199 HNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQPTARSVIGT----P-EFMAPE- 251
++HRDL N+ V H VKI D GLA + + P ++MA E
Sbjct: 128 KR--LVHRDLAARNVLVKTPQH--VKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
+ Y D++S+G+ + E++TF PY
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 38/231 (16%)
Query: 83 EVLGKGAFKTVYKA-FDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
+ LG G+F V + + G I VA +K D + + D K E ++ SL +N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHEN 57
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLH 197
+++ Y + M+TEL G+L +K I + ++A QI +G+ YL
Sbjct: 58 LIRLYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-------------PTARSVIGT 244
S IHRDL NI + + +VKIGD GL A+ Q P A
Sbjct: 115 SKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFA------ 165
Query: 245 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
+ APE L ++ D++ FG+ + EM T+ E P++ + +QI KK+
Sbjct: 166 --WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 21/256 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIE-VAWSRVKI------DDVLQLPGDLQKLYSEVHLLK-S 134
E LG GAF VYK + G +A + + D + + + SEV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQIL 190
L+ N+V++YK+++++ + + M +L L ++ ++K + + I N Q++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVM--DLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFM 248
L YLH I+HRDL +NI + G +V I D GLA +QP ++ SV+GT +
Sbjct: 124 LALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTILYS 180
Query: 249 APELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
PE+ + E Y E D+++FG + +M T + P+ N + K+ + +
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYS 239
Query: 308 PQIKGFIEKCLVPASE 323
+ I CL P +E
Sbjct: 240 EDVTDVITSCLTPDAE 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 77 RYVRYDEVLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
RY++ VLG+G F V Y ++ G VA +K + Q +K E+++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
K+L +N+VK+ + K + +I E G+LR Y KH +++ + +A+QI G
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEG 119
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RSVIGTPE 246
+ YLHS + IHRDL N+ ++ N VKIGD GLA A+ P R +P
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVREDGDSPV 174
Query: 247 F-MAPE-LYEEEYNELVDIYSFGMCILEMVT 275
F A E L E +++ D++SFG+ + E++T
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 54/290 (18%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVK-----IDDVLQLPGDLQKLYSEVHLLKSLKDD- 138
+G+G F V KA G A +K ++ V L E+ L+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR--------EIQALRRLSPHP 58
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLH 197
N+++ + D K + ++ EL NL + K K + K +K++ Q+L L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE--LY 253
+ I HRD+K +NI + + +K+ D G I + P I T + APE L
Sbjct: 118 RNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EYISTRWYRAPECLLT 172
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFK----------KVTSGIKPASL 302
+ Y +DI++ G E+++ +P N QI K +V + +
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSL-FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231
Query: 303 AKVNDPQIKGF-IEKCLVPAS----------------ERLSAKDLLKDPF 335
N P KG + K L AS ER++AK L+ P+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 77 RYVRYDEVLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
R++++ + LGKG F +V Y + G VA +++ L+ E+ +L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEIL 59
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH 191
KSL+ DN+VK+ ++ + ++ E G+LR Y +KH+ +D + + +A QI
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE----- 246
G+ YL S +HRDL NI V + VKIGD GL + Q + P
Sbjct: 120 GMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 247 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIF 290
+ APE L E +++ D++SFG+ + E+ T YS+ +P F
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQK----- 124
S RY++ LG+G + V KA+D G VA +VKI ++ + D Q
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 125 ----LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
E+ ++ +K +N++ +V + +N++ ++ + +L++ + +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTES 119
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---------- 230
+K QIL+GL LH +HRDL NIF+N + G KI D GLA
Sbjct: 120 QVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSD 176
Query: 231 -IAMQQPTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 270
++ + R T + + APEL E+Y+ VD++S G CI
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 48/294 (16%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAW--SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN- 139
E +G+G + VYKA D+ G VA +R+++D+ P L+ E+ LL+ L +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIY 62
Query: 140 VVKFYKSWVDDKKKTVNMITELFT--SGNLRQY-----RKKHKNVDIKVIKNWARQILHG 192
+V+ ++K + +F +L+++ R + + K IK++ Q+L G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV--IGTPEFMAP 250
+ + H H ++HRDLK N+ V+ G +KI DLGL A P I T + AP
Sbjct: 123 VAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 251 E--LYEEEYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFK-------KVTSGI- 297
E L Y+ VDI+S G EM + + SE + IFK +V G+
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 298 -----------KPASLAKVN---DPQIKGFIEKCLV--PASERLSAKDLLKDPF 335
KP L++ P+ ++K L PA +R+SAK L P+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
+G+G + VYKA D+ G VA +V++D+ + G E+ +L+ L N+V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 144 YKSWVDDKKKTVNMITE-----------------LFTSGNLRQYRKKHKNVDIKVIKNWA 186
K V DK+ ++ + L SG L + + H IK++
Sbjct: 72 -KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFM 122
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVI 242
+Q+L GL Y H N +HRD+KC NI +N N G++K+ D GLA +P VI
Sbjct: 123 KQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 243 GTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 275
T + PEL EE Y +D++S G CIL E+ T
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
E +G GA+ V A D +G +VA KI +P ++ E+ +L+ K DN++
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 142 ---KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+ D K V ++ +L S +L + + + I+ + Q+L GL Y+HS
Sbjct: 68 AIRDILRPPGADFK-DVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV-----IGTPEFMAPEL 252
N +IHRDLK N+ VN + E++IGD G+A PT + T + APEL
Sbjct: 126 AN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 253 Y--EEEYNELVDIYSFGMCIL-EMV 274
EY +D++S G CI EM+
Sbjct: 183 LLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 10/184 (5%)
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VD 178
++ E LL +K N+V F +S+ D + M E G+L Q K +
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFP 98
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
I W Q+ G+ H H ++HRD+K NIF+ N G+VK+GD G A + P A
Sbjct: 99 EDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155
Query: 239 RSV--IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295
+ +GTP ++ PE++E YN DI+S G + E+ T ++P+ I K
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 296 GIKP 299
KP
Sbjct: 216 SYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 79/287 (27%), Positives = 141/287 (49%), Gaps = 38/287 (13%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL-QKLYSEVHL 131
DPS + E +GKG + V+K ++ G + A VKI D + D+ +++ +E ++
Sbjct: 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIH---DIDEEIEAEYNI 67
Query: 132 LKSLKDD-NVVKFYKSWVDDKKKTVN---MITELFTSGNL----RQYRKKHKNVDIKVIK 183
LK+L D NVVKFY + K + ++ EL G++ + + K+ + ++ +I
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SV 241
+ L GL +LH IHRD+K +NI + G VK+ D G++ + R +
Sbjct: 128 YILHEALMGLQHLH--VNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 242 IGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295
+GTP +MAPE+ + Y+ D++S G+ +E+ + P ++ +P + K+
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPR 243
Query: 296 GIKPASLAKVNDPQI-----KGFIEKCLVPASE-RLSAKDLLKDPFL 336
P ++ P++ FI KCL E R + DLL+ F+
Sbjct: 244 NPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 58/297 (19%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKSLKDDN 139
V+G+GA+ V K ++ G VA + K D+ ++ + EV +L+ L+ +N
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-----KTALREVKVLRQLRHEN 61
Query: 140 VVKF---YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
+V ++ K + ++ E L + ++++ Q+L + Y
Sbjct: 62 IVNLKEAFRR-----KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPELY 253
HSHN IIHRD+K +NI V+ G +K+ D G A A++ A + T + APEL
Sbjct: 117 HSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 254 --EEEYNELVDIYSFGMCIL-EMVTFE--YP-----------------------YSECKN 285
+ Y + VD+++ G CI+ E++ E +P N
Sbjct: 174 VGDTNYGKPVDVWAIG-CIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 286 PAQIFKKVTSGIKPASL-----AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
P +P SL KV+ P + F++ CL ERL+ +LL+ P+
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 53/177 (29%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNW 185
EV +L ++K N+V++ +S+ ++ + ++ + G+L + + V I +W
Sbjct: 49 EVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 243
QI L H H+ I+HRD+K NIF+ G +K+GD G+A + AR+ IG
Sbjct: 107 FVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 244 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299
TP +++PE+ E YN DI++ G + EM T ++ + E N + K+ G P
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 41/99 (41%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVI 242
+ QI+ GL +LH II+RDLK +N+ ++ N G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 280
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 64/289 (22%), Positives = 120/289 (41%), Gaps = 46/289 (15%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
V+G+GAF V+ D+ G A ++ D+++ + + +E +L +VK
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADADSPWIVKL 66
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
Y S+ D++ + ++ E G+L + + + + +++ L +H
Sbjct: 67 YYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--F 122
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-----------------------------Q 234
IHRD+K DNI + G +K+ D GL M +
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 235 QPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQI 289
Q A S +GTP+++APE L Y D +S G+ + EM+ + +P YS+ +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--TLQET 238
Query: 290 FKKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL-SAKDLLKDPF 335
+ K+ + + P+ I + L +RL S +++ PF
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRV---KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
+G+GA V+KA D G VA +V +++ + E+ L++ + VV
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-----ALREIKALQACQHPYVV 62
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
K + ++ E S R + + + +K++ R +L G+ Y+H++
Sbjct: 63 KLLDVFPHGS--GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG- 119
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV---IGTPEFMAPELY--EEE 256
I+HRDLK N+ + G +KI D GLA + R + T + APEL +
Sbjct: 120 -IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 257 YNELVDIYSFGMCIL-EM 273
Y+ VD+++ G CI E+
Sbjct: 178 YDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 34/286 (11%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL-QKLYSEVHL 131
DP+ + E +GKG + VYK ++ G A VKI D + D+ +++ +E ++
Sbjct: 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPIS---DVDEEIEAEYNI 71
Query: 132 LKSLKDD-NVVKFYKSWVDDKKKT---VNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
L+SL + NVVKFY + K + ++ EL G++ + K ++ +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 188 QILHG--LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIG 243
IL+G L H HN IIHRD+K +NI + G VK+ D G++ + R + +G
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 244 TPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297
TP +MAPE+ Y+ Y+ D++S G+ +E+ + P + +P + K+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNP 249
Query: 298 KPASLAKVNDPQ-----IKGFIEKCLVPASE-RLSAKDLLKDPFLQ 337
P L P+ FI +CL+ E R S LL+ PF++
Sbjct: 250 PPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVI 242
+A QI+ GL H H I++RDLK +N+ ++ +HG V+I DLGLA+ + +
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 243 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP---YSECKNPAQIFKKVTSGIK 298
GTP +MAPE L E Y+ VD ++ G + EM+ P E ++ ++
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--M 213
Query: 299 PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDLLKDPFLQ 337
P+ K E L +RL SA ++ + P +
Sbjct: 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 21/273 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKF 143
+G+GAF TV K + +G +A R++ + + ++L ++ ++ D +VKF
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK---EQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 144 YKSWVDDKKKTVNMITELFTSG--NL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
Y + + + M EL Y + +++ A + L YL
Sbjct: 69 YGALFREGDCWICM--ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE- 125
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPELYEEE-- 256
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE +
Sbjct: 126 ELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 257 --YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIK 311
Y+ D++S G+ + E+ T ++PY + + +V G I S + P
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244
Query: 312 GFIEKCLVPASE-RLSAKDLLKDPFLQVENQKE 343
FI CL+ R K+LL+ PF++ ++
Sbjct: 245 NFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 44/291 (15%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKI------DDVLQLPGDLQKLYSEVHLLKSLKDD 138
+G GA TVYK G A +K+ D V + ++ E+ +L+ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA---LKVIYGNHEDTVRR------QICREIEILRDVNHP 132
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
NVVK + + D + ++ E G+L + + + + ARQIL G+ YLH
Sbjct: 133 NVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVARQILSGIAYLHR 186
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---PTARSVIGTPEFMAPELYEE 255
+ I+HRD+K N+ +N VKI D G++ + Q P SV GT +M+PE
Sbjct: 187 RH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT 242
Query: 256 EYNELV------DIYSFGMCILE--MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
+ N DI+S G+ ILE + F + + A + + P + A +
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS- 301
Query: 308 PQIKGFIEKCLV--PASERLSAKDLLKDPFL----QVENQKEPICDPLKLP 352
+ + FI CL PA +R SA LL+ PF+ + Q P L P
Sbjct: 302 REFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351
|
Length = 353 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 34/235 (14%)
Query: 85 LGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
LG+G+F VY+ VA +K + + + +E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVA---IKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKV--------IKNWARQI 189
VV+ V + T+ ++ EL G+L+ Y + + + A +I
Sbjct: 71 VVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-----PTARSVIGT 244
G+ YL + +HRDL N V + VKIGD G+ + + + ++
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 245 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
P +MAPE L + + D++SFG+ + EM T E PY N ++ K V G
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 77/322 (23%), Positives = 136/322 (42%), Gaps = 56/322 (17%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
D RY+ LG G+ V+ A D VA ++ + D P ++ E+ ++
Sbjct: 2 DLGSRYMDL-RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKII 56
Query: 133 KSLKDDNVVKFYKSWVD---DKKKTVNMITELFTSGNLRQYRK-------KHKNVDIKVI 182
+ L DN+VK Y+ D + V +TEL + +++Y + + + +
Sbjct: 57 RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA 116
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-- 240
+ + Q+L GL Y+HS N ++HRDLK N+F+N +KIGD GLA + +
Sbjct: 117 RLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 241 ---VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT------------------- 275
+ T + +P L Y + +D+++ G CI EM+T
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 276 -----FEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLVPA-SERLS 326
E +E N F + G L + +P+ F+E+ L +RL+
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 327 AKDLLKDPFLQVEN--QKEPIC 346
A++ L P++ + EP+
Sbjct: 294 AEEALMHPYMSCYSCPFDEPVS 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG G F V++ + + VA +K DD+L+ D QK EV LK L+ +++ +
Sbjct: 14 LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQ-QDFQK---EVQALKRLRHKHLISLF 68
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
V + V +ITEL G+L + + + + + + + + A Q+ G+ YL N
Sbjct: 69 A--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN-- 124
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNE 259
IHRDL NI V G K+ D GLA +++ + ++ APE ++
Sbjct: 125 SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 260 LVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
D++SFG+ + EM T+ + PY N +++ ++T+G
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +G+G + VYKA D +A +++++ + G E+ LLK ++ N+V+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHN 200
V +K + ++ E + +L+++ + + ++IK + QIL G+ Y HSH
Sbjct: 66 LQD--VVHSEKRLYLVFE-YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEE 256
++HRDLK N+ ++ +K+ D GLA A P T + T + APE L
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180
Query: 257 YNELVDIYSFGMCILEMVT 275
Y+ VDI+S G EMV
Sbjct: 181 YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNW 185
E ++K L+ +++ Y V ++ + ++TEL G+L +Y + + + + +
Sbjct: 51 EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 243
A Q+ G+ YL + N IHRDL N+ V G + K+ D GLA I AR
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 244 TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
P ++ APE YN D++SFG+ + E+VT+ PY N A++ ++V G
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 71/267 (26%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 84 VLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDD 138
VLGKG+F V K DE ++V +K D +LQ D++ +E +L + K
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQ-DDDVECTMTEKRVLALAGKHP 56
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+ + + + K + + E G+L + ++ D + +A +I+ GL +LH
Sbjct: 57 FLTQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEE 255
II+RDLK DN+ ++ G +KI D G+ T + GTP+++APE L +
Sbjct: 115 RG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGF 313
Y VD ++ G+ + EM+ + P+ E + ++F+ + P L+K +K F
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230
Query: 314 IEKCLVPASERLSA-----KDLLKDPF 335
+ K +RL +D+ PF
Sbjct: 231 LTK---NPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 90/323 (27%), Positives = 141/323 (43%), Gaps = 53/323 (16%)
Query: 79 VRYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
RY + +G GA+ +V AFD G+ VA K+ Q ++ Y E+ LLK +K
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMK 74
Query: 137 DDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+NV+ + + V ++T L +L K K D V + QIL G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHV-QFLIYQILRG 132
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMA 249
L Y+HS + IIHRDLK N+ VN + E+KI D GLA + T + G T + A
Sbjct: 133 LKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA----RHTDDEMTGYVATRWYRA 185
Query: 250 PELYEE--EYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPASLAKV 305
PE+ YN+ VDI+S G + E++T +P ++ + ++ ++ L K+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 306 N--------------------------DPQIKGFIEKCLVPASE-RLSAKDLLKDP-FLQ 337
+ +P +EK LV S+ R++A L F Q
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
Query: 338 VEN-QKEPICDPLKLPIQSLKML 359
+ EP+ DP +S +L
Sbjct: 306 YHDPDDEPVADPYDQSFESRDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 84 VLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
VLGKG+F V K +EF I+ +K D VL+ D++ E +L +L ++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA----LKKDVVLE-DDDVECTMVERRVL-ALAWEH 55
Query: 140 --VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+ + ++ K+ + + E G+L + + D + +A +I+ GL +LH
Sbjct: 56 PFLTHLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYE- 254
II+RDLK DN+ ++ + G +KI D G+ + A + GTP+++APE+ +
Sbjct: 114 KKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSEC 283
++YNE VD +SFG+ + EM+ + P+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 73/209 (34%), Positives = 106/209 (50%), Gaps = 24/209 (11%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKS 134
+Y+ V +G GA+ TVYKA D +G VA V++ +D L L EV LLK
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL-----STVREVALLKR 55
Query: 135 LKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWA 186
L+ N+V+ + D++ V ++ E +LR Y K + + IK+
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTP 245
RQ L GL +LH++ I+HRDLK +NI V + G+VK+ D GLA I Q V+ T
Sbjct: 115 RQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTL 171
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEM 273
+ APE L + Y VD++S G EM
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 87/325 (26%), Positives = 144/325 (44%), Gaps = 63/325 (19%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y+ + LGKGA+ V+KA D VA KI D + D Q+ + E+ L+ L D
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 138 -DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLV 194
N+VK + K + ++ E + +L + + ++V + I Q+L L
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYI---MYQLLKALK 121
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEF 247
Y+HS N +IHRDLK NI +N + VK+ D GLA + P + T +
Sbjct: 122 YIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 248 MAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKKVTSGIKPAS- 301
APE L Y + VD++S G CIL EM+ + +P + N Q+ K + P++
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVG-CILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSAE 235
Query: 302 -------------LAKVNDPQIKG--------------FIEKCLV--PASERLSAKDLLK 332
L + K ++K LV P ++RL+A++ L+
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP-NKRLTAEEALE 294
Query: 333 DPFLQ--VENQKEPICD-PLKLPIQ 354
P++ EP+ P+ +P+
Sbjct: 295 HPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 69/224 (30%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNV 140
LG+G F VYKA G VA ++ + + P + E+ +LK LK NV
Sbjct: 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKLKHPNV 69
Query: 141 VKFYKSWVD------DKKKTVNMITELFT---SGNLRQYRKKHKNVDIKV----IKNWAR 187
V V+ K+ +V M+T SG L +N +K+ IK +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-------ENPSVKLTESQIKCYML 122
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI----AMQQPTARSVIG 243
Q+L G+ YLH ++ I+HRD+K NI ++ N G +KI D GLA P G
Sbjct: 123 QLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 244 TPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 275
T ++ PEL E Y VDI+ G C+ EM T
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 71/294 (24%), Positives = 133/294 (45%), Gaps = 48/294 (16%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSR-VKIDDVLQLPGDLQKL-YSEVHLLKSL 135
+Y+++ +G+G++ V+K + G VA + V+ +D + +K+ E+ +LK L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI----KKIALREIRMLKQL 57
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
K N+V + V +K+ ++++ E L + K + V +IK Q L + +
Sbjct: 58 KHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY 253
H HN IHRD+K +NI + G++K+ D G A + P + T + APEL
Sbjct: 116 CHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 254 --EEEYNELVDIYSFGMCILEMVTFE--YPYSE---------------CKNPAQIFK--K 292
+ +Y VD+++ G E++T + +P QIF +
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 293 VTSGIK----------PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPF 335
G+ + ++ P + F++ CL +ERLS ++LL+ P+
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALS-FLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 40/101 (39%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSV 241
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL + T+ +
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTS-TF 161
Query: 242 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS 281
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 82 DEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+G+G F VY+ E I VA K P +K E ++++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHP 67
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLH 197
++VK ++ V ++ EL G LR Y + +K +D+ + ++ Q+ L YL
Sbjct: 68 HIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTP-EFMAPE-LY 253
S +HRD+ N+ V+ VK+GD GL+ ++ + S P ++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 254 EEEYNELVDIYSFGMCILEMVTF 276
+ D++ FG+C+ E++
Sbjct: 182 FRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 82/292 (28%), Positives = 137/292 (46%), Gaps = 50/292 (17%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +G+G + VYK ++ G VA +++++ + G E+ LLK L+ N+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVC 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYR---KKHKNVDIKVIKNWARQILHGLVYLHSH 199
+ + + + +I E F S +L++Y K + +D +++K++ QIL G+++ HS
Sbjct: 64 LQDVLMQESR--LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE--LY 253
++HRDLK N+ ++ N G +K+ D GLA A P T V T + APE L
Sbjct: 121 R--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLG 175
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPY----SECKNPAQIFKKV---TSGIKP------- 299
Y+ VDI+S G EM T + P SE +IF+ + T + P
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 300 --ASLAKVNDPQIKGF-----------IEKCLV--PASERLSAKDLLKDPFL 336
+ K ++ +EK L+ PA +R+SAK L P+
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA-KRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-15
Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 32/234 (13%)
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-RQYRKKHK---NVDI 179
+L EV++++ LK N+V++ +++ + + ++ E +G+L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 180 KVIKNWARQILHGLVYLHS-----HNPPIIHRDLKCDNIFV--------------NGNHG 220
I + RQ+LH L Y H+ + ++HRDLK NIF+ N +G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 221 E--VKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 274
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 275 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSA 327
+ + P+ + N +Q+ ++ G P K ++ I+ L + A ER SA
Sbjct: 238 SGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 178
P ++ E+ +L +V FY ++ D + ++ M E G+L Q K+ K +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIP 101
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
+++ + +L GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 239 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP 279
S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y++ D+ LG+G + TVYK + VA ++++ P + EV LLK LK
Sbjct: 8 YIKLDK-LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 63
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYL 196
N+V + + +K++ ++ E + +L+QY N +++ +K + Q+L GL Y
Sbjct: 64 ANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE--L 252
H ++HRDLK N+ +N GE+K+ D GLA A PT + + T + P+ L
Sbjct: 121 HRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
Query: 253 YEEEYNELVDIYSFGMCILEMVT 275
+Y+ +D++ G EM T
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 26/279 (9%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
RY + EV+GKG++ V A D G +VA KI+DV + D ++ E+ LL+ L+
Sbjct: 1 RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLR 57
Query: 137 DDNVVKFYKSWVDDKKKTVN---MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
++V+ + ++ ++ EL S +L Q K + ++ + + + Q+L L
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-----IGTPEFM 248
Y+H+ N + HRDLK NI N + ++KI D GLA T ++ + T +
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 249 APEL---YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASL 302
APEL + +Y +DI+S G CI V P KN +T + P ++
Sbjct: 174 APELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 303 AKVNDPQIKGFI----EKCLVPASERLSAKDLLKDPFLQ 337
++V + + + ++ +K VP S++ D L L+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 11/231 (4%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG G V+K + +G+ +A + ++ P ++ E+ +L +V FY
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 204
++ D + ++ M E G+L Q KK + +++ + ++ GL YL + I+
Sbjct: 70 GAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126
Query: 205 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 263
HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 264 YSFGMCILEMVTFEYPY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
+S G+ ++EM YP + K +F G PA P+ G
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG-DPAESETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
YV+ D+ LG+G + TV+K + VA ++++ P + EV LLK+LK
Sbjct: 7 YVKLDK-LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKH 62
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYL 196
N+V + + ++ + ++ E S +L+QY N+ + +K + Q+L GL Y
Sbjct: 63 ANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE--L 252
H I+HRDLK N+ +N GE+K+ D GLA A PT + + T + P+ L
Sbjct: 120 HKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
Query: 253 YEEEYNELVDIYSFGMCILEMVT 275
EY+ +D++ G + EM T
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 9/154 (5%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
E+ +LK L+ +N+V + V +KK + ++ E L K +D ++ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 245
QIL G+ + HSHN IIHRD+K +NI V+ + G VK+ D G A +A + T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 246 EFMAPELY--EEEYNELVDIYSFGMCILEMVTFE 277
+ APEL + +Y VDI++ G + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKID---DVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
+G+G + VY+A D +G VA +V++D D + + E+ LL +L+ N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-----LREITLLLNLRHPNIV 69
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHN 200
+ + V ++ ++ E + +L +K Q+L GL YLH +
Sbjct: 70 ELKEVVVGKHLDSIFLVME-YCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELY--E 254
IIHRDLK N+ + G +KI D GLA P T + V T + APEL
Sbjct: 129 --IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGC 183
Query: 255 EEYNELVDIYSFGMCIL 271
Y +D+++ G CIL
Sbjct: 184 TTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 29/261 (11%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG G+F V A + G A +K ++L++ +Q + E +L L +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK-QVQHVAQEKSILMELSHPFIVN 82
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
S+ D+ + V + E G L + +K V K + +++ YLHS +
Sbjct: 83 MMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD-- 138
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELV 261
II+RDLK +N+ ++ N G VK+ D G A + T ++ GTPE++APE+ + + + + V
Sbjct: 139 IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-TLCGTPEYLAPEVIQSKGHGKAV 196
Query: 262 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA 321
D ++ G+ + E + P+ + P +I++K+ +G + P
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG-------------------RLKFPN 236
Query: 322 SERLSAKDLLKDPFLQVENQK 342
A+DL+K LQ ++ K
Sbjct: 237 WFDGRARDLVKG-LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 88 GAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKS 146
G + VY+A D+ G VA ++K++ + P + L E+++L L+ N+V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP--ITSL-REINILLKLQHPNIVTVKEV 72
Query: 147 WVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIH 205
V + M+ E + +L+ + K +K Q+L G+ +LH + I+H
Sbjct: 73 VVGSNLDKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILH 129
Query: 206 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELV 261
RDLK N+ +N N G +KI D GLA P ++ T + APEL +EY+ +
Sbjct: 130 RDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188
Query: 262 DIYSFGMCIL-EMVT 275
D++S G CI E++T
Sbjct: 189 DMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG+G++ TVYK + G VA ++++ P + E LLK LK N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNP 201
+ + KKT+ ++ E + +L+QY + + ++ + Q+L GL Y H
Sbjct: 68 LHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEY 257
++HRDLK N+ ++ GE+K+ D GLA A P T + + T + P+ L EY
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 258 NELVDIYSFGMCILEMVT 275
+ +D++ G EM T
Sbjct: 182 STSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 85 LGKGAFKTVYKAFD-EFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVK 142
+G+GA+ V+KA D + G VA RV++ + +P + + + L++ + NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 143 FYKSWVDDKKKTVNMITELF--TSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHS 198
+ + +T +F +L Y K V + IK+ Q+L GL +LHS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEE 256
H ++HRDLK NI V + G++K+ D GLA I Q SV+ T + APE L +
Sbjct: 129 HR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 257 YNELVDIYSFGMCILEM 273
Y VD++S G EM
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y++ ++ LG+G + TV+K + VA ++++ P + EV LLK LK
Sbjct: 8 YIKLEK-LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKH 63
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYL 196
N+V + + K++ ++ E + +L+QY N+ + +K + QIL GL Y
Sbjct: 64 ANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE--L 252
H ++HRDLK N+ +N GE+K+ D GLA A PT + + T + P+ L
Sbjct: 121 HRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177
Query: 253 YEEEYNELVDIYSFGMCILEMVT 275
EY+ +D++ G EM +
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 189 ILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPE 246
I+ L YL H +IHRD+K NI ++ + G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 247 FMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA- 300
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 301 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ P F++ CL +R ++LL+ PF++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 73/310 (23%), Positives = 131/310 (42%), Gaps = 62/310 (20%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF- 143
+G+GA+ V A + +VA KI + D ++ E+ LL+ L +NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 144 --YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
+ V ++ EL + +L Q + + + + + Q+L GL Y+HS N
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN- 128
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE 251
++HRDLK N+ +N N ++KI D GL AR+ +FM APE
Sbjct: 129 -VLHRDLKPSNLLLNAN-CDLKICDFGL--------ARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 252 LY--EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKKVTSGIKPASLAKVN 306
L EY +D++S G CI E++ + +P + + ++ ++ L +
Sbjct: 179 LLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 307 DPQIKGFI--------------------------EKCLV-PASERLSAKDLLKDPFLQV- 338
+ + + +I EK LV S+R++ ++ L P+L
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297
Query: 339 -ENQKEPICD 347
+ EP+C
Sbjct: 298 HDPSDEPVCQ 307
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSL 135
++ + LG G F V+ + G +VA +K PG + E ++K L
Sbjct: 8 LKLERKLGAGQFGEVWMGT--WNGTTKVAVKTLK-------PGTMSPEAFLQEAQIMKKL 58
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGL 193
+ D +V+ Y V +++ + ++TE + G+L + K + +++ + + A QI G+
Sbjct: 59 RHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAP 250
YL S N IHRDL NI V G + KI D GLA I + TAR P ++ AP
Sbjct: 117 AYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
Query: 251 E--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 286
E Y + D++SFG+ + E+VT+ PY N
Sbjct: 174 EAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
++ EL G L +Y KK + + + +K A Q+ G+ YL S + +HRDL N+ +
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV 129
Query: 217 GNHGEVKIGDLGLAIAM----QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 270
H + KI D G++ A+ A + P ++ APE + +++ D++S+G+ +
Sbjct: 130 NRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
Query: 271 LEMVTF-EYPYSECKNPAQIFKKVTSG 296
E ++ PY E K ++ + SG
Sbjct: 189 WEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWS-RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
++LGKG+F V+ A E G ++ + DV+ + D++ E +L SL ++
Sbjct: 1 KMLGKGSFGKVFLA--ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVL-SLAWEHPF 57
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
+ K+ + + E G+L + + D+ +A +I+ GL +LHS
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPE-LYEEEYN 258
I++RDLK DNI ++ + G +KI D G+ A++ GTP+++APE L ++YN
Sbjct: 117 -IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 259 ELVDIYSFGMCILEMVTFEYPY 280
VD +SFG+ + EM+ + P+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 83 EVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+VLG GAF TVYK E I VA +KI + P + E ++ S+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLH 197
++V+ + T+ ++T+L G L Y +HK N+ +++ NW QI G++YL
Sbjct: 70 HLVRLLGVCL---SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 198 SHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ----QPTARSVIGTPEFMAPE- 251
++HRDL N+ V NH VKI D GLA ++ + A ++MA E
Sbjct: 127 ERR--LVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF 276
++ ++ D++S+G+ I E++TF
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
E LL+++ +V++ + V M+ ++S K+ + + I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPE 246
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 247 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 286
APE L ++YN DI+S G+ + EM+ YP + ++P
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG+G++ TVYK + G VA +++ + P + E LLK LK N+V
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVL 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNP 201
+ + K+T+ ++ E + +L QY KH + + +K + Q+L GL Y+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEY 257
I+HRDLK N+ ++ + GE+K+ D GLA A P T + + T + P+ L EY
Sbjct: 124 -ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 258 NELVDIYSFGMCILEMV 274
+ +D++ G +EM+
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 10/209 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R+ VLGKG F V G A +++ + + G+ L +E +L+ +
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRF 61
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLR--QYRKKHKNVDIKVIKNWARQILHGLVYLH 197
VV ++ + K + ++ L G+L+ Y + D + +A +I GL LH
Sbjct: 62 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYE-E 255
I++RDLK +NI ++ ++G ++I DLGLA+ + + T R +GT +MAPE+ + E
Sbjct: 120 RER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECK 284
Y D + G I EM+ + P+ + K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 44/137 (32%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 242
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKP 299
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ + ++ ++F+ + + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 300 ASLAKVNDPQIKGFIEK 316
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 21/244 (8%)
Query: 83 EVLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKD 137
+VLGKG+F V K DE I+V +K D +LQ D+ +E +L + K
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQ-DDDVDCTMTEKRILALAAKH 55
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+ + + K + + E G+L ++ + D + +A ++ L++LH
Sbjct: 56 PFLTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYE 254
H +I+RDLK DNI ++ G K+ D G+ + T + GTP+++APE L E
Sbjct: 114 RHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKG 312
EY VD ++ G+ + EM+ + P+ E N +F+ + + P L+K +K
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA 229
Query: 313 FIEK 316
F+ K
Sbjct: 230 FMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +GKG F VYK + EVA + P +K E +LK N+VK
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
V K+ + ++ EL G+L + RKK + +K + + G+ YL S N
Sbjct: 57 LIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE----FMAPE-LYEEE 256
IHRDL N V N+ +KI D G++ + G + + APE L
Sbjct: 114 -CIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
Y D++S+G+ + E + + PY N Q +++ SG
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-13
Identities = 65/245 (26%), Positives = 118/245 (48%), Gaps = 30/245 (12%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEV 129
K+ + +Y VLG GA TV A G A VK+ D+ + D + +EV
Sbjct: 27 AKEQAKKYW-ISRVLGSGATGTVLCAKRVSDGEPFA---VKVVDMEGMSEADKNRAQAEV 82
Query: 130 HLLKSLKDDNVVKFYKSWV-DDKKKTVN-----MITELFTSGNLRQYRKKHKNVDIKVIK 183
L + ++VK ++ + D + N ++ + +G+LRQ K + +
Sbjct: 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFRE 142
Query: 184 NWARQILHGLVYL-------HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL----AIA 232
+ A GL+++ H H+ +IHRD+K NI + N G VK+GD G A
Sbjct: 143 HEA-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAAT 196
Query: 233 MQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291
+ R+ GTP ++APE++ + Y++ D++S G+ + E++T + P+ + +N ++
Sbjct: 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMH 255
Query: 292 KVTSG 296
K +G
Sbjct: 256 KTLAG 260
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+VLGKG+F V A + G A +K D VL + D++ E +L +L +N
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVL-ALAWENPFL 58
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ K+ + + E G+L + + D+ +A +I+ GL +LHS
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAI--AMQQPTARSVIGTPEFMAPELYE-EEYNE 259
II+RDLK DN+ ++ + G +KI D G+ A + GTP+++APE+ + +Y
Sbjct: 117 IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 260 LVDIYSFGMCILEMVTFEYPY 280
VD +SFG+ + EM+ + P+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 80 RYDEVL--GKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY ++ G GA+ TV A D G +VA K+ Q ++ Y E+ LLK +K
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 138 DNVVKFYKSWVDDKKKTVNMITEL-----FTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+NV+ + D +++ + F +L + KH+ + I+ Q+L G
Sbjct: 74 ENVIGLLDVFTPDL--SLDRFHDFYLVMPFMGTDLGKL-MKHEKLSEDRIQFLVYQMLKG 130
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE- 251
L Y+H+ IIHRDLK N+ VN E+KI D GLA V+ T + APE
Sbjct: 131 LKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWYRAPEV 186
Query: 252 -LYEEEYNELVDIYSFGMCILEMVT 275
L Y + VDI+S G + EM+T
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD----LQKLYSEVHLLK 133
RY +G+GA+ V A + G++VA ++ P + Q+ E+ +L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-------PFEHQTFCQRTLREIKILR 58
Query: 134 SLKDDNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 190
K +N++ + + V ++ EL + + + +H + D I+ + QIL
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSND--HIQYFLYQIL 116
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV----IGTP 245
GL Y+HS N ++HRDLK N+ +N N ++KI D GLA IA + + T
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 246 EFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 275
+ APE L + Y + +DI+S G CIL EM++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 78/321 (24%), Positives = 129/321 (40%), Gaps = 68/321 (21%)
Query: 68 DFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLY 126
+F D +Y + ++ G+G F V+KA + VA +V +++ + P + L
Sbjct: 4 EFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP--ITAL- 59
Query: 127 SEVHLLKSLKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
E+ +L+ LK +NVV + + K + ++ E K+ +
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS 119
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 236
IK + +L+GL Y+H + I+HRD+K NI + + G +K+ D GLA A
Sbjct: 120 EIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSK 176
Query: 237 ----TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFEYP---------- 279
T R V T + PEL E +Y +D++ G CI+ EM T P
Sbjct: 177 PNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT-RSPIMQGNTEQHQ 232
Query: 280 ------------------------YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315
+ + + P +KV +KP V DP I+
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLID 288
Query: 316 KCLV-PASERLSAKDLLKDPF 335
K LV ++R+ A L F
Sbjct: 289 KLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 82 DEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+VLG GAF TVYK E I VA +K P +++ E +++ S+ +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDN 68
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYL 196
+V + + TV +IT+L G L Y ++HK N+ + + NW QI G+ YL
Sbjct: 69 PHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 125
Query: 197 HSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE 251
++HRDL N+ V H VKI D GLA + + + G P ++MA E
Sbjct: 126 EERR--LVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
+ Y D++S+G+ + E++TF PY
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E LG+G++ TVYK G VA + + +P + E LLK LK N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNP 201
+ + K+T+ + E + +L QY +H + ++ + Q+L GL Y+H +
Sbjct: 68 LHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEY 257
I+HRDLK N+ ++ GE+K+ D GLA A P T S + T + P+ L +Y
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 258 NELVDIYSFGMCILEMV 274
+ +DI+ G +EM+
Sbjct: 182 SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL--QKLYSEVHLLKSLKDDNVVK 142
LG G F V+ + +VA +K PG + Q E +L+K+L+ D +V+
Sbjct: 14 LGAGQFGEVWMGYYN-NSTKVAVKTLK-------PGTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
Y V K++ + +ITE G+L + K + + + K +++ QI G+ Y+ N
Sbjct: 66 LYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPELYE-EE 256
IHRDL+ N+ V+ KI D GLA I + TAR P ++ APE
Sbjct: 124 --YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKN 285
+ D++SFG+ + E+VT+ + PY N
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 41/140 (29%), Positives = 80/140 (57%), Gaps = 9/140 (6%)
Query: 150 DKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 207
+ K + ++ L G+L+ Y + ++++ + +++ QI G+++LHS + I++RD
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRD 120
Query: 208 LKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIY 264
+K +N+ ++ G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ VD +
Sbjct: 121 MKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWF 178
Query: 265 SFGMCILEMVTFEYPYSECK 284
+ G I EMV P+ + K
Sbjct: 179 AMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 40/129 (31%), Positives = 70/129 (54%), Gaps = 5/129 (3%)
Query: 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217
I +L G+L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 218 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 275
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 276 FEYPYSECK 284
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 54/299 (18%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
D +G GAF V+ D G VA K+ +V Q ++++ E+ +L K DNV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 142 KFYKSWVD-------DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
S +D D + + ++TEL S +L + + + +K + QIL GL
Sbjct: 63 ----SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV---IGTPEFMAPE 251
YLHS I+HRD+K N+ VN N +KI D GLA + ++ + + T + APE
Sbjct: 118 YLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 252 LY--EEEYNELVDIYSFGMCI-------------------LEMVT-------FEYPYSEC 283
+ Y VDI+S G CI L+++T E S C
Sbjct: 175 ILMGSRHYTSAVDIWSVG-CIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 284 KNP-AQIFKKVTSGIKPASLAKVNDP---QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337
+ A I + L ++ + + + LV +R+SA D L P+L
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
LG G + VY+ + + VA +K D + ++++ E ++K +K N+V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
V ++ +ITE T GNL Y + V+ V+ A QI + YL N
Sbjct: 69 G--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPE-LYEEEYN 258
IHRDL N V G + VK+ D GL+ M T + G ++ APE L +++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 259 ELVDIYSFGMCILEMVTF---EYP 279
D+++FG+ + E+ T+ YP
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R VLGKG F V G A R++ + + G+ L +E +L+ +
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-NEKQILEKVNSQF 61
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLR--QYRKKHKNVDIKVIKNWARQILHGLVYLH 197
VV ++ + K + ++ + G+L+ Y + + + +A +IL GL LH
Sbjct: 62 VVNL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPE-LYEE 255
N ++RDLK +NI ++ ++G ++I DLGLA+ + + + R +GT +MAPE L +
Sbjct: 120 REN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 256 EYNELVDIYSFGMCILEMVTFEYPY 280
Y D + G I EM+ + P+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG G F V+ + ++V I + Q + +E +L+K L+ +V+
Sbjct: 12 KKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
Y ++ + +ITE +G+L + K + + + + K + A QI G+ ++ N
Sbjct: 66 LYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE-LYEEE 256
IHRDL+ NI V+ KI D GLA I + TAR P ++ APE +
Sbjct: 123 --YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
+ D++SFG+ + E+VT+ PY NP I
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 66/241 (27%), Positives = 119/241 (49%), Gaps = 15/241 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--V 140
VLGKG+F V A + +G A +K D +LQ D++ +E +L SL ++ +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRIL-SLARNHPFL 58
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
+ Y + + + + E G+L + +K + D + +A +I L++LH
Sbjct: 59 TQLYCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEY 257
II+RDLK DN+ ++ + G K+ D G+ T + GTP+++APE L E Y
Sbjct: 117 --IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIE 315
VD ++ G+ + EM+ P+ E +N +F+ + + + P L++ +K F+
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMT 232
Query: 316 K 316
K
Sbjct: 233 K 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 116 LQLPGDLQKLY--SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQ 169
+ L + Q Y SE+H L + +VK + + D K + +I E + G+L +Q
Sbjct: 101 VMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQ 158
Query: 170 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
K+H + QI+ L +HS ++HRDLK NIF+ G +K+GD G
Sbjct: 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGF 215
Query: 230 AI----AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 284
+ ++ A S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---K 272
Query: 285 NPAQ--IFKKVTSG 296
P+Q I ++V G
Sbjct: 273 GPSQREIMQQVLYG 286
|
Length = 478 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R VLGKG F V G A +++ + + G+ L +E +L+ +
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-NEKQILEKVNSRF 61
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLR--QYRKKHKNVDIKVIKNWARQILHGLVYLH 197
VV ++ + K + ++ L G+L+ Y + +A +I GL LH
Sbjct: 62 VVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYE-E 255
I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +GT +MAPE+ + E
Sbjct: 120 QER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECK 284
Y D ++ G + EM+ + P+ + K
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 74/248 (29%), Positives = 118/248 (47%), Gaps = 20/248 (8%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
RY +V G GA+ +V A D+ G +VA K+ Q ++ Y E+ LLK ++
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 137 DDNVVKFYKSWV-----DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILH 191
+NV+ + D+ + ++ + T +L++ + D ++ Q+L
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT--DLQKIMGHPLSED--KVQYLVYQMLC 128
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE 251
GL Y+HS IIHRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 129 GLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWYRAPE 184
Query: 252 --LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KVTSGIKPASLAKVND 307
L YN+ VDI+S G + EM+T + + Q+ + KVT P + K+ D
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 308 PQIKGFIE 315
K +I+
Sbjct: 245 KAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/267 (25%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 83 EVLGKGAFKTV----YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+V+GKG+F V +KA ++F ++V + +L+ + + LLK++K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA----ILKKKEEKHIMSERNVLLKNVKHP 56
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V + S+ K + + + G L + ++ + + +A +I L YLHS
Sbjct: 57 FLVGLHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 114
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEE 255
N I++RDLK +NI ++ + G + + D GL + T + GTPE++APE L+++
Sbjct: 115 LN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315
Y+ VD + G + EM+ + P +N A+++ + + KP L + +E
Sbjct: 172 PYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLE 228
Query: 316 KCLVP-ASERLSAKDLLKDPFLQVENQ 341
L ++RL A KD F++++N
Sbjct: 229 GLLQKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217
I +L G+L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 218 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 275
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 276 FEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL-----SAK 328
P+ + K + ++T + L P+++ +E L + RL A+
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250
Query: 329 DLLKDPFLQ 337
++ + PF +
Sbjct: 251 EVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 17/247 (6%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
RY V G GA+ +V A+D +VA K+ Q ++ Y E+ LLK +K
Sbjct: 16 RYQNLTPV-GSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMK 72
Query: 137 DDNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+NV+ F + + V ++T L +L K K D + ++ Q+L G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD-EHVQFLIYQLLRG 130
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE- 251
L Y+HS IIHRDLK N+ VN + E++I D GLA + T + APE
Sbjct: 131 LKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADDEMT-GYVATRWYRAPEI 186
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308
L YN+ VDI+S G + E++ + +P ++ + + +V P L K++
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246
Query: 309 QIKGFIE 315
+ +I+
Sbjct: 247 HARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEY 257
H IHRDLK +N F+ G +K+ D GL+ + A SV+G+P++MAPE L + Y
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGY 175
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK------ 311
+ VD +S G C+L +P P + ++ + + +DP+
Sbjct: 176 DFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 312 GFIEKCLVPASERL-SAKDLLKDPF 335
I K + S R S +D+ PF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 120 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKN 176
G +E H+L+++ ++++ ++ T N T L +L Y +N
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAM 233
+ I I R +L + YLH IIHRD+K +NIF+N + G+V +GD G A + +
Sbjct: 179 IAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDI 235
Query: 234 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 275
GT APEL + Y VDI+S G+ + EM T
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 31/235 (13%)
Query: 85 LGKGAFKTVYK--AFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
LG GAF VY+ A D I VA ++ Q + ++ E HL+ +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ---EKKEFLKEAHLMSNFNHP 59
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILH 191
N+VK + ++ +I EL G+L Y + + + +K + + +
Sbjct: 60 NIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLAIAMQQPTARSVIGTP-- 245
G VYL + IHRDL N V+ + VKIGD GLA + + G
Sbjct: 118 GCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 246 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+MAPE L + ++ D++SFG+ + E++T + PY N ++ + VT+G
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 119 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK--KH 174
PG + + E ++K L+ D +V+ Y ++ + ++TE + G+L + K +
Sbjct: 40 PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEG 96
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 232
+ + + + + A Q+ G+ Y+ N IHRDL+ NI V G+ KI D GLA I
Sbjct: 97 RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIE 153
Query: 233 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 288
+ TAR P ++ APE LY + D++SFG+ + E+VT PY N +
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-RE 211
Query: 289 IFKKVTSGIK-------PASLAKV 305
+ ++V G + P SL ++
Sbjct: 212 VLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 242
+ +I+ L YLHS + +++RD+K +N+ ++ G +KI D GL T ++
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 280
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIE-------VAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ LG+GAF V KA E G++ VA +K D + DL L SE+ ++K
Sbjct: 17 GKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEK---DLSDLVSEMEMMKM 71
Query: 135 L-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNV 177
+ K N++ + V + E GNLR + + + +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IA 232
K + ++A Q+ G+ +L S IHRDL N+ V +H +KI D GLA I
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHID 186
Query: 233 MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 279
+ T + ++MAPE L++ Y D++SFG+ + E+ T YP
Sbjct: 187 YYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----------PT 237
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 238 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 280
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 242
+A +I L YLHS N II+RDLK +NI ++ + G V + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 243 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 301
GTPE++APE L ++ Y+ VD + G + EM+ + P ++ A+++ + + KP
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLR 214
Query: 302 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 333
L + +E L ++RL AKD +
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G + VYKA + E ++ +I+ G E+ LL+ LK NV+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQ 64
Query: 145 KSWVDDKKKTVNMITE--------LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
K ++ + V ++ + + + KK + ++K+ QIL G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 197 HSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPTA-----RSVIGTPEFM 248
H++ ++HRDLK NI V G G VKI D+G A P V+ T +
Sbjct: 125 HAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 249 APELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 284
APEL Y + +DI++ G E++T E P C+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
++LGKG F V ++ +G A +K +V+ ++ +E +LK+ + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
S+ K + + E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEE-EYNE 259
I++RDLK +N+ ++ + G +KI D GL T ++ GTPE++APE+ E+ +Y
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 260 LVDIYSFGMCILEMVTFEYPY 280
VD + G+ + EM+ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 180
DL+ L E+ + L+ N++ + S++ D + + +++ L G+ K H +
Sbjct: 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLP 99
Query: 181 --VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQP 236
I + +L+ L Y+HS IHR +K +I ++G+ G+V + L +++M
Sbjct: 100 ELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK 156
Query: 237 TARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSE 282
R V P+ ++PE+ ++ YNE DIYS G+ E+ P+ +
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 78/276 (28%), Positives = 124/276 (44%), Gaps = 21/276 (7%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY ++ +G GA V AFD GI VA K+ Q ++ Y E+ LLK +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 138 DNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ + K + V ++ EL + NL Q H +D + + Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IHMELDHERMSYLLYQMLCGI 136
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE- 251
+LHS IIHRDLK NI V + +KI D GLA A + T + APE
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQ 309
+ Y E VDI+S G + E+V + + Q + KV + S +N P
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRLQPT 252
Query: 310 IKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPI 345
++ ++E P +S ++L D E++++ +
Sbjct: 253 VRNYVEN--RPQYPGISFEELFPDWIFPSESERDKL 286
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 79 VRYDEVLGKGAFKTVYKA-FDEFAGIEVAWSRVKIDDVLQLPGDL--QKLYSEVHLLKSL 135
++ ++ LG G F V+ A +++ + V + PG + + +E +++K+L
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK---------PGSMSVEAFLAEANVMKTL 58
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGL 193
+ D +VK + K+ + +ITE G+L + K + + K +++ QI G+
Sbjct: 59 QHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAP 250
++ N IHRDL+ NI V+ + KI D GLA I + TAR P ++ AP
Sbjct: 116 AFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 251 E-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
E + + D++SFG+ ++E+VT+ PY NP I
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R+ VLGKG F V G A +++ + + G+ L +E +L+ +
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-NEKRILEKVNSRF 61
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLR--QYRKKHKNVDIKVIKNWARQILHGLVYLH 197
VV ++ + K + ++ + G+L+ Y + D + +A ++ GL L
Sbjct: 62 VVSL--AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPE-LYEE 255
I++RDLK +NI ++ + G ++I DLGLA+ + + T R +GT +MAPE + E
Sbjct: 120 RER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECK 284
+Y D + G I EM+ + P+ + K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 69 FVEKDPSGRY--VRYDEVLGKGAFKTVYKAFDEFAGIE----VAWSRVKIDDVLQLPGDL 122
FVEK G++ V E G F A ++ A V R D
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAR 63
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-------- 174
+ EV +L L D N+ + D + MI E +G+L Q+ +KH
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 175 ---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231
K++ + A QI G+ YL S N +HRDL N V N+ +KI D G++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMSR 178
Query: 232 AMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 282
+ V G +MA E + ++ D+++FG+ + E++T E PY
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 43/137 (31%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 242
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 299
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 300 ASLAKVNDPQIKGFIEK 316
S++K KG + K
Sbjct: 222 KSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+GKG F V ++ G +VA +K DD Q +E ++ +L+ N+V+
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLK-DDS----TAAQAFLAEASVMTTLRHPNLVQ 64
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+ + ++TE G+L Y R + + +A + G+ YL
Sbjct: 65 LLGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVIT-LAQQLGFALDVCEGMEYLEEK 121
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEE 256
N +HRDL N+ V+ K+ D GLA Q + + + ++ APE L E++
Sbjct: 122 N--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKK 175
Query: 257 YNELVDIYSFGMCILEMVTF-EYPY 280
++ D++SFG+ + E+ +F PY
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 9/113 (7%)
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV--IG 243
+Q+L + Y+H +IHRD+K +NIF+N + G++ +GD G A+ ++ A +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-PYSE-CKNPAQIFKKV 293
T +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 21/243 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ-KLYSEVHLLKSLKDDNVV 141
E+LGKG F V+K + VA K D LP +L+ K SE +LK N+V
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIV 55
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
K V +++ + ++ EL G+ + RKK + K + +A G+ YL S N
Sbjct: 56 KLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE----FMAPE-LYEE 255
IHRDL N V G + +KI D G++ + S G + + APE L
Sbjct: 114 --CIHRDLAARNCLV-GENNVLKISDFGMS-RQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 256 EYNELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314
Y+ D++S+G+ + E + PY N Q ++V G + + K D + +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPD-DVYKVM 227
Query: 315 EKC 317
++C
Sbjct: 228 QRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 42/137 (30%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 242
+A +I GL +LH II+RDLK DN+ ++ + G +KI D G+ + T R+
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 299
GTP+++APE+ + Y + VD +++G+ + EM+ + P+ + ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 300 ASLAKVNDPQIKGFIEK 316
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/239 (24%), Positives = 114/239 (47%), Gaps = 15/239 (6%)
Query: 66 DSDFVEKDPSGRYVRYDE-----VLGKGAF-KTVYKAFDEFAGIEVAWSRVKIDDVLQLP 119
DSD ++ ++Y++ LG G+F + + + VA R + +++
Sbjct: 14 DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-Q 72
Query: 120 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 179
+ ++SE +L + V Y S+ D+ + ++ E G + +++K
Sbjct: 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
V +A QI+ YL S N I++RDLK +N+ ++ + G +K+ D G A + T
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRT-Y 186
Query: 240 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297
++ GTPE++APE L + + D ++ G+ I E++ P+ P I++K+ GI
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 182 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ------Q 235
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENA 163
Query: 236 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 271
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 39/232 (16%)
Query: 82 DEVLGKGAFKTVYKAFD-EFAGIE-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
+ LG+G F V KA G VK+ +L+ L SE +LLK + +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD--------------------- 178
V+K Y + D + +I E G+LR + ++ + V
Sbjct: 65 VIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 179 ---IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+ + ++A QI G+ YL ++HRDL N+ V ++KI D GL+ + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVYE 179
Query: 236 PTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 279
+ RS P ++MA E L++ Y D++SFG+ + E+VT YP
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
E+ L+ + +N++K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 186 ARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 244
A GL L+ N P +++L + V N ++KI GL + P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNV--- 181
Query: 245 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 298
FM Y+ EY DIYS G+ + E+ T + P+ E +I+ + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKNN 239
Query: 299 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 331
L +IK +E C + +R + K++L
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ +GKG F V ++ G +VA +K D Q +E ++ L+ N+V+
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQ 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNV-DIKVIKNWARQILHGLVYLHSHN 200
V++K + ++TE G+L Y R + ++V + ++ + + YL ++N
Sbjct: 64 LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEY 257
+HRDL N+ V+ ++ K+ D GL + Q T + + ++ APE L E+++
Sbjct: 123 --FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 258 NELVDIYSFGMCILEMVTF-EYPY 280
+ D++SFG+ + E+ +F PY
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G+G + VYKA + + ++ +I+ G E+ LL+ LK NV+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQ 64
Query: 145 KSWVDDKKKTVNMITELFTSGNL-------RQYRKKHKNVDIK--VIKNWARQILHGLVY 195
K ++ + V ++ + + +L R + K V + ++K+ QIL G+ Y
Sbjct: 65 KVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 196 LHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPTA-----RSVIGTPEF 247
LH++ ++HRDLK NI V G G VKI D+G A P V+ T +
Sbjct: 124 LHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 248 MAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 284
APEL Y + +DI++ G E++T E P C+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 11/215 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+GKG+F V A + G A ++ VL + LLK++K +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ S+ +K + + + G L + ++ ++ + +A +I L YLHS N
Sbjct: 61 LHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEFMAPE-LYEEEYN 258
I++RDLK +NI ++ + G V + D GL IA Q T + GTPE++APE + ++ Y+
Sbjct: 117 IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
VD + G + EM+ + P C++ A+++ +
Sbjct: 175 NTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+GKG+F V A + G A ++ +L+ + LLK+LK +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ S+ +K + + + G L + ++ + + +A ++ + YLHS N
Sbjct: 61 LHYSFQTAEK--LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNE 259
II+RDLK +NI ++ + G V + D GL +P T + GTPE++APE L +E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 260 LVDIYSFGMCILEMV 274
VD + G + EM+
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 24/233 (10%)
Query: 84 VLGKGAF-----KTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KD 137
LG GAF T Y A ++VA VK+ + + L SE+ ++ L
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVA---VKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVY 195
+N+V + + +ITE G+L + RK+ + ++ + +++ Q+ G+ +
Sbjct: 99 ENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEV-KIGDLGLAIAMQQPTARSVIGTP----EFMAP 250
L S N IHRDL N+ + HG++ KI D GLA + + V G ++MAP
Sbjct: 157 LASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 251 E-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPAS 301
E ++ Y D++S+G+ + E+ + PY ++ +K + G + A
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL--QKLYSEVHLLKSLK 136
+R D LG+G F V+ G ++V I + PG + + E ++K L+
Sbjct: 8 LRLDVKLGQGCFGEVW------MGTWNGTTKVAIKTLK--PGTMMPEAFLQEAQIMKKLR 59
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLV 194
D +V Y ++ + ++TE G+L + K+ K + + + + A QI G+
Sbjct: 60 HDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE 251
Y+ N IHRDL+ NI V G++ KI D GLA I + TAR P ++ APE
Sbjct: 117 YIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 252 --LYEEEYNELVDIYSFGMCILEMVT 275
LY + D++SFG+ + E+VT
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 84 VLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
VLG GAF TVYK E I VA +K+ P +++ E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHS 198
V + + TV ++T+L G L Y +++K+ + + + NW QI G+ YL
Sbjct: 71 VCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 199 HNPPIIHRDLKCDNIFV-NGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE-L 252
++HRDL N+ V + NH VKI D GLA I + A ++MA E +
Sbjct: 128 VR--LVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 253 YEEEYNELVDIYSFGMCILEMVTF 276
+ D++S+G+ + E++TF
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 36/241 (14%)
Query: 83 EVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
LG+GAF V+ E VA +K D ++ E LL + +
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNFQH 67
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------------RKKHKNVDIKVIK 183
+N+VKFY + M+ E G+L ++ + + +
Sbjct: 68 ENIVKFYGVCTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243
A QI G+VYL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 126 QIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 244 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+M PE +Y + E D++SFG+ + E+ T+ + P+ N ++ + +T G
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQG 240
Query: 297 I 297
Sbjct: 241 R 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 68/272 (25%), Positives = 127/272 (46%), Gaps = 26/272 (9%)
Query: 84 VLGKGAFKTVY---KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN- 139
VLG GA+ V+ K AG A +K ++Q + +E +L++++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 140 -VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
V Y D K +++I + G L + + ++ ++ + +I+ L +LH
Sbjct: 67 LVTLHYAFQTDTK---LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY-- 253
II+RD+K +NI ++ G V + D GL+ +A ++ A S GT E+MAPE+
Sbjct: 124 LG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
+++ VD +S G+ E++T P++ E + ++I +++ P K +
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAE 238
Query: 310 IKGFIEKCLVPASE-RL---SAKDLLKDPFLQ 337
+ FI+K L + RL A ++ PF Q
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 85 LGKGAFKTVYKAFDEFAGIE-------VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
LG+GAF V+ A E + VA +K D L D Q+ E LL +L+
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTKDKMLVAVKALK-DPTLAARKDFQR---EAELLTNLQH 66
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNVDIKV 181
+++VKFY D + M+ E G+L ++ + H + +
Sbjct: 67 EHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 182 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 241
+ + A QI G+VYL S + +HRDL N V G + VKIGD G++ + V
Sbjct: 125 MLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 242 IGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTS 295
G +M PE + ++ D++SFG+ + E+ T+ + P+ + + ++ + +T
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQ 240
Query: 296 G 296
G
Sbjct: 241 G 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 186
E ++ L N+V+ Y V K++ + ++TE +G L Y ++ K + + +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 245
+ + YL S+ IHRDL N V G VK+ D GLA + S GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 246 --EFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 298
++ PE+++ ++ D++SFG+ + E+ + + PY N +++ + V++G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 31/238 (13%)
Query: 82 DEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQK----LYSEVHLLKS 134
+V+G G F V++ + G + VA +K PG +K SE ++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-------PGYTEKQRQDFLSEASIMGQ 62
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHG 192
N+++ V K K +ITE +G L +Y + H + + R I G
Sbjct: 63 FSHHNIIRL--EGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAG 119
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP-----EF 247
+ YL N +HRDL NI VN N E K+ D GL+ ++ + + +
Sbjct: 120 MKYLSDMN--YVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 248 MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASL 302
APE + ++ D++SFG+ + E+++F E PY + N ++ K + G + PA +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAW----SRVKIDDVLQLPGDL--QKLYSEV--H 130
+R ++LG G F TV+K W +KI ++ D ++ + E+ H
Sbjct: 9 LRKLKLLGSGVFGTVHKGI---------WIPEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 131 LLK--SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWAR 187
+L SL +V+ ++ ++T+L G+L + ++H+ ++D + + NW
Sbjct: 60 MLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGT 244
QI G+ YL H ++HR+L NI + + V+I D G+A + + S T
Sbjct: 117 QIAKGMYYLEEHR--MVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 245 P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYS 281
P ++MA E + Y D++S+G+ + EM+++ PY+
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 35/121 (28%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
++T+ + G L + +K K + +++ L +LH ++ I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 217 GNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 272
G + + D GL+ A T + GT E++APE+ +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 273 M 273
M
Sbjct: 190 M 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 36/233 (15%)
Query: 81 YDEVLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVL----QLPGDLQK-----LYS 127
+ E LG+G F V+ + ++F + + VL L D K
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------N 176
E+ ++ LKD N+++ + + MITE +G+L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
+ + A QI G+ YL S N +HRDL N V N+ +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSG 183
Query: 237 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 282
R+V+ + ++ D+++FG+ + E++T E PYS+
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 84 VLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
V+G+G++ V K D+ ++V + DD D+ + +E H+ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----EDIDWVQTEKHVFEQASSNP 56
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+ S + ++ E G+L + ++ + + + + +A +I L +LH
Sbjct: 57 FLVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EE 256
II+RDLK DN+ ++ + G +K+ D G+ P T + GTP ++APE+ EE
Sbjct: 116 G--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 257 YNELVDIYSFGMCILEMVTFEYPY 280
Y VD ++ G+ + EM+ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 12/177 (6%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWA 186
E ++ L + +V+ Y V K++ + ++TE ++G L Y ++H K +
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 245
+ + G+ YL S IHRDL N V+ G VK+ D GL+ + S +G+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 246 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 298
+ PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G++
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL--QKLYSEVHLLKSLK 136
+R + LG+G F V+ G +RV I + PG + + E ++K L+
Sbjct: 8 LRLEVKLGQGCFGEVWM------GTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLR 59
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLV 194
+ +V+ Y ++ + ++TE + G+L + K +++ + + A QI G+
Sbjct: 60 HEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE 251
Y+ N +HRDL+ NI V G + K+ D GLA I + TAR P ++ APE
Sbjct: 117 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 252 --LYEEEYNELVDIYSFGMCILEMVT 275
LY + D++SFG+ + E+ T
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
E+ +LK++ ++ ++ K TV M+ + +L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVI 242
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 273
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 84 VLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
V+G+G++ V K + ++V + DD D+ + +E H+ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNHP 56
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+ S + + + E G+L + ++ + + + + ++ +I L YLH
Sbjct: 57 FLVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EE 256
II+RDLK DN+ ++ + G +K+ D G+ +P T + GTP ++APE+ E+
Sbjct: 116 G--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 257 YNELVDIYSFGMCILEMVTFEYPYS---ECKNPAQ 288
Y VD ++ G+ + EM+ P+ NP Q
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + +G GA V A+D G VA K+ Q ++ Y E+ L+K +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 138 DNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ + K + V ++ EL + NL Q ++D + + Q+L G+
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGI 131
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FM 248
+LHS IIHRDLK NI V + +KI D GLA + S + TP +
Sbjct: 132 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 184
Query: 249 APE-LYEEEYNELVDIYSFGMCIL-EMV 274
APE + Y E VDI+S G CI+ EM+
Sbjct: 185 APEVILGMGYKENVDIWSVG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
D+D + + P+ Y + ++G G+F VY+A I+ + +V I VLQ P Q
Sbjct: 57 DND-INRSPNKSY-KLGNIIGNGSFGVVYEAI----CIDTS-EKVAIKKVLQDP---QYK 106
Query: 126 YSEVHLLKSLKDDNVV----KFYKSWVDDKKKTV--NMITELF---TSGNLRQYRKKHKN 176
E+ ++K+L N++ +Y +K + N++ E ++ Y + +
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA 166
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAM 233
+ + ++K ++ Q+ L Y+HS I HRDLK N+ ++ N +K+ D G A +A
Sbjct: 167 LPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 234 QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYP 279
Q+ S I + + APEL Y +D++S G I EM+ YP
Sbjct: 225 QRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYP 269
|
Length = 440 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----QPTARSV 241
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 242 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 272
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 46/252 (18%)
Query: 85 LGKGAFKTVYKAFDEFAGIE---------VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
LG+G F V A E GI+ VA +K DD + DL L SE+ ++K +
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLK-DDATE--KDLSDLVSEMEMMKMI 77
Query: 136 -KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR------- 187
K N++ + D + +I E + GNLR+Y + + ++ + AR
Sbjct: 78 GKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 188 ---------QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAM 233
Q+ G+ YL S IHRDL N+ V N+ +KI D GLA I
Sbjct: 136 FKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDY 192
Query: 234 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYPYSECKNPAQI 289
+ T + ++MAPE L++ Y D++SFG+ + E+ T YP + ++
Sbjct: 193 YKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 290 FKKVTSGIKPAS 301
K+ KPA+
Sbjct: 252 LKEGHRMDKPAN 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTP 245
+I+ L YLHS + +++RDLK +N+ ++ + G +KI D GL T ++ GTP
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 246 EFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 280
E++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 242
+ +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 280
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 40/227 (17%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
VR+ E LG+ AF +YK G++ VA +K + Q G+ Q+ E L+
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAE 63
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV-------------- 177
L N+V V +++ V M+ E G+L ++ R H +V
Sbjct: 64 LHHPNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--- 234
D + A QI G+ YL SH +H+DL NI + G VKI DLGL+ +
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSAD 178
Query: 235 ----QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
QP + I +M PE + +++ DI+SFG+ + E+ +F
Sbjct: 179 YYRVQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224
G+L KK + +K RQ++ L LH HN IIH D+K +N+ + + +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 225 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--- 280
D GL + P+ GT ++ +PE + Y+ D ++ G+ E++T ++P+
Sbjct: 152 CDYGLCKIIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
Query: 281 -SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA-SERLSA-KDLLKDPFLQ 337
E + + K+ K K F++ L + RL+ +++K PFL+
Sbjct: 210 EDEELDLESLLKRQQ---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
Query: 338 V 338
+
Sbjct: 267 I 267
|
Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 67/233 (28%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 85 LGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
LG+GAF V+ A E + VA +K + D Q+ E LL L+ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQR---EAELLTVLQHQH 68
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW-------------- 185
+V+FY V + + + M+ E G+L ++ + H D K++
Sbjct: 69 IVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKILAGGEDVAPGQLTLGQML 125
Query: 186 --ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243
A QI G+VYL S + +HRDL N V G VKIGD G++ + V G
Sbjct: 126 AIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 244 TP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
+M PE LY + E DI+SFG+ + E+ T+ + P+ + N I
Sbjct: 183 RTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 66/277 (23%), Positives = 132/277 (47%), Gaps = 26/277 (9%)
Query: 83 EVLGKGAFKTVY---KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
+VLG GA+ V+ K +G A +K ++Q + +E +L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 140 -VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V + ++ D K +++I + G L + + + + ++ ++ +I+ L +LH
Sbjct: 66 FLVTLHYAFQTDTK--LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK 123
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY-- 253
II+RD+K +NI ++ N G V + D GL+ + A S GT E+MAP++
Sbjct: 124 LG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
+ +++ VD +S G+ + E++T P++ E + A+I +++ P +
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 238
Query: 310 IKGFIEKCLVP-ASERL-----SAKDLLKDPFLQVEN 340
K I++ L+ +RL A ++ K PF Q N
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 85 LGKGAFKTVYKA----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDN 139
LG+G F V A D+ V VK+ DL L SE+ ++K + K N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIK 183
++ + D V I E + GNLR+Y + + + K +
Sbjct: 86 IINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAMQQPTA 238
+ A Q+ G+ YL S IHRDL N+ V ++ +KI D GLA I + T
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200
Query: 239 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
+ ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 201 NGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/149 (26%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
VV+ + ++ DDK + M+ E G+L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEEE 256
+IHRD+K DN+ ++ HG +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 257 -----YNELVDIYSFGMCILEMVTFEYPY 280
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIGTPEFMAPELYE 254
H H+ II+RDLK +NI ++ G +K+ D GL+ + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 255 EE-YNELVDIYSFGMCILEMVTFEYPY 280
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
+ E + G+L + ++ + + + + ++ +I L +LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 217 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 273
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 AE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 274 VTFEYPY---SECKNPAQ---------IFKKVTSGIK-PASLAKVNDPQIKGFIEKCLVP 320
+ P+ NP Q I +K I+ P SL+ +KGF+ K P
Sbjct: 190 MAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---IRIPRSLSVKASSVLKGFLNK--DP 244
Query: 321 ASERLSAK------DLLKDPFLQ 337
ERL D+ PF +
Sbjct: 245 K-ERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 39/243 (16%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPG--DLQKL-- 125
DPS YV ++V+G G F V + + G I+VA +K G D Q+L
Sbjct: 2 DPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-------AGSSDKQRLDF 52
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKN 184
+E ++ N+++ V K + V +ITE +G+L ++ R+ + +
Sbjct: 53 LTEASIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVG 110
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 244
R I G+ YL N +HRDL NI VN ++ K+ D GL+ T
Sbjct: 111 MLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLS-----RRLEDSEAT 162
Query: 245 PEFM---------APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
APE + ++ D++SFG+ + E++++ E PY + N + K V
Sbjct: 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAV 221
Query: 294 TSG 296
G
Sbjct: 222 EDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 196 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAPE 251
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 252 LYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS 301
+ Y D +S G+ EM+ P+ E A+ + + + +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPE 232
Query: 302 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL------QVENQKEPICDPLK 350
KV+ I+ L ERL + L PF + N P LK
Sbjct: 233 DPKVSS-DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLK 286
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 58/249 (23%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+G+GAF V + G A ++ D+L+ + + +E +L VVK
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE-KEQVAHIRAERDILVEADGAWVVK 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ S+ D K+ + +I E G++ K + + + + + + + +H
Sbjct: 66 MFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT----------- 237
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 238 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK 284
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPFCSE 239
Query: 285 NPAQIFKKV 293
P + ++KV
Sbjct: 240 TPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
VR+ E LG+GAF VYK + + VA +K P Q+ E L+
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVA---IKTLKENAEPKVQQEFRQEAELMS 63
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV----DIKVIK--- 183
L+ N+V V K++ M+ E G+L ++ H +V + +K
Sbjct: 64 DLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 184 ------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA------- 230
+ A QI G+ YL SH+ +HRDL N V G VKI D GL+
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSAD 178
Query: 231 -IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTF 276
+Q ++S++ +M PE LY + E DI+SFG+ + E+ ++
Sbjct: 179 YYRVQ---SKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 225 GDLGLA-IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYS 281
D GL + M+ + GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 282 ECKNPAQIFKKV 293
+ +N ++++K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
D S V+ +EV+G G F V + + G + +K + SE ++
Sbjct: 2 DVS--CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 59
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILH 191
N++ V K + V +ITE +G L + R+ + + R I
Sbjct: 60 GQFDHPNIIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA 117
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSVIGTP-- 245
G+ YL N +HRDL NI VN N K+ D GL+ ++ PT S +G
Sbjct: 118 GMKYLSEMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 246 -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 285
+ APE + ++ D++S+G+ + E++++ E PY + N
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/249 (23%), Positives = 110/249 (44%), Gaps = 45/249 (18%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+G+GAF V + G A ++ D+L+ + + +E +L VVK
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVK 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ S+ D K + +I E G++ K + + + + + + + +H
Sbjct: 66 MFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT----------- 237
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 238 ------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK 284
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPFCSE 239
Query: 285 NPAQIFKKV 293
P + +KKV
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGL--------AIAMQQPT 237
Q+L L +HN I+HRDLK NI V+ K+ D G+ + T
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 238 ARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 275
+ V+GTP + APE L E D+Y++G+ LE +T
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 68/243 (27%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 73 DPSGRYVRYDEVLGK----GAFKTVYKAFDEFAGIEVAWSR------VKIDDVLQLPGDL 122
DP + R VLGK G F V +A E GI+ + VK+ DL
Sbjct: 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61
Query: 123 QKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----------- 170
L SE+ L+K + K N++ + V I E GNLR++
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDY 119
Query: 171 -----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225
+ + + K + + A Q+ G+ YL S IHRDL N+ V ++ +KI
Sbjct: 120 TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIA 176
Query: 226 DLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--- 276
D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 177 DFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235
Query: 277 EYP 279
YP
Sbjct: 236 PYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 116 LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK 175
L L +Q+++ E +L ++ VV + S+ + K+ + M+ E G+ K
Sbjct: 39 LILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIG 96
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQ 234
+ + + + + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ I +
Sbjct: 97 ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLM 153
Query: 235 QPTA----------------RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFE 277
T + V GTPE++APE + + Y + VD ++ G+ + E +
Sbjct: 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 278 YPYSECKNPAQIFKKVTSG 296
P+ P ++F +V S
Sbjct: 214 VPFFG-DTPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E++G+G F V + E+ G +VA +K D Q E ++ L N+V+
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQ------AFLEETAVMTKLHHKNLVR 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
+ + + ++ EL + GNL + + + VI+ ++ + G+ YL S
Sbjct: 64 LLGVILHNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNE 259
++HRDL NI V+ + G K+ D GLA S + ++ APE L ++++
Sbjct: 121 --LVHRDLAARNILVSED-GVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSS 176
Query: 260 LVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 298
D++S+G+ + E+ ++ PY P K+V ++
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 196 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPE 251
+HS H +HRD+K DN+ ++ N G +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 252 LYEE------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASL 302
+ + +Y D +S G+C+ EM+ E P+ S + +I P+ +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 303 AKVNDPQIKGFIEKCLVPASERLSA---KDLLKDPFLQ------VENQKEPICDPLKLPI 353
V++ + K I++ + RL +D K F + + N + P + P
Sbjct: 234 TDVSE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSP- 291
Query: 354 QSLKMLRLPMSGPSSMDIDSD 374
S S+ D+D D
Sbjct: 292 ----------SDTSNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA-MQQPTARS--VIGTPEFMAPELYEE 255
H +HRD+K DNI ++ N G +++ D G + M+ T +S +GTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 256 ------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVN 306
+Y D +S G+C+ EM+ E P+ S + +I PA + V+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 307 DPQIKGFIEKCLVPASERLSA---KDLLKDPFL------QVENQKEPICDPLKLPIQSLK 357
+ K I + + RL +D + PF + N + P + P +
Sbjct: 238 E-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDT-- 294
Query: 358 MLRLPMSGPSSMDIDSD 374
S+ D+D D
Sbjct: 295 ---------SNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-------- 174
+ + E LL +L+ +++VKFY V+ + M+ E G+L ++ + H
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 175 -----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
+ + + A+QI G+VYL S + +HRDL N V G + VKIGD G+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGM 166
Query: 230 AIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 283
+ + V G +M PE + ++ D++S G+ + E+ T+ + P+ +
Sbjct: 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
Query: 284 KNPAQIFKKVTSG 296
N ++ + +T G
Sbjct: 227 SN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 85 LGKGAFKTVYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G F TV K + E VA +K D+ P +L E ++++ L + +V+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVR 60
Query: 143 FY-----KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+SW+ ++ EL G L ++ +K+K+V K I Q+ G+ YL
Sbjct: 61 MIGICEAESWM--------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTP-EFMAPE- 251
N +HRDL N+ + H KI D GL+ A+ A++ P ++ APE
Sbjct: 113 ETN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECK 284
+ +++ D++SFG+ + E ++ + PY K
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEFMAPE-L 252
H H II+RDLK +NI ++ G VK+ D GL +I T + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPEIL 172
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQI 310
+ + VD +S G + +M+T P++ +N + K+ G P L P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEA 227
Query: 311 KGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLPIQ 354
+ ++K L S RL A ++ PF + N + + ++ P +
Sbjct: 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK 277
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 53/286 (18%)
Query: 85 LGKGAFKTVYKAFDEFAGIE---------VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
LG+G F V A E GI+ VA +K D + DL L SE+ ++K +
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDK---DLSDLVSEMEMMKMI 74
Query: 136 -KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----------------RKKHKNVD 178
K N++ + D V + E + GNLR+Y + + +
Sbjct: 75 GKHKNIINLLGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-----IAM 233
K + + A Q+ G+ YL S IHRDL N+ V ++ +KI D GLA I
Sbjct: 133 FKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDY 189
Query: 234 QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYPYSECKNPAQI 289
+ T + ++MAPE L++ Y D++SFG+ + E+ T YP + ++
Sbjct: 190 YKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
Query: 290 FKKVTSGIKPASLAKVNDPQIKGFIEKC--LVPASERLSAKDLLKD 333
K+ KPA+ ++ + +C VP S+R + K L++D
Sbjct: 249 LKEGHRMDKPANCTH----ELYMIMRECWHAVP-SQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNV 140
LG+G F V+ A + E + V + LQ D + E+ + + L NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK-ALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQY---------RKKHKNVDIKVIKNWARQILH 191
V+ + + MI E G+L+Q+ + K + K QI
Sbjct: 71 VRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFM 248
G+ +L + +HRDL N V+ EVK+ L L+ + R+ + ++
Sbjct: 129 GMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 285
APE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL--YSEVHLLKSLKDDNVVK 142
LG+G+F VY+ + + +RV I V + +++ +E ++K +VV+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY----RKKHKN------VDIKVIKNWARQILHG 192
V + + +I EL T G+L+ Y R + +N +K + A +I G
Sbjct: 74 LLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFM 248
+ YL+++ +HRDL N V + VKIGD G+ + + G +M
Sbjct: 132 MAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+PE L + + D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 39/197 (19%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD--------- 178
EV +L LKD N+++ VD+ + MITE +G+L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDP--LCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 179 ----------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228
+ + A QI G+ YL S N +HRDL N V N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183
Query: 229 LAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPY 280
++ + + R+V+ +MA E + ++ D+++FG+ + E++ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 281 SE------CKNPAQIFK 291
E +N + F+
Sbjct: 243 GELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219
E+FT R + + ++ ++ +I+ L +LH I++RD+K +NI ++ +
Sbjct: 91 EMFTHLYQRDNFSEDE------VRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 220 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMV 274
G V + D GL+ ++ ++ S GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 275 TFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 331
T P++ E +++ +++ DP FI P ++ L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 332 KDP 334
KDP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 45/191 (23%), Positives = 74/191 (38%), Gaps = 55/191 (28%)
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 233
H IHRD+K DNI ++ G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 234 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 272
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 273 MVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL---S 326
M+ + P+ PA+ KV + + S AK++ + I + A +RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS-REASDLILRLCCGAEDRLGKNG 294
Query: 327 AKDLLKDPFLQ 337
A ++ PF +
Sbjct: 295 ADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 48/210 (22%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+G+GAF V + A + ++++ D + E ++ VV+
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQ 107
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR----QILHGLVYLHS 198
+ ++ DD+ + M+ E G+L + V + WAR +++ L +HS
Sbjct: 108 LFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHS 160
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE 255
IHRD+K DN+ ++ + G +K+ D G + M + + +GTP++++PE+ +
Sbjct: 161 MG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 256 E-----YNELVDIYSFGMCILEMVTFEYPY 280
+ Y D +S G+ + EM+ + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + +G GA V A+D VA K+ Q ++ Y E+ L+K +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 138 DNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ + K + V ++ EL + NL Q + +D + + Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGI 139
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FM 248
+LHS IIHRDLK NI V + +KI D GLA + S + TP +
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 192
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMV 274
APE + Y E VDI+S G + EM+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 80 RYDEV--LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + +G GA V A+D VA K+ Q ++ Y E+ L+K +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 138 DNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ + K + V ++ EL + NL Q + +D + + Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGI 132
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP-----EFM 248
+LHS IIHRDLK NI V + +KI D GLA + S + TP +
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 185
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMV 274
APE + Y E VDI+S G + EMV
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+G+GAF V + + A + ++++ D + E ++ + +V+
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS-DSAFFWEERDIMAHANSEWIVQ 107
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR----QILHGLVYLHS 198
+ ++ DDK + M+ E G+L N DI + WAR +++ L +HS
Sbjct: 108 LHYAFQDDKY--LYMVMEYMPGGDLVNLMS---NYDIP--EKWARFYTAEVVLALDAIHS 160
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---QPTARSVIGTPEFMAPELYEE 255
IHRD+K DN+ ++ G +K+ D G + M + +GTP++++PE+ +
Sbjct: 161 MG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 256 -----EYNELVDIYSFGMCILEMVTFEYPY 280
Y D +S G+ + EM+ + P+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 58/190 (30%)
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL------------------------AI 231
+H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 117 IHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 232 AMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 274
+ +P A S +GTP+++APE++ + YN+ D +S G+ + EM+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 275 TFEYP--YSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKCLVPASERL--- 325
YP S+ NP + ++K+ + + +L ++ P+ K I++ A RL
Sbjct: 234 V-GYPPFCSD--NPQETYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNN 288
Query: 326 SAKDLLKDPF 335
++ PF
Sbjct: 289 GVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 165 GNLRQYRKKHKNVDIKVIK--------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
GNL+ + ++ + + + + A QI G+ YLH +IH+D+ N ++
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151
Query: 217 GNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCI 270
+VKI D L+ + P +G E +MA E L +EY+ D++SFG+ +
Sbjct: 152 -EELQVKITDNALSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209
Query: 271 LEMVTF-EYPYSE 282
E++T + PY E
Sbjct: 210 WELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL------------Y 126
++ ++V+G G F EV R+K+ ++P ++ L
Sbjct: 6 IKIEKVIGAGEFG------------EVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL 53
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--N 184
SE ++ N++ V K K V ++TE +G+L + +KH + VI+
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVG 110
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TAR 239
R I G+ YL +HRDL NI VN N K+ D GL+ ++ T R
Sbjct: 111 MLRGIASGMKYLSDMG--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 240 SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI 297
+ APE + ++ D++S+G+ + E++++ E PY E N + K + G
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGY 226
Query: 298 K-PASL 302
+ PA +
Sbjct: 227 RLPAPM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 43/175 (24%), Positives = 90/175 (51%), Gaps = 12/175 (6%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 186
E ++ L +V+ Y V ++K + ++TE +G L Y R++ + ++ +
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 244
+ + G+ YL ++ IHRDL N V+ + G VK+ D G+ + + T+ S
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 245 P-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 296
P ++ PE++ +Y+ D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 245
Q+ +G+ +L S N +HRDL N+ + G+ VKI D GLA + + + G+
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 246 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 300
++MAPE ++ Y L D++SFG+ + E+ T PY E Q + + G + A
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 301 SLAKVNDPQIKGFIEKC 317
A +D +I ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPELYEE----- 255
+HRD+K DN+ ++ +G +++ D G + + T +S +GTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 256 -EYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIK----PASLAKVNDPQ 309
Y D +S G+C+ EM+ E P Y+E + + + K+ + + P + V++ +
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 310 IKGFIEKCLVPASERL---SAKDLLKDPF 335
K I + + RL +D PF
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 79/379 (20%), Positives = 136/379 (35%), Gaps = 73/379 (19%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG GAF V A A ++ DVL + + +E +L ++ VVK
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVK 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
Y S+ D K + + + G++ + + + + + ++ + +H
Sbjct: 66 LYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG-- 121
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------------------------- 233
IHRD+K DNI ++ + G +K+ D GL
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 234 --------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 272
Q+ A S++GTP ++APE L + Y +L D +S G+ + E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 273 MVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL---S 326
M+ + P+ P + KV + + K++ P+ I K A ERL
Sbjct: 241 MLVGQPPFL-APTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLGRNG 298
Query: 327 AKDLLKDPFLQ-------VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 379
A D+ PF + Q P + P+ + P+ S + S +
Sbjct: 299 ADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF--DPVEEESPWNDASGDSTRT 356
Query: 380 LSTCTESNNGSPHCPVLEF 398
T N P EF
Sbjct: 357 WDTLCSPNGKHPEHAFYEF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 27/56 (48%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
DI VIK RQ+L GL LH I+HRD+K +N+ V + G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 83 EVLGKGAFKTVYKA-FDEFAGIEV---AWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
V+GKG F VY + G ++ S +I D+ ++++ E ++K
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHP 56
Query: 139 NVVKFYK-SWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYL 196
NV+ + V + G+LR + R + N +K + + Q+ G+ YL
Sbjct: 57 NVLSLLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-----IGTP-EFMAP 250
S +HRDL N ++ + VK+ D GLA + SV P ++MA
Sbjct: 115 ASKK--FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 251 E-LYEEEYNELVDIYSFGMCILEMVT 275
E L +++ D++SFG+ + E++T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 25/170 (14%)
Query: 185 WA--RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 242
WA Q L L LH L + + + G +R
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQSR--- 65
Query: 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 299
P FMAPE+ + Y E DIYS G+ + E + +E PY+E + + I + + +G+
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD 125
Query: 300 ----ASLAKVND-PQIKGFIEKCLVPAS-ERLSAKDLLKDPFLQVENQKE 343
++L V+ + F+ C R +A L E
Sbjct: 126 PRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAW---SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
+G G F V+ + W +V I + + + E ++ L +V
Sbjct: 12 IGSGQFGLVWLGY---------WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
+ Y V ++ + ++ E G L Y R + + + + G+ YL S N
Sbjct: 63 QLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP---EFMAPELYE-EE 256
+IHRDL N V G + VK+ D G+ + S GT ++ +PE++ +
Sbjct: 121 --VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 257 YNELVDIYSFGMCILEMVTFEYPYSECKNP 286
Y+ D++SFG+ + E+ +SE K P
Sbjct: 178 YSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV-KIGDLGLAIAMQQ 235
+D + + +++ Q+ G+ +L S N IHRDL NI + HG + KI D GLA ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 236 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 290 FKKVTSGIK 298
+K + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 157 MITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 211
++ E G+L+ Y + ++ + V++ A ++ GL++LH + IH DL
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALR 129
Query: 212 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV------ 261
N + + VKIGD GLA+ T ++APEL E +L+
Sbjct: 130 NCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 262 --DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
+I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G G F V + +G A VK V + K E +SL+ N+++
Sbjct: 3 IGNGWFGKVILG-EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSH 199
+ ++ E G+L+ Y + + D ++ A +I GL++LH +
Sbjct: 62 GQCTEVTPYL--LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE 255
N IH DL N + + VKIGD GL+ + T + ++APEL +E
Sbjct: 120 N--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 256 EYNELV--------DIYSFGMCILEMVTF-EYPY 280
+ L+ +++S G+ I E+ PY
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 35/149 (23%), Positives = 84/149 (56%), Gaps = 12/149 (8%)
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 186
E+ +L++LK +N+V+ +++ ++ + ++ E + N+ + ++ N V + ++++
Sbjct: 50 ELKMLRTLKQENIVELKEAF--RRRGKLYLVFE-YVEKNMLELLEEMPNGVPPEKVRSYI 106
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---VIG 243
Q++ + + H ++ I+HRD+K +N+ ++ N +K+ D G A + + + + +
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCIL 271
T + +PE L Y + VD++S G CIL
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 32/223 (14%)
Query: 79 VRYDEVLGKGAFKTVYKA--FDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKS- 134
VR+ E LG+ F VYK F G + +K + D + P L++ + +++S
Sbjct: 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHEAMMRSR 64
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV----DIKVIKNW-- 185
L+ N+V V K++ ++MI + +L ++ R H +V D K +K+
Sbjct: 65 LQHPNIVCLLG--VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 186 -------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
QI G+ +L SH+ ++H+DL N+ V + VKI DLGL +
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADY 179
Query: 239 RSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
++G +M+PE + +++ DI+S+G+ + E+ ++
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 53/248 (21%), Positives = 95/248 (38%), Gaps = 56/248 (22%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG GAF V A A ++ DVL L + + +E +L ++ VV+
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVR 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
Y S+ D K + + + G++ + + + + ++ + +H
Sbjct: 66 LYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG-- 121
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------------------------- 233
IHRD+K DNI ++ + G +K+ D GL
Sbjct: 122 FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 234 --------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 272
Q+ A S++GTP ++APE L Y +L D +S G+ + E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 273 MVTFEYPY 280
M+ + P+
Sbjct: 241 MLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 56/234 (23%), Positives = 107/234 (45%), Gaps = 29/234 (12%)
Query: 84 VLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV 140
+LGKG F +V +A ++ + +VA +K D + D+++ E +K NV
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD--IFSSSDIEEFLREAACMKEFDHPNV 63
Query: 141 VKFYKSWVDDKKK---TVNMITELFTS-GNLRQYRKKHK------NVDIKVIKNWARQIL 190
+K + + K + M+ F G+L + + + ++ + + I
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------QQPTARSVIGT 244
G+ YL S N IHRDL N +N N V + D GL+ + +Q A +
Sbjct: 124 SGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKL--P 178
Query: 245 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+++A E L + Y D+++FG+ + E++T + PY+ +N ++I+ + G
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKG 231
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 30/79 (37%), Positives = 40/79 (50%), Gaps = 9/79 (11%)
Query: 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----- 234
K+I+ RQIL L LHS I+HRD+K NI + G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 235 QPTARSVIGTPEFMAPELY 253
P + + P + APE Y
Sbjct: 313 IP--KEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 245
Q+ G+ +L S N +HRDL N+ + G+ VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 246 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 300
++MAPE +++ Y L D++S+G+ + E+ + PY + + K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 51/240 (21%), Positives = 96/240 (40%), Gaps = 42/240 (17%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSR--VKIDDVLQL--PGDLQKLYSEVHLLKSLKDDN 139
LG GAF VY+ + G + V + + + D E ++ N
Sbjct: 13 ALGHGAFGEVYEG--LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILHG 192
+V+ V ++ ++ EL G+L+ + ++++ + +K + AR + G
Sbjct: 71 IVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTP----- 245
YL ++ IHRD+ N + G KI D G+A R +
Sbjct: 129 CKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKG 178
Query: 246 -------EFMAPELYEEE-YNELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSG 296
++M PE + + + D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 62/296 (20%), Positives = 117/296 (39%), Gaps = 72/296 (24%)
Query: 83 EVLGKGAFKTVY-------------KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV 129
++LGKG V+ K D+ I+ R K+ VL +E
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----RNKVKRVL----------TEQ 52
Query: 130 HLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWAR 187
+L +L + Y + + ++ + G L + ++ K + +V + +A
Sbjct: 53 EILATLDHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----------------- 230
++L L YLH I++RDLK +NI ++ + G + + D L+
Sbjct: 111 EVLLALEYLH--LLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 231 ------------IAMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 275
++P+ R S +GT E++APE+ + + VD ++ G+ + EM+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227
Query: 276 FEYPYSECKNPAQIFKKVTSGIKPASLA-KVNDP-QIKGFIEKCLVP-ASERLSAK 328
P+ + N + F + K + + I K LV S+RL +K
Sbjct: 228 GTTPF-KGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224
L Q + +N + +++ A +I G+ ++H HN +H DL N F+ + VK+
Sbjct: 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKV 140
Query: 225 GDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILE 272
GD G+ + + T ++APEL E + L+ ++++ G+ + E
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
Query: 273 MVTFE---YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 324
+ FE PYS + ++ V + D Q+K F + +P SER
Sbjct: 201 L--FENAAQPYSHLSD-REVLNHV-----------IKDQQVKLFKPQLELPYSER 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 27/108 (25%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 248 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 279
MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 20/38 (52%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 45/237 (18%)
Query: 79 VRYDEVLGKGAFKTVYKA-------FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+ Y +G+GAF V++A ++ F VA +K + + D Q+ E L
Sbjct: 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPF--TMVAVKMLKEEASADMQADFQR---EAAL 61
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--------KNVDIKVIK 183
+ N+VK V K + ++ E G+L ++ + + K
Sbjct: 62 MAEFDHPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 184 --------------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
A+Q+ G+ YL +HRDL N V N VKI D GL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGL 176
Query: 230 AIAMQQP---TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-PY 280
+ + A P +M PE ++ Y D++++G+ + E+ ++ PY
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 248 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
MAPE ++++ Y D++SFG+ + E+ + PY + + +++
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 294 TSGIKPASLAKVNDPQIKGFIEKC 317
G + + + P+I + C
Sbjct: 291 KDGTRMRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 25/125 (20%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 248 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 294 TSGIK 298
G +
Sbjct: 296 KEGTR 300
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 49/225 (21%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 83 EVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
++LG+G F +V + D+ + ++VA +K+D ++++ SE +K N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY--SEIEEFLSEAACMKDFDHPN 62
Query: 140 VVKF----YKSWVDDKKKTVNMITELFTSGNLRQY------RKKHKNVDIKVIKNWARQI 189
V+K +++ K +I G+L + + + ++ + + I
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-------QQPTARSVI 242
G+ YL + N IHRDL N + + V + D GL+ + Q A+ +
Sbjct: 123 ALGMEYLSNRN--FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 243 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 285
+++A E L + Y D+++FG+ + E+ T + PY +N
Sbjct: 180 ---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 62/247 (25%), Positives = 110/247 (44%), Gaps = 41/247 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGI--EVAWSRVK----IDDVLQLPGDLQKLYSEVHLL 132
+++ +V+G+G F V KA + G+ + A R+K DD G+L+ L H
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-- 66
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK---VIKNW---- 185
N++ + + + + + E GNL + +K + ++ I N
Sbjct: 67 ----HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 186 --ARQILH-------GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
++Q+LH G+ YL IHRDL NI V N+ KI D GL+ +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVY 177
Query: 237 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYS--ECKNPAQIFK 291
+++ P +MA E L Y D++S+G+ + E+V+ PY C A++++
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE 234
Query: 292 KVTSGIK 298
K+ G +
Sbjct: 235 KLPQGYR 241
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 719 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.26 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.95 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.62 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.56 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.46 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.19 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.09 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.43 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.24 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.02 | |
| PLN02236 | 344 | choline kinase | 95.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.3 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.56 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.52 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.35 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 91.21 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 90.76 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.54 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 89.83 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.21 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 85.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 84.47 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-86 Score=730.79 Aligned_cols=419 Identities=61% Similarity=0.985 Sum_probs=362.2
Q ss_pred CCCCCCcccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeE
Q 005017 64 DADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143 (719)
Q Consensus 64 ~~~~~~~e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl 143 (719)
.....+++++|.|||.++.++||+|+|.+||+|+|..+|.+|||..++..+..+.+..+++|+.|+++|+.|+|||||+|
T Consensus 27 ~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirf 106 (632)
T KOG0584|consen 27 PDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRF 106 (632)
T ss_pred cccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeee
Confidence 45567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 144 ~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
|++|++..++++++|+|+|++|+|+.|++++++++.+.++.|++||++||.|||++.||||||||||+||||+++.|.||
T Consensus 107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecchhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 224 IGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 224 L~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
|+|+|||+.++...+..++|||.|||||++++.|++.+||||||||++||+|+++||++|.+++|+|+++.+|++|..+.
T Consensus 187 IGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred ecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCChHHHHHHHHhcCCCCCCCCHHHHHcCccCccccCCCCCCCCCC----------CcchhhhhccCCCCC--CCCccc
Q 005017 304 KVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLK----------LPIQSLKMLRLPMSG--PSSMDI 371 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~dP~~RpSa~eLL~hpf~~~~~~~~~~~~~l~----------~p~~~~~~~~~~~s~--~~~~~i 371 (719)
++.+|++++||++||...++||||.|||+||||+.+.... ...+.. ......+..+.+... ...+++
T Consensus 267 kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~ 345 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNL 345 (632)
T ss_pred ccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccccceeec
Confidence 9999999999999999999999999999999999875431 111110 111111111111111 011111
Q ss_pred CccccccCccccccCC--CCCCCCCchhhhhcccCcceeeccccCCCC-ceEEEEEeecCCCCccceeecccCCCCcHHH
Q 005017 372 DSDYKQLSLSTCTESN--NGSPHCPVLEFQRMHKNNEFRLRGTKNDDT-SVSLTLRIADSSGRVRNIHFLFYLDSDTALS 448 (719)
Q Consensus 372 d~~~~~~~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-~i~L~Lri~d~~~~~~~i~f~f~~~~Dta~~ 448 (719)
+.| .....+.+.. +........+..+..++..+.++|+.+++. .++|.|||+|..|+.|+|+|||++..|||.+
T Consensus 346 ~~D---~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~ 422 (632)
T KOG0584|consen 346 NTD---ESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPS 422 (632)
T ss_pred CCC---chhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhH
Confidence 111 0111111000 000111123445667788899999999876 9999999999999999999999999999999
Q ss_pred HHHHHHhccccCCCChHHHHHHHHHHHHHhCCCCcCCC
Q 005017 449 VAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSY 486 (719)
Q Consensus 449 va~Emv~~~~i~~~d~~~iA~~i~~~i~~l~~~~~~~~ 486 (719)
||.|||+++.++++++..||+|||.+|.+|+|.|+...
T Consensus 423 Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 423 VAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKAST 460 (632)
T ss_pred HHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence 99999999999999999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=435.09 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=231.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+....+||+|..|+||++.|+.+++.+|+|.+... ..+...+++.+|+++++.++|||||++|+.|+.+.. .+.+
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 344557899999999999999999999999999533 235677899999999999999999999999988765 6999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||.+|||.++++..+++++..+..++.++++||.|||. ++ ||||||||+|||++. .|+|||||||.++.+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeecc-CCCEEeccccccHHhhhh
Confidence 99999999999999999999999999999999999999995 78 999999999999985 589999999999998888
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCC----CCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSE----CKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~----~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.+.+++||..|||||.+.+ .|+.++||||||+.++|+++|++||.. ..+..+++..|..+..|......++++++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~ 312 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR 312 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 8899999999999999886 699999999999999999999999976 24677888888888766655556999999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+||.+||+ ||.+|||++|||+|||++...
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999998 899999999999999998544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=436.57 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=227.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP---GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~---~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
...+|.+.+.||+|+||.|-+|+.+.+|+.||||+++........ .......+|+++|++|+|||||+++++|...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 567788999999999999999999999999999999876543311 1234467999999999999999999998655
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecch
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGL 229 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGl 229 (719)
.+.||||||++||+|.+++-.++.+.+..-+.+++|++.|+.|||+.| |+||||||+|||+..+ .-.+||+|||+
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred -CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 457999999999999999999999999999999999999999999999 9999999999999744 23689999999
Q ss_pred hhhccCC-CcccccCCCCCCCccccccc----cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--c
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--L 302 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~~~----~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~ 302 (719)
|+..+.. ..++.||||.|.|||++... +..++||||+||+||-+++|.+||++...+..+.++|..|..+.. .
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 9987643 56889999999999998642 456899999999999999999999986666668899998876543 3
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+...+.+.++||.+||. ||++|||+.|+|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 44567899999999998 999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=442.15 Aligned_cols=257 Identities=33% Similarity=0.534 Sum_probs=231.9
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.|+..++|..++.||+|||+.||++.+..+|+.||+|+|....... +...+++.+||++.++|+|||||++|++|.+.
T Consensus 13 ~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs- 90 (592)
T KOG0575|consen 13 EDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS- 90 (592)
T ss_pred ecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-
Confidence 4556688999999999999999999999999999999998655443 56779999999999999999999999999765
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.++|+|.|+|..|+|..++++++.++|.+++.+++||+.||.|||+++ |||||||..|+|++.+. +|||+|||||.
T Consensus 91 -~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~-~VKIgDFGLAt 166 (592)
T KOG0575|consen 91 -NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENM-NVKIGDFGLAT 166 (592)
T ss_pred -CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcC-cEEecccceee
Confidence 459999999999999999999999999999999999999999999999 99999999999999775 99999999998
Q ss_pred hccCC--CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 232 AMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 232 ~~~~~--~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
.+..+ ...+.||||.|.|||++. .+++..+||||+||+||.|++|++||.. .+..+.+.+|..... .++...+.
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~ 243 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSA 243 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCH
Confidence 88754 456889999999999886 4699999999999999999999999987 667888888876543 23457789
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
++++||.++|. +|.+|||++++|.|+||.
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 99999999998 899999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=414.54 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=225.3
Q ss_pred cccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 70 ~e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
.+..+....|.+.++||.|.-++||+|+...+++.||||++..++... .++.+.+|++.|+.++||||++++.+|+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 344567788999999999999999999999999999999999887643 47899999999999999999999999988
Q ss_pred CCCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
+.. +|+||.||.+||+.+.++.. .++++..+..+++++++||.|||.+| .||||||+.||||+.+ |.|||+||
T Consensus 96 ~~~--LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadF 170 (516)
T KOG0582|consen 96 DSE--LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADF 170 (516)
T ss_pred cce--eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCc
Confidence 754 99999999999999999863 46999999999999999999999999 9999999999999865 89999999
Q ss_pred chhhhccCC-----Cc-ccccCCCCCCCccccc---cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC
Q 005017 228 GLAIAMQQP-----TA-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 298 (719)
Q Consensus 228 GlA~~~~~~-----~~-~~~~GT~~YmAPEvl~---~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~ 298 (719)
|.+..+... .. .+.+|||+|||||++. .+|+.|+|||||||++.||++|..||........+...+.. ..
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-~p 249 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-DP 249 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CC
Confidence 987544321 11 5678999999999964 36999999999999999999999999986544444444443 33
Q ss_pred C--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCCC
Q 005017 299 P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 299 p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~ 343 (719)
| ..-.+..+..++++|..||+ ||.+||||.+||+|+||+..+...
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 3 22224456789999999998 899999999999999998766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=409.35 Aligned_cols=271 Identities=24% Similarity=0.425 Sum_probs=238.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.-..|.+.++||+|+||+||.++.+.+|+.+|+|+++....... ...+....|..+|.+++||.||+++..|.+.+ .
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~--k 99 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE--K 99 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC--e
Confidence 34568899999999999999999999999999999998776553 56688899999999999999999999997665 4
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|||+||+.||.|+.+|++.+.+++..++-|+..|+.||.|||+++ ||||||||+|||+|. +|+++|+|||+++...
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~-~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDE-QGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecC-CCcEEEeccccchhcc
Confidence 9999999999999999999999999999999999999999999999 999999999999984 5899999999998554
Q ss_pred C--CCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 Q--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 ~--~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
. ..+.++|||+.|||||++. ..|+..+|+||||+++|||++|.+||.. .+...+++++..+.. ...+...+++++
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ar 254 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEAR 254 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHH
Confidence 3 3567789999999999875 5699999999999999999999999987 678888889888763 334566789999
Q ss_pred HHHHHhcC-CCCCCC----CHHHHHcCccCccccCCCCCCCCCCCcc
Q 005017 312 GFIEKCLV-PASERL----SAKDLLKDPFLQVENQKEPICDPLKLPI 353 (719)
Q Consensus 312 ~lI~kcL~-dP~~Rp----Sa~eLL~hpf~~~~~~~~~~~~~l~~p~ 353 (719)
++|.++|. +|.+|. .+.++-+||||...+|+......+..|.
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 99999998 899996 6999999999999998776554444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=405.19 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=223.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.+|..||||.+..... .+...+-+..|+.+|+.|+|||||.+++++... +.+|+
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~l 86 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIYL 86 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEEE
Confidence 34566679999999999999999999999999987654 345667889999999999999999999987655 46999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC-----CcEEEeecchhhh
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-----GEVKIGDLGLAIA 232 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~-----G~vKL~DFGlA~~ 232 (719)
|||||.||+|.+|+.+++.+++..++.++.||+.||++||+++ ||||||||+||||+... -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999 99999999999997541 3589999999999
Q ss_pred ccCC-CcccccCCCCCCCcccc-ccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCCChH
Q 005017 233 MQQP-TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQ 309 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl-~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~~~ 309 (719)
+... ...+.||+|-|||||++ .++|+.|+|+||+|+++|+|++|+.||.. .++.+++..+..+.. .+.++...++.
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCc
Confidence 8765 45788999999999998 57899999999999999999999999987 577888887776654 33445555666
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
..+++-..|. +|..|.+..+-+.|+|+.....
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 7788887776 8999999999999999986553
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=405.16 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=217.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+...+.||+|+||+||++.+..+|...|+|.+..... . ..+.+.+|+.+|++|+|||||+++|.........++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345667899999999999999999999999999986531 2 267899999999999999999999963332224689
Q ss_pred EEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+.|||+++|+|.+++++.+ .+++..++.+.+||+.||+|||+++ ||||||||+|||++...|.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999999999887 7999999999999999999999999 999999999999986457999999999987662
Q ss_pred -----CCcccccCCCCCCCccccccccC--ccccchhhHHHHHHHhhccCCCCCC-CCHHHHHHHHHcCCCCCccccCCC
Q 005017 236 -----PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 236 -----~~~~~~~GT~~YmAPEvl~~~~s--~ksDIwSlGiil~EmlTG~~Pf~~~-~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.......|||.|||||++...+. .++|||||||+++||+||..||.+. .....++........| .++...+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls 249 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLS 249 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccC
Confidence 22346789999999999885433 4999999999999999999999873 3334444444444334 7777789
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+++++||.+|+. +|.+||||.+||+|||++...
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999998 899999999999999997544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=394.65 Aligned_cols=249 Identities=29% Similarity=0.470 Sum_probs=221.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
+...|++.++||+|.||+||++.+..+|..||+|.++..... ....+.+..|+.+|++|+|||||++|+.-+.+++..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md--~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD--AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc--HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 344567788999999999999999999999999999966543 466788999999999999999999999555556667
Q ss_pred eeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCC--eeeecCccceeEecCCCCcEEEeecc
Q 005017 155 VNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPP--IIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~pp--IIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
+++|||||..|+|.+.++. ++.++++.+++++.|++.||..+|+.=|+ |+||||||.||||+.+ |.|||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccch
Confidence 9999999999999987764 45699999999999999999999995444 9999999999999955 899999999
Q ss_pred hhhhccCCC--cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 229 LAIAMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 229 lA~~~~~~~--~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
+++.+.... +.+.+|||.||+||++. .+|+.++||||+||++|||+..+.||.+ .+-.++-++|.++..|+-+...
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHH
Confidence 999887653 56789999999999876 5699999999999999999999999998 5888999999999877766688
Q ss_pred CChHHHHHHHHhcC-CCCCCCCH
Q 005017 306 NDPQIKGFIEKCLV-PASERLSA 327 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa 327 (719)
++..++.+|..|+. ||..||+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCc
Confidence 89999999999998 99999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=406.56 Aligned_cols=258 Identities=25% Similarity=0.490 Sum_probs=225.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh-hhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~-~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~ 152 (719)
..+.|.+++.||+|+||+|+.|.+..+|..||+|.+......... ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345678899999999999999999999999999977654322122 34566778999999999 9999999998876654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+.||+|.+++...+++.+..++.+++||++|++|||+++ |+||||||+|||++.+.+++||+|||++..
T Consensus 95 --~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 --IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred --EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999999899999999999999999999999999 999999999999997647999999999988
Q ss_pred c--cCCCcccccCCCCCCCcccccc-c-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC-
Q 005017 233 M--QQPTARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN- 306 (719)
Q Consensus 233 ~--~~~~~~~~~GT~~YmAPEvl~~-~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~- 306 (719)
. ......+.+|||.|+|||++.+ . | +.++||||+|++||.|++|+.||.+ .+...++..+..+... ++...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~ 247 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLL 247 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcC
Confidence 7 3456788999999999999976 3 6 4789999999999999999999998 6677777777776543 33444
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++++.||.+||. +|.+|+|+.+++.||||+..
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 8999999999998 89999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=408.87 Aligned_cols=261 Identities=26% Similarity=0.460 Sum_probs=230.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.-..|+++++||+|+|++|++|.++.++++||||++..+-+.. ....+.+..|-.+|.+| .||.|++||..|.|+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 4456899999999999999999999999999999987655444 33446677899999999 8999999999997765
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+|+||+++|+|.+++++.+.+++...+.++.||+.||+|||++| ||||||||+|||++++ |++||+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccC
Confidence 49999999999999999999999999999999999999999999999 9999999999999977 79999999999876
Q ss_pred cCC-------------Cc--ccccCCCCCCCccccccc-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC
Q 005017 234 QQP-------------TA--RSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 234 ~~~-------------~~--~~~~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
... .. .+++||-.|.+||++... .++.+|||+||||+|+|+.|.+||.+ .+.-.++++|..-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh-
Confidence 421 11 458999999999999764 68899999999999999999999998 6788888888763
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCCCC
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~~ 344 (719)
.-.++...++.+++||+++|+ +|.+|+|+.+|.+||||...+|...
T Consensus 303 -~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 303 -DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred -cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 334566677999999999998 9999999999999999999888763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=384.26 Aligned_cols=268 Identities=26% Similarity=0.453 Sum_probs=237.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||.|+||.|.+++++.+|..+|+|++.+.+... ..+.+...+|..+|+.+.||.++++++.|.+. ..+|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~--~~ly 120 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN--SNLY 120 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccC--CeEE
Confidence 34566789999999999999999999999999998776655 34567889999999999999999999988765 4599
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||||.+||.|+.++++.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+ |.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc
Confidence 99999999999999999999999999999999999999999999 9999999999999965 89999999999887765
Q ss_pred CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
+.+.||||.|+|||++. ..|+.++|.|+||+++|||+.|.+||.. .++.+++.+|..+.. .++...++++++||+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLK 273 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHH
Confidence 67899999999999886 4699999999999999999999999988 678999999998864 356677899999999
Q ss_pred HhcC-CCCCC-----CCHHHHHcCccCccccCCCCCCCCCCCcch
Q 005017 316 KCLV-PASER-----LSAKDLLKDPFLQVENQKEPICDPLKLPIQ 354 (719)
Q Consensus 316 kcL~-dP~~R-----pSa~eLL~hpf~~~~~~~~~~~~~l~~p~~ 354 (719)
++|+ |-.+| ....++..||||....|.......+..|..
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~ 318 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFE 318 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCC
Confidence 9997 88887 468899999999988887654444444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=411.26 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=219.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
+|..-+.||+|+.|.||.|....+++.||+|++..... ...+-+.+|+.+|+.++|+|||++++.|...+ .+|+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eLWV 347 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--ELWV 347 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc--eeEE
Confidence 34445779999999999999999999999999987653 33466889999999999999999999988774 5999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
|||||+||+|.+.+... .++|.++..+++.++.||+|||.++ |||||||.+|||+..+ |.+||+|||++..+...
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeeeeecccccc
Confidence 99999999999988754 4999999999999999999999999 9999999999999855 79999999999776543
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
...+.+|||.|||||++.+ .|++++||||||++++||+-|++||-.......++.....|......+...++++++|+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 4567899999999999875 69999999999999999999999998733334455555566666677778899999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+||+ |+.+|++|.|||+||||+..
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99998 99999999999999999643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=398.09 Aligned_cols=246 Identities=33% Similarity=0.534 Sum_probs=211.1
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeE-EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIE-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~-VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
.+.+.||+|+||+||+|. +.|.. ||+|++....... ...+.|.+|+.+|.+|+|||||+|+|++..... .+++|
T Consensus 44 ~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~--~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iV 118 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDD--ESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIV 118 (362)
T ss_pred hhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEE
Confidence 345669999999999995 45777 9999998654332 227899999999999999999999999876542 58899
Q ss_pred EecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 159 TELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
|||+++|+|.+++.+ ...+++..+..|+.||++||.|||+++| ||||||||+|||++.+.-++||+|||+++....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999999987 5789999999999999999999999987 999999999999986633999999999987664
Q ss_pred -CCcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 236 -PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 236 -~~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .++...+..+...+.++..+++.+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHH
Confidence 23344789999999999985 399999999999999999999999999665 6666666655555566666889999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 005017 312 GFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+++.||. +|.+||+..+++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 99999998 8999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=403.85 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=229.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.-+++++.||.|+.|.|-+|.+..||+.+|||+|...... .......+.+||.+|+.|.|||++++|+.|.. +..+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEE
Confidence 3468999999999999999999999999999999866322 23456788999999999999999999999954 45699
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+|.||+++|.|++|+.+++++++.++.++++||+.|+.|+|..+ |+||||||+|+|++.+ +++||+|||+|..-..
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCC
Confidence 99999999999999999999999999999999999999999999 9999999999999966 4799999999976543
Q ss_pred CCcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
....+.||+|+|.|||++.+. | +.++||||.|||||.|+||+.||.+ +|...++.++..|... ++...++++++|
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdL 242 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDL 242 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHH
Confidence 346788999999999998764 5 6889999999999999999999997 8999999999999764 456778999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
|.+||. ||.+|.|..|+++|||++.....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 999997 99999999999999999875543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=392.49 Aligned_cols=264 Identities=24% Similarity=0.408 Sum_probs=227.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.-..|.+..+||+|+||.||+|.-+.||..+|+|+++...+.. ..+++.+..|-.+|....+|+||++|.+|.+. .+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--Ce
Confidence 3455677789999999999999999999999999999877665 46678899999999999999999999999654 56
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||||++||++..+|.+.+.+++..++.++.+++.|+.-||++| +|||||||+|+|||.. |++||+||||++-+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhh
Confidence 9999999999999999999999999999999999999999999999 9999999999999955 899999999984211
Q ss_pred C-------------------------CC------------------------cccccCCCCCCCcccccc-ccCccccch
Q 005017 235 Q-------------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVDIY 264 (719)
Q Consensus 235 ~-------------------------~~------------------------~~~~~GT~~YmAPEvl~~-~~s~ksDIw 264 (719)
. .. ....+|||.|||||++.+ +|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 00 013469999999998875 599999999
Q ss_pred hhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHHHHHHHHhcCCCCCCCC---HHHHHcCccCccc
Q 005017 265 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVE 339 (719)
Q Consensus 265 SlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l~~lI~kcL~dP~~RpS---a~eLL~hpf~~~~ 339 (719)
|||||+|||+.|.+||.. .++.+.+++|..... ...-....++++++||.+||.||.+|.. +.||.+||||...
T Consensus 373 SLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccC
Confidence 999999999999999987 788888888876442 2222233468999999999999999974 9999999999999
Q ss_pred cCCCCC
Q 005017 340 NQKEPI 345 (719)
Q Consensus 340 ~~~~~~ 345 (719)
+|....
T Consensus 452 ~W~~l~ 457 (550)
T KOG0605|consen 452 DWDHLR 457 (550)
T ss_pred Ccchhh
Confidence 987653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=383.58 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=221.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||.||+|.++.+|+.||+|+++...... ....+.+.+|+.+|++++||||+++++++.+. ..++
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 94 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVY 94 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEE
Confidence 45788899999999999999999999999999997543222 23457788999999999999999999988765 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCCC
Confidence 99999999999999998888999999999999999999999999 9999999999999855 79999999999765433
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
.....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+ .++...+..+..+.. .++...++.+++||.
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVK 247 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHH
Confidence 235679999999998865 488999999999999999999999986 566777777776643 244557889999999
Q ss_pred HhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 316 KCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 316 kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
+||. ||.+||+ +.+|+.||||....+.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 9998 8999997 7999999999875544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=377.79 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=218.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEE
Confidence 4677899999999999999999999999999987543222 23456788999999999999999999877654 56899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC-
Confidence 9999999999999998888999999999999999999999999 9999999999999854 79999999999766443
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+.. .++...++.+++||++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKK 231 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHH
Confidence 334679999999998864 488999999999999999999999987 556677777766543 3445568899999999
Q ss_pred hcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 317 CLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 317 cL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
||. ||.+||+ +.++++||||+..++.
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 998 8999995 9999999999865543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=382.41 Aligned_cols=252 Identities=23% Similarity=0.432 Sum_probs=214.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.++.+|+.||+|+++...... ......+.+|+.+|++++||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence 36999999999999999999999999997543222 34456788999999999999999999988654 4689999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARS 240 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~~ 240 (719)
++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++.... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence 99999999998888999999999999999999999999 9999999999999855 7999999999875322 22345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC
Q 005017 241 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~ 319 (719)
.+||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+...+...+..+. ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 589999999999999999999999976 45566666665543 23455678899999999998
Q ss_pred -CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 320 -PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 320 -dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
||.+|| ++.++++||||+..++..
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 899999 899999999998766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=395.62 Aligned_cols=251 Identities=30% Similarity=0.498 Sum_probs=221.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|+..+.||+|+||.||+|.|..+++.||+|++..+. ....++.+++|+.+|.+++++||.++|+.++.+.. +|++
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--Lwii 89 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--LWII 89 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc--HHHH
Confidence 344489999999999999999999999999998665 34677889999999999999999999999987754 8999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-- 236 (719)
||||.||++.+.++....+++..+..++++++.||.|||.++ .||||||+.|||+..+ |.+||+|||.+..+...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeechhh
Confidence 999999999999998887899999999999999999999999 9999999999999866 89999999999877654
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
...+++|||.|||||++.+ .|+.++||||||++++||++|++||.++..... ..+.....|+.+...+++.+++||.
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EEeccCCCCCccccccCHHHHHHHH
Confidence 2368899999999999986 699999999999999999999999998654222 2233344667777788999999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCccc
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.||. +|+.||+|.+||+|+|++..
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhc
Confidence 9998 89999999999999999863
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=383.53 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=215.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.++.+++||||+++++.+.+. ..+|+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~l 78 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYL 78 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEE
Confidence 4677899999999999999999999999999997543222 33456788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCcccccccc
Confidence 9999999999999998889999999999999999999999999 9999999999999855 799999999986542110
Q ss_pred -------------------------------------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCC
Q 005017 238 -------------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP 279 (719)
Q Consensus 238 -------------------------------------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~P 279 (719)
....+||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 124579999999998764 589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCccc--cCCChHHHHHHHHhcCCC---CCCCCHHHHHcCccCccccCCCC
Q 005017 280 YSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPA---SERLSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~l~~lI~kcL~dP---~~RpSa~eLL~hpf~~~~~~~~~ 344 (719)
|.. .++...+..+........++ ...+++++++|.+++.+| ..||++.+|++||||+..++...
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~ 304 (363)
T cd05628 236 FCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHI 304 (363)
T ss_pred CCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence 986 45667777776533222222 235789999999977643 45799999999999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.46 Aligned_cols=256 Identities=28% Similarity=0.407 Sum_probs=213.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||.|+||.||+|..+.+|..||||+++.+-. . -++ ---.+|++.|++|+ |||||+++..+.+.+. .+++
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s-~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-S-WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-c-HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 4556789999999999999999999999999875432 1 112 22358999999999 9999999999887664 7999
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||||+. +|.+.++.+ +.+++..++.|+.||++||+|+|.+| +.||||||+|||+.+.. .+||+|||+|+.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~-~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGND-VIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccc-eeEecccccccccccC
Confidence 9999976 899988765 46999999999999999999999999 99999999999998664 8999999999987654
Q ss_pred -CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CC---------------
Q 005017 237 -TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI--------------- 297 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~--------------- 297 (719)
..+.++.|.+|+|||++- +.|+.++|+|++|||++|+.+.++-|.+....+|+++...- |.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 456788999999999764 46999999999999999999999999998778888765421 10
Q ss_pred ----CC-------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 298 ----KP-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 298 ----~p-------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
.| ..+....++++.++|.+||. ||.+||||.++|+|||||.....
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 00 11122356889999999999 99999999999999999975543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=391.60 Aligned_cols=249 Identities=30% Similarity=0.486 Sum_probs=219.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+-+.||+|+||+||+|+.+.+.+.||+|.+..... ...+++.+.+|+++++.|+|||||.++++|.. ...+|+|
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 4455789999999999999999999999999875443 34678889999999999999999999998854 4569999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
+||+.| +|+.++...+.++++.++.++.|+++||.|||+++ |+|||+||+|||+.+. |.+|+||||+|+.+...+
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCce
Confidence 999987 99999999999999999999999999999999999 9999999999999865 799999999999876543
Q ss_pred -cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 238 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
.+.+.|||-|||||++++ .|+..+|.||+||++|||++|++||.. ....++.+.|... |..++...+..++.|++
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQ 232 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHH
Confidence 456789999999999875 599999999999999999999999976 4556677777654 33445567889999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCcc
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+|. ||.+|.|..+|+.|||.+.
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhh
Confidence 9997 8999999999999999974
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=380.76 Aligned_cols=257 Identities=24% Similarity=0.444 Sum_probs=215.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.++||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+|+.++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYL 78 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEE
Confidence 4677899999999999999999999999999997543322 24456788999999999999999999988755 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceeccccc
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999998643211
Q ss_pred ---------------------------------------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhc
Q 005017 237 ---------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF 276 (719)
Q Consensus 237 ---------------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG 276 (719)
.....+||+.|+|||++.. .++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0113469999999998764 589999999999999999999
Q ss_pred cCCCCCCCCHHHHHHHHHcCCCCCccc--cCCChHHHHHHHHhcCCCCCCCC---HHHHHcCccCccccC
Q 005017 277 EYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQ 341 (719)
Q Consensus 277 ~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~l~~lI~kcL~dP~~RpS---a~eLL~hpf~~~~~~ 341 (719)
..||.. .++.+.+..+.........+ ...++++++||.+||.+|.+|++ +.++|.||||....+
T Consensus 236 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 236 YPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999987 45566666665443222222 23578999999999999999987 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.96 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=211.9
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
...++||+|.||.||+|++..+|+.||+|++..+... +....-..+||.+|++|+|||||++.+...+.....+|||+
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~--~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK--EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC--CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3457899999999999999999999999999977532 34456678999999999999999999988877667899999
Q ss_pred ecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 160 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
|||+. +|.-++.. .-.|++.+++.+++||+.||+|||+++ |+|||||++||||| +.|.+||+|||||+++....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCC
Confidence 99987 78777765 347999999999999999999999999 99999999999998 55899999999999776443
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC-----------CC---
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-----------KP--- 299 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~-----------~p--- 299 (719)
.+..+-|.+|+|||++-+ .|+.++|+||.||||.||++|++.|.+....+|+.+.....- .|
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 344567999999998764 599999999999999999999999998766666544332110 01
Q ss_pred ----C--------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 ----A--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 ----~--------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
. ...+..++...+|+.++|. ||.+|.||.+.|+|+||...
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 0 0113346788999999998 99999999999999999533
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=366.40 Aligned_cols=249 Identities=26% Similarity=0.455 Sum_probs=205.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
.++|+|+||+||+++++.||+.||||++.-.. ..+...+-..+||++|++|+|||+|.++..|-. ++.+++|+|||
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLVFE~~ 83 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLVFEYC 83 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEEeeec
Confidence 46999999999999999999999999987433 334555667899999999999999999998854 45699999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Cccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 240 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~~ 240 (719)
+..-|.+.-..-.+++.+.++.++.|++.|+.|+|+++ +|||||||+||||+.+ |.+||||||+|+.+..+ ..+.
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcCCcchhhh
Confidence 88555554333457999999999999999999999999 9999999999999855 79999999999988743 3456
Q ss_pred ccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-------------------CCC-
Q 005017 241 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------GIK- 298 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-------------------g~~- 298 (719)
++.|.+|+|||++-+ +|+..+|||++||++.||+||++-|.+..+.+|++..... |..
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 789999999998765 6999999999999999999999999998888887654321 110
Q ss_pred C-----Cccc---cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 299 P-----ASLA---KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 299 p-----~~~~---~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
| ..+. ...+..+.+|+++||. ||.+|++.++||.||||+.
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 0 1111 1123468899999998 9999999999999999953
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=376.18 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=215.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+|+.||+|+++...... ......+.+|+.++..++||||+++++++... ..+++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEE
Confidence 4678899999999999999999999999999997543221 23456788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~-~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT-Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc-c
Confidence 9999999999999998888999999999999999999999999 9999999999999855 7999999999976544 3
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc------cCCChHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA------KVNDPQI 310 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~------~~~~~~l 310 (719)
....+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+.........+ ...++++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence 345679999999998764 589999999999999999999999987 45666655554322111111 2347899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
.+||.+||. +|.+||++.++++||||....+
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 999999998 6899999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=379.41 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=218.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCC-eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g-~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
..|.+.+.||+|+||.||+|.+..++ ..||+|++....... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 106 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYL 106 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEE
Confidence 45788899999999999999876655 689999987543322 34456788999999999999999999998655 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeecCC
Confidence 999999999999999998889999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
. ....+||+.|||||++.+ .++.++|||||||++|||+||..||.. .++...++.+..+.. .++...++.++++|
T Consensus 184 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 R-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLM 259 (340)
T ss_pred C-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Confidence 2 345689999999998865 488999999999999999999999987 566667777776543 23455678999999
Q ss_pred HHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 315 EKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 315 ~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
++||. +|.+|+ +++++++||||...++..
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99998 899995 899999999998765543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=373.57 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=211.9
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||+||+|.+..+|+.||+|+++..... .......+.+|+.+|++++||||+++++++... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence 79999999999999999999999998754322 234567788999999999999999999988654 468999999999
Q ss_pred CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCccccc
Q 005017 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSVI 242 (719)
Q Consensus 165 GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~~~~ 242 (719)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence 999999988888999999999999999999999999 9999999999999855 7999999999875432 2234567
Q ss_pred CCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-C
Q 005017 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 243 GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-d 320 (719)
||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+..+.+..+..+ +..++...++++++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 9999999998865 589999999999999999999999987 4566666666654 334455678899999999998 8
Q ss_pred CCCCC---CHHHHHcCccCccccC
Q 005017 321 ASERL---SAKDLLKDPFLQVENQ 341 (719)
Q Consensus 321 P~~Rp---Sa~eLL~hpf~~~~~~ 341 (719)
|.+|| ++.++|+||||.....
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99997 5899999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=393.69 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=235.8
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~ 154 (719)
-..|++..+||+|.||+|++|..+.+++.+|||+++.....+ .++.+..+.|..++.... ||.++.+|.+|... .+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~ 443 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EH 443 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--Ce
Confidence 346888999999999999999999999999999999888776 467789999999988885 99999999999654 56
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc-
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM- 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~- 233 (719)
+|+||||+.||++..+.+ .+.+++..++.++..|+.||.|||+++ |||||||.+|||+|.+ |.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccC
Confidence 999999999999655443 467999999999999999999999999 9999999999999966 89999999999754
Q ss_pred -cCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 234 -QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 234 -~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
....+.++||||.|||||++.+ .|+.++|+|||||+||||++|+.||.+ .+.++++..|... ...++...+.++.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAI 596 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHH
Confidence 3446788999999999999875 599999999999999999999999998 7889999998874 3456777889999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCccCccccCCCCCCCCCCCcch
Q 005017 312 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 354 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~~~~~~l~~p~~ 354 (719)
.+++++|. +|.+|+. +.+|.+||||+..+|.......+++|..
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~ 645 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV 645 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC
Confidence 99999998 8999985 6899999999999987766555555544
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=376.42 Aligned_cols=258 Identities=23% Similarity=0.414 Sum_probs=217.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.+..+|+.||+|+++...... ......+..|+.++..++||||+++++.+.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEE
Confidence 4677899999999999999999999999999998654322 24556788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCcccC
Confidence 9999999999999998888999999999999999999999999 9999999999999855 799999999987654322
Q ss_pred -------------------------------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC
Q 005017 238 -------------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN 285 (719)
Q Consensus 238 -------------------------------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~ 285 (719)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-T 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-C
Confidence 234579999999998865 5899999999999999999999999874 4
Q ss_pred HHHHHHHHHcCCCCCccc--cCCChHHHHHHHHhcCCCCCCCC-HHHHHcCccCccccCC
Q 005017 286 PAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS-AKDLLKDPFLQVENQK 342 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~--~~~~~~l~~lI~kcL~dP~~RpS-a~eLL~hpf~~~~~~~ 342 (719)
....+..+........++ ...++.+++||.+||.+|.+||+ +.++++||||+...+.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 555555555522211222 22588999999999999999999 9999999999865543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.36 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=211.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|+..+.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.++++++|+||+++++++.+. ..+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEE
Confidence 567889999999999999999999999999987554322 23345678899999999999999999988655 468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCC
Confidence 9999999999887543 36899999999999999999999999 9999999999999855 69999999999765432
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..+...+.. ....++...++.+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHH
Confidence 2345679999999998864 6899999999999999999999999764322 222222222 22234455678999
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCccCccccCCCC
Q 005017 312 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~~ 344 (719)
+||.+||. +|.+||+ ++++++||||+..++...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 99999998 8999997 999999999987765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=380.04 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=212.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|++++++++||||+++++++.+. ..+|+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK-KDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEE
Confidence 3677899999999999999999999999999987543222 34567788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++...+.+++..++.|+.|++.||+|||+++ |+||||||+|||++.+ |.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeeccccccccccc
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999998532110
Q ss_pred ------------------------------------------------CcccccCCCCCCCcccccc-ccCccccchhhH
Q 005017 237 ------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFG 267 (719)
Q Consensus 237 ------------------------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlG 267 (719)
.....+||+.|+|||++.+ .++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0012469999999998764 589999999999
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCCChHHHHHHHHhcCCCCC---CCCHHHHHcCccCccccC
Q 005017 268 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 268 iil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~l~~lI~kcL~dP~~---RpSa~eLL~hpf~~~~~~ 341 (719)
|++|||+||..||.. .+....+..+........++ ...++++++||.+||.+|.+ |+++.+++.||||+..++
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 236 AIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999976 45556666665432222222 23578999999999986554 569999999999986544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.80 Aligned_cols=251 Identities=22% Similarity=0.422 Sum_probs=212.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.+..+|..||+|+++..... .......+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEeCC
Confidence 3699999999999999999999999999754322 234556778899999999999999999988655 4689999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Cccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 240 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~~ 240 (719)
++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence 99999999988888999999999999999999999999 9999999999999855 79999999998753222 2345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC
Q 005017 241 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~ 319 (719)
..||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+.......+..... .++...+++++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 679999999998864 589999999999999999999999976 445555555554322 3445678999999999998
Q ss_pred -CCCCCC-----CHHHHHcCccCccccCC
Q 005017 320 -PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 320 -dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
+|.+|+ ++.++++||||....+.
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 899998 89999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.16 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=212.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.+..+|..||+|++...... .......+.+|+.+|+.++||||+++++.+... ..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEeCC
Confidence 3699999999999999999999999999754322 234557788999999999999999999988654 4689999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARS 240 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~~ 240 (719)
++|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++.... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence 99999999988888999999999999999999999999 9999999999999855 7999999999875432 22345
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC
Q 005017 241 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~ 319 (719)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+.......+..+. ..++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED--IKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcC
Confidence 679999999998864 589999999999999999999999976 44555555554432 23455678899999999998
Q ss_pred -CCCCCC-----CHHHHHcCccCccccCC
Q 005017 320 -PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 320 -dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
+|.+|+ ++.++++||||...++.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 899997 89999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=378.09 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=210.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.++++++||||+++++++.+. ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEE
Confidence 4667889999999999999999999999999997654322 34557789999999999999999999998754 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCccccccc
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999987532100
Q ss_pred ------------------------------------------------CcccccCCCCCCCcccccc-ccCccccchhhH
Q 005017 237 ------------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFG 267 (719)
Q Consensus 237 ------------------------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlG 267 (719)
.....+||+.|+|||++.+ .++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0124579999999998764 589999999999
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHHHHHHHHhcC---CCCCCCCHHHHHcCccCccccCC
Q 005017 268 MCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLV---PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 268 iil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l~~lI~kcL~---dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
|++|||+||+.||... +.......+..... ........++++++||.+|+. ++..|+++.+++.||||+...+.
T Consensus 236 ~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 236 VILFEMLVGQPPFLAP-TPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred hHHHHHHhCCCCCcCC-CHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9999999999999874 34444444433221 111222467899999999664 45669999999999999875543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=377.54 Aligned_cols=260 Identities=23% Similarity=0.421 Sum_probs=216.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|+++...... ......+..|+.++.+++||||+++++.+.+. ..+++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE-KEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 3677899999999999999999999999999997543322 34557788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCccccccc
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999998643211
Q ss_pred ------------------------------------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCC
Q 005017 237 ------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP 279 (719)
Q Consensus 237 ------------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~P 279 (719)
.....+||+.|+|||++.+ .++.++|||||||++|||+||+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0123579999999998764 589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCccc--cCCChHHHHHHHHhcCCCCCCC---CHHHHHcCccCccccCCCC
Q 005017 280 YSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~l~~lI~kcL~dP~~Rp---Sa~eLL~hpf~~~~~~~~~ 344 (719)
|.. .++...+..+........++ ...+++++++|.+|+.+|.+|+ ++.++++||||+..++...
T Consensus 236 f~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 236 FCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence 987 45666666665432222222 2357899999999888888888 5899999999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=369.35 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=212.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|..||+|.+.... .....+++.+|+++|++++||||+++++++...+ .++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 79 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EIS 79 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--EEE
Confidence 45677899999999999999999999999999987542 2345578999999999999999999999887654 588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+|||++.+ |.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 156 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCcccccccc
Confidence 9999999999999999888899999999999999999999985 6 9999999999999855 7999999999976655
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH---------------------
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV--------------------- 293 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i--------------------- 293 (719)
.......||+.|+|||++.+ .++.++|||||||++|||+||+.||... ...++...+
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccccc
Confidence 55556789999999998864 5899999999999999999999999653 222222111
Q ss_pred -------------------------HcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 294 -------------------------TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 294 -------------------------~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.....+.......++++++||.+||. +|.+|||+.+||+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 11111211222456889999999998 899999999999999998543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=377.65 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=212.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||+||+|.+..+++.||+|++....... ....+.+.+|+.++++++|||||++++.+.+. ..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL-RNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEE
Confidence 3667899999999999999999999999999987543221 34557788999999999999999999998755 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~-- 235 (719)
||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCccccccc
Confidence 9999999999999988888999999999999999999999999 9999999999999855 7999999999743210
Q ss_pred -----------------------------------------------CCcccccCCCCCCCcccccc-ccCccccchhhH
Q 005017 236 -----------------------------------------------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFG 267 (719)
Q Consensus 236 -----------------------------------------------~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlG 267 (719)
......+||+.|+|||++.+ .|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00123579999999998764 699999999999
Q ss_pred HHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCChHHHHHHHHhcCCCCCCCC---HHHHHcCccCccccCC
Q 005017 268 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 342 (719)
Q Consensus 268 iil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~l~~lI~kcL~dP~~RpS---a~eLL~hpf~~~~~~~ 342 (719)
|++|||++|+.||.. .++.+....+........ .....+++++++|.+|+.+|.+|++ +.++++||||+...+.
T Consensus 236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 236 VILYEMLVGQPPFLA-QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHHhCCCCCCC-CCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 999999999999987 445554444443222211 2234578999999998889999987 9999999999875543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.95 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=211.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+|++++||||+++++.+.+. ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEE
Confidence 4678899999999999999999999999999986543221 23456788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|..+...
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCccccccc
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999997432100
Q ss_pred --------------------------------------------CcccccCCCCCCCcccccc-ccCccccchhhHHHHH
Q 005017 237 --------------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCIL 271 (719)
Q Consensus 237 --------------------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~ 271 (719)
.....+||+.|||||++.+ .++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0123579999999998864 5899999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChHHHHHHHHhcCCCCCCC---CHHHHHcCccCccccC
Q 005017 272 EMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQ 341 (719)
Q Consensus 272 EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~l~~lI~kcL~dP~~Rp---Sa~eLL~hpf~~~~~~ 341 (719)
||++|+.||... ++......+...... .......++++.++|.+|+.+|.+|+ ++.++++||||+....
T Consensus 236 ell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 236 EMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred ehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 999999999873 444444444432221 11223457899999999888999999 9999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=366.80 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=205.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---Cc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---~~ 154 (719)
.|++.++||+|+||.||+|.+..+|..||+|+++... .......++.+|+.++++++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 3678899999999999999999999999999987432 112344678899999999999999999998765432 35
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCccccccc
Confidence 789999995 689999988888999999999999999999999999 9999999999999855 799999999997543
Q ss_pred CCC-----cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHH--------------HHH
Q 005017 235 QPT-----ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--------------FKK 292 (719)
Q Consensus 235 ~~~-----~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i--------------~~~ 292 (719)
... ....+||+.|+|||++.+ .++.++|||||||++|||+||+.||.......+. ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 134579999999998753 5899999999999999999999999764322111 011
Q ss_pred HHc-----------CCCCCc---cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 293 VTS-----------GIKPAS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 293 i~~-----------g~~p~~---~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+.. ...+.. .....++.+.++|.+||. +|.+|||+.++|+||||+...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 100 001111 112346789999999998 899999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=369.70 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=212.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..++..+ +||||+++++++... ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcC
Confidence 36999999999999999999999999987543222 23456778898888876 699999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 799999999986532 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999987 556677777765432 234557889999999999
Q ss_pred C-CCCCCCCH------HHHHcCccCccccCC
Q 005017 319 V-PASERLSA------KDLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~RpSa------~eLL~hpf~~~~~~~ 342 (719)
. +|.+||++ +++++||||+...+.
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 8 89999998 999999999865543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=366.45 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=211.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC---c
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK---T 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~---~ 154 (719)
.|.-.+++|.|+||+||+|....+++.||||++..+.... .+|+++|+.++|||||++..+|...... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4556789999999999999999999999999998765433 2699999999999999999888765544 6
Q ss_pred eeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 155 VNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+++|||||+. +|.++++. +..++...++-+..||++||+|||+++ |+||||||+|+|+|.+.|.+||||||.|
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 7799999976 88888774 577999999999999999999999999 9999999999999999999999999999
Q ss_pred hhccCCC-cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-C----------
Q 005017 231 IAMQQPT-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G---------- 296 (719)
Q Consensus 231 ~~~~~~~-~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g---------- 296 (719)
+.+.... ..++.-|..|+|||++-+ .|+.+.||||.||++.||+-|++-|.+.....|+...+.- |
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 8876543 356677999999998764 6999999999999999999999999986555555433211 0
Q ss_pred -----------CCCC----ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 297 -----------IKPA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 297 -----------~~p~----~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+. .+....++++.+|+.++|+ +|.+|.++.|+|.||||+...
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 0111 1334568999999999999 999999999999999998544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=368.74 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=209.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.++.+|+.||+|++....... ......+..|.. +++.++||||+++++.+... ..+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEEcC
Confidence 36999999999999999999999999987543322 223345555554 56889999999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccc
Confidence 999999999998888999999999999999999999999 9999999999999855 7999999999865322 2334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+..+++..+..+.. .+....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998764 589999999999999999999999986 456677777765432 234445889999999999
Q ss_pred C-CCCCCCCH----HHHHcCccCccccCC
Q 005017 319 V-PASERLSA----KDLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~RpSa----~eLL~hpf~~~~~~~ 342 (719)
. +|.+||++ .++++||||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 8 89999987 699999999875543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.46 Aligned_cols=250 Identities=23% Similarity=0.421 Sum_probs=211.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.+..+|..||+|+++..... .......+..|+++++.++||||+++++.+... ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence 3699999999999999999999999999754322 234456778899999999999999999987654 4689999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
++|+|..++...+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence 999999999888889999999999999999999997 68 9999999999999855 7999999999865332 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
...||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+.......+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5679999999998864 589999999999999999999999987 45556666655432 2345567889999999999
Q ss_pred C-CCCCCC-----CHHHHHcCccCccccC
Q 005017 319 V-PASERL-----SAKDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~Rp-----Sa~eLL~hpf~~~~~~ 341 (719)
. +|.+|+ ++.++++||||....+
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 8 899997 9999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.89 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=211.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
|++.+.||+|+||+||+|.+. .+|..||+|++............+.+..|+.+++++ +||||+++++++... ..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AK 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CE
Confidence 577899999999999998764 478999999997544333334556788999999999 599999999887654 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+.+|+|.+++..++.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 8899999999999999988888999999999999999999999999 9999999999999855 799999999997643
Q ss_pred CC---CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCC---CCHHHHHHHHHcCCCCCccccCC
Q 005017 235 QP---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~---~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
.. .....+||+.|+|||++.+ .++.++|||||||++|||+||..||... .....+...+.... ..++...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence 22 2234679999999998864 3788999999999999999999999642 22334444444322 2344567
Q ss_pred ChHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 307 DPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
++.++++|.+||. +|.+|| ++.++++||||+...+.
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 8899999999998 899999 89999999999875543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=357.73 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=204.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.++..||+|+++..... ....+.+.+|+.++++++||||+++++++... ..+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEE
Confidence 467889999999999999999999999999998754322 23456788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||++++++..+......+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCcccccccc
Confidence 9999999888776665667999999999999999999999999 9999999999999855 799999999997654322
Q ss_pred ---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCC--------------
Q 005017 238 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-------------- 298 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~-------------- 298 (719)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||............... +..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 234579999999998764 5899999999999999999999999864433322211110 000
Q ss_pred -----CC---------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -----PA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -----p~---------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+. ......++.+++||++||. +|.+|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=367.41 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=211.8
Q ss_pred EEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.||+|+||.||+|.+. .+|+.||+|+++.............+..|+.+|++++||||+++++.+..+ ..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEEEE
Confidence 57999999999999763 478899999998654333334456778999999999999999999988655 4589999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CC
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~ 237 (719)
||+.+|+|.+++.+.+.+.+..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence 99999999999998888999999999999999999999999 9999999999999855 7999999999864322 22
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+.......+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998864 588999999999999999999999987 445555666655533 3445567899999999
Q ss_pred hcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 317 CLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 317 cL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
||. +|.+|| ++.+++.||||....+.
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 998 899999 89999999999865543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=369.15 Aligned_cols=258 Identities=19% Similarity=0.329 Sum_probs=215.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+..|+.+++.++||||+++++.+.+. ..+++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEE
Confidence 467889999999999999999999999999999854322 234556788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTAN 155 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCC
Confidence 99999999999999876 67999999999999999999999999 9999999999999855 79999999999765433
Q ss_pred C---cccccCCCCCCCccccc-------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--c
Q 005017 237 T---ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--K 304 (719)
Q Consensus 237 ~---~~~~~GT~~YmAPEvl~-------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 304 (719)
. .....||+.|+|||++. ..++.++|||||||++|||++|+.||.. .+....+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCCccCCCCCC
Confidence 2 23347999999999875 3478899999999999999999999987 44555566665543322222 2
Q ss_pred CCChHHHHHHHHhcCCCCCCCCHHHHHcCccCccccCC
Q 005017 305 VNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
..++.+++||.+||.+|.+||++.++++||||...++.
T Consensus 235 ~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 235 KVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHH
Confidence 35789999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=348.81 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=208.4
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
...++||+|.||+||+|.|..+|+.||||+++..+..+ .......+||+.|+.++|+||+.+.+.|...+ .+.+|+
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lVf 80 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLVF 80 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEEE
Confidence 34578999999999999999999999999999875432 33456789999999999999999999986654 488899
Q ss_pred ecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 160 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
|||+. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++.+ |.+||+|||+|+.+..+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence 99977 888887754 46899999999999999999999999 9999999999999855 8999999999998875532
Q ss_pred --ccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCCc-----------
Q 005017 239 --RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPAS----------- 301 (719)
Q Consensus 239 --~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~~----------- 301 (719)
...+-|.+|+|||++-+ .|+..+||||.|||+.||+-|.+-|.+..+.+|+...... ...+..
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 23367999999998754 6999999999999999999998888887777776443321 111111
Q ss_pred ------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 302 ------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 302 ------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+....+..+.+|+.++|. ||.+|++|.|+|+|+||..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112234677999999998 9999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=357.74 Aligned_cols=255 Identities=26% Similarity=0.461 Sum_probs=222.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|.|+.||++.+..+|+++|+|.+......+ ...+++.+|+.+.+.|+|||||++++.+.. ..+.|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 4567789999999999999999999999999998776654 366889999999999999999999997744 356889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~~~~ 235 (719)
|+|+|+||+|..-+-.+-.+++..+-.+++||+.+|.|+|.++ |||||+||+|+++-. +..-+||+|||+|..+..
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 9999999999877766677899999999999999999999999 999999999999942 223699999999988774
Q ss_pred C-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHHH
Q 005017 236 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIK 311 (719)
Q Consensus 236 ~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l~ 311 (719)
. .....+|||+|||||+++. .|+..+|||+.|++||-|+.|.+||.+ .+...+++.|..+.. +...+...+++++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 3 3456789999999999875 699999999999999999999999987 578889999998754 3334556679999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+||++||. ||.+|.|+.|.|+|||+...
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999997 99999999999999999743
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=372.87 Aligned_cols=260 Identities=20% Similarity=0.369 Sum_probs=215.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.+.||+|+||+||+|.+..+|..||+|++....... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~ 117 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KY 117 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CE
Confidence 3456788899999999999999999999999999997543222 23345678899999999999999999988654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeecc
Confidence 89999999999999998654 5889999999999999999999999 9999999999999855 799999999997654
Q ss_pred CC---CcccccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--
Q 005017 235 QP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK-- 304 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~-- 304 (719)
.. .....+||+.|+|||++.. .++.++|||||||++|||++|+.||.. .+....+..+........++.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcC
Confidence 32 2235679999999998753 378999999999999999999999987 455666777765443333332
Q ss_pred CCChHHHHHHHHhcC-CCCC--CCCHHHHHcCccCccccCC
Q 005017 305 VNDPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~--RpSa~eLL~hpf~~~~~~~ 342 (719)
..+.++++||.+||. +|.+ |+++.++++||||+...+.
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 357899999999998 6776 9999999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.18 Aligned_cols=258 Identities=30% Similarity=0.454 Sum_probs=215.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec---CCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD---DKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~---~~~ 152 (719)
.++|...+.||+|+||.|..|.++.+|+.||+|++. +..+..-..++..+|+++|+.++|+||+.+++.+.. +.-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344444688999999999999999999999999886 233445677899999999999999999999998866 344
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+|+|+|+ .+|.+.++..+.++...+..++.||++||.|+|+-+ |+||||||.|+|++.+. .+||+|||+|+.
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c-~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADC-DLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCC-CEEeccccceee
Confidence 57999999994 499999998888999999999999999999999999 99999999999999775 899999999988
Q ss_pred cc----CCCcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH--------------H
Q 005017 233 MQ----QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--------------K 292 (719)
Q Consensus 233 ~~----~~~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~--------------~ 292 (719)
.. ....+.++-|.+|+|||++. ..|+.++||||.|||+.||++|++-|.+.....|+.. .
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 74 34456778899999999774 4699999999999999999999999987554444321 1
Q ss_pred HH---------c-CCCC----CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 293 VT---------S-GIKP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 293 i~---------~-g~~p----~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+. + ...| .......++.+.+|+++||. ||.+|+||+|+|.||||...
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11 0 1111 11224567899999999999 99999999999999999753
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=366.26 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=212.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||.||+|.+..+|+.||+|+++...... ....+.+..|..++..+ +||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeC
Confidence 36999999999999999999999999987543222 34456778899998876 799999999988655 458999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence 999999999988888999999999999999999999999 9999999999999855 7999999999865332 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
...||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+....+..+..+.. ..+...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5679999999998865 589999999999999999999999987 556677777766532 234456789999999999
Q ss_pred C-CCCCCC-------CHHHHHcCccCccccCC
Q 005017 319 V-PASERL-------SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~Rp-------Sa~eLL~hpf~~~~~~~ 342 (719)
. +|.+|| ++.++++||||....+.
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 8 899999 99999999999765544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.94 Aligned_cols=251 Identities=21% Similarity=0.362 Sum_probs=208.6
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||.||+|.+..+|+.||+|+++..... .......+..|..++..+ +||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeC
Confidence 3699999999999999999999999999854322 234556788999999998 799999999988655 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 799999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--------CHHHHHHHHHcCCCCCccccCCChHH
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--------NPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--------~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
..+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.... ....+.+.+.... ..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence 5689999999998865 58999999999999999999999995311 1223344444432 23455667899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHHcCccCccccC
Q 005017 311 KGFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 341 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpS------a~eLL~hpf~~~~~~ 341 (719)
.++|.+||. +|.+|++ +.++++||||....+
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999998 8999987 789999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.25 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=226.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKK 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~ 152 (719)
....+|.+.+.||+|.||.||++.++.+|+.+|+|.+....... ......+.+|+++|++|. |||||.+++.|.+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~- 109 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD- 109 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-
Confidence 34567889999999999999999999999999999998766543 235578899999999998 999999999987654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC---CCcEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~---~G~vKL~DFGl 229 (719)
.+++|||++.||.|++.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||+
T Consensus 110 -~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 110 -SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred -eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 699999999999999998876 4999999999999999999999999 9999999999999643 24799999999
Q ss_pred hhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccC
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKV 305 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~ 305 (719)
|...... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.. .+....+..+..+.. +...+..
T Consensus 186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccc
Confidence 9887653 456789999999999998 6899999999999999999999999987 555666677777754 2333444
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+..+++||.+||. ||.+|+||.++|+|||++...
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 57899999999998 899999999999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.71 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=202.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEE
Confidence 346778999999999999999999999999999875432 12234567899999999999999999988654 4689
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+. ++|.+++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAKSV 155 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceeccC
Confidence 9999995 5787777654 56899999999999999999999999 9999999999999854 7999999999865432
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CC------------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI------------ 297 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~------------ 297 (719)
. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..+.......+.. +.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 2 2234578999999998754 4789999999999999999999999875554443333211 00
Q ss_pred ---CCCccc-------------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 298 ---KPASLA-------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 298 ---~p~~~~-------------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+..+. ...++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000000 0123578999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.01 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=215.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+..|+.++..++|+ +|+++++++... ..+|+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 577899999999999999999999999999987543322 34557788899999999775 577888877654 45899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--C
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~ 235 (719)
||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence 9999999999999988888999999999999999999999999 9999999999999855 799999999986432 2
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+..+.+..+..... .++...+++++++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li 232 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSIC 232 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 23345679999999998865 589999999999999999999999986 456667777765432 34556788999999
Q ss_pred HHhcC-CCCCCCCH-----HHHHcCccCccccCC
Q 005017 315 EKCLV-PASERLSA-----KDLLKDPFLQVENQK 342 (719)
Q Consensus 315 ~kcL~-dP~~RpSa-----~eLL~hpf~~~~~~~ 342 (719)
.+||. +|.+|+++ .++++||||...++.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99998 89999976 899999999876543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.16 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||+||+|.+..++..||+|+++.... ......+.+|+.++++++||||+++++++... ..+++
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 80 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTL 80 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEE
Confidence 46777899999999999999999999999999875432 22335677899999999999999999988654 46889
Q ss_pred EEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+ +|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 9999975 8999887644 4789999999999999999999999 9999999999999855 79999999998654322
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CC------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK------------ 298 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~------------ 298 (719)
......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.... ..+....+... ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-VKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHHhhccccch
Confidence 2334578999999998753 58999999999999999999999998743 33322222110 00
Q ss_pred -------CC-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -------PA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -------p~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+. ......++++++||.+||. +|.+|||++|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=371.02 Aligned_cols=258 Identities=21% Similarity=0.380 Sum_probs=212.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.++||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~ 118 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYL 118 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEE
Confidence 345788899999999999999999999999999987533222 23445678999999999999999999988654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceeccc
Confidence 9999999999999999754 5899999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CC---cccccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcccc--C
Q 005017 236 PT---ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--V 305 (719)
Q Consensus 236 ~~---~~~~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~--~ 305 (719)
.. ....+||+.|||||++.+ .++.++|||||||++|||+||+.||.. .+....+..+........++. .
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCccc
Confidence 22 245679999999998753 278899999999999999999999986 455566666665433222222 3
Q ss_pred CChHHHHHHHHhcCC-C--CCCCCHHHHHcCccCccccC
Q 005017 306 NDPQIKGFIEKCLVP-A--SERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 306 ~~~~l~~lI~kcL~d-P--~~RpSa~eLL~hpf~~~~~~ 341 (719)
.++.++++|.+||.+ + ..|+++.++++||||+...+
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 578899999999974 3 34899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=381.10 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=203.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC-----
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----- 150 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----- 150 (719)
.+.|++.++||+|+||+||+|.+..+|+.||+|++.... ....+|+.+|+.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 456889999999999999999999999999999885332 2235799999999999999998876542
Q ss_pred -CCCceeEEEecccCCChhHHhh----hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 151 -KKKTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 151 -~~~~l~lV~Ey~~gGsL~~~L~----~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
....+++||||+++ +|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 22357799999975 6766654 3457999999999999999999999999 99999999999998665689999
Q ss_pred ecchhhhccCC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC----
Q 005017 226 DLGLAIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---- 298 (719)
Q Consensus 226 DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~---- 298 (719)
|||+|+.+... .....+||+.|+|||++.+ .|+.++|||||||++|||+||.+||.+.....++.+.+.....
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99999866432 2345678999999998754 5899999999999999999999999875544444333221000
Q ss_pred --------------C--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 299 --------------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 299 --------------p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+ ..++...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0 01122356789999999998 89999999999999999754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.08 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=209.8
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||.||+|.++.+|..||+|.++...... ......+..|..++..+ +||||+++++++.+. ..+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECC
Confidence 46999999999999999999999999998543221 23445677788888764 899999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+.+|+|..++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999855 699999999986432 22344
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+..++.+.+..+. ..++...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999986 45666666665543 2344567889999999999
Q ss_pred C-CCCCCCCH-HHHHcCccCccccC
Q 005017 319 V-PASERLSA-KDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~RpSa-~eLL~hpf~~~~~~ 341 (719)
. +|.+||++ .++++||||+...+
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 8 89999997 58999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=363.20 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=209.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHH---HhCCCCCceeEEEeeecCCCCce
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL---KSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
|++.+.||+|+||.||+|.+..+|+.||+|+++...... ....+.+.+|+.++ +.++||||+++++++... ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEE
Confidence 467789999999999999999999999999998543222 23456677776655 567899999999988654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+||||+++|+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCC
Confidence 999999999999988864 56999999999999999999999999 9999999999999855 7999999999865322
Q ss_pred --CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 --~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+..+....+..+.. ..+...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 22345679999999998864 589999999999999999999999987 455666666655432 234456789999
Q ss_pred HHHHhcC-CCCCCC-----CHHHHHcCccCccccC
Q 005017 313 FIEKCLV-PASERL-----SAKDLLKDPFLQVENQ 341 (719)
Q Consensus 313 lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~ 341 (719)
+|.+||. +|.+|| ++.++++||||....+
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999998 899999 7999999999986544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=362.84 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=215.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||+|+||.||+|.+..++..||+|+++...... ....+.+..|..++..+ +|++|+++++++... ..+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence 567899999999999999999999999999987543222 23445677788888887 578999999887654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--C
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~ 235 (719)
||||+++|+|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCC
Confidence 9999999999999988888999999999999999999999999 9999999999999855 799999999986543 2
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
......+||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+...++..+..... .++...++++++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 23345679999999998864 589999999999999999999999987 456677777665433 34456788999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCccCccccCCC
Q 005017 315 EKCLV-PASERLS-----AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 315 ~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~ 343 (719)
.+||. +|.+|++ ..++++||||+..++..
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 99998 8999998 48999999998766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.25 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=204.8
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||+||++.+..+|+.||+|.+....... ....+.+..|+.+++.++||||+++++++... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence 699999999999999999999999987543222 23446778899999999999999999887654 458899999999
Q ss_pred CChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--c
Q 005017 165 GNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 238 (719)
Q Consensus 165 GsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--~ 238 (719)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++....... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccc
Confidence 999987742 356899999999999999999999999 9999999999999854 799999999987654332 3
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 239 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ......+... +...+...++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 34579999999998864 5889999999999999999999999753322 2222222222 2334455778999999
Q ss_pred HHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 315 EKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 315 ~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
.+||. +|.+|| +++++++||||+...+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99998 899999 899999999998755443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=375.22 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=225.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+++|+|+||.++..+++.++..+++|.+....... ...+...+|+.++++++|||||.++++|+.++ ..+++
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~--~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~I 81 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE--PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCI 81 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc--hhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEE
Confidence 3556789999999999999999999999999999776443 44457789999999999999999999998654 46899
Q ss_pred EEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||+||+||+|.+.+++.+ .++++.+..|+.|++.|+.|||+.. |+|||||+.|||++.+ +.|||+|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcCC
Confidence 999999999999988755 5899999999999999999999888 9999999999999977 4789999999999987
Q ss_pred C--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
. .+.+++|||.||.||++.+ .|+.++||||||||+|||++-+.+|.. .+...+..++..+. -..++..++.+++.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~ 236 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRS 236 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHH
Confidence 6 5678999999999999976 599999999999999999999999988 67777777777776 33456677889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+|+.||. +|..||+|.+||.+|.++..
T Consensus 237 lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 237 LVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999998 79999999999999988743
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.59 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=212.2
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..++..||+|+++...... ......+..|+.++..+ +||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 36999999999999999999999999998543222 34456778899999888 799999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+++|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 799999999986432 22234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..... .++...++.+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999976 456666666655432 344567889999999999
Q ss_pred C-CCCCCCCH-----HHHHcCccCccccC
Q 005017 319 V-PASERLSA-----KDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~RpSa-----~eLL~hpf~~~~~~ 341 (719)
. +|.+||++ .+++.||||....+
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 8 89999999 99999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.43 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=207.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..+++.||+|+++..... .......+..|+.++.++ +||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeC
Confidence 4699999999999999999999999999864322 234556788899998877 899999999988665 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||+++.... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 7999999999875322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
...||+.|+|||++.+ .++.++|||||||++|||+||+.||... .....+.+.+.... ..++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence 5679999999998865 5899999999999999999999999521 11223344444332 23455678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHHcCccCccccC
Q 005017 311 KGFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 341 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpS------a~eLL~hpf~~~~~~ 341 (719)
+++|.+||. +|.+||+ +.++++||||+..++
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999998 8999998 589999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=362.78 Aligned_cols=254 Identities=26% Similarity=0.453 Sum_probs=210.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|..+|+|.+.... .......+.+|++++++++||||+++++++... ..++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEE
Confidence 45678899999999999999999999999999887542 234456789999999999999999999998765 4689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+|||++.+ |.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhhh
Confidence 9999999999999999888899999999999999999999974 6 9999999999999855 7999999999976655
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHH------------------------
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF------------------------ 290 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~------------------------ 290 (719)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCcc
Confidence 44455679999999998865 58899999999999999999999997522 22211
Q ss_pred --------------------HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 291 --------------------KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 291 --------------------~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
..+.....+.......++++++||.+||. +|.+|||+.+|++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111111111122356789999999998 89999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=361.46 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=208.8
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh-CCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..+++.||+|+++...... ....+.+..|..++.. ++||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcC
Confidence 36999999999999999999999999998643222 2344556677777765 4899999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+++|+|..++...+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 7999999999975432 2334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|||++|+.||.. .+..+++..+.... ..++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998865 589999999999999999999999987 45666666665532 2345567889999999999
Q ss_pred C-CCCCCCCH-HHHHcCccCccccC
Q 005017 319 V-PASERLSA-KDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~RpSa-~eLL~hpf~~~~~~ 341 (719)
. +|.+||++ .++++||||....+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCH
Confidence 8 89999986 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=366.71 Aligned_cols=259 Identities=20% Similarity=0.364 Sum_probs=214.9
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.+.||+|+||.||+|.++.+++.||+|++....... ....+.+.+|+.+++.++||||+++++.+.+. ..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CE
Confidence 4467788899999999999999999999999999987543222 23445678899999999999999999988654 56
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+++|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence 89999999999999998754 5899999999999999999999999 9999999999999855 799999999997654
Q ss_pred CC---CcccccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--c
Q 005017 235 QP---TARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--K 304 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 304 (719)
.. .....+||+.|||||++.. .++.++|||||||++|||++|+.||.. .+....+..+........++ .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcC
Confidence 32 2235679999999998753 278999999999999999999999986 56666777776544322222 3
Q ss_pred CCChHHHHHHHHhcCCCC---CCCCHHHHHcCccCccccC
Q 005017 305 VNDPQIKGFIEKCLVPAS---ERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~dP~---~RpSa~eLL~hpf~~~~~~ 341 (719)
..++.++++|.+||.+|. .|+++.++++||||+...+
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 467899999999998543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=361.56 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=209.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh-CCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.||+|+||+||+|.+..+++.||+|+++...... ......+..|..++.. ++||||+++++++.+. ..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeC
Confidence 36999999999999999999999999997543211 2334566778888876 4999999999988655 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+++|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence 999999999988788999999999999999999999999 9999999999999865 699999999986432 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
...||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..++++.+..... .++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHh
Confidence 5679999999998864 589999999999999999999999987 456666666654432 234557789999999999
Q ss_pred C-CCCCCCCHH-HHHcCccCccccCC
Q 005017 319 V-PASERLSAK-DLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~RpSa~-eLL~hpf~~~~~~~ 342 (719)
. +|.+||++. ++++||||+...+.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHH
Confidence 8 899999996 89999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=362.98 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=207.3
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHH-HHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV-HLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.||+|+||+||+|.+..++..||+|++........ .....+..|. .+++.++||||+++++++... ..+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEEeC
Confidence 369999999999999999999999999875432221 2233444444 457889999999999988655 458999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcc
Confidence 999999999998888999999999999999999999999 9999999999999855 7999999999875432 2334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+.+..+.... .......++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHc
Confidence 5679999999998865 589999999999999999999999986 45666666665542 2334456789999999999
Q ss_pred C-CCCCCCCHH----HHHcCccCccccCC
Q 005017 319 V-PASERLSAK----DLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~RpSa~----eLL~hpf~~~~~~~ 342 (719)
+ +|.+|+++. ++++|+||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 8 899999865 89999999876554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.74 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=208.1
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..+|..||+|++....... ......+..|.. +++.++||||+++++.+.+. ..+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEEcC
Confidence 36999999999999999999999999987543322 223345555654 67889999999999987654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+++|+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence 999999999988888999999999999999999999999 9999999999999855 7999999999875322 2234
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+++..+.... ..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999987 45666666666543 3344556789999999999
Q ss_pred C-CCCCCCCH----HHHHcCccCccccCC
Q 005017 319 V-PASERLSA----KDLLKDPFLQVENQK 342 (719)
Q Consensus 319 ~-dP~~RpSa----~eLL~hpf~~~~~~~ 342 (719)
. +|.+||++ .++++||||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 8 89999875 599999999865543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.07 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=209.5
Q ss_pred EEEeeeCCeEEEEEEE---cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d---~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.||+|+||.||++.+ ..+|..||+|+++..... ......+..|+++|++++||||+++++++... ..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEE
Confidence 5799999999999876 357899999999754321 22345677899999999999999999988654 4688999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--C
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~ 237 (719)
||+++|+|.+++.+...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999999 9999999999999855 79999999998765433 2
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
.....||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+..+....+..... .++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998864 588999999999999999999999987 455566666654432 2345568899999999
Q ss_pred hcC-CCCCCCC-----HHHHHcCccCccccC
Q 005017 317 CLV-PASERLS-----AKDLLKDPFLQVENQ 341 (719)
Q Consensus 317 cL~-dP~~RpS-----a~eLL~hpf~~~~~~ 341 (719)
||. +|.+||+ +.++++||||+...+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 998 8999999 788999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.31 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=213.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.|++|+||.||+|.|+.+++.||+|+++.+.-. ....-.-.+||.+|.+++|||||.+-...+..+-+.+|+|
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek--~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK--EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc--CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 33446799999999999999999999999999976522 2223345799999999999999999999888887889999
Q ss_pred EecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+. +|+..+...+ ++...+++.++.|+++||+|||.+. |+||||||+|+|++ +.|.+||+|||+|+.+..+.
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCc
Confidence 999987 8999888765 7999999999999999999999999 99999999999998 55899999999999987663
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CC-----CC--------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI-----KP-------- 299 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~-----~p-------- 299 (719)
.+..+-|.+|+|||++-+ .|++++|+||+|||+.||+++++-|.+....+|+.+.+.. |. .|
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 345667999999998754 5999999999999999999999999987777776544321 11 00
Q ss_pred --------------CccccC-CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 --------------ASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 --------------~~~~~~-~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+... .+....+|+..+|. ||.+|.||.+.|+|.||....
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 000111 24677889999998 999999999999999998543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=362.83 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..+|+.||+|++....... ......+..|.. +++.++||||+++++.+... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEEcC
Confidence 36999999999999999999999999987543222 233445556655 57789999999999988654 458899999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence 999999999988888999999999999999999999999 9999999999999855 799999999986532 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL 318 (719)
..+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+++..+..... ......+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHh
Confidence 5679999999998865 589999999999999999999999986 456666666665432 223346788999999999
Q ss_pred C-CCCCCCCH----HHHHcCccCccccC
Q 005017 319 V-PASERLSA----KDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~RpSa----~eLL~hpf~~~~~~ 341 (719)
. +|.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 8 89999876 69999999986544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=352.51 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=209.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.++||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEE
Confidence 567789999999999999999999999999987543222 22345677899999999999999999988654 468999
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCC
Confidence 9999999999887643 45899999999999999999999999 9999999999999855 79999999998765432
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHHcCCCCCccccCCChHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~---~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
......|++.|+|||++.+ .++.++|||||||++|||++|+.||.+..... .+...+.. .+...+...++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAAR 233 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHH
Confidence 2234578999999998864 58899999999999999999999998633221 12222222 12234445678999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 312 GFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 312 ~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
+||.+||. ||.+|| ++.+|++||||...+++.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 99999998 899999 999999999998766554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=364.65 Aligned_cols=252 Identities=31% Similarity=0.530 Sum_probs=216.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.++||+|+||.||+|.++.+|..||+|++..+ .+++++..|+.++.+++.|++|++||+|+... .+|+|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DLWIV 106 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DLWIV 106 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ceEee
Confidence 34457899999999999999999999999999865 46788999999999999999999999987654 49999
Q ss_pred EecccCCChhHHhh-hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 159 TELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~-~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||..|+..+.+. +++.+++.++..+++..+.||+|||... -||||||..|||++.+ |.+||+|||.|..+...
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhhH
Confidence 99999999999876 4678999999999999999999999988 8999999999999855 89999999999877654
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCCChHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKG 312 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~~~l~~ 312 (719)
...+++|||.|||||++.+ +|+.++||||||++..||..|++||.+......++. +.. .+|+.+ +..++.++.+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT-~PPPTF~KPE~WS~~F~D 261 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPT-KPPPTFKKPEEWSSEFND 261 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-ccC-CCCCCCCChHhhhhHHHH
Confidence 3467899999999999986 699999999999999999999999998654433332 222 223333 3446778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccccCCC
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~ 343 (719)
||++||. +|++|-||.+|++|||++..+...
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 9999998 799999999999999998766544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.19 Aligned_cols=252 Identities=30% Similarity=0.438 Sum_probs=198.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcC-CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeec---C
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVD---D 150 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~---~ 150 (719)
.|++.+.||+|+||+||+|.+.. +|..||+|.++...... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 46778899999999999999854 47889999987543222 2234456677777665 69999999998753 2
Q ss_pred CCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEcccc
Confidence 3346889999996 5899988753 45899999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC---CC---
Q 005017 229 LAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PA--- 300 (719)
Q Consensus 229 lA~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~---p~--- 300 (719)
++...... ......||+.|+|||++. ..++.++|||||||++|||++|+.||..... .+.+..+..... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhch
Confidence 99765433 234567999999999875 4689999999999999999999999987443 333333322110 00
Q ss_pred -------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 301 -------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 301 -------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+....++.+++||.+||. +|.+|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112356788999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.72 Aligned_cols=254 Identities=23% Similarity=0.422 Sum_probs=226.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|.+++.||+|-||.||.|+.+.++-.||+|++...+..+ .+...++.+|+++-..|+||||+++|++|.+.. .+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccc--ee
Confidence 345778899999999999999999999999999998776544 355678999999999999999999999998764 59
Q ss_pred eEEEecccCCChhHHhh--hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~--~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
|+++||.+.|+|...|. ..+++++.....+.+|++.||.|+|.++ ||||||||+|+|+... |.+||+|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeec
Confidence 99999999999999998 6778999999999999999999999999 9999999999999755 79999999998776
Q ss_pred cCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 234 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
......+.|||..|.|||+.++ .++..+|+|++|++.||++.|.+||.. .+..+.++++.... ..++...+.++++
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes-~~~~etYkrI~k~~--~~~p~~is~~a~d 251 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES-QSHSETYKRIRKVD--LKFPSTISGGAAD 251 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh-hhhHHHHHHHHHcc--ccCCcccChhHHH
Confidence 6666778999999999999876 589999999999999999999999987 44778888887643 2344677889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+|.+||. +|.+|.+..|++.|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 9999998 8999999999999999964
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.93 Aligned_cols=259 Identities=23% Similarity=0.395 Sum_probs=216.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC----------hhhHHHHHHHHHHHHhCCCCCceeEEEe
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----------PGDLQKLYSEVHLLKSLKDDNVVKFYKS 146 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~----------~~~~~~~~~Ei~iL~~L~HpNIVkl~~~ 146 (719)
..|.+.+.||+|.||.|.+|++..+|+.||+|++........ -..+++.++||.+|++|.|||||+++.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 457788889999999999999999999999999976443211 1234688999999999999999999998
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
.-+.....+|||+|||..|.+..--.....+++.+++.+++.++.||+|||.+| ||||||||+|+||+.+ |+|||+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsD 253 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISD 253 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeec
Confidence 877777889999999999988764433334999999999999999999999999 9999999999999866 8999999
Q ss_pred cchhhhccCC-------CcccccCCCCCCCcccccc---c--cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 005017 227 LGLAIAMQQP-------TARSVIGTPEFMAPELYEE---E--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 227 FGlA~~~~~~-------~~~~~~GT~~YmAPEvl~~---~--~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~ 294 (719)
||.+...... .....+|||.|||||+..+ . .+.+.||||+|++||.|+.|+.||.+ .....++.+|.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHh
Confidence 9998655221 1223689999999998754 2 36789999999999999999999987 56777888888
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.............+.++++|.++|. ||.+|.+..++..|||....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 7654333333456899999999998 89999999999999999743
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=378.15 Aligned_cols=252 Identities=33% Similarity=0.554 Sum_probs=222.2
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
-+||+|.||+||.|+|..+...+|||.+..++ ....+-+..||.+.++|+|.|||+++|++-.+ .++-+.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen--Gf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSVSEN--GFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhccCCC--CeEEEEeecC
Confidence 37999999999999999999999999987554 34567789999999999999999999987443 4677899999
Q ss_pred cCCChhHHhhh-cccc--cHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCC
Q 005017 163 TSGNLRQYRKK-HKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 237 (719)
Q Consensus 163 ~gGsL~~~L~~-~~~l--~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~ 237 (719)
+||||...|.. .+++ ++.++..+.+||+.||.|||... |||||||-+||||+.-.|.+||+|||.++.+. ++.
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999998875 4666 88899999999999999999999 99999999999999878999999999998764 456
Q ss_pred cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
+.++.||..|||||++.. +|+.++|||||||++.||.||++||.+..++...+-++.--...+.++...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 678899999999999974 59999999999999999999999999988887766666555555667777789999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
.+|+. +|.+||+|.+||.+||++..+.+
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCCC
Confidence 99998 79999999999999999987544
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.84 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=209.8
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
++||+|+||+||+|.+..+++.||+|+++..... .....+.+..|+.++.++ +||||+++++++... ..+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeC
Confidence 3699999999999999999999999999854322 234556788999999988 699999999988654 458999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CCCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~~~~ 239 (719)
+++|+|..++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence 999999999988888999999999999999999999999 9999999999999855 799999999987532 22334
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC------CCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~------~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
..+||+.|+|||++.+ .++.++|||||||++|||+||+.||... .....+++.+... +..++...++.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 5689999999998764 5899999999999999999999999532 1223344444433 33455667889999
Q ss_pred HHHHhcC-CCCCCCC------HHHHHcCccCccccCC
Q 005017 313 FIEKCLV-PASERLS------AKDLLKDPFLQVENQK 342 (719)
Q Consensus 313 lI~kcL~-dP~~RpS------a~eLL~hpf~~~~~~~ 342 (719)
+|.+||. +|.+|++ +.+++.||||+..++.
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 9999998 8999998 5799999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.51 Aligned_cols=253 Identities=32% Similarity=0.554 Sum_probs=212.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|.+.+.||+|+||.||+|.+..+|..||+|.+....... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 80 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TLS 80 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eEE
Confidence 3677899999999999999999999999999987543221 1234567889999999999999999999987654 689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|+||+++++|.+++...+.+++..++.++.|++.||.|||+.+ |+||||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999999999999998888999999999999999999999999 9999999999999854 79999999998654332
Q ss_pred Cc-----ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 TA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 ~~-----~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.. ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+........++...+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHHhccCCCCCCCccCCHHH
Confidence 11 33568899999998865 488999999999999999999999987443333 334444434445666778899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.++|.+||. +|.+|||+.++++||||
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.62 Aligned_cols=257 Identities=18% Similarity=0.351 Sum_probs=209.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.++..++|+||+++++++.+. ..+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-RAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYL 78 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEE
Confidence 4678899999999999999999999999999987533222 23456688999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCC
Confidence 9999999999999976 457999999999999999999999999 9999999999999855 79999999998655432
Q ss_pred C---cccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---ccc
Q 005017 237 T---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAK 304 (719)
Q Consensus 237 ~---~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~ 304 (719)
. ....+||+.|||||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+........ ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccC
Confidence 2 22346999999999885 3478899999999999999999999986 445555555554322111 122
Q ss_pred CCChHHHHHHHHhcCC---CCCCCCHHHHHcCccCccccC
Q 005017 305 VNDPQIKGFIEKCLVP---ASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~d---P~~RpSa~eLL~hpf~~~~~~ 341 (719)
..++.+++||.+||.. +..|+++.++++||||....+
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 3578999999999963 344889999999999976544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.92 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=207.1
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeecCCCCceeEEEec
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
||+|+||+||+|.+..+|..||+|++....... ......+..|..++..+ +||||++++..+... ..+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcC
Confidence 799999999999999999999999987543322 23344556677777765 699999999988655 458999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC--CCcc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~--~~~~ 239 (719)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence 999999999998888999999999999999999999999 9999999999999855 7999999999865322 2334
Q ss_pred cccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 240 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+.... .....++.+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 5679999999998754 479999999999999999999999986 55667777776654322 1234578999999999
Q ss_pred cC-CCCCCC----CHHHHHcCccCccccC
Q 005017 318 LV-PASERL----SAKDLLKDPFLQVENQ 341 (719)
Q Consensus 318 L~-dP~~Rp----Sa~eLL~hpf~~~~~~ 341 (719)
|. +|.+|| ++.++++||||....+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 98 899998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=356.42 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=213.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.++||+|+||+||+|.++.+|+.||+|++....... ....+.+..|..++..+.| ++|+++++++... ..+|+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 466789999999999999999999999999987543222 2345667889999988864 6777888877654 45899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCC
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999998754322
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...+++.+..... .++...++++++++
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 232 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSIC 232 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 2345679999999998864 589999999999999999999999987 456667777665432 34456678999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 315 EKCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 315 ~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
.+||. +|.+|++ ..++++||||+...+.
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 99998 8999997 5899999999976654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=339.89 Aligned_cols=256 Identities=32% Similarity=0.538 Sum_probs=213.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|++.++||+|+||.||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||+++++++.+.....++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 467889999999999999999999999999998754322 2234567889999999999999999999988766556788
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence 99999999999999988888999999999999999999999999 9999999999999854 79999999998754321
Q ss_pred -----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 -----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
......|+..|+|||++.+ .++.++||||||+++|+|++|+.||........+ ............+...+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHhcCCCCCCCchhhCHHH
Confidence 2234568999999998754 5889999999999999999999999875444443 33333323333444556789
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCccCc
Q 005017 311 KGFIEKCLVPASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 311 ~~lI~kcL~dP~~RpSa~eLL~hpf~~ 337 (719)
.++|.+|+.+|.+||+++++++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=374.80 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=218.6
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...+..|.+.++||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|..++|+||++++..+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3455678899999999999999999999999999999876543 23556778899999999999999999887754332
Q ss_pred ------CceeEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcE
Q 005017 153 ------KTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 153 ------~~l~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~v 222 (719)
..+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCE
Confidence 1467999999999999998653 46899999999999999999999998 9999999999999865 699
Q ss_pred EEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC
Q 005017 223 KIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 223 KL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGR 261 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC
Confidence 99999998765432 2345679999999998875 589999999999999999999999986 55666666666654
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+ .++...+++++++|.+||. +|.+||++.++++|||++.
T Consensus 262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 43 3455667899999999998 8999999999999999863
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=358.83 Aligned_cols=254 Identities=29% Similarity=0.396 Sum_probs=201.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---- 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---- 152 (719)
..|++.+.||+|+||.||+|.+..+|..||+|++..... ......++.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 456788999999999999999999999999999864421 23445678899999999999999999998865432
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCCccc
Confidence 357899999975 5666553 35889999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH----------------
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------- 294 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~---------------- 294 (719)
.... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+..........+.
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 5332 2345678999999998865 589999999999999999999999986433221111100
Q ss_pred -----cCC--CC----------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 295 -----SGI--KP----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 295 -----~g~--~p----------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
... .+ .......++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 00 00112235689999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=342.58 Aligned_cols=251 Identities=32% Similarity=0.574 Sum_probs=206.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||+||+|.+..+++.||+|.+....... .......+|+.++++++||||+++++++... ..+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE--EEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH--HHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc--cccchhhhhhhcccccccccccccccccccc--cccccc
Confidence 578899999999999999999999999999998664322 2223345699999999999999999988764 458899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc--cCC
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~--~~~ 236 (719)
|||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ +.|.++|+|||.+... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998889999999999999999999999999 99999999999999 4479999999998753 223
Q ss_pred CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHcCCCCCcccc--CCChHH
Q 005017 237 TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAK--VNDPQI 310 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~--~~~~~l 310 (719)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+..... ...+++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 344567899999999987 468999999999999999999999998741 22223322222111111111 113789
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=346.66 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec--CCCCceeEEEe
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITE 160 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~--~~~~~l~lV~E 160 (719)
..||+|++|.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++|||||++++++.+ .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4699999999999976 799999999875432 223345778899999999999999999999877 44557899999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcc
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~ 239 (719)
|+++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+||+++.+ |.+||+|||+++...... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~-~ 178 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP-F 178 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhcccc-c
Confidence 999999999999888899999999999999999999984 7 8899999999999865 799999999997654432 3
Q ss_pred cccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 240 SVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
...||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+..+++..+..+......+...++++++||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999998864 689999999999999999999999987 456667776655444444555678899999999
Q ss_pred hcC-CCCCCCCHHHHHc
Q 005017 317 CLV-PASERLSAKDLLK 332 (719)
Q Consensus 317 cL~-dP~~RpSa~eLL~ 332 (719)
||. +|.+|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 998 8999999999986
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=340.10 Aligned_cols=256 Identities=34% Similarity=0.558 Sum_probs=211.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|...++||+|+||.||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 356778999999999999999999999999998754322 1224456788999999999999999999988765556788
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+++||+++++|.+++...+.+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence 99999999999999988788999999999999999999999998 9999999999999855 69999999998755321
Q ss_pred -----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 -----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
......++..|+|||.+.+ .++.++|||||||++|||++|+.||........+.+. ......+.++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHA 238 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-hcCCCCCCCchhcCHHH
Confidence 1223468899999998864 4789999999999999999999999875444444433 33333344555677899
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCccCc
Q 005017 311 KGFIEKCLVPASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 311 ~~lI~kcL~dP~~RpSa~eLL~hpf~~ 337 (719)
+++|..|+.+|.+||+++++++||||+
T Consensus 239 ~~li~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFLGCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHhcCChhhCcCHHHHhcCcccc
Confidence 999954445999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=372.14 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=214.0
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCC-CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~-g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.+....|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+|+.++|||||++++++...
T Consensus 63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~- 137 (478)
T PTZ00267 63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSD- 137 (478)
T ss_pred CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-
Confidence 34455688999999999999999998877 7889988765432 34446678899999999999999999998765
Q ss_pred CCceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+||
T Consensus 138 -~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DF 213 (478)
T PTZ00267 138 -DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDF 213 (478)
T ss_pred -CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeC
Confidence 458999999999999987754 346899999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 005017 228 GLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 228 GlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 302 (719)
|+++..... .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||.. .+..+++..+..+..+ ..
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~ 291 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PF 291 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CC
Confidence 999765433 2345679999999998864 589999999999999999999999976 4556666666655443 23
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+...++.++++|.+||. +|.+||++.++|.|||++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 44567899999999998 8999999999999999963
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=354.00 Aligned_cols=258 Identities=18% Similarity=0.351 Sum_probs=211.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||+||++.++.+++.||+|.+....... ......+..|+.++..++|+||+++++.+.+. ..+++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYL 78 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH-hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEE
Confidence 4677899999999999999999999999999986433221 23345678899999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMED 155 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccC
Confidence 9999999999999987 457899999999999999999999999 9999999999999855 79999999998654322
Q ss_pred C---cccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc---cc
Q 005017 237 T---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AK 304 (719)
Q Consensus 237 ~---~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~---~~ 304 (719)
. ....+||+.|+|||++. +.++.++|||||||++|||++|+.||.. .+..+.+..+........+ ..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccc
Confidence 1 22357999999999874 3488999999999999999999999987 4566666666554322222 23
Q ss_pred CCChHHHHHHHHhcC-C--CCCCCCHHHHHcCccCccccCC
Q 005017 305 VNDPQIKGFIEKCLV-P--ASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-d--P~~RpSa~eLL~hpf~~~~~~~ 342 (719)
..++++++||.+||. + +..|+++.++++||||+...+.
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 457899999999996 3 3447899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.91 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=216.6
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChh----hHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG----DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~----~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
.-.++||+|..++|.++.++.+|.+.|+|++.......+.. .++.-.+|+.+|+++ .||||+++.++|.. ...
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~sF 97 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--DAF 97 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--cch
Confidence 34578999999999999999999999999997654333332 234556899999998 69999999998754 456
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++|+|+|+.|.|++||...-.++++..+++++|++.|++|||.++ |+||||||+|||++.+. ++||+|||+|+.+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~-~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNM-NIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecccc-ceEEeccceeeccC
Confidence 8899999999999999998888999999999999999999999999 99999999999999775 99999999999887
Q ss_pred CC-CcccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--c
Q 005017 235 QP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--K 304 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 304 (719)
.. ..+..||||+|.|||.++. +|+..+|+|++|+|||.|+.|.+||.. ...-.+...|..|......+ .
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchh
Confidence 65 4577899999999997742 588899999999999999999999975 34445667788876543332 3
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
..+...++||.+||+ ||.+|.|++|.|.||||+.
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 346789999999998 9999999999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.83 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=202.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+.+.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+++|+.++|+||+++++++... ..++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEE
Confidence 34566788999999999999999999999999986432 234457789999999999999999999988654 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+.+|+|.... ..++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 149 lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceecccc
Confidence 999999999987542 3567788899999999999999999 9999999999999855 79999999999765433
Q ss_pred C--cccccCCCCCCCcccccc-----c-cCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCC
Q 005017 237 T--ARSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-----~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~ 306 (719)
. .....||+.|+|||++.. . .+.++|||||||++|||++|+.||..... .......+.... +.......
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCcc
Confidence 2 245679999999998742 2 35689999999999999999999974221 122222332222 23344556
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++++++||.+||. +|.+|||+.|+|+||||....
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 7899999999998 899999999999999998643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=353.91 Aligned_cols=258 Identities=18% Similarity=0.354 Sum_probs=211.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||++.++.+++.||+|.+....... ......+..|+.++..++|+||+++++++.+. ..+|+
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~l 78 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK-RAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYL 78 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEE
Confidence 4678899999999999999999999999999987533222 23456688899999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+|+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCC
Confidence 9999999999999987 467899999999999999999999999 9999999999999855 79999999998765433
Q ss_pred C---cccccCCCCCCCcccccc------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc---c
Q 005017 237 T---ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA---K 304 (719)
Q Consensus 237 ~---~~~~~GT~~YmAPEvl~~------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~---~ 304 (719)
. ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..+.+..+........++ .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccc
Confidence 2 223579999999998763 478899999999999999999999986 45556666665433222222 2
Q ss_pred CCChHHHHHHHHhcCCCCC---CCCHHHHHcCccCccccCC
Q 005017 305 VNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~dP~~---RpSa~eLL~hpf~~~~~~~ 342 (719)
..+++++++|.+||..+.+ |++++++++||||+...+.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 3468999999999974323 5799999999999876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=367.62 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=218.2
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.||...|..+ +-||.|+||.||.|.|..+.+.||||++...... +....+.+..|+..|.+|+|||+|.+-++|..+.
T Consensus 22 ~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ-s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 22 DDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH 99 (948)
T ss_pred CCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeeccccccc-cHHHHHHHHHHHHHHHhccCCCcccccceeeccc
Confidence 3444444433 4599999999999999999999999999876543 3456688999999999999999999999998664
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+.|+|||||- ||-.|.+.-+ +++.+..+..|+.+.+.||+|||+++ .||||||..|||++ +.|.|||+|||.|
T Consensus 100 --TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSA 173 (948)
T KOG0577|consen 100 --TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSA 173 (948)
T ss_pred --hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccch
Confidence 5889999995 5888877654 57999999999999999999999999 99999999999998 4589999999999
Q ss_pred hhccCCCcccccCCCCCCCcccc----ccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 231 IAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl----~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
....+ ..+++|||.|||||++ .+.|+-++|||||||+..||...++|+... |.......|.....|.-....+
T Consensus 174 si~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~eW 250 (948)
T KOG0577|consen 174 SIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEW 250 (948)
T ss_pred hhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCchh
Confidence 77654 5688999999999986 367999999999999999999999998874 4444444555555555555667
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+..++.|+..||+ .|.+|||+.+||+|+|......
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 8899999999999 5999999999999999985543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.75 Aligned_cols=251 Identities=31% Similarity=0.428 Sum_probs=197.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeecC---CC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KK 152 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~~---~~ 152 (719)
|.+.+.||+|+||+||+|.++.+|+.||+|.++...... .....+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 567789999999999999999999999999987543221 2223455677766655 799999999987643 23
Q ss_pred CceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 153 KTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCcc
Confidence 458899999974 898888764 35899999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---C----C--
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---K----P-- 299 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~---~----p-- 299 (719)
...... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||........ ...+.... . +
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCccc
Confidence 766533 234457899999999875 4589999999999999999999999976433332 22221100 0 0
Q ss_pred ----------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ----------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.......+..++++|.+||. ||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112346678999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=362.70 Aligned_cols=246 Identities=27% Similarity=0.336 Sum_probs=197.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++|++|+|||||++++++... ...+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 159 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYN--KFTC 159 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeE
Confidence 45788899999999999999999999999999643 13467899999999999999999988654 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+|+|++. ++|..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCcccccccc
Confidence 8999995 689999988888999999999999999999999999 9999999999999855 7999999999965432
Q ss_pred --CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-------CHHHHHHHHHc-CCCC-----
Q 005017 236 --PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTS-GIKP----- 299 (719)
Q Consensus 236 --~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-------~~~~i~~~i~~-g~~p----- 299 (719)
......+||+.|+|||++.+ .++.++|||||||++|||+||..||.... ...++...+.. +..|
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 22334679999999998864 58999999999999999999998875321 11111111100 0000
Q ss_pred ---------------------Ccc-----ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 300 ---------------------ASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 300 ---------------------~~~-----~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
... ....+.++++||.+||. ||.+||||.|+|+||||+.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000 01124578999999998 9999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=353.42 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeec
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD 149 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~ 149 (719)
...|++.++||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34578899999999999999975 2356789999986432 123456789999999999 89999999998764
Q ss_pred CCCCceeEEEecccCCChhHHhhhc-------------------------------------------------------
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH------------------------------------------------------- 174 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~------------------------------------------------------- 174 (719)
. ...+++||||+++|+|.+++...
T Consensus 83 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 P-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred C-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 4 34688999999999999998652
Q ss_pred -------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC----cccccC
Q 005017 175 -------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIG 243 (719)
Q Consensus 175 -------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~G 243 (719)
..+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++...... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCC
Confidence 23778889999999999999999999 9999999999999855 699999999997653321 123346
Q ss_pred CCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-C
Q 005017 244 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 244 T~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-d 320 (719)
++.|+|||++. ..++.++|||||||++|||++ |..||............+..+..+ ..+...++.++++|.+||. +
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCC
Confidence 78899999875 458999999999999999997 999998755445555555554433 3345667899999999998 8
Q ss_pred CCCCCCHHHHHc
Q 005017 321 ASERLSAKDLLK 332 (719)
Q Consensus 321 P~~RpSa~eLL~ 332 (719)
|.+|||+.+|++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.34 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=198.9
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC------CceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD------NVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp------NIVkl~~~~~ 148 (719)
....|++.++||+|+||+||+|.+..+++.||+|+++... .....+..|+.+++.++|. ++++++++|.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3566888999999999999999999999999999986321 2234456677777777554 5888888876
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCC--------
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH-------- 219 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~-------- 219 (719)
.. ...+++|||++ +++|.+++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++.+.
T Consensus 202 ~~-~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NE-TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cC-CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence 54 34688999988 77999999888889999999999999999999997 48 99999999999997542
Q ss_pred -------CcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH
Q 005017 220 -------GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291 (719)
Q Consensus 220 -------G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~ 291 (719)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+...+ .
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~ 355 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-H 355 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H
Confidence 1499999998754322 2345689999999998865 5999999999999999999999999864433222 1
Q ss_pred HHHc--CCCCCcc--------------------------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 005017 292 KVTS--GIKPASL--------------------------------------AKVNDPQIKGFIEKCLV-PASERLSAKDL 330 (719)
Q Consensus 292 ~i~~--g~~p~~~--------------------------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eL 330 (719)
.+.. +..|..+ ....++.+.+||.+||+ ||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111 1111000 01124668899999998 99999999999
Q ss_pred HcCccCccc
Q 005017 331 LKDPFLQVE 339 (719)
Q Consensus 331 L~hpf~~~~ 339 (719)
|+||||+..
T Consensus 436 L~Hp~~~~~ 444 (467)
T PTZ00284 436 TTHPYVLKY 444 (467)
T ss_pred hcCcccccc
Confidence 999999854
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.40 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=217.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 78 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYL 78 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEE
Confidence 4678899999999999999999999999999987543222 34557789999999999999999999988655 45889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||+|+|||++.+ |.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC-
Confidence 9999999999999998888999999999999999999999999 9999999999999855 79999999998766544
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
.....|++.|+|||.+.. .++.++||||||+++|+|++|..||... ......+.+..+.. .++...++.++++|.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHHH
Confidence 345578999999998754 5788999999999999999999999773 45556666654432 2344568899999999
Q ss_pred hcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 317 CLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 317 cL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
||. +|.+|+ ++++|++||||+...+.
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 998 899999 99999999999765543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.75 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=191.8
Q ss_pred eEEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 82 DEVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.+||+|+||+||+|.++ .++..||+|.+.... ....+.+|+.+|++++||||+++++.+.......+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 457999999999999865 467899999886432 124567899999999999999999998877667889999
Q ss_pred ecccCCChhHHhhhc---------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec---CCCCcEEEeec
Q 005017 160 ELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGDL 227 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~---------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~---~~~G~vKL~DF 227 (719)
||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...|.+||+||
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9986 4888876532 24889999999999999999999999 99999999999994 23468999999
Q ss_pred chhhhccCC-----CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCH---------HHHHH
Q 005017 228 GLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQIFK 291 (719)
Q Consensus 228 GlA~~~~~~-----~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---------~~i~~ 291 (719)
|++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|++||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 1235678999999998764 4899999999999999999999999642211 11110
Q ss_pred HHHc-CCC-----------C-----------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 292 KVTS-GIK-----------P-----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 292 ~i~~-g~~-----------p-----------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
.+.. +.. + .......+..+.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0000 000 0 00011234578999999998 9999999999999999
Q ss_pred C
Q 005017 336 L 336 (719)
Q Consensus 336 ~ 336 (719)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.27 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=219.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.+++.+.||.|.-|+||++.+..++..+|+|++....... ...+.+.+.|-+||+.++||.++.+|..|.. .++.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 45667788999999999999999999999999998665443 5667888999999999999999999999854 46799
Q ss_pred EEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|||||+||+|...++++ +.+++..++.++..++.||+|||..| ||+|||||+||||..+ |++.|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence 999999999999998875 46999999999999999999999999 9999999999999754 899999999873210
Q ss_pred ----------------------------------C-C-----------------------CcccccCCCCCCCcccccc-
Q 005017 235 ----------------------------------Q-P-----------------------TARSVIGTPEFMAPELYEE- 255 (719)
Q Consensus 235 ----------------------------------~-~-----------------------~~~~~~GT~~YmAPEvl~~- 255 (719)
. . ....++||-+|.|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 0113579999999999986
Q ss_pred ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCC----HHHH
Q 005017 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDL 330 (719)
Q Consensus 256 ~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpS----a~eL 330 (719)
+.+.++|+|+|||.+|||+.|..||.+..+.+.+...+.+...-+..+ ..+-.+++||+++|+ ||++|.. |.||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 589999999999999999999999999666655555554433322222 445689999999998 8999998 9999
Q ss_pred HcCccCccccCCC
Q 005017 331 LKDPFLQVENQKE 343 (719)
Q Consensus 331 L~hpf~~~~~~~~ 343 (719)
-+||||+..+|.-
T Consensus 390 K~HpFF~gVnWaL 402 (459)
T KOG0610|consen 390 KRHPFFEGVNWAL 402 (459)
T ss_pred hcCccccCCChhh
Confidence 9999999999873
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.49 Aligned_cols=249 Identities=29% Similarity=0.546 Sum_probs=212.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..+|..|++|.+...... ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIV 77 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEE
Confidence 56778999999999999999999999999998754432 34567889999999999999999999988755 468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCc
Confidence 9999999999999764 56899999999999999999999998 9999999999999865 69999999998765433
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..+. .....++.++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPP-VSQMYSQQLAQL 232 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 234578999999998764 578999999999999999999999976 44566666666654433 334667899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.92 Aligned_cols=251 Identities=27% Similarity=0.515 Sum_probs=207.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||.||+|.+..++..||+|.+.... .....+++.+|+.++++++||||+++++++...+ ..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--RISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--EEEE
Confidence 3566789999999999999999999999999987542 2344567889999999999999999999987654 5789
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|..+. .+++..+..++.|++.||.|||+++ |+|+||||+|||++.+ |.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 77 CTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred EEecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceeccccc
Confidence 99999999997653 4788899999999999999999999 9999999999999865 799999999997765555
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC------HHHHHHHHHcCCCCCccccCCChHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN------PAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~------~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... +....+.+.....+.......++++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 556789999999998864 589999999999999999999999964221 1233333333333332334467899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++||.+||. +|.+||++.++++||||+..+
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999998 899999999999999998553
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=371.62 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=214.3
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
.-||-|+||.||+|..+.++...|.|+|... +...++.+.-||.+|..++||+||++++.|+.+++ +|++.|||
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--LwiliEFC 111 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWILIEFC 111 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEEEEeec
Confidence 4489999999999999989988888888654 35778999999999999999999999998877765 88999999
Q ss_pred cCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Ccc
Q 005017 163 TSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 239 (719)
Q Consensus 163 ~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~ 239 (719)
.||-.+..+-. ...+.+.++.-+++|++.||.|||+++ |||||||..|||++.+ |.++|+|||.+...... ...
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchhHHhhhc
Confidence 99999887554 557999999999999999999999999 9999999999999866 89999999987544322 345
Q ss_pred cccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc-cccCCChHHHH
Q 005017 240 SVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKG 312 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~~~~~l~~ 312 (719)
+++|||+|||||+.. ..|+.++||||||++|.||..+++|.++ .++..++-+|....+|.. -+..++..+++
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 789999999999763 3599999999999999999999999988 566666666665544433 35667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
|+.+||. +|..||++.+||+|||++....+
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 9999998 89999999999999999965544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=342.60 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=201.2
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||.||++.++.+|+.||+|.+....... ......+..|++++++++||||+++++.+... ..+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEecCCC
Confidence 699999999999999999999999987543322 12234556799999999999999999987654 468999999999
Q ss_pred CChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-cccc
Q 005017 165 GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSV 241 (719)
Q Consensus 165 GsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~-~~~~ 241 (719)
|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.++|+|||++....... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence 99998876543 5889999999999999999999999 9999999999999855 699999999987654332 2345
Q ss_pred cCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 242 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 242 ~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
.|++.|+|||++.+ .++.++|||||||++|||++|+.||..... ..++.........+. .....+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 68999999998754 589999999999999999999999975322 223333333322221 1234678999999999
Q ss_pred cC-CCCCCCCH----HHHHcCccCccccC
Q 005017 318 LV-PASERLSA----KDLLKDPFLQVENQ 341 (719)
Q Consensus 318 L~-dP~~RpSa----~eLL~hpf~~~~~~ 341 (719)
|+ +|.+||++ .++++||||+..++
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 98 89999999 77889999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.80 Aligned_cols=255 Identities=28% Similarity=0.380 Sum_probs=201.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
+.|++.+.||+|+||.||+|.+..+++.||+|++..... ......++.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456788999999999999999999999999998864322 2344577889999999999999999999886533 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCccccc
Confidence 357899999975 67776643 5889999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---------------
Q 005017 233 MQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------- 295 (719)
Q Consensus 233 ~~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--------------- 295 (719)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 54432 345679999999998765 5899999999999999999999999764322221111100
Q ss_pred ------C-CC------C-----------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 296 ------G-IK------P-----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 296 ------g-~~------p-----------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
. .. + .......+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 0 00111234578999999998 89999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.00 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=209.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||.||+|.+..+|..+|+|.++... ......++.+|++++++++||||+++++++... ..+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEE
Confidence 4678899999999999999999999999999887432 234456788999999999999999999998765 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++.+ |.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCccccccc
Confidence 99999999999999988889999999999999999999997 57 9999999999999855 79999999998766555
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH---------------------
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--------------------- 294 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~--------------------- 294 (719)
......|++.|+|||++.+ .++.++||||||+++|+|+||+.||... +.......+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP-DAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc-chhhHHHhhcCccccccccCCcccccCCCCC
Confidence 4556789999999998764 4889999999999999999999998642 2222222111
Q ss_pred ---------------cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 295 ---------------SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 295 ---------------~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
....|.......++++++||.+||. +|.+||++.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111112356789999999998 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=345.01 Aligned_cols=254 Identities=30% Similarity=0.468 Sum_probs=208.5
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCC----CCcee
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDK----KKTVN 156 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~----~~~l~ 156 (719)
.++||+|+||+||+|+++.+|+.||+|+++..... +.......+|+.+|+.|+|+| ||.+++++...+ ...++
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 35699999999999999999999999999876432 233455689999999999999 999999887654 23688
Q ss_pred EEEecccCCChhHHhhhcc----cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 157 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~----~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+|+||+.. +|..|+.... .++...++.+++||+.||+|||+++ |+||||||+||||+. .|.+||+|||+|+.
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~-~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISS-SGVLKLADFGLARA 169 (323)
T ss_pred EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECC-CCcEeeeccchHHH
Confidence 99999965 9999998755 5888999999999999999999999 999999999999996 58999999999987
Q ss_pred ccCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCC-----C---
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-----P--- 299 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~-----p--- 299 (719)
..-+ .....++|.+|+|||++-+ .|+..+||||+|||++||++++.-|.+..+..++...... |.+ |
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 6533 3456789999999998754 5999999999999999999999999886666665443321 100 0
Q ss_pred ---------------Cccc---cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 300 ---------------ASLA---KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 300 ---------------~~~~---~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
..+. ...++...+++.+||. +|.+|.||+..|.||||+....
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 0000 1113578999999999 9999999999999999986543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=358.52 Aligned_cols=255 Identities=29% Similarity=0.403 Sum_probs=205.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---Cce
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTV 155 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---~~l 155 (719)
|.+.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||+++++++...+. ..+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 456789999999999999999999999999886321 223345678899999999999999999998865431 258
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeeccc
Confidence 89999996 588888887788999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CC---cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---------------
Q 005017 236 PT---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------- 295 (719)
Q Consensus 236 ~~---~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--------------- 295 (719)
.. .....+|+.|+|||++.+ .++.++|||||||++|||++|+.||... ++.+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 22 234468999999998764 4789999999999999999999999763 33333222211
Q ss_pred ---------CCCCC------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 296 ---------GIKPA------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 296 ---------g~~p~------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...+. ......++++.+||.+||. ||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1123346789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.43 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=208.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|+..++||+|+||.||+|.+..+++.||+|.+....... ......+.+|+.++++++|+||+++++.+.+. ..+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEE
Confidence 456788999999999999999999999999987543322 23345677899999999999999999988654 468999
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCC
Confidence 9999999999988653 35899999999999999999999998 9999999999999855 68999999998654332
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHHcCCCCCccccCCChHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||...... ......+... .+.......++.+++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARS 234 (285)
T ss_pred ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHH
Confidence 2234579999999998864 5899999999999999999999999763321 1112222111 122344556789999
Q ss_pred HHHHhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 313 FIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 313 lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
||.+||+ +|.+||| +.++++||||+...+.
T Consensus 235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 9999998 8999999 9999999999864433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.89 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=202.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
..|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+.... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45778899999999999999999999999999986432 22344567889999999999999999999875432 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+.+ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCccc
Confidence 357899999965 67777653 5788999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC------------
Q 005017 233 MQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------ 298 (719)
Q Consensus 233 ~~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~------------ 298 (719)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+..+.....
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 54432 345679999999998865 58999999999999999999999998643 3333332221100
Q ss_pred ---------C-------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 299 ---------P-------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 299 ---------p-------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+ .......+..+++||.+||. ||.+|||+.++|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00011224578999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.05 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=215.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||.|+||.||+|.+..+|..||+|.+...... ....+++..|++++++++||||+++++++.......++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 56778999999999999999999999999998755432 3456788899999999999999999998887666778999
Q ss_pred EecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhh-----cCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 159 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLH-----SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLH-----s~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+ |+||||||+||+++.+ +.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEecccc
Confidence 999999999999875 356899999999999999999999 777 9999999999999855 7999999999
Q ss_pred hhhccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 230 AIAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 230 A~~~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
+....... .....|++.|+|||++.. .++.++||||||+++|+|++|..||... +...+.+.+..+..+ .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRY 234 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCcccc
Confidence 97765433 345578999999998764 5789999999999999999999999874 466666666665443 345566
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+..+.+++.+||. +|.+||++.++++|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 7899999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=335.42 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=210.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
|+..+.||+|+||.||+|.+..+|..||+|++........ ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEE
Confidence 4567889999999999999999999999999875432211 22457889999999999999999999988654 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++||||||+||+++.+...+||+|||++......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999988888999999999999999999999999 9999999999999866447999999998765432
Q ss_pred C------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCCC
Q 005017 237 T------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 237 ~------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
. .....|+..|+|||++.+ .++.++||||||+++|+|++|+.||..... .......+.........+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 223468899999998764 588999999999999999999999964322 2233333333333444555677
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+.+++++.+||. +|.+||++.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 899999999998 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=385.70 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=219.0
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..-..|.+.+.||+|+||+||+|.+..++..||+|.+...... ......+..|+.+|++|+|||||+++++|......
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~--e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK--EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3345678899999999999999999999999999998765432 34567889999999999999999999999877777
Q ss_pred ceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCC-----CCeeeecCccceeEecCC------
Q 005017 154 TVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN-----PPIIHRDLKCDNIFVNGN------ 218 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~-----ppIIHrDLKp~NILl~~~------ 218 (719)
.+|+||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999999999999875 256999999999999999999999854 349999999999999532
Q ss_pred ----------CCcEEEeecchhhhccCC-CcccccCCCCCCCccccc---cccCccccchhhHHHHHHHhhccCCCCCCC
Q 005017 219 ----------HGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECK 284 (719)
Q Consensus 219 ----------~G~vKL~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~---~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~ 284 (719)
.+.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|||+||..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 235899999999766433 234567999999999874 248899999999999999999999998766
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
...++...+..+.. ......++++.+||..||. +|.+||++.++|.||||+..
T Consensus 248 ~~~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NFSQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cHHHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 66666666655432 2223457899999999998 89999999999999999744
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.42 Aligned_cols=254 Identities=28% Similarity=0.532 Sum_probs=207.1
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 151 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 151 (719)
++.|+| .+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred Chhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 344444 56688999999999999999999999999987432 2345788999999998 7999999999987543
Q ss_pred ----CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 152 ----KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 152 ----~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
...+++||||+.+|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEc
Confidence 24688999999999999998864 35899999999999999999999999 9999999999999855 699999
Q ss_pred ecchhhhccCC--CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC
Q 005017 226 DLGLAIAMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 226 DFGlA~~~~~~--~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
|||++...... ......|++.|+|||++. ..++.++|||||||++|||++|+.||.... +......+....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~ 232 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNP 232 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCC
Confidence 99998765432 234567999999999874 247889999999999999999999997643 333333333332
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+.......+..+++||.+||. +|.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3333334567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.42 Aligned_cols=255 Identities=22% Similarity=0.448 Sum_probs=225.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
...+|.+.+.||+|.||.|-+|.+...|+.||||.++.+... ..+++..+.+||++|..|+||||+.+|..|... .-
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENk--dK 127 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--DK 127 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC--ce
Confidence 345677889999999999999999899999999999876654 467888999999999999999999999988544 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+.+||||..+|.|.+|+...+.+++.+++.+++||.+|+.|+|.++ ++|||||.+|||+|.+ +++||+|||++..+.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhc
Confidence 9999999999999999999999999999999999999999999999 9999999999999966 699999999998876
Q ss_pred CC-CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. ...++||+|-|.+||++++. | ++.+|.||||++||.|+.|..||.+ .+-..++++|..|..... ..+..+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~ 280 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDAS 280 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHH
Confidence 54 46789999999999999875 4 6889999999999999999999988 566778888888765332 1234688
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.||+.||. +|.+|.|+.++-.|=|++-.
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 99999996 99999999999999998643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.44 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=202.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.++..||+|.++..... .....+.+|+.++++++||||+++++++... ..+++
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEE
Confidence 467789999999999999999999999999998754321 2334577899999999999999999988655 45889
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSVP 157 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecCCC
Confidence 9999975 888887654 45899999999999999999999999 9999999999999855 79999999998654332
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC---C------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---I------------ 297 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g---~------------ 297 (719)
......+|+.|+|||++.+ .++.++|||||||++|+|+||+.||.... .......+... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST-VEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 2234568999999998753 47899999999999999999999997643 22222222110 0
Q ss_pred ------CCC-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 ------KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 ------~p~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+. ......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0112346789999999998 899999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.67 Aligned_cols=250 Identities=28% Similarity=0.542 Sum_probs=209.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|++|.||+|.++.+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+... ...+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEE
Confidence 67889999999999999999999999999998754322 24456788999999999999999999877533 3468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEeccc
Confidence 9999999999998763 45899999999999999999999999 9999999999999855 79999999998765432
Q ss_pred --CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......|++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..+ ..+...++++.+|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLP-PMPKDYSPELGEL 233 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCC-CCccccCHHHHHH
Confidence 2334568999999998764 588999999999999999999999976 3444555555555443 2445577899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.23 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=210.2
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-C-----CCceeEEE
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-D-----DNVVKFYK 145 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pNIVkl~~ 145 (719)
.+..+..|.+.++||+|+||.|.+|.|..+++.||||+++-.. ....+...|+.+|..|+ | -|+|++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 3444446678999999999999999999999999999998543 45567778999999997 5 38999999
Q ss_pred eeecCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCCcE
Q 005017 146 SWVDDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEV 222 (719)
Q Consensus 146 ~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G~v 222 (719)
+|...+ ++|+|+|++. .+|.++++.++ +++...++.++.||+.||.+||+.+ |||+||||+||||.. ....|
T Consensus 256 ~F~fr~--HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 256 YFYFRN--HLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred cccccc--ceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence 998764 5999999995 59999999764 6899999999999999999999999 999999999999952 22479
Q ss_pred EEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH-cCCCC-
Q 005017 223 KIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-SGIKP- 299 (719)
Q Consensus 223 KL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~-~g~~p- 299 (719)
||+|||+|+...+... +++-+..|+|||++-+ .|+.+.||||||||++||+||.+-|.+....+|+...+. .|.+|
T Consensus 331 KVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred eEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999988776655 8889999999998765 699999999999999999999888887544444432211 00000
Q ss_pred --------------------------------------------------C-c-------cccCCChHHHHHHHHhcC-C
Q 005017 300 --------------------------------------------------A-S-------LAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 300 --------------------------------------------------~-~-------~~~~~~~~l~~lI~kcL~-d 320 (719)
+ . .....+..+.+||.+||. |
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0 0 001223468999999998 9
Q ss_pred CCCCCCHHHHHcCccCcccc
Q 005017 321 ASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 321 P~~RpSa~eLL~hpf~~~~~ 340 (719)
|.+|+|+.+.|+||||....
T Consensus 490 P~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTGTS 509 (586)
T ss_pred chhcCCHHHHhcCccccccc
Confidence 99999999999999998544
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=333.60 Aligned_cols=252 Identities=33% Similarity=0.501 Sum_probs=207.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~--~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
|++.+.||+|+||.||+|.+. +|..+|+|.+...... ........+.+|+++|++++|+||+++++++.+. ..++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEE
Confidence 456788999999999999864 8889999998754321 1223456788999999999999999999998655 5689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+|+||+++++|.+++.+...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.+ |.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence 99999999999999988888999999999999999999999999 9999999999999855 7999999999875421
Q ss_pred -------CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 236 -------PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 236 -------~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||...................+..+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11234568999999998864 4789999999999999999999999864444333332222122333455678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.++.+||.+||. +|.+||++.++|+||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 899999999997 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=351.29 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=202.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
..|.+.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 346677899999999999999999999999999864321 1234466789999999999999999998875432 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++++++++ +++|.++++ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCcccee
Confidence 3578899988 779988776 456999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCC---------
Q 005017 233 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP--------- 299 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p--------- 299 (719)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+..+... ..+
T Consensus 168 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND-YIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhcch
Confidence 5443 345679999999998864 48899999999999999999999997633 22222222110 000
Q ss_pred ---------------C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 ---------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 ---------------~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
. ......++.+.+||.+||. ||.+|||+.++|.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0012245678999999998 89999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.95 Aligned_cols=249 Identities=28% Similarity=0.484 Sum_probs=205.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++... ..+++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~l 83 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWI 83 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEE
Confidence 4566788999999999999999999999999987543 23345678899999999999999999988765 45889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEccCcc
Confidence 9999999999999988888999999999999999999999999 9999999999999855 699999999986554322
Q ss_pred --cccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCCChH
Q 005017 238 --ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQ 309 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~ 309 (719)
.....|++.|+|||++. +.++.++|||||||++|+|++|..||..................+.... ...+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 23457999999999863 3488999999999999999999999976443333333222222222221 134678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
+++||.+||. +|.+||++.+|++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=331.89 Aligned_cols=255 Identities=32% Similarity=0.554 Sum_probs=215.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc-cCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|++.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|++++++++||||+++++++.+.....++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 47788999999999999999999999999998865321 12234567889999999999999999999998776666788
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|+||+++++|.+++...+.+++..++.|+.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence 99999999999999988778999999999999999999999999 9999999999999855 69999999999765321
Q ss_pred -----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 -----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
......|++.|+|||++.+ .++.++|||||||++|+|++|+.||........+. .+.....+..++...++++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHHH
Confidence 1234568999999998865 47899999999999999999999998754444443 3443334445566678899
Q ss_pred HHHHHHhcCCCCCCCCHHHHHcCccC
Q 005017 311 KGFIEKCLVPASERLSAKDLLKDPFL 336 (719)
Q Consensus 311 ~~lI~kcL~dP~~RpSa~eLL~hpf~ 336 (719)
+++|.+||.+|..||++.+++.|||.
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=332.77 Aligned_cols=247 Identities=33% Similarity=0.504 Sum_probs=203.7
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
...||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++... ..+++|+||
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 86 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFMEQ 86 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEec
Confidence 368999999999999999999999999886443 34557889999999999999999999988655 468899999
Q ss_pred ccCCChhHHhhhc-ccc--cHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--
Q 005017 162 FTSGNLRQYRKKH-KNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236 (719)
Q Consensus 162 ~~gGsL~~~L~~~-~~l--~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-- 236 (719)
+++++|.+++... ..+ ++..+..++.||+.||+|||+++ |+||||||+||+++.+.+.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999998764 445 88889999999999999999998 9999999999999865679999999998655322
Q ss_pred CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......|++.|+|||++.. .++.++||||||+++|+|++|+.||.....................++...++++++|
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2233468999999998753 3789999999999999999999999765443333222222122334455677899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+.+||. +|.+|||+.+++.||||
T Consensus 245 i~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHcCCCchhCCCHHHHHhCCCC
Confidence 999998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=332.12 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=212.8
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||.|+||.||+|.+..++..||+|++....... ....+.+.+|+.+++.++||||+++++.+.+. ..+++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence 699999999999999999999999987544322 23457899999999999999999999987654 458899999999
Q ss_pred CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-CcccccC
Q 005017 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 243 (719)
Q Consensus 165 GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~~~~~~G 243 (719)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+ |.++|+|||++...... ......|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence 999999988888999999999999999999999999 9999999999999865 79999999999766543 2334578
Q ss_pred CCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-C
Q 005017 244 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 244 T~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-d 320 (719)
++.|+|||.+.. .++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++.++++|.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999998754 58899999999999999999999997643 25556666664444444455558899999999998 8
Q ss_pred CCCCCC-----HHHHHcCccCccccC
Q 005017 321 ASERLS-----AKDLLKDPFLQVENQ 341 (719)
Q Consensus 321 P~~RpS-----a~eLL~hpf~~~~~~ 341 (719)
|.+||+ +.|+++||||...++
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999986544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.75 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=199.9
Q ss_pred EeEEEeee--CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 81 YDEVLGKG--AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 81 l~e~LG~G--~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.++||+| +|++||++.++.+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|..++ .+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEE
Confidence 35689999 7899999999999999999998754321 234567888999999999999999999987654 58899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++|+|.+++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.++++||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccc
Confidence 9999999999998753 45899999999999999999999999 9999999999999855 69999999865432211
Q ss_pred ---------CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC----
Q 005017 237 ---------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---- 300 (719)
Q Consensus 237 ---------~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~---- 300 (719)
......++..|+|||++.+ .|+.++|||||||++|||++|+.||............ ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccc
Confidence 1122356788999998864 4889999999999999999999999764333222222 2111110
Q ss_pred ----------------------------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 ----------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 ----------------------------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......++.+++||.+||. ||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112235789999999998 99999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.13 Aligned_cols=252 Identities=27% Similarity=0.512 Sum_probs=212.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.++.+++.||+|.+..... .....++.+|++++++++||||+++++.+... ..+++|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---hHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEE
Confidence 4556789999999999999999999999998875432 24557788999999999999999999988765 568999
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||+.+++|.+++... ..+++..+..++.|++.||+|||+ .+ ++||||||+||+++. .|.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNS-RGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECC-CCCEEEeecccchhhHHH
Confidence 9999999999999876 779999999999999999999999 88 999999999999986 479999999998766544
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC----CCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~----~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||... .......+.+..+..+.......+++++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 3334778999999998764 5889999999999999999999999764 2333444555554444333333788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
++|.+||. +|.+|||+.+++.||||+.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999998 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=331.57 Aligned_cols=251 Identities=30% Similarity=0.526 Sum_probs=208.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-----~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
|.+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++... .
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--D 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--C
Confidence 4567899999999999999998999999998875433221 12346788999999999999999999988665 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
..++||||+++++|.+++...+.+++..+..++.|++.||+|||+++ ++||||+|+||+++.+ +.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence 68899999999999999998888999999999999999999999999 9999999999999855 69999999998765
Q ss_pred cCCC--------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 234 QQPT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 234 ~~~~--------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
.... .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||....... .+..+..... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~ 234 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIGENAS-PEIPS 234 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHHhccCC-CcCCc
Confidence 4211 123458899999998764 58889999999999999999999998754433 3333333322 23445
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
..+..++++|++||. +|.+||++.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.56 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=200.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|++++++++||||+++++++.+. ..+++|
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv 77 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLV 77 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEE
Confidence 56778999999999999999999999999998764322 22335677899999999999999999988654 468999
Q ss_pred EecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 159 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
+||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPV 153 (284)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCC
Confidence 99997 578887765 467999999999999999999999999 9999999999999855 79999999998765432
Q ss_pred -CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 005017 237 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 298 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--------------- 298 (719)
......+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 2234567899999998754 3789999999999999999999986554444433333221100
Q ss_pred ----C--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 ----P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 ----p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+ .......++++++||.+||. +|.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112346789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=338.05 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=201.2
Q ss_pred EEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHH---HHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL---LKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~i---L~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
+||+|+||.||+|.+..+|..||+|.+....... ......+.+|..+ +...+||||+++++++...+ .+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--KLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--eEEEEEe
Confidence 4899999999999999999999999987544322 1222333444433 34457999999999886543 5889999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCccc
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~ 240 (719)
|+++|+|.+++..++.+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceeccccCccC
Confidence 9999999999988888999999999999999999999999 9999999999999855 699999999987655444445
Q ss_pred ccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHH-HHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 241 VIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 241 ~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~-~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
..||+.|+|||.+. ..++.++|||||||++|+|++|..||....... ........ ..+..++...+++++++|.+|
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCccccCHHHHHHHHHH
Confidence 67999999999875 347899999999999999999999997532221 11111111 123344555678999999999
Q ss_pred cC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 318 LV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 318 L~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
|. +|.+|| ++.++++||||+..++..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 98 899999 699999999998766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=353.60 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=220.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
-|.+.+.||+|-|++|.+|.+..+|..||||++...++.. .....+.+|+..|+.++|||||++|... +.+.-+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~--~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT--LSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch--hhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEE
Confidence 3578899999999999999999999999999998765433 3346788999999999999999999965 44456999
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|+|+-.+|+|++|+-++ .++.+..++++++||+.|+.|+|+.. +|||||||+||.+-...|.|||.|||++..+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999999876 47999999999999999999999999 9999999999988778899999999999766654
Q ss_pred -CcccccCCCCCCCcccccc-ccC-ccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s-~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
...+.||+..|-|||++-+ .|+ +++||||||+|||-|++|++||.+. |..+...+|..... ..+.+.+.++++|
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-NDSETLTmImDCKY--tvPshvS~eCrdL 249 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-NDSETLTMIMDCKY--TVPSHVSKECRDL 249 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-cchhhhhhhhcccc--cCchhhhHHHHHH
Confidence 4578899999999998765 465 7899999999999999999999984 44455556655443 3456778899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
|..||+ ||.+|.+.++|..|+|+|....
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999998 9999999999999999997654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=358.24 Aligned_cols=243 Identities=24% Similarity=0.426 Sum_probs=204.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.+++.+.||+|-||.||.|... ....||+|.++.... ..+.|.+|+++|++|+|+|||++++++..++ .+|
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piy 277 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIY 277 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceE
Confidence 44556778999999999999654 333899999986643 3367889999999999999999999987654 699
Q ss_pred EEEecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
||||||+.|+|.+||+. ...+.....+.|+.|||+|++||++++ +|||||-..||||+.+ +.+||+|||||+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccccccccC
Confidence 99999999999999997 456999999999999999999999999 9999999999999866 599999999999554
Q ss_pred CCCcccccC---CCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QPTARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~~~~~~G---T~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
........| ...|.|||.+. +.++.++|||||||+||||+| |+.||.+ ....+.++.+..|...+. +..++++
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~-P~~CP~~ 432 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPR-PEGCPDE 432 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCC-CCCCCHH
Confidence 433222222 34799999886 679999999999999999998 7888887 556778888988877554 3457889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.+++..||. +|++|||+..|..
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHH
Confidence 9999999998 8999999997653
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=334.97 Aligned_cols=251 Identities=27% Similarity=0.484 Sum_probs=206.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD----K 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~----~ 151 (719)
..|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++++ +||||+++++++... .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 45567789999999999999999999999999886432 3346788899999998 799999999988643 2
Q ss_pred CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
...++++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCcc
Confidence 45789999999999999998753 34888889999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCC--CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc
Q 005017 230 AIAMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 301 (719)
Q Consensus 230 A~~~~~~--~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~ 301 (719)
+...... ......|++.|+|||++. ..++.++|||||||++|||++|..||........+ ..+.....+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~ 246 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPPPKL 246 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hhHhhCCCCCC
Confidence 8755422 234567899999999874 34788999999999999999999999774433333 23333333333
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.....++++.+||.+||. +|.+||++.+||+||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 344567899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.83 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=190.7
Q ss_pred eEEEeeeCCeEEEEEEEcC--CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 82 DEVLGKGAFKTVYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~--~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.+||+|+||+||+|.+.. ++..||+|.+.... ....+.+|+.+|++++||||+++++++.......+++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999998653 66889999886432 224577899999999999999999998876667889999
Q ss_pred ecccCCChhHHhhhc---------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec---CCCCcEEEeec
Q 005017 160 ELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGDL 227 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~---------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~---~~~G~vKL~DF 227 (719)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...|.+||+||
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 99865 777776421 24788999999999999999999999 99999999999994 23468999999
Q ss_pred chhhhccCCC-----cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCH---------HHHHH
Q 005017 228 GLAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQIFK 291 (719)
Q Consensus 228 GlA~~~~~~~-----~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---------~~i~~ 291 (719)
|+++...... .....||+.|+|||++.+ .++.++|||||||++|||+||++||...... .++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 9997654321 234578999999998764 4789999999999999999999999642210 11111
Q ss_pred HHHc-CCC---------------------------C-------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 292 KVTS-GIK---------------------------P-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 292 ~i~~-g~~---------------------------p-------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
.+.. +.. . .......+..+.++|.+||. ||.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 0000 000 0 00011234568899999998 8999999999999999
Q ss_pred C
Q 005017 336 L 336 (719)
Q Consensus 336 ~ 336 (719)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.09 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=201.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++.++ ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEE
Confidence 56778999999999999999999999999998754321 23346778899999999999999999998764 458899
Q ss_pred EecccCCChhHHhhhc---ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 159 TELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~---~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCC
Confidence 99997 6888887643 46899999999999999999999999 9999999999999854 7999999999865543
Q ss_pred CC--cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-------------
Q 005017 236 PT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------- 298 (719)
Q Consensus 236 ~~--~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~------------- 298 (719)
.. .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||..................
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 22 233467899999998754 4788999999999999999999999864433333222111000
Q ss_pred -------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
........+++++++|.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001122357889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.18 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=207.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|+..+.||+|+||+||+|.+..+|+.||+|.+....... ......+.+|+++|++++|+||+++++.+..+ ..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEE
Confidence 456688999999999999999999999999987543321 23345678899999999999999999888654 468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCC
Confidence 9999999999888653 36999999999999999999999999 9999999999999855 69999999998654332
Q ss_pred -CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHHcCCCCCccccCCChHHH
Q 005017 237 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~---i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
......|++.|+|||++. ..++.++|||||||++|+|++|..||........ +...+... ...+....++.+.
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAK 233 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHH
Confidence 223457999999999875 4589999999999999999999999986433221 22222221 1223445678899
Q ss_pred HHHHHhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 312 GFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
+|+.+||. +|.+||+ +.++++||||+....+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 99999998 8999999 8999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.15 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=204.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++... ..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEE
Confidence 345678899999999999999999999999999987542 23345678999999999999999999998765 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccceeecc
Confidence 899999999999999988788999999999999999999999998 9999999999999855 7899999999976543
Q ss_pred CC--cccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCCC
Q 005017 236 PT--ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVND 307 (719)
Q Consensus 236 ~~--~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~ 307 (719)
.. .....|++.|+|||.+. ..++.++|||||||++|||++|+.||..................+..+ ....+
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence 22 23456899999999873 347889999999999999999999997533222222111112222211 12346
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
..+++||.+||. +|.+|||++++|+|+|
T Consensus 239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 789999999998 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=335.40 Aligned_cols=251 Identities=29% Similarity=0.509 Sum_probs=207.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||+|.+..++..+++|.+.... ....+.+.+|+++++.++||||+++++++... ...++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEE
Confidence 455678999999999999999999999999886432 34567788999999999999999999988765 458899
Q ss_pred EecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 159 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
+||+++|+|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence 999999999988764 456899999999999999999999999 9999999999999855 79999999998654332
Q ss_pred -CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCCCh
Q 005017 237 -TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDP 308 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~~~ 308 (719)
......|++.|+|||++. ..++.++|||||||++|+|++|+.||... +.......+.....+ ...+...+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc-CHHHHHHHHhhcCCCCCCCccccCH
Confidence 223457899999999873 23778999999999999999999999874 344444444333222 223345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+++||.+||. +|.+||++.++++||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999998 89999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.10 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=209.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++.+... ..++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~ 93 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 93 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEE
Confidence 355677889999999999999999999999999875442 2346788999999999999999999988764 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccccchhcccc
Confidence 99999999999999864 45889999999999999999999999 9999999999999855 69999999998765432
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.........+.....+..+...+...++.+.++
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 2 234578999999998765 4789999999999999999999999764433333333333332323344566889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|.+||. +|.+||++.++++||||....
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 999998 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.64 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=203.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||.||+|.+..++..||+|.++..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEE
Confidence 3467889999999999999999999999999998754322 2335677899999999999999999998654 4688
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKSI 156 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhccCC
Confidence 9999997 5898888754 46899999999999999999999999 9999999999999855 6999999999875432
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC--------------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------------- 297 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~-------------- 297 (719)
. ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||..... ......+....
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcc
Confidence 2 2234467899999998754 478899999999999999999999987433 22222211100
Q ss_pred -------CCC-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 -------KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 -------~p~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+. ......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112356789999999998 899999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.76 Aligned_cols=252 Identities=34% Similarity=0.514 Sum_probs=210.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
|+..++||+|+||.||+|.+..+|..|++|.+...... ......+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 79 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYI 79 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEE
Confidence 45678999999999999999989999999998764422 2234567889999999999999999999987654 46889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|+||+++++|.+++.+.+.+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence 9999999999999988888999999999999999999999999 9999999999999855 699999999987654332
Q ss_pred -cccccCCCCCCCcccccc-c-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 238 -ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~-~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
.....|++.|+|||.+.. . ++.++|+||||+++|+|++|+.||......... ..+.........+...++.+++|+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHhcccCCCcCCCcCHHHHHHH
Confidence 345668999999997753 3 789999999999999999999999875433333 333332233344556678999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccC
Q 005017 315 EKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+||. +|.+||++.+++.|||+
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHhhcCcccCcCHHHHhcCCCC
Confidence 99998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.48 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=211.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++.+..+. .++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 85 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLW 85 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEE
Confidence 45677889999999999999999999999999986432 455678889999999999999999999886554 588
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++++|..++.+ ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+ |.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccceeccc
Confidence 99999999999987754 456899999999999999999999999 9999999999999854 7999999998865432
Q ss_pred C--CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCC
Q 005017 236 P--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVN 306 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 306 (719)
. ......+++.|+|||++. ..++.++|||||||++|+|++|+.||... ++...+..+.....+. ..+...
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCccc
Confidence 2 223456899999999873 23688999999999999999999999763 3444444444443322 223445
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCCC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~ 343 (719)
+..+.++|.+||. +|.+||++.++++||||.......
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 6789999999998 899999999999999998655443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.01 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=203.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|.+.+.||+|+||.||+|.+..+|+.||+|+++.... .....++..|+.+ ++.++||||+++++++...+ .++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEE
Confidence 46778899999999999999999999999999875432 1223455556664 67779999999999987554 588
Q ss_pred EEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 157 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+||||++ |+|.+++.. ...+++..++.++.||+.||+|||++ + ++||||||+||+++.+ +.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeeccccc
Confidence 9999996 688777653 34689999999999999999999987 7 9999999999999865 699999999987
Q ss_pred hccCCCc-ccccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 232 AMQQPTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 232 ~~~~~~~-~~~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
....... ....|+..|+|||++.+ .++.++|+|||||++|+|++|+.||.......+....+..+..+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred ccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 6544322 33568999999998753 46889999999999999999999997644444444444444333333334
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 67899999999998 899999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.58 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=212.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|.+....... ....+.+..|+++++.++||||+++++.+... ...++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEE
Confidence 4677899999999999999999999999999997654322 23557789999999999999999999987654 46899
Q ss_pred EEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||||+.+++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.+ |.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhcccc
Confidence 99999999999998764 46899999999999999999999999 9999999999999855 7999999999864321
Q ss_pred C-------------------------------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC
Q 005017 236 P-------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC 283 (719)
Q Consensus 236 ~-------------------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~ 283 (719)
. ......||..|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1 1123468999999998764 4889999999999999999999999874
Q ss_pred CCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCC----HHHHHcCccCccccCCC
Q 005017 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 284 ~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpS----a~eLL~hpf~~~~~~~~ 343 (719)
. ....+..+.............++.++++|.+||. +|.+||| +.++|+||||+...+..
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 236 N-RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred c-hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 4 3444444443322222222257899999999998 8999999 99999999998765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.08 Aligned_cols=255 Identities=30% Similarity=0.523 Sum_probs=211.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.+.||.|+||+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG--DEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceE
Confidence 345778899999999999999999999999999987543 23356788999999999999999999988654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++|+||+.+++|..++.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.+ |.+||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchhccc
Confidence 899999999999998865 45899999999999999999999999 9999999999999854 7999999999876543
Q ss_pred CC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
.. .....|++.|+|||.+.. .++.++|||||||++|+|++|+.||..................+...+...++.+++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 22 234568999999998764 588999999999999999999999987443333333222232233334456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+|.+||. +|.+||++.++++||||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999998 899999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.61 Aligned_cols=253 Identities=38% Similarity=0.612 Sum_probs=218.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|++|.||+|.+..+|..|++|++...... ....+.+.+|+.++++++||||+++++.+.......+++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 56778999999999999999999999999998765432 3556889999999999999999999998876644568999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
+||+.+++|.+++.....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.+ |.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEecccccc
Confidence 999999999999998888999999999999999999999998 9999999999999864 799999999987665543
Q ss_pred ---cccccCCCCCCCccccccc-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 238 ---ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.....++..|+|||.+... ++.++||||||+++|+|++|..||....+.......+........++...+..+++|
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 3456789999999988654 899999999999999999999999875545555555554344445566668899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.18 Aligned_cols=233 Identities=30% Similarity=0.451 Sum_probs=200.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
+-||.|+.|.||+|. ..++.||||+++.- -..+|+-|++|+||||++|.|+|.. ...+++|||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeeecc
Confidence 569999999999995 46889999988621 2358899999999999999998854 45688999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-Ccccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV 241 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~~~~~ 241 (719)
..|-|...|+....+.......|.++|+.|+.|||.|+ |||||||.-||||..+. .|||+|||.++..... +.-.+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999 99999999999998665 8999999999876544 44578
Q ss_pred cCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-
Q 005017 242 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 319 (719)
Q Consensus 242 ~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~- 319 (719)
+||..|||||+++. ..++|+|||||||+||||+||+.||.+... ..++.-+......-..+..++..++-||+.||.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 99999999999975 579999999999999999999999987433 333333444444445667788899999999998
Q ss_pred CCCCCCCHHHHHcCc
Q 005017 320 PASERLSAKDLLKDP 334 (719)
Q Consensus 320 dP~~RpSa~eLL~hp 334 (719)
+|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 899999999999984
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=324.35 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=210.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..++..+|+|.+...... ......+.+|+.+|++++||||+++++.+... ..+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIV 77 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEE
Confidence 56789999999999999999999999999998755432 34567899999999999999999999987644 468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+.+.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999999764 34899999999999999999999999 9999999999999866567899999999766543
Q ss_pred C-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 237 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 ~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
. .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++.++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 233 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLI 233 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHH
Confidence 2 234568999999998864 4788999999999999999999999774 444444454443332 23444678999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccC
Q 005017 315 EKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+||. +|.+|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.14 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=194.9
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.-.++||+|+||.||+|... +|..||||++...... . ..+|.+|+.+|.+++|||+|+++|||.+.+. .
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 4455566689999999999999765 5689999977654321 1 4569999999999999999999999987653 5
Q ss_pred eeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 155 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+||||||++|+|.++|.... .++|..+.+|+.++|+||+|||.. .||||||||||+|||+|.+ .++||+|||+|+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAK 225 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcc
Confidence 788999999999999998765 899999999999999999999996 5599999999999999966 599999999996
Q ss_pred hccC-CCc-ccc-cCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHH----HHHcCCC---
Q 005017 232 AMQQ-PTA-RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFK----KVTSGIK--- 298 (719)
Q Consensus 232 ~~~~-~~~-~~~-~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~----~i~~g~~--- 298 (719)
.... ... .+. .||.+|+|||++. +..+.++||||||++++||+||+.|..... ....+.. .+..+..
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 6553 322 222 8999999999886 578999999999999999999998876422 1111222 2222211
Q ss_pred -CCccc-cCCC--hH---HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 299 -PASLA-KVND--PQ---IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 299 -p~~~~-~~~~--~~---l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+.+. ...+ .+ +..+..+|+. +|.+||++.++++
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 12221 2222 23 4455678998 7999999999755
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.88 Aligned_cols=251 Identities=27% Similarity=0.491 Sum_probs=205.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCC----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK---- 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~---- 151 (719)
..|.+.+.||+|+||.||+|.++.++..+++|.+.... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45677899999999999999999899999999887543 2346788999999999 7999999999987643
Q ss_pred CCceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++.+ +.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEEECCC
Confidence 4568899999999999998765 347899999999999999999999999 9999999999999865 79999999
Q ss_pred chhhhccCC--CcccccCCCCCCCcccccc------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC
Q 005017 228 GLAIAMQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 228 GlA~~~~~~--~~~~~~GT~~YmAPEvl~~------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
|++...... ......|++.|+|||++.. .++.++|||||||++|+|+||..||....... ....+..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNPPP 236 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccCCC
Confidence 998654332 2234568999999998742 36789999999999999999999997643333 33334433322
Q ss_pred Ccc-ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 ASL-AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ~~~-~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
... ....+..+++||.+||. +|.+|||+.++++|||+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 211 22256789999999998 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.37 Aligned_cols=250 Identities=31% Similarity=0.516 Sum_probs=207.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||.|+||+||+|.+..+|..+|+|++..... ....+.+.+|+++|+.++|+||+++++.+... ...++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEE
Confidence 46788999999999999999988999999998865432 23567889999999999999999999988655 45889
Q ss_pred EEecccCCChhHHhhhc---ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 158 ITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~---~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.++|+|||++..+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhc
Confidence 99999999999998764 45899999999999999999999999 9999999999999865 699999999987665
Q ss_pred CCC------cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc----
Q 005017 235 QPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---- 302 (719)
Q Consensus 235 ~~~------~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~---- 302 (719)
... .....|++.|+|||++.. .++.++|+||||+++|+|++|+.||.... ....+........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGAD 232 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC-hhhhHHHHhcCCCCCcCCccc
Confidence 432 134568999999998754 48899999999999999999999998743 33344444333222111
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
....++.+++++.+||. +|.+||++.+|++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12446789999999998 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.28 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=204.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCC---C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK---K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~---~ 152 (719)
..|.+.+.||+|+||.||+|.+..+|+.+|+|.+.... .....+.+|+.++.++ +||||+++++++...+ .
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 44677889999999999999999999999999886432 2335677899999999 8999999999887543 2
Q ss_pred CceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 153 KTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
..+++||||+++|+|.++++. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl~dfg 173 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDFG 173 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEeecc
Confidence 468899999999999998753 356899999999999999999999998 9999999999999855 689999999
Q ss_pred hhhhccCCC--cccccCCCCCCCcccccc------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 229 LAIAMQQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 229 lA~~~~~~~--~~~~~GT~~YmAPEvl~~------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
++....... .....|++.|+|||++.. .++.++|||||||++|||++|+.||.... +......+..+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~~~~~~ 252 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-PVKTLFKIPRNPPPT 252 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHhcCCCCC
Confidence 987654322 234568999999998743 26889999999999999999999998743 333333333332221
Q ss_pred -ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 301 -SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 301 -~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
..+......++++|.+||. +|.+||++.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1222345689999999998 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.00 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=203.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC---C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD---K 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~---~ 151 (719)
...|.+.+.||+|+||.||+|.+..+|+.+|+|++.... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 345577889999999999999999999999999875322 2235678899999999 699999999987542 3
Q ss_pred CCceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
...+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEEccC
Confidence 3568999999999999988753 346889999999999999999999998 9999999999999865 68999999
Q ss_pred chhhhccCC--CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-
Q 005017 228 GLAIAMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK- 298 (719)
Q Consensus 228 GlA~~~~~~--~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~- 298 (719)
|++...... ......|++.|+|||++. ..++.++|||||||++|||++|+.||........+. .+.....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~ 247 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPP 247 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCC
Confidence 998765432 223457999999999874 347889999999999999999999998744333332 2222222
Q ss_pred CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
....+...+..++++|.+||. +|.+|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 222334456789999999998 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.76 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=210.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|++.+.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+++++.++||||+++++++... ..++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEE
Confidence 45667789999999999999999999999999887543 234567889999999999999999999998765 4689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++.+ +.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhh
Confidence 999999999999999888889999999999999999999997 57 9999999999999855 7999999999866544
Q ss_pred CCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCH-------H---HHHHHHHcCCCCCcccc
Q 005017 236 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP-------A---QIFKKVTSGIKPASLAK 304 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~-------~---~i~~~i~~g~~p~~~~~ 304 (719)
.......|+..|+|||++. +.++.++|||||||++|+|+||+.||...... . .....+.....+.....
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 4444567999999999875 46889999999999999999999999753321 1 22233333222222222
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+..+.+||.+||. +|.+|||+.|+++||||....
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 356789999999998 899999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.65 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=213.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEE
Confidence 456688999999999999999999999999987543 234456788999999999999999999988765 468999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-- 236 (719)
+||+++++|.+++... .+++..++.++.|++.||.|||+++ ++||||+|+||+++.+ |.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccccc
Confidence 9999999999998865 7899999999999999999999999 9999999999999865 79999999999776543
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
......|++.|+|||++.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.+++.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence 2334578999999998764 5899999999999999999999999763 3455555555544333222226789999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+||. +|.+|||+.++++||||+.....
T Consensus 233 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 233 LCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 9997 89999999999999999865443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=325.36 Aligned_cols=254 Identities=30% Similarity=0.521 Sum_probs=216.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|++|.||+|.+..+|+.||+|++..... ......+.+|+..+.+++||||+++++++... ..+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEE
Confidence 35677999999999999999999999999999875532 14567899999999999999999999988765 46889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|+||+++++|.+++.....+++..++.++.|++.||+|||+ .+ ++||||+|+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccC
Confidence 99999999999999888889999999999999999999999 98 9999999999999865 79999999998766543
Q ss_pred Cc--ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 TA--RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 ~~--~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. ....++..|+|||.+.. .++.++||||||+++|+|+||..||.... ...+..+.+.....+.......+..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 32 24568999999998764 57889999999999999999999997754 555666666654444333332678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++|.+||. +|.+||++.++++|||++..
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999998 79999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.35 Aligned_cols=249 Identities=29% Similarity=0.504 Sum_probs=207.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.++++++||||+++++++... ..+++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 77 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWI 77 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEE
Confidence 4677899999999999999999899999999997543 23567889999999999999999999988665 45899
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhhhhh
Confidence 99999999999998776 68999999999999999999999999 9999999999999855 79999999998765432
Q ss_pred --CcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCCh
Q 005017 237 --TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDP 308 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~ 308 (719)
......++..|+|||.+.. .++.++||||||+++|+|+||+.||..................+.. .....+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2234578999999998753 5788999999999999999999999875433333332222222221 1223457
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
++++||++||. +|.+|||+.+++.|||
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 89999999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.76 Aligned_cols=249 Identities=26% Similarity=0.476 Sum_probs=212.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|+..++||.|+||.||.+.+..+|..+++|.+...... ....+++.+|+.++++++|+||+++++++.+. ..++++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~ 77 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS--EKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIE 77 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc--hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEE
Confidence 56789999999999999999999999999998765432 24557788999999999999999999998765 468899
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSE 154 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEcccc
Confidence 9999999999999765 45899999999999999999999999 9999999999999865 69999999998765433
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+....+..+..+. .....+.++.++
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 345578999999998764 478899999999999999999999976 45666666666554433 335567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++|+|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999997 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.85 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=204.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.++++++||||+++++++... ..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD--PVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC--ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEE
Confidence 467778999999999999999999999999998754321 22345678999999999999999999988654 45889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++++|..++.....+++..++.++.||+.||+|||+++ ++||||||+||+++.+ |.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCCc
Confidence 9999999999988877778999999999999999999999999 9999999999999855 799999999997654432
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CC--------------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI-------------- 297 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~-------------- 297 (719)
.....++..|+|||++.+ .++.++||||||+++|+|++|+.||.+..+.+........ ..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 234568899999998754 4789999999999999999999999875544433322110 00
Q ss_pred ----CCC--------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 298 ----KPA--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 298 ----~p~--------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0012236789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.07 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=211.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||.|+||.||+|.+..+|..||+|.+....... ....+.+.+|++++++++||||+++++.+... ..+++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEE
Confidence 577899999999999999999999999999997544322 34567899999999999999999999887544 468999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-C
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~ 237 (719)
+||+.+++|.+++.....+++..+..|+.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence 999999999999988778999999999999999999999999 9999999999999855 79999999998765443 2
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
.....|+..|+|||++.. .++.++|+||||+++|+|++|..||..... .......... .....+...++.+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence 344568899999998764 479999999999999999999999987543 3444333332 22334445678999999
Q ss_pred HHhcC-CCCCCCCH--HHHHcCccC
Q 005017 315 EKCLV-PASERLSA--KDLLKDPFL 336 (719)
Q Consensus 315 ~kcL~-dP~~RpSa--~eLL~hpf~ 336 (719)
.+||. +|.+||++ .++++||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=333.67 Aligned_cols=251 Identities=30% Similarity=0.544 Sum_probs=210.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES----EEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWIL 80 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC----HHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEE
Confidence 566778999999999999998899999999987542 34567888999999999999999999988754 468899
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchhhcccc
Confidence 9999999999998764 46999999999999999999999999 9999999999999855 79999999998655432
Q ss_pred -CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCCh
Q 005017 237 -TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDP 308 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~ 308 (719)
......|++.|+|||++. ..++.++||||||+++|+|++|+.||... ........+..+..+. ..+...+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCH
Confidence 223457899999999864 23678999999999999999999999874 4445455555443322 23345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++.++|.+||. +|.+||++.++|+||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999998 89999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=330.69 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=210.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.||.|++|.||+|.+..+++.+|+|.+..... .....++.+|++++++++||||+++++++.......+++|
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5667899999999999999999999999999875432 2455778999999999999999999999887766778999
Q ss_pred EecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 159 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeecccccccc
Confidence 999999999988653 345889999999999999999999999 9999999999999855 689999999987655
Q ss_pred CCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCC----CCHHHHHHHHHcCCCCCc---cc--c
Q 005017 235 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPAS---LA--K 304 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~----~~~~~i~~~i~~g~~p~~---~~--~ 304 (719)
........++..|+|||.+. ..++.++||||||+++|+|++|..||... ..+.+....+.....+.. .. .
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 44444556889999999876 45899999999999999999999999764 233444444443222211 11 1
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..++.+++||.+||. +|.+|||+.|+++||||+...
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 235689999999998 899999999999999996443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.33 Aligned_cols=252 Identities=22% Similarity=0.388 Sum_probs=202.5
Q ss_pred EEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHH---HHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE---VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~E---i~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
+||+|+||.||+|.+..+|+.||+|.+........ .....+..| +..++...||||+++++++... ..+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEe
Confidence 48999999999999999999999999875433221 111223333 3445556899999999988654 46889999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCccc
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 240 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~ 240 (719)
|+.+|+|.+++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCccCCcC
Confidence 9999999999988888999999999999999999999998 9999999999999865 699999999987665444455
Q ss_pred ccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 241 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
..|++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......... . .+..++...++.+.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T-MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-c-cCCCCCCcCCHHHHHHHHH
Confidence 679999999998863 488999999999999999999999976422 222222222 1 2333445568899999999
Q ss_pred hcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 317 CLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 317 cL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
||. +|.+|| ++.++++||||....+..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 998 899999 999999999998765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.68 Aligned_cols=250 Identities=35% Similarity=0.601 Sum_probs=210.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..++..||+|.++..... ....+.+..|+.++++++|+||+++++.+... ..+++|
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIF 77 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEE
Confidence 56789999999999999999989999999998765432 35678899999999999999999999976544 468899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
+||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||+|+||+++. .+.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEcccccccccCCCCC
Confidence 999999999999988777999999999999999999999999 999999999999986 47999999999876543221
Q ss_pred ------ccccCCCCCCCcccccc-c---cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC--C
Q 005017 239 ------RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV--N 306 (719)
Q Consensus 239 ------~~~~GT~~YmAPEvl~~-~---~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~--~ 306 (719)
....+++.|+|||++.+ . ++.++||||||+++|+|++|+.||....+.......+..+.. ..++.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-PPIPDSLQL 233 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-CCCCccccc
Confidence 13467899999998764 2 788999999999999999999999875555554444444322 223333 3
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
++.+.+||.+||. +|.+||++.+++.|||+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 7899999999998 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.78 Aligned_cols=255 Identities=29% Similarity=0.499 Sum_probs=209.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|.+.+.||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEE
Confidence 455677899999999999999999999999999875432 2346788999999999999999999988754 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ |.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCccceEccCC
Confidence 99999999999999865 45889999999999999999999999 9999999999999854 79999999998655432
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...............+..+...+...++.+++|
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 2 234578999999998764 5889999999999999999999999764333333322222323333345567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
|.+||. +|.+||++.++++||||+....
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999998 8999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.88 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=199.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
...|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+|++|+|||||++++.+... .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~--~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWK--S 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeC--C
Confidence 345888999999999999999754 35678999987532 2345799999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++|||++. ++|.+++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCcccccc
Confidence 5889999995 689999977788999999999999999999999999 9999999999999855 79999999999765
Q ss_pred cCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHHc-----------
Q 005017 234 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTS----------- 295 (719)
Q Consensus 234 ~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--~~i~~~i~~----------- 295 (719)
.... .....||+.|+|||++.. .|+.++|||||||++|||++|+.||.+.... ...+..+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 4322 234679999999998864 5899999999999999999999999653321 111111111
Q ss_pred ---------------CCCC-Cccc-----cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 296 ---------------GIKP-ASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 296 ---------------g~~p-~~~~-----~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
...+ ...+ ...+.++++||.+||. +|.+|||+.++|.||||+....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0000 0000 1235678999999998 8999999999999999986544
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=332.37 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=209.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+|..||+|.++... .......+.+|+.++++++||||+++++.+... ..+++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEE
Confidence 3566788999999999999999999999999886431 234457888999999999999999999988654 46889
Q ss_pred EEecccCCChhHHhhhc---ccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 158 ITELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~---~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
||||+++++|..++... ..+++..+..++.||+.||.|||+ ++ |+||||||+||+++. .+.+||+|||++...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence 99999999999998763 378999999999999999999996 57 999999999999986 479999999999776
Q ss_pred cCCCcccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHH---HHHHcCCCCCccc
Q 005017 234 QQPTARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF---KKVTSGIKPASLA 303 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~---~~i~~g~~p~~~~ 303 (719)
.........|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+ ..+..+. +...+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~~ 231 (286)
T cd06622 154 VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-PPTLP 231 (286)
T ss_pred cCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC-CCCCC
Confidence 5555556678999999998743 25789999999999999999999997532 22222 2333333 33344
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...++.+++||.+||. +|.+||++.+++.||||....
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 4578899999999998 899999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=328.21 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=203.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||+|.+..+|..||+|++...... ......+.+|+.++++++||||+++++++... ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 77 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLV 77 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEE
Confidence 57789999999999999999999999999998765432 23456789999999999999999999988664 468899
Q ss_pred EecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
+||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||+||+++.+ |.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEE 153 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCC
Confidence 9999 9999998865 456899999999999999999999999 9999999999999864 799999999987665432
Q ss_pred ---cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC-CC------------
Q 005017 238 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KP------------ 299 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~-~p------------ 299 (719)
.....|+..|+|||++.+ .++.++||||||+++|+|+||.+||....+. ..+..+.... .+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcc
Confidence 334578999999998753 4689999999999999999998888664332 2222222110 00
Q ss_pred --------C-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 300 --------A-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 300 --------~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
. ......+..+.++|.+||. +|.+|||++++|+||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0112335789999999998 899999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.58 Aligned_cols=247 Identities=18% Similarity=0.312 Sum_probs=202.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...|++.++||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-- 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--
Confidence 456889999999999999999765 456789999887532 234456788999999999999999999988654
Q ss_pred CceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.+ +.+|++|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCcccc
Confidence 4688999999999999999774 46899999999999999999999999 9999999999999865 699999999875
Q ss_pred hccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 232 AMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 232 ~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
...... .....+++.|+|||++. ..++.++|||||||++|||++ |+.||.. .+...+.+.+..+..++ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD-MSGQDVIKAVEDGFRLP-APRNC 233 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHCCCCCC-CCCCC
Confidence 432221 11234567899999875 468999999999999999775 9999987 44555666666654433 35567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+.+++.+||. +|.+||++.+|++
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 7899999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=333.24 Aligned_cols=259 Identities=22% Similarity=0.384 Sum_probs=213.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++.+... ..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEE
Confidence 366778999999999999999999999999988754321 234456788999999999999999999988654 46899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++. .|.+||+|||+++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~-~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECC-CCCEEEeeCCCccccCcCc
Confidence 9999999999999988888999999999999999999999999 999999999999985 479999999988632110
Q ss_pred ----------------CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC
Q 005017 237 ----------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 237 ----------------~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
......|++.|+|||.+. ..++.++|||||||++|||++|..||.+ ....++...+..+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC
Confidence 011245788999999775 4689999999999999999999999986 4556666666554322
Q ss_pred -CccccCCChHHHHHHHHhcC-CCCCCCC---HHHHHcCccCccccCCC
Q 005017 300 -ASLAKVNDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 300 -~~~~~~~~~~l~~lI~kcL~-dP~~RpS---a~eLL~hpf~~~~~~~~ 343 (719)
+......+++++++|.+||. +|.+||+ +.++|.||||.......
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 22223567889999999998 8999998 89999999998665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=322.00 Aligned_cols=249 Identities=24% Similarity=0.476 Sum_probs=210.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||++.+..+|..||+|.+...... ....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 77 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIV 77 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEE
Confidence 57789999999999999999999999999998754332 23456789999999999999999999988654 468899
Q ss_pred EecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNST 154 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcc
Confidence 99999999999987643 5789999999999999999999999 9999999999999855 69999999998655432
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..++++
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNL 232 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHH
Confidence 2 234568999999998754 578899999999999999999999976 45566666666655443 334567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=333.87 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=206.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.+.||+|+||.||+|.+..+|..||+|.++...... .....+.+|+.++++++|+||+++++++.......+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 345778899999999999999999999999999987654221 222345679999999999999999999877665678
Q ss_pred eEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++ ++||||||+||+++.+ |.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeeecC
Confidence 999999965 88888765 356899999999999999999999999 9999999999999855 799999999997665
Q ss_pred CC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CC--------
Q 005017 235 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA-------- 300 (719)
Q Consensus 235 ~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~-------- 300 (719)
.. ......+++.|+|||++.+ .++.++|||||||++|||++|+.||... +..+.+..+..... +.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhhc
Confidence 33 2233456889999998754 4789999999999999999999999864 44444433322100 00
Q ss_pred -------cc-----------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 -------SL-----------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 -------~~-----------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.. ....++.+.+||.+||. ||.+|||+.++|.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 01246789999999998 89999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.24 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=201.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||.|+||.||+|.++.+|..||+|++...... ......+.+|++++++++||||+++++++.+. ...++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEE
Confidence 56778999999999999999999999999988754321 23346788999999999999999999987654 468899
Q ss_pred EecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+. ++|..++.. ...+++..++.++.|++.||+|||+++ ++||||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccC
Confidence 99996 689888865 346899999999999999999999999 9999999999999855 69999999998765432
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA------------ 300 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~------------ 300 (719)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 2233457889999998764 368899999999999999999999977544443333222111110
Q ss_pred --------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 301 --------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 301 --------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
......++.++++|.+||. +|.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112356789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.09 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=206.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC------ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ------LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~------~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
|.+.+.||+|+||.||+|.+..+|+.||+|.++...... .....+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-- 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--
Confidence 567789999999999999999899999999986532211 112345788899999999999999999987654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeecccccc
Confidence 468899999999999999988888999999999999999999999998 9999999999999855 7999999999875
Q ss_pred ccCC----CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---CCCcc
Q 005017 233 MQQP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASL 302 (719)
Q Consensus 233 ~~~~----~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~---~p~~~ 302 (719)
.... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||................. .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 5432 1234468899999998753 378999999999999999999999976444433333222221 12223
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
....+..++++|.+||. +|.+||++.++|+|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 33457899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.85 Aligned_cols=247 Identities=34% Similarity=0.558 Sum_probs=205.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..++..|++|.+.... ..+.+.+|++++++++||||+++++++... ..+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l 75 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWI 75 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEE
Confidence 4567788999999999999999889999999986432 257899999999999999999999988765 56889
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
++||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhcccC
Confidence 9999999999999875 456899999999999999999999999 9999999999999865 69999999999766543
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCCChHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKG 312 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~~~l~~ 312 (719)
. .....|+..|+|||++.+ .++.++||||||+++|+|++|+.||..... ......+..... ....+...+..+.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 2 234568999999998764 588999999999999999999999976433 222222222111 11223345678999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+|.+||. +|.+|||+.++|.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999998 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.03 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=208.5
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||.||+|.+..+|+.||+|.+....... ....+.+.+|+.++++++||||+++++.+... ..+++|+||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEecCCC
Confidence 689999999999999899999999987543321 34567889999999999999999999887544 568899999999
Q ss_pred CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--------
Q 005017 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-------- 236 (719)
Q Consensus 165 GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-------- 236 (719)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence 999999988788999999999999999999999999 9999999999999865 79999999998654332
Q ss_pred --CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......+++.|+|||.+.. .++.++||||||+++|+|++|..||.. ......+..+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 2234568899999997754 478899999999999999999999976 456666666665443322222237899999
Q ss_pred HHHhcC-CCCCCCCH---HHHHcCccCcccc
Q 005017 314 IEKCLV-PASERLSA---KDLLKDPFLQVEN 340 (719)
Q Consensus 314 I~kcL~-dP~~RpSa---~eLL~hpf~~~~~ 340 (719)
|.+||. +|.+|||+ .++|+||||...+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999998 89999999 9999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.51 Aligned_cols=250 Identities=24% Similarity=0.430 Sum_probs=203.1
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.||+|+||.||+|.+..+|+.||+|.+....... ......+..|..+ ...++||||+++++++... ..+++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEec
Confidence 46899999999999999999999999986543222 1223344455544 4556899999999988654 468999999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 241 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~ 241 (719)
+++++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc--cccC
Confidence 999999999988888999999999999999999999999 9999999999999855 7999999998865433 2345
Q ss_pred cCCCCCCCccccccc-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHHHHHHHHhc
Q 005017 242 IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 242 ~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l~~lI~kcL 318 (719)
.|++.|+|||.+.+. ++.++||||||+++|+|+||..||.. .+..+.+..+..+.. +.......++.+.++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 689999999987654 78999999999999999999999976 455566555544332 33334456789999999999
Q ss_pred C-CCCCCCCH---HHHHcCccCccccC
Q 005017 319 V-PASERLSA---KDLLKDPFLQVENQ 341 (719)
Q Consensus 319 ~-dP~~RpSa---~eLL~hpf~~~~~~ 341 (719)
. +|.+||++ .|+|.||||...++
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 8 89999954 79999999976554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.66 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=205.5
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||+||+|.+..+|+.||+|.+....... ......+..|+.+|++++||||+++++.+... ..+++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence 699999999999999999999999987543222 23455677899999999999999999988654 458899999999
Q ss_pred CChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-Ccccc
Q 005017 165 GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV 241 (719)
Q Consensus 165 GsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~~~~~ 241 (719)
++|.+++.+.+ .+++..++.++.|++.||.|||+++ ++||||+|+||+++.+ +.+||+|||++...... .....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence 99999997765 6999999999999999999999999 9999999999999855 69999999998765432 22345
Q ss_pred cCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 242 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 242 ~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
.++..|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 67889999998754 488999999999999999999999976332 1222222221 23344455688999999999
Q ss_pred cC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 318 LV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 318 L~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
|. +|.+|| ++.+|+.||||...++..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 98 899999 999999999998766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.19 Aligned_cols=242 Identities=32% Similarity=0.498 Sum_probs=207.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.+.+.||+|+||+||+|.+- | .||||+++..... ++.++.|.+|+.+|++-+|.||+-|.|++.... +.+|
T Consensus 394 v~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt--~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIi 465 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPT--PEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAII 465 (678)
T ss_pred hhccceeccccccceeecccc--c-ceEEEEEecCCCC--HHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeee
Confidence 456788999999999999643 4 5999999987654 468899999999999999999999999987543 4889
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc---
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--- 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--- 234 (719)
+.+|+|.+|..++.-. ..|+....+.|++||+.|+.|||.++ |||||||..|||+..+ +.|||+|||++..-.
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccceeeeeeec
Confidence 9999999999998753 46899999999999999999999999 9999999999999855 799999999985432
Q ss_pred -CCCcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---cccCC
Q 005017 235 -QPTARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKVN 306 (719)
Q Consensus 235 -~~~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~~~ 306 (719)
........|...|||||+++. .|++.+|||||||++|||+||..||. ..+.++++-++..|...+. ....+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccC
Confidence 222334457889999998863 48999999999999999999999999 6899999999999954433 33445
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..++++|+..||. ++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6699999999998 8999999999987
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.17 Aligned_cols=246 Identities=27% Similarity=0.364 Sum_probs=192.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..++..||+|..... ....|+.++++++||||+++++++.... ..+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--ITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCC--eeE
Confidence 3478889999999999999999999999999964321 2346999999999999999999887654 578
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+|+||+. |+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCcccccccc
Confidence 8999995 588888765 456999999999999999999999999 9999999999999855 6999999999875432
Q ss_pred -CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CH---------HHHHHHHHc-CCCCCcc
Q 005017 236 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NP---------AQIFKKVTS-GIKPASL 302 (719)
Q Consensus 236 -~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~---------~~i~~~i~~-g~~p~~~ 302 (719)
.......||+.|+|||++.+ .++.++|||||||++|||+++..|+.... .. ..+...+.. +..+..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 23345679999999998764 58999999999999999999765543211 11 111111111 1111111
Q ss_pred c------------------------------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 303 A------------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 303 ~------------------------------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+ ...+..+.+||.+||. ||.+||||.|+|+||||+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1 1234567789999998 8999999999999999974
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.22 Aligned_cols=251 Identities=28% Similarity=0.476 Sum_probs=207.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.++||+|+||.||+|.+..+|..||+|.++...... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEE
Confidence 35788899999999999999999999999999887543322 34556788999999999999999999988765 4588
Q ss_pred EEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 157 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+|+||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++..
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~~ 155 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECcccccee
Confidence 99999999999988753 345899999999999999999999999 9999999999999855 6999999999876
Q ss_pred ccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCCCh
Q 005017 233 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 233 ~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||.... +.......+.....+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred ccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 54322 234568999999998754 58899999999999999999999986532 334555565555545444455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.++++|.+||. +|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999998 89999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=354.79 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=197.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
+..|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++|+|||||++++++... ...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEE
Confidence 3357888999999999999999999999999996431 2356899999999999999999988655 357
Q ss_pred eEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++|||++. ++|..++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~~ 311 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceecc
Confidence 88999995 6888888654 46999999999999999999999999 9999999999999855 699999999997654
Q ss_pred CCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-------CHHHHHHHHHcCCC----
Q 005017 235 QPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTSGIK---- 298 (719)
Q Consensus 235 ~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-------~~~~i~~~i~~g~~---- 298 (719)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+.....
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 321 224579999999998865 58999999999999999999876643211 12334333332111
Q ss_pred -CC-------------------------ccc--cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 299 -PA-------------------------SLA--KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 299 -p~-------------------------~~~--~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+. .+. ...++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 000 1234679999999998 9999999999999999974
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.36 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=204.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||+|+||.||+|.+..+|+.||+|.+........ ......+..|++++++++|+||+++++++.+. ..+++
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l 79 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINL 79 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEE
Confidence 5677899999999999999999999999999986543311 22345677899999999999999999998764 56899
Q ss_pred EEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence 99999 999999998766 7999999999999999999999999 9999999999999865 79999999999766543
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC-CC------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KP------------ 299 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~-~p------------ 299 (719)
......+++.|+|||.+.+ .++.++|||||||++|||++|.+||..... ...+..+.... .+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhhhhccccc
Confidence 2233457889999998753 478999999999999999999877765333 22222222110 00
Q ss_pred -------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 -------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......+..+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00112335788999999998 899999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=320.79 Aligned_cols=250 Identities=26% Similarity=0.474 Sum_probs=208.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.++.+|..||+|.+...... ....+.+.+|+.+++.++|+||+++++.+... ..+++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv 77 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP--VKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIV 77 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc--chhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEE
Confidence 57789999999999999999999999999998764322 23456788999999999999999999987654 468999
Q ss_pred EecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||+++++|.+++.... .+++..++.|+.|++.||.|||+++ ++|+||||+||+++.+...+||+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999987644 4789999999999999999999999 9999999999999866446799999998766543
Q ss_pred C--cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||++. ..++.++|+||||+++|+|++|..||... +.......+..+..+. .....+..++++
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRSL 233 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHHH
Confidence 2 23346899999999875 45889999999999999999999999763 4444555554443332 233456789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.28 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=201.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCC---C
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKK---K 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~---~ 153 (719)
.|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.+++.+. ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 367788999999999999999999999999988754321 223467888999999995 6999999998765432 2
Q ss_pred ceeEEEecccCCChhHHhhhc-----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 154 TVNMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecc
Confidence 47899999985 888887542 35799999999999999999999999 99999999999998746799999999
Q ss_pred hhhhccCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-----
Q 005017 229 LAIAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP----- 299 (719)
Q Consensus 229 lA~~~~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p----- 299 (719)
++...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||..........+....-..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98755332 1223457889999998753 47899999999999999999999998754444333222110000
Q ss_pred -----------------C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 300 -----------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 300 -----------------~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
. ......++++.+||.+||. +|.+||++.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0012356789999999998 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.83 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=194.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc----------------CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE----------------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV 140 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~----------------~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 140 (719)
..|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+|.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCe
Confidence 35678899999999999999753 244579999887432 23455678999999999999999
Q ss_pred eeEEEeeecCCCCceeEEEecccCCChhHHhhhcc-------------------cccHHHHHHHHHHHHHHhhhhhcCCC
Q 005017 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-------------------NVDIKVIKNWARQILHGLVYLHSHNP 201 (719)
Q Consensus 141 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~-------------------~l~~~~i~~i~~QIl~gL~yLHs~~p 201 (719)
+++++++.+.+ .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++
T Consensus 82 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 158 (304)
T cd05096 82 IRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN- 158 (304)
T ss_pred eEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 99999987654 5889999999999999986532 3677889999999999999999999
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT- 275 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT- 275 (719)
|+||||||+|||++.+ +.+||+|||+++...... .....+++.|||||++. +.++.++|||||||++|||++
T Consensus 159 -ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 -FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred -ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999855 799999999997654322 12334578999999875 468999999999999999987
Q ss_pred -ccCCCCCCCCHHHHHHHHHc----C--CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 276 -FEYPYSECKNPAQIFKKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 276 -G~~Pf~~~~~~~~i~~~i~~----g--~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..||.... ..+....+.. . ......+...++.+.++|.+||. +|.+|||+.+|.+
T Consensus 237 ~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 237 CKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred cCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 567887643 3333333221 1 11111233456789999999998 8999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=345.10 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=201.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|++.+.||+|+||+||+|.+ ..++..||+|+++.... ....+.+.+|+.+|+.+ +||||++++++|...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC---cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3578899999999999999964 34677899999864331 23456788999999999 899999999988665
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-------------------------------------------------------
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK------------------------------------------------------- 175 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~------------------------------------------------------- 175 (719)
+ ..++||||+++|+|.+++....
T Consensus 112 ~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 112 G--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred C--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 4 5889999999999999986421
Q ss_pred --------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 176 --------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 176 --------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccC
Confidence 3678889999999999999999999 9999999999999854 6899999999976543
Q ss_pred CCcc----cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 236 PTAR----SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 236 ~~~~----~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... ...+++.|+|||++.+ .++.++|||||||++|||++ |..||..........+.+..+..+. .+...+.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 345 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-SPECAPSE 345 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-CCCCCCHH
Confidence 3221 2234567999998764 58999999999999999998 8899987555566666666554332 33456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++++|.+||. +|.+|||+.++++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=385.23 Aligned_cols=251 Identities=31% Similarity=0.512 Sum_probs=221.4
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
.+..||.|.||.||.|.+..+|+..|+|.+++.... ......+.+|..+|..|+|||+|++||.-++.+ .+++.||
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFME 1314 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFME 1314 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH--HHHHHHH
Confidence 456899999999999999999999999999876543 345567889999999999999999999766554 4778999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC---
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 237 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--- 237 (719)
||.+|+|.+.+...+..++...+.+..|++.||+|||++| ||||||||.|||++.+ |.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCchhcC
Confidence 9999999999987777888888899999999999999999 9999999999999855 799999999997765542
Q ss_pred ---cccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 238 ---ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....|||.|||||++.+ +...+.|||||||+++||+||+.||...++..+++-.+..|..|..... .+++.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls~~g 1470 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LSSEG 1470 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hhHhH
Confidence 235689999999999864 3567899999999999999999999999999999999999988865555 78899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++||+.||. ||.+|+++.|||.|.|-+..
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999997 99999999999999987643
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.78 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=198.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|..||+|.+..... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEE
Confidence 457788999999999999999999999999999875432 12234567899999999999999999988654 4688
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||+++....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAKSI 155 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccccCC
Confidence 9999996 677776654 346788899999999999999999999 9999999999999855 7999999999865432
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC-----------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK----------- 298 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~----------- 298 (719)
. ......+++.|+|||++.+ .++.++||||||+++|+|+||..||.......+....+.. +..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 2 2234467999999998864 4788999999999999999999999765444333322211 000
Q ss_pred ------------CCcc-----ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 ------------PASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 ------------p~~~-----~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+..+ ....++.+.+++.+||. +|.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 00125689999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.75 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=206.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|...+.||+|+||+||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++.+.+ ..++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~l 92 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWL 92 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEE
Confidence 356778999999999999999999999999998654322 2344567889999999999999999999987654 5889
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+ |.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecCcceecCCC
Confidence 999997 577776653 456899999999999999999999999 9999999999999855 79999999998654332
Q ss_pred CcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 237 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
....|++.|+|||++. +.++.++||||||+++|||+||..||... +.......+.....+.......+..+++
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 3456899999999863 45889999999999999999999999763 3333333444333333333446778999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+|.+||. +|.+||++.+++.||||+..
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 9999998 89999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=326.61 Aligned_cols=246 Identities=25% Similarity=0.366 Sum_probs=204.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCC-----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g-----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
.|++.+.||+|+||.||+|.+...+ ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-- 80 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-- 80 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--
Confidence 4667789999999999999876555 689999886432 234556789999999999999999999988654
Q ss_pred CceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec
Q 005017 153 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~ 216 (719)
...+++|||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 4588999999999999999764 45788999999999999999999999 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHH
Q 005017 217 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 290 (719)
Q Consensus 217 ~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~ 290 (719)
.+ +.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .+..++.
T Consensus 159 ~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~ 236 (283)
T cd05048 159 EG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVI 236 (283)
T ss_pred CC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 55 699999999987543221 22345688999999765 568999999999999999998 9999987 4566777
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+..+..+. .+...++++.+++.+||. +|.+||++.+++++
T Consensus 237 ~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777665443 345667899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.24 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=205.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|++++++++|+||+++++++... ..+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEE
Confidence 46788999999999999999999999999998875432 223457889999999999999999999998764 46889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||++++.+..+..+...+++..++.++.||+.||.|||+++ ++||||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCCc
Confidence 9999999888777776677999999999999999999999999 9999999999999854 799999999987665432
Q ss_pred ---cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC------------
Q 005017 238 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK------------ 298 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~------------ 298 (719)
.....+++.|+|||++.+ .++.++||||||+++|+|++|+.||........+...... ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 234578899999998754 5789999999999999999999999865443333221110 000
Q ss_pred -------C--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -------p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+ ..++...++++++||.+||. +|.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01122347889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.41 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=207.4
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh----------hhHHHHHHHHHHHHhCCCCCcee
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP----------GDLQKLYSEVHLLKSLKDDNVVK 142 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~----------~~~~~~~~Ei~iL~~L~HpNIVk 142 (719)
+..+||..+.+.||.|+||+||+|.+..+|+.||+|.++........ .....+.+|+.++++++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 45678888889999999999999999999999999998754322111 01124778999999999999999
Q ss_pred EEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcE
Q 005017 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 143 l~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~v 222 (719)
+++++... ..+++||||+. |+|.+++.....+++..+..++.|++.||+|||+++ |+||||||+||+++.+ |.+
T Consensus 85 ~~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~~ 158 (335)
T PTZ00024 85 LVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GIC 158 (335)
T ss_pred eeEEEecC--CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CCE
Confidence 99988655 46889999996 699999988888999999999999999999999999 9999999999999855 799
Q ss_pred EEeecchhhhccCC----------------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCC
Q 005017 223 KIGDLGLAIAMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK 284 (719)
Q Consensus 223 KL~DFGlA~~~~~~----------------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~ 284 (719)
||+|||++...... ......+++.|+|||++.+ .++.++|||||||++|+|+||..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998655411 1122356889999998764 37899999999999999999999998644
Q ss_pred CHHHHHHHHHcC---CCCC-----------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 285 NPAQIFKKVTSG---IKPA-----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 285 ~~~~i~~~i~~g---~~p~-----------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
.... ...+... ..+. ......+..+.++|.+||. +|.+|||+.++|.||||+
T Consensus 239 ~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 3332 2222110 0000 0012336788999999998 899999999999999998
Q ss_pred ccc
Q 005017 338 VEN 340 (719)
Q Consensus 338 ~~~ 340 (719)
...
T Consensus 318 ~~~ 320 (335)
T PTZ00024 318 SDP 320 (335)
T ss_pred CCC
Confidence 543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.96 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=203.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||.|+||.||+|.+..+|+.+|+|.++..... ......+.+|+.++++++||||+++++++...+...+++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 456678899999999999999999999999999865432 223346678999999999999999999988775578999
Q ss_pred EEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+ +|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+||+++.+ |.+||+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeeccCC
Confidence 9999974 9999887644 5899999999999999999999999 9999999999999855 79999999998765543
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--------------- 297 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~--------------- 297 (719)
......+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ....+....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhccc
Confidence 2234567899999998754 36889999999999999999999997643322 222221100
Q ss_pred --------------CCCccccC-CChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 298 --------------KPASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 298 --------------~p~~~~~~-~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
....++.. .++.++++|.+||. +|++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111122 46789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.60 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=198.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~l 157 (719)
|++.+.||+|+||.||+|.+..++..||+|+++.... .. ......+|+.++.++. ||||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 4567889999999999999999999999998864321 11 2234457899999985 999999999988765567899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|+||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++. |.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 999997 578887765 356899999999999999999999999 999999999999986 79999999999766433
Q ss_pred C-cccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC--C-------------
Q 005017 237 T-ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K------------- 298 (719)
Q Consensus 237 ~-~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~--~------------- 298 (719)
. .....+++.|+|||++. +.++.++|||||||++|||++|..||... +....+..+.... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 23456899999999764 34788999999999999999999999763 3333322222100 0
Q ss_pred -----CC-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -----PA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -----p~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+. ......+..++++|.+||. +|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 0112346889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=362.79 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=205.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEe-eecC--
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKS-WVDD-- 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~-~~~~-- 150 (719)
.+..+++.++|.+|||+.||.|.+...|.+||+|++-..+ ...++.+.+||.+|++|+ |+|||.|+++ ....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d----e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND----EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC----HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3456788899999999999999999888999999987553 567889999999999997 9999999993 3221
Q ss_pred -C-CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 151 -K-KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 151 -~-~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
+ ...++|.||||.||.|-+++..+ .+|++.++++|+.|+++|+++||...|||||||||-+||||+.+ |..||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCD 189 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCD 189 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCc
Confidence 2 34678999999999999999853 46999999999999999999999999999999999999999855 7999999
Q ss_pred cchhhhccCCC-c-c---------cccCCCCCCCccccc---c-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH
Q 005017 227 LGLAIAMQQPT-A-R---------SVIGTPEFMAPELYE---E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291 (719)
Q Consensus 227 FGlA~~~~~~~-~-~---------~~~GT~~YmAPEvl~---~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~ 291 (719)
||.|....... . . ...-|+.|+|||+++ + ..++|+|||+|||+||-||....||.+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99986432221 1 1 123699999999874 3 4899999999999999999999999763221
Q ss_pred HHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 292 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 292 ~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.|..+.........++..+++||..||+ +|.+||++-+++.+-+.
T Consensus 265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 2444443333334566799999999998 89999999998875433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=344.10 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=199.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC-----CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~-----g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|.+.+.||+|+||.||+|.+... +..||+|.++.... ....+.+.+|+.+++.+ +|||||+++++|...
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH---TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC---HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3578889999999999999986543 35799999875431 33456788999999999 899999999988655
Q ss_pred CCCceeEEEecccCCChhHHhhhc--------------------------------------------------------
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-------------------------------------------------------- 174 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-------------------------------------------------------- 174 (719)
..+++||||+++|+|.+++...
T Consensus 115 --~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 115 --GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred --CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 4588999999999999988542
Q ss_pred --------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcc-
Q 005017 175 --------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR- 239 (719)
Q Consensus 175 --------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~- 239 (719)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCccee
Confidence 13678889999999999999999999 9999999999999854 69999999999765433221
Q ss_pred ---cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 240 ---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 240 ---~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
...+++.|||||++. ..++.++|||||||++|||++ |+.||............+..+.. ...+...+++++++|
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 348 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-MSRPDFAPPEIYSIM 348 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-ccCCCCCCHHHHHHH
Confidence 223556899999875 468999999999999999997 99999875444444444444432 233445678999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 005017 315 EKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~ 332 (719)
.+||. +|.+|||+.++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=311.68 Aligned_cols=247 Identities=34% Similarity=0.584 Sum_probs=206.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|++|.||+|.+..+|..+++|++..... .....+.+|++++++++||||+++++.+... ...+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEE
Confidence 5667899999999999999998999999999875432 3567889999999999999999999988765 458899
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
+||+++++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++.+ +.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeeccccccccccc
Confidence 9999999999998876 57999999999999999999999998 9999999999999855 799999999987665443
Q ss_pred -cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-ccCCChHHHHHH
Q 005017 238 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AKVNDPQIKGFI 314 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~-~~~~~~~l~~lI 314 (719)
.....|+..|+|||.+.. .++.++||||||+++|+|++|+.||........+..... ...+... ....+..+.++|
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence 345678999999998764 478899999999999999999999987433333333222 2222221 222378899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCcc
Q 005017 315 EKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf 335 (719)
.+||. +|.+|||+.++|+|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99998 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.91 Aligned_cols=256 Identities=28% Similarity=0.384 Sum_probs=202.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---- 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 151 (719)
.+.|+..+.||+|+||.||+|.+..+|..||+|.+.... .......++.+|+.++++++||||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 355777899999999999999999999999999886332 12344567888999999999999999999876443
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...+++||||+. ++|.+++... +++..+..++.|++.||+|||+++ |+||||||+||+++.+ |.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccce
Confidence 235789999996 5888887654 899999999999999999999999 9999999999999865 799999999997
Q ss_pred hccCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC--C---------
Q 005017 232 AMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K--------- 298 (719)
Q Consensus 232 ~~~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~--~--------- 298 (719)
...... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhh
Confidence 654432 234568999999998764 5899999999999999999999999764322 2222221100 0
Q ss_pred ----------C------------Cc--------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 299 ----------P------------AS--------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 299 ----------p------------~~--------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+ .. .....++.+++||.+||. ||.+|||+.++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 0 00 011235578999999998 899999999999999998433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.68 Aligned_cols=243 Identities=28% Similarity=0.502 Sum_probs=197.6
Q ss_pred EEeEEEeeeCCeEEEEEEEc----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 80 RYDEVLGKGAFKTVYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
.+.+.||.|+||.||+|... ..+..|+||.++.. ......+.+.+|++.+++++||||+++++++...+ .+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cc
Confidence 56789999999999999887 45678999998542 22345788999999999999999999999998443 48
Q ss_pred eEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||+|+|+|||++.+ +.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-cccccccccccccc
Confidence 8999999999999999986 67999999999999999999999999 9999999999999965 69999999999766
Q ss_pred cCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 234 QQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 234 ~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.... .....+...|+|||.+.. .++.++||||||+++|||+| |+.||.+. +..++...+..+..+. .+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 3221 123346778999998864 58999999999999999999 68999875 6677777776665433 455567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+.++|.+||. +|.+|||+.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999998 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.41 Aligned_cols=251 Identities=27% Similarity=0.549 Sum_probs=206.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+... ...++|
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv 97 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVV 97 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEE
Confidence 333467999999999999999999999999886432 34456788999999999999999999988655 458899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
|||+++++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhcccccc
Confidence 999999999998854 46899999999999999999999999 9999999999999855 699999999987553322
Q ss_pred -cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCChHHHHHH
Q 005017 238 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFI 314 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~l~~lI 314 (719)
.....|++.|+|||++.+ .++.++||||||+++|||++|+.||.. ....+.+..+.....+. ......+..++++|
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 234578999999998764 588999999999999999999999976 34444444444332221 12224577899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+||. +|.+|||+.++++||||+...
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccC
Confidence 99998 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.13 Aligned_cols=249 Identities=29% Similarity=0.540 Sum_probs=212.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+++++.++|||++++++.+... ...++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEE
Confidence 56778999999999999999999999999998765432 34567788999999999999999999988765 568899
Q ss_pred EecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 159 TELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~ 154 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLS 154 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeecc
Confidence 9999999999998764 67999999999999999999999998 9999999999999854 799999999987654
Q ss_pred CC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 ~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. ......|++.|+|||.+.. .++.++|+||||+++|+|++|..||.. .+...+........ ...++...+..++
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQ-YPPIPSQYSSELR 232 (258)
T ss_pred cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCC-CCCCCCCCCHHHH
Confidence 43 2334578999999997754 588999999999999999999999976 34566666655543 3334556778999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+++.+||. +|.+|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.77 Aligned_cols=266 Identities=23% Similarity=0.422 Sum_probs=228.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.++||+|.||+|.++..+.+|+.+|+|+++..-... ......-..|-++|+..+||.+..+-.+|.. +..+++|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFV 246 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFV 246 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEE
Confidence 455678999999999999999999999999998765544 4566777889999999999999998887754 4569999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc--CC
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~--~~ 236 (719)
|||..||.|+-+|.+.+.+++...+.+...|++||.|||+++ ||+||||.+|.|+|.+ |++||+|||+++.-. ..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhcccccc
Confidence 999999999999999899999999999999999999999999 9999999999999966 899999999997543 34
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
...++||||.|.|||++.. .|+.++|.|.+|+++|||++|+.||.. .+...++..|..+. ..++...+++++.|+.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed--~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMED--LKFPRTLSPEAKTLLS 400 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhh--ccCCccCCHHHHHHHH
Confidence 5678999999999999975 599999999999999999999999987 45666777766542 3456677899999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccCccccCCCCCCCCCCCcc
Q 005017 316 KCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLPI 353 (719)
Q Consensus 316 kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~~~~~~l~~p~ 353 (719)
.+|. ||.+|. .|.|+.+|+||...+|.....+.+.+|.
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 9997 899997 4999999999998888655444444443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.77 Aligned_cols=251 Identities=32% Similarity=0.551 Sum_probs=206.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC---CCCceeEEEeeecCCCCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~~~~ 154 (719)
.|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++ |||++++++++... ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CE
Confidence 3556688999999999999999999999999886432 2344567889999999997 99999999988654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.+ |.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecC
Confidence 8899999999999999865 47899999999999999999999999 9999999999999864 799999999987654
Q ss_pred CCC--cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcccc-CCChH
Q 005017 235 QPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK-VNDPQ 309 (719)
Q Consensus 235 ~~~--~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~-~~~~~ 309 (719)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... ........+... .+..+.. ..+++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIPKS-KPPRLEDNGYSKL 230 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-ChhhhhhccccC-CCCCCCcccCCHH
Confidence 432 234578999999998754 3688999999999999999999999763 333333222222 2222322 36789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+.+++.+||. +|.+||++.++++||||+..
T Consensus 231 ~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 231 LREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 9999999998 89999999999999999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.24 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=200.3
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV 158 (719)
...+.||+|+||.||++.+..+|..||+|.+..... ......+.+|+.++.++. ||||+++++++... ...+++
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 345679999999999999999999999999875432 244567889999999996 99999999988765 347789
Q ss_pred EecccCCChhHHh---h--hcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 159 TELFTSGNLRQYR---K--KHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 159 ~Ey~~gGsL~~~L---~--~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
|||+.. +|.++. . ....+++..+..++.|++.||+|||+. + |+||||||+||+++.+ +.+||+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence 999864 554432 2 245799999999999999999999974 7 9999999999999855 6999999999976
Q ss_pred ccCCC-cccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc---cc
Q 005017 233 MQQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AK 304 (719)
Q Consensus 233 ~~~~~-~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~---~~ 304 (719)
..... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||.......+....+..+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 54432 234568999999998864 48899999999999999999999997654333333333333322211 12
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..++++.+||.+||. +|.+|||+.++++||||+...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 357889999999998 899999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.23 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=198.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|.+...... .....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEE
Confidence 3567889999999999999999999999999998754321 1224467899999999999999999988654 4688
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+.+ +|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKSV 155 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccCC
Confidence 99999975 999988764 46899999999999999999999999 9999999999999855 7999999999865432
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC---CC----------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IK---------- 298 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g---~~---------- 298 (719)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......+....+... ..
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 2 1223357889999998754 47899999999999999999999997654333322222110 00
Q ss_pred ------------CCcc---ccCCC--hHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 ------------PASL---AKVND--PQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 ------------p~~~---~~~~~--~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+... ....+ ..+.++|.+||. +|.+|||+.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01122 678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.23 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=207.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~ 92 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVG--DELW 92 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeC--CcEE
Confidence 45577899999999999999998899999999986432 23346788999999999999999999988765 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcceeccccc
Confidence 999999999999998754 5789999999999999999999999 9999999999999855 69999999988654332
Q ss_pred --CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......|++.|+|||.+. +.++.++||||||+++|+|++|+.||.......++......+..........+..++++
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 223456899999999875 45889999999999999999999999764333333222222222222233456789999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|.+||. +|.+||++.+++.||||+..+
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999998 899999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.26 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=200.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||.|++|.||+|.+..+|..||+|+++.... ......+.+|+.++++++||||+++++++.+.+ .+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 76 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLV 76 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEE
Confidence 5678899999999999999999999999999876532 223456778999999999999999999987654 47899
Q ss_pred EecccCCChhHHhhhc---ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 159 TELFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~---~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+ |.++|+|||++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGI 152 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcC
Confidence 999985 888887654 35899999999999999999999999 9999999999999855 7999999999975543
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC-CCC-----------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKP----------- 299 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g-~~p----------- 299 (719)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+... ..|
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcC
Confidence 2 2234567899999998754 468899999999999999999999987544332 2222110 000
Q ss_pred ---------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 ---------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ---------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
..+....++.++++|.+||+ +|.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.42 Aligned_cols=258 Identities=33% Similarity=0.562 Sum_probs=214.0
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
+.....|...+.||+|+||.||+|.+..++..|++|++..... ..+.+.+|++++++++|+||+++++++...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG-- 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--
Confidence 3445556777899999999999999998999999999875432 456788999999999999999999998766
Q ss_pred CceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.+ |.++|+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~ 164 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAA 164 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchhh
Confidence 46889999999999999998876 8999999999999999999999998 9999999999999855 799999999986
Q ss_pred hccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCCC
Q 005017 232 AMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVND 307 (719)
Q Consensus 232 ~~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~ 307 (719)
..... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||... ++......+..... +.......+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWS 243 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCC
Confidence 55432 2234468899999998764 5899999999999999999999999863 44444334333222 222233367
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
..+++||.+||. +|.+||++.+++.||||.....
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 889999999998 8999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.44 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=202.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|++|+||+|.++.+|+.||+|.+...... ....+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 78 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYL 78 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEE
Confidence 467789999999999999999999999999988654321 23346788999999999999999999998754 46899
Q ss_pred EEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||||+. ++|.+++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++...+.+||+|||++.....
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999996 588887765443 578889999999999999999998 999999999999986556899999999975533
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCCC-----------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP----------- 299 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~p----------- 299 (719)
. ......+++.|+|||++.+ .++.++||||||+++|+|+||..||........+.+.... +...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 2 2234467899999998754 4788999999999999999999999764433333332211 0000
Q ss_pred -----------C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 -----------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 -----------~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
. ......++.++++|.+||. +|.+||++.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0112346789999999998 89999999999999999854
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.18 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=207.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||++.+..++..+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+. ..+++|
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence 5678999999999999999999999999999875432 34557788999999999999999999988655 468999
Q ss_pred EecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeeccc
Confidence 9999999999988653 45899999999999999999999999 9999999999999855 79999999998765433
Q ss_pred C--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..++++
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 231 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRSL 231 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHHH
Confidence 2 234578999999998865 488999999999999999999999986 45555555665554332 344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCc
Q 005017 314 IEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hp 334 (719)
|.+||. +|.+||++.+++.--
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 999998 899999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.73 Aligned_cols=248 Identities=28% Similarity=0.545 Sum_probs=207.4
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
-+.||+|++|.||+|.+..++..+++|++.... ....+.+.+|+.+++.++||||+++++++... ...++|+||
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e~ 97 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVMEF 97 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEec
Confidence 468999999999999999899999999886432 23446688999999999999999999988754 458899999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Ccc
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 239 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~ 239 (719)
+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.+ |.++|+|||++...... ...
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccc
Confidence 999999999887 67899999999999999999999999 9999999999999855 79999999988654332 223
Q ss_pred cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc-cccCCChHHHHHHHHh
Q 005017 240 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKGFIEKC 317 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~~~~~l~~lI~kc 317 (719)
...|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.. .++......+.....+.. .....++.+.+||.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4568999999998764 588999999999999999999999976 455555566655532221 1222567999999999
Q ss_pred cC-CCCCCCCHHHHHcCccCcccc
Q 005017 318 LV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 318 L~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|. +|.+||++.++++||||+...
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 98 899999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.89 Aligned_cols=251 Identities=30% Similarity=0.542 Sum_probs=206.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.....||+|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..+++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEE
Confidence 3344579999999999999999999999999875432 2346688999999999999999999988765 458899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-- 236 (719)
+||+++++|..++.. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhcccccc
Confidence 999999999997754 56899999999999999999999999 9999999999999855 79999999998755432
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCCChHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~~~~l~~lI 314 (719)
......|++.|+|||++.+ .++.++|||||||++|||++|+.||.. ..+......+.....+ .......++.+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence 2344679999999998764 588999999999999999999999976 3444444444433222 112234567899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+||. +|.+||++.++++||||....
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCC
Confidence 99998 899999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.92 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=200.4
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCe--EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----CC
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KK 153 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~--~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~~ 153 (719)
.++++||+|+||.||+|.+..++. .||+|.++... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 456889999999999999877765 68999886542 22355678899999999999999999999875432 23
Q ss_pred ceeEEEecccCCChhHHhhh------cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 154 TVNMITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~------~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..++|+||+.+|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCC
Confidence 56889999999999998742 234889999999999999999999998 9999999999999855 69999999
Q ss_pred chhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 005017 228 GLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 301 (719)
Q Consensus 228 GlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 301 (719)
|+++...... .....+++.|+|||.+.. .++.++||||||+++|||++ |+.||.. ....++...+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9997654322 122346778999998764 58999999999999999999 7899976 45566777777664433
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.....+..++++|.+||. +|.+|||+.+|+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 233456789999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.65 Aligned_cols=241 Identities=25% Similarity=0.408 Sum_probs=205.5
Q ss_pred EEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.||+|+||.||+|.+... +..||+|.++.... ....+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4699999999999998866 89999999875432 1246788999999999999999999998876 45689999
Q ss_pred ecccCCChhHHhhhc---------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 160 ELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~---------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
||+++++|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence 999999999999875 67999999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 231 IAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 231 ~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 7665432 344567899999998764 68999999999999999999 59999874 566777777765433 3344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..++++.+++.+||. +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 557899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.15 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=200.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeE----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~----VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||+||+|.+..+|.. ||+|.++... .....+++.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--
Confidence 4577889999999999999987666654 8999886322 234557888999999999999999999988653
Q ss_pred CceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..++|+||+.+|+|.+++.... .+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a~ 157 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEccccccc
Confidence 3678999999999999998754 5889999999999999999999999 9999999999999855 699999999998
Q ss_pred hccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 232 AMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 232 ~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
....... ....++..|+|||++. ..++.++||||||+++|||++ |+.||.+ ....++...+..+..+. .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 235 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPI 235 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC-CCCC
Confidence 6653321 1223467899999876 468999999999999999998 9999976 34555555554443332 3345
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+..+.+++.+||. +|.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67889999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.04 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=197.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC------
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------ 151 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~------ 151 (719)
.|.+.+.||+|+||.||+|.+..+|..||+|.+...... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc--CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 367788999999999999999999999999998754321 122345678999999999999999999876543
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
....++||||+.+ +|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEECcCCCc
Confidence 2356899999965 788777654 36899999999999999999999999 9999999999999855 79999999998
Q ss_pred hhccCCC------cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CCCC
Q 005017 231 IAMQQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKP 299 (719)
Q Consensus 231 ~~~~~~~------~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~~p 299 (719)
....... .....++..|+|||++.+ .++.++||||||+++|+|+||..||.... .......+.. ...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~-~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT-EQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCh
Confidence 7653321 123457889999998754 37889999999999999999999997633 3222111111 1000
Q ss_pred C---------------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 A---------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ~---------------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
. ......++.+++||.+||. +|.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0011235678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.64 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=200.7
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
.+.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|++++++++||||+++++++.+. ...++||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEE
Confidence 4568899999999999999999999999998765322 23345678899999999999999999988655 5688999
Q ss_pred ecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 160 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||+. ++|.+++.... .+++..++.++.|++.||+|||+++ ++||||+|+||+++. .+.++|+|||++......
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccCCCc
Confidence 9995 69999988766 6899999999999999999999998 999999999999986 479999999998655322
Q ss_pred -CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC---------------
Q 005017 237 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------------- 298 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--------------- 298 (719)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||.......+..+.......
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1233457899999998754 3688999999999999999999999764333332222111000
Q ss_pred -----------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 -----------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 -----------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
........++.+.++|.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123345789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.34 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=202.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEE
Confidence 366789999999999999999989999999987643321 23456788999999999999999999988644 56899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
|+||+.+++|..+......+++..++.++.||+.||.|||+.+ |+||||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc
Confidence 9999999999988776667999999999999999999999998 9999999999999855 79999999998765432
Q ss_pred -CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH--c----------------
Q 005017 237 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--S---------------- 295 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~--~---------------- 295 (719)
......++..|+|||++.+ .++.++||||||+++|||++|+.||.............. .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2234568899999998754 478899999999999999999999975433222211110 0
Q ss_pred -CC-CCC--------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 296 -GI-KPA--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 296 -g~-~p~--------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+. .+. ......+..+++|+.+||. +|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 000 0012346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.61 Aligned_cols=254 Identities=31% Similarity=0.485 Sum_probs=199.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcC--CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~--~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
|.+.+.||+|+||.||+|.+.. +|..||+|.+..... ......+.+.+|+.++++++||||+++++++.+.....++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5677889999999999999988 899999999886432 1123346678899999999999999999999877557799
Q ss_pred EEEecccCCChhHHhhhc-----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC---CCCcEEEeecc
Q 005017 157 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLG 228 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~---~~G~vKL~DFG 228 (719)
+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ..|.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 676665432 36899999999999999999999999 999999999999985 14799999999
Q ss_pred hhhhccCCC-----cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHH--------HHHHHH
Q 005017 229 LAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------QIFKKV 293 (719)
Q Consensus 229 lA~~~~~~~-----~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~--------~i~~~i 293 (719)
++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||....... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 987654322 234568999999997754 47899999999999999999999997532211 000000
Q ss_pred Hc------------------------CCCCCccc-----------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 294 TS------------------------GIKPASLA-----------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 294 ~~------------------------g~~p~~~~-----------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.. ........ ...+..+.++|.+||. +|.+|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000000 1456789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=369.67 Aligned_cols=261 Identities=21% Similarity=0.369 Sum_probs=225.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.++||+|+||.|..++++.+++.||+|+++.-.+.. ......|..|-.+|..-+.+-||.++..|.++ .++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE--RYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cce
Confidence 344667789999999999999999999999999998644443 23456788899999999999999999888654 679
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+||||++||+|-..+.+..+++++-++.++..|+.||.-||+.| +|||||||+|||||.. |++||+|||.+..+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCC
Confidence 999999999999999999999999999999999999999999999 9999999999999855 8999999999877764
Q ss_pred C-C--cccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--c
Q 005017 236 P-T--ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--K 304 (719)
Q Consensus 236 ~-~--~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~ 304 (719)
+ . ....+|||.|++||++. +.|++.+|+||+||++|||+.|..||+. .+....|.+|........+| .
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCccc
Confidence 3 2 34568999999999874 3589999999999999999999999987 56777788887654333333 3
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---HHHHHcCccCccccCCC
Q 005017 305 VNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~dP~~RpS---a~eLL~hpf~~~~~~~~ 343 (719)
..++++++||.+.+.+|..|.. +.++-.||||....|..
T Consensus 307 ~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred ccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhh
Confidence 3689999999999999999888 99999999999999854
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.58 Aligned_cols=249 Identities=31% Similarity=0.522 Sum_probs=207.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+|..||+|.++...... ....+.+.+|++++++++|+||+++++++... ...++
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~l 79 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNI 79 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEE
Confidence 5788899999999999999999999999999987544322 34467889999999999999999999998765 45889
Q ss_pred EEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 158 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
||||+++|+|..++.. ...+++..++.|+.|++.||.|||+++ |+||||||+||+++.+ |.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceeeec
Confidence 9999999999998864 245899999999999999999999999 9999999999999855 79999999998765
Q ss_pred cCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCCChH
Q 005017 234 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... +.......+..+..++......+..
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred cCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 4322 234568999999998754 58899999999999999999999996432 3344555555555544444456779
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++|.+||. +|.+|||+.+|++
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999998 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.73 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=207.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC--CCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKK 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~--~~~ 153 (719)
++.|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+|++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 3667888999999999999999999999999999875422 123456788899999999999999999877543 234
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 6889999995 689999987788999999999999999999999999 9999999999999855 79999999998655
Q ss_pred cCCC------cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC-----
Q 005017 234 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK----- 298 (719)
Q Consensus 234 ~~~~------~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~----- 298 (719)
.... .....|+..|+|||++.. .++.++||||||+++|||++|+.||.......++ ..+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhh
Confidence 3221 124478999999998753 4889999999999999999999999764332221 11110 000
Q ss_pred -------------------CC---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 299 -------------------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 299 -------------------p~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+. ......++.++++|.+||+ +|.+||++.+++.||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00 0112347889999999998 899999999999999998544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.26 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=212.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||++.+..+|..+|+|.+...... .....++.+|+.++++++||||+++++++... ...++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEE
Confidence 56788999999999999999999999999998754432 34456788999999999999999999988765 568899
Q ss_pred EecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 159 TELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.+ +.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~ 154 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLK 154 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhc
Confidence 999999999999876 356899999999999999999999999 9999999999999864 799999999998776
Q ss_pred CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
........|++.|+|||.+.+ .++.++|+||||+++|+|++|+.||... +.......+..+..+. .....+.+++++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08530 155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNF 232 (256)
T ss_pred cCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHH
Confidence 555455678999999998754 4788999999999999999999999874 4555555555554433 333567899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||. +|.+||++.++++||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.37 Aligned_cols=253 Identities=29% Similarity=0.515 Sum_probs=209.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 80 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWII 80 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEE
Confidence 344577999999999999999999999999887543 234567889999999999999999999988765 468999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
|||+++|+|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCCcc
Confidence 999999999999875 46899999999999999999999999 9999999999999855 699999999986554322
Q ss_pred -cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 238 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
.....++..|+|||++.+ .++.++|+||||+++|||+||..||... .+......+..+ .++......+..+.++|.
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKN-NPPTLTGEFSKPFKEFID 234 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcC-CCCCCchhhhHHHHHHHH
Confidence 234468889999998754 5789999999999999999999999874 344444433333 233444556788999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+||. +|.+||++.++++||||.....+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHcccCcccCcCHHHHHhChHhhhcchh
Confidence 9998 89999999999999999755443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.57 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=201.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---K 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---~ 152 (719)
++.|.+.+.||+|+||.||+|.+..+|..||+|++.... ......++.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 456788999999999999999999999999999986422 1234567889999999999999999998765433 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++|+||+.+ +|.+++. .+.+++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccceee
Confidence 357899999965 8887775 356899999999999999999999999 9999999999999855 7999999999865
Q ss_pred ccCCC-----cccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CC-----
Q 005017 233 MQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GI----- 297 (719)
Q Consensus 233 ~~~~~-----~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~----- 297 (719)
..... .....||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+...... ...+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHH
Confidence 53221 12357899999999764 3588999999999999999999999976332211 111100 00
Q ss_pred --------------CC----C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 298 --------------KP----A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 298 --------------~p----~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+ . ......++++.+||.+||. +|.+|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0 0112246789999999998 89999999999999999843
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=316.14 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=204.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.+.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.++++++||||+++++++... ..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 78 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 78 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcE
Confidence 45778899999999999999999999999999876332 3456788999999999999999999988654 4588
Q ss_pred EEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCccccccc
Confidence 999999999999998753 35899999999999999999999998 9999999999999854 799999999987665
Q ss_pred CCCcc---cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~~~---~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
..... ...+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .+....+..+..+..+ ..+...+++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPK 233 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 43221 123456899999876 458899999999999999998 8999976 4566666666665433 344556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.++|.+||. +|.+||++.++++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.17 Aligned_cols=248 Identities=20% Similarity=0.341 Sum_probs=201.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
|++.++||+|+||.||+|.+..+ +..||+|.++.... .......+.+|+..++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 35678999999999999987653 47899999875432 23456788999999999999999999998765432
Q ss_pred -CceeEEEecccCCChhHHhhhc------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 153 -KTVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 153 -~~l~lV~Ey~~gGsL~~~L~~~------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
...++|+||+++|+|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEEC
Confidence 3478999999999999988532 35899999999999999999999998 9999999999999855 699999
Q ss_pred ecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 005017 226 DLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 226 DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
|||+++...... .....++..|+|||.+.. .++.++|||||||++|||++ |..||.+ ....+.++.+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999987654322 112235678999998764 58999999999999999999 8899976 4455666666655433
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+...++.+.+++.+||+ +|.+|||+.+++++
T Consensus 235 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 -KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445677899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=332.87 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=205.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
++.|++.+.||+|+||+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4467788899999999999999999999999999874321 22334667889999999999999999998765432
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 35789999995 689999988888999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC--CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---C---------
Q 005017 233 MQQP--TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---G--------- 296 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g--------- 296 (719)
.... ......++..|+|||.+. ..++.++|||||||++|+|++|+.||.... .......+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhc
Confidence 5432 223456899999999775 358899999999999999999999997532 2111111100 0
Q ss_pred ---------------CCC--CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 297 ---------------IKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 297 ---------------~~p--~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
..+ .......++.++++|.+||. +|.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01122456889999999998 89999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.45 Aligned_cols=249 Identities=29% Similarity=0.513 Sum_probs=206.1
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
..+.||+|+||.||+|.+..+|..||+|.+..... ....+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIME 82 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEEE
Confidence 44679999999999999999999999998864431 24457889999999999999999999988654 45889999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--c
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 238 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--~ 238 (719)
|+++++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccCcchhh
Confidence 9999999998865 46899999999999999999999998 9999999999999854 799999999987654322 2
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 239 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
....|+..|+|||.+.+ .++.++|||||||++|||+||..||... .+......+..+. +..+....+..+.++|.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHHHHH
Confidence 23468899999998865 5788999999999999999999999763 3334333333332 3334445677899999999
Q ss_pred cC-CCCCCCCHHHHHcCccCcccc
Q 005017 318 LV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 318 L~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|. +|.+||++.++++||||....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 237 LNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ccCCcccCcCHHHHHHhHHHHHHh
Confidence 98 899999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.41 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=210.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
|++.+.||+|+||.||+|.+. .+|..||+|+++...........+++.+|+.+|+++ +|+||+++++.+... ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--Ce
Confidence 567889999999999999874 478999999987544333334457788999999999 599999999887654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 8899999999999999988888999999999999999999999999 9999999999999865 799999999987654
Q ss_pred CCC---cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHHcCCCCCccccC
Q 005017 235 QPT---ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 235 ~~~---~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~ 305 (719)
... .....|+..|+|||.+.. .++.++||||||+++|+|+||..||.... ....+...+..... .++..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCcc
Confidence 321 234568999999998753 46889999999999999999999996422 22333333333322 23455
Q ss_pred CChHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 306 NDPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
.++.+.+++.+||. +|.+|| ++.+++.||||+..++.
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 77899999999998 899997 89999999999987753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=333.54 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=203.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
+..|.+.+.||.|+||.||+|.++.+|..||+|++..... ...+.+.+|++++++++||||+++++.+.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 4667888999999999999999999999999999876542 345678899999999999999999987654332
Q ss_pred ---------CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 153 ---------KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 153 ---------~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
..+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 34789999997 589888864 46899999999999999999999999 999999999999986666899
Q ss_pred EeecchhhhccCCC-----cccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC
Q 005017 224 IGDLGLAIAMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296 (719)
Q Consensus 224 L~DFGlA~~~~~~~-----~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g 296 (719)
|+|||++....... .....|+..|+|||++. ..++.++|||||||++|+|++|+.||....... ....+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 99999987653221 12235788999999764 347889999999999999999999997643322 22222111
Q ss_pred C------------------------CC----CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 297 I------------------------KP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 297 ~------------------------~p----~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
. .+ .......+.++++||.+||. +|.+|||+.++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 00 00112356789999999998 8999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.04 Aligned_cols=249 Identities=33% Similarity=0.573 Sum_probs=211.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|++|.||+|.+..++..|++|.+...... ....+.+.+|++++++++|||++++++++... ..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEE
Confidence 56789999999999999999999999999999765432 34567899999999999999999999987654 568899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.+ |.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCcc
Confidence 999999999999988888999999999999999999999999 9999999999999864 7999999999976654332
Q ss_pred --ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 239 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 239 --~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
....++..|+|||...+ .++.++||||||+++|+|++|..||........... ...... ..++...+..++++|.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDH-PPLPEGISPELKDFLM 232 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCC-CCCCCCCCHHHHHHHH
Confidence 34578999999998754 478899999999999999999999987443333333 332222 2345556789999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccC
Q 005017 316 KCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+||. +|.+||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9998 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=319.33 Aligned_cols=250 Identities=31% Similarity=0.522 Sum_probs=208.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++||||+++++++... ..+++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEE
Confidence 4456789999999999999998999999998764332 34456788999999999999999999998765 458899
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-- 236 (719)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.+ |.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence 999999999999875 46899999999999999999999999 9999999999999855 79999999998655432
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
......|+..|+|||.+.. .++.++|+|||||++|+|++|..||.. .........+..+. +..+....+.++.++|.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHH
Confidence 1234568899999998764 578899999999999999999999976 34444444444432 33345556789999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCccc
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+||. +|.+||++.++++||||...
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhh
Confidence 9997 89999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.24 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=202.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
+.|.+.+.||+|+||.||+|.+. .++..||+|.++... .....+.+.+|+++|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-
Confidence 44667789999999999999874 346789999886432 123457899999999999999999999988765
Q ss_pred CCceeEEEecccCCChhHHhhhc--------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH--------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~--------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
...++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~ 157 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGY 157 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcC
Confidence 4689999999999999998754 24788899999999999999999999 999999999999986
Q ss_pred CCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 291 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~ 291 (719)
+ +.+||+|||++....... .....+++.|+|||++. +.++.++|||||||++|||++ |..||... +......
T Consensus 158 ~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~ 235 (280)
T cd05049 158 D-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIE 235 (280)
T ss_pred C-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHH
Confidence 5 799999999986543221 22344678999999876 458999999999999999999 99999874 4566666
Q ss_pred HHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 292 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 292 ~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+..+..+. .+...+..+++++.+||. +|.+||++.|+++
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666655433 334567899999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.61 Aligned_cols=240 Identities=21% Similarity=0.363 Sum_probs=195.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|++++++++||||+++++++... ..+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEeec
Confidence 36999999999999999999999999875322 234457789999999999999999999988654 4588999999
Q ss_pred cCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCccc-
Q 005017 163 TSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS- 240 (719)
Q Consensus 163 ~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~- 240 (719)
++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++..........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence 999999998764 35899999999999999999999999 9999999999999855 699999999987544322111
Q ss_pred ---ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 241 ---VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 241 ---~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
..++..|+|||.+.+ .++.++||||||+++|||++ |..||... ........+..... ...+...+..+.+++.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHHHH
Confidence 122457999998764 58899999999999999998 88888763 34444444444333 2345566789999999
Q ss_pred HhcC-CCCCCCCHHHHHc
Q 005017 316 KCLV-PASERLSAKDLLK 332 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~ 332 (719)
+||. +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.42 Aligned_cols=249 Identities=30% Similarity=0.525 Sum_probs=205.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|.+..+|..+|+|.+....... ......+.+|+.+++.++||||+++++++...+ .+++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeEeCC--eEEE
Confidence 3566788999999999999999999999999887544322 344578889999999999999999999887654 5889
Q ss_pred EEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 158 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhcc
Confidence 9999999999998863 345899999999999999999999999 9999999999999855 69999999998765
Q ss_pred cCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCCChH
Q 005017 234 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ......+.+.....+.......++.
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred ccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 4332 234578999999998754 58889999999999999999999996532 2234445555544444444557789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++|.+||. +|.+|||+.++++
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999998 8999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.50 Aligned_cols=238 Identities=23% Similarity=0.342 Sum_probs=191.6
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEeccc
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFT 163 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey~~ 163 (719)
||+|+||.||++.++.+|..+|+|.+....... .|+.....+ +||||+++++.+...+ .+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCC
Confidence 699999999999999999999999987543211 122222222 7999999999987654 6899999999
Q ss_pred CCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccC
Q 005017 164 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243 (719)
Q Consensus 164 gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~G 243 (719)
+|+|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...... ....|
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 168 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDG 168 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCC
Confidence 9999999988878999999999999999999999999 9999999999999866448999999998765432 23468
Q ss_pred CCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHH-HHHHHHcCCCCCccccCCChHHHHHHHHhcC-C
Q 005017 244 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 244 T~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~-i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-d 320 (719)
++.|+|||++.+ .++.++||||||+++|+|++|+.||........ ..........+.......++.+++||.+||+ +
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccC
Confidence 999999998864 588999999999999999999999975332211 1111111122333445678999999999998 8
Q ss_pred CCCCCC-HHHHHcCccCc
Q 005017 321 ASERLS-AKDLLKDPFLQ 337 (719)
Q Consensus 321 P~~RpS-a~eLL~hpf~~ 337 (719)
|.+||+ ++++|+||||.
T Consensus 249 p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 249 INYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hhhCCchHHHHhcCCccc
Confidence 999996 59999999996
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.71 Aligned_cols=249 Identities=22% Similarity=0.374 Sum_probs=200.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
....|++.+.||+|+||.||+|.+. .++..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4456888999999999999999764 245789999875332 22345678899999999999999999998754
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc----------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~----------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~ 219 (719)
. ...++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 81 ~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~- 155 (277)
T cd05062 81 G--QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED- 155 (277)
T ss_pred C--CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-
Confidence 4 46889999999999999986532 2577889999999999999999998 9999999999999865
Q ss_pred CcEEEeecchhhhccCCCc----ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHH
Q 005017 220 GEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 293 (719)
Q Consensus 220 G~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i 293 (719)
+.+||+|||++........ ....+++.|||||++.+ .++.++|||||||++|||++ |..||.+ .+.....+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 7999999999875433211 12345788999998764 58999999999999999999 6889976 4555555555
Q ss_pred HcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 294 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 294 ~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 554332 2344567789999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.84 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=203.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
.+..|.+.+.||+|+||+||++.+ ..++..+|+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 345688899999999999999975 3356678998876332 3456778999999999999999999998865
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc-------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK-------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~-------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~ 216 (719)
. ..+++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ ++||||||+||+++
T Consensus 79 ~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~ 154 (288)
T cd05093 79 G--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG 154 (288)
T ss_pred C--CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 4 45889999999999999987543 4899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHH
Q 005017 217 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 290 (719)
Q Consensus 217 ~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~ 290 (719)
.+ +.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|+| |..||... ......
T Consensus 155 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~ 232 (288)
T cd05093 155 EN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVI 232 (288)
T ss_pred cC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence 55 799999999987553321 12334577899999876 458999999999999999999 89999763 455666
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+..+. .....++++.+++.+||. +|.+|||+.+++.
T Consensus 233 ~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 233 ECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6776665432 344567899999999998 8999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.66 Aligned_cols=250 Identities=20% Similarity=0.348 Sum_probs=202.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
.++.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45668888999999999999999887 77889999876432 12344678899999999999999999998865
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc-------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CC
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HG 220 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~-------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G 220 (719)
.+ ..++||||+.+|+|.+++...+ .+++..+..++.||+.||+|||+++ ++||||||+||+++.+ ..
T Consensus 81 ~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 RL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred CC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCc
Confidence 54 4788999999999999987653 4889999999999999999999999 9999999999999743 23
Q ss_pred cEEEeecchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHH
Q 005017 221 EVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~ 294 (719)
.+||+|||+++....... ....+++.|+|||++. ..++.++|||||||++|||++ |..||... ....+...+.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~ 235 (277)
T cd05036 157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVT 235 (277)
T ss_pred ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH
Confidence 699999999976533211 1223356899999875 458999999999999999997 99999863 4455555555
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....+ ..+...++.+.+++.+||+ +|.+||++.++++|
T Consensus 236 ~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 GGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 44332 3345567899999999998 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.89 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=201.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeec
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD 149 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~ 149 (719)
++.|++.++||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 346788899999999999999743 345789999886432 123456788999999999 89999999998765
Q ss_pred CCCCceeEEEecccCCChhHHhhhc-------------------------------------------------------
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH------------------------------------------------------- 174 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~------------------------------------------------------- 174 (719)
.+ ..+++++||+++|+|.+++...
T Consensus 83 ~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 PG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred CC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 43 4688999999999999988542
Q ss_pred ------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC----cccccCC
Q 005017 175 ------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGT 244 (719)
Q Consensus 175 ------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT 244 (719)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..+.... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCC
Confidence 25788999999999999999999998 9999999999999865 699999999997653321 1234567
Q ss_pred CCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CC
Q 005017 245 PEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PA 321 (719)
Q Consensus 245 ~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP 321 (719)
..|+|||++. ..++.++|||||||++|||++ |..||............+..+..+ ..+...++++.+++.+||+ +|
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCCh
Confidence 7899999775 569999999999999999998 999997644334444444444332 3345567899999999998 89
Q ss_pred CCCCCHHHHHcC
Q 005017 322 SERLSAKDLLKD 333 (719)
Q Consensus 322 ~~RpSa~eLL~h 333 (719)
.+||++.+|++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.30 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=203.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||+|+||.||+|.+..+|..+|+|.+.... ........+.+|+.++++++|||++++++++.......+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 356788999999999999999999999999998653 122344678899999999999999999999876644679999
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
+||+++ +|..++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.+ |.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 999975 898888765 57999999999999999999999999 9999999999999855 799999999997665432
Q ss_pred ---cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC---CC---------
Q 005017 238 ---ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PA--------- 300 (719)
Q Consensus 238 ---~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~---p~--------- 300 (719)
.....++..|+|||.+.+ .++.++||||||+++|||+||+.||.... .......+..... +.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST-ELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCchhhccccccch
Confidence 233457889999997653 47899999999999999999999998744 3333222221100 00
Q ss_pred -----------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 301 -----------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 301 -----------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111236789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.82 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=201.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..+++.+.||+|+||+||+|... ..+..||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--
Confidence 34678899999999999999853 456789999886432 234557788999999999999999999987654
Q ss_pred CceeEEEecccCCChhHHhhhc-----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 153 KTVNMITELFTSGNLRQYRKKH-----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~-----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 4588999999999999998532 23788889999999999999999999 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHH
Q 005017 216 NGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 289 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i 289 (719)
+.+ +.+||+|||+++...... .....++..|+|||++. ..++.++||||||+++|||++ |..||.+ .....+
T Consensus 158 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~ 235 (283)
T cd05090 158 GEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEV 235 (283)
T ss_pred cCC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 855 689999999997653321 22344677899999876 458999999999999999998 8899976 345566
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...+.....+ ..+...++.+++++.+||. +|.+||++.+|+++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6666655433 3455678899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=318.98 Aligned_cols=250 Identities=29% Similarity=0.481 Sum_probs=209.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|.+.+.||+|+||.||+|.+..+|..||+|++....... ....+.+.+|+.++++++ ||||+++++.+... ..++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEE
Confidence 4677899999999999999999999999999987543322 334577889999999998 99999999987544 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+.+++|.+++.+.+.+++..++.|+.|++.||.|||+++ ++|+||+|+||+++.+ |.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCc
Confidence 99999999999999998888999999999999999999999999 9999999999999854 79999999998755432
Q ss_pred C----------------------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 005017 237 T----------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293 (719)
Q Consensus 237 ~----------------------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i 293 (719)
. .....|+..|+|||++.. .++.++||||||+++++|++|+.||.... ....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHH
Confidence 2 123457899999998754 57889999999999999999999998743 44444554
Q ss_pred HcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCH----HHHHcCccC
Q 005017 294 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA----KDLLKDPFL 336 (719)
Q Consensus 294 ~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa----~eLL~hpf~ 336 (719)
..... .++...++.+.+||.+||. +|.+||++ .+||+||||
T Consensus 235 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 LKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 43222 2334457899999999998 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.67 Aligned_cols=244 Identities=24% Similarity=0.423 Sum_probs=201.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+... ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPI 76 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCc
Confidence 456888999999999999999865 66789999876432 2357789999999999999999999987554 458
Q ss_pred eEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCccceec
Confidence 8999999999999998753 45888999999999999999999998 9999999999999855 79999999999765
Q ss_pred cCCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... ....++..|+|||++. +.++.++|||||||++|+|+| |..||.. .........+..+...+ .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPD 231 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence 43221 2234567899999876 458889999999999999998 9999976 44556666666554333 2345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.+++.+||. +|.+||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.64 Aligned_cols=239 Identities=24% Similarity=0.354 Sum_probs=199.1
Q ss_pred EEeeeCCeEEEEEEE--cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 84 VLGKGAFKTVYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d--~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.||+|+||.||+|.+ ..++..+|+|+++... ......+.+..|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence 589999999999964 4578899999886443 223456788999999999999999999997642 346889999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc---
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--- 238 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~--- 238 (719)
+++|+|.+++...+.+++..+..++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999999 9999999999999865 6999999999976543321
Q ss_pred --ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 239 --RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 239 --~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
....+++.|+|||.+.. .++.++|||||||++|||+| |..||.. .+...+...+..+..+ ..+...+++++++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 12234678999998764 58889999999999999998 9999976 4566677777766543 34556788999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 005017 315 EKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~ 332 (719)
.+||+ +|.+||++.+|.+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.90 Aligned_cols=242 Identities=21% Similarity=0.393 Sum_probs=199.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||.||+|..+ .+..+|+|.+.... .....+.+|+.+|++++||||+++++++... ..+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i 76 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYI 76 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEE
Confidence 4677789999999999999765 56689999876432 2235788999999999999999999988654 45889
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCC
Confidence 99999999999998753 46899999999999999999999999 9999999999999855 69999999998765332
Q ss_pred Cc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 ~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. ....++..|+|||++. ..++.++||||||+++|||++ |+.||.. .+..+....+..+..+. .+...++.+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~ 231 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASMTVY 231 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHH
Confidence 21 1223556899999886 458899999999999999999 8999976 45566677777664432 3445678899
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 005017 312 GFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++.+||. +|.+||++.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.49 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=208.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKK 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~ 152 (719)
..|+.|.+.+.||+||-+.||++... +...||+|++.... ...+.+..+.+|+.+|.+|+ |.+||++|+|-+.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-- 432 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-- 432 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--
Confidence 36788888899999999999999654 44567777766443 23567889999999999995 89999999987764
Q ss_pred CceeEEEecccCCChhHHhhhcccccH-HHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDI-KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~-~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.++||||||-+. +|..+|++.....+ -.++.+..|++.|+.++|.+| |||.||||.|+|+- .|.+||+|||.|.
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIAN 507 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhc
Confidence 579999999754 99999988765433 478889999999999999999 99999999999986 3799999999998
Q ss_pred hccCCCc----ccccCCCCCCCcccccc------------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc
Q 005017 232 AMQQPTA----RSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 232 ~~~~~~~----~~~~GT~~YmAPEvl~~------------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~ 295 (719)
.+..+++ .+-+||+.||+||.+.. +.++++||||||||||+|+.|+.||....+....+..|..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 8877654 35589999999997631 2568999999999999999999999876555555555554
Q ss_pred CCCCCccccCCChH-HHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 296 GIKPASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 296 g~~p~~~~~~~~~~-l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
-.....++....+. +.++++.||. ||.+|||+.+||+|||++.
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 33333455554444 9999999998 9999999999999999984
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.65 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=198.7
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.+||+++.+.||+|+||+||++. ...++..||+|.++... .......+.+|+++|++++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 35788899999999999998764 34578899999886442 123456788999999999999999999988766
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
....+++||||+.+|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccc
Confidence 666789999999999999999764 5999999999999999999999999 9999999999999865 69999999998
Q ss_pred hhccCCCc-----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHH--------------HH
Q 005017 231 IAMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--------------IF 290 (719)
Q Consensus 231 ~~~~~~~~-----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~--------------i~ 290 (719)
........ ....++..|+|||.+. ..++.++||||||+++|||+||..||........ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 76543221 1234566799999876 4589999999999999999999999864321110 01
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+.. ...+...+.++++++.+||. +|++|||+++++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111 11234457899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.53 Aligned_cols=254 Identities=28% Similarity=0.390 Sum_probs=198.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
-..|.+.+.||+|+||.||+|.+..+|..||+|++....... .....+.+|++++++++||||+++++.+.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 356788899999999999999999999999999987643221 223456789999999999999999998765432
Q ss_pred ---CceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 153 ---KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 153 ---~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
..+++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcCc
Confidence 357899999975 66666554 457999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCCC-------------cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 005017 229 LAIAMQQPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293 (719)
Q Consensus 229 lA~~~~~~~-------------~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i 293 (719)
++....... .....|++.|+|||++.+ .++.++|||||||++|||++|+.||.+... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 987543221 123457889999998753 478999999999999999999999976333 2222222
Q ss_pred Hc---CCCC----------------------Ccc---ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 294 TS---GIKP----------------------ASL---AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 294 ~~---g~~p----------------------~~~---~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.. ...+ ..+ .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 11 0000 000 01223678899999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.43 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=223.0
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..-..|.+...||+|.|++|.+|.+..+|.+||+|.+..... ....++++.+|+++|+.|+|||||++|.+.... .
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~ 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--A 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--c
Confidence 344567888999999999999999999999999998875543 235567799999999999999999999977544 5
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+||||+.+|.+++|+.+++++.+..++.++.|+.+|++|||+++ |+|||||++||||+.+. ++||+|||++..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~m-nikIaDfgfS~~~ 205 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENM-NIKIADFGFSTFF 205 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccccc-ceeeeccccceee
Confidence 69999999999999999999999999999999999999999999999 99999999999999876 8999999999877
Q ss_pred cCC-CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
... ...+.+|+|.|.|||++.+. | ++.+|+||+|+++|-|+.|..||.+ .+...+-..+..+.... +...+.++
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~ms~dc 282 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYMSCDC 282 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--cceeechh
Confidence 643 46789999999999999864 4 6899999999999999999999987 44445555555554433 33345689
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+++|.++|. +|.+|++.+++.+|.|.......
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999998 89999999999999999865544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.70 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=204.7
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
...+.||+|+||+||+|.+..+|..||+|.+...... .....+.+.+|+++++.++|||++++++++.+. ...|+||
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 100 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVM 100 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEE
Confidence 3446799999999999999999999999998754332 234456788999999999999999999988765 4588999
Q ss_pred ecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 160 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 160 Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.+||+|||++..... .
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~~~~~~--~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASKSSP--A 174 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCCcccCC--C
Confidence 9996 577777654 456899999999999999999999999 9999999999999855 6999999998854322 2
Q ss_pred ccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 239 RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
....|++.|+|||++. +.++.++||||||+++|+|++|..||......... ..+.....+.......+..+++||
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCHHHHHHH
Confidence 3457899999999873 45888999999999999999999999874433333 334333334333445567899999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+||. +|.+||++.++++||||+...
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99998 899999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.90 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=202.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..|.+.++||+|+||.||+|.++. .+..||+|.++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 456788999999999999997652 35689999876432 123445678899999999999999999987654
Q ss_pred CCceeEEEecccCCChhHHhhhc----------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 221 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~----------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~ 221 (719)
...++||||+++|+|.+++.+. ...+...+..++.||+.||.|||+++ |+||||||+||+++.+ +.
T Consensus 82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~~ 157 (288)
T cd05061 82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-FT 157 (288)
T ss_pred -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-Cc
Confidence 3588999999999999999753 23466788999999999999999999 9999999999999865 79
Q ss_pred EEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 222 VKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 222 vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||++ |..||.. ....+..+.+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence 9999999987543221 12234567899999876 458999999999999999999 7889976 445566666655
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc------CccCcccc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVEN 340 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~------hpf~~~~~ 340 (719)
+..+. .+...++.+++++.+||. +|.+|||+.++++ ||||+...
T Consensus 237 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 237 GGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 43332 234456899999999998 8999999999987 89887543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.13 Aligned_cols=244 Identities=23% Similarity=0.408 Sum_probs=200.8
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...+++.+.||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCe
Confidence 456788999999999999999875 567899999875432 246688999999999999999999987654 458
Q ss_pred eEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEc
Confidence 89999999999999997654 6899999999999999999999999 9999999999999855 79999999999766
Q ss_pred cCCCcccccC---CCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTARSVIG---TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~~~~~G---T~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
.........| +..|+|||++.. .++.++||||||+++|||+| |+.||.. .+.......+...... ..+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG-MTNAEVLQQVDQGYRM-PCPPGCPK 231 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCH
Confidence 5432222223 357999998764 58999999999999999999 9999976 4455566666554332 23345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+++++.+||. +|.+||++.+|++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.23 Aligned_cols=239 Identities=23% Similarity=0.395 Sum_probs=197.6
Q ss_pred EEEeeeCCeEEEEEEEcCCC---eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g---~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
++||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.+.||||+++++++.. ..+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence 36999999999999876554 78999988754422 355778999999999999999999997642 3478999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcc
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~ 239 (719)
||+.+|+|.+++.+.+.+++..+..|+.|++.||+|||.++ ++||||||+|||++.+ +.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999999 9999999999999855 79999999999765433211
Q ss_pred -----cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 240 -----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 240 -----~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||... +..+....+..+.. ...+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 112346799999876 458999999999999999998 99999874 45566666665543 2344556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 005017 313 FIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+|.+||. +|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.99 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=205.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
..|.+.+.||+|+||.||+|.+..+|..+|+|++..... .......+.+|+.+++++ +||||+++++++...+...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456677899999999999999998999999998864321 123445677899999999 99999999998876666678
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+. ++|..++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhcccc
Confidence 99999997 5999988765 7888999999999999999999999 9999999999999855 7999999999875533
Q ss_pred C-------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---------
Q 005017 236 P-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--------- 297 (719)
Q Consensus 236 ~-------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~--------- 297 (719)
. ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||..........+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2 2234568999999997743 478899999999999999999999976443332221111100
Q ss_pred -------------------CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 -------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 -------------------~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.........+.++.++|.+||. +|.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0011112257789999999998 899999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.61 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=201.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
...|.+.++||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 4567888999999999999998777776 47889886432 234557788999999999999999999988642
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..++++||+++|+|.+++... +.+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~ 156 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLA 156 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCce
Confidence 467899999999999999764 46899999999999999999999999 9999999999999754 68999999999
Q ss_pred hhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 231 IAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 231 ~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
+....... ....+++.|+|||.+. ..++.++|||||||++|||+| |..||.. .....+...+..+..+. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~ 234 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPP 234 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCc
Confidence 76643221 1223467899999875 458999999999999999998 8999976 34555555555554332 344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..++.+.++|.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.93 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=201.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.+.|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 456788899999999999999753 355678888876432 23456788999999999999999999988654
Q ss_pred CCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 214 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NIL 214 (719)
...++||||+++++|.+++..+. .+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 155 (291)
T cd05094 80 --DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCL 155 (291)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence 45889999999999999987542 3789999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHH
Q 005017 215 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 288 (719)
Q Consensus 215 l~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~ 288 (719)
++.+ +.+||+|||++....... .....+++.|+|||.+. ..++.++||||||+++|||+| |..||.. .+...
T Consensus 156 ~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~ 233 (291)
T cd05094 156 VGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTE 233 (291)
T ss_pred EccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 9865 699999999987553321 23345688999999776 458899999999999999999 9999876 34555
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
....+..+..+. .....+..+++++.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 234 VIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 556665554433 344567889999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=329.00 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=197.5
Q ss_pred EEEeee--CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 83 EVLGKG--AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 83 e~LG~G--~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
+.||+| +||+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+ .+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--WLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--ceEEEEe
Confidence 346666 9999999999999999999998754322 345578899999999999999999999987654 5889999
Q ss_pred cccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-C
Q 005017 161 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 237 (719)
Q Consensus 161 y~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~ 237 (719)
|+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.+|++||+.+...... .
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence 99999999998764 35899999999999999999999998 9999999999999855 69999999865332211 0
Q ss_pred --------cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-C------
Q 005017 238 --------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P------ 299 (719)
Q Consensus 238 --------~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p------ 299 (719)
.....++..|+|||++.+ .++.++|||||||++|+|++|..||............+..... +
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 011234667999998864 3789999999999999999999999875544443332221100 0
Q ss_pred -------------------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 -------------------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 -------------------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00112245678999999998 999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.20 Aligned_cols=247 Identities=22% Similarity=0.401 Sum_probs=202.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.+.||+|+||+||+|.++.+ ...||+|.++... .......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--R 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--C
Confidence 3577889999999999999988654 4579999876432 234456788999999999999999999987654 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+++|+|.+++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~ 155 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRR 155 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhc
Confidence 588999999999999998764 46899999999999999999999999 9999999999999855 6999999999987
Q ss_pred ccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 233 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 233 ~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+...+ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 233 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRLP-PPMDC 233 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 64211 11223467899999876 458999999999999999998 99999764 4455566666553332 23456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++.+.+++.+||. +|.+||++.+++++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.04 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=201.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC-----CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~-----g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..|.+.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG- 81 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-
Confidence 3567889999999999999987644 4789999876432 223456788999999999999999999988655
Q ss_pred CCceeEEEecccCCChhHHhhhcc----------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 221 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~----------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~ 221 (719)
...++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~ 157 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LT 157 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CC
Confidence 45889999999999999986432 3678899999999999999999999 9999999999999865 79
Q ss_pred EEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 222 VKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 222 vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
+||+|||+++...... .....++..|+|||.+. +.++.++|||||||++|||+| |..||.. .+..+..+.+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhc
Confidence 9999999987654321 22345678999999875 458999999999999999998 8999976 456666666665
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+ ..+...+..+.++|.+||. +|.+|||+.+|+.
T Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4333 3344457899999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=334.84 Aligned_cols=262 Identities=25% Similarity=0.414 Sum_probs=219.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
+..+|+.-++||+||||.||-+..+.+|+.+|.|.+..+.... ........+|-.+|.+++.+.||.+-..|... ..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETK--DA 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--Cc
Confidence 3456777799999999999999999999999999887654433 33445667899999999999999997777544 56
Q ss_pred eeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++|+..|.||+|.-++.+.+ .+++..++.++.+|+.||++||..+ ||+|||||+|||+| ++|++.|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEe
Confidence 999999999999999998766 8999999999999999999999999 99999999999998 558999999999987
Q ss_pred ccCCCc-ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~~-~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---~~i~~~i~~g~~p~~~~~~~~ 307 (719)
+..... +..+||.+|||||++. +.|+...|.|||||++|||+.|+.||...... +++-+.+.. .+..++...+
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS 414 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFS 414 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccC
Confidence 765433 4448999999999986 46999999999999999999999999753221 223333332 3556677788
Q ss_pred hHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCCC
Q 005017 308 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~~ 344 (719)
++++++.+.+|. ||.+|. .+.++.+||||+..++...
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 999999999997 899887 5789999999999887654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.32 Aligned_cols=244 Identities=21% Similarity=0.389 Sum_probs=199.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceE
Confidence 34677889999999999999876 566899998763321 235688899999999999999999987544 4688
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++++|.+++..+ ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ |.+||+|||+++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccc
Confidence 999999999999998764 46899999999999999999999999 9999999999999855 7999999999876543
Q ss_pred CCccccc---CCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 236 PTARSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 236 ~~~~~~~---GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
....... ++..|+|||++. ..++.++||||||+++|+|+| |..||.. ....+....+..+..+ ..+...++++
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER-FSNSEVVESVSAGYRL-YRPKLAPTEV 230 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHH
Confidence 3222222 345799999876 468999999999999999999 7999976 3455666666655433 3345578899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+++.+||. +|.+|||+.++++.
T Consensus 231 ~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 231 YTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.85 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=200.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcE
Confidence 34678899999999999999765 455699998864322 236688999999999999999999988654 4588
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.+ +.+||+|||+++....
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCC
Confidence 999999999999998764 36899999999999999999999999 9999999999999855 6999999999875543
Q ss_pred CCccc---ccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 236 PTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 236 ~~~~~---~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
..... ..++..|+|||++. ..++.++|||||||++|+|+| |..||.. .+.......+..+..+ ..+...++.+
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLRL-YRPHLASEKV 230 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 32222 23456799999886 458999999999999999999 9999976 3455566666665443 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++++.+||. +|.+||++.+|+.+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.91 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=208.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---CCce
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTV 155 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---~~~l 155 (719)
|.+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++.... ...+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 677899999999999999999899999999887432 12345577899999999999999999999876653 2368
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+. ++|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeecc
Confidence 89999998 489999988778999999999999999999999999 9999999999999866 7999999999976654
Q ss_pred CC-----cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CC------
Q 005017 236 PT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA------ 300 (719)
Q Consensus 236 ~~-----~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~------ 300 (719)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ..+.+..+..... +.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhc
Confidence 32 334568999999998764 47899999999999999999999998743 3333333322110 00
Q ss_pred ---------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 301 ---------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 301 ---------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
......++.+.+||.+||. +|.+||++.++++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0011246789999999998 899999999999999998544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.02 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=198.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeE--EEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~--VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
..|.+.+.||+|+||.||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--C
Confidence 3567889999999999999998878765 466655421 1234557788999999999 899999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 154 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
.+++||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence 5899999999999999987532 4788999999999999999999999 999999999999985
Q ss_pred CCCcEEEeecchhhhccCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~ 294 (719)
+ +.+||+|||++....... .....++..|+|||++.+ .++.++|||||||++|||+| |..||.. .+..+.+..+.
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~ 237 (303)
T cd05088 160 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 237 (303)
T ss_pred C-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHh
Confidence 5 699999999985432111 112234668999998764 47899999999999999998 9999976 44555666665
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
.+..+. .+...++.+.++|.+||. +|.+||++.++|.+.
T Consensus 238 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 238 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 543222 233457899999999998 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.42 Aligned_cols=241 Identities=21% Similarity=0.328 Sum_probs=188.9
Q ss_pred EEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 84 VLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEEEEC
Confidence 5899999999999754 3567899998765431 23345788899999999999999999988654 458899999
Q ss_pred ccCCChhHHhhhcc-----cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 162 FTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 162 ~~gGsL~~~L~~~~-----~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+++|+|.+++.... ..++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccCc
Confidence 99999999987532 3567788899999999999999999 9999999999999865 69999999998654322
Q ss_pred C----cccccCCCCCCCcccccc--------ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCC---CC
Q 005017 237 T----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK---PA 300 (719)
Q Consensus 237 ~----~~~~~GT~~YmAPEvl~~--------~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~---p~ 300 (719)
. .....|++.|+|||++.. .++.++||||||+++|||++ |+.||............+..... .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 123457889999998753 25789999999999999996 99999875444333332322211 12
Q ss_pred ccccCCChHHHHHHHHhcCCCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~dP~~RpSa~eLL~ 332 (719)
......++.+++++++|+.+|.+|||+++|++
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22334567899999999989999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=341.08 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=205.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCe---E-EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGI---E-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~---~-VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
+.+.++||+|+||.||+|..+..+. . ||+|..+.... .....+.++.+|.++|++++|||||+|||+...+. .
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--P 235 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--P 235 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--c
Confidence 3456899999999999998776533 3 89998875322 23577889999999999999999999999887654 5
Q ss_pred eeEEEecccCCChhHHhhhccc-ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~-l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++|||+|.||+|.+||++.+. ++..+...++.+.+.||+|||+++ +|||||-.+|+|++.+ +.+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCccccccCC
Confidence 9999999999999999999875 999999999999999999999999 9999999999999855 47899999998765
Q ss_pred cCCCc-c-cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 234 QQPTA-R-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~~~-~-~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
..... . ...-...|+|||.+.. .|+.++|||||||++||+++ |..||.+ ....++..+|.....+...+...++.
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKE 391 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHH
Confidence 42211 1 1123468999998874 59999999999999999998 7889998 45667777884444444555577788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..++.+|+. +|..||++.++.+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHH
Confidence 9999999998 9999999999876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.83 Aligned_cols=240 Identities=28% Similarity=0.425 Sum_probs=198.2
Q ss_pred EEEeeeCCeEEEEEEEcC-CC--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEF-AG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~-~g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
++||+|++|.||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 468999999999998765 33 36999988755432 566789999999999999999999998876 5688999
Q ss_pred ecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 160 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence 9999999999997754 6899999999999999999999999 9999999999999866 799999999997664321
Q ss_pred -----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 238 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 238 -----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....++..|+|||.+.. .++.++|||||||++|+|++ |+.||... +..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 123457789999998764 68999999999999999999 99999763 45556555553322223334557899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+++.+||. +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.25 Aligned_cols=249 Identities=22% Similarity=0.434 Sum_probs=209.3
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEe
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
...||.|+-|+|+++..+.+|..+|||.+.... ...+.++++..+.++... ..|+||+.||+|+.+.. +++.||
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMe 171 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICME 171 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHH
Confidence 356999999999999999999999999997543 356678888888876665 48999999999987755 777889
Q ss_pred cccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 161 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 161 y~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
.|.. -+...+++ .+++++..+-++...+++||.||..+ + |||||+||+|||+| +.|++|+||||.+..+....+
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEc-cCCCEEeecccccceeecccc
Confidence 9843 34444443 45799999999999999999999865 6 99999999999998 458999999999987766554
Q ss_pred c-cccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc--cCCChHHH
Q 005017 239 R-SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIK 311 (719)
Q Consensus 239 ~-~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~--~~~~~~l~ 311 (719)
+ ...|-+.|||||.+. ..|+.++||||||+.++||+||++||.+|....+...++....+ +.++ ...++.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence 4 346899999999885 35999999999999999999999999999999999888888544 3333 23689999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+|+..||. |+.+||...+||+|||+....
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999998 899999999999999997443
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.44 Aligned_cols=243 Identities=26% Similarity=0.462 Sum_probs=206.9
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|+||.||++.+..+|..+|+|.+....... ......+..|+.++++++||||+++++.+... ..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEecCCC
Confidence 699999999999999899999999987654322 34567889999999999999999999887543 568999999999
Q ss_pred CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Cccccc
Q 005017 165 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 242 (719)
Q Consensus 165 GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~~~~ 242 (719)
++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence 999999998888999999999999999999999998 9999999999999855 79999999998765443 334567
Q ss_pred CCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-C
Q 005017 243 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 243 GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-d 320 (719)
++..|+|||...+ .++.++|+||||+++|+|++|..||.. .........+.... ..++...+..++++|.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 8999999998764 478899999999999999999999976 34455566655532 23445557899999999998 8
Q ss_pred CCCCCCH---HHHHcCccC
Q 005017 321 ASERLSA---KDLLKDPFL 336 (719)
Q Consensus 321 P~~RpSa---~eLL~hpf~ 336 (719)
|.+||++ .++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.16 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=206.1
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcC----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
..+..|.+.++||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 456778899999999999999999875 3578999987532 123456778999999999999999999998765
Q ss_pred CCCCceeEEEecccCCChhHHhhhc--------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 221 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~--------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~ 221 (719)
. ....+++++|+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.
T Consensus 80 ~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~ 155 (280)
T cd05043 80 D-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQ 155 (280)
T ss_pred C-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-Cc
Confidence 4 34678899999999999998653 35889999999999999999999999 9999999999999855 79
Q ss_pred EEEeecchhhhccCCCc----ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 222 VKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 222 vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
+||+|||+++.+..... ....++..|+|||++.. .++.++|||||||++|||++ |+.||.. .++..+...+..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~ 234 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKD 234 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHc
Confidence 99999999976543221 22345678999998764 58999999999999999999 9999987 466667766666
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+. .....++.+.+++.+||. +|++|||+.++++
T Consensus 235 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 54433 234457899999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.00 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=205.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC--
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-- 151 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~-- 151 (719)
.++.+|++.+.||+|||+-||++....++..+|+|++.... .+..+...+|++..++++|||+++++++.+.+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 36778899999999999999999999999999999998765 466788999999999999999999999876543
Q ss_pred -CCceeEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 152 -KKTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 152 -~~~l~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
....|+++.|...|||.+.+... ..+++..++.|+.+|++||.+||+..||++||||||.|||+.+ .|.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEe
Confidence 45799999999999999988653 2599999999999999999999999999999999999999985 47999999
Q ss_pred cchhhhccCCC-----------cccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCH-HHHH
Q 005017 227 LGLAIAMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIF 290 (719)
Q Consensus 227 FGlA~~~~~~~-----------~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~-~~i~ 290 (719)
||.++...-.. .....-|.-|+|||++.- ..++++|||||||++|.|+.|.-||...... ..+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99986542110 011235888999999863 4789999999999999999999999541100 0011
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
-.+..+.....-....+..+.++|+.||+ ||.+||++.+|+.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11112111111122367899999999998 99999999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.00 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=200.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeec
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVD 149 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~ 149 (719)
...|.+.++||+|+||.||+|.+.. .+..||+|+++... .....+.+.+|+++|+++. |||||+++++|..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3456788999999999999998643 34579999986442 1234567899999999996 9999999999865
Q ss_pred CCCCceeEEEecccCCChhHHhhhc-------------------------------------------------------
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH------------------------------------------------------- 174 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~------------------------------------------------------- 174 (719)
. ..+++||||+++|+|.+++...
T Consensus 113 ~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 113 S--GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred C--CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 4 4589999999999999987642
Q ss_pred -----------------------------------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcccee
Q 005017 175 -----------------------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 213 (719)
Q Consensus 175 -----------------------------------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NI 213 (719)
..+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence 23677888999999999999999999 99999999999
Q ss_pred EecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHH
Q 005017 214 FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPA 287 (719)
Q Consensus 214 Ll~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~ 287 (719)
|++.+ +.+||+|||+++...... .....+++.|+|||++. ..++.++|||||||++|||++ |..||.......
T Consensus 269 ll~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 269 LLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99865 699999999997653321 22345678899999875 458999999999999999997 899998754445
Q ss_pred HHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 288 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 288 ~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+..+..+. .+...++.+++++.+||. +|.+||++.+|.+
T Consensus 348 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 5556666554332 344567899999999998 8999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.47 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=213.5
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEEe
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
.++||+|+|+.|-.++...+|.++|||++.... .-...++.+|++++.+++ |+||+.++.+|.++. .+|+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEe
Confidence 578999999999999999999999999986432 345688999999999995 999999999987664 4899999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC--CcEEEeecchhhhccC---
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQQ--- 235 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~--G~vKL~DFGlA~~~~~--- 235 (719)
-|.||.|..++.+++.+++.++.++.+.|+.||.|||.+| |.||||||+|||....+ .-||||||.+......
T Consensus 157 Km~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999999999999999999999999999999999 99999999999986332 3589999998754321
Q ss_pred ------CCcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCC--------------HHHH
Q 005017 236 ------PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKN--------------PAQI 289 (719)
Q Consensus 236 ------~~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--------------~~~i 289 (719)
+...+.+|+..|||||+.. ..|+.++|.||||||+|-|+.|.+||.+.-. ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1223567999999999753 2489999999999999999999999964211 2357
Q ss_pred HHHHHcCCC--CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 290 FKKVTSGIK--PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 290 ~~~i~~g~~--p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+..|..|.. |..-+...+.+.+++|..+|. ++..|.+|.++++|||++.-..
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 888888864 555556678899999999997 8999999999999999986443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.85 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=206.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.||+|+||.||+|.+..+|..||+|.+...... .......+.+|++++++++|||++++++++.... ..++|
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 103 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLV 103 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEE
Confidence 55677899999999999999999999999998754332 2345567889999999999999999999887654 58899
Q ss_pred EecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.+||+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 999975 77777654 456899999999999999999999999 9999999999999855 7999999998865432
Q ss_pred cccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 238 ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.....|++.|+|||++. +.++.++|||||||++|+|++|+.||.... .......+..+..+.......++.++++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 23456899999999863 458899999999999999999999997743 3333444444434433444567889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|.+||. +|.+||++.++++|+|+....
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhccC
Confidence 999998 899999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.68 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=202.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~ 148 (719)
....|.+.+.||+|+||.||+|.+ ..++..||+|.++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 345688899999999999999975 33566899998764321 34457789999999999 7999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
.. ..+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|
T Consensus 110 ~~--~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~d 184 (302)
T cd05055 110 IG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKICD 184 (302)
T ss_pred cC--CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEECC
Confidence 55 45889999999999999987543 3899999999999999999999999 9999999999999855 6999999
Q ss_pred cchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 227 LGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 227 FGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
||++........ ....+++.|+|||.+. ..++.++|||||||++|||+| |..||..........+.+..+..+
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~- 263 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM- 263 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-
Confidence 999976543221 1234577899999775 458999999999999999998 999998755445555555544333
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+...++++++++.+||. +|.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3344567899999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.09 Aligned_cols=242 Identities=23% Similarity=0.391 Sum_probs=203.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
.+.+.+.+.||+|+||.||+|... |..||+|.++... ...+++.+|+.+++.++|+||+++++++.+. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCe
Confidence 456778899999999999999764 8899999987443 2457899999999999999999999988653 568
Q ss_pred eEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++.+ |.+||+|||.+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEccccccccc
Confidence 89999999999999998765 6899999999999999999999999 9999999999999855 79999999999766
Q ss_pred cCCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 234 QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
..... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.
T Consensus 153 ~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd05039 153 SQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVY 229 (256)
T ss_pred ccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHH
Confidence 43322 334466899999775 468889999999999999997 9999976 4556666666555433 33445678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 005017 312 GFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++|.+||. +|.+||++.++++
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 99999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.15 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC-----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----- 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 151 (719)
..|.+.+.||+|+||.||+|.++.+|+.||+|+++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3567789999999999999999999999999999765422 223356778999999999999999999886543
Q ss_pred ---CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 ---KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ---~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
...+++|+||+++ +|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcc
Confidence 2368999999986 677766653 46899999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCCCc---ccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CCCC
Q 005017 228 GLAIAMQQPTA---RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKP 299 (719)
Q Consensus 228 GlA~~~~~~~~---~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~~p 299 (719)
|++........ ....+++.|+|||++.+ .++.++|||||||++|+|++|++||...... .....+.. +..+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 99876543321 22346888999998753 4788999999999999999999999763332 22222211 1111
Q ss_pred Cc-------------------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 AS-------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ~~-------------------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.. .....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 10 112346889999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.61 Aligned_cols=245 Identities=24% Similarity=0.434 Sum_probs=193.6
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCChh
Q 005017 89 AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 168 (719)
Q Consensus 89 ~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~ 168 (719)
++|.||.+.+..+|+.||+|+++.... .....+.+.+|+.++++++||||+++++++... ..++++|||+++|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEeccCCCCHH
Confidence 445566666677999999999986532 234667899999999999999999999988765 4588999999999999
Q ss_pred HHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC---------C
Q 005017 169 QYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---------T 237 (719)
Q Consensus 169 ~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~---------~ 237 (719)
+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.+ |.+||+|||.+...... .
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccccccccccc
Confidence 998764 45889999999999999999999999 9999999999999854 79999999988544211 1
Q ss_pred cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--------C-------
Q 005017 238 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--------P------- 299 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--------p------- 299 (719)
.....++..|+|||++.. .++.++|||||||++|||++|+.||............+..... +
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 223457889999998864 4889999999999999999999999875544444443322110 0
Q ss_pred ----------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 ----------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......++++.+|+.+||. +|.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00011123578899999998 899999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=354.82 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=206.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
..+.+++.+.||+|+||+||+|.... ....||||.++... ..+..++|++|+++|..|+|||||+|+|.|..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34566778899999999999996532 34579999988543 24567899999999999999999999999876
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc--------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~--------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
+ +.++||+|||..|+|.+||..+. .++..+.+.++.||+.|+.||-++. +|||||-.+|+||
T Consensus 561 ~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLV 636 (774)
T KOG1026|consen 561 G--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLV 636 (774)
T ss_pred C--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhcee
Confidence 5 45999999999999999997532 2788899999999999999999999 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCCCccccc----CCCCCCCcccc-ccccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHH
Q 005017 216 NGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 289 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~~~~~~~----GT~~YmAPEvl-~~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i 289 (719)
..+. .|||+|||+++..-........ -..+|||||.+ .++|++++|||||||+|||+++ |+.||.+. ..+++
T Consensus 637 ge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EV 714 (774)
T KOG1026|consen 637 GENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEV 714 (774)
T ss_pred ccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-chHHH
Confidence 8665 9999999999765433222222 24589999955 5789999999999999999998 78999985 45677
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHH
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 331 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL 331 (719)
++.+..|.. -.-+..++.++.+|+..||+ .|.+||+++||-
T Consensus 715 Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 715 IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 788888876 45567788999999999998 899999999984
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.07 Aligned_cols=241 Identities=23% Similarity=0.393 Sum_probs=199.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|.+.++||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.++++++|+|++++++++...+ ..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceE
Confidence 4567889999999999999965 4888999987532 23467889999999999999999999765433 4578
Q ss_pred EEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.+ |.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 153 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 153 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceecc
Confidence 9999999999999987654 3889999999999999999999999 9999999999999855 799999999987543
Q ss_pred CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
... ....++..|+|||++.. .++.++|||||||++|+|++ |+.||.. .+..+....+..+..+ ......++.+++
T Consensus 154 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05082 154 STQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYD 230 (256)
T ss_pred ccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 322 23345678999998764 58899999999999999998 9999976 4566666666665443 344566789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 005017 313 FIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+|.+||. +|.+|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.01 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=203.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCC-----CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~-----g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~ 148 (719)
....|++.+.||+|+||.||+|.+... ...+|+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 345678889999999999999987643 3789999886432 234456788999999999 8999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhh----------------cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccce
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKK----------------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 212 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~----------------~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~N 212 (719)
.. ..+++||||+++|+|..++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 87 ~~--~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 87 QE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred CC--CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 54 458999999999999999854 245889999999999999999999998 9999999999
Q ss_pred eEecCCCCcEEEeecchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCH
Q 005017 213 IFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNP 286 (719)
Q Consensus 213 ILl~~~~G~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~ 286 (719)
||++.+ +.+||+|||+++.+..... ....++..|+|||++. ..++.++|||||||++|||++ |..||.. ...
T Consensus 163 il~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 240 (293)
T cd05053 163 VLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 240 (293)
T ss_pred EEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCH
Confidence 999855 7999999999976543221 1223457899999865 458999999999999999997 8999976 455
Q ss_pred HHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 287 ~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+.++.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66677766665433 334557899999999998 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.03 Aligned_cols=257 Identities=28% Similarity=0.389 Sum_probs=204.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
...|.+.+.||+|+||.||+|.+..+|..||+|++.... ......+.+.+|+.+|++++||||+++++.+.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 344677899999999999999999999999999886432 223345678899999999999999999998865432
Q ss_pred -CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 -~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeccccc
Confidence 2468999998 7799888764 56899999999999999999999999 9999999999999855 799999999987
Q ss_pred hccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC------------
Q 005017 232 AMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------ 297 (719)
Q Consensus 232 ~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~------------ 297 (719)
..... .....+++.|+|||++.+ .++.++|+||||+++|+|++|+.||.................
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 167 QTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 65432 234567999999998764 478999999999999999999999986433222221111000
Q ss_pred -------------CC---CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 -------------KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 -------------~p---~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+ .......++.+.++|.+||. +|.+|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 01123456789999999998 899999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.36 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=195.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..+++.+.||+|+||+||+|. +..+|..||+|.+.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 356778999999999999996 45678899999986432 3456788999999999999999999998776666
Q ss_pred CceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccc
Confidence 6789999999999999999764 45899999999999999999999999 9999999999999855 699999999997
Q ss_pred hccCCCcc-----cccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH---------------HHHH
Q 005017 232 AMQQPTAR-----SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIF 290 (719)
Q Consensus 232 ~~~~~~~~-----~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---------------~~i~ 290 (719)
........ ...++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65433211 1223446999998764 5889999999999999999987775432110 0011
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+.. .......+.++.+||.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11222211 12234456789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.75 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=207.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
|.+.+.||+|+||.||+|.+. .++..||+|.++...........+.+.+|++++.++ +||||+++++.+... ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CE
Confidence 567899999999999999764 467899999987544333334556788999999999 599999999887544 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+.+|+|.+++.....+++..++.|+.|++.||.|||+.+ ++||||||+||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 8899999999999999987778999999999999999999999998 9999999999999865 799999999987654
Q ss_pred CCC---cccccCCCCCCCccccccc---cCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHHcCCCCCccccC
Q 005017 235 QPT---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 235 ~~~---~~~~~GT~~YmAPEvl~~~---~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~ 305 (719)
... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence 322 2234689999999987542 6889999999999999999999996321 12233333333322 23445
Q ss_pred CChHHHHHHHHhcC-CCCCCCC---HHHHHcCccCccccCC
Q 005017 306 NDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQK 342 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpS---a~eLL~hpf~~~~~~~ 342 (719)
.++.++++|.+||. +|.+||| +.++|+||||+...+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 67899999999998 8999998 6788999999876653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=317.36 Aligned_cols=246 Identities=22% Similarity=0.376 Sum_probs=199.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCe--EEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~--~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
.|++.++||+|+||.||+|.++.+|. .+++|.++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 77 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GY 77 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Cc
Confidence 46788999999999999999887775 46887765321 234456789999999999 799999999987654 45
Q ss_pred eeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC
Q 005017 155 VNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~ 218 (719)
+++|+||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~ 155 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN 155 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC
Confidence 889999999999999987542 4788999999999999999999999 9999999999999865
Q ss_pred CCcEEEeecchhhhccCCCccc-ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 219 HGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~~~~~-~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
+.+||+|||++.......... ...+..|+|||++.. .++.++|||||||++|||++ |..||.. .........+..
T Consensus 156 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~ 233 (297)
T cd05089 156 -LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ 233 (297)
T ss_pred -CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhc
Confidence 699999999986433221111 223457999998764 58999999999999999997 9999977 455666666665
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+..+ ..+...++.+++||.+||. +|.+||++.++++.
T Consensus 234 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5433 2345577899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=313.65 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=196.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeE----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~----VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.|++.+.||+|+||+||+|.+..+|.. +++|.+... .......++..|+..+++++||||+++++++.. .
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 456778999999999999998777764 666665422 122345678889999999999999999998743 3
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++|+||+++|+|.+++... +.+++..++.|+.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||+++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCcccee
Confidence 467899999999999999764 56899999999999999999999999 9999999999999855 6999999999976
Q ss_pred ccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 233 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 233 ~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....++..|+|||.+. +.++.++|||||||++|||+| |..||.+. .+....+.+..+..+ ..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 236 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQIC 236 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCC
Confidence 53221 22345677899999875 468999999999999999998 99999763 445555555554433 334456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+.+++.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7789999999998 8999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.69 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=199.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
+.+.+.+.||+|+||.||+|.. ..++..+|+|.+.... ....+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQHIVRFYGVCTEG- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-
Confidence 4567789999999999999964 3356789998876332 34567899999999999999999999988665
Q ss_pred CCceeEEEecccCCChhHHhhhcc---------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK---------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~---------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~ 216 (719)
...++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~ 156 (280)
T cd05092 80 -RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG 156 (280)
T ss_pred -CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc
Confidence 45889999999999999987643 4789999999999999999999999 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHH
Q 005017 217 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 290 (719)
Q Consensus 217 ~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~ 290 (719)
.+ +.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|||++ |..||... ......
T Consensus 157 ~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~ 234 (280)
T cd05092 157 QG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAI 234 (280)
T ss_pred CC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHH
Confidence 54 699999999986543221 12234578899999776 458999999999999999998 89999763 444555
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+..+ ..+...++.+.++|.+||. +|.+||++.+|+.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555555433 2344567899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.51 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=205.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.||+|+||.||+|.++.++..+|+|.+...... .....+++.+|+++++.++|+|++++++++... ...++|
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 93 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLV 93 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEE
Confidence 45567899999999999999999999999998753222 234456788999999999999999999988765 458899
Q ss_pred EecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+ |.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCcccceeecCc-
Confidence 99996 578776653 446899999999999999999999998 9999999999999865 79999999998655432
Q ss_pred cccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 238 ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
....|++.|+|||.+. +.++.++|||||||++|+|++|..||.... .......+..+..+.......+..+++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 3456899999999863 357889999999999999999999997643 3333333444444444445677889999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
|.+||. +|.+||++.++++|||+..
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccc
Confidence 999998 8999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.92 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=187.6
Q ss_pred EEeeeCCeEEEEEEEcC--CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 84 VLGKGAFKTVYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~--~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+... ..+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEEEEe
Confidence 58999999999996432 34567877765322 233456788999999999999999999988654 458899999
Q ss_pred ccCCChhHHhhhcc-----cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 162 FTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 162 ~~gGsL~~~L~~~~-----~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+++|+|.+++.... ..++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEeccccccccccc
Confidence 99999999987643 2467788999999999999999999 9999999999999865 69999999998653221
Q ss_pred ----CcccccCCCCCCCcccccc--------ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCC---CC
Q 005017 237 ----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK---PA 300 (719)
Q Consensus 237 ----~~~~~~GT~~YmAPEvl~~--------~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~---p~ 300 (719)
......+++.|+|||++.. .++.++|||||||++|||++ |..||....+.......+..+.. .+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1123345778999998642 46789999999999999999 78899875444333333333321 22
Q ss_pred ccccCCChHHHHHHHHhcCCCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~dP~~RpSa~eLL~ 332 (719)
......++.+++++..|+.+|.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 33445678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.17 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=199.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCC----------------eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAG----------------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV 140 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g----------------~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 140 (719)
..|++.+.||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|++++++++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCCCCE
Confidence 34677899999999999999876544 5689998774432 2456788999999999999999
Q ss_pred eeEEEeeecCCCCceeEEEecccCCChhHHhhhcc-----------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 141 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~-----------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
+++++++... ..+++|+||+.+++|.+++.... .+++..++.++.|++.||+|||+++ |+|||||
T Consensus 82 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred eEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 9999988765 46889999999999999998765 6899999999999999999999999 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh--ccCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--FEYPYSE 282 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT--G~~Pf~~ 282 (719)
|+||+++.+ +.++|+|||++....... .....+++.|+|||++.+ .++.++|||||||++|||++ +..||..
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999866 799999999987553322 223456788999998764 68999999999999999998 6788876
Q ss_pred CCCHHHHHHHHHcC------CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 283 CKNPAQIFKKVTSG------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 283 ~~~~~~i~~~i~~g------~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
. +..+.+..+... ......+...++++.++|.+||. +|.+|||+.+|++
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 L-TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred c-ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 3 344444444332 11111233456799999999998 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.11 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=200.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEE----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
+++|++.+.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 46778889999999999999973 4578899999986432 2344577999999999999999999999987765
Q ss_pred CCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
...+++||||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+||+++.+ |.+||+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCccc
Confidence 567899999999999999987653 5899999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCC--------------CHHHHH
Q 005017 231 IAMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQIF 290 (719)
Q Consensus 231 ~~~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--------------~~~~i~ 290 (719)
....... .....|+..|+|||++. ..++.++||||||+++|||+|+..|+.... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 7654322 12345677899999865 458899999999999999999877653211 111122
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+..+... ..+...+..+.+||.+||. +|.+|||+.+++++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 222233222 2234467899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=324.31 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=201.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---- 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---- 152 (719)
..|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 456778999999999999999999999999998864321 12334568899999999999999999998765422
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++|+||+.. +|..++. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~~~ 166 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARH 166 (342)
T ss_pred ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCCcC
Confidence 346899999964 7777653 46899999999999999999999999 9999999999999865 7999999999875
Q ss_pred ccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC-------------
Q 005017 233 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------- 297 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~------------- 297 (719)
.... .....+++.|+|||++.+ .++.++|||||||++|||++|+.||... +....+..+....
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-DYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 4332 234568899999998754 4789999999999999999999999863 3222222221100
Q ss_pred ---------CC----Cc---cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 298 ---------KP----AS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 298 ---------~p----~~---~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
.+ .. .....++.+.+||.+||. +|.+||++.++|.||||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00 00 012346789999999998 89999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.29 Aligned_cols=237 Identities=19% Similarity=0.370 Sum_probs=194.2
Q ss_pred EeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 85 LGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 85 LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++.+.. ...++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeC
Confidence 899999999999765 456679999886432 23445778999999999999999999997732 3578999999
Q ss_pred cCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc---
Q 005017 163 TSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--- 238 (719)
Q Consensus 163 ~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~--- 238 (719)
++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCcccee
Confidence 99999999875 456899999999999999999999999 9999999999999855 6999999999875543211
Q ss_pred --ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 239 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 239 --~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
....+++.|+|||.+. +.++.++||||||+++|||++ |..||... ........+..+..+ ..+...++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALM 231 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1122357899999876 458999999999999999996 99999874 455566666665443 34556678999999
Q ss_pred HHhcC-CCCCCCCHHHHHc
Q 005017 315 EKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~ 332 (719)
.+||. +|.+||++.++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99998 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=317.62 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEee
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSW 147 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~ 147 (719)
...|.+.+.||+|+||.||+|.+.. ++..+|+|.++... .......+..|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3567889999999999999997643 33579999887432 234456788999999999 799999999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccc
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 211 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~ 211 (719)
...+ .+++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ ++||||||+
T Consensus 94 ~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 169 (307)
T cd05098 94 TQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169 (307)
T ss_pred ecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence 6554 5889999999999999997642 4788999999999999999999998 999999999
Q ss_pred eeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCC
Q 005017 212 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKN 285 (719)
Q Consensus 212 NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~ 285 (719)
||+++.+ +.+||+|||++....... .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.. .+
T Consensus 170 Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~ 247 (307)
T cd05098 170 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 247 (307)
T ss_pred heEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CC
Confidence 9999865 699999999987554221 112234578999998764 58999999999999999998 8888876 55
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..++...+..+..+ ..+...+.+++++|.+||. +|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66677666665433 3445567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.12 Aligned_cols=256 Identities=23% Similarity=0.432 Sum_probs=203.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~ 154 (719)
...|.+.+.||+|+||.||+|.+..+|..||+|.++.... ......+..|+.++.++. ||||+++++++.+.. .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS--D 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC--e
Confidence 3456788999999999999999998899999999875432 233456677887776664 999999999987654 5
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+. ++|..++.. ...+++..+..++.||+.||+|||+ ++ |+||||+|+||+++.+ +.+||+|||++..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchh
Confidence 889999985 477776655 4568999999999999999999997 57 9999999999999854 7999999999876
Q ss_pred ccCCC-cccccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc-cccC
Q 005017 233 MQQPT-ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKV 305 (719)
Q Consensus 233 ~~~~~-~~~~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~-~~~~ 305 (719)
..... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+....+.....+.. ....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 54332 223457889999998753 3788999999999999999999999764444445555544433221 1223
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+.++++||.+||. +|.+||++.++++||||+...
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 57889999999998 899999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=314.11 Aligned_cols=244 Identities=26% Similarity=0.405 Sum_probs=198.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
|++.+.||+|+||.||+|.+.. ....+|+|.+.... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~ 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--G 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--C
Confidence 5677899999999999998753 23578888776332 234457889999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhc------------------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 154 TVNMITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~------------------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
..++|+||+.+|+|.+++... ..+++..++.++.|++.||.|||+++ |+|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 578899999999999997642 24788899999999999999999999 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 283 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~ 283 (719)
|+|||++.+ +.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|||+| |..||.+
T Consensus 155 p~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~- 232 (290)
T cd05045 155 ARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 232 (290)
T ss_pred hheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence 999999855 699999999987543221 12234567899999765 458999999999999999999 9999976
Q ss_pred CCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 284 ~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+...+..+..+. .+...+..+++|+.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 55677777666554433 345567899999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.61 Aligned_cols=247 Identities=30% Similarity=0.539 Sum_probs=204.2
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
.+||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++|+||+++++.+... ...++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEecC
Confidence 57999999999999999999999999875432 23456788999999999999999999988765 4588999999
Q ss_pred cCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Cccc
Q 005017 163 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARS 240 (719)
Q Consensus 163 ~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~~ 240 (719)
++++|.+++.. ..+++..++.++.|++.||+|||+++ ++||||+|+||+++.+ |.++|+|||++...... ....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence 99999998754 46899999999999999999999999 9999999999999855 79999999988654332 2234
Q ss_pred ccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCChHHHHHHHHhc
Q 005017 241 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCL 318 (719)
Q Consensus 241 ~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~l~~lI~kcL 318 (719)
..|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .........+..+..+. ......++.+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 568999999998754 578999999999999999999999976 34444444444333221 122345788999999999
Q ss_pred C-CCCCCCCHHHHHcCccCcccc
Q 005017 319 V-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 319 ~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
. +|.+||++.+++.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 8 899999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.26 Aligned_cols=249 Identities=29% Similarity=0.417 Sum_probs=199.6
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||+|+||+||+|.+..+++.||+|++..... ........+|+..+++++ ||||+++++++.+ ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence 4567899999999999999998999999998864322 122234567999999999 9999999998866 356889
Q ss_pred EEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||||+ +|+|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccC
Confidence 99999 889999887754 7899999999999999999999999 9999999999999854 7999999999976554
Q ss_pred CC-cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-------------
Q 005017 236 PT-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------- 299 (719)
Q Consensus 236 ~~-~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p------------- 299 (719)
.. .....|+..|+|||++.. .++.++|+||||+++++|++|+.||..........+.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 32 234568999999998743 47899999999999999999999997654433333222110000
Q ss_pred --------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 --------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 --------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.......++.+++||.+||. +|.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111225789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.13 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=202.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--- 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~--- 151 (719)
....|.+.+.||+|+||.||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 34567888999999999999999999999999998864321 1233467889999999999999999999875432
Q ss_pred -CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 -KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 -~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
...++++++++ +++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ |.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEeccccc
Confidence 23467788876 7899888764 46899999999999999999999999 9999999999999855 79999999998
Q ss_pred hhccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--C---------
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--I--------- 297 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~--------- 297 (719)
...... .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+... .
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHhhc
Confidence 765432 334578999999998754 47889999999999999999999997533 22222221110 0
Q ss_pred --------------CC----CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 298 --------------KP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 298 --------------~p----~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+ .......++.+++||.+||. +|.+||++.+++.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 00 00112346789999999998 89999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.30 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=211.6
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+++||.|-||+||-|+++.+|+.||||++...+... .....+.+|+.+|.++.||.||.+--.|... ..+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET~--ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFETP--ERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecCC--ceEEEEehh
Confidence 689999999999999999999999999998765544 3347889999999999999999998766444 559999999
Q ss_pred ccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhhccCC-C
Q 005017 162 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-T 237 (719)
Q Consensus 162 ~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~~~~~-~ 237 (719)
+.|.-|.-.|.. .++++++..+.++.||+.||.|||-++ |+|+||||+|||+.. +...+||||||+|+.+... .
T Consensus 645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 966555555543 467999999999999999999999999 999999999999963 3458999999999988765 5
Q ss_pred cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCCCccccCCChHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p~~~~~~~~~~l~~lI 314 (719)
.++++|||.|.|||++. .+|+...|+||.|+|+|.-+.|.+||.+..+ +..+|... ..|+..++..++++.+||
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHHHHHHH
Confidence 67899999999999987 4699999999999999999999999987443 44444432 235556666788999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+|+ +-++|.|.+..|.|||+|...
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcch
Confidence 99998 899999999999999998643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=325.13 Aligned_cols=257 Identities=29% Similarity=0.414 Sum_probs=206.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC--
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK-- 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~-- 152 (719)
.+..|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3456788899999999999999999999999999886432 122345677889999999999999999887654332
Q ss_pred --CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 153 --KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 153 --~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ |.+||+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEcccccc
Confidence 3588999998 6799998875 56999999999999999999999999 9999999999999855 79999999998
Q ss_pred hhccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--C-------
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P------- 299 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p------- 299 (719)
...... .....+++.|+|||++.+ .++.++|||||||++|+|+||+.||.... ....+..+..... +
T Consensus 166 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD-HIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCCHHHHhhc
Confidence 765443 344578999999998754 57899999999999999999999997643 3333333222110 0
Q ss_pred -----------------C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 -----------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 -----------------~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
. ......++.+.+||.+||. +|.+|||+.+|++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 0112347889999999998 899999999999999998544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.07 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=202.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||.|+||.||+|.+.. +..+|+|.+.... ......+..|+.+++.++||||+++++++... ..+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 79 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYI 79 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEE
Confidence 45677899999999999999886 8899999987543 23456788999999999999999999987654 45889
Q ss_pred EEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCC
Confidence 99999999999999753 45899999999999999999999999 9999999999999855 6999999999976643
Q ss_pred CC--cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 236 PT--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 236 ~~--~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. .....+++.|+|||.+. +.++.++||||||+++|+|++ |+.||.. .+..+.+..+..+..+ ..+...++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIY 234 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHH
Confidence 32 12334567899999875 458899999999999999998 8999976 4455666666655433 23456678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHc
Q 005017 312 GFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++|.+||. +|.+|||+.+|++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 99999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=325.33 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=200.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|++.+.||+|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3578899999999999999974 3467899999987432 123456788999999999 689999999988654
Q ss_pred CCCceeEEEecccCCChhHHhhhc--------------------------------------------------------
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-------------------------------------------------------- 174 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-------------------------------------------------------- 174 (719)
+ ..+++||||+++|+|.+++...
T Consensus 84 ~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 G-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred C-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 3 4678999999999999988642
Q ss_pred -----------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC----cc
Q 005017 175 -----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----AR 239 (719)
Q Consensus 175 -----------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~ 239 (719)
..+++..+..|+.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++....... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcC
Confidence 23677888999999999999999999 9999999999999855 699999999987653221 11
Q ss_pred cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHh
Q 005017 240 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kc 317 (719)
...+++.|+|||++. ..++.++||||||+++|+|++ |..||............+..+..+ ..+...++.+.+++.+|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHH
Confidence 234567899999775 458999999999999999997 899998755555555555555433 23445678999999999
Q ss_pred cC-CCCCCCCHHHHHcC
Q 005017 318 LV-PASERLSAKDLLKD 333 (719)
Q Consensus 318 L~-dP~~RpSa~eLL~h 333 (719)
|. +|.+|||+.+|++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 98 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.96 Aligned_cols=251 Identities=30% Similarity=0.417 Sum_probs=197.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeecCCC---
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~~~~--- 152 (719)
|++.+.||+|+||.||+|.++.+|..||+|.++..... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 45678999999999999999988999999999754321 22334566788777666 69999999999876542
Q ss_pred CceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..++++|||+.+ +|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcc
Confidence 248899999974 8999887643 4899999999999999999999999 9999999999999866 79999999998
Q ss_pred hhccCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC----------
Q 005017 231 IAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------- 298 (719)
Q Consensus 231 ~~~~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~---------- 298 (719)
....... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCCC
Confidence 7654332 234457899999998764 58899999999999999999999997643 3333333322100
Q ss_pred ------------CC---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 299 ------------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 299 ------------p~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+. ......++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 0001234678999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=355.10 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=196.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.++||+|+||.||+|.+..+|+.||+|++.... .......+++.+|+.++++++||||+++++++.+. ...++
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyL 79 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYY 79 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEE
Confidence 4678899999999999999999999999999987432 22234557899999999999999999999988654 45889
Q ss_pred EEecccCCChhHHhhhc-----------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 158 ITELFTSGNLRQYRKKH-----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-----------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
||||++||+|.+++... ..++...+..++.||+.||+|||+++ |+||||||+||+++.+ |.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEEEe
Confidence 99999999999988641 23566778899999999999999999 9999999999999855 7999999
Q ss_pred cchhhhccCC--------------------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC
Q 005017 227 LGLAIAMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN 285 (719)
Q Consensus 227 FGlA~~~~~~--------------------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~ 285 (719)
||+++..... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9999755210 0123469999999998764 589999999999999999999999976332
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.....................++.+.+++.+||. +|.+|++..+.+.+
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222221111111111123457889999999998 89999876665543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.69 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=200.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCC--CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC--CCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD--KKK 153 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~--g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~--~~~ 153 (719)
|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 67789999999999999999888 8999999886422 1123356778899999999 599999999875432 234
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.++++++|+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceec
Confidence 5778889885 689999988888999999999999999999999999 9999999999999855 79999999999755
Q ss_pred cCCC------cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc----------
Q 005017 234 QQPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---------- 295 (719)
Q Consensus 234 ~~~~------~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---------- 295 (719)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD-YVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence 4221 233578999999997754 58899999999999999999999997632 2211111110
Q ss_pred ----------------CCCCC---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 296 ----------------GIKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 296 ----------------g~~p~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
..... ......++.+++|+.+||. +|.+|||+.+++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00001 1112346789999999998 89999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.00 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=198.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.++++++||||+++++++.. ..++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIY 76 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcE
Confidence 45778899999999999999865 67889999886433 234678899999999999999999987632 3588
Q ss_pred EEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeecC
Confidence 999999999999998653 35889999999999999999999999 9999999999999855 699999999987654
Q ss_pred CCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
... .....++..|+|||++. ..++.++||||||+++|||++ |+.||... +.......+..+..+ ..+...+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEE 231 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHH
Confidence 222 12234567899999876 458899999999999999999 99999874 455555566555433 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++|.+||. +|.+||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.30 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=211.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeec--C
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD--D 150 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~--~ 150 (719)
....|..-.++||-|-.|.|..++++.+|+.+|+|++.- ..+..+|+++.-.. .|||||.+++.|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 344444445789999999999999999999999998752 24556788876655 69999999998743 3
Q ss_pred CCCceeEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEee
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGD 226 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~D 226 (719)
+.+.+.+|||.|+||.|+..+..++. ++++++..|++||..|+.|||+.+ |.||||||+|+|.... +..+||+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecc
Confidence 45678899999999999999987665 999999999999999999999999 9999999999999633 24689999
Q ss_pred cchhhhccC-CCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHHcCCC--C
Q 005017 227 LGLAIAMQQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIK--P 299 (719)
Q Consensus 227 FGlA~~~~~-~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i~~g~~--p 299 (719)
||+|+.-.. ....+.+-||.|.|||++. ++|+..+|+||+|+++|-|++|.+||..... ...+..+|..|.. |
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 999987653 3456778899999999986 5699999999999999999999999965332 2345566776654 4
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..-+...+...+++|+++|. +|.+|.|+.+++.|||+....
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 44445567899999999998 899999999999999997544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.82 Aligned_cols=243 Identities=26% Similarity=0.446 Sum_probs=203.3
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCC----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
.+.+.||+|+||.||+|.+..++ ..||+|.++.... ....+.+..|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD---EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC---hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence 45678999999999999998766 8999999864431 22567889999999999999999999988765 468
Q ss_pred eEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++|||+++++|.+++..... +++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceec
Confidence 899999999999999976554 999999999999999999999999 9999999999999855 69999999998765
Q ss_pred cCCCcc---cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~~---~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 433111 123678999999875 458999999999999999998 7888876 56666777776665443 3344678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999998 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.49 Aligned_cols=249 Identities=28% Similarity=0.460 Sum_probs=200.8
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
.+.+.||+|++|.||+|.+..+|+.+++|++...... ......+.+|+.+|++++||||+++++++... ..+++|+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEE
Confidence 3457899999999999999999999999998754322 23457788999999999999999999987655 5688999
Q ss_pred ecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 160 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcc
Confidence 99975 88887766 357899999999999999999999999 9999999999999855 699999999987665432
Q ss_pred -cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--C-------------
Q 005017 238 -ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P------------- 299 (719)
Q Consensus 238 -~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p------------- 299 (719)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||.......++......... +
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 223468889999998753 5789999999999999999999999774443333222211000 0
Q ss_pred ------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 300 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 300 ------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.......+.++++||.+||. +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00112346789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=349.47 Aligned_cols=150 Identities=25% Similarity=0.371 Sum_probs=133.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|.+.+.||+|+||+||+|.+..+|+.||+|+++...... ......+..|+.+++.++||||++++..+... ..+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEE
Confidence 346788899999999999999999999999999997654322 34557788999999999999999999887654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
|+||||+.+++|.+++...+.+++..++.|+.||+.||.|||.++ ||||||||+|||++.+ |.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999999999999999988888999999999999999999999998 9999999999999855 799999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=309.19 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=203.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||+|+||.||+|.+...+..+++|.++...... .......+..|+.+++.++||||+++++++.+.. ..++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 79 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFCI 79 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceEE
Confidence 567889999999999999998887777777765433211 1233456778999999999999999999886553 5889
Q ss_pred EEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 158 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++. +.+||+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeec
Confidence 9999999999988753 356899999999999999999999999 999999999999974 47999999998765
Q ss_pred cCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .........+..+..+ ..+...+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQL 233 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHH
Confidence 432 2234568999999998754 578899999999999999999999976 3444444555444333 3455667899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
.++|.+||. +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.51 Aligned_cols=242 Identities=24% Similarity=0.389 Sum_probs=196.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+.+.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIY 76 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcE
Confidence 3478889999999999999987644 469999876433 223678899999999999999999987632 3478
Q ss_pred EEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEcc
Confidence 9999999999999997643 4789999999999999999999998 9999999999999855 799999999997654
Q ss_pred CCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... ....++..|+|||... ..++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+...+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPES 231 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHH
Confidence 3221 1234567899999875 458899999999999999999 89999873 445555555554333 233456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++++.+||. +|.+||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.24 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=200.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc-------CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEe
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKS 146 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~-------~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~ 146 (719)
....+.+.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++++ +||||++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3456778899999999999999763 235579999876432 234567788999999999 69999999998
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
+... ..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 87 ~~~~--~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 87 CTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EccC--CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 8654 4588999999999999998653 34788999999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECK 284 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~ 284 (719)
+|||++.+ +.+||+|||+++...... .....+++.|||||++. +.++.++||||||+++|+|++ |..||.. .
T Consensus 163 ~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~ 240 (314)
T cd05099 163 RNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-I 240 (314)
T ss_pred eeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-C
Confidence 99999855 799999999997654321 11223456899999875 458999999999999999999 8899976 4
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.....+..+..+..+ ..+...+.+++++|.+||. +|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 566667666665433 2334556789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.07 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=203.5
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEc-------CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEE
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYK 145 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~-------~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~ 145 (719)
.....|.+.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 45667788999999999999999752 245579999876331 134557889999999999 8999999999
Q ss_pred eeecCCCCceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 146 SWVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 146 ~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
++... ..+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+|||||
T Consensus 89 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 164 (304)
T cd05101 89 ACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLA 164 (304)
T ss_pred EEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence 88654 4688999999999999998753 24778889999999999999999999 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 283 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~ 283 (719)
|+||+++.+ +.+||+|||+++...... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||..
T Consensus 165 p~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~- 242 (304)
T cd05101 165 ARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 242 (304)
T ss_pred cceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-
Confidence 999999855 799999999997654321 12234567899999875 458999999999999999998 7888876
Q ss_pred CCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 284 ~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....++.+.+..+..+ ..+...+..+++||.+||. +|.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4566777777665433 2344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=312.85 Aligned_cols=246 Identities=21% Similarity=0.277 Sum_probs=200.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
.|++.+.||+|+||.||+|.+.. .+..||+|+++... .....+.+..|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~- 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ- 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-
Confidence 35667889999999999998753 35789999987432 2234567889999999999999999999886554
Q ss_pred CceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec
Q 005017 153 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~ 216 (719)
.+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 488899999999999998532 24788889999999999999999999 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHH
Q 005017 217 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 290 (719)
Q Consensus 217 ~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~ 290 (719)
.+ +.+||+|||+++...... .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ ....++.
T Consensus 159 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~ 236 (283)
T cd05091 159 DK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVI 236 (283)
T ss_pred CC-CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 55 689999999987653322 12334678999999875 568999999999999999998 7888876 4556677
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+..+..+ ..+...+..+.+++.+||+ +|.+||++++++..
T Consensus 237 ~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 777665433 2345567889999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=306.46 Aligned_cols=235 Identities=23% Similarity=0.384 Sum_probs=188.1
Q ss_pred EEEeeeCCeEEEEEEEcCCC----------eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 83 EVLGKGAFKTVYKAFDEFAG----------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g----------~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.++++++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 46999999999999998776 457777665432 115788899999999999999999998876
Q ss_pred CceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC------CcEEEe
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH------GEVKIG 225 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~------G~vKL~ 225 (719)
...++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+. +.+||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeC
Confidence 34688999999999999998766 7899999999999999999999999 99999999999998542 169999
Q ss_pred ecchhhhccCCCcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 005017 226 DLGLAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 301 (719)
Q Consensus 226 DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 301 (719)
|||++..... .....++..|+|||++.. .++.++||||||+++|+|++ |..||.... ........... ..
T Consensus 151 Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~~ 224 (259)
T cd05037 151 DPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---HR 224 (259)
T ss_pred CCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---CC
Confidence 9999876543 233457788999998864 48899999999999999999 578887643 32222222211 11
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+......+.++|.+||. +|.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 112223789999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.09 Aligned_cols=240 Identities=20% Similarity=0.333 Sum_probs=185.7
Q ss_pred EEeeeCCeEEEEEEEcCCC--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 84 VLGKGAFKTVYKAFDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.||+|+||+||+|.....+ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+... ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEEEec
Confidence 5899999999999754322 345556554332 234557899999999999999999999988754 458899999
Q ss_pred ccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 162 FTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 162 ~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
+++|+|.+++.+. ...++..++.++.||+.||+|||+++ ++||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcch
Confidence 9999999998754 34677788899999999999999999 9999999999999855 79999999998543211
Q ss_pred ---CcccccCCCCCCCcccccc--------ccCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHHcCC----CCC
Q 005017 237 ---TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI----KPA 300 (719)
Q Consensus 237 ---~~~~~~GT~~YmAPEvl~~--------~~s~ksDIwSlGiil~EmlTG-~~Pf~~~~~~~~i~~~i~~g~----~p~ 300 (719)
......|++.|+|||++.. .++.++||||||+++|||+++ ..||.... ....+..+..+. ..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcccccCCC
Confidence 1234568899999998742 357889999999999999974 67887644 334444333221 122
Q ss_pred ccccCCChHHHHHHHHhcCCCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~dP~~RpSa~eLL~ 332 (719)
.+....++.+++++..||.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 33445678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=356.37 Aligned_cols=247 Identities=32% Similarity=0.546 Sum_probs=206.8
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---------
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--------- 152 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--------- 152 (719)
.++||+||||.||+++++.+|..||||+|.... +.....++.+|+.+|.+|+|||||+||..|++...
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 467999999999999999999999999998664 24566889999999999999999999988865100
Q ss_pred --------------------------------------------------------------------------------
Q 005017 153 -------------------------------------------------------------------------------- 152 (719)
Q Consensus 153 -------------------------------------------------------------------------------- 152 (719)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred ----------------------------CceeEEEecccCCChhHHhhhcccc-cHHHHHHHHHHHHHHhhhhhcCCCCe
Q 005017 153 ----------------------------KTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPI 203 (719)
Q Consensus 153 ----------------------------~~l~lV~Ey~~gGsL~~~L~~~~~l-~~~~i~~i~~QIl~gL~yLHs~~ppI 203 (719)
..+|+=||||+.-+|++++..+... .....+++++||+.||.|+|+.| |
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--i 718 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--I 718 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--e
Confidence 2367889999998888888776554 46778999999999999999999 9
Q ss_pred eeecCccceeEecCCCCcEEEeecchhhhcc----------C----------CCcccccCCCCCCCcccccc----ccCc
Q 005017 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----------Q----------PTARSVIGTPEFMAPELYEE----EYNE 259 (719)
Q Consensus 204 IHrDLKp~NILl~~~~G~vKL~DFGlA~~~~----------~----------~~~~~~~GT~~YmAPEvl~~----~~s~ 259 (719)
|||||||.|||++.+ +.|||+|||+|+... . ...+..+||--|+|||++.+ .|+.
T Consensus 719 IHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 999999999999955 599999999997621 0 02245689999999999863 5999
Q ss_pred cccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 260 ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
|+|+|||||+++||+. ||........+...+..+..|.. +... -+.-..+|+++|+ ||.+||||.|||++-|
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~-~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPE-HPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCccccccc-chHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 9999999999999996 78876777778888888877765 2222 2567889999998 9999999999999999
Q ss_pred Ccc
Q 005017 336 LQV 338 (719)
Q Consensus 336 ~~~ 338 (719)
|.+
T Consensus 874 lpp 876 (1351)
T KOG1035|consen 874 LPP 876 (1351)
T ss_pred CCc
Confidence 984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=307.70 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=202.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
...|++.+.||+|+||+||+|.++.+|. .||+|...... .......+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 3567888999999999999998876665 58888776442 23456788899999999999999999998875
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
...++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCccc
Confidence 4588999999999999998764 46899999999999999999999998 9999999999999855 69999999999
Q ss_pred hhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 231 IAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 231 ~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
+....... ....++..|+|||.+. ..++.++||||||+++|||+| |+.||.. ....++...+..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 234 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERL-PQPP 234 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCC
Confidence 76543221 1122356899999775 468999999999999999999 9999987 4566666666655332 3344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+.+++.+||. +|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999997 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.94 Aligned_cols=237 Identities=20% Similarity=0.339 Sum_probs=187.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCe-------EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 83 EVLGKGAFKTVYKAFDEFAGI-------EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~-------~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
+.||+|+||.||+|.+...+. .||+|.+.... ....+.+..|+.+++.++||||+++++++.... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD--ES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--Cc
Confidence 469999999999998865544 38877765322 244567889999999999999999999987654 47
Q ss_pred eEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC-------CcEEEeec
Q 005017 156 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-------GEVKIGDL 227 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~-------G~vKL~DF 227 (719)
++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+||+++.+. +.++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 88999999999999997654 5899999999999999999999999 99999999999997543 23799999
Q ss_pred chhhhccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhcc-CCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 228 GLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 228 GlA~~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~-~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
|++..... .....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.. ..+......... ...++.
T Consensus 153 g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~ 226 (258)
T cd05078 153 GISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPA 226 (258)
T ss_pred ccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCC
Confidence 98865433 234568899999998864 4789999999999999999995 66654 333322222221 122333
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+.++.++|.+||+ +|.+|||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 445789999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.67 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=199.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..+++.+.||+|+||.||+|.++.+|. .||+|.++... .......+..|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--R 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--C
Confidence 357889999999999999999887665 59999886432 244567899999999999999999999987554 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+++|+|.+++... +.+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccccc
Confidence 588999999999999998763 56899999999999999999999999 9999999999999855 6999999999875
Q ss_pred ccCCCc-----cccc--CCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 233 MQQPTA-----RSVI--GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 233 ~~~~~~-----~~~~--GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
...... .... .+..|+|||.+. ..++.++|||||||++|||++ |..||.. .+.......+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~ 233 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDYRL-PPP 233 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcC-CCc
Confidence 543211 1111 245799999876 458999999999999999886 9999977 3455556666544322 223
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
...++.+.+++.+||. +|.+||++.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4457889999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.32 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=202.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+..|.+.+.||+|+||.||+|.+..+|..||+|++..... .....+.+..|+.++++++||||++++++|.... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-ED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-Cc
Confidence 45567888999999999999999999999999998864322 1234567889999999999999999999886533 35
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++|+||+ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+ |.+||+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCccccccccC
Confidence 78999998 5689888764 45788889999999999999999999 9999999999999854 799999999987543
Q ss_pred CCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-----------------
Q 005017 235 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 295 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~----------------- 295 (719)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.... ....+..+..
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 PQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 32 234567899999998754 58999999999999999999999997632 2211111100
Q ss_pred -------CC--CC---CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 296 -------GI--KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 296 -------g~--~p---~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.. .+ .......++.++++|.+||. +|.+||++.+++.||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00 00 01112356789999999998 89999999999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.82 Aligned_cols=246 Identities=23% Similarity=0.393 Sum_probs=200.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|...+.||+|+||.||+|.++.++. .+|+|.++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--K 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--C
Confidence 456778999999999999999876654 68888876432 234457789999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++||||+++++|.+++... +.+++..+..++.|++.||+|||+.+ ++||||||+||+++.+ +.+||+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~ 156 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRV 156 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCcccee
Confidence 588999999999999998764 56899999999999999999999999 9999999999999855 6999999999875
Q ss_pred ccCCCcc-----cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPTAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~~~-----~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
....... ....++.|+|||++. ..++.++|||||||++|||++ |..||.. .+.......+..+...+ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~ 234 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDGFRLP-APMD 234 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcCCCCC-CCCC
Confidence 5432211 112345799999876 458999999999999999998 9999976 34556666666543322 2334
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+..+.+++.+||. +|.+||++.++++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 57889999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.62 Aligned_cols=246 Identities=23% Similarity=0.402 Sum_probs=200.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCC---eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g---~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--K 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--C
Confidence 45678899999999999999886544 379998876432 134457889999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+++|+|.+++.+. +.+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~ 155 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRV 155 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCcccc
Confidence 688999999999999999765 45899999999999999999999999 9999999999999855 6999999999876
Q ss_pred ccCCCc-----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~~-----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
...... ....++..|+|||.+. +.++.++||||||+++||+++ |..||.+. ...+....+..+..++ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~ 233 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APMD 233 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCCC
Confidence 543221 1122356899999886 468999999999999999886 99999773 4555666666654332 2334
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.++.+++++.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 57899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.29 Aligned_cols=269 Identities=23% Similarity=0.387 Sum_probs=236.8
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
++....||-||||.|-++........+|+|.++...... ..+.+.+..|-++|..++.|.||++|..|- +.+++||+
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYmL 498 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYML 498 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhhh
Confidence 444567999999999998766555558999988777655 345688999999999999999999999885 45789999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-C
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~ 237 (719)
||-|-||.|+..+..++.++..+.+.++..++.|++|||+++ ||+|||||+|.+++. .|-+||.|||+|+.+... .
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~-~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDN-RGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeecc-CCceEEeehhhHHHhccCCc
Confidence 999999999999999999999999999999999999999999 999999999999984 489999999999988754 5
Q ss_pred cccccCCCCCCCcccc-ccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl-~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
+.++||||.|.|||++ +.+.+.++|.||||+++|||+||.+||++ .++-..|..|..|+....+++.....+.++|++
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 7899999999999965 67799999999999999999999999998 788999999999999888898889999999998
Q ss_pred hcC-CCCCCCC-----HHHHHcCccCccccCCCCCCCCCCCcch
Q 005017 317 CLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 354 (719)
Q Consensus 317 cL~-dP~~RpS-----a~eLL~hpf~~~~~~~~~~~~~l~~p~~ 354 (719)
+-. +|.+|.. +.+|-+|.||...+|.......+..|+.
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 776 7999985 8999999999999988765555555543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.00 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=193.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC--------------CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA--------------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~--------------g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk 142 (719)
+.|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 4567889999999999999977543 2358999886432 2345567899999999999999999
Q ss_pred EEEeeecCCCCceeEEEecccCCChhHHhhhcc------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 143 l~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
+++++... ..+++||||+.+++|.+++.... .+++..+..++.|++.||+|||+++ ++||||||
T Consensus 82 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp 157 (295)
T cd05097 82 LLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLAT 157 (295)
T ss_pred EEEEEcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccCh
Confidence 99988654 45889999999999999986432 3678889999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh--ccCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSEC 283 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT--G~~Pf~~~ 283 (719)
+||+++.+ +.+||+|||++........ ....+++.|+|||++. +.++.++|||||||++|+|++ +..||...
T Consensus 158 ~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 158 RNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999855 6999999999875533221 2234567899999765 568999999999999999998 66788763
Q ss_pred CCHHHHHHHHHc------CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 284 KNPAQIFKKVTS------GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 284 ~~~~~i~~~i~~------g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+....+.. ...........++.+++||.+||. +|.+|||++++++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 -SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred -ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 33444333221 111122233456899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.06 Aligned_cols=242 Identities=23% Similarity=0.387 Sum_probs=197.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+ ..||+|.++.... ..+.+.+|++++++++||||+++++.+.. ...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~ 76 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 76 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcE
Confidence 3478899999999999999988755 4699998874332 23578899999999999999999987632 3478
Q ss_pred EEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeecc
Confidence 999999999999999763 35789999999999999999999998 9999999999999855 799999999997654
Q ss_pred CCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... ....++..|+|||+.. ..++.++|||||||++|+|+| |..||... ...+....+..+... ......++.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPES 231 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCHH
Confidence 3321 1234567899999775 468999999999999999999 88898763 445555555554332 223456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.++|.+||. +|.+||++.+++.
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.26 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=200.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.++||+|+||+||+|.+. .+..||+|.+.... ...+.+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 76 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPI 76 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC--Cce
Confidence 456788999999999999999876 56789999887443 2346788999999999999999999987543 458
Q ss_pred eEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++++|.+++.... .+++..+..|+.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceec
Confidence 99999999999999997653 6899999999999999999999999 9999999999999855 79999999998765
Q ss_pred cCCCc---ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~---~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... ....++..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+ .........+..+.... .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG-MTNREVLEQVERGYRMP-RPPNCPE 231 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCH
Confidence 43211 12234568999998764 58899999999999999999 9999976 34555666665543322 2333478
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+++++.+||. +|.+||++++++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.41 Aligned_cols=247 Identities=24% Similarity=0.431 Sum_probs=199.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...+.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---
Confidence 44577889999999999999987543 3468888876432 13455788999999999999999999998754
Q ss_pred CceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...++||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~ 155 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSR 155 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceee
Confidence 34678999999999999997644 5899999999999999999999999 9999999999999855 699999999987
Q ss_pred hccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 232 AMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 232 ~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
...... .....+++.|+|||.+. ..++.++||||||+++|||++ |..||..... .+....+..+..+ ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~ 233 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNC 233 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCC
Confidence 654332 11223456899999875 458899999999999999986 9999987543 4444555555433 234456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++.++++|.+|+. +|.+|||+.+++..
T Consensus 234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.16 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~- 80 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG- 80 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-
Confidence 346778899999999999998743 67889999886432 233456788999999999999999999988654
Q ss_pred CCceeEEEecccCCChhHHhhhcc----------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~----------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
..+++|+||+++|+|.+++.... .+++..++.++.||+.||.|||+++ ++|||||
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 81 -KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred -CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 35889999999999999987432 3678889999999999999999998 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 283 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~ 283 (719)
|+||+++.+ +.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|||++ |..||.+
T Consensus 158 p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~- 235 (288)
T cd05050 158 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG- 235 (288)
T ss_pred HhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Confidence 999999855 799999999986543221 12233567899999875 468999999999999999998 8889876
Q ss_pred CCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 284 ~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+..+....+..+..+. .+...+.++.+||.+||. +|.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 45566666666554332 234457899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.74 Aligned_cols=241 Identities=24% Similarity=0.399 Sum_probs=196.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||.||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYI 77 (260)
T ss_pred HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEE
Confidence 4567789999999999999766 667799998875432 23568899999999999999999997632 34789
Q ss_pred EEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccC
Confidence 99999999999998753 35899999999999999999999999 9999999999999855 6999999999976543
Q ss_pred CCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 236 PTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 236 ~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
... ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...+..+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRM-PCPQDCPISL 232 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 221 1223556899999875 458899999999999999999 8899977 3455555666554333 3345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++.+||. +|.+|||+.+++.
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 999999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.87 Aligned_cols=240 Identities=25% Similarity=0.377 Sum_probs=195.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.+. ++..||+|.++... .......+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence 36999999999999865 78899999876432 123445788999999999999999999988655 4588999999
Q ss_pred cCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc---
Q 005017 163 TSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--- 238 (719)
Q Consensus 163 ~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~--- 238 (719)
++|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccccC
Confidence 999999998754 45789999999999999999999999 9999999999999855 6999999999865433211
Q ss_pred ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 239 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
....+++.|+|||++. +.++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1223466899999876 458899999999999999998 99999874 455555555554332 2334467899999999
Q ss_pred hcC-CCCCCCCHHHHHcC
Q 005017 317 CLV-PASERLSAKDLLKD 333 (719)
Q Consensus 317 cL~-dP~~RpSa~eLL~h 333 (719)
||. +|.+||++.++++.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 230 CWDYKPENRPKFSELQKE 247 (250)
T ss_pred HcccCcccCCCHHHHHHH
Confidence 998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.90 Aligned_cols=239 Identities=25% Similarity=0.393 Sum_probs=195.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
++||+|+||.||+|.+.. |+.||+|.+..... ......+.+|+.++++++||||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence 369999999999999887 99999998875432 23557889999999999999999999988655 4588999999
Q ss_pred cCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc---
Q 005017 163 TSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--- 238 (719)
Q Consensus 163 ~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~--- 238 (719)
.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence 99999999865 346899999999999999999999999 9999999999999855 6999999999875542211
Q ss_pred -ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 239 -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 239 -~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+. ....+...+.++.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHHHH
Confidence 1223356799999876 458999999999999999999 78898763 4445555555442 22234556789999999
Q ss_pred HhcC-CCCCCCCHHHHHc
Q 005017 316 KCLV-PASERLSAKDLLK 332 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~ 332 (719)
+||. +|.+|||+.++++
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.13 Aligned_cols=242 Identities=21% Similarity=0.329 Sum_probs=192.9
Q ss_pred EEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++.+...+ ...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEE
Confidence 368999999999998653 34679999875321 2345678889999999999999999999776433 3577899
Q ss_pred ecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 160 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
||+.+|+|.+++.+. ...++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence 999999999999764 34677888999999999999999998 9999999999999855 699999999987543221
Q ss_pred -----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 238 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 238 -----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG-~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....+++.|+|||.+. ..++.++|||||||++|||++| .+||.. .+...+...+..+..+. .+...++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 12334677899999875 4689999999999999999996 555654 55666666666554333 334457789
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+++.+||. +|.+||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.34 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=200.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~ 150 (719)
..+.+.+.||+|+||.||+|.+. ..+..||+|+++... .....+.+.+|+.+|.++. |||||+++++|...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34667899999999999999853 456789999997532 1234467889999999997 99999999998765
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-------------------------------------------------------
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK------------------------------------------------------- 175 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~------------------------------------------------------- 175 (719)
..+++||||+.+|+|.+++.+.+
T Consensus 114 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 114 --GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred --CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 45889999999999999986432
Q ss_pred -------------------------------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccce
Q 005017 176 -------------------------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 212 (719)
Q Consensus 176 -------------------------------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~N 212 (719)
.+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcce
Confidence 2566778889999999999999988 9999999999
Q ss_pred eEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCH
Q 005017 213 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNP 286 (719)
Q Consensus 213 ILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~ 286 (719)
||++.+ +.+||+|||+++...... .....+++.|||||++.. .++.++||||||+++|||++ |+.||......
T Consensus 270 iLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 270 VLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999854 699999999997543221 223457889999998764 58899999999999999998 89999875555
Q ss_pred HHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 287 ~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
......+..+..+ ..+...+.++.+++.+||. +|.+||++++|++.
T Consensus 349 ~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555555555433 2344567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.18 Aligned_cols=240 Identities=25% Similarity=0.377 Sum_probs=192.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCe--EEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~--~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
++||+|+||.||+|.++.+|. .+|+|.++... .....+.+.+|++++.++ +||||+++++++... ..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence 368999999999999988776 46777765321 234456788999999999 899999999988654 4588999
Q ss_pred ecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 160 ELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+||+++.+ +.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEE
Confidence 9999999999987542 4788999999999999999999998 9999999999999855 6999
Q ss_pred EeecchhhhccCCCc-ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 224 IGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 224 L~DFGlA~~~~~~~~-~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
|+|||++........ .....++.|+|||++. ..++.++||||||+++|||++ |..||.. .+....+..+..+..+.
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE 231 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCCC
Confidence 999999853322111 1123456799999875 458899999999999999997 9999976 44555666665543332
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334467889999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=301.51 Aligned_cols=243 Identities=19% Similarity=0.395 Sum_probs=199.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 76 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICL 76 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEE
Confidence 5677899999999999999875 577899998764322 235688999999999999999999987654 45889
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++... ..++++.++.++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccC
Confidence 99999999999998764 45899999999999999999999999 9999999999999854 69999999998655332
Q ss_pred Cc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 237 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 237 ~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. ....++..|+|||++. +.++.++||||||+++|||++ |..||.. .....+...+..+..+. .+...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQSVY 231 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCHHHH
Confidence 21 1223467899999876 468899999999999999998 8999976 44566666666554332 2345678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 005017 312 GFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+|+.+||. +|.+|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=340.99 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=187.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCC-eEEEEEEEe-------------eccccCChhhHHHHHHHHHHHHhCCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVK-------------IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g-~~VAvK~i~-------------~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk 142 (719)
..|++.+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.+|++++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 45788899999999999998764332 222222110 0111112234567889999999999999999
Q ss_pred EEEeeecCCCCceeEEEecccCCChhHHhhhc-----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 143 l~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~-----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
+++++...+ ..|+|++++. ++|..++... .......++.|+.||+.||.|||+++ ||||||||+|||++.
T Consensus 228 l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 228 IEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred EeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 999886654 5788999985 5777776432 22446678889999999999999999 999999999999985
Q ss_pred CCCcEEEeecchhhhccCCC---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCC-CCCC-CCH-HHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP-YSEC-KNP-AQIF 290 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~~---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~P-f~~~-~~~-~~i~ 290 (719)
+ |.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..| |... ..+ .++.
T Consensus 303 ~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 D-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred C-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 5 799999999997664332 234679999999998864 589999999999999999999864 4322 122 2222
Q ss_pred HHHHcCC-----CCC-------------------c----c-ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 291 KKVTSGI-----KPA-------------------S----L-AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 291 ~~i~~g~-----~p~-------------------~----~-~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+.+.... .|. . + ....+..+.++|.+||. ||.+|||+.|+|.||||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 2221100 000 0 0 01234567888999998 999999999999999997543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.25 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=201.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..|++.+.||+|+||.||+|..+. ....|++|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-
Confidence 346677899999999999998654 34678888765322 123567899999999999999999999987554
Q ss_pred CCceeEEEecccCCChhHHhhhcc---------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcE
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK---------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~---------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~v 222 (719)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.+ +.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcE
Confidence 45889999999999999998655 6899999999999999999999999 9999999999999855 799
Q ss_pred EEeecchhhhccCC---CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCC
Q 005017 223 KIGDLGLAIAMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 223 KL~DFGlA~~~~~~---~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
+|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+.
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~ 235 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGK 235 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCC
Confidence 99999998644322 122345677899999875 457889999999999999999 78899763 4455566665554
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+.......+..+.+++.+||. +|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4444445567899999999998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.63 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=192.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC----------------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF----------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV 140 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~----------------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 140 (719)
+.|++.+.||+|+||.||++.+.. ++..||+|.++... .......+.+|+.+|+.++||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence 347889999999999999985432 34578999886432 23455788999999999999999
Q ss_pred eeEEEeeecCCCCceeEEEecccCCChhHHhhhcc-----------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 141 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~-----------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
+++++++...+ .+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+|||||
T Consensus 82 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlk 157 (296)
T cd05095 82 IRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLA 157 (296)
T ss_pred ceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 99999886654 5889999999999999987542 3677889999999999999999999 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh--ccCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSE 282 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT--G~~Pf~~ 282 (719)
|+|||++.+ +.++|+|||++..+..... ....+++.|+|||+.. +.++.++|||||||++|||+| |..||..
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999854 7999999999876543221 2233467899999654 568999999999999999998 7789876
Q ss_pred CCCHHHHHHHHHc----C--CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 283 CKNPAQIFKKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 283 ~~~~~~i~~~i~~----g--~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
. +..+....... . ......+...++.+++|+.+||. +|.+||++.++++
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 L-SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred c-ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 33333322211 1 01111223456899999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.19 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=201.7
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEe
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKS 146 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~ 146 (719)
.+.+|.+.+.||+|+||.||+|.+.. .+..||+|.++... .....+.+.+|+.+++++ +||||++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34568899999999999999997643 23468999776332 234567889999999999 89999999998
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
+... ..+++|+||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||
T Consensus 87 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 87 CTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EccC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 8654 45889999999999999987532 3778889999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECK 284 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~ 284 (719)
+|||++.+ +.+||+|||+++...... .....++..|+|||++.+ .++.++||||||+++|||++ |..||.. .
T Consensus 163 ~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~ 240 (334)
T cd05100 163 RNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-I 240 (334)
T ss_pred ceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-C
Confidence 99999855 699999999987654321 112234567999998754 58999999999999999998 8899976 4
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
+....+..+..+..+. .+...+.++.++|.+||. +|.+||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 241 PVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 5666666666654332 334556789999999998 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.22 Aligned_cols=250 Identities=24% Similarity=0.417 Sum_probs=200.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.+++++.+.||+|+||.||+|.... ++..||+|.++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 3566777999999999999998543 4889999998754321 34678999999999999999999999887766
Q ss_pred CCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
....++||||+++++|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 667899999999999999997755 6899999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCCCc-----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCH--------------HHHH
Q 005017 231 IAMQQPTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIF 290 (719)
Q Consensus 231 ~~~~~~~~-----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--------------~~i~ 290 (719)
........ ....++..|+|||.+. ..++.++||||||+++|||+||..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 76653211 1223456799999775 45889999999999999999999998653211 1122
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+.. ...+...+.++.+++.+||. +|.+|||+.+++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222222 22233456789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=348.91 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=203.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC-CC----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF-AG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~-~g----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
...+.+.+.||+|+||.||.|.... .| ..||+|.++.. .+.+....|.+|..+|+.++|||||+++|.+.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4567788999999999999997654 23 34888887643 2356778999999999999999999999999884
Q ss_pred CCCceeEEEecccCCChhHHhhhc-------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
. ..++++|||++|+|..||++. ..++.+....++.||++|+.||++++ +|||||-++|+|++.. ..||
T Consensus 768 ~--~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VK 842 (1025)
T KOG1095|consen 768 G--PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVK 842 (1025)
T ss_pred C--CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEE
Confidence 4 477899999999999999875 24889999999999999999999999 9999999999999966 6999
Q ss_pred EeecchhhhccCCCcccc----cCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCC
Q 005017 224 IGDLGLAIAMQQPTARSV----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 224 L~DFGlA~~~~~~~~~~~----~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
|+|||+|+.+........ .-...|||||.+. +.++.++|||||||++||++| |..||.+..+ .++...+..+-
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHHHhCC
Confidence 999999985433322111 1235899999886 679999999999999999999 6899988544 45555444433
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.-..+..++..+.+++..||. +|.+||++..|++
T Consensus 922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 334466777888999999998 8999999999998
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.02 Aligned_cols=249 Identities=33% Similarity=0.466 Sum_probs=200.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+..|+.++++++|+||+++++++... ..+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEE
Confidence 3456789999999999999999999999999886531 123446778899999999999999999988655 568899
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
+||+. ++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||+|+||+++.+ |.+||+|||++.......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPL 152 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCc
Confidence 99997 5999999876 57999999999999999999999999 9999999999999864 799999999987654332
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC-----------------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG----------------- 296 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g----------------- 296 (719)
.....++..|+|||.+.+ .++.++|||||||++|||++|..||......... ..+...
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-FKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHHHhCCCcHHHHHhhccccc
Confidence 223456788999998753 5789999999999999999999999764333222 211110
Q ss_pred ---CCCC-------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 297 ---IKPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 297 ---~~p~-------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
..+. ......+..+.++|.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011226789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=336.38 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=178.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCC----CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeee--
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFA----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV-- 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~----g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~-- 148 (719)
....|.+.+.||+|+||.||+|.+..+ +..||+|++.... ..+....+ .+....+.+++.++..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 445688899999999999999999988 9999999875321 11111111 222223333333322221
Q ss_pred --cCCCCceeEEEecccCCChhHHhhhccc--------------------ccHHHHHHHHHHHHHHhhhhhcCCCCeeee
Q 005017 149 --DDKKKTVNMITELFTSGNLRQYRKKHKN--------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHR 206 (719)
Q Consensus 149 --~~~~~~l~lV~Ey~~gGsL~~~L~~~~~--------------------l~~~~i~~i~~QIl~gL~yLHs~~ppIIHr 206 (719)
......+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 1334578999999999999998864321 123456789999999999999998 9999
Q ss_pred cCccceeEecCCCCcEEEeecchhhhccCC---CcccccCCCCCCCcccccc-----------------------ccCcc
Q 005017 207 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNEL 260 (719)
Q Consensus 207 DLKp~NILl~~~~G~vKL~DFGlA~~~~~~---~~~~~~GT~~YmAPEvl~~-----------------------~~s~k 260 (719)
||||+|||++.+.+.+||+|||+|+.+... .....+||+.|||||.+.. .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999999866679999999999765432 2345689999999996521 23456
Q ss_pred ccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC----------C---Cc------cccCCChHHHHHHHHhcC-C
Q 005017 261 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK----------P---AS------LAKVNDPQIKGFIEKCLV-P 320 (719)
Q Consensus 261 sDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~----------p---~~------~~~~~~~~l~~lI~kcL~-d 320 (719)
+|||||||++|||+++..|+.. ...+....+..... + .. .....+....+||.+||. |
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999998776543 22222222211100 0 00 001112345689999998 8
Q ss_pred CCCCCCHHHHHcCccCccccC
Q 005017 321 ASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 321 P~~RpSa~eLL~hpf~~~~~~ 341 (719)
|.+|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999986554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.86 Aligned_cols=236 Identities=19% Similarity=0.295 Sum_probs=184.9
Q ss_pred EEeeeCCeEEEEEEEcCC------------------------CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC
Q 005017 84 VLGKGAFKTVYKAFDEFA------------------------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~------------------------g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN 139 (719)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 489999999999974322 2458888775432 234467888999999999999
Q ss_pred ceeEEEeeecCCCCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC
Q 005017 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 140 IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~ 218 (719)
|+++++++.... ..++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 999999987654 57889999999999999875 456899999999999999999999998 9999999999999742
Q ss_pred ------CCcEEEeecchhhhccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHh-hccCCCCCCCCHHHH
Q 005017 219 ------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQI 289 (719)
Q Consensus 219 ------~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~Eml-TG~~Pf~~~~~~~~i 289 (719)
.+.+|++|||++...... ....+++.|+|||.+.+ .++.++||||||+++|||+ +|+.||... .+.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHH
Confidence 124899999987543222 23457888999998754 4889999999999999994 789999764 33333
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
........ ..+....+.+.++|.+||. +|.+|||+.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222211 1222345689999999998 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.72 Aligned_cols=243 Identities=23% Similarity=0.401 Sum_probs=198.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
+..+++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~ 75 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI 75 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCe
Confidence 456788999999999999999765 56679999876432 234678899999999999999999998765 457
Q ss_pred eEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++|||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~ 152 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVI 152 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeec
Confidence 8999999999999999763 35788899999999999999999998 9999999999999855 79999999998755
Q ss_pred cCCCc---ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~---~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... ....++..|+|||++.. .++.++||||||+++|+|+| |..||.. .+.......+..+.... .....+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENCPE 230 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCCC-CcccCCH
Confidence 43221 12235677999998864 58889999999999999999 8999986 34455555665554332 3345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.+++.+||. +|.+||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999998 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=304.58 Aligned_cols=237 Identities=19% Similarity=0.330 Sum_probs=184.9
Q ss_pred EEEeeeCCeEEEEEEEcC------------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 83 EVLGKGAFKTVYKAFDEF------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~------------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
+.||+|+||.||+|.... ....||+|.+.... ......+..|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 368999999999997432 23458888765432 23456788899999999999999999988755
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC------CcEE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH------GEVK 223 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~------G~vK 223 (719)
...++||||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+. +.+|
T Consensus 77 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 77 --VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred --CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeE
Confidence 3578999999999999998754 56899999999999999999999999 99999999999997432 1389
Q ss_pred EeecchhhhccCCCcccccCCCCCCCccccc--cccCccccchhhHHHHHHHh-hccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 224 IGDLGLAIAMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 224 L~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~Eml-TG~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
++|||++...... ....|+..|+|||++. ..++.++|||||||++|||+ +|..||... ...+.. ....+...
T Consensus 153 l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~~~- 227 (262)
T cd05077 153 LSDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQCM- 227 (262)
T ss_pred eCCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcCcc-
Confidence 9999998654322 3456888999999875 45889999999999999997 588888753 222222 22222111
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.....+++++++|.+||. +|.+||++.+|+++
T Consensus 228 -~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 -LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235689999999998 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.66 Aligned_cols=227 Identities=20% Similarity=0.280 Sum_probs=186.8
Q ss_pred eCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCCh
Q 005017 88 GAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 167 (719)
Q Consensus 88 G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL 167 (719)
|.||.||++.++.+|+.||+|++.... .+.+|...+....||||+++++++... ..+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 899999999999999999999987532 123455556667899999999988654 468899999999999
Q ss_pred hHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCC
Q 005017 168 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247 (719)
Q Consensus 168 ~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~Y 247 (719)
.+++.+...+++..+..|+.|++.||.|||+++ |+||||||+||+++.+ |.++++|||.+....... ....++..|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhcccccc-ccCCcCccc
Confidence 999988888999999999999999999999999 9999999999999865 699999999876554432 334567889
Q ss_pred CCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCC
Q 005017 248 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 325 (719)
Q Consensus 248 mAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~Rp 325 (719)
+|||.+. ..++.++||||+|+++|||++|+.|+..... .. .......++...++.++++|.+||. ||.+||
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999876 4588999999999999999999988754211 11 1111122344567899999999998 899999
Q ss_pred CH-----HHHHcCccC
Q 005017 326 SA-----KDLLKDPFL 336 (719)
Q Consensus 326 Sa-----~eLL~hpf~ 336 (719)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=299.94 Aligned_cols=239 Identities=22% Similarity=0.409 Sum_probs=197.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||++. .++..||+|.++... ..+.+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcE
Confidence 346788999999999999985 578899999886432 336788999999999999999999987543 368
Q ss_pred EEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.+ |.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceecc
Confidence 9999999999999997643 4789999999999999999999998 9999999999999855 699999999986543
Q ss_pred CCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
.. ......+..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+.......+..+..+. .....++.+++
T Consensus 152 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (254)
T cd05083 152 MG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK-MSLKEVKECVEKGYRME-PPEGCPADVYV 228 (254)
T ss_pred cc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhCCCCCC-CCCcCCHHHHH
Confidence 32 12233467899999876 468899999999999999998 9999987 34555566666554433 33456789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHc
Q 005017 313 FIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.+||. +|.+||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=301.91 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=201.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcC-CCeEEEEEEEeecccc------CChhhHHHHHHHHHHHHh-CCCCCceeEEEeeecC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVL------QLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVDD 150 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~~------~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~~~~~~~ 150 (719)
|.+.+.||+|+||.||+|.+.. ++..+|+|.+...... .......++.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999987 6889999988754321 223455677889988875 7999999999988654
Q ss_pred CCCceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEe
Q 005017 151 KKKTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||||+||+++.+ +.+||+
T Consensus 82 --~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~ 156 (269)
T cd08528 82 --DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTIT 156 (269)
T ss_pred --CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEe
Confidence 468899999999999988743 3468999999999999999999996 56 9999999999999855 699999
Q ss_pred ecchhhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 226 DLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 226 DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
|||++...... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..++...
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence 99998765443 2345568999999998764 488999999999999999999999976 34444555555544433333
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...++.+.++|.+||. +|.+||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 4567899999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=308.31 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=188.5
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhh-------HHHHHHHHHHHHhCCCCCce
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGD-------LQKLYSEVHLLKSLKDDNVV 141 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~-------~~~~~~Ei~iL~~L~HpNIV 141 (719)
.+..+..|++.++||+|+||+||+|.+..+ +..+|+|...........+. ......+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 355667899999999999999999998777 66777776543321110000 01122344556678999999
Q ss_pred eEEEeeecCCCC--ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC
Q 005017 142 KFYKSWVDDKKK--TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219 (719)
Q Consensus 142 kl~~~~~~~~~~--~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~ 219 (719)
++++++...... ..+++++++.. ++.+.+......++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~- 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN- 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-
Confidence 999876544322 34577787743 67777766556788899999999999999999999 9999999999999855
Q ss_pred CcEEEeecchhhhccCC---------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHH
Q 005017 220 GEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 289 (719)
Q Consensus 220 G~vKL~DFGlA~~~~~~---------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i 289 (719)
+.+||+|||+|+..... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 69999999999765321 1123469999999998765 5899999999999999999999999875332222
Q ss_pred --------HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 290 --------FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 290 --------~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+.+..+.. .....++++.++++.|+. +|.+||++.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222222211 123456889999999998 8999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.03 Aligned_cols=269 Identities=25% Similarity=0.384 Sum_probs=229.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|.+..+||+|+||.|.+|..+.+.+.+|||+++.+-..+. .+.+--..|-++|... +-|.++.++.+|..- +.+|
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTm--DRLy 426 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM--DRLY 426 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhh--hhee
Confidence 35667899999999999999998999999999998776663 4556667788888877 457888888877544 4699
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc--c
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--Q 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~--~ 234 (719)
+||||+.||+|--.++..+++.+..+..++..|+-||-|||+++ ||+||||.+||+++.+ |++||+|||+++.. .
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFD 503 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccC
Confidence 99999999999999999999999999999999999999999999 9999999999999976 89999999999753 4
Q ss_pred CCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
..+++++||||.|+|||++. +.|+..+|+||||++||||+.|++||.+ .+..++++.|.... ..+++..+.++.++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~i 580 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAI 580 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHH
Confidence 45678899999999999876 6799999999999999999999999988 67888999888743 45677888999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccCccccCCCCCCCCCCCcchh
Q 005017 314 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQS 355 (719)
Q Consensus 314 I~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~~~~~~l~~p~~~ 355 (719)
.+..|. .|.+|.. -.++-.||||+...|.......++.|..+
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkP 628 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKP 628 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCC
Confidence 999997 7999975 37889999999988876555555555543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=301.81 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=197.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC--
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK-- 153 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~-- 153 (719)
|++.++||+|+||.||+|.++. +|..||+|++..... .....+++.+|++++++++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 3567889999999999998653 578999999865432 234567789999999999999999999987654321
Q ss_pred --ceeEEEecccCCChhHHhhhc------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 154 --TVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 154 --~l~lV~Ey~~gGsL~~~L~~~------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
..+++++|+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEEC
Confidence 346889999999999886432 24788999999999999999999998 9999999999999855 699999
Q ss_pred ecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 005017 226 DLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 226 DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
|||++....... .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.. .+...++..+..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987654321 123345678999998764 57889999999999999999 8899876 4455566655554332
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
. .....++.+.+++.+||. +|.+|||+.++++.
T Consensus 235 ~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 233456799999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.80 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=196.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.++..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 45667889999999999999877776 46878775332 123345688999999999999999999988643
Q ss_pred ceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++++||+++|+|.+++..++ .+++..+..|+.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcccccccc
Confidence 3568999999999999987654 5899999999999999999999999 9999999999999754 6899999999976
Q ss_pred ccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 233 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 233 ~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....++..|+|||++. ..++.++||||||+++|||++ |..||.+. ........+..+..+ ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 236 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPIC 236 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCC
Confidence 54322 12234577899999876 458999999999999999997 89999763 344444444444333 233456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+..+++++.+||. +|.+||++.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7889999999997 89999999999884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.51 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=213.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL---PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~---~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
+|-+..+||+|||+.||+|+|....+.||+|+-...+.... ....+...+|..+.+.|.||.||++|++|.-+. ..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-ds 542 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-DS 542 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-cc
Confidence 34456889999999999999999999999997665442221 122345678999999999999999999986543 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~ 232 (719)
++-|+|||+|.+|+-||+.++.+++++++.|+.||+.||.||....|||||-||||.|||+-. ..|.+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 788999999999999999999999999999999999999999999999999999999999842 247899999999998
Q ss_pred ccCCCc---------ccccCCCCCCCccccc-c----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--
Q 005017 233 MQQPTA---------RSVIGTPEFMAPELYE-E----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-- 296 (719)
Q Consensus 233 ~~~~~~---------~~~~GT~~YmAPEvl~-~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g-- 296 (719)
+..... ....||.+|++||.|- + ..+.++||||.|+|+|..+.|+.||........+.+..+--
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 865432 3457999999999763 2 47899999999999999999999998755555554433211
Q ss_pred -CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 297 -IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 297 -~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
........+.++++++||++||+ .-..|..+.+|-.||+|.+
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11122234567899999999999 6889999999999999975
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=301.81 Aligned_cols=240 Identities=26% Similarity=0.417 Sum_probs=192.7
Q ss_pred EEeeeCCeEEEEEEEcCCC------eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 84 VLGKGAFKTVYKAFDEFAG------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g------~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CCeEE
Confidence 5899999999999876433 679999875432 123456788999999999999999999988654 45889
Q ss_pred EEecccCCChhHHhhhc-------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC----CcEEEee
Q 005017 158 ITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGD 226 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~----G~vKL~D 226 (719)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+. ..+||+|
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999998642 34788999999999999999999998 99999999999998542 1799999
Q ss_pred cchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 227 LGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 227 FGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
||++....... .....++..|+|||++. +.++.++|||||||++|||+| |..||.. .+..+....+..+..+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~- 232 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA-LNNQEVLQHVTAGGRL- 232 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc-cCHHHHHHHHhcCCcc-
Confidence 99987553321 12234578899999876 458999999999999999998 9999976 3445555555544332
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
......++.+.++|.+||. +|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2334457889999999998 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=308.36 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=207.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHH-HhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL-KSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
..||.|+||+|++-.++.+|+..|||+++.... ....+++..|.... +.-+.||||+|||..+.++. .|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHHH
Confidence 469999999999999999999999999986553 35567888888764 45579999999999877655 8899999
Q ss_pred ccCCChhHHhh-----hcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 162 FTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 162 ~~gGsL~~~L~-----~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|.- ||..+-+ +...+++..+..+...++.||.||-.. + |||||+||+|||++.. |.+||||||.+..+..
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH-GDVKLCDFGICGQLVD 220 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC-CCEeeecccchHhHHH
Confidence 954 7765433 345799999999999999999999864 6 9999999999999965 8999999999988776
Q ss_pred CCcc-cccCCCCCCCccccc---cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc----cCCC
Q 005017 236 PTAR-SVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA----KVND 307 (719)
Q Consensus 236 ~~~~-~~~GT~~YmAPEvl~---~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~----~~~~ 307 (719)
..+. .-.|-..|||||.+. .+|+.++||||||++|||++||.+||.+..+..+....+..|..|.-.. ...+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 6543 346888999999885 3599999999999999999999999998777766677777776664433 2257
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..++.||..||. |.+.||...+|+++||++...
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 889999999997 799999999999999997543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.48 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=199.3
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.++||+|.||+||+|....+++.||+|+++.++.. ........+||-+|+.|+|.|||++++....+. .+.+|+||
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrldddd--egvpssalreicllkelkhknivrl~dvlhsdk--kltlvfe~ 82 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEF 82 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCC--CCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEeHHH
Confidence 46899999999999999999999999999987632 345567889999999999999999999765444 47789999
Q ss_pred ccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--c
Q 005017 162 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 238 (719)
Q Consensus 162 ~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--~ 238 (719)
|.. +|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||+|.||+.+ |.+|++|||+|+.+.-+. .
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEee
Confidence 955 78887765 567999999999999999999999999 9999999999999866 899999999998877654 2
Q ss_pred ccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc-CCC-CCccc----------
Q 005017 239 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS-GIK-PASLA---------- 303 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~-g~~-p~~~~---------- 303 (719)
...+-|.+|++|.++-+ -|++..|+||.|||+.|+.. |++-|.+..-..|+.+.... |.. ...++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 33456999999998865 49999999999999999986 45556664444444332211 110 00011
Q ss_pred --------------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 304 --------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 304 --------------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
...+..-+++++++|. +|.+|.+|++.|+||||..
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0112356899999998 8999999999999999974
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=306.80 Aligned_cols=257 Identities=31% Similarity=0.469 Sum_probs=201.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
+|.....||+|.||.||+|+.+.++. .+|+|+++..+.. .......-+|+.+++.|+||||+.+...|... .+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 45666789999999999997665443 7899998865332 13335667999999999999999999988865 46
Q ss_pred ceeEEEecccCCChhHHhhhc-----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC---CCcEEEe
Q 005017 154 TVNMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIG 225 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~---~G~vKL~ 225 (719)
.+++++||.+. +|.+.++-+ +.++...++.++.||+.|+.|||++- |+||||||.|||+.++ .|.|||+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence 79999999987 888877643 45899999999999999999999998 9999999999999755 4799999
Q ss_pred ecchhhhccCCC-----cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCC------CCHHHH--H
Q 005017 226 DLGLAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQI--F 290 (719)
Q Consensus 226 DFGlA~~~~~~~-----~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~------~~~~~i--~ 290 (719)
|||+++.+..+. ...++-|.+|+|||++-+ .|+.++|||+.|||+.||+|.++-|.+. .+|.+. .
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999887653 345677999999998764 5999999999999999999988877541 111111 1
Q ss_pred HHHHc--CCC-----------CC----------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 291 KKVTS--GIK-----------PA----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 291 ~~i~~--g~~-----------p~----------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
.+|-. |.+ |. ...+..++...+|+.++|. ||-+|.|+++.|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 11110 100 00 0012346678899999998 999999999999999
Q ss_pred cCcccc
Q 005017 335 FLQVEN 340 (719)
Q Consensus 335 f~~~~~ 340 (719)
||....
T Consensus 339 yF~~d~ 344 (438)
T KOG0666|consen 339 YFTEDP 344 (438)
T ss_pred ccccCC
Confidence 998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.74 Aligned_cols=243 Identities=22% Similarity=0.376 Sum_probs=205.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
...|.+...+|.|+|+.|..+.+..+++..++|++.... ....+|+.++... +||||+++++.+.+ ...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYED--GKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecC--Cce
Confidence 344566777999999999999999999999999987542 1233577555554 79999999997754 466
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+|||++.||.|.+.+...+.+. ..+..|++||+.|+.|||++| +|||||||+|||++++.|+++|+|||.++...
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999999999998887766555 778889999999999999999 99999999999996566899999999998876
Q ss_pred CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.. ..+.+-|..|.|||++.. .|++++||||||++||+|++|+.||....+..++...+..+. +....+.++++|
T Consensus 468 ~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdL 542 (612)
T KOG0603|consen 468 RS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDL 542 (612)
T ss_pred hh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHH
Confidence 65 344566889999999875 599999999999999999999999987666656666665543 336678999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccC
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
|.+||+ +|.+||++.+++.||||
T Consensus 543 l~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhccCChhhCcChhhhccCcch
Confidence 999998 99999999999999999
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=331.84 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=210.4
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC---CCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD---KKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~---~~~~ 154 (719)
+.+.++||.|.+|.||++.++.+|+.+|+|+.....- .-+++..|..+|+.+ .|||++.+|++|... ..+.
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 4677999999999999999999999999998876542 336677899999988 699999999988653 3457
Q ss_pred eeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+|||||||.+||..|.+++. .++.|..+..|++.++.||.+||.+. +||||||-.|||++.+ |.|||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEeeeeeeee
Confidence 99999999999999998764 46899999999999999999999999 9999999999999966 7999999999987
Q ss_pred ccCC--CcccccCCCCCCCcccccc------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-c
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-A 303 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~-~ 303 (719)
+... ...+.+|||.|||||++.. .|+.++|+||||+++.||.-|.+|+.+......+++. ....+|... +
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-pRNPPPkLkrp 251 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-PRNPPPKLKRP 251 (953)
T ss_pred eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-CCCCCccccch
Confidence 7543 4567899999999999852 4788999999999999999999999885544444433 232222222 4
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+.++.++.+||..||. |-.+||+..++|+|||+.
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 5567889999999998 899999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=326.94 Aligned_cols=204 Identities=29% Similarity=0.453 Sum_probs=174.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----CC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~~ 153 (719)
-+...+.||+||||.||+|+++.+|+.||||.++... .....++.-+|+++|++|+|||||++++.-.... .+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3455789999999999999999999999999988644 3456688899999999999999999999644433 34
Q ss_pred ceeEEEecccCCChhHHhhh---cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCC--cEEEeec
Q 005017 154 TVNMITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHG--EVKIGDL 227 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~---~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G--~vKL~DF 227 (719)
.-.+|||||.||||+..+.+ ..++++.+++.++..+..||.|||+++ |+||||||.||++.. ..| .-||+||
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 56689999999999999975 457999999999999999999999999 999999999999842 223 4699999
Q ss_pred chhhhccCC-CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCH
Q 005017 228 GLAIAMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 286 (719)
Q Consensus 228 GlA~~~~~~-~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~ 286 (719)
|.|+.+.+. ...+++||+.|.+||+++ +.|+..+|.|||||++|+.+||..||-....+
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999988765 456789999999999998 45899999999999999999999999654444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.11 Aligned_cols=240 Identities=34% Similarity=0.577 Sum_probs=204.4
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCChh
Q 005017 89 AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 168 (719)
Q Consensus 89 ~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~ 168 (719)
+||.||+|.+..+|..+|+|++....... ..+.+.+|++.+++++|+||+++++++... ...++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK---KRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc---HHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence 68999999999889999999987554321 157899999999999999999999988765 4588999999999999
Q ss_pred HHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-CcccccCCCCC
Q 005017 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEF 247 (719)
Q Consensus 169 ~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~~~~~~GT~~Y 247 (719)
.++.....+++..+..++.+++.+|.|||+.+ ++|+||+|+||+++.+ +.++|+|||.+...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence 99987766899999999999999999999998 9999999999999866 79999999999766543 34456789999
Q ss_pred CCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC-CChHHHHHHHHhcC-CCCCC
Q 005017 248 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKGFIEKCLV-PASER 324 (719)
Q Consensus 248 mAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~-~~~~l~~lI~kcL~-dP~~R 324 (719)
+|||.+. ..++.++||||||+++++|++|..||........+...+..+......... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999876 468889999999999999999999997755666666666655444332222 66789999999998 89999
Q ss_pred CCHHHHHcCccC
Q 005017 325 LSAKDLLKDPFL 336 (719)
Q Consensus 325 pSa~eLL~hpf~ 336 (719)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=314.54 Aligned_cols=259 Identities=22% Similarity=0.370 Sum_probs=212.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|...+.||-|+||.|.++....+...+|.|.+...+... .........|-.||..-..+-||+||.+|.+.+ .+|+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkd--nLYFV 707 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV 707 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--ceEEE
Confidence 334577999999999999888888899999998777654 345577889999999999999999999997665 59999
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc----
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---- 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~---- 234 (719)
|||++||++-.+|-+.+-|.+..++.++..+..|+++.|..| +|||||||+|||||.+ |++||+||||++-++
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceeccc
Confidence 999999999999999999999999999999999999999999 9999999999999966 899999999984221
Q ss_pred -----C------C-----------------------------CcccccCCCCCCCccccc-cccCccccchhhHHHHHHH
Q 005017 235 -----Q------P-----------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 273 (719)
Q Consensus 235 -----~------~-----------------------------~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~Em 273 (719)
. + .....+||+.|+|||++. .+|+..+|+||.|+|||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0 0 011346999999999886 5799999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHH-cCCCCCccccCCChHHHHHHHHhcCCCCCCC---CHHHHHcCccCccccCCC
Q 005017 274 VTFEYPYSECKNPAQIFKKVT-SGIKPASLAKVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 274 lTG~~Pf~~~~~~~~i~~~i~-~g~~p~~~~~~~~~~l~~lI~kcL~dP~~Rp---Sa~eLL~hpf~~~~~~~~ 343 (719)
+.|+.||......+..++.+. ............++++.++|.++...+..|+ .++++..||||+...+..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 999999987433222222111 1122333445568999999999888888776 478899999999877655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.41 Aligned_cols=247 Identities=23% Similarity=0.413 Sum_probs=210.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
-.++++.++||.|.||.|++|..+..|+ .||||.++... ...+...|+.|..+|.++.||||++|-|.. ...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKS 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecC
Confidence 3668899999999999999999988774 69999998654 245678899999999999999999999965 455
Q ss_pred CceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+.+++|+|||++|+|+.||+.+ +.++.-++..+++.|+.|+.||-+.+ +|||||-..|||+|.+. .+|++|||+++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL-vCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL-VCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce-EEEecccccee
Confidence 6799999999999999999875 56999999999999999999999999 99999999999999775 89999999999
Q ss_pred hccCCCc--ccccC---CCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 232 AMQQPTA--RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 232 ~~~~~~~--~~~~G---T~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
.+.++.. .+..| ..+|.|||.+. ++++.++|||||||+|||.++ |+.||.+..| .+.++.|..+...+. +-
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPp-Pm 857 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPP-PM 857 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCC-CC
Confidence 8765432 22222 35899999875 789999999999999999765 8999998655 556678888765443 44
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.++..+.+|+..||+ +..+||.+.+|+.
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 567899999999998 7999999999987
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.80 Aligned_cols=249 Identities=25% Similarity=0.463 Sum_probs=204.6
Q ss_pred CCCCCcEEEe-------EEEeeeCCeEEEEEEEcC--CC--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCce
Q 005017 73 DPSGRYVRYD-------EVLGKGAFKTVYKAFDEF--AG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141 (719)
Q Consensus 73 d~~gr~~~l~-------e~LG~G~fG~Vyka~d~~--~g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 141 (719)
.|++|.|.+. ++||.|-||.||+|.... .| ..||||..+.+. .++..+.|..|..+|+.++|||||
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIi 454 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHII 454 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchh
Confidence 4677777764 579999999999997532 23 458888776433 245678999999999999999999
Q ss_pred eEEEeeecCCCCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC
Q 005017 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 220 (719)
Q Consensus 142 kl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G 220 (719)
+++|.|.+. .+|+|||+++-|.|+.||+.++ .++......++.||+.||+|||+.+ +|||||-..|||+....
T Consensus 455 kLIGv~~e~---P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~- 528 (974)
T KOG4257|consen 455 KLIGVCVEQ---PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQ- 528 (974)
T ss_pred heeeeeecc---ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcc-
Confidence 999998754 4899999999999999999876 5899999999999999999999999 99999999999998765
Q ss_pred cEEEeecchhhhccCCCcc---cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 221 EVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~~~~~---~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
.|||+|||+++.+...... ...-..-|||||-++ +.++.++|||-||+|+||++. |..||.+..|.+.+ -.+..
T Consensus 529 CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEn 607 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIEN 607 (974)
T ss_pred eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecC
Confidence 8999999999988765322 222245799999876 679999999999999999876 78999986654433 34445
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
|..++ .+..++|.+..++.+||. +|.+||.+.+|..
T Consensus 608 GeRlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 GERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 54443 456678999999999999 9999999988754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.90 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=186.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEeeecCC--
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDDK-- 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~~~~~~~~-- 151 (719)
...+.+.++||+|+||.||+|. ..++.||||++.. +..+.+++|-.+.+. ++|+||++|++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 4556778899999999999995 4579999999874 345677777777665 58999999998532222
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-------CCCCeeeecCccceeEecCCCCcEEE
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-------HNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-------~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
...++||++|.+.|+|.+||+.+ .+++....+++..+++||+|||+ ++|+|+|||||..|||+..+ ++..|
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccI 357 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCI 357 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEe
Confidence 34789999999999999999865 58999999999999999999996 46789999999999999755 79999
Q ss_pred eecchhhhccCC----CcccccCCCCCCCccccccccC-------ccccchhhHHHHHHHhhcc------------CCCC
Q 005017 225 GDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTFE------------YPYS 281 (719)
Q Consensus 225 ~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~~~s-------~ksDIwSlGiil~EmlTG~------------~Pf~ 281 (719)
+|||+|..+... ....-+||.+|||||++++..+ .+.||||+|.+||||++.- .||.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999776533 2334689999999999987543 3589999999999999742 2232
Q ss_pred ----CCCCHHHHHHHHHcCCCCC----ccccCCC-hHHHHHHHHhcC-CCCCCCCHHHH
Q 005017 282 ----ECKNPAQIFKKVTSGIKPA----SLAKVND-PQIKGFIEKCLV-PASERLSAKDL 330 (719)
Q Consensus 282 ----~~~~~~~i~~~i~~g~~p~----~~~~~~~-~~l~~lI~kcL~-dP~~RpSa~eL 330 (719)
.....+++...+......+ .+.+... ..+++.++.||. ||..|.||.=+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1122334444444433333 3333322 457899999998 89999997533
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=301.34 Aligned_cols=257 Identities=20% Similarity=0.334 Sum_probs=202.8
Q ss_pred cccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CC----ceeE
Q 005017 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DN----VVKF 143 (719)
Q Consensus 70 ~e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pN----IVkl 143 (719)
...|.....|.+...+|+|.||.|..+.|..++..||+|+++-- ....+...-|+++|.+|.+ |+ +|.+
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 44555566677788999999999999999999999999998743 2455667789999999943 22 4555
Q ss_pred EEeeecCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC---
Q 005017 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--- 218 (719)
Q Consensus 144 ~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--- 218 (719)
.++|-. ...+++|+|.+ |-|+++|++.+. +++...++.++.|++.+++|||+.+ ++|.||||+|||+...
T Consensus 157 ~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 157 RDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred ehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceE
Confidence 554432 34689999999 669999998865 6899999999999999999999999 9999999999998321
Q ss_pred ----------------CCcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCC
Q 005017 219 ----------------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYS 281 (719)
Q Consensus 219 ----------------~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~ 281 (719)
.-.|+|+|||.|+...+.. .+.+.|..|+|||++-+ +++..+||||+||||+|++||..-|.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 1258999999998766554 56788999999998765 79999999999999999999999998
Q ss_pred CCCCHHHH--HHHHHcCCCCCc-----------------cc----------------------cCCC---hHHHHHHHHh
Q 005017 282 ECKNPAQI--FKKVTSGIKPAS-----------------LA----------------------KVND---PQIKGFIEKC 317 (719)
Q Consensus 282 ~~~~~~~i--~~~i~~g~~p~~-----------------~~----------------------~~~~---~~l~~lI~kc 317 (719)
...+.+.+ ++.|.. ..|.. ++ ...| .++.+||++|
T Consensus 311 tHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 87766643 333322 11100 00 0111 2578899999
Q ss_pred cC-CCCCCCCHHHHHcCccCcc
Q 005017 318 LV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 318 L~-dP~~RpSa~eLL~hpf~~~ 338 (719)
|. ||.+|+|+.|+|.||||..
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HccCccccccHHHHhcCHHhhc
Confidence 98 9999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.99 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=198.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.+.+.||+|-||.|.++.-. .+..||+|.++.... ......|.+|+++|.+|+|||||++++.|+.++ .+++|
T Consensus 540 L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI 613 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMI 613 (807)
T ss_pred eehhhhhcCcccceeEEEEec-CceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHH
Confidence 456789999999999999643 469999999986653 234588999999999999999999999998765 48899
Q ss_pred EecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 159 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|||++|+|.+|+.++. .+.-....+++.||++|++||.+.+ +|||||.+.|+|++++ +++||+|||+++-+-..
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccC
Confidence 99999999999999873 3344556779999999999999999 9999999999999977 59999999999865443
Q ss_pred Ccccc----cCCCCCCCccc-cccccCccccchhhHHHHHHHhh--ccCCCCCCCCHHHHHHHHHcC---CCC---Cccc
Q 005017 237 TARSV----IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSG---IKP---ASLA 303 (719)
Q Consensus 237 ~~~~~----~GT~~YmAPEv-l~~~~s~ksDIwSlGiil~EmlT--G~~Pf~~~~~~~~i~~~i~~g---~~p---~~~~ 303 (719)
..... +-..+|||||. +.++++.++|||+||+++||+++ .+.||.... .+++......- ..+ ...+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcCCCCcceeccCC
Confidence 33222 33579999994 56899999999999999999865 589998743 45554443321 111 2234
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..++..+.+++..||. +-.+|||+++|..|
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 5677889999999998 89999999998653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=309.42 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=186.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc----------------CCCeEEEEEEEeeccccCCh----------hhHHHHHHH
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE----------------FAGIEVAWSRVKIDDVLQLP----------GDLQKLYSE 128 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~----------------~~g~~VAvK~i~~~~~~~~~----------~~~~~~~~E 128 (719)
....|.+.++||+|+||+||+|.+. ..++.||+|+++........ ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4556888999999999999999752 34568999998754311000 011223457
Q ss_pred HHHHHhCCCCCc-----eeEEEeeecC------CCCceeEEEecccCCChhHHhhhc-----------------------
Q 005017 129 VHLLKSLKDDNV-----VKFYKSWVDD------KKKTVNMITELFTSGNLRQYRKKH----------------------- 174 (719)
Q Consensus 129 i~iL~~L~HpNI-----Vkl~~~~~~~------~~~~l~lV~Ey~~gGsL~~~L~~~----------------------- 174 (719)
+.++.+++|.++ ++++++|... .....++||||+++|+|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 6677776532 124578999999999999988632
Q ss_pred -ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC---cccccCCCCCCCc
Q 005017 175 -KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAP 250 (719)
Q Consensus 175 -~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~---~~~~~GT~~YmAP 250 (719)
..+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++....... .....+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999 9999999999999865 699999999996554321 1123458999999
Q ss_pred cccccc---------------------cC--ccccchhhHHHHHHHhhccC-CCCCCCCH----------HHHHHHHHcC
Q 005017 251 ELYEEE---------------------YN--ELVDIYSFGMCILEMVTFEY-PYSECKNP----------AQIFKKVTSG 296 (719)
Q Consensus 251 Evl~~~---------------------~s--~ksDIwSlGiil~EmlTG~~-Pf~~~~~~----------~~i~~~i~~g 296 (719)
|.+... |+ .+.||||+||++|+|++|.. ||.....- ...+..+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 976421 22 34799999999999999985 76532111 1111222222
Q ss_pred CCCCccccCCChHHHHHHHHhcC-CC---CCCCCHHHHHcCccCcc
Q 005017 297 IKPASLAKVNDPQIKGFIEKCLV-PA---SERLSAKDLLKDPFLQV 338 (719)
Q Consensus 297 ~~p~~~~~~~~~~l~~lI~kcL~-dP---~~RpSa~eLL~hpf~~~ 338 (719)
..........++..++|+.+||. +| .+|+|+.|+|+||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 22222334457899999999997 43 68999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.75 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=199.3
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec------CCCCce
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD------DKKKTV 155 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~------~~~~~l 155 (719)
..+||+|.||.||+|..+.+|+.||+|++-.+... ........+|+.+|..|+|+|++.++..|.. .....+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK--eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc--cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 36799999999999999999999999887653321 2333556789999999999999988776532 223468
Q ss_pred eEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
|+|+++|+. +|.-.|... .+++...+++++.+++.||.|+|... |+|||+||.|+||+++ |.+||+|||+++.+.
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFGlar~fs 175 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFGLARAFS 175 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeecccccccee
Confidence 999999987 888888765 57999999999999999999999999 9999999999999966 799999999997654
Q ss_pred CCCc------ccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHH--HHHHcCCCCCcc--
Q 005017 235 QPTA------RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF--KKVTSGIKPASL-- 302 (719)
Q Consensus 235 ~~~~------~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~--~~i~~g~~p~~~-- 302 (719)
.... ...+-|..|++||++- ..|+++.|||..||++.||.|+.+-+.+..+..++. ..+.....+..+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 3221 2234589999999775 469999999999999999999998888755444432 111111111101
Q ss_pred ----------------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 303 ----------------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 303 ----------------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+-+.++++.+|++++|. ||.+|+.++++|+|.||..+.
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 11235688999999998 999999999999999997543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.24 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=211.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+....+||.|-||.||.|+++.-...||||.++.+. ..+++|+.|..+|+.++|||+|++++.|..+ ..+|+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYI 340 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYI 340 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEE
Confidence 4566788999999999999999999999999987543 5678999999999999999999999998655 45899
Q ss_pred EEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+|||..|+|.+||..-. .++.-.++.++.||.+|++||..++ +|||||-..|+|+..++ .|||+|||+++.+..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnh-iVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-IVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccc-eEEeeccchhhhhcC
Confidence 999999999999998643 4777788899999999999999999 99999999999998664 999999999999987
Q ss_pred CCcccccCC---CCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 236 PTARSVIGT---PEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 236 ~~~~~~~GT---~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
++.....|. ..|.|||-+. ..++.++|||+||++|||+.| |-.||.+ .+..++|..+..+.... -+..+++.+
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkV 495 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKV 495 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHH
Confidence 765554453 4799999775 569999999999999999988 6789988 56788888888876544 456788999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+|+..||+ .|..||++.|+-+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHH
Confidence 999999999 9999999988854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=331.12 Aligned_cols=237 Identities=21% Similarity=0.308 Sum_probs=179.6
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
...++||+|+||.||+|.+..+|..||+|++..... ....|++.+++++|||||++++++.+.+ ..++||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEE
Confidence 445689999999999999999999999998863321 1124688999999999999999987654 578999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
||+++|+|.++++ .+++..+..++.||+.||+|||.+ .++|+||||||+||+++.+ +..++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-eccccccccC--
Confidence 9999999999996 388999999999999999999955 3459999999999999865 466665 6655433221
Q ss_pred ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHHHHc---CC-----CCCcccc----
Q 005017 239 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKKVTS---GI-----KPASLAK---- 304 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~-~~~i~~~i~~---g~-----~p~~~~~---- 304 (719)
....||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...+...... .. ..+....
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 23468999999998764 599999999999999999999999853211 1111111111 00 0001100
Q ss_pred --CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 305 --VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 305 --~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....++.+++.+||. +|.+|||+.++++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 011256788999998 89999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=286.67 Aligned_cols=269 Identities=20% Similarity=0.316 Sum_probs=220.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
...|.+.++||+|+|++|..+.++.+.+.+|+|+++.+-. +..+.++-.+.|-.+..+- +||.+|-++.+|..+ ..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~-nddedidwvqtek~vfe~asn~pflvglhscfqte--sr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE--SR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc-CCcccchhHHhhHHHHHhccCCCeEEehhhhhccc--ce
Confidence 3568889999999999999999999999999999986543 3345666677888887776 799999999988654 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++|.||++||+|--++++..+++++.++.+...|+.||.|||++| ||+||||.+|+|++.+ |++||+|+|+++..-
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCC
Confidence 9999999999999999998899999999999999999999999999 9999999999999966 899999999997643
Q ss_pred --CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCC--CCC-----CHHHHHHHHHcCCCCCcccc
Q 005017 235 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYS--ECK-----NPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 235 --~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~--~~~-----~~~~i~~~i~~g~~p~~~~~ 304 (719)
.+.+.++||||.|.|||++++ .|+..+|+|+||++++||+.|+.||. +.. ....+++.|..... .++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--ripr 480 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPR 480 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccc
Confidence 345678999999999999986 59999999999999999999999994 222 23345565554322 2344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCC------HHHHHcCccCccccCCCCCCCCCCCc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQKEPICDPLKLP 352 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpS------a~eLL~hpf~~~~~~~~~~~~~l~~p 352 (719)
..+-.+..+++.-|. ||.+|.. ..++-.|+||+...|.....+...+|
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 445566777888887 8998863 78999999999887765444444333
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=307.37 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=209.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCC-C--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFA-G--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~-g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+++.+.||+|.||+|++|.++.. | ..||||.++.+... .....|.+|+.+|.+|+|||++++||...+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc---ch
Confidence 355678999999999999976543 3 46999999876543 367899999999999999999999998765 34
Q ss_pred eeEEEecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+.||+|+++.|||.+.|.+ ...|....+..++.||+.|+.||.+++ .|||||-..|+|+-.. ..|||+||||.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceeeeecccceec
Confidence 7899999999999999987 235788889999999999999999999 9999999999999765 4899999999988
Q ss_pred ccCCCccccc-----CCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~~~~~~-----GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
+......... -...|+|||.++ +.++.++|||+||+++|||+| |+.||.++ +..++.+.|..+... .-++.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL-pRPk~ 339 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL-PRPKY 339 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-CCCCC
Confidence 7654333222 234799999886 679999999999999999998 68999984 678888888855433 34567
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
++..+.+++..||. +|.+|||+..|..+-+++.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 88899999999999 8999999999987666653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=293.11 Aligned_cols=246 Identities=28% Similarity=0.513 Sum_probs=189.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEeeecCC--
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDDK-- 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~~~~~~~~-- 151 (719)
.|.+.+.+.||+|.||.||+| .+.|+.||||++... +.+.+.+|.++... |+|+||+.|++.=..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeec--cccCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 477889999999999999999 467999999998743 34667787777765 69999999998543332
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc------CCCCeeeecCccceeEecCCCCcEEEe
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs------~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
...+|||++|.+.|||+|||.+ ..++.+...+++..+++||++||. .+|.|.|||||..|||+..+ |.+-|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA 358 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 358 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence 2368999999999999999987 568999999999999999999994 36789999999999999855 799999
Q ss_pred ecchhhhccCC------CcccccCCCCCCCccccccccC-------ccccchhhHHHHHHHhh----------ccCCCCC
Q 005017 226 DLGLAIAMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVT----------FEYPYSE 282 (719)
Q Consensus 226 DFGlA~~~~~~------~~~~~~GT~~YmAPEvl~~~~s-------~ksDIwSlGiil~EmlT----------G~~Pf~~ 282 (719)
|+|||...... ..+..+||.+|||||++....+ ..+||||||.++||++. -++||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999765443 2345689999999999976433 35899999999999985 2578865
Q ss_pred CC----CHHHHHHHHHcCCCCCccccC--CChH---HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 283 CK----NPAQIFKKVTSGIKPASLAKV--NDPQ---IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 283 ~~----~~~~i~~~i~~g~~p~~~~~~--~~~~---l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.. +-+++.+-+-.....+.++.. .++. +-.+++.||. +|.-|.||--+-+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 32 223343333222222222222 2344 4556899997 8999999876644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=275.04 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=208.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~ 154 (719)
...|.+.+.+|+|-++.||.|....++++++||+++. -..+++.+|+.+|..|. ||||+++++...+...+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3456677889999999999999988999999999984 34578999999999997 999999999988888888
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
..+|+||+.+.+.+..- +.++...++.++.|++.||.|+|+.| |+|||+||.|++||.....++|+|+|+|....
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 88999999887666543 46788889999999999999999999 99999999999999877789999999999887
Q ss_pred CCCc-ccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCC-CCCCCHHHHHHHHHc---------------
Q 005017 235 QPTA-RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIFKKVTS--------------- 295 (719)
Q Consensus 235 ~~~~-~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf-~~~~~~~~i~~~i~~--------------- 295 (719)
.... ...+.+..|--||++- ..|+...|+|||||++..|+..+-|| .+..|..|+++...-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 6643 3345678899999875 46999999999999999999998886 566677776542210
Q ss_pred ----------CC---------CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 296 ----------GI---------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 296 ----------g~---------~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+. .+..-....+|++.+|+.++|. |..+|+||+|.+.||||...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 00 0011112336899999999999 99999999999999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-33 Score=314.16 Aligned_cols=239 Identities=28% Similarity=0.386 Sum_probs=188.3
Q ss_pred eEEEeeeCCeE-EEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEE
Q 005017 82 DEVLGKGAFKT-VYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 82 ~e~LG~G~fG~-Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
.+++|.|+-|+ ||+|. ..|++||||++-. +-.....+|+..|+.- +|||||++|+ .+.+...+|+..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 56799999985 79995 5688999998753 2345678999999998 6999999987 566777899999
Q ss_pred ecccCCChhHHhhhc-ccc---cHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC----CCcEEEeecchhh
Q 005017 160 ELFTSGNLRQYRKKH-KNV---DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----HGEVKIGDLGLAI 231 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~-~~l---~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~----~G~vKL~DFGlA~ 231 (719)
|+|.. +|.++++.. ..+ .-...+..+.|+++||++||+.+ ||||||||+||||... ...++|+|||+++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99966 999999874 111 11345678999999999999999 9999999999999752 2478999999998
Q ss_pred hccCCC-----cccccCCCCCCCccccccc-cCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHHcCCC-CCccc
Q 005017 232 AMQQPT-----ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASLA 303 (719)
Q Consensus 232 ~~~~~~-----~~~~~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG-~~Pf~~~~~~~~i~~~i~~g~~-p~~~~ 303 (719)
.+.... .....||-+|+|||++... -+.++|||||||++|+.++| ..||.+. -+.-..|..+.. ...+.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---~~R~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---LERQANILTGNYTLVHLE 736 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---HHhhhhhhcCccceeeec
Confidence 875432 3456799999999998754 56789999999999999997 8999752 222223444433 22233
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
...+.++++||.+|+. +|..||+|.++|.||||=
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 3333389999999998 899999999999999994
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-33 Score=307.71 Aligned_cols=259 Identities=29% Similarity=0.518 Sum_probs=222.4
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
..+|...| .+..++|.|.||.||+|+|+.+|+..|+|+++..- .....-++.|+-+++.++|||||.+++.+...
T Consensus 10 rrnP~ddy-ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 10 RRNPQDDY-ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred hcCCccch-hheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 34554444 45578999999999999999999999999998764 34456678899999999999999999999876
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
++ +|++||||.+|+|.+.-.-.+.+++.++...++..+.||+|||+.+ -+|||||-.||+++ +.|.+|++|||.+
T Consensus 85 dk--lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvs 159 (829)
T KOG0576|consen 85 DK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVS 159 (829)
T ss_pred cC--cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCch
Confidence 55 8899999999999998887889999999999999999999999999 99999999999998 4589999999999
Q ss_pred hhccCC--CcccccCCCCCCCcccc----ccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc-
Q 005017 231 IAMQQP--TARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA- 303 (719)
Q Consensus 231 ~~~~~~--~~~~~~GT~~YmAPEvl----~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~- 303 (719)
..+... ....++|||.|||||+- .+.|+..+|||++|+.+.|+...++|-.+......++-.-.++..|+.+.
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD 239 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence 776644 34578999999999974 36799999999999999999999999776555556666667777776654
Q ss_pred -cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 304 -KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 304 -~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
...++.+-+|++.||. +|.+||+++.+|.|||....
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3357889999999997 89999999999999999744
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=266.45 Aligned_cols=209 Identities=29% Similarity=0.486 Sum_probs=180.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.||+|++|.|-+-++..+|...|+|.+...-. .+..+++.+|+.+..+. .+|.+|.|||.+..+.. +|+.||.
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME~ 126 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICMEL 126 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHHH
Confidence 569999999999999999999999999975432 35567888999887665 79999999998877655 8899999
Q ss_pred ccCCChhHH----hhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 162 FTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 162 ~~gGsL~~~----L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
|.. ||..| +++.+.+++..+-+++..++.||.|||++ . +||||+||+||||+.+ |+|||||||.+..+.+.
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYD-GQVKICDFGISGYLVDS 202 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccC-CcEEEcccccceeehhh
Confidence 954 77765 44567899999999999999999999997 6 9999999999999965 89999999999888877
Q ss_pred Cccc-ccCCCCCCCcccccc-----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 237 TARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 237 ~~~~-~~GT~~YmAPEvl~~-----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
.+.+ ..|-..|||||.+.. .|+-++||||||+.++||.++++||....++.+..+++.....|.
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 6665 568888999998752 589999999999999999999999999999999999988765543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=296.84 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=201.2
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC------CCceeEEEeeecCCCC
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD------DNVVKFYKSWVDDKKK 153 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H------pNIVkl~~~~~~~~~~ 153 (719)
.+.-..|+|-|++|.+|.|...|..||||+|.-..... +.=+.|+++|++|+. -++++|+..|... .
T Consensus 435 ~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--n 507 (752)
T KOG0670|consen 435 EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--N 507 (752)
T ss_pred EEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--c
Confidence 33455899999999999999999999999998654332 445689999999953 3789999888654 4
Q ss_pred ceeEEEecccCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 154 TVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
++|||+|.+ ..+|++.|++.+ ++..++++.++.|++.||..|-.++ |+|.||||+|||++.....+||||||.|
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccc
Confidence 699999998 569999999865 5889999999999999999999999 9999999999999977778999999999
Q ss_pred hhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH-HHHcCCCCC--------
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK-KVTSGIKPA-------- 300 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~-~i~~g~~p~-------- 300 (719)
..........+.-+..|.|||++-+ .|+...|+||.||+||||.||+..|.+..|...+-. .-..|..|.
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 8877666666666889999998776 699999999999999999999999998665443311 111111110
Q ss_pred -----------------------------------ccc----c---CCC------hHHHHHHHHhcC-CCCCCCCHHHHH
Q 005017 301 -----------------------------------SLA----K---VND------PQIKGFIEKCLV-PASERLSAKDLL 331 (719)
Q Consensus 301 -----------------------------------~~~----~---~~~------~~l~~lI~kcL~-dP~~RpSa~eLL 331 (719)
.+. . ..+ .++++|+.+||. ||.+|.|..+.|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 000 0 000 268899999998 999999999999
Q ss_pred cCccCcc
Q 005017 332 KDPFLQV 338 (719)
Q Consensus 332 ~hpf~~~ 338 (719)
+||||+.
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=303.43 Aligned_cols=244 Identities=25% Similarity=0.403 Sum_probs=203.3
Q ss_pred EEeEEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCC
Q 005017 80 RYDEVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 151 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 151 (719)
.+.+.||+|+||.|++|.... ....||||..+.... ..+.+.+..|+++|+.+ +||||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~---~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS---SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccC---cHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 455699999999999996431 145799998874432 25678899999999999 59999999999876
Q ss_pred CCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
...+++|+||+..|+|..|++..+ .++......++.||+.|++||++.. +|||||-++|||+
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLI 451 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEe
Confidence 456889999999999999998765 3888999999999999999999998 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCCCcccc---cC--CCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHH
Q 005017 216 NGNHGEVKIGDLGLAIAMQQPTARSV---IG--TPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 288 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~~~~~~---~G--T~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~ 288 (719)
..+ ..+||+|||+|+.......... .| ...|||||.+.. .|+.++||||||++||||+| |..||.+......
T Consensus 452 ~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 452 TKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred cCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 876 4999999999986554332221 22 235999998765 69999999999999999998 6899988665777
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++.+..|..... +..+++++.++++.||. +|.+||++.++..
T Consensus 531 l~~~l~~G~r~~~-P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQ-PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhcCCCCCC-CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7888888876543 55668999999999998 8999999999876
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=293.98 Aligned_cols=242 Identities=29% Similarity=0.426 Sum_probs=199.6
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
+.+++||.|+||+||+|.....|+ +||+|++.... ....-.++..|+-+|.+|+|||++++++++.... +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence 346789999999999998866664 68888776432 3445678999999999999999999999987543 7
Q ss_pred eEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
.+|++|++.|+|.+|++.++ .+..+..+.|+.||++||.|||.+. ++||||-.+|||+..- ..+||.|||+|+.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccC
Confidence 88999999999999998764 6899999999999999999999998 9999999999999855 499999999998876
Q ss_pred CCCcc----cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 235 QPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 235 ~~~~~----~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... ...-.+-|||-|.+. ..|+.++||||||+.+||++| |..||.+ ...+++-+.+..|.+ -.-+..++-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccH
Confidence 54321 122345688888665 569999999999999999998 7899987 456677777776665 334556778
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+.-++.+||. |+..||++++|-.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 89999999997 9999999988854
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=273.35 Aligned_cols=252 Identities=31% Similarity=0.448 Sum_probs=200.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
||..+ ..+|.|+- .|..|.|..++..||+|++... .......++.++|..++..++|+||++++.+|.-.. .
T Consensus 18 Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 18 RYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeee-cccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 44433 56888888 8889999999999999988765 233455688899999999999999999999886543 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+|||||. .+|.+.+. -.++-+.+..++.|++.|++|||+.+ |+||||||+||+++.+ +.+||.|||+|+.
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhcc
Confidence 35789999995 48888776 45788899999999999999999999 9999999999999866 5999999999987
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-C-------------
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------- 296 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g------------- 296 (719)
.... ....++.|..|.|||++-+ .|.+.+||||+||++.||++|+.-|.+.....+..+.+.. |
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 6665 4566789999999997653 5999999999999999999999888764433333222211 0
Q ss_pred ------------------CCCCc-cc------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 297 ------------------IKPAS-LA------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 297 ------------------~~p~~-~~------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
..|.. ++ +.....+++++.+||. +|++|.|++++|+|||++.
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 01111 00 1122468999999998 9999999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=271.99 Aligned_cols=252 Identities=27% Similarity=0.468 Sum_probs=199.5
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---CceeEE
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNMI 158 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---~~l~lV 158 (719)
++-||-|+||+||...|..+|+.||.|++. ...+.-...+++.+|+++|..++|.|++..++.....+- ..+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 467999999999999999999999999875 233333456789999999999999999988775433221 257889
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC-
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~- 237 (719)
+|+|.+ +|...+-.-..++...++-++.||++||.|||+-+ |.||||||.|.|++.+. .+||||||+|+.-....
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCc-eEEecccccccccchhhh
Confidence 999966 88888887788999999999999999999999999 99999999999999775 89999999998765432
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH-------------------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT------------------- 294 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~------------------- 294 (719)
....+-|..|+|||++.+ .|+.++||||.|||+.|++..+.-|.. .++-+..+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 334456889999998875 599999999999999999999988876 34444333332
Q ss_pred -----cCCCCCcccc---CC-----ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 295 -----SGIKPASLAK---VN-----DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 295 -----~g~~p~~~~~---~~-----~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+.+++.+.. .. ..+...++.++|. +|.+|.+..+.+.|+++....
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 1223333221 11 2356677778887 899999999999999986443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.71 Aligned_cols=131 Identities=31% Similarity=0.447 Sum_probs=112.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----C---CCceeEEEeee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----D---DNVVKFYKSWV 148 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pNIVkl~~~~~ 148 (719)
.+|.+.++||.|-|++||+|.|..+.+.||+|+++-.. ...+....||++|++++ | ..||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 55567789999999999999999999999999998443 44567788999999983 3 36999999986
Q ss_pred cC--CCCceeEEEecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEe
Q 005017 149 DD--KKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFV 215 (719)
Q Consensus 149 ~~--~~~~l~lV~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl 215 (719)
.. +..+++||+|++ |-+|..++++ .++++...++.|++||+.||.|||.. + |||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 54 456899999999 5578888775 46899999999999999999999986 6 9999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=240.46 Aligned_cols=209 Identities=37% Similarity=0.629 Sum_probs=183.2
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccC
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 164 (719)
||+|++|.||++.+..+|..+++|++....... ..+.+.+|++.++.++|++|+++++++... ...++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence 689999999999998889999999987554211 357789999999999999999999988654 468899999999
Q ss_pred CChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--cccc
Q 005017 165 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSV 241 (719)
Q Consensus 165 GsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--~~~~ 241 (719)
++|.+++... ..+++..+..++.+++.+|.|||+++ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999999876 57899999999999999999999998 99999999999998624699999999997665543 4445
Q ss_pred cCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC
Q 005017 242 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319 (719)
Q Consensus 242 ~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~ 319 (719)
.+...|++||.+.. .++.+.|+|+||+++++| +.+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 68899999998865 678999999999999999 589999999997
Q ss_pred -CCCCCCCHHHHHcCc
Q 005017 320 -PASERLSAKDLLKDP 334 (719)
Q Consensus 320 -dP~~RpSa~eLL~hp 334 (719)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 899999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=240.56 Aligned_cols=212 Identities=33% Similarity=0.515 Sum_probs=181.0
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEE
Confidence 35678999999999999999988999999998754321 2567889999999999999999999987654 458889
Q ss_pred EecccCCChhHHhhhccc-ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 159 TELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~-l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
+||+.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++.+ +.++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc
Confidence 999999999999988766 899999999999999999999998 9999999999999866 79999999998766543
Q ss_pred --CcccccCCCCCCCcccc-c-cccCccccchhhHHHHHHHhhccCCCCC-CCCHHHHHHHHHcCCC
Q 005017 237 --TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIFKKVTSGIK 298 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl-~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~-~~~~~~i~~~i~~g~~ 298 (719)
......++..|++||.+ . ..++.++|||+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 23455788899999987 3 3477899999999999999999999976 4555677777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=266.59 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=197.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDK 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~ 151 (719)
...|+..++||+|.|++||+|.+.. .+..||+|.+.... ...++.+|+++|..+. +.||+++.+++-.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn- 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRNN- 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence 3456778899999999999999887 78899999987543 3467899999999995 89999999987544
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+.+.+|+||++.-...++.. .++...++.+++.++.||.++|..| ||||||||+|+|.+...+.-.|.|||+|.
T Consensus 108 -d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 -DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred -CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 45888999999988888876 4678899999999999999999999 99999999999999888889999999996
Q ss_pred hcc-----------------C----------------CCc-------------ccccCCCCCCCcccccc--ccCccccc
Q 005017 232 AMQ-----------------Q----------------PTA-------------RSVIGTPEFMAPELYEE--EYNELVDI 263 (719)
Q Consensus 232 ~~~-----------------~----------------~~~-------------~~~~GT~~YmAPEvl~~--~~s~ksDI 263 (719)
... . +.. ....|||+|+|||++.. .-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 000 01249999999998764 46889999
Q ss_pred hhhHHHHHHHhhccCCCCCCCCHHHHHHHHH--------------cCC--------------------------------
Q 005017 264 YSFGMCILEMVTFEYPYSECKNPAQIFKKVT--------------SGI-------------------------------- 297 (719)
Q Consensus 264 wSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~--------------~g~-------------------------------- 297 (719)
||.|+|++-++++++||....+.......+. .|.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999865433222111110 011
Q ss_pred ---CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 298 ---KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 298 ---~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+.......+..+.+|+++||. ||.+|.||++.|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0011112334578999999998 9999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=275.25 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=175.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChh----hHHHHHHHHHHHHhCC---CCCceeEEEeeecCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG----DLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDK 151 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~----~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~ 151 (719)
|...+.||.|+||.|++|.++.+..+|++|.+..++.....- .+-.+-.||++|..|+ |+||+|++++|.++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd- 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD- 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-
Confidence 455678999999999999999999999999998766543221 1223557999999998 99999999999654
Q ss_pred CCceeEEEeccc-CCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFT-SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~-gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
.++|++||-.. +-+|++|+..++.+++..++.|++||+.|+++||+.+ |||||||-+|+.++++ |.+||+|||.|
T Consensus 642 -d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsa 717 (772)
T KOG1152|consen 642 -DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSA 717 (772)
T ss_pred -CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccch
Confidence 56999999864 5689999999999999999999999999999999999 9999999999999966 89999999999
Q ss_pred hhccCCCcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCC
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSE 282 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~ 282 (719)
.......-..++||..|.|||++.+. | +..-|||++|++||.++..+.||.+
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88888778889999999999999864 4 6778999999999999999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=288.02 Aligned_cols=200 Identities=20% Similarity=0.228 Sum_probs=147.7
Q ss_pred HhCCC-CCceeEEEeeecC-----CCCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeee
Q 005017 133 KSLKD-DNVVKFYKSWVDD-----KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 205 (719)
Q Consensus 133 ~~L~H-pNIVkl~~~~~~~-----~~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIH 205 (719)
+.++| +||++++++|... ....+++++||+ +++|.+++.. ...+++..++.+++||+.||+|||+++ |||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34555 5777788776211 123577788987 6699999975 346999999999999999999999999 999
Q ss_pred ecCccceeEecC------------------CCCcEEEeecchhhhccCC------------------CcccccCCCCCCC
Q 005017 206 RDLKCDNIFVNG------------------NHGEVKIGDLGLAIAMQQP------------------TARSVIGTPEFMA 249 (719)
Q Consensus 206 rDLKp~NILl~~------------------~~G~vKL~DFGlA~~~~~~------------------~~~~~~GT~~YmA 249 (719)
|||||+||||+. ..+.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2346777788877532110 0012468999999
Q ss_pred ccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCH
Q 005017 250 PELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA 327 (719)
Q Consensus 250 PEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa 327 (719)
||++. ..|+.++|||||||++|||++|..|+.. .......+.....+.... ...+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 99875 4699999999999999999999888753 222233333333332221 124567889999998 89999999
Q ss_pred HHHHcCccCccc
Q 005017 328 KDLLKDPFLQVE 339 (719)
Q Consensus 328 ~eLL~hpf~~~~ 339 (719)
.++|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=226.73 Aligned_cols=160 Identities=24% Similarity=0.343 Sum_probs=127.7
Q ss_pred CChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccC
Q 005017 165 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243 (719)
Q Consensus 165 GsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~G 243 (719)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++....... ..|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~---~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQ---SRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeecccc---CCC
Confidence 7899999874 45999999999999999999999987 9999999855 68999 99987654432 368
Q ss_pred CCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-----ccCCCh--HHHHHHH
Q 005017 244 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-----AKVNDP--QIKGFIE 315 (719)
Q Consensus 244 T~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~-----~~~~~~--~l~~lI~ 315 (719)
|+.|||||++.+ .|+.++|||||||++|||+||+.||............+.....+... ....+. .++++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998864 58999999999999999999999997654444444444433222211 111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCcc
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+||. +|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9998 8999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=236.08 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=192.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
..|.+.+.||+|.||.+-++.|+.+...+++|.+.... ...+.|.+|.+.--.| .|.||+.-|+.-... .+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceE
Confidence 34667789999999999999999999999999987543 4568899999876667 589999988764433 3478
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe-cCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-NGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl-~~~~G~vKL~DFGlA~~~~ 234 (719)
++++||++-|+|..-+.. .++.+...+.++.|+++||.|+|+++ +||||||.+|||| +.+.-.|||||||+.+..+
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 899999999999987765 46889999999999999999999999 9999999999998 4455689999999886543
Q ss_pred CCCcccccCCCCCCCcccccc----c--cCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHHcCCCC--Cccc
Q 005017 235 QPTARSVIGTPEFMAPELYEE----E--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKP--ASLA 303 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~----~--~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~---i~~~i~~g~~p--~~~~ 303 (719)
... ...--+..|.|||+... . .++.+|||.||+++|..+||.+||.......+ -+.+...+..+ +...
T Consensus 175 ~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 175 TTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred cee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 221 12234667999997642 2 57889999999999999999999975322222 22333333332 2223
Q ss_pred cCCChHHHHHHHHhcC-CCCCC---CCHHHHHcCccCc
Q 005017 304 KVNDPQIKGFIEKCLV-PASER---LSAKDLLKDPFLQ 337 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~R---pSa~eLL~hpf~~ 337 (719)
+..++.+..+.++-|. ++.+| .+++...+.-|..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 4456778888888887 67777 6777777777763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.54 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=199.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCC-----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g-----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
++++..++-+|.||.||+|+..... +.|.+|.++.. .++-+...+..|--.|..+.|||+..+.+....+.
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~- 360 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY- 360 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-
Confidence 3666778999999999999665432 34666665532 23456678899999999999999999999887654
Q ss_pred CceeEEEecccCCChhHHhhhc--------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 153 KTVNMITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~--------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
...++++.++.-|+|+.||..- +.++-.++..++.|++.|++|||.++ |||.||-..|.+|+.. -+|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~-LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ-LQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh-eeEEe
Confidence 4566789999999999999721 23666778889999999999999999 9999999999999855 59999
Q ss_pred eecchhhhccCCCcc----cccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 005017 225 GDLGLAIAMQQPTAR----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 298 (719)
Q Consensus 225 ~DFGlA~~~~~~~~~----~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~ 298 (719)
+|=.+++.+-+...+ ..-....||+||.+. ..|+.++||||||++||||+| |+.||.+ -+|.++...+..|..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccce
Confidence 999999876543221 112356899999775 579999999999999999998 7899998 679999999999876
Q ss_pred CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 299 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 299 p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
... +..++.++..++..||+ .|++||+..+|..
T Consensus 517 laQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 554 44567899999999998 8999999999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=215.05 Aligned_cols=254 Identities=29% Similarity=0.411 Sum_probs=204.1
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIVkl~~~~~~~~~~~l~l 157 (719)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence 567789999999999999877 788999887654332 13567899999999999988 799999988443 33789
Q ss_pred EEecccCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 158 ITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++|+.++++.+++.... .+.......++.|++.++.|+|+.+ ++|||+||+||+++.....++++|||++....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999998887765 7999999999999999999999999 99999999999998653379999999987554
Q ss_pred CC--------CcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHHcCCCC
Q 005017 235 QP--------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKP 299 (719)
Q Consensus 235 ~~--------~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i~~g~~p 299 (719)
.. ......||+.|+|||.+.. .++...|+||+|++++++++|..||..... ..+....+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 33 2356689999999998864 578899999999999999999999876543 45555555554433
Q ss_pred -CccccCCC------hHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 -ASLAKVND------PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 -~~~~~~~~------~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
........ ..+.+++.+|+. +|..|.+..+...++|.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 11111111 478999999998 799999999999987665433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=250.20 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=196.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeec--cccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~--~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
|.+..+++|.|++|.|+.+.........++|..... ...........+..|+.+-..|.|||++.......+... .
T Consensus 319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~ 396 (601)
T KOG0590|consen 319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--I 396 (601)
T ss_pred cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--c
Confidence 556678999999999998887777776777765422 111111222236678888889999999887776554433 3
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
.-+||||++ +|+.++.....+....+..+++|++.|+.|||++| |.||||||+|+++..+ |.+||+|||.+.....
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFRY 472 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeecc
Confidence 345999999 99999998878999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred C------CcccccCCCCCCCcccccc-ccCc-cccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH-cC-----CCCCc
Q 005017 236 P------TARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-SG-----IKPAS 301 (719)
Q Consensus 236 ~------~~~~~~GT~~YmAPEvl~~-~~s~-ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~-~g-----~~p~~ 301 (719)
+ .....+|+..|+|||++.+ .|++ .+||||.|+++..|++|++||.......+.+.... .+ .-+..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 3 2345689999999999875 4765 58999999999999999999965433333211111 10 11223
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+....+...+.+|.++|+ +|.+|.|+++|++++||+...
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 334456678999999998 899999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=224.01 Aligned_cols=176 Identities=20% Similarity=0.210 Sum_probs=133.9
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcC-CCeEEEEEEEeeccc-cCChhhHHHHHHHHHHHHhCCCCCcee-EEEeeec
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVK-FYKSWVD 149 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpNIVk-l~~~~~~ 149 (719)
.+....|.+.++||+|+||+||+|.+.. +|..||+|++..... .......+.+.+|+++|++|+|+||+. ++. +
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c--
Confidence 4456678899999999999999998876 678889998652211 012234567899999999999999985 443 1
Q ss_pred CCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecC-ccceeEecCCCCcEEEeecc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDL-Kp~NILl~~~~G~vKL~DFG 228 (719)
...++||||++|++|... ... . ...|+.|++.||.|||+++ |+|||| ||+|||++.+ |.+||+|||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFG 157 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQ 157 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECc
Confidence 237899999999999732 211 1 1468899999999999999 999999 9999999754 699999999
Q ss_pred hhhhccCCC----------cccccCCCCCCCccccccc-------cCccccch
Q 005017 229 LAIAMQQPT----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 264 (719)
Q Consensus 229 lA~~~~~~~----------~~~~~GT~~YmAPEvl~~~-------~s~ksDIw 264 (719)
+|+.+.... .....+++.|+|||.+... .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 998654332 1345789999999988532 33446766
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-24 Score=224.74 Aligned_cols=270 Identities=33% Similarity=0.565 Sum_probs=204.7
Q ss_pred CCCCCCCcccCCCCCcEEEeEEEeeeC---CeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC
Q 005017 63 PDADSDFVEKDPSGRYVRYDEVLGKGA---FKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139 (719)
Q Consensus 63 ~~~~~~~~e~d~~gr~~~l~e~LG~G~---fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN 139 (719)
....+++.+..|++|+.+..+..|+.. .-.||++.++..|.+|+|..+....+.......++...-+..|-++-|.|
T Consensus 49 s~~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsn 128 (458)
T KOG1266|consen 49 SEDESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSN 128 (458)
T ss_pred ccchhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHH
Confidence 344567788999999998888888753 45789999999999999998887665554455556666677888999999
Q ss_pred ceeEEEeeecCC---CCceeEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccce
Q 005017 140 VVKFYKSWVDDK---KKTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 212 (719)
Q Consensus 140 IVkl~~~~~~~~---~~~l~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~N 212 (719)
||+++.+|.+.. .....+++|||..|+|.+||++. +.+..+.+++|+.||+.||.|||+..|||+|+++.++.
T Consensus 129 lvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~t 208 (458)
T KOG1266|consen 129 LVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDT 208 (458)
T ss_pred HHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhh
Confidence 999999997643 34688999999999999999864 45889999999999999999999999999999999999
Q ss_pred eEecCCCCcEEEeecchhhhc------cCCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCC
Q 005017 213 IFVNGNHGEVKIGDLGLAIAM------QQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN 285 (719)
Q Consensus 213 ILl~~~~G~vKL~DFGlA~~~------~~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~ 285 (719)
|++. .+|.+||+---..... .........+-++|.|||.-. .+.+.++|||+||+|++||..|+..-.+...
T Consensus 209 ifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS 287 (458)
T KOG1266|consen 209 IFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES 287 (458)
T ss_pred eeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc
Confidence 9998 5588888643221110 011112234678999999765 3567889999999999999999866433222
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
....-..+.. ......++.-+++|.+||. .|..||+++++|.||.+-.
T Consensus 288 ~~~~ee~ia~-----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 288 KVEVEENIAN-----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeehhhhhhh-----heeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 2111111111 1122234456789999999 7999999999999997753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-21 Score=208.45 Aligned_cols=248 Identities=20% Similarity=0.220 Sum_probs=183.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCC-eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC----CCceeEEEeeecCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----DNVVKFYKSWVDDKK 152 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g-~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H----pNIVkl~~~~~~~~~ 152 (719)
.|++.+.||+|+||.||.+.+..++ ..+|+|......... . ..+..|+.+|..+.+ +++.++++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---C-ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 6889999999999999999988775 678888776543211 1 257789999999873 58888888664 234
Q ss_pred CceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC----CcEEEee
Q 005017 153 KTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGD 226 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~----G~vKL~D 226 (719)
.+-++||+++ |.+|.++.+.. +.++..++..++.|++.+|++||+.| ++||||||+|+++.... ..+.|.|
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 5677899988 77999988654 47999999999999999999999999 99999999999996432 3699999
Q ss_pred cchhh--hcc-CC--------C-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHH--HHH
Q 005017 227 LGLAI--AMQ-QP--------T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFK 291 (719)
Q Consensus 227 FGlA~--~~~-~~--------~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~--i~~ 291 (719)
||+++ ... .. . .....||..|+++....+ ..+.+.|+||++.++.+++.|..||........ .+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 321 11 1 123569999999998765 589999999999999999999999976543322 222
Q ss_pred HHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 292 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 292 ~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...............+.++..+...+-. +...+|....+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2222111111223344566666665555 67778877766554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=233.31 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=199.2
Q ss_pred EEeeeCCeEEEEEE---EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEE
Q 005017 84 VLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 84 ~LG~G~fG~Vyka~---d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
++|+|+||.|+++. -...|.-+|.|+.+......... .....|..++..++ ||.+|+++..+..+.+ +++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~--~~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR--THTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc--cccccHHHHHhhccCCCceeeeeeeeccccc--hhHhh
Confidence 47999999998662 23457778998887655443222 25567888999997 9999999998876655 77799
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCcc
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~ 239 (719)
+|..+|.|...+.+...+++...+.+...++-+++++|+.+ |+|||+|++||+++.+ |++|+.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc
Confidence 99999999999999888999999999999999999999999 9999999999999966 89999999999876544333
Q ss_pred cccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC
Q 005017 240 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319 (719)
Q Consensus 240 ~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~ 319 (719)
|||..|||||+++ .+..++|.||||++++||+||..||.. ++...|..... ..+...+..+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAEL--EMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhcc--CCchhhhHHHHHHHHHHHh
Confidence 9999999999998 778899999999999999999999976 44444444222 2344556789999999997
Q ss_pred -CCCCCCC-----HHHHHcCccCccccCC
Q 005017 320 -PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 320 -dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
+|..|.- +.++++|+||+...+.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHh
Confidence 8888864 6899999999987766
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=188.27 Aligned_cols=146 Identities=18% Similarity=0.175 Sum_probs=112.7
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChh----------------------hHHHHHHHHHHHHhCCCCC
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG----------------------DLQKLYSEVHLLKSLKDDN 139 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~----------------------~~~~~~~Ei~iL~~L~HpN 139 (719)
...||+|+||.||+|.+. +|+.||+|+++......... .......|+++|.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999998653211000 0122345999999998887
Q ss_pred ceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhh-hcCCCCeeeecCccceeEecCC
Q 005017 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 140 IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yL-Hs~~ppIIHrDLKp~NILl~~~ 218 (719)
+...+.... .. .++||||++++++.........+++..+..++.|++.+|.|| |+.+ |+||||||+|||++ +
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 644333221 11 378999999988876654566799999999999999999999 6888 99999999999998 3
Q ss_pred CCcEEEeecchhhhccCC
Q 005017 219 HGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~ 236 (719)
+.++|+|||+|.....+
T Consensus 154 -~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 -GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred -CcEEEEEccccccCCCc
Confidence 68999999999755443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=184.91 Aligned_cols=242 Identities=20% Similarity=0.269 Sum_probs=185.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEeeecCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~~~~~~~~~ 152 (719)
..+..|++.+.||.|+||.+|.|....+|.+||+|.-.... .-..+..|..+.+.|+| ..|..+..+.. +.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------~hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------KHPQLLYESKVYRILQGGVGIPHIRHYGT--EK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------CCcchhHHHHHHHHhccCCCCchhhhhcc--cc
Confidence 35667899999999999999999999999999999765332 22456789999999976 55666655443 33
Q ss_pred CceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGl 229 (719)
.+-.+||+++ |-||.+...- .+.++.++++-.+-|++.-++|+|.++ +|||||||+|.|.. .....+.++|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence 4566899998 6789887653 467999999999999999999999999 99999999999973 3345789999999
Q ss_pred hhhccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHcCC
Q 005017 230 AIAMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGI 297 (719)
Q Consensus 230 A~~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~g~ 297 (719)
|+.+.... .+...||.+|.+--..-+ .-+.+.|+-|+|.+|.+..-|..||.+.. +..|.+.+|....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 98765432 234569999987664433 35778999999999999999999998753 3456677776543
Q ss_pred ---CCCccccCCChHHHHHHHHhcC-CCCCCCC
Q 005017 298 ---KPASLAKVNDPQIKGFIEKCLV-PASERLS 326 (719)
Q Consensus 298 ---~p~~~~~~~~~~l~~lI~kcL~-dP~~RpS 326 (719)
.+..+.+..+.++.-.+.-|-. --.+-|.
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 3445566778888888888875 3344444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.9e-20 Score=182.76 Aligned_cols=146 Identities=20% Similarity=0.200 Sum_probs=113.8
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--------------------h--hhHHHHHHHHHHHHhCCCCC
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--------------------P--GDLQKLYSEVHLLKSLKDDN 139 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--------------------~--~~~~~~~~Ei~iL~~L~HpN 139 (719)
...||+|+||.||+|.+. +|+.||+|+++....... . .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 367999999999999987 999999999986531100 0 00123467999999999998
Q ss_pred ceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCC
Q 005017 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 140 IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~ 218 (719)
|.....++... .++||||++|+++.........++...+..++.|++.+|.+||+ +| |+||||||+||+++ +
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence 85544433321 37899999998665443344568888999999999999999999 88 99999999999998 4
Q ss_pred CCcEEEeecchhhhccCC
Q 005017 219 HGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~ 236 (719)
|.++|+|||++.....+
T Consensus 154 -~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 154 -GKPYIIDVSQAVELDHP 170 (190)
T ss_pred -CCEEEEEcccceecCCC
Confidence 69999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=192.07 Aligned_cols=238 Identities=16% Similarity=0.194 Sum_probs=152.9
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC----------CCceeE
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----------DNVVKF 143 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H----------pNIVkl 143 (719)
...|.+..++.||.|+++.||.+.|..+|+++|+|++.... .......+.+.+|.-....+.+ -.++..
T Consensus 9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 34566778899999999999999999999999999998776 3334567788877766655433 122222
Q ss_pred EEeeecC---------C-CC-----ceeEEEecccCCChhHHhhh---cc----cccHHHHHHHHHHHHHHhhhhhcCCC
Q 005017 144 YKSWVDD---------K-KK-----TVNMITELFTSGNLRQYRKK---HK----NVDIKVIKNWARQILHGLVYLHSHNP 201 (719)
Q Consensus 144 ~~~~~~~---------~-~~-----~l~lV~Ey~~gGsL~~~L~~---~~----~l~~~~i~~i~~QIl~gL~yLHs~~p 201 (719)
++..... . .. ..+++|+-+ .++|.+++.- .. .+.......+..|+++.+++||++|
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G- 165 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG- 165 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence 2211111 0 01 134567766 5588877542 22 2334445666799999999999999
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc---------ccCccccchhhHHHHHH
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILE 272 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~---------~~s~ksDIwSlGiil~E 272 (719)
++|+||||+|+|++.+ |.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+++|.
T Consensus 166 -lVHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 166 -LVHGDIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp -EEEST-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred -eEecccceeeEEEcCC-CCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999965 89999999876544432222 345678999997632 37889999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCC
Q 005017 273 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASER 324 (719)
Q Consensus 273 mlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~R 324 (719)
|.+|+.||.... +...... ........+..++.||..+|+ +|.+|
T Consensus 243 lWC~~lPf~~~~-~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSS-PEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCG-GGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCC-ccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999997531 1111000 111222456789999999998 78877
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=215.75 Aligned_cols=225 Identities=25% Similarity=0.431 Sum_probs=171.8
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
...|....|...+.|..|+||.||...|+.+.+.+|.| ++.... +.+- +|..-..|.+
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l---------ilRn--ilt~a~npfv---------- 134 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL---------ILRN--ILTFAGNPFV---------- 134 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch---------hhhc--cccccCCcce----------
Confidence 55677777888899999999999999999999999984 332211 0000 2222222222
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
| |+-...++.-+.++... +.+++|||+.+ |+|||+||+|.+|. ..|++|++|||++
T Consensus 135 -------v------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 135 -------V------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLS 190 (1205)
T ss_pred -------e------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhh
Confidence 2 55566666655555433 78999999999 99999999999998 5589999999998
Q ss_pred hhccCC-----------------CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHH
Q 005017 231 IAMQQP-----------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292 (719)
Q Consensus 231 ~~~~~~-----------------~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~ 292 (719)
+..-.. ....++|||.|+|||++. ++|+..+|+|++|+|+||.+.|..||.+ +++++++..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~ 269 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQ 269 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhh
Confidence 642110 123568999999999865 6799999999999999999999999988 788998888
Q ss_pred HHcCC--CCCccccCCChHHHHHHHHhcC-CCCCCC---CHHHHHcCccCccccCCC
Q 005017 293 VTSGI--KPASLAKVNDPQIKGFIEKCLV-PASERL---SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 293 i~~g~--~p~~~~~~~~~~l~~lI~kcL~-dP~~Rp---Sa~eLL~hpf~~~~~~~~ 343 (719)
+.... .|+. .....++++++|.++|+ +|..|. .+-++.+|+||+.-.+..
T Consensus 270 visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ 325 (1205)
T KOG0606|consen 270 VISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS 325 (1205)
T ss_pred hhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence 77542 3433 44456899999999997 898885 688999999999888763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=188.23 Aligned_cols=232 Identities=18% Similarity=0.306 Sum_probs=179.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKK 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~ 152 (719)
..|-.|+++++||+|+||+.+.|....+++.||||.-..+ ....++..|....+.|. .++|...|.+. ...
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG 96 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEG 96 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeec--ccc
Confidence 3567899999999999999999999999999999965433 23356778888888885 58898887644 334
Q ss_pred CceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC----CCCcEEEeec
Q 005017 153 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDL 227 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~----~~G~vKL~DF 227 (719)
.+-.||+|++ |-||.|...- ...++.+++.-++.|++.-++|+|+++ +|.|||||+|.||.. +...+.|+||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence 4556799998 6688886653 457999999999999999999999999 999999999999952 2236899999
Q ss_pred chhhhccCCCc---------ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHc
Q 005017 228 GLAIAMQQPTA---------RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTS 295 (719)
Q Consensus 228 GlA~~~~~~~~---------~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~ 295 (719)
|+|+.+.++.+ ....||.+||+--..- ..-+.+.|.-|||-++++.+-|..||.+.. +..+.+++|..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 99998876543 2456999999987543 446889999999999999999999998753 44567777765
Q ss_pred CCCCCc---cccCCChHHHHHHHH
Q 005017 296 GIKPAS---LAKVNDPQIKGFIEK 316 (719)
Q Consensus 296 g~~p~~---~~~~~~~~l~~lI~k 316 (719)
...... +....+.++...+.-
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~y 277 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRY 277 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHH
Confidence 443322 233344455554443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-20 Score=187.32 Aligned_cols=176 Identities=15% Similarity=0.104 Sum_probs=133.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHH------HHHHHHHHHhCCCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLKDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~------~~~Ei~iL~~L~HpNIVkl~~~~~ 148 (719)
....|+..++||.|+||.||++.+ ++..+|+|++....... +....+ +.+|++.+.+|.||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 345678899999999999999744 47789999987544322 333333 578999999999999999998876
Q ss_pred cCCC------CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcE
Q 005017 149 DDKK------KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 149 ~~~~------~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~v 222 (719)
.... ...++||||++|.+|.++.. +++ ....+++.+|..||.+| ++|||+||+||+++.+ | +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-E
Confidence 5432 34789999999999988742 333 24669999999999999 9999999999999854 6 9
Q ss_pred EEeecchhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHh
Q 005017 223 KIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 274 (719)
Q Consensus 223 KL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~Eml 274 (719)
+|+|||............. =++...|+.++||||||+.+....
T Consensus 174 ~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 9999998765432221110 023456888999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-20 Score=217.04 Aligned_cols=243 Identities=22% Similarity=0.278 Sum_probs=181.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+.+.+.||.+.|=+|.+|.|. .|. |++|++-..+..-.-....+...|++ ...++|||.+.|...- ...+..||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHH
Confidence 4567789999999999999775 565 88898865542222223334445566 6677999999987643 34466888
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh--ccC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~--~~~ 235 (719)
|-+|+.. +|.|.+..++-+..-+.+.|+.|++.||.-+|..| |+|||||++||||+.= .-+.|+||..-+- +..
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccCCC
Confidence 9999976 89999998888999999999999999999999999 9999999999999844 4799999976532 111
Q ss_pred CCcc-------cccCCCCCCCcccccc-----------c-cCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHc
Q 005017 236 PTAR-------SVIGTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 236 ~~~~-------~~~GT~~YmAPEvl~~-----------~-~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~ 295 (719)
+... +-..-.+|.|||.+-. . .+++-||||+||+++||++ |++||. ..|++..-..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~ 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSG 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhcc
Confidence 1111 1122348999996632 1 4678899999999999987 567763 4555544433
Q ss_pred CC-CCC-ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 296 GI-KPA-SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 296 g~-~p~-~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+. .+. .+.++.+..+|.+|..|++ +|++|.+|++.|+-
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 21 121 2445667889999999998 99999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=178.47 Aligned_cols=184 Identities=15% Similarity=0.078 Sum_probs=136.9
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEE
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
...+|++|+||+||.+.. .+.+++.+.+.........-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 357899999999998743 677888666654332211112235789999999995 5889999884 2268899
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecC-ccceeEecCCCCcEEEeecchhhhccCCCc
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDL-Kp~NILl~~~~G~vKL~DFGlA~~~~~~~~ 238 (719)
||+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||+|||++.+ |.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcch
Confidence 99999999764321 12357889999999999999 999999 7999999854 7999999999975433221
Q ss_pred ---------------ccccCCCCCCCccccc--cccC-ccccchhhHHHHHHHhhccCCCCC
Q 005017 239 ---------------RSVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTFEYPYSE 282 (719)
Q Consensus 239 ---------------~~~~GT~~YmAPEvl~--~~~s-~ksDIwSlGiil~EmlTG~~Pf~~ 282 (719)
....+++.|++|+-.. ...+ .+.+.++-|+-+|.++|+..|+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0113688899998432 2333 567889999999999999988654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=177.54 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=108.1
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-----CCCCceeEEEeeecCCC-Cc-
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-----KDDNVVKFYKSWVDDKK-KT- 154 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpNIVkl~~~~~~~~~-~~- 154 (719)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.++++| .||||+++|+++..+.. ..
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 36899999999995 7777766 6888865432 2346789999999999 67999999999876542 23
Q ss_pred eeEEEec--ccCCChhHHhhhcccccHHHHHHHHHHHHHHh-hhhhcCCCCeeeecCccceeEecC---CCCcEEEeecc
Q 005017 155 VNMITEL--FTSGNLRQYRKKHKNVDIKVIKNWARQILHGL-VYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLG 228 (719)
Q Consensus 155 l~lV~Ey--~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL-~yLHs~~ppIIHrDLKp~NILl~~---~~G~vKL~DFG 228 (719)
+.+|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ..+.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5589999999764 46665 46788888888 9999999 999999999999973 22479999954
Q ss_pred hh
Q 005017 229 LA 230 (719)
Q Consensus 229 lA 230 (719)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-19 Score=180.14 Aligned_cols=237 Identities=16% Similarity=0.276 Sum_probs=181.4
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEec
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
..+|.+.-.|..|+|. +.|..+++|+++..+.. ....+.|..|+-.|+-+.||||+.+++.|... ..+.+|..|
T Consensus 195 ~tkl~e~hsgelwrgr--wqgndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~ 268 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGR--WQGNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQY 268 (448)
T ss_pred hhhhccCCCccccccc--ccCcchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeee
Confidence 3457888889999995 45667788888766543 23446788999999999999999999988655 458889999
Q ss_pred ccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE--eecchhhhccCCC
Q 005017 162 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI--GDLGLAIAMQQPT 237 (719)
Q Consensus 162 ~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL--~DFGlA~~~~~~~ 237 (719)
|+-|+|+..+.... .++-.++.+++..|++|++|||+..|-|.---|....++||.+. +.+| +|--++. +.
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf---qe- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF---QE- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee---ec-
Confidence 99999999998654 36778899999999999999999986555567899999998664 4444 3322221 11
Q ss_pred cccccCCCCCCCccccccc----cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~~----~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......|.||+||.+... .-.++|+|||.+++||+.|.+.||.+....+--.+....|. ...++...++.+..+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl-rv~ippgis~hm~kl 421 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL-RVHIPPGISRHMNKL 421 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc-cccCCCCccHHHHHH
Confidence 122357899999988653 23579999999999999999999998655544444444554 345566677899999
Q ss_pred HHHhcC-CCCCCCCHHHHH
Q 005017 314 IEKCLV-PASERLSAKDLL 331 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL 331 (719)
+.-|+. ||.+||.++.++
T Consensus 422 m~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhcCCCCcCCCcceeh
Confidence 999998 999999876653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-18 Score=181.95 Aligned_cols=194 Identities=22% Similarity=0.349 Sum_probs=141.6
Q ss_pred CCCCceeEEEeeec-------------------------CCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHH
Q 005017 136 KDDNVVKFYKSWVD-------------------------DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 190 (719)
Q Consensus 136 ~HpNIVkl~~~~~~-------------------------~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl 190 (719)
+|||||++++.|.+ ...+++|+||.-.+. +|++|+-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999988866 234578899988865 899998754 356677778899999
Q ss_pred HHhhhhhcCCCCeeeecCccceeEecC---CCCcEEEeecchhhhccC-----CCc---ccccCCCCCCCccccccc---
Q 005017 191 HGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQ-----PTA---RSVIGTPEFMAPELYEEE--- 256 (719)
Q Consensus 191 ~gL~yLHs~~ppIIHrDLKp~NILl~~---~~G~vKL~DFGlA~~~~~-----~~~---~~~~GT~~YmAPEvl~~~--- 256 (719)
+|+.|||.|| |.|||||.+|||+.- .-..+.|+|||.+-.-.. +.. -..-|.-.-||||+....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999832 223678999997632211 111 123477889999988632
Q ss_pred ----cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCH---H
Q 005017 257 ----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA---K 328 (719)
Q Consensus 257 ----~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa---~ 328 (719)
.-.++|.|+.|.+.||+++...||.... ...+-..--+....+.++..+++.+++++..+|+ +|++|+++ .
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1358999999999999999999998621 1111111111222345666778999999999998 89999984 4
Q ss_pred HHHcCc
Q 005017 329 DLLKDP 334 (719)
Q Consensus 329 eLL~hp 334 (719)
.+|+-.
T Consensus 509 Nvl~Ls 514 (598)
T KOG4158|consen 509 NVLNLS 514 (598)
T ss_pred hHHHHH
Confidence 445433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-18 Score=173.91 Aligned_cols=153 Identities=21% Similarity=0.196 Sum_probs=118.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEE-EcCCCeEEEEEEEeeccccC------------------Chh--hHHHHHHHHHHHH
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAF-DEFAGIEVAWSRVKIDDVLQ------------------LPG--DLQKLYSEVHLLK 133 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~-d~~~g~~VAvK~i~~~~~~~------------------~~~--~~~~~~~Ei~iL~ 133 (719)
.|+-|.+.+.||+|+||.||+|. +..+|+.||+|+++...... ... ....+..|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 45667788999999999999998 67799999999998543110 000 1134578999999
Q ss_pred hCCCCC--ceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccc
Q 005017 134 SLKDDN--VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 211 (719)
Q Consensus 134 ~L~HpN--IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~ 211 (719)
++.+.. +.+++.. . ..++||||+.+++|..+......+....+..++.||+.+|.|||+++ .|+||||||+
T Consensus 106 ~L~~~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe----c--CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 997633 4455542 1 24789999999998876644556677778899999999999999986 4999999999
Q ss_pred eeEecCCCCcEEEeecchhhhccCC
Q 005017 212 NIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 212 NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||+++ .+.++|+|||.+.....+
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccCCc
Confidence 99998 368999999998765443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-18 Score=190.54 Aligned_cols=174 Identities=26% Similarity=0.499 Sum_probs=138.9
Q ss_pred CceeEEEecccCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
.++|+.|++|...+|.+|+...+ ..+....+.|+.|++.|+.| ++ .+|||+||.||+...+ ..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhh
Confidence 36889999999999999997544 36677889999999999999 67 9999999999999755 5899999999
Q ss_pred hhhccCCC--------cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 005017 230 AIAMQQPT--------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 230 A~~~~~~~--------~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
........ ....+||..||+||.+. ..|+.++||||||++|+|+++ -..++ .....+..+..+..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCC
Confidence 86554332 23457999999999887 569999999999999999998 33333 223345566777777
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+.+... .|+-..|+.++|. .|.+||++.+.-.|+|++
T Consensus 479 ~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 544433 3577899999998 799999888888888764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-17 Score=195.80 Aligned_cols=194 Identities=22% Similarity=0.303 Sum_probs=156.3
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC---CCCceeEEEeeec
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVD 149 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~ 149 (719)
...|..|.+...||+|+||+||+|.+.. |+.||+|+-+..... +|+--.+++.+|+ -+.|+.++..++.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3457778899999999999999998875 999999987754432 2344445555665 2456666665555
Q ss_pred CCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC------CCCcEE
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVK 223 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~------~~G~vK 223 (719)
.+. -++|+||.+.|+|.+++...+.+++..+..+..|++..++.||.++ |||+||||+|.||.. +.--++
T Consensus 766 ~~~--S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QNA--SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CCc--ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceE
Confidence 544 5679999999999999999999999999999999999999999999 999999999999942 223589
Q ss_pred Eeecchhhhcc---CC-CcccccCCCCCCCccccccc-cCccccchhhHHHHHHHhhccC
Q 005017 224 IGDLGLAIAMQ---QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEY 278 (719)
Q Consensus 224 L~DFGlA~~~~---~~-~~~~~~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG~~ 278 (719)
|+|||.+..+. .. .-...++|-.+-.+|+..+. ++..+|.|.|..+++-|+.|++
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986553 22 23456789999999998865 8999999999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=160.74 Aligned_cols=138 Identities=20% Similarity=0.207 Sum_probs=110.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC----hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.||+|++|.||+|.+ .|..|++|+......... .....++.+|+.++..+.|++|+....++.+.. ..++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence 4699999999999976 688899997653322110 112346788999999999999877666655443 46789
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
|||++|++|.+++..... ....++.+++.+|.+||+++ ++|||++|.|||++ + +.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999999999875432 77889999999999999999 99999999999998 3 6899999998854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.7e-17 Score=180.92 Aligned_cols=196 Identities=27% Similarity=0.439 Sum_probs=153.4
Q ss_pred HHhCCCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCe-eeecCc
Q 005017 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPI-IHRDLK 209 (719)
Q Consensus 132 L~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppI-IHrDLK 209 (719)
|+.+.|.|+.+|++.+++. ..++.|.+||.-|+|.+.+.. ...+++.-...+.+.|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999877 568889999999999999987 456888889999999999999999864 5 999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccC----CCcccccCCCCCCCccccccc--------cCccccchhhHHHHHHHhhcc
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTFE 277 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~----~~~~~~~GT~~YmAPEvl~~~--------~s~ksDIwSlGiil~EmlTG~ 277 (719)
+.|.+++... .+||+|||+...... .......-..-|.|||++... .+.+.||||||++++|+++..
T Consensus 77 s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999775 899999999866532 111112234579999988642 467799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCCC--Cccc-c-CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 278 YPYSEC---KNPAQIFKKVTS-GIKP--ASLA-K-VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 278 ~Pf~~~---~~~~~i~~~i~~-g~~p--~~~~-~-~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
-||... ..+.++...+.. +..+ +.+. . ...+++..++..||. +|.+||+++++-.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 999652 233556666666 3221 1111 1 234578999999998 8999999988744
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=157.07 Aligned_cols=134 Identities=21% Similarity=0.244 Sum_probs=105.0
Q ss_pred EEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC----ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEE
Q 005017 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ----LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~----~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
.||+|+||.||+|. .+|..|++|+........ ......++.+|++++..+.|+++.....++...+ ..++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 38999999999997 468899999865432111 1112366788999999999887654444444333 367899
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
||++|++|.+++..... .++.|++.+|.+||+.+ ++|||++|.||+++ + +.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 99999999998765321 78999999999999999 99999999999998 3 6899999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.1e-18 Score=194.88 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=197.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~ 154 (719)
..|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ...........|..+-+.+. |+|++++++.+... ..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RS 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC--cc
Confidence 345566779999999998886643 33456666655433 23344556667888888887 99999999977544 45
Q ss_pred eeEEEecccCCChhHHh-hhcc-cccHHHHHHHHHHHHHHhhhhh-cCCCCeeeecCccceeEecCCCC-cEEEeecchh
Q 005017 155 VNMITELFTSGNLRQYR-KKHK-NVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLA 230 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L-~~~~-~l~~~~i~~i~~QIl~gL~yLH-s~~ppIIHrDLKp~NILl~~~~G-~vKL~DFGlA 230 (719)
.+++++|..+|++...+ .... ..+......++.|+..+|.|+| ..+ +.|||+||+|.+++.. | .+|++|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCchhh
Confidence 77899999999999988 6555 6778888999999999999999 888 9999999999999855 6 8999999999
Q ss_pred hhccC-CC----cccccC-CCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CC
Q 005017 231 IAMQQ-PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA 300 (719)
Q Consensus 231 ~~~~~-~~----~~~~~G-T~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~ 300 (719)
..+.. .. ....+| ++.|+|||++.+ ...+..|+||.|+++.-|++|..|+.........+........ ..
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ 252 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc
Confidence 87655 22 234578 999999998876 3578899999999999999999999764433333222222211 13
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
......+....+++.+++. +|..|.+.+++-.+||+..
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 3344556788999999996 8999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=157.06 Aligned_cols=145 Identities=23% Similarity=0.238 Sum_probs=110.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC--Ch----------------hhHHHHHHHHHHHHhCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ--LP----------------GDLQKLYSEVHLLKSLKD 137 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~--~~----------------~~~~~~~~Ei~iL~~L~H 137 (719)
+..+.+.+.||+|+||.||+|.+. +|+.||+|++....... .. ........|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 345667789999999999999875 89999999877533100 00 011236779999999988
Q ss_pred CC--ceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 138 DN--VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 138 pN--IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
++ +++.++. ...++||||+++++|...... .....++.+++.++.++|+++ |+||||||+||++
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE
Confidence 74 4445431 235789999999999775431 345678899999999999998 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCC
Q 005017 216 NGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+.+ +.++|+|||++......
T Consensus 159 ~~~-~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 159 DDD-EKIYIIDWPQMVSTDHP 178 (198)
T ss_pred cCC-CcEEEEECCccccCCCc
Confidence 864 79999999998655443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.6e-16 Score=178.20 Aligned_cols=141 Identities=20% Similarity=0.184 Sum_probs=109.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc----CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL----QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~----~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..+...+.||+|+||+||+|... +..+++|+....... ......+++.+|+++++.++|++++..+.++....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~- 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE- 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-
Confidence 33455789999999999999754 444555543222111 11123467889999999999999988777665543
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++||||+++++|.+++. ....++.|++.+|.|||+++ ++||||||+|||++ + +.++|+|||+++.
T Consensus 410 -~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 410 -EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred -CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCccccc
Confidence 3678999999999999885 34678999999999999999 99999999999994 3 5899999999865
Q ss_pred c
Q 005017 233 M 233 (719)
Q Consensus 233 ~ 233 (719)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-15 Score=146.74 Aligned_cols=140 Identities=23% Similarity=0.195 Sum_probs=99.8
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHH---------------------HHHHHHHHHHhCCCCC-
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ---------------------KLYSEVHLLKSLKDDN- 139 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~---------------------~~~~Ei~iL~~L~HpN- 139 (719)
.+.||+|+||+||+|.+. +|+.||+|+++...... ..... ....|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999887 89999999987543211 11111 1135666777765443
Q ss_pred -ceeEEEeeecCCCCceeEEEecccCCChhHH-hhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEec
Q 005017 140 -VVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 140 -IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~-L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~ 216 (719)
+.+.++.. ..++||||++++.+... +... ... ..+..++.|++.++.++|. ++ |+||||||+||+++
T Consensus 80 ~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 80 PVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CCCceEecC------CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 45555421 25789999999654321 1111 111 5678899999999999999 88 99999999999998
Q ss_pred CCCCcEEEeecchhhhccC
Q 005017 217 GNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 217 ~~~G~vKL~DFGlA~~~~~ 235 (719)
.+.++|+|||.+.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 46899999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=146.35 Aligned_cols=141 Identities=14% Similarity=0.190 Sum_probs=106.6
Q ss_pred eEEEe-eeCCeEEEEEEEcCCCeEEEEEEEeeccc----cC-----ChhhHHHHHHHHHHHHhCCCCCc--eeEEEeeec
Q 005017 82 DEVLG-KGAFKTVYKAFDEFAGIEVAWSRVKIDDV----LQ-----LPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVD 149 (719)
Q Consensus 82 ~e~LG-~G~fG~Vyka~d~~~g~~VAvK~i~~~~~----~~-----~~~~~~~~~~Ei~iL~~L~HpNI--Vkl~~~~~~ 149 (719)
+.+|| .||.|+||.+.. .|..+++|.+..... .. ......++.+|+.++.+|+|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45788 899999999865 378899998864321 00 11234678899999999998885 667766443
Q ss_pred CCCC--ceeEEEecccC-CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 150 DKKK--TVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 150 ~~~~--~l~lV~Ey~~g-GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++| |+||||||.|||++.+ +.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEE
Confidence 3221 12489999997 689988865 3455543 578999999999999 9999999999999865 5899999
Q ss_pred cchhhh
Q 005017 227 LGLAIA 232 (719)
Q Consensus 227 FGlA~~ 232 (719)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=127.09 Aligned_cols=133 Identities=21% Similarity=0.108 Sum_probs=107.3
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CCceeEEEeeecCCCCceeEEE
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~~~~~~~~~~~l~lV~ 159 (719)
.+.||+|.++.||++.+. +..+++|....... ...+..|+.+++.++| .++++++.+.... ...++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 367999999999999864 37899998754321 4578899999999977 5888988866443 4688999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCC-CCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~-ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
||+.++.+..+ +......++.+++.+|++||... .+++|+|++|+||+++. .+.+++.|||.+..
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 99999888765 45666778999999999999852 24999999999999986 46999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-14 Score=158.50 Aligned_cols=251 Identities=24% Similarity=0.269 Sum_probs=194.6
Q ss_pred EEeEEEee--eCCeEEEEEEE--cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 80 RYDEVLGK--GAFKTVYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 80 ~l~e~LG~--G~fG~Vyka~d--~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
.....+|. |.+|.||.+.. ..++..+|+|.-+... ..+....+=++|+...+.+ .|+|.++.+..|... ..
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~~ 192 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--GI 192 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--Cc
Confidence 34567899 99999999988 8899999998744322 1122223335677777777 499999988888654 45
Q ss_pred eeEEEecccCCChhHHhhhccc-ccHHHHHHHHHHHHH----HhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 155 VNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH----GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~-l~~~~i~~i~~QIl~----gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+++-+|++. .+|..|...... ++...++..+.+... ||.++|+.+ ++|-|+||.||+...+....+++|||+
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 777888885 788888776544 888899999999999 999999999 999999999999987756899999999
Q ss_pred hhhccCCCc-------ccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 005017 230 AIAMQQPTA-------RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 230 A~~~~~~~~-------~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 302 (719)
...+..... ....|...|++||+.++-++...|||++|.+..+..++..+.....+ ..+..+..+..+..+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC--CCccccccccCchhh
Confidence 877654431 11247788999999999999999999999999999998766544211 123344455566666
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
....+..++..+..++. +|..|+++..++.|+++...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 66667777888888887 79999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2e-13 Score=160.23 Aligned_cols=259 Identities=20% Similarity=0.325 Sum_probs=199.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
+.+.+-+-+|+++.++.+.-..+|...+.|.......... ...+....+-.++-...||-++.....+... ...+++
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L~ 882 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPLV 882 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcchh
Confidence 3444578899999999987666776666665544333221 2234445555566666778888777664333 457889
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc----
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---- 234 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~---- 234 (719)
++|+.+++|...+.+-+..+.+..+.+...+..+++|||... +.|||++|.|+++..+ |..+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccccccccC
Confidence 999999999999998888888888889999999999999987 9999999999999744 799999998432100
Q ss_pred ---C------------------C--------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC
Q 005017 235 ---Q------------------P--------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 284 (719)
Q Consensus 235 ---~------------------~--------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~ 284 (719)
. . ......||+.|.|||...+ .....+|+|++|++++|.++|..||.. .
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-E 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-c
Confidence 0 0 0123468999999997654 578899999999999999999999987 6
Q ss_pred CHHHHHHHHHcCCCCCc-cccCCChHHHHHHHHhcC-CCCCCCCHH---HHHcCccCccccCCCC
Q 005017 285 NPAQIFKKVTSGIKPAS-LAKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQVENQKEP 344 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~-~~~~~~~~l~~lI~kcL~-dP~~RpSa~---eLL~hpf~~~~~~~~~ 344 (719)
.+.+++..+..+..+.. -+...++++++++...|. +|.+|..+. ++-.||||+...+...
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 78889888887665433 344567899999999997 899999887 9999999998887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.3e-11 Score=135.84 Aligned_cols=144 Identities=22% Similarity=0.195 Sum_probs=96.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhh--------------------------H----------HHHH
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD--------------------------L----------QKLY 126 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~--------------------------~----------~~~~ 126 (719)
+.||.|++|.||+|... +|+.||||+.+..-......+ . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999865 899999999865321110000 0 0234
Q ss_pred HHHHHHHhC----CCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHH-HhhhhhcCC
Q 005017 127 SEVHLLKSL----KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILH-GLVYLHSHN 200 (719)
Q Consensus 127 ~Ei~iL~~L----~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~-gL~yLHs~~ 200 (719)
+|...+.++ +|.+-+.+-..+.+.. ...++||||++|++|.++.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 456555555 2333333333322211 2357899999999999876532 1222 3345666655 467889988
Q ss_pred CCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 201 ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++|+|+||.||+++.+ |.++++|||++..+.
T Consensus 278 --~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 9999999999999755 799999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.9e-11 Score=136.14 Aligned_cols=142 Identities=16% Similarity=0.126 Sum_probs=94.2
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC--------------------------Ch----hhHHH------HH
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ--------------------------LP----GDLQK------LY 126 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~--------------------------~~----~~~~~------~~ 126 (719)
+.||.|++|.||+|..+.+|+.||||+.+..-... -. +..+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 57999999999999998779999999997542100 00 01111 33
Q ss_pred HHHHHHHhCC----CCCceeEEEeeecCCCCceeEEEecccCCChhHH--hhhcc----cccHHHHHHHHHHHHHHhhhh
Q 005017 127 SEVHLLKSLK----DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHK----NVDIKVIKNWARQILHGLVYL 196 (719)
Q Consensus 127 ~Ei~iL~~L~----HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~--L~~~~----~l~~~~i~~i~~QIl~gL~yL 196 (719)
+|...+.+++ +.+.+.+-..+.+- ....++||||+.|+.+.++ +...+ .+.+..+..++.|++.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~----- 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR----- 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-----
Confidence 4554444442 44444433333221 1235689999999999874 33322 3555566667777653
Q ss_pred hcCCCCeeeecCccceeEecCCC---CcEEEeecchhhhcc
Q 005017 197 HSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQ 234 (719)
Q Consensus 197 Hs~~ppIIHrDLKp~NILl~~~~---G~vKL~DFGlA~~~~ 234 (719)
.| ++|+|+||.||+++.+. |.+++.|||++..+.
T Consensus 279 --~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 279 --DG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --CC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 67 99999999999998552 389999999986554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.8e-11 Score=113.75 Aligned_cols=128 Identities=20% Similarity=0.066 Sum_probs=93.8
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCce-eEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV-KFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV-kl~~~~~~~~~~~l~lV~Ey 161 (719)
+.|+.|.++.||++... |..|++|....... ....+..|+.+++.+.+.+++ +++... .. .-++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEEe
Confidence 56899999999999754 78899998653321 123457899999998765544 454432 22 24689999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCC---CeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~p---pIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
++|.++.... .....++.+++.+|+.||..+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 73 i~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred cCCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 9998887531 1123457899999999999862 359999999999998 3 579999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-11 Score=137.00 Aligned_cols=246 Identities=21% Similarity=0.196 Sum_probs=173.5
Q ss_pred EEEeEEEeeeCCeEEEEEEEc-CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCcee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDE-FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~-~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.+...||.|.|+.|+...-. .++..|++|.+...- ....++ ..-..|+.+...+ .|.+++.++..|....+ .|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~ 342 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GY 342 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhh-hcchhhhhHhhHhhcccccCCCCCCcccccc--cc
Confidence 445678999999999987544 577889988876432 222222 2234566666666 59999999999976655 45
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+=.|||.++++...+.-...+++...++...|++.++.++|+.. ++|+|+||+||++..+.+..+++|||.++.+...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee
Confidence 67899999999887765566888899999999999999999998 9999999999999765468899999988653222
Q ss_pred CcccccCCCCCC-Ccccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 TARSVIGTPEFM-APELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 ~~~~~~GT~~Ym-APEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.. ...+.-+++ .+|++.. .+..++|+||||.-+.+.+++. |+... .+....+..+..+. .+... .++..+
T Consensus 421 ~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~ls~~---~~~~~~i~~~~~p~-~~~~~-~~~q~~ 493 (524)
T KOG0601|consen 421 SG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PLSES---GVQSLTIRSGDTPN-LPGLK-LQLQVL 493 (524)
T ss_pred cc-cccccccccccchhhccccccccccccccccccccccccCc-ccCcc---cccceeeecccccC-CCchH-Hhhhhh
Confidence 11 122334455 3555543 4778999999999999999986 32221 11122233333322 12222 566777
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
.+.++. ++..||.+.++..|+-|.
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhh
Confidence 777776 788899999999887553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.2e-10 Score=112.32 Aligned_cols=144 Identities=18% Similarity=0.159 Sum_probs=102.3
Q ss_pred EEEeeeCCeEEEEEEEcC------CCeEEEEEEEeecccc---------C---------ChhhHHHHH----HHHHHHHh
Q 005017 83 EVLGKGAFKTVYKAFDEF------AGIEVAWSRVKIDDVL---------Q---------LPGDLQKLY----SEVHLLKS 134 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~------~g~~VAvK~i~~~~~~---------~---------~~~~~~~~~----~Ei~iL~~ 134 (719)
..||.|--+.||.|.... .+..+|+|+.+..... + .......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 3579999988742210 0 011122333 79999999
Q ss_pred CCC--CCceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhh-hcCCCCeeeecCccc
Q 005017 135 LKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCD 211 (719)
Q Consensus 135 L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yL-Hs~~ppIIHrDLKp~ 211 (719)
|.. -++.+.+++ ..-++||||+.++.+..-.-+...++......+..|++.+|.+| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 853 466667653 12457999998764433222233455666778889999999998 8888 999999999
Q ss_pred eeEecCCCCcEEEeecchhhhccCC
Q 005017 212 NIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 212 NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||++.. |.+.|+|||.+.....+
T Consensus 155 NIL~~~--~~v~iIDF~qav~~~hp 177 (197)
T cd05146 155 NMLWHD--GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HEEEEC--CcEEEEECCCceeCCCC
Confidence 999973 58999999988655443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.6e-10 Score=127.24 Aligned_cols=167 Identities=23% Similarity=0.261 Sum_probs=123.2
Q ss_pred EEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhc
Q 005017 95 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH 174 (719)
Q Consensus 95 ka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~ 174 (719)
.|..+.+|.+|.|...+.... ...+...+-++.|+.|+||||++|+..+..++ .+|+|+|-+.- |..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~P--l~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVRP--LETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeecccc--HHHHHHHh
Confidence 456677888999888775432 34456778889999999999999999886654 69999999864 67777654
Q ss_pred ccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--cccccCCCCCCCcc
Q 005017 175 KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE 251 (719)
Q Consensus 175 ~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--~~~~~GT~~YmAPE 251 (719)
+ ...+..-+.||+.||.|||. ++ ++|++|.-+.|+++.. |.+||++|-++....... .....---.|..|+
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 3 55666678999999999984 56 9999999999999855 899999998875433222 11111122345555
Q ss_pred ccccccCccccchhhHHHHHHHhhc
Q 005017 252 LYEEEYNELVDIYSFGMCILEMVTF 276 (719)
Q Consensus 252 vl~~~~s~ksDIwSlGiil~EmlTG 276 (719)
.+... .-..|.|-|||++++++.|
T Consensus 176 ~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc-ccchhhhhHHHHHHHHhCc
Confidence 33211 1347999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.3e-09 Score=105.89 Aligned_cols=145 Identities=21% Similarity=0.214 Sum_probs=105.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CCceeEEEeeecCC-CCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDK-KKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~~~~~~~~-~~~l~lV~ 159 (719)
+.||.|.++.||++... +|..+++|........ .....+..|+++++.+.+ .++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 56899999999999764 4688999987543321 124567899999999976 34566776543321 12467999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC----------------------------------------
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH---------------------------------------- 199 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~---------------------------------------- 199 (719)
||++|.++.+.+.. ..+++.....++.+++.+|.+||+.
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988876532 3567777778888888888888842
Q ss_pred --------------CCCeeeecCccceeEecCC-CCcEEEeecchhhh
Q 005017 200 --------------NPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIA 232 (719)
Q Consensus 200 --------------~ppIIHrDLKp~NILl~~~-~G~vKL~DFGlA~~ 232 (719)
...++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1247999999999999863 35689999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-08 Score=110.83 Aligned_cols=214 Identities=20% Similarity=0.247 Sum_probs=152.3
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC--CCCceeEEEecccC-C
Q 005017 89 AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMITELFTS-G 165 (719)
Q Consensus 89 ~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~--~~~~l~lV~Ey~~g-G 165 (719)
.-.+.|+++...+|..|++|+++..+... . .+...-++.++++.|+|+|+|...|... +...+++||+|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-T---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-c---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 34678999999999999999996443222 1 2233567899999999999999887632 23468899999875 5
Q ss_pred ChhHHhh---------------hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 166 NLRQYRK---------------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 166 sL~~~L~---------------~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+|.++-- .+...++..+|.++.|+..||.++|+.| +..+-|.|.+|+++++. +++|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence 7776432 1234788999999999999999999999 88899999999999775 7888777765
Q ss_pred hhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHH-HHHHHcCCCCCccccCCChH
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i-~~~i~~g~~p~~~~~~~~~~ 309 (719)
..+..+.. |.+++ -.+-|.=.||.+++-|.||..--.......+. ...+ ...++.+
T Consensus 441 Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTD 497 (655)
T ss_pred eeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHH
Confidence 54443321 11211 13467778999999999996442221222222 2233 2345678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++++|.-... .+++ -++.+|+.|
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 8999988776 4665 788888875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=98.46 Aligned_cols=144 Identities=19% Similarity=0.238 Sum_probs=104.0
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-----GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~-----~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+|-+|+-+.|+++. ..|+...||.-.. +....+ -...+..+|+++|.++.--.|.-..-++++.....
T Consensus 12 l~likQGAEArv~~~~--~~Ge~~iIK~Rf~-K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~-- 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGS--FSGEAAIIKERFS-KRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ-- 86 (229)
T ss_pred ceeeeccceeeEeeec--cCCceeEEeeccc-ccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe--
Confidence 4789999999999995 5688877775332 222222 23456788999999986555543333455555544
Q ss_pred EEEecccC-CChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcE--EEeecchhh
Q 005017 157 MITELFTS-GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV--KIGDLGLAI 231 (719)
Q Consensus 157 lV~Ey~~g-GsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~v--KL~DFGlA~ 231 (719)
++|||++| -++.+|+.... .........++++|-+.+.-||..+ |||+||..+||++..+.+.+ .++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 47899977 47888886542 2333334788999999999999999 99999999999997665544 899999985
Q ss_pred h
Q 005017 232 A 232 (719)
Q Consensus 232 ~ 232 (719)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.1e-08 Score=97.28 Aligned_cols=134 Identities=20% Similarity=0.257 Sum_probs=95.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhh-----HHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-----LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~-----~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
..+++|+-+.+|.+. .-|..+++| ..+.+....+.- ..+..+|+.+|.+++--.|...+=+.++... ..+
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K-~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVK-ERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLI 76 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEE-eecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEE
Confidence 357899999999983 345555555 344443333322 2455679999998864444332223355544 456
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+|||.+|-.|++++... ...+++.+-.-+.-||..+ |||+||.++||++.+. .+.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence 99999999999998765 2445666777777899999 9999999999999744 599999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.2e-07 Score=92.15 Aligned_cols=131 Identities=26% Similarity=0.258 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCeEEEEEEEeecccc------------C----------ChhhHHHHHHHHHHHHhCCCC--CceeEEEee
Q 005017 92 TVYKAFDEFAGIEVAWSRVKIDDVL------------Q----------LPGDLQKLYSEVHLLKSLKDD--NVVKFYKSW 147 (719)
Q Consensus 92 ~Vyka~d~~~g~~VAvK~i~~~~~~------------~----------~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~ 147 (719)
.||.|... +|..+|+|..+..... . .........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999764 7889999987753110 0 001123467899999999765 566776532
Q ss_pred ecCCCCceeEEEeccc--CCChhHHhhhcccccHHHHHHHHHHHHHHhhh-hhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 148 VDDKKKTVNMITELFT--SGNLRQYRKKHKNVDIKVIKNWARQILHGLVY-LHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~--gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~y-LHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
. -++||||+. |..+....... ++......++.+++..+.. +|..| |+|+||.+.||+++.+ .+.|
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i 147 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI 147 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred --C----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence 2 357999998 55554433221 2234556677888885555 57888 9999999999999844 8999
Q ss_pred eecchhhhccC
Q 005017 225 GDLGLAIAMQQ 235 (719)
Q Consensus 225 ~DFGlA~~~~~ 235 (719)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998865543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.7e-07 Score=94.74 Aligned_cols=136 Identities=16% Similarity=0.097 Sum_probs=91.7
Q ss_pred EEEEEEcCCCeEEEEEEEeecccc---C----ChhhHHHHHHHHHHHHhCCCCCc--eeEEEeeecCC---CCceeEEEe
Q 005017 93 VYKAFDEFAGIEVAWSRVKIDDVL---Q----LPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDK---KKTVNMITE 160 (719)
Q Consensus 93 Vyka~d~~~g~~VAvK~i~~~~~~---~----~~~~~~~~~~Ei~iL~~L~HpNI--Vkl~~~~~~~~---~~~l~lV~E 160 (719)
|++. ...|+.|.+|+....... . ...-...+.+|...+.+|..-+| ++..++..... ...-++|||
T Consensus 38 vvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4454 235777888866432210 0 00011246788888888743333 33333333211 234678999
Q ss_pred cccCC-ChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC------CCCcEEEeecchhh
Q 005017 161 LFTSG-NLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVKIGDLGLAI 231 (719)
Q Consensus 161 y~~gG-sL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~------~~G~vKL~DFGlA~ 231 (719)
++++- +|.+++.. ....+......++.+++..+.-||..| |+|+||++.|||++. +.+.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99886 89998864 234566777889999999999999999 999999999999974 23589999999774
Q ss_pred h
Q 005017 232 A 232 (719)
Q Consensus 232 ~ 232 (719)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.3e-08 Score=112.48 Aligned_cols=151 Identities=19% Similarity=0.292 Sum_probs=106.5
Q ss_pred HHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCc-----------ccccCCCCCCCcccccc-
Q 005017 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-----------RSVIGTPEFMAPELYEE- 255 (719)
Q Consensus 188 QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~-----------~~~~GT~~YmAPEvl~~- 255 (719)
+++.||.|+|.+ +.+||++|.|++|.++.+ |.+||+.|+.+.....+.. ....-...|.|||++..
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 444999999987 249999999999999966 7999999998754433211 11234668999998765
Q ss_pred ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHH--HHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK--VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 256 ~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~--i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+.++|+||+|+++|.+..|..+-....+....+.. ...+..........+.++++=+.++|. ++.-||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4678999999999999999555443221211111111 111112222335567899999999997 8999999999999
Q ss_pred CccCcccc
Q 005017 333 DPFLQVEN 340 (719)
Q Consensus 333 hpf~~~~~ 340 (719)
-|||+...
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99998554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-06 Score=95.07 Aligned_cols=235 Identities=18% Similarity=0.244 Sum_probs=149.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCcee--------EEEee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVK--------FYKSW 147 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVk--------l~~~~ 147 (719)
.-+..++-||+|+-+.+|..- .-+..|| |+...... .... .-+..|... .||-+-. ++|
T Consensus 11 e~i~~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Ppp----a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G-- 78 (637)
T COG4248 11 EPIPPGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPPP----AAQA---QKVAELAATPDAPLLNYRVAWPQATLHG-- 78 (637)
T ss_pred cccCCCccccCCccceeeecc--hhhchhh-eeecCCCc----hHHH---HHHHHhccCCCCcchhhhhcccHHHhhC--
Confidence 334455679999999999762 2333454 55543221 1111 122233333 5654322 122
Q ss_pred ecCCCCceeEEEecccCCC-hhHH------hhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC
Q 005017 148 VDDKKKTVNMITELFTSGN-LRQY------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 220 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGs-L~~~------L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G 220 (719)
......+-++|..+.+.. ...+ .+..+..++....+.++.++.+.+.||.+| .+-+|+.++|+|+.++ +
T Consensus 79 -~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~ 154 (637)
T COG4248 79 -GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-S 154 (637)
T ss_pred -CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-c
Confidence 122233667788776642 2222 222345788999999999999999999999 8999999999999744 7
Q ss_pred cEEEeecchhhhccCC-CcccccCCCCCCCccccc-c-----ccCccccchhhHHHHHHHhhc-cCCCCCCC------CH
Q 005017 221 EVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTF-EYPYSECK------NP 286 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~-~-----~~s~ksDIwSlGiil~EmlTG-~~Pf~~~~------~~ 286 (719)
.|.|.|=..-....+. .....+|.+.|.+||.-. . ..+...|-|.||+++++++.| +.||++.. ++
T Consensus 155 ~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 155 KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred eEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 8998885432222222 234557999999999754 1 246779999999999999887 99997631 11
Q ss_pred HHHHHHHHc-----------CCCC--Cc-cccCCChHHHHHHHHhcCC---CCCCCCHHH
Q 005017 287 AQIFKKVTS-----------GIKP--AS-LAKVNDPQIKGFIEKCLVP---ASERLSAKD 329 (719)
Q Consensus 287 ~~i~~~i~~-----------g~~p--~~-~~~~~~~~l~~lI~kcL~d---P~~RpSa~e 329 (719)
-+ ..|.. +.+| .. .....++.++.+..+|+.+ +.-|||++.
T Consensus 235 ~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 235 LE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11 12222 2222 11 2244578999999999974 568999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-08 Score=111.64 Aligned_cols=242 Identities=19% Similarity=0.237 Sum_probs=164.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~~~~ 154 (719)
++|+..-.-+++|++++++|++...+...+ .+.+... ....-++++|.+++||| .+..++.+ +...+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~ 308 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDY 308 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccc
Confidence 455555566899999999999776555444 5555422 23445889999999999 55555543 44567
Q ss_pred eeEEEecccCC-C-hhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSG-N-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gG-s-L~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++++++.+| + ........-.+..-+....++.-+++|+|||+.. -+||| ||+... +..|.+||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccCCcc
Confidence 88999999887 2 2221111223444556667778889999999875 58998 887753 5899999999876
Q ss_pred ccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-c-cCCCh
Q 005017 233 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-A-KVNDP 308 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~-~-~~~~~ 308 (719)
+... ..++..+|+.++|||+.. ..+....|+|++|.-..+|.-|.+|-.. |......+..+.....+ . ....+
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCc
Confidence 6554 456778999999999765 5689999999999988899888877543 11111111111100000 0 11112
Q ss_pred H-HHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 309 Q-IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 309 ~-l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
. -+++...|+. -|..|+.....+.|.+|..=+
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 2 2347788998 699999999999999997543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.9e-06 Score=86.31 Aligned_cols=109 Identities=20% Similarity=0.193 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHHhCCCCC--ceeEEEeeecCC--CCceeEEEecccCC-ChhHHhhhcccccHHHHHHHHHHHHHHhhhh
Q 005017 122 LQKLYSEVHLLKSLKDDN--VVKFYKSWVDDK--KKTVNMITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196 (719)
Q Consensus 122 ~~~~~~Ei~iL~~L~HpN--IVkl~~~~~~~~--~~~l~lV~Ey~~gG-sL~~~L~~~~~l~~~~i~~i~~QIl~gL~yL 196 (719)
..+..+|...+..|..-. ..+.+++..... ....++|||++++- +|.+++......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888888775333 344444433322 12457899999874 8999998755577778889999999999999
Q ss_pred hcCCCCeeeecCccceeEecCCC--CcEEEeecchhhh
Q 005017 197 HSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIA 232 (719)
Q Consensus 197 Hs~~ppIIHrDLKp~NILl~~~~--G~vKL~DFGlA~~ 232 (719)
|..| |+|+|+++.|||++.+. ..+.++||+.+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998553 2689999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.3e-06 Score=103.19 Aligned_cols=207 Identities=22% Similarity=0.338 Sum_probs=146.2
Q ss_pred hHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC--ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc
Q 005017 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK--TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198 (719)
Q Consensus 121 ~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~--~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs 198 (719)
.+.....|+..+..+.|+|++.++.+....... .+.+..+++..-++...+..-..++...++.+..+++.||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344455677788889999999999887664433 234567899999999999988899999999999999999999999
Q ss_pred CCCCeeeecCccc---eeEecCCCCcEEEe--ecchhhhccCC-CcccccCCCCCCCccccccc---cCccccchhhHHH
Q 005017 199 HNPPIIHRDLKCD---NIFVNGNHGEVKIG--DLGLAIAMQQP-TARSVIGTPEFMAPELYEEE---YNELVDIYSFGMC 269 (719)
Q Consensus 199 ~~ppIIHrDLKp~---NILl~~~~G~vKL~--DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~~---~s~ksDIwSlGii 269 (719)
.. ..|.-|... +-..+++ +.+.++ ||+....+... ......-+..+.|||..... .....|+|.+|..
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 86 666555544 3333333 356666 88877655433 22333446678888877644 3344799999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 270 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 270 l~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+..+..|..+-..... ... .+.........+++.+|+. ++++|+++.+++.|||+......
T Consensus 382 ~~~~~~~~~i~~~~~~----~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV----PVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred HhhhhhcCcccccccc----hhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 9999988655321110 001 1111122267888999997 79999999999999999865443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.8e-06 Score=87.90 Aligned_cols=140 Identities=21% Similarity=0.206 Sum_probs=95.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc-----cCCh-------------hhHHHHHHHHHHHHhCCCC-
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV-----LQLP-------------GDLQKLYSEVHLLKSLKDD- 138 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~-----~~~~-------------~~~~~~~~Ei~iL~~L~Hp- 138 (719)
...++..||-|--+.||.|.+. .|.++|+|.=+.... .... -......+|+++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999876 899999996543210 0000 1123456899999999755
Q ss_pred -CceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 139 -NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 139 -NIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
.+.+.+++ +.-.+||||++|-.|....- +.+....++..|+.-+.-+-..| |||+|+.+-||+++.
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~ 237 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEec
Confidence 77777762 23557999999977765432 22233334444444444444567 999999999999986
Q ss_pred CCCcEEEeecchhhh
Q 005017 218 NHGEVKIGDLGLAIA 232 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~ 232 (719)
+ |.+.++||--+..
T Consensus 238 d-g~~~vIDwPQ~v~ 251 (304)
T COG0478 238 D-GDIVVIDWPQAVP 251 (304)
T ss_pred C-CCEEEEeCccccc
Confidence 5 7999999975543
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.6e-06 Score=63.19 Aligned_cols=32 Identities=41% Similarity=0.534 Sum_probs=27.4
Q ss_pred eEEEEEeecCCC------CccceeecccCCCCcHHHHH
Q 005017 419 VSLTLRIADSSG------RVRNIHFLFYLDSDTALSVA 450 (719)
Q Consensus 419 i~L~Lri~d~~~------~~~~i~f~f~~~~Dta~~va 450 (719)
|.|+||++|+++ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=80.39 Aligned_cols=141 Identities=16% Similarity=0.154 Sum_probs=98.8
Q ss_pred eeeCCeEEEEEEEcCCCeEEEEEEEee--ccccCChhhHHHHHHHHHHHHhCCCCC--ceeEE--EeeecCCCCceeEEE
Q 005017 86 GKGAFKTVYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFY--KSWVDDKKKTVNMIT 159 (719)
Q Consensus 86 G~G~fG~Vyka~d~~~g~~VAvK~i~~--~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IVkl~--~~~~~~~~~~l~lV~ 159 (719)
|+||-+.|++... .|..+-+|+-.- ......+-....|.+|+..|.+|..-+ +.+.. +.-.....-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6788899998743 455677887541 111111345578999999999985432 33333 211112223466899
Q ss_pred ecccC-CChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc--EEEeecchhh
Q 005017 160 ELFTS-GNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAI 231 (719)
Q Consensus 160 Ey~~g-GsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~--vKL~DFGlA~ 231 (719)
|-+.+ -+|.+++... .+.+......++.+|+..+.-||..| +.|+|+-+.|||++.+ |. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 96653 5898888653 34577777899999999999999999 9999999999999744 45 9999997553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.2e-05 Score=75.33 Aligned_cols=79 Identities=15% Similarity=0.151 Sum_probs=54.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEeeecCC-CCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDDK-KKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~~~~~-~~~l~lV~ 159 (719)
+.|+.|..+.||+..... ..+++|..... .....+..|..++..|... .+.+++....... ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 579999999999997653 48888875422 2456777898888888533 3456665432222 23468899
Q ss_pred ecccCCChhH
Q 005017 160 ELFTSGNLRQ 169 (719)
Q Consensus 160 Ey~~gGsL~~ 169 (719)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.8e-05 Score=88.22 Aligned_cols=144 Identities=18% Similarity=0.207 Sum_probs=87.8
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhH--------------------------H----------HHH
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL--------------------------Q----------KLY 126 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~--------------------------~----------~~~ 126 (719)
+-|+.++-|.||+|... +|+.||||+.+..-......++ + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999876 6999999998754221111111 1 123
Q ss_pred HHHHHHHhCC-----CCCceeEEEeeecCCCCceeEEEecccCCChhHH--hhhcccccHHHHHHHHHHHHHHhhhhhcC
Q 005017 127 SEVHLLKSLK-----DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSH 199 (719)
Q Consensus 127 ~Ei~iL~~L~-----HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~--L~~~~~l~~~~i~~i~~QIl~gL~yLHs~ 199 (719)
+|...+.+++ .|++ ++=..+.+-. ..-.++|||+.|-.+.+. ++. .+++.+.+..-..++.- .-+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-Eeceeehhcc-CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 3444444442 2332 2222222211 224579999999999887 343 44554433332222211 111124
Q ss_pred CCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 200 ~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
| ++|.|..|.||+++.+ |.+-+.|||+...+..
T Consensus 285 g--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred C--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 6 9999999999999866 7999999998865543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.5e-05 Score=76.44 Aligned_cols=135 Identities=14% Similarity=0.160 Sum_probs=78.2
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc--eeEEEeeecCCCCceeEEEe
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI--Vkl~~~~~~~~~~~l~lV~E 160 (719)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-.+ .+.+.+.... ....+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--Ceeeeeee
Confidence 56899999999984 25567777765321 22456889999998864433 5555544333 34677999
Q ss_pred cccCCC-hhHHh--------------hh-----c----ccccHHHH-HHHHHHH----------HH-Hhhhh--hcCCCC
Q 005017 161 LFTSGN-LRQYR--------------KK-----H----KNVDIKVI-KNWARQI----------LH-GLVYL--HSHNPP 202 (719)
Q Consensus 161 y~~gGs-L~~~L--------------~~-----~----~~l~~~~i-~~i~~QI----------l~-gL~yL--Hs~~pp 202 (719)
+++|.. +...+ .. + ...+.... ..+-.++ .. ...+| +...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 999863 11110 00 1 01111110 1111111 01 11122 222345
Q ss_pred eeeecCccceeEecCCCCcEEEeecchhh
Q 005017 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 203 IIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
++|+|+.|.||+++.+ | +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 8999999999999854 5 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00044 Score=71.53 Aligned_cols=74 Identities=16% Similarity=0.056 Sum_probs=48.0
Q ss_pred EeeeCC-eEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEEecc
Q 005017 85 LGKGAF-KTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 85 LG~G~f-G~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
|-.|.. ..||+... .+..+.+|...... ...+.+|+++++.+. +--+.+++.+.... ..-++|||++
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEee
Confidence 444555 78999854 34567777654321 234667888888884 34456677655433 3467899999
Q ss_pred cCCChhH
Q 005017 163 TSGNLRQ 169 (719)
Q Consensus 163 ~gGsL~~ 169 (719)
+|.+|..
T Consensus 75 ~G~~l~~ 81 (244)
T cd05150 75 PGVPAAA 81 (244)
T ss_pred CCccHhH
Confidence 9987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00063 Score=83.16 Aligned_cols=147 Identities=20% Similarity=0.272 Sum_probs=89.6
Q ss_pred EEEeeeCCeEEEEEEEcCCC--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCc--eeEEEeeecCC-CCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNV--VKFYKSWVDDK-KKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNI--Vkl~~~~~~~~-~~~l~ 156 (719)
+.|+.|.+..+|+......+ ..+++|+....... .....+.+|+++|+.|. |+++ .+++.++.+.. ....|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 66899999999998654332 46777765433221 12346789999999995 6665 77777654431 13467
Q ss_pred EEEecccCCChhH--------------------Hhhh-cc------c---------ccHHHHHHHHHHH-----------
Q 005017 157 MITELFTSGNLRQ--------------------YRKK-HK------N---------VDIKVIKNWARQI----------- 189 (719)
Q Consensus 157 lV~Ey~~gGsL~~--------------------~L~~-~~------~---------l~~~~i~~i~~QI----------- 189 (719)
+||||++|..+.+ .+.. +. . .....+..|..|.
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 8999999865321 0110 00 0 1112343443332
Q ss_pred ----HHHhhhhhcCCC---------CeeeecCccceeEecCCCCc-EEEeecchhhh
Q 005017 190 ----LHGLVYLHSHNP---------PIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIA 232 (719)
Q Consensus 190 ----l~gL~yLHs~~p---------pIIHrDLKp~NILl~~~~G~-vKL~DFGlA~~ 232 (719)
...+.+|..+-| .+||+|+++.||+++.+.+. +-|.||.++..
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223556644322 39999999999999854333 57999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00047 Score=70.88 Aligned_cols=140 Identities=14% Similarity=0.148 Sum_probs=85.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHH------HHHHHHHHHhCC---CCCceeEEEee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLK---DDNVVKFYKSW 147 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~------~~~Ei~iL~~L~---HpNIVkl~~~~ 147 (719)
..++..+++-......|.+- ..+|..+.+|..+...... ...... ..+.+..+.+++ -.....++...
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34455566666665655554 4578889988876543221 111111 123333333332 23333333322
Q ss_pred ecCC---CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 148 VDDK---KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 148 ~~~~---~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
.... ....++||||++|..|.++.. +++ .+...|..++.-||.+| +.|+|..|.|++++.+ .+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEE
Confidence 2111 123558999999998877643 222 24456777889999999 9999999999999843 6999
Q ss_pred eecchhh
Q 005017 225 GDLGLAI 231 (719)
Q Consensus 225 ~DFGlA~ 231 (719)
.||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00047 Score=71.80 Aligned_cols=142 Identities=20% Similarity=0.178 Sum_probs=93.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC---------------ChhhHHH-----HHHHHHHHHhCC--CCCc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ---------------LPGDLQK-----LYSEVHLLKSLK--DDNV 140 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~---------------~~~~~~~-----~~~Ei~iL~~L~--HpNI 140 (719)
-.|..|--+.||+|.. .++..+|+|+.+.....- .....++ ..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4677888889999964 478899999987532110 0001111 235888888874 4445
Q ss_pred eeEEEeeecCCCCceeEEEecccCCChh-HHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCC
Q 005017 141 VKFYKSWVDDKKKTVNMITELFTSGNLR-QYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 141 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~-~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~ 218 (719)
.+-+++. .-.+||||+....+. -.|+ .-.+..+....+..+++..+.-|-. .+ +||+||..-|||+. +
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D 202 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C
Confidence 5555533 134799999654211 1122 1223333677778888888887766 67 99999999999997 3
Q ss_pred CCcEEEeecchhhhccCC
Q 005017 219 HGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~ 236 (719)
|.+.|+|||-|.....+
T Consensus 203 -~~p~iID~~QaV~~~hp 219 (268)
T COG1718 203 -GEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -CeEEEEECccccccCCC
Confidence 58999999988765544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00052 Score=78.98 Aligned_cols=144 Identities=18% Similarity=0.139 Sum_probs=88.7
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhh---------------------------HH------HHHHHH
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD---------------------------LQ------KLYSEV 129 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~---------------------------~~------~~~~Ei 129 (719)
+-||.-+.|.||+|..+ +|+.||||+-+..-......+ .+ .|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67999999999999877 599999998664321110000 01 122343
Q ss_pred HHH----HhCCCCC------ceeEEEeeecCCCCceeEEEecccCCChhHH--hhhcccccHHHHHHHHHHHHHHhhhhh
Q 005017 130 HLL----KSLKDDN------VVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLH 197 (719)
Q Consensus 130 ~iL----~~L~HpN------IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~--L~~~~~l~~~~i~~i~~QIl~gL~yLH 197 (719)
+.. +.+.|-+ |.++|-.+. ..-.|+||||.|.-+.+. +.+. +++...+..-+.+...-+ +-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~q--If 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQ--IF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHH--HH
Confidence 332 2334555 445543321 235689999999887664 4443 355544433333322222 22
Q ss_pred cCCCCeeeecCccceeEecC---CCCcEEEeecchhhhccCC
Q 005017 198 SHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 198 s~~ppIIHrDLKp~NILl~~---~~G~vKL~DFGlA~~~~~~ 236 (719)
.+| ++|+|=.|.||+++. ..+.+.+-|||+...+...
T Consensus 319 ~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 346 999999999999983 3568999999998665443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=2.2e-05 Score=96.53 Aligned_cols=213 Identities=14% Similarity=0.017 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhh
Q 005017 122 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLH 197 (719)
Q Consensus 122 ~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLH 197 (719)
.+-...|...++...|++++..+.-.........|.+++|+.+|.+++.+-+. +.++..-+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34455677777888999999988776666666788899999999999987543 33444444444455466766666
Q ss_pred cC---CCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHH
Q 005017 198 SH---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCIL 271 (719)
Q Consensus 198 s~---~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~ 271 (719)
+. +-..+|++||+-|.+|..++ .+|++++|+.+..... ......+++.|++|++.+. .++.++|+|..|+-+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 54 23579999999999999776 8999999999843332 2345678889999998875 5888899999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhc-CCCCCCCCHHHHHcCccCc
Q 005017 272 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 272 EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL-~dP~~RpSa~eLL~hpf~~ 337 (719)
+..-|..||... ..-..+.+........++...+.+.-......| -+-..||.-...+.-+.+-
T Consensus 1432 ~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 999988777431 111111122222222333332223333333333 2556678877777766664
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.001 Score=68.61 Aligned_cols=75 Identities=11% Similarity=0.046 Sum_probs=44.6
Q ss_pred EEEeeeCCe-EEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC---CceeEEEeeecCCC-CceeE
Q 005017 83 EVLGKGAFK-TVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKK-KTVNM 157 (719)
Q Consensus 83 e~LG~G~fG-~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIVkl~~~~~~~~~-~~l~l 157 (719)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.++|..|... .+.+++......+. ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457777776 48886 234666653321 1235788899999888532 34444443322111 23478
Q ss_pred EEecccCCChh
Q 005017 158 ITELFTSGNLR 168 (719)
Q Consensus 158 V~Ey~~gGsL~ 168 (719)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00098 Score=67.06 Aligned_cols=99 Identities=23% Similarity=0.150 Sum_probs=77.4
Q ss_pred HHHHHHHhCCC-CCceeEEEeeecCCCCceeEEEecccCCChhH---HhhhcccccHHHHHHHHHHHHHHhhhhhcCCC-
Q 005017 127 SEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ---YRKKHKNVDIKVIKNWARQILHGLVYLHSHNP- 201 (719)
Q Consensus 127 ~Ei~iL~~L~H-pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~---~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~p- 201 (719)
.|.-+|+.+++ +++++++|+|- -++|+||...+++.. .+...-.-+++.+.+++.+++..+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888999977 69999999881 245899998776642 11222246899999999999999999987522
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
++.-.|++|+|+-++.+ |.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcch
Confidence 37779999999999854 7999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0047 Score=66.48 Aligned_cols=78 Identities=10% Similarity=0.102 Sum_probs=53.1
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEeeecCC-CCceeE
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVDDK-KKTVNM 157 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pNIVkl~~~~~~~~-~~~l~l 157 (719)
.+.||.|..+.||+..+. +| .+.+|..+.. .....+..|...|+.|.- -.+.++++.+.+.. ...-++
T Consensus 19 ~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDS-QG-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcC-CC-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 467999999999998433 34 4566664311 112468889999998853 35778887664432 234688
Q ss_pred EEecccCCCh
Q 005017 158 ITELFTSGNL 167 (719)
Q Consensus 158 V~Ey~~gGsL 167 (719)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0034 Score=63.88 Aligned_cols=132 Identities=20% Similarity=0.249 Sum_probs=90.2
Q ss_pred CCcEEEeEEEeeeCC-eEEEEEEEcCCCeEEEEEEEee---ccc-------cCCh-------hhHHHHHHHHHHHHhCC-
Q 005017 76 GRYVRYDEVLGKGAF-KTVYKAFDEFAGIEVAWSRVKI---DDV-------LQLP-------GDLQKLYSEVHLLKSLK- 136 (719)
Q Consensus 76 gr~~~l~e~LG~G~f-G~Vyka~d~~~g~~VAvK~i~~---~~~-------~~~~-------~~~~~~~~Ei~iL~~L~- 136 (719)
+..+++.+.||.|+- |.||++. -.|..+|+|.++. ... .... ....-|..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 367888899999999 9999995 4688999999432 110 0000 22345778888777764
Q ss_pred --CCCc--eeEEEeeecCC-C---------------CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhh
Q 005017 137 --DDNV--VKFYKSWVDDK-K---------------KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196 (719)
Q Consensus 137 --HpNI--Vkl~~~~~~~~-~---------------~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yL 196 (719)
+.++ |++||+..-.. + ....+|.||.+... .+... =+.+|++-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHH
Confidence 4566 99999874331 1 12236777665533 22222 356778888889
Q ss_pred hcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 197 Hs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g--I~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG--IVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HHCC--eeeccCcccccc------CCEEEecccC
Confidence 9999 999999999965 2379999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0078 Score=67.49 Aligned_cols=80 Identities=21% Similarity=0.241 Sum_probs=54.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc--C-ChhhHHHHHHHHHHHHhCC---CCCceeEEEeeecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL--Q-LPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~--~-~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.||.|.+..||++.+...++.|+||+-...... . .+...++...|.+.|..+. -.++.+++.+ +. ...+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~--~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE--ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC--CCCE
Confidence 5689999999999988643368999985422111 1 1334577788888888863 2457778764 33 3366
Q ss_pred EEEecccCCC
Q 005017 157 MITELFTSGN 166 (719)
Q Consensus 157 lV~Ey~~gGs 166 (719)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 8999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0043 Score=63.64 Aligned_cols=74 Identities=15% Similarity=0.135 Sum_probs=45.9
Q ss_pred EEEeeeCCeEEEEEEEcC-CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCCCCceeEEEe
Q 005017 83 EVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~~~~l~lV~E 160 (719)
+.|..|-...+|+..... .+..|++|....... ..-...+|+.+++.+...+ ..+++..+ .+ .+|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence 467888888999985432 256788886543211 1112346888888885333 44555432 21 26999
Q ss_pred cccCCCh
Q 005017 161 LFTSGNL 167 (719)
Q Consensus 161 y~~gGsL 167 (719)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0026 Score=63.21 Aligned_cols=131 Identities=25% Similarity=0.257 Sum_probs=86.7
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCcee-EEEeeecCCCCceeEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK-FYKSWVDDKKKTVNMI 158 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk-l~~~~~~~~~~~l~lV 158 (719)
+..+.||+|.+|.||++. +.|.++|+|+-+.+ .....+..|+++|..++-.++-. +|.+- . .++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d------s~r~~l~kEakiLeil~g~~~~p~vy~yg--~----~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD------SPRRNLEKEAKILEILAGEGVTPEVYFYG--E----DFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCC------cchhhHHHHHHHHHHhhhcCCCceEEEec--h----hhhh
Confidence 345679999999999994 56889999875543 23467889999999998777643 44432 2 3346
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc-cc-eeEecCCCCcEEEeecchhhhccC
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK-CD-NIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK-p~-NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|||+.|-.|...-... +.+.+. .++..---|-..| |-|..|. |. ||+++ + +.+.|+||..|+....
T Consensus 91 me~i~G~~L~~~~~~~---~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~-~-~~~~iIDFd~At~k~~ 158 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVN-D-RDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEec-C-CcEEEEEccchhhccC
Confidence 9999998887755421 223332 3333322244446 7777775 33 55554 4 4899999999875443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0075 Score=61.33 Aligned_cols=134 Identities=20% Similarity=0.309 Sum_probs=87.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC------------ChhhHHHHHHHHHHHHhCC------CCCceeEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ------------LPGDLQKLYSEVHLLKSLK------DDNVVKFY 144 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~------------~~~~~~~~~~Ei~iL~~L~------HpNIVkl~ 144 (719)
..||+|+.=.||.- . ......||+........ .........+|+....++. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999984 3 44456788887654000 0112455667777776666 78899999
Q ss_pred EeeecCCCCceeEEEecccC------CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC
Q 005017 145 KSWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 145 ~~~~~~~~~~l~lV~Ey~~g------GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~ 218 (719)
|....+. .+-+|+|.... -+|.++++. +.++. .....+.+ -..||-.+. |+.+||+|.||++...
T Consensus 84 G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~---f~~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNL--GLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE---FKRYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCC--ceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH---HHHHHHHcC--CeecCCCcccEEEEec
Confidence 9765443 46678887653 368888854 44665 44443443 345666667 9999999999999533
Q ss_pred C-C--cEEEee-cc
Q 005017 219 H-G--EVKIGD-LG 228 (719)
Q Consensus 219 ~-G--~vKL~D-FG 228 (719)
. | .+.|+| ||
T Consensus 155 ~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 155 DSGEFRLVLIDGLG 168 (199)
T ss_pred CCCceEEEEEeCCC
Confidence 2 2 466776 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0093 Score=62.31 Aligned_cols=134 Identities=19% Similarity=0.165 Sum_probs=73.8
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCceeEEEeccc
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFT 163 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~ 163 (719)
+..|-...+|+.. .+|..+++|....... ...-...+|..+++.+....+ .+++... . -++|+||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEecc
Confidence 4567778899885 4567788876432211 100124678888888864433 3344322 2 247999999
Q ss_pred CCChhHH--------------hhh-c------ccccHH-HHHHHHHHH---------HHHhhhhhcC------CCCeeee
Q 005017 164 SGNLRQY--------------RKK-H------KNVDIK-VIKNWARQI---------LHGLVYLHSH------NPPIIHR 206 (719)
Q Consensus 164 gGsL~~~--------------L~~-~------~~l~~~-~i~~i~~QI---------l~gL~yLHs~------~ppIIHr 206 (719)
|..+..- +.+ + ..++.. .+..+..++ ...+..+-.. .+.++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 8765421 111 0 111211 122222222 1111111111 2248999
Q ss_pred cCccceeEecCCCCcEEEeecchhhh
Q 005017 207 DLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 207 DLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
|+.|.||+++++ | +.|+||..|..
T Consensus 152 Dl~~~Nil~~~~-~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTPQ-G-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeCC-C-CEEEeccccCc
Confidence 999999999854 3 78999987743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.018 Score=61.52 Aligned_cols=75 Identities=20% Similarity=0.162 Sum_probs=45.5
Q ss_pred EEEeeeCCeEEEEEEEcC------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCce
Q 005017 83 EVLGKGAFKTVYKAFDEF------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTV 155 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l 155 (719)
+.|..|-...||+..... .+..+++|...... .......+|.+++..+....+ .++++++ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 446667777889886432 25788888754321 112345678888888854333 3455543 22
Q ss_pred eEEEecccCCChh
Q 005017 156 NMITELFTSGNLR 168 (719)
Q Consensus 156 ~lV~Ey~~gGsL~ 168 (719)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 2488999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.01 Score=67.37 Aligned_cols=163 Identities=21% Similarity=0.232 Sum_probs=101.3
Q ss_pred HHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCC
Q 005017 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202 (719)
Q Consensus 123 ~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~pp 202 (719)
.++.-.++.++.+.|+|...++++-.. ...+..+|+|++ +.||.+++..+. +-.... + .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~-~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~----------~----~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRG-KHERVIVVMEHY-TMSLEDILKTGN-LKDESL----------L----AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecC-ccceEEEEehhh-ccchHHHHHhcc-cchhhh----------c----ccc--
Confidence 445667889999999999999876433 334578899999 559999887655 211111 1 122
Q ss_pred eeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCC
Q 005017 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSE 282 (719)
Q Consensus 203 IIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~ 282 (719)
+.| -| .++++| .++.. . ....| +++||||+|.++.|+.-|..-+..
T Consensus 88 ~~~-----~~--------~~~~td-~~~t~---~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 VLH-----LN--------IIYITD-HFLTK---Y--PSPIG---------------PKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred cce-----eh--------hhhccc-ccccc---C--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence 222 12 233343 11100 0 11111 499999999999999999877765
Q ss_pred CCCHHHHHHHHHcCCCCC---------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 283 CKNPAQIFKKVTSGIKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 283 ~~~~~~i~~~i~~g~~p~---------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
..+.++......-...+. .+...+|....++..+|+- .|..||...++.+++-|..
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 444333322222121121 1223356678888999997 7999999999999988853
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.047 Score=60.41 Aligned_cols=84 Identities=14% Similarity=0.105 Sum_probs=54.3
Q ss_pred EEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc---cCChhhHHHHHHHHHHHHhCC--CC-CceeEEEeeecCCCCceeE
Q 005017 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV---LQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~---~~~~~~~~~~~~Ei~iL~~L~--Hp-NIVkl~~~~~~~~~~~l~l 157 (719)
.||.|....||++.+...++.|+||+-..--. ...+-..++..-|...|+... -| .+.++|. .+.. ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--ccee
Confidence 37999999999998764446899998653221 123555677778888887763 24 4566665 3332 3557
Q ss_pred EEecccCC-ChhHHh
Q 005017 158 ITELFTSG-NLRQYR 171 (719)
Q Consensus 158 V~Ey~~gG-sL~~~L 171 (719)
|||+++.. .|++.|
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 99999653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.031 Score=59.41 Aligned_cols=139 Identities=17% Similarity=0.135 Sum_probs=77.3
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEee----ecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSW----VDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~----~~~~~~~l~ 156 (719)
+.|..|....+|+... .+..+++|+... .....+..|+.++..|.+. .+.+++... ........+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 4577787789998743 344688887642 1224566788888887533 244544321 101123467
Q ss_pred EEEecccCCChhH-----H------hhh-c---ccc----------cHHHH--H--------HHHHHHHHHhhhhhc---
Q 005017 157 MITELFTSGNLRQ-----Y------RKK-H---KNV----------DIKVI--K--------NWARQILHGLVYLHS--- 198 (719)
Q Consensus 157 lV~Ey~~gGsL~~-----~------L~~-~---~~l----------~~~~i--~--------~i~~QIl~gL~yLHs--- 198 (719)
+|+++++|..+.. + +.+ + ..+ .+... . .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 8999999876532 0 000 0 000 00000 0 011112233444432
Q ss_pred --CCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 199 --HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 199 --~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
....++|+|+.|.||+++.+ +.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 11249999999999999854 456899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.063 Score=59.07 Aligned_cols=137 Identities=15% Similarity=0.179 Sum_probs=78.0
Q ss_pred EEeeeCCeEEEEEEEcC----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCceeEE
Q 005017 84 VLGKGAFKTVYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 84 ~LG~G~fG~Vyka~d~~----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l~lV 158 (719)
.|-.|-.-.+|++.... .++.|++|...... ...+.+ .+|+.+++.+..-++ .++++.+ .+. .|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v 111 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG----RV 111 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc----eE
Confidence 45557788889875322 24678888664321 122222 678888888865444 3455544 221 37
Q ss_pred EecccCCChhHH-------h-------hh-c-------c-cccHHHHHHHHHHHHH--------------------Hhh-
Q 005017 159 TELFTSGNLRQY-------R-------KK-H-------K-NVDIKVIKNWARQILH--------------------GLV- 194 (719)
Q Consensus 159 ~Ey~~gGsL~~~-------L-------~~-~-------~-~l~~~~i~~i~~QIl~--------------------gL~- 194 (719)
++|+++.+|... + .+ | . ....+.+..|..++.. .|.
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 899987766421 0 00 0 0 1112334444433211 111
Q ss_pred hhhc--CCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 195 YLHS--HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 195 yLHs--~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+.. ....++|+|+++.||+++...+.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1221 122589999999999998655689999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.078 Score=58.41 Aligned_cols=149 Identities=18% Similarity=0.215 Sum_probs=95.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc--------------------cCChhhHHH--HHHHHHHHHhCC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV--------------------LQLPGDLQK--LYSEVHLLKSLK 136 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~--------------------~~~~~~~~~--~~~Ei~iL~~L~ 136 (719)
..+...|..|--+.||.|.. .+|..+|||+.+..-+ ...+..+-+ ...|+..|++|+
T Consensus 146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 44556788899999999964 4899999998764211 011111111 245888888887
Q ss_pred CCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhh-cCCCCeeeecCccceeEe
Q 005017 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 137 HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLH-s~~ppIIHrDLKp~NILl 215 (719)
.-.|.-.--..+. .-.|||+|+.......=+-+.-.++...+..+-.|++.-+.-|- .++ +||.||.--|+|+
T Consensus 225 ~aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 225 NAGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY 298 (520)
T ss_pred hcCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE
Confidence 6554322221121 24579999963222221222345666677777777777776654 456 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCC
Q 005017 216 NGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~ 236 (719)
. .|.+.|+|.+-+.....+
T Consensus 299 h--dG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 299 H--DGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred E--CCEEEEEEccccccCCCh
Confidence 5 379999999877554443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.11 Score=55.55 Aligned_cols=32 Identities=19% Similarity=0.245 Sum_probs=25.1
Q ss_pred CCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 201 ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+.++|+|++|.|||++.+....-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35999999999999985422356999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.081 Score=59.24 Aligned_cols=85 Identities=19% Similarity=0.201 Sum_probs=56.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeecc--ccCChhhHHHHHHHHHHHHhCC--CC-CceeEEEeeecCCCCceeE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~--~~~~~~~~~~~~~Ei~iL~~L~--Hp-NIVkl~~~~~~~~~~~l~l 157 (719)
+.||-|.-..||++.+...+..|+||+-..-- ..+++-..++..-|.+.|+.+. -| .+.++|. .+. ....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~--e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS--VMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc--HHhhH
Confidence 56899999999999875345679999754221 1234556778888999888773 24 4666765 333 33557
Q ss_pred EEecccCC-ChhHHh
Q 005017 158 ITELFTSG-NLRQYR 171 (719)
Q Consensus 158 V~Ey~~gG-sL~~~L 171 (719)
|||+++.. .|++.|
T Consensus 111 vMEdL~~~~ilR~~L 125 (409)
T PRK12396 111 VMEDLSDHTILRTAL 125 (409)
T ss_pred HHHhCcccHHHHHHH
Confidence 99999653 355554
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.01 Score=68.28 Aligned_cols=68 Identities=26% Similarity=0.389 Sum_probs=57.1
Q ss_pred CCceEEEEEeecCCC----CccceeecccCCCCcHHHHHHHHHhccccCCCChHHHHHHHHHHHHHhCCCCc
Q 005017 416 DTSVSLTLRIADSSG----RVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 483 (719)
Q Consensus 416 ~~~i~L~Lri~d~~~----~~~~i~f~f~~~~Dta~~va~Emv~~~~i~~~d~~~iA~~i~~~i~~l~~~~~ 483 (719)
+..++|.+|..|.++ ..+.|+|.|+++.|+++.||+|||+++++++.|...+|..+...+.++--...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~ 387 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRN 387 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhh
Confidence 345567788887763 35689999999999999999999999999999999999999998887765543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.096 Score=56.32 Aligned_cols=139 Identities=17% Similarity=0.158 Sum_probs=75.6
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEee----ecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSW----VDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~----~~~~~~~l~ 156 (719)
+.++.|....||+... .+| .+++|+..... ..+.+..|++++..|... ++.+++... ........+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~------~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEKRV------KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecCCC------CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4577777789998743 344 57778664321 123455677777777432 244444321 111123467
Q ss_pred EEEecccCCChh-----HH------hhh-c---ccc--------cHHHHH---------------HHHHHHHHHhhhhhc
Q 005017 157 MITELFTSGNLR-----QY------RKK-H---KNV--------DIKVIK---------------NWARQILHGLVYLHS 198 (719)
Q Consensus 157 lV~Ey~~gGsL~-----~~------L~~-~---~~l--------~~~~i~---------------~i~~QIl~gL~yLHs 198 (719)
++++|++|..+. ++ +.+ + ..+ ...... .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 899999886532 11 000 0 001 001000 001122334544432
Q ss_pred -----CCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 199 -----HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 199 -----~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+.++|+|+.+.||+++.+ +.+.|+||+.+
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccc
Confidence 12359999999999999865 45689999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.23 Score=55.99 Aligned_cols=83 Identities=16% Similarity=0.077 Sum_probs=53.5
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC---ChhhHHHHHHHHHHHHhCC---CCCceeEEEeeecCCCCce
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ---LPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~---~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~~~~l 155 (719)
.+.||.|....||+..+. +..++||+-....... .+-...+-..|...|+.+. ..++.++|.++. + ..
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d--~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T--MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C--CC
Confidence 356899999999998763 4568888765322211 1224556666777777664 247888887653 2 25
Q ss_pred eEEEecccC--CChhHH
Q 005017 156 NMITELFTS--GNLRQY 170 (719)
Q Consensus 156 ~lV~Ey~~g--GsL~~~ 170 (719)
+++||++++ ..+++.
T Consensus 111 vlvME~L~~~~~ilr~~ 127 (418)
T PLN02756 111 LIGMRYLEPPHIILRKG 127 (418)
T ss_pred EEEEeecCCcceehhhh
Confidence 679999977 344443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.22 Score=53.57 Aligned_cols=29 Identities=31% Similarity=0.393 Sum_probs=23.9
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+||+|+.|.||+++++ ...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 49999999999999844 245799999763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.019 Score=62.22 Aligned_cols=137 Identities=22% Similarity=0.223 Sum_probs=90.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecc-----ccCCh-----------hhHH--HHHHHHHHHHhCCC--
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD-----VLQLP-----------GDLQ--KLYSEVHLLKSLKD-- 137 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~-----~~~~~-----------~~~~--~~~~Ei~iL~~L~H-- 137 (719)
.+.+++.||-|--+-||.+.+. .|.+.++|.-+... ..... ..+. ...+|+..|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3466889999999999999765 78888887533211 00000 0111 23578999998853
Q ss_pred CCceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 138 pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
--+.+.+++ ...++|||++.+-.|.+... ..+..+ +...+..-+.-|..+| +||+|..-=||++..
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VEDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee---cCChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEec
Confidence 234455442 23567999999988776432 122233 3334444455577788 999999999999985
Q ss_pred CCCcEEEeecchh
Q 005017 218 NHGEVKIGDLGLA 230 (719)
Q Consensus 218 ~~G~vKL~DFGlA 230 (719)
+ +.++++||--.
T Consensus 238 d-~~i~vIDFPQm 249 (465)
T KOG2268|consen 238 D-DKIVVIDFPQM 249 (465)
T ss_pred C-CCEEEeechHh
Confidence 4 68999999644
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.23 Score=54.27 Aligned_cols=141 Identities=16% Similarity=0.163 Sum_probs=77.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCc
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKT 154 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~ 154 (719)
+.+ +.|..|-.-.+|+...... +..|++++..... ...-.-.+|..+++.+..-++ .++++++ .+.
T Consensus 17 i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-----~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G-- 86 (330)
T PLN02421 17 FSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-----DYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG-- 86 (330)
T ss_pred eEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-----CeEechHHHHHHHHHHHhcCCCCceeEEe--CCc--
Confidence 344 3455577778888854322 2378888664321 111123578888888865555 3555544 222
Q ss_pred eeEEEecccCCChhH-------Hh-------hh-c--c-----cc-cHHHHHHHHHHHH---------------------
Q 005017 155 VNMITELFTSGNLRQ-------YR-------KK-H--K-----NV-DIKVIKNWARQIL--------------------- 190 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~-------~L-------~~-~--~-----~l-~~~~i~~i~~QIl--------------------- 190 (719)
+|.+|+++-.|.. .+ ++ + + .. -...+..|..++-
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 3889997766532 11 10 0 0 01 1223333333221
Q ss_pred ----HHhh-hhhcCC--CCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 191 ----HGLV-YLHSHN--PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 191 ----~gL~-yLHs~~--ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+. ++...+ ..++|.|+.+.||+++.+.+.++++||..|.
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1111 121111 2489999999999997555689999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.31 Score=52.45 Aligned_cols=74 Identities=18% Similarity=0.088 Sum_probs=44.4
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC---CCCceeEEEeeecCCCCceeE
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~~~~l~l 157 (719)
-.+.|+.|....+|+.. .++..+.+|.-. . .....|..|.+-|+.|. --.+.+.+++....+. -+|
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fL 89 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS-E------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFL 89 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-G------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecC-h------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceE
Confidence 34678999999999985 577888888765 1 22245778888888883 3346677776554433 478
Q ss_pred EEecccCC
Q 005017 158 ITELFTSG 165 (719)
Q Consensus 158 V~Ey~~gG 165 (719)
|+||++.+
T Consensus 90 lle~l~~~ 97 (288)
T PF03881_consen 90 LLEFLEMG 97 (288)
T ss_dssp EEE-----
T ss_pred EEEeecCC
Confidence 99999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.48 Score=51.71 Aligned_cols=128 Identities=14% Similarity=0.162 Sum_probs=71.7
Q ss_pred CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CCceeEEEeeecCCCCceeEEEecccCCChh----------H
Q 005017 102 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNLR----------Q 169 (719)
Q Consensus 102 g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~----------~ 169 (719)
++++++. .. .. ........+..+|..+++.+.- --+.+-++.|.++.....+.||+|++|..+. +
T Consensus 48 ~~~~vlR-~P-~~-~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~ 124 (321)
T COG3173 48 GQKYVLR-KP-PR-GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQ 124 (321)
T ss_pred CceEEEe-cC-Cc-cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHH
Confidence 7777766 22 11 1112334566778888888753 2334455555544424678899999984322 1
Q ss_pred Hhh--------h-c-------------ccccHHHHHHHHHHH--------------HHHhhhhhcCC------CCeeeec
Q 005017 170 YRK--------K-H-------------KNVDIKVIKNWARQI--------------LHGLVYLHSHN------PPIIHRD 207 (719)
Q Consensus 170 ~L~--------~-~-------------~~l~~~~i~~i~~QI--------------l~gL~yLHs~~------ppIIHrD 207 (719)
+.. . + .......+..|..+. ..-..||+.+. +.++|+|
T Consensus 125 ~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD 204 (321)
T COG3173 125 FALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGD 204 (321)
T ss_pred HHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCC
Confidence 111 0 0 001112223333222 12234554433 3699999
Q ss_pred CccceeEecCCCCcEEEeecchhhhc
Q 005017 208 LKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 208 LKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+.+.||+++... .+-|.||+++..-
T Consensus 205 ~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 205 YRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred cccCCEEEeCCC-eeEEEeccccccC
Confidence 999999998664 6899999988643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.17 Score=51.34 Aligned_cols=30 Identities=40% Similarity=0.535 Sum_probs=19.8
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.++|.||.|.||+++...+.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 489999999999994455799999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.34 Score=52.21 Aligned_cols=29 Identities=10% Similarity=0.104 Sum_probs=25.1
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.++|+|+.++|++++++ |.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 59999999999999865 579999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=91.21 E-value=0.32 Score=55.00 Aligned_cols=30 Identities=27% Similarity=0.325 Sum_probs=22.5
Q ss_pred CCeeeecCccceeEecCCCC----cEEEeecchh
Q 005017 201 PPIIHRDLKCDNIFVNGNHG----EVKIGDLGLA 230 (719)
Q Consensus 201 ppIIHrDLKp~NILl~~~~G----~vKL~DFGlA 230 (719)
+-++|+||...|||++.+.+ ...|+||-.+
T Consensus 268 ~VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~v 301 (414)
T PF07914_consen 268 PVLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCV 301 (414)
T ss_pred cceecCCccHHheeeecCCchhHHHHHHHHHHHh
Confidence 46999999999999987443 3457777544
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=90.76 E-value=1.1 Score=46.73 Aligned_cols=74 Identities=16% Similarity=0.193 Sum_probs=45.9
Q ss_pred EEEeeeCCeEEEEEEEcCCC-eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC---CceeEEEeeecCCCCceeEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g-~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIVkl~~~~~~~~~~~l~lV 158 (719)
+.+..|..-..|.. .+| .++-+|.-. ......|..|+.-|..|.-. ++.+++.+ ...+.+.|+|
T Consensus 22 ~~v~gG~inea~~v---~dg~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~--G~~~~~sylV 89 (286)
T COG3001 22 EEVSGGDINEAWRL---RDGTDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIAV--GASRDHSYLV 89 (286)
T ss_pred cccCCccccceeEe---ecCCcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEEe--cCCCCeeEEE
Confidence 33444444444554 344 456666432 24456788888888877544 45666653 4455678899
Q ss_pred EecccCCChh
Q 005017 159 TELFTSGNLR 168 (719)
Q Consensus 159 ~Ey~~gGsL~ 168 (719)
+||++-|.+.
T Consensus 90 le~L~~~~~d 99 (286)
T COG3001 90 LEYLPTGPLD 99 (286)
T ss_pred EeeccCCCCC
Confidence 9999987665
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.54 E-value=0.75 Score=51.61 Aligned_cols=62 Identities=18% Similarity=0.240 Sum_probs=43.4
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhh-hcCCCCeeeecCccceeEecCCC
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNH 219 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yL-Hs~~ppIIHrDLKp~NILl~~~~ 219 (719)
..++-+|..|-++..+++. +..+++..+.++.--..||--+ --.+ ++|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence 4467789999999998874 3445556666666555555432 2335 99999999999996444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=89.83 E-value=0.063 Score=60.99 Aligned_cols=69 Identities=17% Similarity=0.423 Sum_probs=57.7
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
+..+.++|+|+||+|+.+..+.++-.+|||+|..... .....+..+|..-+..+.|+++++++..|...
T Consensus 51 ~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 51 FEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred ccccccccccCccccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 3456789999999999999888888999999987654 33456778899999999999999999888654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.21 E-value=2 Score=48.10 Aligned_cols=80 Identities=16% Similarity=0.071 Sum_probs=42.7
Q ss_pred EEEeeeCCeEEEEEEEcCC-CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCceeEEEe
Q 005017 83 EVLGKGAFKTVYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~-g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l~lV~E 160 (719)
+.|..|-...+|++..... +..+.+|.+-...........-.-.+|+++++.|...++ .++++.+. -++|+|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEEE
Confidence 3455588888998854322 122222211111100111111223568999999976555 55666542 246999
Q ss_pred cccCCChh
Q 005017 161 LFTSGNLR 168 (719)
Q Consensus 161 y~~gGsL~ 168 (719)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=85.93 E-value=1.9 Score=47.90 Aligned_cols=105 Identities=18% Similarity=0.223 Sum_probs=65.9
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+..+.|++|++. |+.+.- .+....+++..++.+.+..|.-+... -+.=|||+.-+||||+ .|+|-|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeee
Confidence 345677777776 434332 12235677788888877777666554 3699999999999998 489999999999
Q ss_pred hhccCCCcccccCCCCCCCccccccccCccccchhh
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSF 266 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSl 266 (719)
+.-... ..+--..+--|-++.+.-+..-+||-+
T Consensus 369 Rl~~~q---~~isy~rldhp~lF~G~dd~QFeIYrl 401 (488)
T COG5072 369 RLSYSQ---GIISYNRLDHPDLFNGVDDYQFEIYRL 401 (488)
T ss_pred ecccCC---ceeeccccCchhhhcCccceeeeHHHH
Confidence 742211 111112233444555544555666543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=84.47 E-value=1.6 Score=46.59 Aligned_cols=27 Identities=26% Similarity=0.417 Sum_probs=23.5
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
.++|+|+.+.||+++. +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 5999999999999985 46899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 719 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-76 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-20 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-149
Identities = 140/283 (49%), Positives = 189/283 (66%), Gaps = 5/283 (1%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
+ + ++ V GR++++D +G+G+FKTVYK D +EVAW ++
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--L 64
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQYRKKHK 175
+ Q+ E +LK L+ N+V+FY SW KK + ++TEL TSG L+ Y K+ K
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+ IKV+++W RQIL GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA +
Sbjct: 125 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 236 PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295
A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPYSEC+N AQI+++VTS
Sbjct: 185 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244
Query: 296 GIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
G+KPAS KV P++K IE C+ ER S KDLL F Q
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-62
Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 18/273 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+G G++ K + G + W + + Q L SEV+LL+ LK N+V+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVR 69
Query: 143 FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+Y +D T+ ++ E G+L + K+ + +D + + Q+ L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 199 HNPP---IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELY 253
+ ++HRDLK N+F++G VK+GD GLA + T A++ +GTP +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 254 EEE-YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
YNE DI+S G C+L E+ P+ + ++ K+ G K + ++
Sbjct: 189 NRMSYNEKSDIWSLG-CLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELN 245
Query: 312 GFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
I + L R S +++L++P + +
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 19/287 (6%)
Query: 58 GTAEPPDADSDFVEKDPSGRYV-RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD 114
G A + P + + LG G++ V+K + G A R
Sbjct: 35 GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94
Query: 115 VLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
+ P D + +EV + + V+ ++W + + + TE +L+Q+ +
Sbjct: 95 --RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTE-LCGPSLQQHCEA 149
Query: 174 H-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232
++ + + R L L +LHS ++H D+K NIF+ G K+GD GL +
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVE 206
Query: 233 MQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291
+ G P +MAPEL + Y D++S G+ ILE+ + Q+ +
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266
Query: 292 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
A L +++ + L P R +A+ LL P L+
Sbjct: 267 GYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-62
Identities = 91/294 (30%), Positives = 136/294 (46%), Gaps = 17/294 (5%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
+ E D +SD +E D VLGKG + VY D + +A + D
Sbjct: 4 STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---- 59
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ-YRKKHKNV 177
Q L+ E+ L K LK N+V++ S+ ++ + + E G+L R K +
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF--IKIFMEQVPGGSLSALLRSKWGPL 117
Query: 178 DIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM 233
I + +QIL GL YLH + I+HRD+K DN+ +N G +KI D G + +A
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 234 QQPTARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 290
P + GT ++MAPE Y + DI+S G I+EM T + P+ E P
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
KV + + + K FI KC P +R A DLL D FL+V ++K+
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-61
Identities = 60/261 (22%), Positives = 122/261 (46%), Gaps = 15/261 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ +G+G+F G + + I + ++ EV +L ++K N+V+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQ 87
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHN 200
+ +S+ ++ + ++ + G+L + K V I +W QI L ++H
Sbjct: 88 YRESFEENGS--LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-Y 257
I+HRD+K NIF+ + G V++GD G+A + AR+ IGTP +++PE+ E + Y
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317
N DI++ G + E+ T ++ + E + + K+ SG ++ ++ + +
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQL 260
Query: 318 LVP-ASERLSAKDLLKDPFLQ 337
+R S +L+ F+
Sbjct: 261 FKRNPRDRPSVNSILEKGFIA 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-60
Identities = 76/288 (26%), Positives = 135/288 (46%), Gaps = 16/288 (5%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
+P A + + + + +G+G F VY+A G+ VA +V+I D L
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIE-KKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMD 72
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKH 174
E+ LLK L NV+K+Y S+++D +N++ EL +G+L + ++K+
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQK 130
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
+ + + + + Q+ L ++HS ++HRD+K N+F+ G VK+GDLGL
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFS 187
Query: 235 QPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIF 290
T A S++GTP +M+PE E YN DI+S G + EM + P+ + N +
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247
Query: 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
KK+ P + +++ + C+ P +R +
Sbjct: 248 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-60
Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 38/280 (13%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E++G G F V+KA G RVK ++ +K EV L L N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68
Query: 143 FYKSWVDD--------------KKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWA 186
+ W K K + + E G L Q+ +K + + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTP 245
QI G+ Y+HS +I+RDLK NIF+ +VKIGD GL +++ R GT
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 246 EFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 304
+M+PE + Y + VD+Y+ G+ + E++ E F + GI
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISDIF-- 240
Query: 305 VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
D + K ++K L +R + ++L+ + + E
Sbjct: 241 --DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW-KKSPE 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-58
Identities = 94/312 (30%), Positives = 137/312 (43%), Gaps = 47/312 (15%)
Query: 75 SGRYV-RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
S RY ++ VLG+GAF V KA + A +++ + L + SEV L
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-----EKLSTILSEVML 55
Query: 132 LKSLKDDNVVKFYKSWVDD-----------KKKTVNMITELFTSGNLRQY-RKKHKNVDI 179
L SL VV++Y +W++ KK T+ + E +G L ++ N
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
RQIL L Y+HS IIHRDLK NIF++ + VKIGD GLA + +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDI 172
Query: 240 ----------------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYS 281
S IGT ++A E+ + YNE +D+YS G+ EM+ YP+S
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229
Query: 282 ECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQV 338
I KK+ S P K I + ++R A+ LL +L V
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 339 ENQKEPICDPLK 350
++Q E I + LK
Sbjct: 290 KHQDEVIKEALK 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-58
Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 76 GRYV-RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
GRY+ ++ + LG+G F V++A ++ A R+++ + +K+ EV L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKAL 57
Query: 133 KSLKDDNVVKFYKSWVDD----------KKKTVNMITELFTSGNLRQY---RKKHKNVDI 179
L+ +V+++ +W++ K + + +L NL+ + R + +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
V + QI + +LHS ++HRDLK NIF + VK+GD GL AM Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174
Query: 240 --------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK 284
+GT +M+PE Y+ VDI+S G+ + E++ YP+S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ V + P + P ++ L P ER A +++++ +
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKY-PCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-56
Identities = 62/309 (20%), Positives = 117/309 (37%), Gaps = 23/309 (7%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
G E ++ + +G+G+F V++ D+ G + A +V+++
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 98
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV 177
E+ L +V Y + + VN+ EL G+L Q K+ +
Sbjct: 99 ---------EELVACAGLSSPRIVPLYGAVREGPW--VNIFMELLEGGSLGQLIKQMGCL 147
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA------- 230
+ Q L GL YLH+ I+H D+K DN+ ++ + + D G A
Sbjct: 148 PEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 231 IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 289
+ T + GT MAPE+ + + VDI+S +L M+ +P+++
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 348
K + + P I++ L R SA +L + ++ + + P
Sbjct: 266 LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ-EVGGLKSP 324
Query: 349 LKLPIQSLK 357
K + +
Sbjct: 325 WKGEYKEPR 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-55
Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVV 141
E +G G F +V+K G A R K D Q EV+ L +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI----KVIKNWARQILHGLVYLH 197
+++ +W +D + + E G+L ++ + +K+ Q+ GL Y+H
Sbjct: 75 RYFSAWAEDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 198 SHNPPIIHRDLKCDNIFVNGN------------------HGEVKIGDLGLAIAMQQPTAR 239
S + ++H D+K NIF++ KIGDLG + + +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--VTRISSPQ 188
Query: 240 SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297
G F+A E+ +E + DI++ + ++ E + ++ G
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 298 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 342
P + +V + ++ + P R SA L+K L ++K
Sbjct: 245 LP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-54
Identities = 68/243 (27%), Positives = 113/243 (46%), Gaps = 20/243 (8%)
Query: 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV 140
+EV+G+GAF V KA ++ +VA +K ++ + + E+ L + N+
Sbjct: 12 VEEVVGRGAFGVVCKA--KWRAKDVA---IK---QIESESERKAFIVELRQLSRVNHPNI 63
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLH 197
VK Y + V ++ E G+L + +W Q G+ YLH
Sbjct: 64 VKLYGAC----LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 198 SHNP-PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-E 255
S P +IHRDLK N+ + +KI D G A +Q + G+ +MAPE++E
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGS 178
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFI 314
Y+E D++S+G+ + E++T P+ E PA I V +G +P L K I+ +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLM 237
Query: 315 EKC 317
+C
Sbjct: 238 TRC 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-54
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 25/255 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI------DDVLQLPGDLQKLYSEVHLL 132
+ Y++ +GKG F V+K VA +K + ++ Q+ EV ++
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILH 191
+L N+VK Y M+ E G+L K + V I
Sbjct: 78 SNLNHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLAIAMQQPTARSVIGTPEF 247
G+ Y+ + NPPI+HRDL+ NIF+ K+ D GL+ + ++G ++
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLLGNFQW 192
Query: 248 MAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASL 302
MAPE E Y E D YSF M + ++T E P+ E I G++P ++
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TI 251
Query: 303 AKVNDPQIKGFIEKC 317
+ P+++ IE C
Sbjct: 252 PEDCPPRLRNVIELC 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 61/331 (18%), Positives = 135/331 (40%), Gaps = 38/331 (11%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKD--DN 139
+ +G G V++ +E A +K ++ + L +E+ L L+ D
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+++ Y + D+ + M+ E + +L + KK K++D K++ + +L + +H H
Sbjct: 71 IIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 200 NPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL-- 252
I+H DLK N V+G +K+ D G+A MQ T S +GT +M PE
Sbjct: 128 G--IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 253 ----------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
+ + + D++S G + M + P+ + N +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 361
+ + ++ ++ CL +R+S +LL P++Q++ ++ + + ++
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN-----QMAKGTTEEMKY 297
Query: 362 PMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 392
+ ++ + + + + + G H
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGESH 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 62 PPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD 121
D D ++ + E +G G+F TV++A E+ G +VA VKI +
Sbjct: 24 QGAMDGDDMDIPWC--DLNIKEKIGAGSFGTVHRA--EWHGSDVA---VKILMEQDFHAE 76
Query: 122 -LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV 177
+ + EV ++K L+ N+V F + + ++++TE + G+L + + +
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 235
D + + A + G+ YLH+ NPPI+HR+LK N+ V+ VK+ D GL+
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTF 193
Query: 236 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294
+++S GTPE+MAPE+ E NE D+YSFG+ + E+ T + P+ +
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
Query: 295 SGIKPASLAKVNDPQIKGFIEKC 317
+ + + +PQ+ IE C
Sbjct: 254 KCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 64/310 (20%), Positives = 128/310 (41%), Gaps = 37/310 (11%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL 116
++ + + S + Y + +G G V++ +E A +K ++
Sbjct: 8 SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLE 63
Query: 117 QL-PGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 173
+ L +E+ L L+ D +++ Y + D+ + M+ E + +L + KK
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME-CGNIDLNSWLKK 120
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIA 232
K++D K++ + +L + +H H I+H DLK N V+G +K+ D G+A
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM---LKLIDFGIANQ 175
Query: 233 MQQPT----ARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCIL-EMVT 275
MQ T S +GT +M PE ++ + D++S G CIL M
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTY 234
Query: 276 FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 334
+ P+ + N + + + ++ ++ CL +R+S +LL P
Sbjct: 235 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 335 FLQVENQKEP 344
++Q++
Sbjct: 295 YVQIQTHPVN 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 65/299 (21%), Positives = 126/299 (42%), Gaps = 37/299 (12%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKD--DN 139
+ +G G V++ +E A +K ++ + L +E+ L L+ D
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+++ Y + D+ + M+ E + +L + KK K++D K++ + +L + +H H
Sbjct: 118 IIRLYDYEITDQY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 200 NPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE 254
I+H DLK N V+G +K+ D G+A MQ T S +G +M PE +
Sbjct: 175 G--IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 255 EE------------YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPAS 301
+ + D++S G CIL M + P+ + N +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 302 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 359
+ + ++ ++ CL +R+S +LL P++Q Q P+ K + +K +
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYV 345
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-50
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 15/244 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E++G G F VY+A + G EVA + D + ++ + E L LK N++
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP- 201
+ K+ + ++ E G L + + + ++ NWA QI G+ YLH
Sbjct: 71 LRGVCL--KEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 202 PIIHRDLKCDNIFVN-------GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE 254
PIIHRDLK NI + ++ +KI D GLA + T S G +MAPE+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIR 187
Query: 255 -EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313
+++ D++S+G+ + E++T E P+ A + + + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKL 246
Query: 314 IEKC 317
+E C
Sbjct: 247 MEDC 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 44/246 (17%), Positives = 94/246 (38%), Gaps = 17/246 (6%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKD 137
+ + L + ++K + G ++ VK+ V + + E L+
Sbjct: 12 LNFLTKLNENHSGELWKG--RWQGNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVY 195
NV+ + +IT G+L + VD +A + G+ +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE 255
LH+ P I L ++ ++ +I + + Q P + P ++APE ++
Sbjct: 127 LHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMYAPAWVAPEALQK 182
Query: 256 E----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
+ D++SF + + E+VT E P+++ N K G++P ++ P +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVS 241
Query: 312 GFIEKC 317
++ C
Sbjct: 242 KLMKIC 247
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 88/291 (30%), Positives = 141/291 (48%), Gaps = 32/291 (10%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH 130
+ DP + + E +GKG+F V+K D VA +KI D+ + +++ + E+
Sbjct: 17 KADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEIT 72
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNM-------ITELFTSGNLRQYRKKHKNVDIKVIK 183
+L V K+Y S++ D K + M +L G L + I I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-------TQIATI- 124
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SV 241
R+IL GL YLHS IHRD+K N+ ++ HGEVK+ D G+A + + +
Sbjct: 125 --LREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTF 179
Query: 242 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKP 299
+GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P + +F + P
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN--NP 236
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 349
+L +K F+E CL S R +AK+LLK F+ +K L
Sbjct: 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 88/299 (29%), Positives = 149/299 (49%), Gaps = 36/299 (12%)
Query: 54 SGMLGTAEPPDADSDFV-EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI 112
SG++ + A V + DP Y +G+G+ V A ++ +G +VA VK+
Sbjct: 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVA---VKM 77
Query: 113 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM-------ITELFTSG 165
D+ + + L++EV +++ + NVV+ YKS++ ++ V M +T++ +
Sbjct: 78 MDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV 136
Query: 166 NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225
L + I + +L L YLH+ +IHRD+K D+I + + G VK+
Sbjct: 137 RLNEE-------QIATV---CEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLS 183
Query: 226 DLGLA--IAMQQPTARSVIGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTFEYPYSE 282
D G I+ P +S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY
Sbjct: 184 DFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243
Query: 283 CKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+P Q + + S P L + P ++ F+E+ LV ER +A++LL PFL
Sbjct: 244 -DSPVQAMKRLRDSP--PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 84/281 (29%), Positives = 143/281 (50%), Gaps = 35/281 (12%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH 130
DP +Y R+ E +G+GA TVY A D G EVA ++ ++ Q P + + +E+
Sbjct: 15 VGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQP-KKELIINEIL 69
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNM-------ITELFTSGNLRQYRKKHKNVDIKVIK 183
+++ K+ N+V + S++ + V M +T++ T + + I +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-------GQIAAV- 121
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSV 241
R+ L L +LHS+ +IHRD+K DNI + + G VK+ D G I +Q ++
Sbjct: 122 --CRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM 176
Query: 242 IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKP 299
+GTP +MAPE+ + Y VDI+S G+ +EM+ E PY +NP + ++ T+G
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNG--T 233
Query: 300 ASLAKVND--PQIKGFIEKCL-VPASERLSAKDLLKDPFLQ 337
L + F+ +CL + +R SAK+LL+ FL+
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVV 141
E++GKG F VY + G EVA +++ D+ + D L+ EV + + +NVV
Sbjct: 39 ELIGKGRFGQVYHGR--WHG-EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
F + + + +IT L L R +D+ + A++I+ G+ YLH+
Sbjct: 93 LFMGACM--SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPEL- 252
I+H+DLK N+F ++G+V I D GL ++ R G +APE+
Sbjct: 151 --ILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 253 ---------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
+ +++ D+++ G E+ E+P+ + I ++ +G+KP
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQ 265
Query: 304 KVNDPQIKGFIEKC 317
+I + C
Sbjct: 266 IGMGKEISDILLFC 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 77/304 (25%), Positives = 133/304 (43%), Gaps = 32/304 (10%)
Query: 60 AEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP 119
+ + + + DP+ + LG GAF VYKA ++ G A K+ +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAA---AKVIETKSEE 58
Query: 120 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-- 177
+L+ E+ +L + +VK ++ D K + + E G + +
Sbjct: 59 -ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI--EFCPGGAVDAIMLELDRGLT 115
Query: 178 --DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM 233
I+V+ RQ+L L +LHS IIHRDLK N+ + G++++ D G++
Sbjct: 116 EPQIQVV---CRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLK 169
Query: 234 QQPTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA 287
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P+ E NP
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPM 228
Query: 288 Q-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
+ + K S P +L + + + F++ L R SA LL+ PF+ +
Sbjct: 229 RVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
Query: 344 PICD 347
+ +
Sbjct: 287 ALRE 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 36/291 (12%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
Y EV+G GA V A+ +VA +K ++ + + +L E+ +
Sbjct: 12 INRDDYELQ-EVIGSGATAVVQAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAM 67
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNW 185
N+V +Y S+V + + M + ++ + + K +D I
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI-VAKGEHKSGVLDESTIATI 126
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTA 238
R++L GL YLH + IHRD+K NI + + G V+I D G++ +
Sbjct: 127 LREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVR 183
Query: 239 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKK 292
++ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T PY + P + +
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQN 242
Query: 293 VTSGIKPASLAKVND----PQIKGFIEKCLV--PASERLSAKDLLKDPFLQ 337
++ K + I CL P +R +A +LL+ F Q
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP-EKRPTAAELLRHKFFQ 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 23/289 (7%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
G+ + PD F + DP + +G G+F VY A D VA +K
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVA---IKKMSYSG 91
Query: 118 LPG--DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK 175
Q + EV L+ L+ N +++ ++ + + M E K
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM--EYCLGSASDLLEVHKK 149
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+ I L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP 206
Query: 236 PTARSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IF 290
A S +GTP +MAPE + E +Y+ VD++S G+ +E+ + P N ++
Sbjct: 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALY 263
Query: 291 KKVTSGIKPASLAKVN-DPQIKGFIEKCL-VPASERLSAKDLLKDPFLQ 337
+ +L + + F++ CL +R +++ LLK F+
Sbjct: 264 HIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-46
Identities = 71/248 (28%), Positives = 122/248 (49%), Gaps = 25/248 (10%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVV 141
+ +G G+F TVYK ++ G +VA VK+ +V + + +EV +L+ + N++
Sbjct: 30 QRIGSGSFGTVYKG--KWHG-DVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
F + ++T+ +L + ++K + + ARQ G+ YLH+ +
Sbjct: 84 LFMGYS---TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE 256
IIHRDLK +NIF+ VKIGD GLA + + G+ +MAPE+ +
Sbjct: 141 --IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 257 ----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQ 309
Y+ D+Y+FG+ + E++T + PYS N QI + V G L+KV +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 310 IKGFIEKC 317
+K + +C
Sbjct: 258 MKRLMAEC 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 85/280 (30%), Positives = 138/280 (49%), Gaps = 23/280 (8%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL 125
D D + K P + E LG+G++ +VYKA + G VA +K V ++ K
Sbjct: 19 DEDSLTKQPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVA---IKQVPVESDLQEIIK- 73
Query: 126 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ-YRKKHKNVDIKVIKN 184
E+ +++ +VVK+Y S+ + + M E +G++ R ++K + I
Sbjct: 74 --EISIMQQCDSPHVVKYYGSYFKNTDLWIVM--EYCGAGSVSDIIRLRNKTLTEDEIAT 129
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 242
+ L GL YLH IHRD+K NI +N G K+ D G+A + +VI
Sbjct: 130 ILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 243 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPA 300
GTP +MAPE + E YN + DI+S G+ +EM + PY++ +P + IF T+ P
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNP--PP 243
Query: 301 SLAKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ K F+++CLV +R +A LL+ PF++
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 81/309 (26%), Positives = 145/309 (46%), Gaps = 34/309 (11%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+DP+G + E++G G + VYK G A +K+ DV + +++ E+++
Sbjct: 20 RDPAGIFEL-VELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTG--DEEEEIKQEINM 73
Query: 132 LKSLKD-DNVVKFYKSWVDDKKKTVN----MITELFTSGNLRQYRKKHKNVDIK--VIKN 184
LK N+ +Y +++ ++ ++ E +G++ K K +K I
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVI 242
R+IL GL +LH H +IHRD+K N+ + + EVK+ D G++ + + R + I
Sbjct: 134 ICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 243 GTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKK 292
GTP +MAPE + Y+ D++S G+ +EM P + +P I +
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN 249
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKL 351
+K +K + + FIE CLV S+R + + L+K PF++ + + + LK
Sbjct: 250 PAPRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKD 305
Query: 352 PIQSLKMLR 360
I K R
Sbjct: 306 HIDRTKKKR 314
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 33/287 (11%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
++LG+GA V++ + G A +K+ + + + E +LK L N+V
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHS 198
K + + + +I E G+L ++ N R ++ G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 199 HNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE 254
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 255 ---------EEYNELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPA 300
++Y VD++S G T F P+ + ++ K+ +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSG 246
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLS--AKDLLKDPF---LQVENQK 342
+++ V + +P S LS + LL L+ + +K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 68/339 (20%), Positives = 121/339 (35%), Gaps = 85/339 (25%)
Query: 75 SGRYVR-YDEV--LGKGAFKTVYKAFDEFAGIEVA----------------WSRVKIDDV 115
+ RY+ ++ + +G+G F V++A ++ A VK
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60
Query: 116 LQLPG--------------------------------------DLQKLYSEVHLLKSLKD 137
L+ PG + ++ +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLV 194
N V + K + + +L NL+ + R ++ + V + QI +
Sbjct: 121 KNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--------------S 240
+LHS ++HRDLK NIF + VK+GD GL AM Q
Sbjct: 179 FLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 241 VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299
+GT +M+PE Y+ VDI+S G+ + E++ Y +S +I V + P
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFP 292
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ PQ ++ L P +ER A D++++ +
Sbjct: 293 LLFTQKY-PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-44
Identities = 64/295 (21%), Positives = 121/295 (41%), Gaps = 50/295 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
++ + +GKG + V+ ++ G +VA VK+ + ++ +E++ ++ +
Sbjct: 39 IQMVKQIGKGRYGEVWMG--KWRGEKVA---VKVFFTTEEASWFRE--TEIYQTVLMRHE 91
Query: 139 NVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N++ F + + + IT+ +G+L Y K +D K + A + GL +L
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150
Query: 197 HS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGT 244
H+ P I HRDLK NI V N G I DLGLA+ T + +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 245 PEFMAPELYEE-------EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPA 287
+M PE+ +E + + D+YSFG+ + E+ ++ PY +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 288 QIFKKVTSG---------IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
++ + + Q+ + +C + RL+A + K
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 59/286 (20%), Positives = 113/286 (39%), Gaps = 31/286 (10%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
++LG+GA V++ + G A +K+ + + + E +LK L N+V
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHS 198
K + + + +I E G+L ++ N R ++ G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 199 HNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE 254
+ I+HR++K NI K+ D G A ++ S+ GT E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 255 ---------EEYNELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPA 300
++Y VD++S G T F P+ + ++ K+ +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSG 246
Query: 301 SLAKVNDPQIKGFIEKCLVPASERLS--AKDLLKDPFLQVENQKEP 344
+++ V + +P S LS + LL P L + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT-PVLANILEADQ 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 34/295 (11%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
++ + + LG+G F V G A R+ + D ++ E + +
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLF 83
Query: 136 KDDNVVKFYKSWVDDK--KKTVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQI 189
N+++ + ++ K ++ F G L + K + I I
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVI------ 242
GL +H+ HRDLK NI + G+ + DLG A
Sbjct: 144 CRGLEAIHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 243 ----GTPEFMAPELYEEE----YNELVDIYSFGMCIL-EMVTFEYPY-SECKNPAQIFKK 292
T + APEL+ + +E D++S G C+L M+ E PY + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP-FLQVENQKEPI 345
V + + + + + + + +R LL LQ +
Sbjct: 260 VQNQLSIPQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+ E +GKG + V++ + G VA VKI ++ E++ L+ +
Sbjct: 10 ITLLECVGKGRYGEVWRG--SWQGENVA---VKIFSSRDEKSWFRET--ELYNTVMLRHE 62
Query: 139 NVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N++ F S + + + + IT G+L Y + +D I GL +L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHL 121
Query: 197 HS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGT 244
H P I HRDLK NI V N G+ I DLGLA+ Q T + +GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 245 PEFMAPELYEE-------EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPA 287
+MAPE+ +E + + VDI++FG+ + E+ ++ P+ +
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 288 QIFKKVTSG---------IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
F+ + I + + +++C S RL+A + K
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 50/295 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+ E +GKG F V++ ++ G EVA VKI + ++ +E++ L+ +
Sbjct: 44 IVLQESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHE 96
Query: 139 NVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N++ F + D + +++ G+L Y ++ V ++ + A GL +L
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHL 155
Query: 197 HS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGT 244
H P I HRDLK NI V N G I DLGLA+ T +GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 245 PEFMAPELYEE-------EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPA 287
+MAPE+ ++ E + DIY+ G+ E+ ++ PY +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 288 QIFKKVTSG---------IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
+++ I + + + +C + RL+A + K
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 56/272 (20%), Positives = 118/272 (43%), Gaps = 19/272 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVV 141
+G G V+K G +A VK + +++ ++ ++ D +V
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
+ + +++ + V + EL + + ++ + +++ I+ L YL +
Sbjct: 88 QCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE------LYE 254
+IHRD+K NI ++ G++K+ D G++ + A+ G +MAPE +
Sbjct: 146 -VIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKG 312
+Y+ D++S G+ ++E+ T ++PY CK ++ KV +P L +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQS 262
Query: 313 FIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343
F++ CL +R LL+ F++ E
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 88/307 (28%), Positives = 140/307 (45%), Gaps = 33/307 (10%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQL 118
E P+ D RYVR LGKG F ++ D A KI +L
Sbjct: 3 EIPEVLVD---PRSRRRYVRG-RFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLK 55
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 178
P +K+ E+ + +SL +VV F+ + D+ V ++ EL +L + K+ K +
Sbjct: 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKALT 113
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
+ + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE 170
Query: 239 R--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 294
R + GTP ++APE L ++ ++ VD++S G CI+ ++ P E + + ++
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLV-GKPPFETSCLKETYLRIK 228
Query: 295 SGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKL 351
P + P I+K L + R + +LL D F P +L
Sbjct: 229 KNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARL 278
Query: 352 PIQSLKM 358
PI L +
Sbjct: 279 PITCLTI 285
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 91/330 (27%), Positives = 147/330 (44%), Gaps = 30/330 (9%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VL 116
A P + + S R LGKG F ++ D A KI +L
Sbjct: 23 AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLL 79
Query: 117 QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 176
P +K+ E+ + +SL +VV F+ + D+ V ++ EL +L + K+ K
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRKA 137
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
+ + + RQI+ G YLH + +IHRDLK N+F+N + EVKIGD GLA ++
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD 194
Query: 237 TAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKK 292
R + GTP ++APE L ++ ++ VD++S G CI+ ++ P E + + +
Sbjct: 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLV-GKPPFETSCLKETYLR 252
Query: 293 VTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 349
+ P + P I+K L + R + +LL D F P
Sbjct: 253 IKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPA 302
Query: 350 KLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 379
+LPI L + PSS+D + K L+
Sbjct: 303 RLPITCLTIPPRFSIAPSSLDPSNR-KPLT 331
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 20/273 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVV 141
LG+GA+ V K +G +A VK + ++L ++ ++++ V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 142 KFYKSWVDDKKKTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
FY + + V + EL + +Q K + + ++ A I+ L +LHS
Sbjct: 70 TFYGALFREGD--VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 199 -HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE----- 251
+ +IHRD+K N+ +N G+VK+ D G++ + A+ G +MAPE
Sbjct: 128 KLS--VIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
L ++ Y+ DI+S G+ ++E+ +PY P Q K+V P A +
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244
Query: 312 GFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343
F +CL + ER + +L++ PF + K
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 61/278 (21%), Positives = 121/278 (43%), Gaps = 26/278 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVV 141
+G+GA+ +V K + +G +A VK + ++L ++ ++ D +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLH 197
+FY + + + EL ++ + Y+ + +++ + L +L
Sbjct: 85 QFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 198 S-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPE---- 251
IIHRD+K NI ++ G +K+ D G++ + A++ G +MAPE
Sbjct: 143 ENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--- 307
+ Y+ D++S G+ + E+ T +PY + + +V G P L+ +
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREF 258
Query: 308 -PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343
P F+ CL S+R K+LLK PF+ + ++
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 79/316 (25%), Positives = 121/316 (38%), Gaps = 26/316 (8%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ 117
G P + G + E LG G F V + + G +VA +K
Sbjct: 1 GGGRSPSLPTQTC-----GPW-EMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQEL 51
Query: 118 LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN----MITELFTSGNLRQYRKK 173
P + ++ E+ ++K L NVV + +K N + E G+LR+Y +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 174 HKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI--FVNGNHGEVKIGDLG 228
+N I+ I L YLH + IIHRDLK +NI KI DLG
Sbjct: 112 FENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169
Query: 229 LAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 286
A + Q +GT +++APEL E ++Y VD +SFG E +T P+ P
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
Query: 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQ---VENQKE 343
Q KV + + F P L+ +LQ + +Q++
Sbjct: 230 VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE-RWLQCMLMWHQRQ 288
Query: 344 PICDPLKLPIQSLKML 359
DP + + L
Sbjct: 289 RGTDPQNPNVGCFQAL 304
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-40
Identities = 60/357 (16%), Positives = 117/357 (32%), Gaps = 72/357 (20%)
Query: 73 DPSGRYVRYDEVLGKGA--FKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEV 129
G Y V+GKG TV A + G V V+ ++ + + L E+
Sbjct: 22 PEGGCYELL-TVIGKGFEDLMTVNLARYKPTGEYVT---VRRINLEACSNEMVTFLQGEL 77
Query: 130 HLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNWAR 187
H+ K N+V + +++ D + + ++T G+ + H + I +
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-------- 239
+L L Y+H +HR +K +I ++ + G+V + L ++M R
Sbjct: 136 GVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 240 -SVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSEC----------KN 285
+ +++PE+ ++ Y+ DIYS G+ E+ P+ +
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 286 PAQIFKKVTSGIKPASLAKVND---------------------------------PQIKG 312
++ + P
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 313 FIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSS 368
F+E+CL R SA LL F + K + L ++ + + S
Sbjct: 313 FVEQCLQRNPDARPSASTLLNHSFFK--QIKRRASEALPELLRPVTPITNFEGSQSQ 367
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-40
Identities = 70/305 (22%), Positives = 124/305 (40%), Gaps = 52/305 (17%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G V+K + +G+ +A K+ + P ++ E+ +L +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNP 201
FY ++ D + +++ E G+L Q KK + +++ + ++ GL YL H
Sbjct: 96 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNEL 260
I+HRD+K NI VN + GE+K+ D G++ + A S +GT +M+PE L Y+
Sbjct: 153 -IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 210
Query: 261 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK---------------- 304
DI+S G+ ++EM YP A+
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 305 --------------VND-----------PQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338
VN+ + + F+ KCL+ +ER K L+ F++
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
Query: 339 ENQKE 343
+ +E
Sbjct: 331 SDAEE 335
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 54/311 (17%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+R VL +G F VY+A D +G E A R+ ++ + + EV +K L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKL 82
Query: 136 KD-DNVVKFYKSWVDDKKKTVN-----MITELFTSGNLRQYRKKHKNVDI---KVIKNWA 186
N+V+F + K+++ ++ G L ++ KK ++ +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV----- 241
Q + ++H PPIIHRDLK +N+ ++ G +K+ D G A + S
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 242 ---------IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPA 287
TP + PE+ + E DI++ G CIL + ++P+ E
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPF-EDGAKL 259
Query: 288 QIFKKVTSGIKPASLAKVNDPQ-------IKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 339
+I K + P I L ERLS +++
Sbjct: 260 RIVN-----------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 340 NQKEPICDPLK 350
+ P+
Sbjct: 309 ARNVNPKSPIT 319
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 68/258 (26%), Positives = 104/258 (40%), Gaps = 29/258 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKD 137
+ + EVLGKG F K G + +K +++ + Q+ + EV +++ L+
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMV---MKE--LIRFDEETQRTFLKEVKVMRCLEH 66
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYL 196
NV+KF K K +N ITE G LR + ++A+ I G+ YL
Sbjct: 67 PNVLKFIGVLY--KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----------------IAMQQPTARS 240
HS N IIHRDL N V N V + D GLA + +
Sbjct: 125 HSMN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 241 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299
V+G P +MAPE + Y+E VD++SFG+ + E++ + F G
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 300 ASLAKVNDPQIKGFIEKC 317
P +C
Sbjct: 242 RYCPPNCPPSFFPITVRC 259
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 65/275 (23%), Positives = 128/275 (46%), Gaps = 19/275 (6%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVV 141
LGKG F VY A ++ + +A +K+ L+ G +L EV + L+ N++
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
+ Y + D + V +I E G + + +K D + + ++ + L Y HS
Sbjct: 73 RLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNEL 260
+IHRD+K +N+ + G+ GE+KI D G ++ + GT +++ PE+ E ++E
Sbjct: 130 -VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 261 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCL 318
VD++S G+ E + + P+ E + +K+++ P + + I + L
Sbjct: 188 VDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFV----TEGARDLISRLL 242
Query: 319 VP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLP 352
S+R +++L+ P++ + K C +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-38
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 17/287 (5%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNV 140
+ LG GA+ V D+ +E A +KI + KL EV +LK L N+
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERA---IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
+K Y + D + ++ E + G L + +Q+L G+ YLH HN
Sbjct: 99 MKLYDFFEDKRN--YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 201 PPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEY 257
I+HRDLK +N+ + +KI D GL+ + + +GT ++APE+ ++Y
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 314
+E D++S G+ + ++ P+ + +I +KV G V K I
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLI 272
Query: 315 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
++ L + R+SA+ L+ P+++ K+ L +++ +R
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 76/307 (24%), Positives = 118/307 (38%), Gaps = 31/307 (10%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
+ E D D + +VLG GA T+ F +VA VK L
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVA---VKR----IL 57
Query: 119 PGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKN 176
P EV LL+ + NV++++ + D + + EL + L++Y +K
Sbjct: 58 PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQF--QYIAIEL-CAATLQEYVEQKDFA 114
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLAIA 232
+Q GL +LHS N I+HRDLK NI ++ + I D GL
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 233 MQQP-----TARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEY-PYSE 282
+ V GT ++APE+ E+ VDI+S G +++ P+ +
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 283 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ-VEN 340
+ K D + IEK + +R SAK +LK PF +E
Sbjct: 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292
Query: 341 QKEPICD 347
Q + D
Sbjct: 293 QLQFFQD 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 6e-37
Identities = 82/286 (28%), Positives = 131/286 (45%), Gaps = 17/286 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVV 141
+LGKG+F V K D E A VK+ + D + EV LLK L N++
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
K ++ D ++ EL+T G L K K +Q+ G+ Y+H HN
Sbjct: 85 KLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 202 PIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYN 258
I+HRDLK +NI + ++KI D GL+ QQ + IGT ++APE+ Y+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD 200
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIE 315
E D++S G+ + +++ P+ KN I K+V +G ++D K I
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIR 258
Query: 316 KCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
K L S R++A L+ P++Q + + P L ++ +R
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-37
Identities = 47/327 (14%), Positives = 97/327 (29%), Gaps = 58/327 (17%)
Query: 56 MLGTAEPPDADSDFVEKDPSGRYVRY--DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
++ T+ VE + R VLG+ +A D+ G V +
Sbjct: 55 LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVP 111
Query: 114 DVLQLPG--DLQKLYSEVHLLKSL----------------------KDDNVVKFYKSWVD 149
+ P ++++ EV L+ L KD K + +D
Sbjct: 112 YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 171
Query: 150 DKKKTVNMITELFTS---------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
++ V L+ L + HK++ Q++ L LH +
Sbjct: 172 ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELY---- 253
++H L+ +I ++ G V + + PE A +
Sbjct: 232 --LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQ 288
Query: 254 --EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311
D ++ G+ I + + P ++ + + K ++
Sbjct: 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------QPVR 341
Query: 312 GFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+E L +RL ++ P +
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 77/305 (25%), Positives = 136/305 (44%), Gaps = 41/305 (13%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKS 134
+ LG GA V AF+ +VA +KI + + +E+ +LK
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
L ++K ++ D + ++ EL G L +K + K + Q+L +
Sbjct: 72 LNHPCIIKIK-NFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE 251
YLH + IIHRDLK +N+ ++ + +KI D G + + + + R++ GTP ++APE
Sbjct: 129 YLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 252 ----LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI--- 297
+ YN VD +S G IL + P+SE + + ++TSG
Sbjct: 187 VLVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 298 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSL 356
P A+V++ ++K LV R + ++ L+ P+LQ E+ K D L +S
Sbjct: 240 IPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298
Query: 357 KMLRL 361
+ ++
Sbjct: 299 ALPQV 303
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 43/309 (13%)
Query: 64 DADSDFVEKDPSGRYVRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI-------DD 114
D D P Y + LG GA V AF+ +VA ++I
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA---IRIISKRKFAIG 176
Query: 115 VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH 174
+ + +E+ +LK L ++K ++ D + ++ EL G L +
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIK-NFFDAED--YYIVLELMEGGELFDKVVGN 233
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLAIA 232
K + K + Q+L + YLH + IIHRDLK +N+ + +KI D G +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 233 MQQPTA-RSVIGTPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTFEY-------PY 280
+ + + R++ GTP ++APE + YN VD +S G IL + P+
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL------FICLSGYPPF 344
Query: 281 SECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
SE + + ++TSG P A+V++ ++K LV R + ++ L+ P+L
Sbjct: 345 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWL 403
Query: 337 QVENQKEPI 345
Q E+ K
Sbjct: 404 QDEDMKRKF 412
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 45/323 (13%), Positives = 93/323 (28%), Gaps = 62/323 (19%)
Query: 62 PPDADSDFVEKD-PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP- 119
+ R + VLG+ +A D+ G V + + P
Sbjct: 57 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERPP 113
Query: 120 -GDLQKLYSEVHLLKSL----------------------KDDNVVKFYKSWVDDKKKTVN 156
++++ EV L+ L KD K + +D++ V
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 157 MITELFTS---------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 207
L+ L + HK++ Q++ L LH + ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 231
Query: 208 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE----------- 256
L+ +I ++ G V + + + F PEL
Sbjct: 232 LRPVDIVLDQR-GGVFLTGFEHLVRDGARV--VSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 257 -YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315
D ++ G+ I + + P ++ + + K ++ +E
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP------QPVRALLE 341
Query: 316 KCLVP-ASERLSAKDLLKDPFLQ 337
L +RL ++ P +
Sbjct: 342 GFLRYPKEDRLLPLQAMETPEYE 364
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 19/287 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSLKDDNV 140
VLGKG+F V D+ G E A VK+ Q+ D + L EV LLK L N+
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECA---VKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
+K Y+ + D ++ E++T G L K RQ+L G+ Y+H +
Sbjct: 89 MKLYEFFEDKGY--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 201 PPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEY 257
I+HRDLK +N+ + ++I D GL+ + + IGT ++APE+ Y
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 314
+E D++S G+ + +++ P++ N I KKV G + KV++ K I
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLI 262
Query: 315 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
K L S R+SA+D L ++Q +++ D ++ +R
Sbjct: 263 RKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV-PSLDNAILNIR 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 85/276 (30%), Positives = 129/276 (46%), Gaps = 23/276 (8%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLK 136
RY+ +LGKG+F V K D E A VK+ + D + EV LLK L
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLD 79
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N++K ++ D ++ EL+T G L K K +Q+ G+ Y+
Sbjct: 80 HPNIMKLFEILEDSSS--FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY 253
H HN I+HRDLK +NI + + +KI D GL+ QQ T + IGT ++APE+
Sbjct: 138 HKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDP 308
Y+E D++S G IL ++ P Y + N I K+V +G ++D
Sbjct: 196 RGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD- 251
Query: 309 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
K I K L S R++A L+ P++Q + +E
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 72/263 (27%), Positives = 130/263 (49%), Gaps = 24/263 (9%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LGKG+F VY+A G+EVA +K+ D + G +Q++ +EV + LK ++++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
Y + D V ++ E+ +G + +Y + + K +++ QI+ G++YLHSH
Sbjct: 76 LYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG- 132
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYN 258
I+HRDL N+ + N +KI D GLA ++ P + ++ GTP +++PE +
Sbjct: 133 -ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 259 ELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIE 315
D++S G C+ ++ P+ + KV P+ L+ + K I
Sbjct: 191 LESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIH 244
Query: 316 KCLVP-ASERLSAKDLLKDPFLQ 337
+ L ++RLS +L PF+
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMS 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 60/273 (21%), Positives = 120/273 (43%), Gaps = 33/273 (12%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
LG GAF V+ + +G+E +K + + ++++ +E+ +LKSL N++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
K ++ + D + ++ E G L + + K + + +Q+++ L Y H
Sbjct: 84 KIFEVFEDYHN--MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 198 SHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE 254
S + ++H+DLK +NI F + H +KI D GLA + + GT +MAPE+++
Sbjct: 142 SQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK 199
Query: 255 EEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-------KPASLAKV 305
+ DI+S G ++ + + ++ +K T +P +
Sbjct: 200 RDVTFKCDIWSAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT---- 252
Query: 306 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
PQ +++ L R SA +L + +
Sbjct: 253 --PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 25/295 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVA---------WSRVKIDDVLQLPGDLQKLYSEVHLLK 133
LG GA+ V ++ E A DD + +++Y+E+ LLK
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
SL N++K + + D K ++TE + G L + D N +QIL G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 194 VYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAP 250
YLH HN I+HRD+K +NI N + +KI D GL+ + R +GT ++AP
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 251 ELYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVN 306
E+ +++YNE D++S G I+ ++ P+ +N I KKV G +
Sbjct: 218 EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNI- 274
Query: 307 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
+ K I+ L ++R +A++ L +++ D K +L +R
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD-QKTLCGALSNMR 328
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 57/280 (20%), Positives = 119/280 (42%), Gaps = 29/280 (10%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAW---SRVKIDDVLQLPGDLQKLYSEVHLLKS 134
Y +G+G++ V A + I A + ++DV + E+ ++KS
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKS 62
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
L N+++ Y+++ D+ + ++ EL T G L + + + +L +
Sbjct: 63 LDHPNIIRLYETFEDNTD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE 251
Y H N + HRDLK +N + + +K+ D GLA + R+ +GTP +++P+
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVN 306
+ E Y D +S G ++ ++ YP + +++ K+ G V+
Sbjct: 179 VLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVS 235
Query: 307 DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 345
Q + I + L +R+++ L+ + + + P
Sbjct: 236 P-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 65/326 (19%), Positives = 119/326 (36%), Gaps = 71/326 (21%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLK 133
+Y +G+G++ V A + A +KI + ++ P D++++ +EV L+K
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA------- 186
L N+ + Y+ + D++ + ++ EL G+L +
Sbjct: 84 KLHHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 187 ---------------------------------RQILHGLVYLHSHNPPIIHRDLKCDNI 213
RQI L YLH+ I HRD+K +N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENF 199
Query: 214 -FVNGNHGEVKIGDLGLAIAMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDI 263
F E+K+ D GL+ + + GTP F+APE+ E Y D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 264 YSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLV 319
+S G +L ++ P+ N A +V + + + ++ + + L
Sbjct: 260 WSAG-VLLHLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLN 316
Query: 320 P-ASERLSAKDLLKDPFLQVENQKEP 344
ER A L+ P++ + K
Sbjct: 317 RNVDERFDAMRALQHPWISQFSDKIY 342
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 69/315 (21%), Positives = 121/315 (38%), Gaps = 52/315 (16%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
+ D ++ + ++ EV +G F V+KA + VA VKI +
Sbjct: 8 HSSGVDLGTENLYFQSMP--LQLLEVKARGRFGCVWKA--QLLNEYVA---VKIFPIQDK 60
Query: 119 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKN 176
+ EV+ L +K +N+++F + V++ IT G+L + K +
Sbjct: 61 QSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117
Query: 177 VDIKVIKNWARQILHGLVYLHS--------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228
V + + A + GL YLH H P I HRD+K N+ + N I D G
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFG 176
Query: 229 LAI----AMQQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVT--- 275
LA+ +GT +MAPE+ ++ + +D+Y+ G+ + E+ +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 276 -FEYPYSECKNPAQ----------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318
+ P E P + + KK ++ + IE+C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 319 VP-ASERLSAKDLLK 332
A RLSA + +
Sbjct: 297 DHDAEARLSAGCVGE 311
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 69/278 (24%), Positives = 132/278 (47%), Gaps = 21/278 (7%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVV 141
LGKG F VY A ++ +A +K+ QL G +L E+ + L+ N++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMA---LKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
+ Y + D K+ + ++ E G L + +KH D + + ++ L Y H
Sbjct: 78 RMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 134
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNEL 260
+IHRD+K +N+ + G GE+KI D G ++ R++ GT +++ PE+ E + ++E
Sbjct: 135 -VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEK 192
Query: 261 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCL 318
VD++ G+ E + P+ + + + +++ + +K P L K I K L
Sbjct: 193 VDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKLL 247
Query: 319 VP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 355
+RL K +++ P+++ N + + P+ QS
Sbjct: 248 RYHPPQRLPLKGVMEHPWVK-ANSR-RVLPPVYQSTQS 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 43/323 (13%), Positives = 89/323 (27%), Gaps = 52/323 (16%)
Query: 59 TAEPPDADSDFV-EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI--DDV 115
T P +A++ R ++ E L G V+ D + A +K+
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA---LKVFTMGA 99
Query: 116 LQLPGDLQKLYSEVHLLKSLKDDN------------------------VVKFYKSWVDDK 151
+L++L+ L ++ + D
Sbjct: 100 ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159
Query: 152 KKTVNMITELFTS------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 205
++ + L + I + Q++ L S ++H
Sbjct: 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217
Query: 206 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELV 261
DN+F+ G + +GD+ + T P AP + + +
Sbjct: 218 GHFTPDNLFI-MPDGRLMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 262 DIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQI----KGFIE 315
+ + G+ I + P+ + SLA + + K I
Sbjct: 275 NAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334
Query: 316 KCLVP-ASERLSAKDLLKDPFLQ 337
+ L RL + ++ P
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFL 357
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 73/276 (26%), Positives = 128/276 (46%), Gaps = 34/276 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLK 136
YD E LGKGAF V + + G+E A KI + +L D QKL E + + L+
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N+V+ + S ++ ++ +L T G L + + + +QIL + Y
Sbjct: 64 HPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 197 HSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-L 252
HS+ I+HR+LK +N+ + VK+ D GLAI + GTP +++PE L
Sbjct: 122 HSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASL 302
++ Y++ VDI++ G IL Y P+ + ++ +++ ++ +G
Sbjct: 180 KKDPYSKPVDIWACG-VIL------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEW 231
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
V + K I+ L +R++A LK P++
Sbjct: 232 DTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-34
Identities = 54/280 (19%), Positives = 99/280 (35%), Gaps = 41/280 (14%)
Query: 82 DEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+LG+GAF VY+A D + +K+ P + + LK
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFV---LKVQK-PANPWEFYIGTQLMERLKPSM 125
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN-----WARQILH 191
+KFY + + ++ EL++ G L +KN KV+ +A ++L+
Sbjct: 126 QHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNG----------NHGEVKIGDLGLAIAMQQP----T 237
+ +H IIH D+K DN + + + DLG +I M+
Sbjct: 184 MIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 238 ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296
+ T F E L + +N +D + + M+ Y + + + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 297 IKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPF 335
+ + F L +P L + DLL+
Sbjct: 302 LP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 33/286 (11%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG----DLQKLYSEVHLLK 133
Y+ EV+GKG F V + + G + A VKI DV + + L E +
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFA---VKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVDI--KVIKNWARQI 189
LK ++V+ +++ D + M+ E +L ++ V ++ RQI
Sbjct: 82 MLKHPHIVELLETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQP--TARSVIGTP 245
L L Y H +N IIHRD+K + + N VK+G G+AI + + A +GTP
Sbjct: 140 LEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KP 299
FMAPE + E Y + VD++ G IL ++ Y ++F+ + G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNP 253
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 344
+ +++ K + + L+ +ER++ + L P+L+ ++
Sbjct: 254 RQWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 83/313 (26%), Positives = 154/313 (49%), Gaps = 23/313 (7%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKS 134
G Y R + +GKG F V A G EVA +KI D QL P LQKL+ EV ++K
Sbjct: 15 GNY-RLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
L N+VK ++ V + +KT+ +I E + G + Y H + K ++ RQI+ +
Sbjct: 71 LNHPNIVKLFE--VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY 253
Y H I+HRDLK +N+ ++ + +KI D G + + G P + APEL+
Sbjct: 129 YCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 254 E-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQ 309
+ ++Y+ VD++S G+ + +V+ P+ +N ++ ++V G P ++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMS----TD 240
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSS 368
+ +++ LV +R + + ++KD ++ ++++ + ++ + R+ +
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIM--VG 298
Query: 369 MDIDSDYKQLSLS 381
M + Q SLS
Sbjct: 299 MGYSQEEIQESLS 311
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 47/227 (20%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE--VHLLKSLKDDN 139
E++G+G + VYK VA VK+ + Q +E ++ + ++ DN
Sbjct: 18 LELIGRGRYGAVYKG--SLDERPVA---VKVFS----FANRQNFINEKNIYRVPLMEHDN 68
Query: 140 VVKFYKSWVDDKKKTVN------MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+ +F D++ T + ++ E + +G+L +Y H D A + GL
Sbjct: 69 IARFIVG---DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 194 VYLHS-------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------QQP 236
YLH+ + P I HRDL N+ V + G I D GL++ + +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 237 TARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 275
A S +GT +MAPE+ E E + VD+Y+ G+ E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 78/309 (25%), Positives = 140/309 (45%), Gaps = 35/309 (11%)
Query: 67 SDFVEKDPSGRYVRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQ 123
S+F+ + YD E LGKGAF V + + G+E A KI + +L D Q
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQ 73
Query: 124 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK 183
KL E + + L+ N+V+ + S ++ ++ +L T G L + +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQEESF--HYLVFDLVTGGELFEDIVAREFYSEADAS 131
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RS 240
+ +QIL + Y HS+ I+HR+LK +N+ + VK+ D GLAI + A
Sbjct: 132 HCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 241 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKK 292
GTP +++PE L ++ Y++ VDI++ G IL Y P+ + ++ +++ +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWD-EDQHRLYAQ 241
Query: 293 VTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 348
+ +G V + K I+ L +R++A LK P++ ++
Sbjct: 242 IKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWIC-NRERVASAIH 299
Query: 349 LKLPIQSLK 357
+ + LK
Sbjct: 300 RQDTVDCLK 308
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-33
Identities = 69/322 (21%), Positives = 117/322 (36%), Gaps = 57/322 (17%)
Query: 59 TAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL 118
A P+ + V +++LG G+ TV F G VA VK L
Sbjct: 3 IANIPNFEQSL------KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVA---VKR----ML 48
Query: 119 PGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV 177
E+ LL D NV+++Y S D+ + + EL + NL+ +
Sbjct: 49 IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALEL-CNLNLQDLVESKNVS 105
Query: 178 DIKVIKNWA-------RQILHGLVYLHSHNPPIIHRDLKCDNIFVN------------GN 218
D + RQI G+ +LHS IIHRDLK NI V+
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 219 HGEVKIGDLGLAIAMQ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDIY 264
+ + I D GL + + + GT + APEL + +DI+
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 265 SFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP- 320
S G +++ + + I + + S + L + + I + +
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 321 ASERLSAKDLLKDPFLQVENQK 342
+R +A +L+ P +++K
Sbjct: 284 PLKRPTAMKVLRHPLFWPKSKK 305
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 31/299 (10%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLL 132
YD E LG G F V K ++ G+E A K Q +++ EV +L
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+ + NV+ + + + V +I EL + G L + + +++ + ++ +QIL G
Sbjct: 70 RQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 193 LVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFM 248
+ YLH+ I H DLK +NI + N +K+ D GLA ++ +++ GTPEF+
Sbjct: 128 VNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASL 302
APE + E D++S G I ++ + + +TS
Sbjct: 186 APEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFF 242
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
+ ++ K FI K LV +RL+ ++ L+ P++ + ++ + + +L+ R
Sbjct: 243 SHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA--MVRRESVVNLENFR 298
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 27/258 (10%)
Query: 57 LGTAEPPDADSDFVEKDP---SGRYVRYDEVLGKGAFKTVYKA----FDEFAGIEVAWSR 109
+G A + +DP R+++Y LGKG F +V + G VA
Sbjct: 1 MGHHHHHHAQL-YACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVA--- 56
Query: 110 VKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 167
VK D Q+ E+ +LK+L D +VK+ ++++ ++ E SG L
Sbjct: 57 VKQLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
Query: 168 RQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226
R + ++H+ +D + ++ QI G+ YL S +HRDL NI V + VKI D
Sbjct: 114 RDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIAD 170
Query: 227 LGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYP 279
GLA + R +P F APE L + ++ D++SFG+ + E+ T+ +
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
Query: 280 YSECKNPAQIFKKVTSGI 297
S ++
Sbjct: 231 CSPSAEFLRMMGCERDVP 248
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/307 (19%), Positives = 119/307 (38%), Gaps = 45/307 (14%)
Query: 84 VLGKGAFKTVY-----------KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
L +G F + K +++ + +D + + +E+ ++
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK--------VIKN 184
+K++ + + + V +I E + ++ ++ + +D VIK
Sbjct: 98 TDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 244
+ +L+ Y+H+ I HRD+K NI + +G VK+ D G + M + GT
Sbjct: 156 IIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFGESEYMVDKKIKGSRGT 213
Query: 245 PEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG----- 296
EFM PE + E VDI+S G+C+ M P+S + ++F + +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 297 ------------IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
K + F++ L +ER++++D LK +L + E
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA-DTNIE 332
Query: 344 PICDPLK 350
+ + K
Sbjct: 333 DLREFSK 339
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+ EVLG GAF V+ G A +K L +E+ +LK +K
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFA---LKCIKKSPA-FRDSSLENEIAVLKKIKH 65
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLV 194
+N+V + ++ +L + G L R + D ++ +Q+L +
Sbjct: 66 ENIVTLED-IYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLV---IQQVLSAVK 120
Query: 195 YLHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE- 251
YLH + I+HRDLK +N+ + ++ I D GL+ Q + GTP ++APE
Sbjct: 121 YLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV 178
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI------------ 297
L ++ Y++ VD +S G I ++ YP Y E +++F+K+ G
Sbjct: 179 LAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDIS 235
Query: 298 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ A K FI L +ER + + L P++
Sbjct: 236 ESA----------KDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 26/276 (9%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
YD E LG GAF V++ ++ G K + P D + +E+ ++ L
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFV---AKFINT-PYPLDKYTVKNEISIMNQLHH 107
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVY 195
++ + ++ D + + +I E + G L R + +K + +VI N+ RQ GL +
Sbjct: 108 PKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVI-NYMRQACEGLKH 164
Query: 196 LHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-L 252
+H H+ I+H D+K +NI VKI D GLA + + T EF APE +
Sbjct: 165 MHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVND 307
E D+++ G + ++ E + + + V + + V+
Sbjct: 223 DREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 342
+ K FI+ L +RL+ D L+ P+L+ ++
Sbjct: 280 -EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-32
Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 36/297 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLK 136
Y E LGKGAF V + AG E A I + +L D QKL E + + LK
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLK 68
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
N+V+ + S ++ +I +L T G L + + + +QIL +++
Sbjct: 69 HPNIVRLHDSISEEGH--HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 197 HSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE- 251
H ++HR+LK +N+ + VK+ D GLAI ++ GTP +++PE
Sbjct: 127 HQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 252 LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPAS 301
L ++ Y + VD+++ G IL Y P+ + ++ ++++++ +G
Sbjct: 185 LRKDPYGKPVDLWACG-VIL------YILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPE 236
Query: 302 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 357
V + K I K L S+R++A + LK P++ C + + LK
Sbjct: 237 WDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWIS-HRSTVASCMHRQETVDCLK 291
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 74/306 (24%), Positives = 134/306 (43%), Gaps = 28/306 (9%)
Query: 60 AEPPDADSDFVEKDPSGRYVRYD----EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV 115
A P D V Y E+LG G F V+K + G+++A KI
Sbjct: 68 APPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA---AKIIKT 124
Query: 116 LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKK 173
+ D +++ +E+ ++ L N+++ Y ++ + ++ E G L R +
Sbjct: 125 RGMK-DKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDES 181
Query: 174 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIA 232
+ ++ I + +QI G+ ++H I+H DLK +NI VN + ++KI D GLA
Sbjct: 182 YNLTELDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 233 MQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ 288
+ + GTPEF+APE + + + D++S G+ I M+ + N A+
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAE 295
Query: 289 IFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 344
+ + + +++ + K FI K L+ S R+SA + LK P+L
Sbjct: 296 TLNNILACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354
Query: 345 ICDPLK 350
+ K
Sbjct: 355 LSAQKK 360
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 69/290 (23%), Positives = 126/290 (43%), Gaps = 35/290 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLL 132
YD E LG G F V K ++ G+E A K Q +++ EV +L
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQI 189
+ + N++ + + + V +I EL + G L +K+ + + +QI
Sbjct: 70 RQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLSEEEATSF---IKQI 124
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTP 245
L G+ YLH+ I H DLK +NI + N +K+ D GLA ++ +++ GTP
Sbjct: 125 LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KP 299
EF+APE + E D++S G I ++ + + +T+
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYDFDE 239
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 348
++ ++ K FI K LV +RL+ ++ L+ P++ + ++ +
Sbjct: 240 EFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRR 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 71/300 (23%), Positives = 134/300 (44%), Gaps = 33/300 (11%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLL 132
YD E LG G F V K ++ G++ A K + + + EV +L
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYA---AKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
K ++ NV+ ++ + + V +I EL G L + + +++ + + +QIL+G
Sbjct: 69 KEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 193 LVYLHSHNPPIIHRDLKCDNI-FVNGNH--GEVKIGDLGLAIAMQQPTA-RSVIGTPEFM 248
+ YLHS I H DLK +NI ++ N +KI D GLA + +++ GTPEF+
Sbjct: 127 VYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASL 302
APE + E D++S G I ++ + + V++ +
Sbjct: 185 APEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYF 241
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 361
+ + K FI + LV +R++ +D L+ P+++ ++ ++ L ++ M +
Sbjct: 242 SNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ----ALSRKASAVNMEKF 296
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 67/322 (20%), Positives = 127/322 (39%), Gaps = 55/322 (17%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+Y + +G+G++ V+K + G VA + + P + E+ +LK LK
Sbjct: 4 KYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK 60
Query: 137 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVY 195
N+V + V +K+ ++++ E + + +++ V ++K+ Q L + +
Sbjct: 61 HPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----AP 250
H HN IHRD+K +NI + H +K+ D G A + P+ E +P
Sbjct: 118 CHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDEVATRWYRSP 171
Query: 251 ELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE--------------------- 282
EL + +Y VD+++ G C+ E+++ P S+
Sbjct: 172 ELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229
Query: 283 -CKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 336
N K+ L G ++ CL P ERL+ + LL P+
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTCEQLLHHPYF 288
Query: 337 QVENQKEPICDPLKLPIQSLKM 358
+ + E + P ++L
Sbjct: 289 ENIREIEDLAKEHDKPAENLYF 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 33/300 (11%)
Query: 54 SGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
SG+ + P+ V D Y +VLG G V + F G + A +K+
Sbjct: 10 SGLEVLFQGPEPKKYAVTDD----YQLSKQVLGLGVNGKVLECFHRRTGQKCA---LKLL 62
Query: 114 DVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD--KKKTVNMITELFTSGNL--R 168
D K EV ++V + + K+ + +I E G L R
Sbjct: 63 Y------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGD 226
+ + + R I + +LHSHN I HRD+K +N+ + + +K+ D
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 227 LGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSEC 283
G A Q ++ TP ++APE L E+Y++ D++S G I+ ++ +P YS
Sbjct: 175 FGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNT 233
Query: 284 KN--PAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ +++ G ++V++ K I L +ERL+ + P++
Sbjct: 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWIN 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 35/284 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG-----DLQKLYSEVHLL 132
Y+ E LG G F V K + G E A K +L +++ EV++L
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYA---AKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQI 189
+ ++ N++ + + + V +I EL + G L K+ + +QI
Sbjct: 63 REIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLTEDEATQF---LKQI 117
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTP 245
L G+ YLHS I H DLK +NI + N + +K+ D G+A ++ +++ GTP
Sbjct: 118 LDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP 175
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KP 299
EF+APE + E D++S G I ++ E + +++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTNISAVNYDFDE 232
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 342
+ ++ K FI + LV R++ L+ +++ ++
Sbjct: 233 EYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 77 RYVRYDEVLGKGAFKTVYKA----FDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVH 130
R++++ + LGKG F +V + G VA VK LQ L+ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIE 94
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQI 189
+LKSL+ DN+VK+ ++ + +I E G+LR Y +KHK +D + + QI
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P 245
G+ YL + IHRDL NI V N VKIGD GL + + + P
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 246 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
F APE L E +++ D++SFG+ + E+ T+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 77 RYVRYDEVLGKGAFKTVYKA----FDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVH 130
R++++ + LGKG F +V + G VA VK LQ L+ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIE 63
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQI 189
+LKSL+ DN+VK+ ++ + +I E G+LR Y +KHK +D + + QI
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P 245
G+ YL + IHRDL NI V N VKIGD GL + + + P
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 246 EF-MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
F APE L E +++ D++SFG+ + E+ T+
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 26/293 (8%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSL 135
Y+ + LG+G F V + + G E A K + ++ E+ +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAVLELA 85
Query: 136 KDD-NVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHG 192
K V+ ++ + + + + +I E G + + + V + +QIL G
Sbjct: 86 KSCPRVINLHEVYENTSE--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 193 LVYLHSHNPPIIHRDLKCDNI-FVNGN-HGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMA 249
+ YLH +N I+H DLK NI + G++KI D G++ + R ++GTPE++A
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLA 303
PE L + D+++ G+ I M+ E + + + ++ + +
Sbjct: 202 PEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFS 258
Query: 304 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 355
V+ FI+ LV +R +A+ L +LQ + E + P + S
Sbjct: 259 SVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSS 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 68/293 (23%), Positives = 121/293 (41%), Gaps = 27/293 (9%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
YD E LG GAF V++ + G A K D + + E+ + L+
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFA---AKFVMT-PHESDKETVRKEIQTMSVLRH 213
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNL-RQYRKKHKNVDIKVIKNWARQILHGLVYL 196
+V + ++ DD + + MI E + G L + +H + + RQ+ GL ++
Sbjct: 214 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 197 HSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LY 253
H +N +H DLK +NI F E+K+ D GL + + + GT EF APE
Sbjct: 272 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDP 308
+ D++S G + ++ E N + + V S ++ + +++
Sbjct: 330 GKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISE- 385
Query: 309 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
K FI K L+ + R++ L+ P+L N ++P +R
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD---SQIPSSRYTKIR 435
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 77 RYVRYDEVLGKGAFKTVYKA----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
RY++ LG+G F V ++ G VA VK P E+ +L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDIL 87
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
++L ++++K+ D ++ ++ E G+LR Y +H + + + +A+QI G
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF- 247
+ YLH+ + IHRDL N+ + N VKIGD GLA A+ + R +P F
Sbjct: 147 MAYLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 248 MAPE-LYEEEYNELVDIYSFGMCILEMVTF---------------EYPYSECKNPAQIFK 291
APE L E ++ D++SFG+ + E++T + ++ +
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTE 262
Query: 292 KVTSG 296
+ G
Sbjct: 263 LLERG 267
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 69/312 (22%), Positives = 132/312 (42%), Gaps = 26/312 (8%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLL 132
G+Y ++LG+G++ V + D A VKI + ++P + E+ LL
Sbjct: 5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILH 191
+ L+ NV++ +++K+ + M+ E G K + + Q++
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEF 247
GL YLHS I+H+D+K N+ + G +KI LG+A A+ A G+P F
Sbjct: 121 GLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 248 MAPELY--EEEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASL 302
PE+ + ++ VDI+S G+ + + T YP+ E N ++F+ + G P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC 236
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 361
P + ++ L ++R S + + + + + ++ P+ + R
Sbjct: 237 ----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRS 292
Query: 362 PMSGPSSMDIDS 373
P D+
Sbjct: 293 MTVVPYLEDLHG 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 19/233 (8%)
Query: 55 GMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKA----FDEFAGIEVAWSRV 110
G + + + P + D + R+++ LG+G F V + G +VA V
Sbjct: 1 GDIVSEKKPATEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---V 55
Query: 111 KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY 170
K + L E+ +L++L +N+VK+ +D + +I E SG+L++Y
Sbjct: 56 KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 171 RKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
K+K +++K +A QI G+ YL S +HRDL N+ V H +VKIGD GL
Sbjct: 116 LPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVKIGDFGL 172
Query: 230 AIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
A++ T + +P F APE L + ++ D++SFG+ + E++T+
Sbjct: 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 56/295 (18%), Positives = 125/295 (42%), Gaps = 28/295 (9%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y E LG+G F V++ + + K V D + E+ +L +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYM---AKF--VKVKGTDQVLVKKEISILNIARH 60
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVY 195
N++ ++S+ ++ + MI E + ++ + R ++ + I ++ Q+ L +
Sbjct: 61 RNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 196 LHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-L 252
LHSHN I H D++ +NI + +KI + G A ++ R + PE+ APE
Sbjct: 118 LHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVND 307
+ + D++S G ++ ++ +E QI + + + + +++
Sbjct: 176 QHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 361
+ F+++ LV R++A + L+ P+L+ + + ++ L
Sbjct: 233 -EAMDFVDRLLVKERKSRMTASEALQHPWLK-QKIERVSTKVIRTLKHRRYYHTL 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 56/317 (17%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y+ ++G+G++ V K ++ G VA + D + E+ LLK L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRH 83
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYL 196
+N+V + V KKK ++ E F + + N +D +V++ + QI++G+ +
Sbjct: 84 ENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----APE 251
HSHN IIHRD+K +NI V+ G VK+ D G A + P E APE
Sbjct: 141 HSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDEVATRWYRAPE 194
Query: 252 LY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE---------------------- 282
L + +Y + VD+++ G C++ EM E P S+
Sbjct: 195 LLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 283 CKNP---AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQ 337
KNP ++ + +KCL P +R +LL F Q
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD-KRPFCAELLHHDFFQ 311
Query: 338 VENQKEPICDPLKLPIQ 354
++ E L+L +Q
Sbjct: 312 MDGFAERFSQELQLKVQ 328
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 70/314 (22%), Positives = 130/314 (41%), Gaps = 51/314 (16%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
Y ++VLG+GA V + E A VKI + +++ EV +L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPG-HIRSRVFREVEMLYQCQ 68
Query: 137 D-DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHG 192
NV++ + + ++ + ++ E G++ ++++H N ++ V+ + +
Sbjct: 69 GHRNVLELIEFFEEEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASA 123
Query: 193 LVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ---------QPTARSV 241
L +LH+ I HRDLK +NI + N VKI D L ++ P +
Sbjct: 124 LDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 242 IGTPEFMAPE------LYEEEYNELVDIYSFG--MCIL------------EMVTFEYPYS 281
G+ E+MAPE Y++ D++S G + IL ++ +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 282 ECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+F+ + G A ++ K I K LV A +RLSA +L+ P++Q
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
Query: 338 VENQKEPICDPLKL 351
+ + P+ L
Sbjct: 301 GCAPENTLPTPMVL 314
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 57/291 (19%), Positives = 122/291 (41%), Gaps = 28/291 (9%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVA---WSRVKIDDVLQLPGDLQKLYSEVHLL 132
+Y + +LG G F +VY + VA + +I D +LP + ++ EV LL
Sbjct: 43 SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-NGTRVPMEVVLL 100
Query: 133 KSLK--DDNVVKFYKSWVDDKKKTVNMITELFT-SGNLRQYRKKHKNVDIKVIKNWARQI 189
K + V++ W + V +I E +L + + + ++ +++ Q+
Sbjct: 101 KKVSSGFSGVIRLLD-WFERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMA 249
L + + H+ ++HRD+K +NI ++ N GE+K+ D G ++ GT +
Sbjct: 159 LEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 216
Query: 250 PELYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKV 305
PE Y+ ++S G+ + +MV + P+ +++ G ++
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS-- 267
Query: 306 NDPQIKGFIEKCLVPA-SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 355
+ + I CL S+R + +++ P++Q + + +
Sbjct: 268 --SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 81/319 (25%), Positives = 131/319 (41%), Gaps = 64/319 (20%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS--EVHLLKS 134
Y +V+G G+F V++A + EVA +V D K + E+ +++
Sbjct: 41 AYTNC-KVIGNGSFGVVFQAKLVESD-EVAIKKVLQD----------KRFKNRELQIMRI 88
Query: 135 LKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWA 186
+K NVV FY + + +N++ E + R Y K + + + +IK +
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTP 245
Q+L L Y+HS I HRD+K N+ ++ G +K+ D G A I + S I +
Sbjct: 148 YQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 246 EFMAPELY--EEEYNELVDIYSFGMCIL-EMVT-----------------FEY---PYSE 282
+ APEL Y +DI+S G C++ E++ + P E
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 283 ---CKNPAQIFKKVTSGIKPASLAKV----NDPQIKGFIEKCLV--PASERLSAKDLLKD 333
NP + K I+P +KV P I + L P S RL+A + L
Sbjct: 265 QIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTAIEALCH 322
Query: 334 PF---LQVENQKEPICDPL 349
PF L+ + P L
Sbjct: 323 PFFDELRTGEARMPNGREL 341
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ +VLG GAF TVYK E I VA +K P +++ E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 135 LKDDNVVKFY----KSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQI 189
+ + +V + S TV +IT+L G L Y ++HK N+ + + NW QI
Sbjct: 74 VDNPHVCRLLGICLTS-------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP- 245
G+ YL ++HRDL N+ V VKI D GLA + ++ + G P
Sbjct: 127 AKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
++MA E + Y D++S+G+ + E++TF PY ++I + G
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 25/280 (8%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
++ LG+GA VY+ + A +K D + + +E+ +L L
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSH 107
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
N++K + + + ++++ EL T G L + + + +QIL + YLH
Sbjct: 108 PNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 198 SHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LY 253
+ I+HRDLK +N+ + +KI D GL+ ++ ++V GTP + APE L
Sbjct: 166 ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR 223
Query: 254 EEEYNELVDIYSFG--MCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDP 308
Y VD++S G IL + FE P+ + + +F+++ + +V+
Sbjct: 224 GCAYGPEVDMWSVGIITYIL-LCGFE-PFYDERGDQFMFRRILNCEYYFISPWWDEVSL- 280
Query: 309 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 347
K + K +V +RL+ L+ P++ + D
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 72/319 (22%), Positives = 129/319 (40%), Gaps = 35/319 (10%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVA---WSRVKIDD 114
GT PP D + Y R +LGKG F TV+ ++VA R ++
Sbjct: 15 GTPTPPPGGKD--REAFEAEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
Query: 115 VLQLPGDLQKLYSEVHLLKSLKDD----NVVKFYKSWVDDKKKTVNMITELFTSGN-LRQ 169
L D EV LL + V++ W + ++ + ++ E L
Sbjct: 72 WSPLS-DSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFETQEGFM-LVLERPLPAQDLFD 128
Query: 170 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
Y + + + + Q++ + + HS ++HRD+K +NI ++ G K+ D G
Sbjct: 129 YITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGS 186
Query: 230 AIAMQQPTARSVI-GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNP 286
A+ + GT + PE +Y+ ++S G+ + +MV + P+
Sbjct: 187 G-ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---- 241
Query: 287 AQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPA-SERLSAKDLLKDPFLQVENQKE 343
+++ PA ++ P I +CL P S R S +++L DP++Q +
Sbjct: 242 ---DQEILEAELHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
Query: 344 PICDPLKLPIQSLKMLRLP 362
P+ +P K L LP
Sbjct: 295 PL-NPSKGGPAPLAWSLLP 312
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 41/291 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVA-----WSRVKIDDVLQLPGDLQKLYSEVHLL 132
Y+ E+LG+G V + + E A + ++ + EV +L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 133 KSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILH 191
+ + N+++ ++ + ++ +L G L Y + + K + R +L
Sbjct: 78 RKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAP 250
+ LH N I+HRDLK +NI ++ + +K+ D G + + R V GTP ++AP
Sbjct: 136 VICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 251 E-------LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSG 296
E Y + VD++S G I+ Y P+ + + + + SG
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTG-VIM------YTLLAGSPPFWH-RKQMLMLRMIMSG 244
Query: 297 I---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
+D K + + LV +R +A++ L PF Q +E
Sbjct: 245 NYQFGSPEWDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 74/307 (24%), Positives = 134/307 (43%), Gaps = 68/307 (22%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--------VLQLPGDLQKLYSE 128
+Y + E +G+G + TV+KA + VA RV++DD L+ E
Sbjct: 3 KYEK-LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----------E 51
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWAR 187
+ LLK LK N+V+ + DKK + ++ E F +L++Y D +++K++
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKK--LTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+L GL + HS N ++HRDLK N+ +N +GE+K+ + GLA A P R + E
Sbjct: 109 QLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAEV 162
Query: 248 M-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------- 282
+ P++ + Y+ +D++S G CI E+ P
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
Query: 283 ---------CKNP-AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDL 330
K P + + + ++ + + ++ L P +R+SA++
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV-QRISAEEA 280
Query: 331 LKDPFLQ 337
L+ P+
Sbjct: 281 LQHPYFS 287
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 63/302 (20%), Positives = 128/302 (42%), Gaps = 36/302 (11%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
Y +VLG G V + F++ + A +K+ D K EV L
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKMLQ------DCPKARREVELHWRAS 112
Query: 137 D-DNVVKFYKSWVD--DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILH 191
++V+ + + +K + ++ E G L R + + + + I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 192 GLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ-QPTARSVIGTPEFM 248
+ YLHS N I HRD+K +N+ + + +K+ D G A + + TP ++
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGI---KPA 300
APE L E+Y++ D++S G I+ ++ YP YS + ++ G
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 301 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 359
++V++ ++K I L ++R++ + + P++ ++ K P + P+ + ++L
Sbjct: 290 EWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVL 342
Query: 360 RL 361
+
Sbjct: 343 KE 344
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 73/324 (22%), Positives = 131/324 (40%), Gaps = 21/324 (6%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ + LG+GA+ V A + VA VKI D+ + + + E+ + K L
Sbjct: 7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKML 62
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+NVVKFY + + E + G L + + + + Q++ G+VY
Sbjct: 63 NHENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPE 251
LH I HRD+K +N+ ++ +KI D GLA + ++ GT ++APE
Sbjct: 121 LHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 252 LYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDP 308
L + E++ E VD++S G+ + M+ E P+ + + Q K+ D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DS 236
Query: 309 QIKGFIEKCLVP-ASERLSAKDLLKDPFLQV---ENQKEPICDPLKLPIQSLKMLRLPMS 364
+ K LV S R++ D+ KD + + K P + + S
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQS 296
Query: 365 GPSSMDIDSDYKQLSLSTCTESNN 388
++S + E ++
Sbjct: 297 NLDFSPVNSASRTPGSGWSKEHHH 320
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 16/269 (5%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ + LG+GA+ V A + VA VKI D+ + + + E+ + K L
Sbjct: 7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKML 62
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+NVVKFY + + E + G L + + + + Q++ G+VY
Sbjct: 63 NHENVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPE 251
LH I HRD+K +N+ ++ +KI D GLA + ++ GT ++APE
Sbjct: 121 LHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 252 -LYEEEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
L E++ E VD++S G+ + M+ E P+ + + Q + + K D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ K LV S R++ D+ KD +
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 64/294 (21%), Positives = 124/294 (42%), Gaps = 41/294 (13%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI----------------------- 112
+Y DE +GKG++ V A++E A +K+
Sbjct: 13 NQYTLKDE-IGKGSYGVVKLAYNENDNTYYA---MKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 113 --DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY 170
+Q G ++++Y E+ +LK L NVVK + D + + M+ EL G + +
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 171 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230
+ + + + ++ G+ YLH IIHRD+K N+ V + G +KI D G++
Sbjct: 129 PTLKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVS 184
Query: 231 IAMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTFEYPYSECK 284
+ A + +GTP FMAPE + ++ + +D+++ G+ + V + P+ + +
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-E 243
Query: 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ K+ S +K I + L R+ ++ P++
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 23/271 (8%)
Query: 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLL 132
+ RY + + LG G TVY A D I+VA +K + L++ EVH
Sbjct: 10 NERY-KIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNS 65
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
L N+V +D ++ E L +Y + H + + N+ QIL G
Sbjct: 66 SQLSHQNIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMA 249
+ + H I+HRD+K NI + ++ +KI D G+A A+ + + V+GT ++ +
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 250 PELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVND 307
PE + E +E DIYS G+ + EM+ E P++ + I K + + P V
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRK 238
Query: 308 ---PQIKGFIEKCLV--PASERLSAKDLLKD 333
+ I + A+ + +++ D
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 63/287 (21%), Positives = 119/287 (41%), Gaps = 46/287 (16%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVH 130
+YD +V+G+G V + G E A VKI QL + E H
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 131 LLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQI 189
+L+ + +++ S+ + ++ +L G L Y + + K ++ R +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL 209
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFM 248
L + +LH++N I+HRDLK +NI ++ N ++++ D G + ++ R + GTP ++
Sbjct: 210 LEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 249 APE-------LYEEEYNELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVT 294
APE Y + VD+++ G IL + P+ + + + +
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACG-VIL------FTLLAGSPPFWH-RRQILMLRMIM 318
Query: 295 SGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
G + K I + L RL+A+ L+ PF +
Sbjct: 319 EGQYQFSSPEWDDRSSTV-KDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 77 RYVRYDEVLGKGAFKTVYKA--FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ +G+G + VYKA D + A +++ + E+ LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN---------VDIKVIKNW 185
LK NV+ K ++ + V ++ + + +L K H+ + ++K+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPTARSVI 242
QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A P
Sbjct: 134 LYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 243 GTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 275
P + APEL Y + +DI++ G CI E++T
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 42/239 (17%)
Query: 60 AEPPDADSDFVEKDPSGRYV-RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD-- 114
A+ S V PS + RY LG+G + VYKA D VA R++++
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73
Query: 115 ------VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 168
++ EV LLK L+ N+++ + + +++I E + +L+
Sbjct: 74 EGVPGTAIR----------EVSLLKELQHRNIIELKSVIHHNHR--LHLIFE-YAENDLK 120
Query: 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEVKI 224
+Y K+ +V ++VIK++ Q+++G+ + HS +HRDLK N+ ++ +KI
Sbjct: 121 KYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 225 GDLGLAIAMQQPTARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 275
GD GLA A P + T E + PE+ Y+ VDI+S CI EM+
Sbjct: 179 GDFGLARAFGIPIRQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 75/345 (21%), Positives = 136/345 (39%), Gaps = 41/345 (11%)
Query: 57 LGTAEPPDADSDFVEKDPSGRYV-RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKI- 112
+ EPP A G Y +Y LG GAF V+ A D+ EV VK
Sbjct: 1 MALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFI 57
Query: 113 ------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGN 166
+D L K+ E+ +L ++ N++K + + + ++ E SG
Sbjct: 58 KKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGL 115
Query: 167 -LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225
L + +H +D + RQ++ + YL + IIHRD+K +NI + + +K+
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLI 172
Query: 226 DLGLAIAMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSE 282
D G A +++ + GT E+ APE+ Y ++++S G+ + +V E P+ E
Sbjct: 173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
Query: 283 CKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ-- 337
++ P ++ ++ + L P R + + L+ DP++
Sbjct: 233 -------LEETVEAAIHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 338 ---VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 379
+ E + K L L M S D+ +
Sbjct: 282 VNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCG 326
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 66/325 (20%), Positives = 122/325 (37%), Gaps = 76/325 (23%)
Query: 79 VRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
V Y +V+G G+F VY+A +G VA +V D + E+ +++ L
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLD 105
Query: 137 DDNVVK----FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQ 188
N+V+ FY S + +N++ + + R Y + + + + +K + Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 248
+ L Y+HS I HRD+K N+ ++ + +K+ D G A+ ++ E
Sbjct: 165 LFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRG-EPN 213
Query: 249 ----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKN-------- 285
APEL +Y +D++S G C+L E++ + +P +
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 286 ----PAQIFKKVTSG--------IKPASLAKV----NDPQIKGFIEKCLV--PASERLSA 327
+ +++ IK KV P+ + L P + RL+
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTP 331
Query: 328 KDLLKDPFLQV---ENQKEPICDPL 349
+ F N K P
Sbjct: 332 LEACAHSFFDELRDPNVKLPNGRDT 356
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 34/298 (11%)
Query: 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKD-DN 139
D+ LG+G+F K + + A VK I E+ LK + N
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFA---VKIISK-----RMEANTQKEITALKLCEGHPN 67
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+VK ++ + D ++ EL G L + KK K+ R+++ + ++H
Sbjct: 68 IVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 200 NPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYE 254
++HRDLK +N+ F + N E+KI D G A ++ T + APE L +
Sbjct: 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 255 EEYNELVDIYSFGMCILEMVTFEYP--YSE-----CKNPAQIFKKVTSG---IKPASLAK 304
Y+E D++S G IL + S C + +I KK+ G + +
Sbjct: 184 NGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 305 VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ--KEPICDPLKLPIQSLKML 359
V+ + K I+ L ++RL L + +LQ +Q P+ P L +
Sbjct: 243 VSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 16/225 (7%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+ E +G+G F V+ VA VK P K E +LK
Sbjct: 116 LVLGEQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLH 197
N+V+ V +K+ + ++ EL G+ + R + + +K + G+ YL
Sbjct: 173 NIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-L 252
S IHRDL N V + +KI D G++ + G + APE L
Sbjct: 231 SKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 253 YEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 24/273 (8%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLK 133
G Y + LG G F V + G +VA VKI + ++ + K+ E+ LK
Sbjct: 11 GHY-VLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLK 66
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+ +++K Y+ V M+ E + G L Y KH V+ + +QIL +
Sbjct: 67 LFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE 251
Y H H ++HRDLK +N+ ++ + KI D GL+ M R+ G+P + APE
Sbjct: 125 DYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPE 180
Query: 252 LYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVND 307
+ Y VDI+S G+ + ++ P+ + ++ +FKK+ G+ P L
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN---- 235
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 339
+ + L +R + KD+ + + + +
Sbjct: 236 RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 66/229 (28%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ +VLG GAF TVYK E I VA +K P +++ E +++ S
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMAS 73
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGL 193
+ + +V + + TV +IT+L G L Y ++HK N+ + + NW QI G+
Sbjct: 74 VDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMA 249
YL ++HRDL N+ V VKI D GLA + ++ + G P ++MA
Sbjct: 131 NYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
E + Y D++S+G+ + E++TF PY ++I + G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS----EVHLL 132
Y++ + LG+G + TVYK + VA ++++ P EV LL
Sbjct: 3 TYIK-LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-------CTAIREVSLL 54
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILH 191
K LK N+V + +K + ++ E + +L+QY N+ ++ +K + Q+L
Sbjct: 55 KDLKHANIVTLHDIIHTEKS--LTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM--- 248
GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT E +
Sbjct: 112 GLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNEVVTLW 165
Query: 249 --APELY--EEEYNELVDIYSFGMCIL-EMVT 275
P++ +Y+ +D++ G CI EM T
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--------VLQLPGDLQKLYSE 128
+Y + E +G+G + VYKA D G VA R+++D ++ E
Sbjct: 22 KYQK-LEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR----------E 69
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWAR 187
+ LLK L N+V ++ + ++ E F +L++ ++K IK +
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERC--LTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLY 126
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+L G+ + H H I+HRDLK N+ +N + G +K+ D GLA A P T E
Sbjct: 127 QLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THEV 180
Query: 248 M-----APELY--EEEYNELVDIYSFGMCIL-EMVT 275
+ AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 23/228 (10%)
Query: 79 VRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLK 133
+R E LG G+F V + + VA VK DVL P + EV+ +
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHG 192
SL N+++ Y V + M+TEL G+L +KH+ + + + +A Q+ G
Sbjct: 77 SLDHRNLIRLYG--VV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EF 247
+ YL S IHRDL N+ + VKIGD GL + P +
Sbjct: 134 MGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 248 MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 293
APE L ++ D + FG+ + EM T+ + P+ +QI K+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 39/216 (18%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--------VLQLPGDLQKLYSE 128
+Y E +G+G + VYKA + G A +++++ ++ E
Sbjct: 3 KYHG-LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR----------E 50
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWAR 187
+ +LK LK N+VK Y K+ + ++ E +L++ + + K++
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKR--LVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q+L+G+ Y H ++HRDLK N+ +N GE+KI D GLA A P R T E
Sbjct: 108 QLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THEI 161
Query: 248 M-----APELY--EEEYNELVDIYSFGMCIL-EMVT 275
+ AP++ ++Y+ +DI+S G CI EMV
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y+ E +G G++ + + +E A VKI + + E+ +L
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFA---VKI-----IDKSKRDPTEEIEILLRYGQ 74
Query: 138 -DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGL 193
N++ + D K V ++TEL G L + R+K + + + I +
Sbjct: 75 HPNIITLKDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAV---LFTITKTV 129
Query: 194 VYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFM 248
YLH+ ++HRDLK NI +GN ++I D G A ++ + T F+
Sbjct: 130 EYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECK-NPAQIFKKVTSG---IKPAS 301
APE L + Y+ DI+S G +L + Y + P +I ++ SG +
Sbjct: 188 APEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246
Query: 302 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 341
V+D K + K L +RL+A +L+ P++ +Q
Sbjct: 247 WNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 36/217 (16%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS----EVHLL 132
++ + E LG G + TVYK ++ G+ VA VK+D P S E+ L+
Sbjct: 6 QFKQ-LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-------STAIREISLM 57
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY------RKKHKNVDIKVIKNWA 186
K LK +N+V+ Y + K + ++ E F +L++Y + +++ ++K +
Sbjct: 58 KELKHENIVRLYDVIHTENK--LTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
Q+L GL + H + I+HRDLK N+ +N G++K+GD GLA A P + E
Sbjct: 115 WQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF---SSE 168
Query: 247 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 275
+ AP++ Y+ +DI+S G CIL EM+T
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+R +VLG G F TV+K E I V +K+ + Q + + + S
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGL 193
L ++V+ ++ ++T+ G+L + ++H+ + +++ NW QI G+
Sbjct: 72 LDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTP-EFMA 249
YL H ++HR+L N+ + +V++ D G+A + S TP ++MA
Sbjct: 129 YYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
E ++ +Y D++S+G+ + E++TF PY+ + A++ + G
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 71/273 (26%), Positives = 128/273 (46%), Gaps = 25/273 (9%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLK 133
G Y E LG+G+F V A +VA +K +L+ ++ E+ LK
Sbjct: 9 GPY-IIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLK 64
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
L+ +++K Y V + M+ E + G L Y + K + + + +QI+ +
Sbjct: 65 LLRHPHIIKLYD--VITTPTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE 251
Y H H I+HRDLK +N+ ++ N VKI D GL+ + ++ G+P + APE
Sbjct: 122 EYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 177
Query: 252 LYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVND 307
+ + Y VD++S G+ + M+ P+ + + +FKKV S + P L
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFL----S 232
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 339
P + I + +V +R++ +++ +DP+ V
Sbjct: 233 PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 84/345 (24%), Positives = 142/345 (41%), Gaps = 75/345 (21%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+ +LG+GA+ V A + G VA +K + P + E+ +LK K
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 138 DNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
+N++ + + + V +I EL + +L + D I+ + Q L +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVK 126
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFM---- 248
LH N +IHRDLK N+ +N N ++K+ D GLA I G M
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 249 ------APE--LYEEEYNELVDIYSFGMCIL-EMVT-----------------FEY---P 279
APE L +Y+ +D++S G CIL E+ F P
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 280 YSE-----CKNP-AQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAK 328
+S+ ++P A+ + K A L K+ +P+ +++ LV P ++R++AK
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AKRITAK 301
Query: 329 DLLKDPFLQV--ENQKEPICDPL------------KLPIQSLKML 359
+ L+ P+LQ + EP +P+ L + LK L
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKL 346
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 22/226 (9%)
Query: 82 DEVLGKGAFKTVYKAF--DEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKD 137
D+ LG G F TV K + + VA VKI ++ P +L +E ++++ L +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEAND-PALKDELLAEANVMQQLDN 77
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+V+ + + + + ++ E+ G L +Y +++++V K I Q+ G+ YL
Sbjct: 78 PYIVRMIG--ICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE- 251
N +HRDL N+ + H KI D GL+ + + ++ P ++ APE
Sbjct: 135 ESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ +++ D++SFG+ + E ++ + PY K ++ + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 20/239 (8%)
Query: 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLY 126
V PS V ++EV+G+G F VY ++ I A VK + + G++ +
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFL 74
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 185
+E ++K NV+ + + ++ G+LR + R + N +K + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
Q+ G+ YL S +HRDL N ++ VK+ D GLA M SV
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKT 190
Query: 246 EF------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD----VLQLPGDLQKLYS----EVHLLKS 134
+G GA+ TVYKA D +G VA V++ + LP EV LL+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP-------ISTVREVALLRR 67
Query: 135 LKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWA 186
L+ NVV+ + D++ V ++ E +LR Y + + + IK+
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
RQ L GL +LH++ I+HRDLK +NI V + G VK+ D GLA A TP
Sbjct: 127 RQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPV 179
Query: 247 FM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 275
+ APE L + Y VD++S G CI EM
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 69/318 (21%), Positives = 133/318 (41%), Gaps = 25/318 (7%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY + + +G G F D+ VA VK + + + E+ +SL
Sbjct: 20 DRY-DFVKDIGSGNFGVARLMRDKLTKELVA---VKYIERGAA--IDENVQREIINHRSL 73
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+ N+V+F + V + +I E + G L + + + +Q+L G+ Y
Sbjct: 74 RHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY 253
HS I HRDLK +N ++G+ +KI D G + + + +S +GTP ++APE+
Sbjct: 132 CHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 254 E-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKV 305
+EY+ ++ D++S G+ + M+ YP+ E + ++K I P +
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRI- 247
Query: 306 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMS 364
P+ I + V + R+S ++ + N + + Q + + S
Sbjct: 248 -SPECCHLISRIFVADPATRISIPEIKTHSWFLK-NLPADLMNESNTGSQFQEPEQPMQS 305
Query: 365 GPSSMDIDSDYKQLSLST 382
+ M I S+ ++
Sbjct: 306 LDTIMQIISEATIPAVRN 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 44/240 (18%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY+ ++G G++ V +A+D+ VA KI V + D +++ E+ +L L
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNH 111
Query: 138 DNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
D+VVK +K + ++ E+ S + ++ + + IK +L G+
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------------------IAMQQ 235
Y+HS I+HRDLK N VN + VK+ D GLA M
Sbjct: 171 YVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 236 PTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSE 282
T + APE L +E Y E +D++S G CI E++
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENVA 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKS 134
RY + + LG+G F TVYKA D+ VA ++K+ + + L E+ LL+
Sbjct: 11 RYEK-LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQE 68
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGL 193
L N++ ++ ++++ + F +L K + V IK + L GL
Sbjct: 69 LSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----- 248
YLH H I+HRDLK +N+ ++ +G +K+ D GLA + P R+ T + +
Sbjct: 126 EYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQVVTRWYR 179
Query: 249 APELY--EEEYNELVDIYSFGMCIL-EMVT 275
APEL Y VD+++ G CIL E++
Sbjct: 180 APELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 24/274 (8%)
Query: 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHL 131
S RY E+LG G V+ A D +VA VK+ L D + E
Sbjct: 11 SDRY-ELGEILGFGGMSEVHLARDLRDHRDVA---VKVLR-ADLARDPSFYLRFRREAQN 65
Query: 132 LKSLKDDNVVKFYKSWVDD--KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQI 189
+L +V Y + + ++ E LR + K
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-----SVIGT 244
L + H + IIHRD+K NI + VK+ D G+A A+ +VIGT
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 245 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASL 302
++++PE + + D+YS G + E++T E P++ +P + ++ V P S
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSA 241
Query: 303 AKVNDPQ-IKGFIEKCLV--PASERLSAKDLLKD 333
+ + K L P + +A ++ D
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 81/330 (24%), Positives = 132/330 (40%), Gaps = 62/330 (18%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y +G GA+ +V A D+ +G +VA K+ Q ++ Y E+ LLK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 138 DNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+NV+ F + ++ + +L++ + I+ Q+L GL
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGL 139
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-- 251
Y+HS ++HRDLK N+ VN + E+KI D GLA V+ T + APE
Sbjct: 140 KYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWYRAPEVI 195
Query: 252 LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVND 307
L YN+ VDI+S G CI+ EM+T + + K+ ++ + K+ND
Sbjct: 196 LSWMHYNQTVDIWSVG-CIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 308 PQIKGFI--------------------------EKCLV--PASERLSAKDLLKDPFLQV- 338
K +I EK L +RL+A L PF +
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTHPFFEPF 312
Query: 339 -ENQKEPICDP--------LKLPIQSLKML 359
+ ++E KL + K
Sbjct: 313 RDPEEETEAQQPFDDSLEHEKLTVDEWKQH 342
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 84/354 (23%), Positives = 141/354 (39%), Gaps = 66/354 (18%)
Query: 60 AEPPDADSDFVEKDPSG-------RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI 112
+ PP A S F ++ + Y R + +G GA+ V A D G +VA K+
Sbjct: 2 SSPPPARSGFYRQEVTKTAWEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KL 58
Query: 113 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNLR 168
Q ++ Y E+ LLK ++ +NV+ F D ++ + +L
Sbjct: 59 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLG 117
Query: 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228
+ K K + + I+ Q+L GL Y+H+ IIHRDLK N+ VN + E+KI D G
Sbjct: 118 KLMKHEKLGEDR-IQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFG 173
Query: 229 LAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKN 285
LA V+ T + APE L Y + VDI+S G CI+ EM+T + + +
Sbjct: 174 LARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVG-CIMAEMITGK-TLFKGSD 230
Query: 286 PAQIFKKVTSGI---KPASLAKVNDPQIKGFI--------------------------EK 316
K++ + ++ + K ++ EK
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 317 CLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL-------KLPIQSLKML 359
LV +R++A + L P+ + + + EP + K +
Sbjct: 291 MLVLDA-EQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 343
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 92/339 (27%), Positives = 136/339 (40%), Gaps = 80/339 (23%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY +G GA+ +V AFD G+ VA K+ Q ++ Y E+ LLK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 138 DNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+NV+ F + ++ V ++T L + +L K K D ++ QIL GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDH-VQFLIYQILRGL 145
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----- 248
Y+HS + IIHRDLK N+ VN + E+KI D GL AR T + M
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL--------ARH---TADEMTGYVA 191
Query: 249 -----APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--- 297
APE L YN+ VDI+S G CI+ E++T + K + +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGR-TLFPGTDHIDQLKLILRLVGTP 249
Query: 298 KPASLAKVNDPQIKGFI--------------------------EKCLV--PASERLSAKD 329
L K++ + +I EK LV +R++A
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQ 308
Query: 330 LLKDPFLQV--ENQKEPICDPL-------KLPIQSLKML 359
L + + EP+ DP L I K L
Sbjct: 309 ALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSL 347
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G + VY+ + + VA +K D + ++++ E ++K +K N+V+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQ 280
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
V ++ +ITE T GNL Y ++ ++ + A QI + YL N
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEE 256
IHR+L N V G + VK+ D GL+ M TA + P ++ APE L +
Sbjct: 339 --FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
++ D+++FG+ + E+ T+ PY +Q+++ +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 45/244 (18%), Positives = 91/244 (37%), Gaps = 45/244 (18%)
Query: 79 VRYDEVLGKGAFKTVYKA-------FDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEV 129
+ ++E LG+G F ++K + + EV +K+ +
Sbjct: 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVL---LKVLDKAHRNYSESFFE---AA 63
Query: 130 HLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQ 188
++ L ++V Y V ++ E G+L Y KK+KN ++I A+Q
Sbjct: 64 SMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVN-------GNHGEVKIGDLGLAIAMQQPTARSV 241
+ + +L + +IH ++ NI + GN +K+ D G+ + +V
Sbjct: 122 LAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------SITV 171
Query: 242 IGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 292
+ + PE + N D +SFG + E+ + + P S + + +
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQF 230
Query: 293 VTSG 296
Sbjct: 231 YEDR 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 24/273 (8%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLK 133
G Y + LG G F V E G +VA VKI + ++ + K+ E+ LK
Sbjct: 16 GHY-ILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLK 71
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+ +++K Y+ V + M+ E + G L Y K+ +D K + +QIL G+
Sbjct: 72 LFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE 251
Y H H ++HRDLK +N+ ++ + KI D GL+ M R+ G+P + APE
Sbjct: 130 DYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPE 185
Query: 252 LYE-EEYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVND 307
+ Y VDI+S G+ + ++ P+ + + +FKK+ GI P L +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL----N 240
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 339
P + ++ L +R + KD+ + + + +
Sbjct: 241 PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 46/233 (19%)
Query: 70 VEKDPSGRYV-RYD--EVLGKGAFKTVYKAFDEFAGIE-VAWSRVKIDD--------VLQ 117
+EKD R +Y+ +G+GA+ V+KA D G VA RV++ ++
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 118 LPGDLQKLYSEVHLLKSLKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQYR 171
EV +L+ L+ NVV+ + D++ + ++ E +L Y
Sbjct: 61 ----------EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYL 109
Query: 172 KKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
K + IK+ Q+L GL +LHSH ++HRDLK NI V + G++K+ D GL
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGL 166
Query: 230 AIAMQQPTARSVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 275
A A T + APE L + Y VD++S G CI EM
Sbjct: 167 ARIYSFQMAL----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 66/338 (19%), Positives = 115/338 (34%), Gaps = 93/338 (27%)
Query: 79 VRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
R+ + G+G F TV ++ G+ VA I V+Q P + + L L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLH 77
Query: 137 DDNVVK---FYKSWVDDKKKTV--NMITELFTSGNL----RQYRKKHKNVDIKVIKNWAR 187
N+V+ ++ + + ++ + N++ E L R Y ++ +IK +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
Q++ + LH + + HRD+K N+ VN G +K+ D G A+ + + E
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EP 187
Query: 248 M----------APELY--EEEYNELVDIYSFGMCIL-EMVT------------------- 275
APEL + Y VDI+S G CI EM+
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 276 -------------------FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
+ S+ + +F + + D +
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY----D-----LLSA 297
Query: 317 CLV--PASERLSAKDLLKDPFLQV---ENQKEPICDPL 349
L P ER+ + L P+ K P L
Sbjct: 298 LLQYLP-EERMKPYEALCHPYFDELHDPATKLPNNKDL 334
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 24/215 (11%)
Query: 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVLQLPGD---LQKLYSEVH 130
+G+Y + G +Y A D G V +K L GD +E
Sbjct: 79 AGQY-EVKGCIAHGGLGWIYLALDRNVNGRPVV---LK---GLVHSGDAEAQAMAMAERQ 131
Query: 131 LLKSLKDDNVVKFYKSWVDDKKKTVNMIT----ELFTSGNLRQYRKKHKNVDIKVIKNWA 186
L + ++V+ + ++V+ + + + E +L++ + + V + I +
Sbjct: 132 FLAEVVHPSIVQIF-NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYL 188
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
+IL L YLHS +++ DLK +NI + ++K+ DLG + + GTP
Sbjct: 189 LEILPALSYLHSIG--LVYNDLKPENIML--TEEQLKLIDLGAVSRINSFGY--LYGTPG 242
Query: 247 FMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYS 281
F APE+ DIY+ G + + +
Sbjct: 243 FQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 79 VRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
V + +LG+G F VY+ + I VA VK + +K SE ++K+L
Sbjct: 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVA---VKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLV 194
++VK + +++ +I EL+ G L Y + ++ + + ++ QI +
Sbjct: 71 DHPHIVKLIG--IIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMAPE 251
YL S N +HRD+ NI V VK+GD GL+ ++ T P ++M+PE
Sbjct: 128 YLESIN--CVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ + D++ F +C+ E+++F + P+ +N + + G
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 46/226 (20%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+ + + +G G F V+ + +VA ++ + + E ++ L
Sbjct: 10 LTFVQEIGSGQFGLVHLG--YWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSH 62
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYL 196
+V+ Y V ++ + ++TE G L Y + + + + + G+ YL
Sbjct: 63 PKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE- 251
+IHRDL N V G + +K+ D G+ + S GT +F +PE
Sbjct: 121 EEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEV 176
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
Y+ D++SFG+ + E+ + + PY N +++ + +++G
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 70/319 (21%), Positives = 128/319 (40%), Gaps = 63/319 (19%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + LG G V+ A D VA ++ + D ++ E+ +++ L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ----SVKHALREIKIIRRLDH 67
Query: 138 DNVVKFY------------KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 185
DN+VK + + +V ++ E + +L ++ ++ + +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH-ARLF 125
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
Q+L GL Y+HS N ++HRDLK N+F+N +KIGD GLA M + +
Sbjct: 126 MYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 246 E-----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT----F----------------- 276
+ +P L Y + +D+++ G CI EM+T F
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 277 ---EYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAK 328
E E + ++ + L ++ + F+E+ L P +RL+A+
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAE 301
Query: 329 DLLKDPFLQV--ENQKEPI 345
+ L P++ + EPI
Sbjct: 302 EALSHPYMSIYSFPMDEPI 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 83/346 (23%), Positives = 133/346 (38%), Gaps = 81/346 (23%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + +G GA V A+D VA K+ Q ++ Y E+ L+K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 138 DNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ F ++ + V ++ EL + NL Q + +D + + Q+L G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI 140
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FM 248
+LHS IIHRDLK NI V + +KI D GLA + S + TP +
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYR 193
Query: 249 APE-LYEEEYNELVDIYSFGMCIL-EMVT----F-------------------------- 276
APE + Y E VDI+S G CI+ EM+ F
Sbjct: 194 APEVILGMGYKENVDIWSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 277 ----------EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASER 324
P + ++F V + K+ Q + + K LV S+R
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLF-PADSEHNKLKASQARDLLSKMLVIDA-SKR 310
Query: 325 LSAKDLLKDPFLQV--ENQKEPICDPL---------KLPIQSLKML 359
+S + L+ P++ V + + P + I+ K L
Sbjct: 311 ISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 23/248 (9%)
Query: 61 EPPDADSDFV-EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVL 116
EP A F E + S + ++++G G V G + VA +K
Sbjct: 34 EPGRAGRSFTREIEAS--RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA---IKALKAG 88
Query: 117 QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 176
+ SE ++ N+++ V + + ++TE +G+L + + H
Sbjct: 89 YTERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 177 -VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM 233
I + R + G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLED 203
Query: 234 QQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 288
A + G P + APE + ++ D++SFG+ + E++ + E PY N
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RD 262
Query: 289 IFKKVTSG 296
+ V G
Sbjct: 263 VISSVEEG 270
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
+ LG G + VY+ + + VA +K D + ++++ E ++K +K
Sbjct: 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHP 69
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYL 196
N+V+ V ++ +ITE T GNL Y ++ + V V+ A QI + YL
Sbjct: 70 NLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE- 251
N IHRDL N V NH VK+ D GL+ M T + G +F APE
Sbjct: 128 EKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPES 183
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
L +++ D+++FG+ + E+ T+ PY +Q+++ +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 22/222 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
+ LG G F V ++ G +VA +K + + + E + L +V
Sbjct: 14 KELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLV 66
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
KFY V K+ + ++TE ++G L Y R K ++ + + G+ +L SH
Sbjct: 67 KFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE-LYEE 255
IHRDL N V VK+ D G+ + S +GT +F APE +
Sbjct: 125 --FIHRDLAARNCLV-DRDLCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYF 180
Query: 256 EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+Y+ D+++FG+ + E+ + + PY N +++ KV+ G
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 73/329 (22%), Positives = 120/329 (36%), Gaps = 82/329 (24%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDD--------VLQLPGDLQKLYSEVHLLKS 134
+G+G F V+KA G +VA +V +++ L+ E+ +L+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----------EIKILQL 72
Query: 135 LKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWAR 187
LK +NVV S + K ++ ++ + F +L + IK +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG-TPE 246
+L+GL Y+H + I+HRD+K N+ + G +K+ D GLA A T
Sbjct: 132 MLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 247 -----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT----------------------- 275
+ PEL E +Y +D++ G CI+ EM T
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247
Query: 276 ---------FEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASE 323
Y Y + + +KV +K DP I+K LV PA +
Sbjct: 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR----DPYALDLIDKLLVLDPA-Q 302
Query: 324 RLSAKDLLKDPFLQVENQKEPICDPLKLP 352
R+ + D L F D +
Sbjct: 303 RIDSDDALNHDFF---WSDPMPSDLKGML 328
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 59/305 (19%), Positives = 121/305 (39%), Gaps = 61/305 (20%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
Y ++ G+G + V++A + +V +K P +K+ E+ +L++L+
Sbjct: 37 DYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLR 88
Query: 137 D-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
N++ D +T ++ E + + +Q + + DI+ +IL L Y
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY---MYEILKALDY 145
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPE- 251
HS I+HRD+K N+ ++ H ++++ D GLA Q+ R + + F PE
Sbjct: 146 CHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPEL 201
Query: 252 -LYEEEYNELVDIYSFGMCIL-EMVT---------------------------FEYPYSE 282
+ + Y+ +D++S G C+L M+ ++Y
Sbjct: 202 LVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 283 CKNPAQIF--------KKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLK 332
F +K + + P+ F++K L RL+A++ ++
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ-SRLTAREAME 319
Query: 333 DPFLQ 337
P+
Sbjct: 320 HPYFY 324
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 35/291 (12%)
Query: 54 SGMLGTAEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKID 113
SG++ D ++ E G Y R ++G+G VY+A D VA +K
Sbjct: 12 SGLVPRGSHMDGTAESREGTQFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVA---LK-- 65
Query: 114 DVL--QLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 168
++ L D ++ E L++ +VV + D + V+M L +L
Sbjct: 66 -LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM--RLINGVDLA 122
Query: 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228
++ + RQI L H+ HRD+K +NI V+ + + D G
Sbjct: 123 AMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFG 179
Query: 229 LAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCIL-EMVTFEYPYSEC 283
+A A + +GT +MAPE + DIY+ C+L E +T PY
Sbjct: 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPYQG- 237
Query: 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDP 334
+ + + I S P I A + + A+ + K+P
Sbjct: 238 DQLSVMGAHINQAIPRPSTV---RPGIP--------VAFDAVIARGMAKNP 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ +G+G F V++ + VA +K +K E ++
Sbjct: 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQF 73
Query: 136 KDDNVVKFYK--SWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHG 192
++VK + + V +I EL T G LR + + K ++D+ + +A Q+
Sbjct: 74 DHPHIVKLIGVIT-----ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMA 249
L YL S +HRD+ N+ V+ N VK+GD GL+ M+ T P ++MA
Sbjct: 129 LAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 250 PE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
PE + + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 79 VRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ +G+G F V++ E + VA +K +K E ++
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLV 194
++VK + V +I EL T G LR + + K +D+ + +A Q+ L
Sbjct: 449 DHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT--P-EFMAPE 251
YL S +HRD+ N+ V+ N VK+GD GL+ M+ T P ++MAPE
Sbjct: 506 YLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG 608
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 61/359 (16%), Positives = 123/359 (34%), Gaps = 103/359 (28%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG G+F V + FD +G A +V D + E+ ++K L N++K
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--------RYKNRELDIMKVLDHVNIIK 64
Query: 143 ----FYKSWVDDKKKT--------------------------------VNMITELFTS-- 164
FY + ++ K +N+I E
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 165 -GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223
L+ + + +++ + +I + Q+ + ++HS I HRD+K N+ VN +K
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182
Query: 224 IGDLGLAIAMQQPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL 271
+ D G A+ +I + E APEL EY +D++S G C+
Sbjct: 183 LCDFGS--------AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVF 232
Query: 272 -EMVTFE--YPYSECKN------------PAQIFKKVTSG--------IKPASLAKV--- 305
E++ + + + + ++ +K K+
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 306 -NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPLKLPIQSLKML 359
+E+ L P R++ + + PF + + + + P + +
Sbjct: 293 GTPSLAIDLLEQILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 20/230 (8%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
D V+GKG F VY I+ A +K + ++ E L++ L
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLV 194
NV+ + + +++ G+L Q+ R +N +K + ++ Q+ G+
Sbjct: 80 NHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEF----M 248
YL +HRDL N ++ + VK+ D GLA I ++ +
Sbjct: 139 YLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
A E L + D++SFG+ + E++T PY + + G
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQG 244
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 22/226 (9%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+ + + LG G F V ++ G +VA +K + + E ++ +L
Sbjct: 26 LTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSH 78
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYL 196
+ +V+ Y V K++ + +ITE +G L Y R+ + + + + + YL
Sbjct: 79 EKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF----MAPE- 251
S +HRDL N V + G VK+ D GL+ + S +G+ +F PE
Sbjct: 137 ESKQ--FLHRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEV 192
Query: 252 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
L +++ DI++FG+ + E+ + + PY N ++ + + G
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 75/333 (22%), Positives = 134/333 (40%), Gaps = 63/333 (18%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY +G+GA+ V A+D + VA +K + Q+ E+ +L +
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 138 DNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
+N++ ++ ++ K V ++ +L + +L + K + I + QIL GL
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLK 142
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMA 249
Y+HS N ++HRDLK N+ +N ++KI D GLA + T + A
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 250 PE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKN------------PAQIFKK 292
PE L + Y + +DI+S G CIL EM++ +P + +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 293 VTS-----------GIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 336
+ + ++ D + ++K L P +R+ + L P+L
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAHPYL 317
Query: 337 QV--ENQKEPICDPL--------KLPIQSLKML 359
+ + EPI + LP + LK L
Sbjct: 318 EQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 350
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 73/381 (19%), Positives = 133/381 (34%), Gaps = 109/381 (28%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y ++G+G++ VY A+D+ VA K++ + + D +++ E+ +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 138 DNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
D +++ Y K + ++ E+ S +L++ K + + IK +L G
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--------------IAMQQPTARS 240
++H IIHRDLK N +N + VK+ D GLA + +
Sbjct: 144 FIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 241 VIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEY--------- 278
+ + APE L +E Y + +DI+S G CI E++
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSHINDPTNR 259
Query: 279 ----PYSECKNPAQIFKKVTSGIK-----------------PASLAKVNDPQIKGFI--- 314
P S C + K L +N P++ +I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 315 -----------------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICD 347
E L P ++R++ L P+L+ + + E
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNP-NKRITIDQALDHPYLKDVRKKKLENFST 378
Query: 348 P---------LKLPIQSLKML 359
+ L L+ +
Sbjct: 379 KKIILPFDDWMVLSETQLRYI 399
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 47/225 (20%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 82 DEVLGKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
D LG G F +V + I+VA +K+ D +++ E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V+ V + + + ++ E+ G L ++ K + + + + Q+ G+ YL
Sbjct: 72 IVRLIG--VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-L 252
N +HRDL N+ + H KI D GL+ + + P ++ APE +
Sbjct: 129 KN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 253 YEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+++ D++S+G+ + E +++ + PY + K ++ + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 20/239 (8%)
Query: 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLY 126
V PS V ++EV+G+G F VY ++ I A VK + + G++ +
Sbjct: 82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFL 138
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 185
+E ++K NV+ + + ++ G+LR + R + N +K + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
Q+ G+ +L S +HRDL N ++ VK+ D GLA M SV
Sbjct: 198 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKT 254
Query: 246 E------FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+MA E L +++ D++SFG+ + E++T PY + I + G
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 30/302 (9%)
Query: 53 LSGMLGTAEPPDADSDFVEKDPSGRYVRYD-----EVLGKGAFKTVYKAFDEFAGIEVAW 107
+ G P + P R R + ++LG+G+F TV A + E A
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 108 SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 167
++ +++ + + E ++ L VK Y ++ DD+K + +G L
Sbjct: 61 KILEKRHIIKE-NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGEL 117
Query: 168 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227
+Y +K + D + + +I+ L YLH IIHRDLK +NI +N ++I D
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDF 174
Query: 228 GLA----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSE 282
G A +Q A S +GT ++++PE L E+ + D+++ G I ++V P+
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-R 233
Query: 283 CKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL------SAKDLLKD 333
N IF+K+ P P+ + +EK LV A++RL L
Sbjct: 234 AGNEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 334 PF 335
PF
Sbjct: 290 PF 291
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 23/248 (9%)
Query: 61 EPPDADSDFV-EKDPSGRYVRYDEVLGKGAFKTVYKA---FDEFAGIEVAWSRVKIDDVL 116
+P +F E D + + D+V+G G F V I VA +K V
Sbjct: 30 DPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVA---IKTLKVG 84
Query: 117 QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 176
+ E ++ N+++ V K K V ++TE +G+L + +KH
Sbjct: 85 YTEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 177 -VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAM 233
+ + R I G+ YL +HRDL NI +N N K+ D GL +
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLED 199
Query: 234 QQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 288
A + G P + +PE + ++ D++S+G+ + E++++ E PY E N
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QD 258
Query: 289 IFKKVTSG 296
+ K V G
Sbjct: 259 VIKAVDEG 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD 138
++ + +GKG F V ++ G +VA VK ++ Q +E ++ L+
Sbjct: 23 LKLLQTIGKGEFGDVMLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHS 74
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYL 196
N+V+ + ++K + ++TE G+L Y + + + ++ + + YL
Sbjct: 75 NLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEF----MAP 250
+N +HRDL N+ V+ ++ K+ D GL + Q T + AP
Sbjct: 134 EGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGK-------LPVKWTAP 183
Query: 251 E-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
E L E++++ D++SFG+ + E+ +F PY + +V G
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 86/351 (24%), Positives = 131/351 (37%), Gaps = 91/351 (25%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY + +G GA V A+D VA K+ Q ++ Y E+ L+K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 138 DNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
N++ F ++ + V ++ EL + NL Q + +D + + Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGI 177
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----- 248
+LHS IIHRDLK NI V + +KI D GL AR+ GT M
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL--------ART-AGTSFMMTPYVV 225
Query: 249 -----APE-LYEEEYNELVDIYSFGMCIL-EMVT----F--------------------- 276
APE + Y E VDI+S G CI+ EMV F
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 277 ---------------EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-- 319
P ++F + K+ Q + + K LV
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVID 343
Query: 320 PASERLSAKDLLKDPFLQV---ENQKEPICDPL--------KLPIQSLKML 359
PA +R+S D L+ P++ V + E + + I+ K L
Sbjct: 344 PA-KRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 59/347 (17%), Positives = 113/347 (32%), Gaps = 84/347 (24%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVA-------WSRVKIDDVLQLPGDLQKLYSEVH 130
Y + G++ V D GI VA S + ++L +++ E+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 131 LLKSLKDDNVVKFY---KSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 186
LL N++ + + + ++TEL + +L Q + + + I+ +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFM 140
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
IL GL LH ++HRDL NI + N ++ I D L AR
Sbjct: 141 YHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNL--------ARE-DTADA 188
Query: 247 FM----------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKV 293
APE + + + +LVD++S G C++ EM + K+
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRK-ALFRGSTFYNQLNKI 246
Query: 294 TSGI---KPASLAKVNDPQIKGFI---------------------------EKCLV--PA 321
+ K + + P + ++ K L P
Sbjct: 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP- 305
Query: 322 SERLSAKDLLKDPFLQV--ENQKEPICDPL-------KLPIQSLKML 359
R+S + L+ P+ + + + + +
Sbjct: 306 QRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKI 352
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/245 (21%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+LGKG F +V +A ++ + ++VA +K D + D+++ E +K
Sbjct: 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEF 82
Query: 136 KDDNVVKFY----KSWVDDKKKTVNMITELFTSGNLRQYRKKHK------NVDIKVIKNW 185
+V K +S + +I G+L + + N+ ++ + +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 245
I G+ YL S N IHRDL N + + V + D GL+ R +
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGD 191
Query: 246 EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 291
+ +A E L + Y D+++FG+ + E++T + PY+ +N A+I+
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYN 250
Query: 292 KVTSG 296
+ G
Sbjct: 251 YLIGG 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-23
Identities = 45/225 (20%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 82 DEVLGKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
D LG G F +V + I+VA +K+ D +++ E ++ L +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHS 198
+V+ + + + ++ E+ G L ++ + + + + Q+ G+ YL
Sbjct: 398 IVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-L 252
N +HR+L N+ + H KI D GL+ + + P ++ APE +
Sbjct: 455 KN--FVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 253 YEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+++ D++S+G+ + E +++ + PY + K P ++ + G
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG+G F V+ VA +K + + E ++K L+ + +V+
Sbjct: 190 VKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQ 243
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHN 200
Y ++ + ++TE + G+L + K K + + + + A QI G+ Y+ N
Sbjct: 244 LYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEE 256
+HRDL+ NI V G + K+ D GLA ++ TAR P ++ APE
Sbjct: 301 --YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/249 (24%), Positives = 104/249 (41%), Gaps = 24/249 (9%)
Query: 61 EPPDADSDFV-EKDPSGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDV 115
+P A F E PS V +V+G G F VYK + VA +K
Sbjct: 29 DPNQAVLKFTTEIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKA 83
Query: 116 LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK 175
E ++ N+++ V K K + +ITE +G L ++ ++
Sbjct: 84 GYTEKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKD 141
Query: 176 N-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 232
+ + R I G+ YL + N +HRDL NI V ++ K+ D GL+ +
Sbjct: 142 GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV-NSNLVCKVSDFGLSRVLE 198
Query: 233 MQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPA 287
+ G P + APE + ++ D++SFG+ + E++T+ E PY E N
Sbjct: 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-H 257
Query: 288 QIFKKVTSG 296
++ K + G
Sbjct: 258 EVMKAINDG 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 79/369 (21%), Positives = 136/369 (36%), Gaps = 101/369 (27%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y+ + LGKGA+ V+K+ D G VA KI D Q D Q+ + E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 138 -DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 196
+N+V D + V ++ + + +L + + + + Q++ + YL
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVH-KQYVVYQLIKVIKYL 125
Query: 197 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-------------IAMQQPTARSVIG 243
HS ++HRD+K NI +N VK+ D GL+ +
Sbjct: 126 HSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 244 TPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT----F---------- 276
+ APE L +Y + +D++S G CIL E++ F
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIFPGSSTMNQLE 241
Query: 277 ---------------------------------EYPYSECKNPAQIFKKVTSGIKPASLA 303
E S ++ +K + I P +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 304 KVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP---------LK 350
+ + ++K L P ++R+SA D LK PF+ + +EP CD +K
Sbjct: 302 ---NEEALDLLDKLLQFNP-NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVK 357
Query: 351 LPIQSLKML 359
I + L
Sbjct: 358 HSIDDYRNL 366
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG+G F V+ VA +K + + E ++K L+ + +V+
Sbjct: 273 VKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQ 326
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
Y ++ + ++TE + G+L + K +++ + + A QI G+ Y+ N
Sbjct: 327 LYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEE 256
+HRDL+ NI V G + K+ D GLA ++ TAR P ++ APE
Sbjct: 384 --YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ D++SFG+ + E+ T PY N ++ +V G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 57/301 (18%), Positives = 115/301 (38%), Gaps = 57/301 (18%)
Query: 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSL 135
Y +VLG G V + F++ + A +K + D K EV L
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKMLQDC-------PKARREVELHWRA 67
Query: 136 KD-DNVVKFYKSWVD--DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQIL 190
++V+ + + +K + ++ E G L R + + + + I
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 191 HGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 248
+ YLHS N I HRD+K +N+ + + + +K+ D G
Sbjct: 128 EAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF------------------- 166
Query: 249 APELYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGIKPASLAK 304
A E E+Y++ D++S G I+ ++ YP YS + ++ G
Sbjct: 167 AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--QYEFPN 223
Query: 305 VNDPQI----KGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 359
++ K I L ++R++ + + P++ ++ K P + P+ + ++L
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVL 277
Query: 360 R 360
+
Sbjct: 278 K 278
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 77/330 (23%), Positives = 120/330 (36%), Gaps = 78/330 (23%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY LG G F TV+ A D VA +KI V + E+ LL+ +
Sbjct: 19 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVA---MKI--VRGDKVYTEAAEDEIKLLQRV 72
Query: 136 KD-----------DNVVKFYKS--WVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIK 180
D ++++K V M+ E+ NL KK+++ +
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLI 131
Query: 181 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-----NGNHGEVKIGDLGLAIAMQQ 235
+K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A +
Sbjct: 132 YVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 236 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT----FE------------- 277
+ I T E+ +PE L + DI+S I E++T FE
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 278 -------------YPYSECKNPAQIFK-----KVTSGIKPASLAKV----------NDPQ 309
Y K F + S +K L V +
Sbjct: 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309
Query: 310 IKGFIEKCLV--PASERLSAKDLLKDPFLQ 337
I F+ L P +R A L+ P+L+
Sbjct: 310 ISDFLSPMLQLDP-RKRADAGGLVNHPWLK 338
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 57/255 (22%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHL 131
+ LG+GAF V+ A + VA VK D L D Q+ E L
Sbjct: 17 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVA---VKALKDPTLAARKDFQR---EAEL 70
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----------------K 175
L +L+ +++VKFY V + M+ E G+L ++ + H
Sbjct: 71 LTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+ + + + A QI G+VYL S + +HRDL N V N VKIGD G+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM------ 179
Query: 236 PTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYS 281
+R V T + M PE + ++ D++SFG+ + E+ T+ + P+
Sbjct: 180 --SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 282 ECKNPAQIFKKVTSG 296
+ N ++ + +T G
Sbjct: 238 QLSN-TEVIECITQG 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 46/247 (18%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ LG+G+F VY+ + VA +K + + + +E ++K
Sbjct: 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA---IKTVNEAASMRERIEFLNEASVMK 83
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----------RKKHKNVDIKVIK 183
+VV+ V + + +I EL T G+L+ Y + +
Sbjct: 84 EFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243
A +I G+ YL+++ +HRDL N V + VKIGD G+ R +
Sbjct: 142 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGM--------TRDIYE 190
Query: 244 TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
T + M+PE L + + D++SFG+ + E+ T E PY N Q+
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQV 249
Query: 290 FKKVTSG 296
+ V G
Sbjct: 250 LRFVMEG 256
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ LG GAF VY+ ++ + ++VA VK + D E ++
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIIS 88
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-------KNVDIKVIKNWA 186
N+V+ V + ++ EL G+L+ + ++ ++ + + + A
Sbjct: 89 KFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGT 244
R I G YL ++ IHRD+ N + G KIGD G+A + + + G
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 245 PEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ +GKG F V ++ G +VA VK ++ Q +E ++ L+ N+V+
Sbjct: 199 QTIGKGEFGDVMLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNLVQ 250
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHN 200
+ ++K + ++TE G+L Y + + + ++ + + YL +N
Sbjct: 251 LLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-------FMAPE-L 252
+HRDL N+ V+ ++ K+ D GL + T + + APE L
Sbjct: 310 --FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 358
Query: 253 YEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
E++++ D++SFG+ + E+ +F PY + +V G
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 46/244 (18%), Positives = 102/244 (41%), Gaps = 40/244 (16%)
Query: 79 VRYDEVLGKGAFKTVYKAF---DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ ++LG+G F +V + ++ ++VA +K+D+ Q ++++ SE +K
Sbjct: 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDF 93
Query: 136 KDDNVVKFYKSWVDDKKKTVN---MITELFTSGNLRQYRKKHK------NVDIKVIKNWA 186
NV++ ++ + + +I G+L Y + ++ ++ + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
I G+ YL + N +HRDL N + + V + D GL ++ +
Sbjct: 154 VDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGDY 202
Query: 247 F------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 292
+ +A E L + Y D+++FG+ + E+ T PY +N +++
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDY 261
Query: 293 VTSG 296
+ G
Sbjct: 262 LLHG 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG G F V+ A +VA +K + ++ +E +++K+L+ D +VK
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVK 247
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHN 200
+ K+ + +ITE G+L + K + + K +++ QI G+ ++ N
Sbjct: 248 LHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTP-EFMAPE-LYEEE 256
IHRDL+ NI V+ + KI D GLA ++ TAR P ++ APE +
Sbjct: 305 --YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 257 YNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ D++SFG+ ++E+VT+ PY NP ++ + + G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 46/194 (23%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
M+ +L G+LR + +++ + + +K + +++ L YL + IIHRD+K DNI ++
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD 149
Query: 217 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCIL 271
HG V I D +A + + T ++ GT +MAPE++ Y+ VD +S G+
Sbjct: 150 -EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 272 EMVT----FEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASER 324
E++ + S + +I + + P++ ++ ++K L P +R
Sbjct: 209 ELLRGRRPYHIRSST--SSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 325 L-SAKDLLKDPFLQ 337
D+ P++
Sbjct: 263 FSQLSDVQNFPYMN 276
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 62/246 (25%), Positives = 119/246 (48%), Gaps = 16/246 (6%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF 143
LG G+F V + +G A + V++L ++ +E +L+++ +VK
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFPFLVKL 106
Query: 144 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 203
S+ D+ + M+ E G + + ++ + +A QI+ YLHS + +
Sbjct: 107 EFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--L 162
Query: 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVD 262
I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVD 220
Query: 263 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP 320
++ G+ I EM P+ P QI++K+ SG ++ P+ +K + L
Sbjct: 221 WWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHF----SSDLKDLLRNLLQV 275
Query: 321 -ASERL 325
++R
Sbjct: 276 DLTKRF 281
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-22
Identities = 76/336 (22%), Positives = 124/336 (36%), Gaps = 82/336 (24%)
Query: 80 RY--DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
RY +V+GKG+F V KA+D VA +K+ V ++ E+ +L+ L+
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVA---LKM--VRNEKRFHRQAAEEIRILEHLRK 152
Query: 138 D------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQI 189
NV+ + M EL S NL + KK+K + +++ +A I
Sbjct: 153 QDKDNTMNVIHML-ENFTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 248
L L LH + IIH DLK +NI +K+ D G + Q + I + +
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYR 266
Query: 249 APE-LYEEEYNELVDIYSFGMCIL-EMVT------------------------------- 275
APE + Y +D++S G CIL E++T
Sbjct: 267 APEVILGARYGMPIDMWSLG-CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 276 -------FE---YPYSECKNPAQIFKKVTSGIKP---------------ASLAKVNDPQI 310
YP V +G + +L +DP
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 311 KGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 345
F+++CL + R++ L+ P+L+ K P
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPT 421
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 83 EVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
E LG G F V+ + G +VA +K + +E +L+K L+ +V
Sbjct: 19 ERLGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLV 71
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSH 199
+ Y + + +ITE +G+L + K + + + K + A QI G+ ++
Sbjct: 72 RLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP-EFMAPE-LYEE 255
N IHRDL+ NI V+ KI D GLA I + TAR P ++ APE +
Sbjct: 129 N--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 256 EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
+ D++SFG+ + E+VT PY NP ++ + + G
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 52/253 (20%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
VR+ E LG+ F VYK VA +K ++ E L
Sbjct: 11 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVA---IKTLKDKAEGPLREEFRHEAMLRA 67
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNV 177
L+ NVV V K + ++MI + G+L ++ +
Sbjct: 68 RLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 178 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237
+ + QI G+ YL SH+ ++H+DL N+ V VKI DLGL
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLF------- 175
Query: 238 ARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 283
R V + MAPE + +++ DI+S+G+ + E+ ++ PY
Sbjct: 176 -REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 284 KNPAQIFKKVTSG 296
N + + + +
Sbjct: 235 SN-QDVVEMIRNR 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 28/238 (11%)
Query: 79 VRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ LG GAF VY+ ++ + ++VA VK + D E ++
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIIS 129
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-------NVDIKVIKNWA 186
N+V+ V + ++ EL G+L+ + ++ + ++ + + + A
Sbjct: 130 KFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGT 244
R I G YL ++ IHRD+ N + G KIGD G+A + + G
Sbjct: 188 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 245 PEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
M PE E + D +SFG+ + E+ + PY N ++ + VTSG
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG 302
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 40/246 (16%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHL 131
+ LG+GAF V+ A E + VA VK + Q E L
Sbjct: 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVA---VKALKEASES---ARQDFQREAEL 96
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH---------------KN 176
L L+ ++V+F+ V + + + M+ E G+L ++ + H
Sbjct: 97 LTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
+ + + A Q+ G+VYL + +HRDL N V VKIGD G++ +
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYST 211
Query: 237 TARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIF 290
V G M PE + ++ D++SFG+ + E+ T+ + P+ + N +
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAI 270
Query: 291 KKVTSG 296
+T G
Sbjct: 271 DCITQG 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 54/256 (21%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ + + LG GAF V +A A + VA +K L + + L SE+ +L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT---EREALMSELKVLS 81
Query: 134 SLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN-------- 184
L + N+V + V ITE G+L + ++ ++ I +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 185 ----------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
++ Q+ G+ +L S N IHRDL NI + KI D GL
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGR-ITKICDFGL----- 191
Query: 235 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
AR + + MAPE ++ Y D++S+G+ + E+ + PY
Sbjct: 192 ---ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 281 SECKNPAQIFKKVTSG 296
++ +K + G
Sbjct: 249 PGMPVDSKFYKMIKEG 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 6e-21
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216
I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 217 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 274
HG V+I DLGLA + + +GT +MAPE Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 275 TFEYPY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL-----S 326
P+ + K+ +I + + L P+++ +E L + RL
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 327 AKDLLKDPF 335
A+++ + PF
Sbjct: 444 AQEVKESPF 452
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 51/254 (20%)
Query: 79 VRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
++ + LG+GAF V +A VA +K + + L SE+ +L
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILI 85
Query: 134 SL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN-------- 184
+ NVV + + +I E GNL Y + +N +
Sbjct: 86 HIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 185 --------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236
++ Q+ G+ +L S IHRDL NI ++ + VKI D GL
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL------- 194
Query: 237 TARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSE 282
AR + P++ MAPE +++ Y D++SFG+ + E+ + PY
Sbjct: 195 -ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 283 CKNPAQIFKKVTSG 296
K + +++ G
Sbjct: 254 VKIDEEFCRRLKEG 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 60/287 (20%), Positives = 121/287 (42%), Gaps = 27/287 (9%)
Query: 67 SDFVEKDPSGRYVRYD----EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
D + K R D +V+G+GAF V + A + ++++ D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDS 113
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 182
+ E ++ VV+ + ++ DD+ + M+ E G+L + V K
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKWA 170
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TAR 239
+ + +++ L +HS IHRD+K DN+ ++ G +K+ D G + M +
Sbjct: 171 RFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCD 227
Query: 240 SVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKV 293
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y++ + + K+
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTYSKI 285
Query: 294 TSGIKPASLAKVND--PQIKGFIEKCLVPASERL---SAKDLLKDPF 335
+ + ND + K I L RL +++ + F
Sbjct: 286 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 50/252 (19%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+++ + LG GAF V +A E A ++VA +K + + L SE+ ++
Sbjct: 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSELKIMS 104
Query: 134 SLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKN------- 184
L +N+V V +ITE G+L + R+K + ++
Sbjct: 105 HLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 185 ------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
++ Q+ G+ +L S N IHRD+ N+ + N KIGD GL A
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL--------A 211
Query: 239 RSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECK 284
R ++ + MAPE +++ Y D++S+G+ + E+ + PY
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 285 NPAQIFKKVTSG 296
++ +K V G
Sbjct: 272 VNSKFYKLVKDG 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 60/261 (22%)
Query: 79 VRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ + LG+G F V KA VA VK+ P +L+ L SE ++LK
Sbjct: 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVA---VKMLKENASPSELRDLLSEFNVLK 81
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN--------- 184
+ +V+K Y + + +I E G+LR + ++ + V + +
Sbjct: 82 QVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 185 ---------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
+A QI G+ YL ++HRDL NI V ++KI D GL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL 196
Query: 230 AIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
+R V + MA E L++ Y D++SFG+ + E+VT
Sbjct: 197 --------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 277 -EYPYSECKNPAQIFKKVTSG 296
PY ++F + +G
Sbjct: 249 GGNPYPGIPP-ERLFNLLKTG 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 52/261 (19%), Positives = 92/261 (35%), Gaps = 60/261 (22%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ Y +G+GAF V++A VA VK+ E L+
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMA 105
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW-------- 185
+ N+VK V K + ++ E G+L ++ + + + +
Sbjct: 106 EFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 186 ----------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
ARQ+ G+ YL +HRDL N V N VKI D GL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGL 220
Query: 230 AIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
+ R++ + M PE ++ Y D++++G+ + E+ ++
Sbjct: 221 S--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 277 -EYPYSECKNPAQIFKKVTSG 296
PY + ++ V G
Sbjct: 273 GLQPYYGMAH-EEVIYYVRDG 292
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 55/256 (21%)
Query: 79 VRYDEVLGKGAFKTVYKA-------FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+ + LG+GAF V A + VA VK+ DL L SE+ +
Sbjct: 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSDLVSEMEM 93
Query: 132 LKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN------ 184
+K + N++ + + +I E + GNLR+Y + + ++ +
Sbjct: 94 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 185 ----------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
Q+ G+ YL S IHRDL N+ V N+ +KI D GL
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL----- 203
Query: 235 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
AR + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 204 ---ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 281 SECKNPAQIFKKVTSG 296
++FK + G
Sbjct: 261 PGIPV-EELFKLLKEG 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 55/256 (21%)
Query: 79 VRYDEVLGKGAFKTVYKA-------FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+ + LG+G F V A + VA VK+ DL L SE+ +
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSDLVSEMEM 139
Query: 132 LKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN------ 184
+K + N++ + + +I E + GNLR+Y + + ++ +
Sbjct: 140 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 185 ----------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
Q+ G+ YL S IHRDL N+ V N+ +KI D GLA
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA---- 250
Query: 235 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 251 ----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 281 SECKNPAQIFKKVTSG 296
++FK + G
Sbjct: 307 PGIPV-EELFKLLKEG 321
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 59/261 (22%)
Query: 79 VRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
+ + +VLG GAF V A I+VA +K + + L SE+ ++
Sbjct: 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSELKMMT 103
Query: 134 SLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN-------- 184
L +N+V +I E G+L Y + + +
Sbjct: 104 QLGSHENIVNLL-GACTLSGPIY-LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 185 ---------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229
+A Q+ G+ +L + +HRDL N+ V VKI D GL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL 218
Query: 230 AIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
AR ++ + MAPE L+E Y D++S+G+ + E+ +
Sbjct: 219 --------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 277 -EYPYSECKNPAQIFKKVTSG 296
PY A +K + +G
Sbjct: 271 GVNPYPGIPVDANFYKLIQNG 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 66/265 (24%), Positives = 131/265 (49%), Gaps = 29/265 (10%)
Query: 84 VLGKGAFKTVY----KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
LG G+F V+ + + ++V +K + V++L ++ E +L +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRL-KQVEHTNDERLMLSIVTHPF 67
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+++ + ++ D ++ + MI + G L +K + V K +A ++ L YLHS
Sbjct: 68 IIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYN 258
+ II+RDLK +NI ++ N G +KI D G A + T ++ GTP+++APE + + YN
Sbjct: 126 D--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYN 181
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEK 316
+ +D +SFG+ I EM+ P+ N + ++K+ + ++ P + +K + +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFF----NEDVKDLLSR 236
Query: 317 CLVP-ASERL-----SAKDLLKDPF 335
+ S+RL +D+ P+
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY D ++GKG+F V KA+D VA +KI + L + EV LL+ +
Sbjct: 54 DRY-EIDSLIGKGSFGQVVKAYDRVEQEWVA---IKI--IKNKKAFLNQAQIEVRLLELM 107
Query: 136 KDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWAR 187
+V + + + + ++ E+ S NL + V + + + +A+
Sbjct: 108 NKHDTEMKYYIVHLKRHF--MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 246
Q+ L++L + IIH DLK +NI N +KI D G + + Q I +
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-QYIQSRF 223
Query: 247 FMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 275
+ +PE L Y+ +D++S G CIL EM T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 54/240 (22%), Positives = 99/240 (41%), Gaps = 31/240 (12%)
Query: 79 VRYDEVLGKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+++ +V+G+G F V KA + ++ A R+K D + E+ +L L
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLG 83
Query: 137 D-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW---------- 185
N++ + + + + E GNL + +K + ++
Sbjct: 84 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 186 ------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 239
A + G+ YL IHRDL NI V N+ KI D GL+ + +
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKK 198
Query: 240 SVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 296
++ P +MA E L Y D++S+G+ + E+V+ PY A++++K+ G
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 184 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQP 236
AR +++ + +H + +HRD+K DNI ++ +G +++ D G +
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231
Query: 237 TARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYP-YSECKNPAQI 289
+ +GTP++++PE+ + Y D +S G+C+ EM+ E P Y+E + +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVET 289
Query: 290 FKKVTSGIK----PASLAKVNDPQIKGFIEKCLVPASERLSAKD 329
+ K+ + + P + V K I + + RL
Sbjct: 290 YGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNG 332
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219
++ ++ + + + QI+ GL +LH N II+RDLK +N+ ++ +
Sbjct: 271 DIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DD 325
Query: 220 GEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 276
G V+I DLGLA + Q + GTP FMAPE L EEY+ VD ++ G+ + EM+
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 277 EYPY---SECKNPAQIFKKVTSG 296
P+ E ++ ++V
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQ 408
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 55/256 (21%)
Query: 79 VRYDEVLGKGAFKTVYKA-------FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+ + LG+GAF V A +VA +K D + DL L SE+ +
Sbjct: 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEM 127
Query: 132 LKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN------ 184
+K + N++ + + +I E + GNLR+Y + + ++ N
Sbjct: 128 MKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 185 ----------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234
A Q+ G+ YL S IHRDL N+ V ++ +KI D GLA
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA---- 238
Query: 235 QPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 280
R + + MAPE L++ Y D++SFG+ + E+ T PY
Sbjct: 239 ----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 281 SECKNPAQIFKKVTSG 296
++FK + G
Sbjct: 295 PGVPV-EELFKLLKEG 309
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 184 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 236
AR +I+ + +H +HRD+K DNI ++ G +++ D G + ++
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218
Query: 237 TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPA 287
+ +GTP++++PE+ Y D ++ G+ EM + P Y++ + A
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STA 276
Query: 288 QIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVPASERL---SAKDLLKDPF 335
+ + K+ + SL V++ + + FI++ L P RL A D PF
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 243
A +I L YLHS N I++RDLK +NI ++ G + + D GL T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A+++ + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 303 AKVNDPQIKGFIEKCLV--PASERLSAKD 329
+ +E L +RL AKD
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 185 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 243
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPA 300
T +MAPE + E Y D ++ G + EM+ + P+ + + ++V + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPE 406
Query: 301 SLAKVNDPQIKGFIEKCLV--PASERL-----SAKDLLKDPF 335
++ PQ + + L PA ERL SA+++ + P
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
+I L +LH II+RDLK +NI +N G VK+ D GL ++ + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296
E+MAPE L +N VD +S G + +M+T P+ +N + K+
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKC 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ ++ A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + +
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMI 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
+I+ GL +LHS I++RDLK DNI ++ + G +KI D G+ M + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 304
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ ++F + +
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM--DNPFYPR 239
Query: 305 VNDPQIKGFIEKCLV--PASERL-SAKDLLKDPF 335
+ + K + K V P +RL D+ + P
Sbjct: 240 WLEKEAKDLLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 34/119 (28%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGT 244
+I+ L +LH II+RD+K +NI ++ ++G V + D GL+ +A + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 245 PEFMAPELYEEE---YNELVDIYSFGMCILEMVT----FEYPYSECKNPAQIFKKVTSG 296
E+MAP++ +++ VD +S G+ + E++T F E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKS 281
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 243
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA 300
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 301 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 335
S++K KG + K +RL +D+ + F
Sbjct: 564 SMSKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 600
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 43/160 (26%), Positives = 85/160 (53%), Gaps = 17/160 (10%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIG 243
+I+ L YLHS + +++RD+K +N+ ++ + G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCG 167
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PA 300
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 301 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 335
+L+ + G ++K +RL AK++++ F
Sbjct: 227 TLSPEAKSLLAGLLKKD---PKQRLGGGPSDAKEVMEHRF 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
+I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 302
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 303 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 335
+K KG + K +RL +D+ + F
Sbjct: 245 SKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 279
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 7/108 (6%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
+I+ L++LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292
+++APE L E Y VD ++ G+ + EM+ P+ E +N +F+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEA 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 63/341 (18%), Positives = 111/341 (32%), Gaps = 94/341 (27%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ +G G F V A VK+ V + + E +LK +
Sbjct: 35 NAF-LVIRKMGDGTFGRVLLCQHIDNKKYYA---VKV--VRNIKKYTRSAKIEADILKKI 88
Query: 136 KDD-----NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQ 188
++D N+VK++ + + +I E +L + ++ I+ IK + +
Sbjct: 89 QNDDINNNNIVKYHGKF--MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG------------------------EVKI 224
IL L YL + + H DLK +NI ++ + +K+
Sbjct: 146 ILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 225 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT------- 275
D G A S+I T ++ APE + ++ D++SFG C+L E+ T
Sbjct: 204 IDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELYTGSLLFRT 261
Query: 276 --------------------------------------FEYPYSECKNPAQIFKKVTSGI 297
+ + E + K V
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC- 320
Query: 298 KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
P + F+ L + R S +LLK FL+
Sbjct: 321 LPLYK-IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 243
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 288
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 243
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 288
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 245
+I+ L YLHS +++RDLK +N+ ++ + G +KI D GL ++ T ++ GTP
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 246 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 302
E++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + P +L
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTL 372
Query: 303 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 335
+ G ++K +RL AK++++ F
Sbjct: 373 GPEAKSLLSGLLKKD---PKQRLGGGSEDAKEIMQHRF 407
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 69/341 (20%), Positives = 124/341 (36%), Gaps = 86/341 (25%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIE-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
RY + LG+GAF V + D AG VA VKI V + + SE+ +L+
Sbjct: 14 ARY-EIVDTLGEGAFGKVVECIDHKAGGRHVA---VKI--VKNVDRYCEAARSEIQVLEH 67
Query: 135 LKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWA 186
L V+ W + ++ EL + + K++ + + I+ A
Sbjct: 68 LNTTDPNSTFRCVQML-EWFEHHGHIC-IVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG------------------EVKIGDLG 228
QI + +LHS+ + H DLK +NI + ++K+ D G
Sbjct: 125 YQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 229 LAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT----------- 275
A + +++ T + APE + +++ D++S G CIL E
Sbjct: 183 SATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTVFPTHDSK 240
Query: 276 --------------------------FEYPYSECKNPAQIFKKVTSGIKP----ASLAKV 305
F + + + + V+ KP V
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 306 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 345
++ I+K L ++R++ ++ LK PF + K+ I
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFDL--LKKSI 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 66/367 (17%), Positives = 125/367 (34%), Gaps = 94/367 (25%)
Query: 70 VEKDPSGRYV---------RY--DEVLGKGAFKTVYKAFDEFAGIE-VAWSRVKIDDVLQ 117
VE D G V RY LG+G F V + D G VA +KI +
Sbjct: 1 VEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVA---LKI--IRN 55
Query: 118 LPGDLQKLYSEVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR 171
+ + E+++LK +K+ V + + + + EL N ++
Sbjct: 56 VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF--NFHGHMCIAFELL-GKNTFEFL 112
Query: 172 KKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----------- 218
K++ + +++ A Q+ H L +LH + + H DLK +NI +
Sbjct: 113 KENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 219 -------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 270
+ +++ D G A +++ T + PE + E + + D++S G CI
Sbjct: 171 CEEKSVKNTSIRVADFGSAT-FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CI 228
Query: 271 L-EMVT----F------------------------------------EYPYSECKNPAQI 289
L E F + E + +
Sbjct: 229 LFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY 288
Query: 290 FKKVTSGIKPASLAK-VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 347
K+ +K L + Q+ + + L ++R++ + L PF +E
Sbjct: 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
Query: 348 PLKLPIQ 354
+ P +
Sbjct: 349 TSRNPSR 355
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 20/96 (20%)
Query: 192 GLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTP 245
GL YLH H +P IIHRD+K NI ++ E +GD GLA M + V GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTI 199
Query: 246 EFMAPELYEEEY------NELVDIYSFGMCILEMVT 275
+AP EY +E D++ +G+ +LE++T
Sbjct: 200 GHIAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 28/216 (12%), Positives = 56/216 (25%), Gaps = 37/216 (17%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLK 133
GRY R G ++A D +VA + + LQ+ S L
Sbjct: 31 GRY-RLLIFHGGVPPLQFWQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+ V + V E G+L++ + + + +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAA 142
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY 253
H + + V+ + G+V + M +
Sbjct: 143 DAAHRAG--VALSIDHPSRVRVSID-GDVVLAYPA---TMPDANPQD------------- 183
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 289
DI G + ++ +P E + +
Sbjct: 184 --------DIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 84 VLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL---YSEVHLLKSLKDDNV 140
+G+G F VYK + VA VK + + E+ ++ + +N+
Sbjct: 38 KMGEGGFGVVYKGYVN--NTTVA---VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVD----IKVIKNWARQILHGL 193
V+ D ++ +G+L + K+ + A G+
Sbjct: 93 VELLGFSSDGDDLC--LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GI 146
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARS--VIGTPEFMA 249
+LH IHRD+K NI ++ KI D GLA T + ++GT +MA
Sbjct: 147 NFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203
Query: 250 PELYEEEYNELVDIYSFGMCILEMVT 275
PE E DIYSFG+ +LE++T
Sbjct: 204 PEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 60/256 (23%), Positives = 96/256 (37%), Gaps = 65/256 (25%)
Query: 58 GTAEPPDADSDFVEKDPSGRYVRYDE------------VLGKGAFKTVYKAF-DEFAGIE 104
T DA S V + ++G G F VYK + G +
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD--GAK 65
Query: 105 VAWSRVKIDDVLQL-PGDLQKL---YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT- 159
VA +K + P Q + +E+ L + ++V + MI
Sbjct: 66 VA---LK-----RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EMILI 113
Query: 160 -ELFTSGNLRQ--YRKKHKNVDIKVIKNW----------ARQILHGLVYLHSHNPPIIHR 206
+ +GNL++ Y + + +W AR GL YLH IIHR
Sbjct: 114 YKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAAR----GLHYLH--TRAIIHR 163
Query: 207 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQP------TARSVIGTPEFMAPELYEEEY-NE 259
D+K NI ++ N KI D G++ + T V GT ++ PE + + E
Sbjct: 164 DVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTLGYIDPEYFIKGRLTE 220
Query: 260 LVDIYSFGMCILEMVT 275
D+YSFG+ + E++
Sbjct: 221 KSDVYSFGVVLFEVLC 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 2e-13
Identities = 87/605 (14%), Positives = 164/605 (27%), Gaps = 183/605 (30%)
Query: 3 LPFEIGGIRFLLDCLRIILRLQTSPFHPQFLKTKNIKPIIAVFFLVAVWFLSGMLGTAEP 62
+ FE G ++ + IL + F F+ + K + +L E
Sbjct: 7 MDFETGEHQY---QYKDILSV----FEDAFVDNFDCKDVQD--------MPKSILSKEE- 50
Query: 63 PDADSDFVEKDP-SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGD 121
D + KD SG + +L K + V K +E I + I + P
Sbjct: 51 --IDHIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107
Query: 122 LQKLYSEVH--------------------------LLKSLKDDNVVKFY------KSW-- 147
+ ++Y E L L+ V K+W
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 148 ---VDDKKKTVNMITELF--TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
K M ++F N +++++ QI H+
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNS-----PETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 203 IIH---------RDLKCDNIFVNG--------NHGEVKIGDLG---LAIAMQQPTARSVI 242
I R L + N N +L L + +
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 243 GTP------EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTS 295
+ + L +E L L+ + P NP ++ S
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSL-----LLKY-LDCRPQDLPREVLTTNPRRL-----S 331
Query: 296 GIKPASL----------AKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQV----ENQ 341
I S+ VN ++ IE L L + + F ++ +
Sbjct: 332 II-AESIRDGLATWDNWKHVNCDKLTTIIESSL----NVLEPAE-YRKMFDRLSVFPPS- 384
Query: 342 KEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP---------- 391
+P L ++ + M + + + SL + S
Sbjct: 385 -------AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPSIYLEL 435
Query: 392 HCPVLEFQRMHKN--NEFRL-RGTKNDDTSVSLT-----------LRIADSSGRVRNIHF 437
+ +H++ + + + + +DD L+ + R+
Sbjct: 436 KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT---- 491
Query: 438 LF---YLD----------SDTALSVAGEMVEQL-DL-------ADHDVAFIAEFIDYLIM 476
LF +LD TA + +G ++ L L D+D + E + I+
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY--ERLVNAIL 549
Query: 477 KLLPG 481
LP
Sbjct: 550 DFLPK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 7e-06
Identities = 80/618 (12%), Positives = 174/618 (28%), Gaps = 184/618 (29%)
Query: 169 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI--FVNG--NHGEVKI 224
+ H + + + + IL + C ++ + E+
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS-------VFEDAFVDNFDCKDVQDMPKSILSKEEID- 52
Query: 225 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEEYNELVDI-YSFGMCILEMVTFEYP 279
+ + + T E+ ++ E++ I Y F ++ +
Sbjct: 53 -HI-----IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF---LMSPIK---- 99
Query: 280 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE 339
+E + P+ + + ND Q+ K V RL L+ L++
Sbjct: 100 -TEQRQPSMMTRMYIEQRDRLY----NDNQV---FAKYNVS---RLQPYLKLRQALLELR 148
Query: 340 NQKEPICDPLKLPIQSLKMLRLPM--SGPSSMDID--SDYKQ----------LSLSTCTE 385
K + I + SG + + +D YK L+L C
Sbjct: 149 PAK-------NVLIDG-------VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 386 SNNGSPHCPVLE-FQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSD 444
VLE Q++ + T D S ++ LRI +R L +
Sbjct: 195 PET------VLEMLQKLL--YQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSKPYE 244
Query: 445 TALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP----SYDYSSSGAL---SFY 497
L V L +V +++ S L F
Sbjct: 245 NCLLV-------LL----NV-----------------QNAKAWNAFNLSCK-ILLTTRFK 275
Query: 498 SVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQ---------- 547
V+ L T+ S P E + ++ QDL P +
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDL-PREVLTTNPRRLS 331
Query: 548 --GENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSY 605
E++ D + + + + I ++S + +E+ +
Sbjct: 332 IIAESIRDG--------LATWDNWKHVNCDKLTTII---ESSLNVLEPAEYRKM-----F 375
Query: 606 KDL-----NGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSL 660
L + ++ + L + + + +++ + K S + + +S+
Sbjct: 376 DRLSVFPPSAHIPTILL-------SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 661 TSSYSSLSLTGKDVDEL-KMEIDA--IEAQYEH-----------WFQELS------KMKE 700
S Y L + ++ L + +D I ++ ++ + + E
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 701 EALEASRK----RWMAKK 714
R++ +K
Sbjct: 489 RMTLFRMVFLDFRFLEQK 506
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 49/438 (11%), Positives = 117/438 (26%), Gaps = 121/438 (27%)
Query: 10 IRFLLDCLRIILR-LQTSPFHPQFLKTKNIKPIIAVFFLVAVW-------FLSG--MLGT 59
I+ + ++ LR L S + L ++ L+ V F +L T
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCL-------LV----LLNVQNAKAWNAFNLSCKILLT 271
Query: 60 AEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP 119
+ + DE + + + + D LP
Sbjct: 272 T----RFKQVTDFLSAATTTHISLDHHSMTLTP-----DEVKSLLLKYLDCRPQD---LP 319
Query: 120 GDLQKLYSEVHLL------KSLKDD-NVVKFYKSWVDDK-KKTVNMITELFTSGNLRQYR 171
++ + +S++D +K DK + + R+
Sbjct: 320 REVLT----TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 172 KK----HKNVDI--KVIKN-WA-------RQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217
+ + I ++ W +++ L H ++ + K I +
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-----HKYSLVEKQPKESTISI-- 428
Query: 218 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFE 277
+ L + ++ ++ + +VD Y+
Sbjct: 429 -P------SIYLELKVKLENEYAL---------------HRSIVDHYNIPKT-------- 458
Query: 278 YPYSECKNPAQ---IFKKVTSGIKPASLAKVND--PQIK---GFIEKCLVPASERLSAKD 329
+ + P + + +K + + F+E+ + S +A
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASG 518
Query: 330 LLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNG 389
+ + Q++ K ICD + P + + L E+
Sbjct: 519 SILNTLQQLKFYKPYICD----------------NDPKYERLVNAILDF-LPKIEENLIC 561
Query: 390 SPHCPVLEFQRMHKNNEF 407
S + +L M ++
Sbjct: 562 SKYTDLLRIALMAEDEAI 579
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 25/127 (19%)
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 243
++ Q+ G+ +L S IHRDL NI ++ + VKI D GL AR +
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYK 245
Query: 244 TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 289
P++ MAPE +++ Y D++SFG+ + E+ + PY K +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 290 FKKVTSG 296
+++ G
Sbjct: 306 CRRLKEG 312
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 37/193 (19%), Positives = 72/193 (37%), Gaps = 39/193 (20%)
Query: 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 144
+G G F +Y AF + A VK++ + L+SE+ + + + +K
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCIK-- 97
Query: 145 KSWVDDKKKTVNMITELFTSG-------------------NLRQYRKKHKNVDIKVIKNW 185
W++ K+ I + SG +L++ ++ +
Sbjct: 98 -KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQL 156
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 235
++L L Y+H + +H D+K N+ + N +V + D GL+ Q+
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 236 PTARSVIGTPEFM 248
+ GT EF
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 79/369 (21%), Positives = 125/369 (33%), Gaps = 118/369 (31%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
GRY LG G F TV+ ++D VA +K+ V + E+ LLKS+
Sbjct: 37 GRY-HVIRKLGWGHFSTVWLSWDIQGKKFVA---MKV--VKSAEHYTETALDEIRLLKSV 90
Query: 136 KDDNVVKFYKSWV----DD-KKKTVN-----MITELFTSGNLRQYRKKHKN--VDIKVIK 183
++ + + V DD K VN M+ E+ +L ++ K + + +K
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLPLPCVK 149
Query: 184 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---------------------------- 215
+Q+L GL YLH+ IIH D+K +NI +
Sbjct: 150 KIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 216 --------------------NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYE 254
N +VKI DLG A + + I T ++ + E L
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVLIG 267
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPY------------------------------SECK 284
YN DI+S E+ T +Y + K
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 285 NPAQIFK-----KVTSGIKPASLAKV----------NDPQIKGFIEKCLV--PASERLSA 327
+ F K + +KP L +V F+ L P +R +A
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP-EKRATA 386
Query: 328 KDLLKDPFL 336
+ L+ P+L
Sbjct: 387 AECLRHPWL 395
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 42/186 (22%), Positives = 69/186 (37%), Gaps = 25/186 (13%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY R +G G+F +Y D AG EVA + +L+ E + K +
Sbjct: 9 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMM 61
Query: 136 KD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGL 193
+ + + M+ EL +L + +K + A Q++ +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 194 VYLHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLAIAMQQP---------TARSVI 242
Y+HS N IHRD+K DN + V I D GLA + +++
Sbjct: 119 EYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 243 GTPEFM 248
GT +
Sbjct: 177 GTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 31/159 (19%), Positives = 63/159 (39%), Gaps = 16/159 (10%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
++ R +G G+F +Y + EVA + +L E + + L
Sbjct: 7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKIYRIL 59
Query: 136 KD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGL 193
+ + V+ ++ +L +L + + +K + A Q+++ +
Sbjct: 60 QGGTGIPNVRWFGVEGDYNV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 194 VYLHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLA 230
++HS + +HRD+K DN + +V I D GLA
Sbjct: 117 EFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 4e-10
Identities = 56/333 (16%), Positives = 96/333 (28%), Gaps = 76/333 (22%)
Query: 69 FVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK---- 124
F P+ + R E +G+G F V++ + VA + I+ + G QK
Sbjct: 13 FSHCLPTEKLQRC-EKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 125 LYSEVHLLKSLKD---------DNVVKFYKSWV----------------DDKKKTVNMIT 159
+ E+ + K L + + + K + N
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 160 ELFTSGNLRQY-----------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 208
+ F L + + K + K+ Q+ L + HRDL
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDL 188
Query: 209 KCDNIFVN------------------GNHG-EVKIGDLGLAIAMQQPTARSVIGTPEFMA 249
N+ + + G +V I D L+ + V+ M
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---VVFCDVSMD 245
Query: 250 PELYEEEYNELVDIYSFGMCILEMVTFEY-PYSECK-----NPAQIFKKVTSGIKPASLA 303
+L+ + + DIY EY PYS + +
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305
Query: 304 KVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 336
K +I+ F L + SA DLL L
Sbjct: 306 KQIKRKIQEFHRTMLNFS----SATDLLCQHSL 334
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 26/161 (16%), Positives = 60/161 (37%), Gaps = 18/161 (11%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
Y + +G+G+F +++ + +VA D +L E K L
Sbjct: 10 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLL 62
Query: 136 KD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGL 193
+ Y + ++ +L +L + +K + A+Q+L +
Sbjct: 63 AGCTGIPNVYYFGQEGLHNV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLA 230
+H + +++RD+K DN + + + + + D G+
Sbjct: 120 QSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 18/161 (11%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ R + +G G F + + + VA +K++ + +L+ E K L
Sbjct: 9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPM---KSRAPQLHLEYRFYKQL 61
Query: 136 KD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGL 193
D + + Y K M+ EL +L + +K + A Q++ +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 194 VYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGDLGLA 230
Y+HS N +I+RD+K +N + N + I D LA
Sbjct: 119 EYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 31/203 (15%), Positives = 65/203 (32%), Gaps = 30/203 (14%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSR-----VKIDDVLQLPGDLQKLY 126
D SGR + + +Y+A + + +K+D + Q +
Sbjct: 37 TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFF 96
Query: 127 SEVHL---------LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK--HK 175
L S + V K ++ +L+
Sbjct: 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGR-SLQSALDVSPKH 154
Query: 176 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---- 230
+ + + A ++L L +LH + +H ++ +NIFV+ + +V + G A
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 231 -----IAMQQPTARSVIGTPEFM 248
+A + + G EF+
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 44/204 (21%), Positives = 74/204 (36%), Gaps = 39/204 (19%)
Query: 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ + + +G+G F +Y A D + V + V P D L++E+ +
Sbjct: 34 AAAW-KVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVE--PSDNGPLFTELKFYQR 89
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSG----NLRQYR----------------KKH 174
++ W+ +K + + + SG N + YR
Sbjct: 90 AAKPEQIQ---KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 175 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA--- 230
K K + + +IL L Y+H H +H D+K N+ +N N +V + D GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 231 ------IAMQQPTARSVIGTPEFM 248
A R GT EF
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-05
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 407 FRLRGTKNDD---TSVSLTLRIADS---SGRVRN---IHFLFYLDSDTALSVAGEMVEQL 457
R+ + DD ++ L LRI D G+ ++ I F F L+ D VA EMVE
Sbjct: 11 VRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESG 70
Query: 458 DLADHDVAFIAEFIDYLIMKLLP 480
+ + D +A+ I + +
Sbjct: 71 YVCEGDHKTMAKAIKDRVSLIKR 93
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 719 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.5 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.01 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.5 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.32 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 86.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.27 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=514.27 Aligned_cols=267 Identities=52% Similarity=0.951 Sum_probs=243.1
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
...+.|||+++.+.||+|+||+||+|.++.+|..||+|++..... .....+++.+|+.+|++|+|||||+++++|.+.
T Consensus 20 ~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 345678999999999999999999999999999999999975543 245668899999999999999999999998652
Q ss_pred --CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 151 --KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 151 --~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
....+|+|||||++|+|.+++.+.+.+++..++.|++||+.||+|||+++++||||||||+||||+...|.+||+|||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence 345689999999999999999999999999999999999999999999998999999999999998656899999999
Q ss_pred hhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 229 LAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 229 lA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
+|+........+.+|||.|||||++.+.|+.++|||||||++|||+||+.||.+..+..+++..+..+..|..++...++
T Consensus 178 la~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 178 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred CCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 99877666677889999999999999899999999999999999999999999878888999999998888888888899
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999998 89999999999999999853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=479.09 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=228.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|++|+|||||+++++|.+. ..+|+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yi 109 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 109 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEE
Confidence 5899999999999999999999999999999998654322 24567899999999999999999999998765 46999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCC
Confidence 9999999999999999999999999999999999999999999 9999999999999855 79999999999876432
Q ss_pred ---CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 237 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 237 ---~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
...+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~d 263 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARD 263 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHH
Confidence 3456799999999999875 599999999999999999999999987 678888888887643 345567899999
Q ss_pred HHHHhcC-CCCCCCCHHH------HHcCccCccccCCCC
Q 005017 313 FIEKCLV-PASERLSAKD------LLKDPFLQVENQKEP 344 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~e------LL~hpf~~~~~~~~~ 344 (719)
||.+||. ||.+|||++| |++||||+..++...
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 9999998 8999999887 689999998877653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=479.82 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=221.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.+|++.+.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|+.+|++|+|||||+++++|.+.+ .+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 457888999999999999999999999999999986543 23356889999999999999999999997664 599
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|||||+||+|.+++.+ +.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ |.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCceecCCC
Confidence 99999999999999875 56999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred --CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCChHHHH
Q 005017 237 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKG 312 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~l~~ 312 (719)
...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+ .+..+++..+..+..+. ......++++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 3457899999999999875 599999999999999999999999987 56777777777664432 234456899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 9999998 89999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-56 Score=481.28 Aligned_cols=253 Identities=23% Similarity=0.440 Sum_probs=217.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+++.+|+.+|++|+|||||+++++|.+. ..+|+
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yi 100 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYI 100 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEE
Confidence 57888999999999999999999999999999986543 245678899999999999999999999998765 45999
Q ss_pred EEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|||||+||+|.+++...+ .+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ |.+||+|||+|+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence 999999999999997543 5799999999999999999999999 9999999999999855 7999999999987654
Q ss_pred C--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+..+. .+...++++++
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~ 255 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHH
Confidence 3 2346789999999999875 599999999999999999999999987 57778888888776553 44567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999998 89999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=464.94 Aligned_cols=251 Identities=25% Similarity=0.484 Sum_probs=207.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+++.+|+++|++|+|||||++++++.+. ..+|+
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 90 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIM 90 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 3688899999999999999999999999999998654332 34567899999999999999999999998755 46999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+ +|+|.+++.+++.+++..++.|++||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|+.....
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCeecCCCC
Confidence 99999 7899999999999999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
...+.+||+.|||||++.+. | +.++|||||||++|||+||+.||.+ .+..++++.+..+..+ ++...++++++||
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 243 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAAGLI 243 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence 34567899999999998754 4 6899999999999999999999987 6778888888876543 4566789999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+||. ||.+|||+.|+|+||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 99998 8999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=472.20 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=217.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.+.||+|+||+||+|.+. .+++.||+|+++...... ....++.+|+++|++|+|||||++++++.+. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTE--G 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEET--T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--C
Confidence 46899999999999999999874 468899999997544322 2234678899999999999999999998765 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceec
Confidence 59999999999999999999999999999999999999999999999 9999999999999855 79999999999765
Q ss_pred cC--CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 QQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~~--~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.. ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 253 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEA 253 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHH
Confidence 43 23456789999999999874 599999999999999999999999987 677788888877644 3456678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHHcCccCccccCCC
Q 005017 311 KGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~ 343 (719)
++||.+||. ||.+||| ++|+++||||+..++..
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 999999998 8999998 58999999999776543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=482.69 Aligned_cols=252 Identities=29% Similarity=0.530 Sum_probs=221.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.+|++.+.||+|+||+||+|.++.+|+.||+|++..... ...+.+.+|+.+|++|+|||||+++++|.+.+ .+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEE
Confidence 457888999999999999999999999999999986542 23456889999999999999999999997654 599
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|||||+||+|.++++. +.+++..++.|++||+.||+|||+++ ||||||||+||||+.+ |.+||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccceECCCC
Confidence 99999999999999864 56999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred --CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCChHHHH
Q 005017 237 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKG 312 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~l~~ 312 (719)
...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+++..+..+..+. ......++++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 3467899999999999875 599999999999999999999999987 56777777777664432 234456899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
||.+||. ||.+|||+.|||+||||+..
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 9999998 99999999999999999854
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=467.21 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=213.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
...+|.+.++||+|+||+||+|.++.+|+.||+|+++.... ..+|+.+|++|+|||||++++++.+. ..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CE
Confidence 34578899999999999999999999999999999985432 13699999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+|||||+||+|.+++++.+.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+...+||+|||+|+.+.
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 8999999999999999999899999999999999999999999999 99999999999998663369999999998764
Q ss_pred CC-------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-CccccC
Q 005017 235 QP-------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKV 305 (719)
Q Consensus 235 ~~-------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~ 305 (719)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+. +..+++..+..+..+ ..++..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 281 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPS 281 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHHSCCGGGGSCTT
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHcCCCCchhcCcc
Confidence 32 1234689999999998875 5999999999999999999999999873 444555566655443 345667
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHH-------------HcCccCcc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDL-------------LKDPFLQV 338 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eL-------------L~hpf~~~ 338 (719)
.++++++||.+||. ||.+|||+.|| |+|||++.
T Consensus 282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 78999999999998 89999999998 56888864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=452.51 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=201.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC------
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK------ 152 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~------ 152 (719)
|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++|+|||||+++++|.+.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 788999999999999999999999999999997653 24456789999999999999999999999976543
Q ss_pred ----CceeEEEecccCCChhHHhhhccc---ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 153 ----KTVNMITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 153 ----~~l~lV~Ey~~gGsL~~~L~~~~~---l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
.++|+|||||++|+|.+++..... .++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEc
Confidence 247899999999999999987654 445678899999999999999999 9999999999999865 799999
Q ss_pred ecchhhhccCCC--------------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHH
Q 005017 226 DLGLAIAMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 290 (719)
Q Consensus 226 DFGlA~~~~~~~--------------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~ 290 (719)
|||+|+.+.... ..+.+||+.|||||++.+ .|+.++|||||||++|||++ ||..........
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 999998764321 124579999999998875 59999999999999999996 886533333444
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+.....|+.+ ...++.+++||.+||. ||.+|||+.|+|+||||+..+
T Consensus 238 ~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 555555554433 3345788999999998 899999999999999998544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=457.91 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=214.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC----C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----K 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----~ 151 (719)
+..|++.+.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+++|++|+|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 456889999999999999999999999999999986433 2345567889999999999999999999987543 3
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...+|+|||||. |+|.+++.+.+.+++..++.|++||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecceee
Confidence 357899999995 689999999999999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccC------CCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCCc
Q 005017 232 AMQQ------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPAS 301 (719)
Q Consensus 232 ~~~~------~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~~ 301 (719)
.+.. ....+.+||+.|||||++.+ .|+.++||||+||++|||+||++||.+ .+....+..+.. +..+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g-~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG-KNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC-SSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC-CCHHHHHHHHHHhcCCCChH
Confidence 6532 23456799999999998764 479999999999999999999999987 444444444432 111110
Q ss_pred ---------------------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 302 ---------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 302 ---------------------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.....++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 112357899999999998 99999999999999999853
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=439.34 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=211.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..+.+.+.||+|+||+||+|.+. .+|..||||+++.. .....++|.+|+++|++|+|||||++++++.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-
Confidence 46889999999999999999864 36889999998743 245668899999999999999999999998765
Q ss_pred CCceeEEEecccCCChhHHhhhc-------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~ 218 (719)
..+++|||||++|+|.+++.++ ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 88 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 4589999999999999999764 35899999999999999999999999 9999999999999865
Q ss_pred CCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHH
Q 005017 219 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 292 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~ 292 (719)
+.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..+++..
T Consensus 165 -~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~ 242 (299)
T 4asz_A 165 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIEC 242 (299)
T ss_dssp -GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHH
T ss_pred -CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHH
Confidence 799999999998664332 23457999999999886 569999999999999999999 8999987 567788888
Q ss_pred HHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 293 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 293 i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+..+..+. .+..+++++.+||.+||. +|.+|||+.+| ++||+.
T Consensus 243 i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 243 ITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 88876543 456678999999999998 89999999999 457753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=439.82 Aligned_cols=245 Identities=30% Similarity=0.446 Sum_probs=205.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..+.+.+.||+|+||+||+|.+. ..||||+++... ......+.|.+|+.+|++|+|||||++++++.. ..++
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEE
Confidence 35678899999999999999754 359999987543 234667889999999999999999999998743 3478
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+|||||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceeccc
Confidence 999999999999999764 57999999999999999999999998 9999999999999855 7999999999976543
Q ss_pred C----CcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---ccc
Q 005017 236 P----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAK 304 (719)
Q Consensus 236 ~----~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~ 304 (719)
. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+...+..+..++. .+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 2345689999999998853 4899999999999999999999999987777777777777655433 345
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+++++++||.+||. +|.+|||+.++++
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 568899999999998 8999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=439.73 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=206.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
...+.+.+.||+|+||+||+|.+. .+|..||||+++.. .....++|.+|+++|++|+|||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 456889999999999999999754 46899999998643 245668899999999999999999999998765
Q ss_pred CCCceeEEEecccCCChhHHhhhc---------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH---------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~---------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
..+++|||||++|+|.+++.++ ..+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 116 --~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 116 --RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp --SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred --CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 4589999999999999999764 35899999999999999999999999 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHH
Q 005017 216 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 289 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i 289 (719)
+.+ +.+||+|||+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+ .+..++
T Consensus 192 ~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~ 269 (329)
T 4aoj_A 192 GQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEA 269 (329)
T ss_dssp ETT-TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHH
T ss_pred CCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHH
Confidence 865 69999999999866432 2235679999999998865 69999999999999999999 8999987 466777
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+..+..+..+. .+..+++++++||.+||. ||.+|||+.||+++
T Consensus 270 ~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 88888776543 456678999999999998 89999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=435.72 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=209.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..+++.+.||+|+||+||+|.. ..+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-
Confidence 4578889999999999999975 3467899999987432 234567899999999999999999999998765
Q ss_pred CCceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 215 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl 215 (719)
..+++|||||++|+|.++|... ..+++..+..|+.||+.||+|||+++ ||||||||+||||
T Consensus 102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 4588999999999999999643 35899999999999999999999999 9999999999999
Q ss_pred cCCCCcEEEeecchhhhccCC----CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHH
Q 005017 216 NGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI 289 (719)
Q Consensus 216 ~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i 289 (719)
+.+ +.+||+|||+|+..... .....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++
T Consensus 179 ~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~ 256 (308)
T 4gt4_A 179 YDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDV 256 (308)
T ss_dssp CGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHH
T ss_pred CCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHH
Confidence 855 79999999999765432 234568999999999876 569999999999999999998 8999987 567788
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...+..+..++ .+..+++++.+|+.+||. +|.+|||+.+|+++
T Consensus 257 ~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88888776544 455678999999999998 89999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=440.45 Aligned_cols=250 Identities=19% Similarity=0.343 Sum_probs=204.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||+||+|.++ .+++.||+|++... ....++.+|+++|+.+ +|||||+++++|.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-- 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-- 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--
Confidence 45789999999999999999875 46789999988643 2345688999999998 699999999988765
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+++|+|.++++ .+++..++.+++||+.||+|||++| ||||||||+|||++.+.|.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 46999999999999999985 5899999999999999999999999 999999999999987768999999999965
Q ss_pred ccCC------------------------------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCC
Q 005017 233 MQQP------------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPY 280 (719)
Q Consensus 233 ~~~~------------------------------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf 280 (719)
.... ...+.+||+.|||||++.+ .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 4321 1234579999999998864 4899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHc--C--------------------------------------C------------CCCccccCCCh
Q 005017 281 SECKNPAQIFKKVTS--G--------------------------------------I------------KPASLAKVNDP 308 (719)
Q Consensus 281 ~~~~~~~~i~~~i~~--g--------------------------------------~------------~p~~~~~~~~~ 308 (719)
....+..+....+.. | . .........++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 765554443333211 0 0 00011234578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++++||.+||+ ||.+||||+|+|+||||+..
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999998 99999999999999999853
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=473.35 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=224.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
+-..|.+.++||+|+||+||+|.++.+|+.||+|+++....... .........++.+++.++|||||+++++|.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-- 264 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-- 264 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--
Confidence 44568999999999999999999999999999999986543221 11222333456778888999999999999765
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ |.+||+|||+|+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeee
Confidence 459999999999999999999999999999999999999999999999 9999999999999855 8999999999988
Q ss_pred ccCCCcccccCCCCCCCccccc-c-ccCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHHcCCCCCccccCCCh
Q 005017 233 MQQPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~-~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
+......+.+|||.|||||++. + .|+.++|||||||++|||+||++||.+. .+..++...+.... ..++...++
T Consensus 342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~ 419 (689)
T 3v5w_A 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSP 419 (689)
T ss_dssp CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCH
T ss_pred cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCH
Confidence 8777777889999999999985 3 5999999999999999999999999753 23455666665543 334566789
Q ss_pred HHHHHHHHhcC-CCCCCCC-----HHHHHcCccCccccCCCC
Q 005017 309 QIKGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~~ 344 (719)
++++||.+||. ||.+|++ +.|+++||||+..+|...
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 99999999998 9999998 899999999998887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=458.89 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=224.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.|+|||||+++++|.+. ..+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 230 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMV 230 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEE
Confidence 35789999999999999999999999999999997543 34557789999999999999999999998755 5699
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC-CCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~-~G~vKL~DFGlA~~~~ 234 (719)
+|||||.||+|.+++.. .+.+++..++.|++||+.||+|||+++ |+||||||+|||++.+ .|.+||+|||+|+.+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999999999864 467999999999999999999999999 9999999999999753 4799999999998776
Q ss_pred CC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 310 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l 310 (719)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+ .+..+.+..+..+.. +.......++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 44 3456789999999998875 599999999999999999999999987 567777777776543 344455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
++||.+||. ||.+|||+.|+|+||||+..+.
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 999999998 9999999999999999986554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=434.45 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=212.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC-----CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~-----g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~~~~~~~ 150 (719)
..|++.+.||+|+||+||+|.+... ++.||+|+++... .....+.|.+|+.+|++++| ||||+++++|...
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4689999999999999999987643 4689999986432 23456789999999999976 8999999988654
Q ss_pred CCCceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 214 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NIL 214 (719)
+ ..+++|||||++|+|.++|++. ..+++..+..|+.||+.||+|||+++ ||||||||+|||
T Consensus 141 ~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NIL 217 (353)
T 4ase_A 141 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 217 (353)
T ss_dssp T-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred C-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCcccee
Confidence 3 4588999999999999999753 23899999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHH
Q 005017 215 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 288 (719)
Q Consensus 215 l~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~ 288 (719)
++.+ +.+||+|||+|+.+.... ....+||+.|||||++. +.|+.++|||||||++|||+| |+.||.+......
T Consensus 218 l~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9855 799999999998764332 23467999999999886 469999999999999999998 8999998766777
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+.+.+..+..+. .+..+++++.++|.+||. ||.+|||+.+|++|
T Consensus 297 ~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777887776543 455678999999999998 89999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=405.27 Aligned_cols=268 Identities=53% Similarity=0.952 Sum_probs=241.4
Q ss_pred cccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 70 ~e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
......+++|++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|++++||||++++++|..
T Consensus 19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 3446688999999999999999999999999999999999875443 24567889999999999999999999998865
Q ss_pred C--CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 150 D--KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 150 ~--~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
. +...+++||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||++.+.|.+||+||
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 3 34568999999999999999998889999999999999999999999998889999999999999856689999999
Q ss_pred chhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 228 GLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 228 GlA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
|++............||+.|+|||++.+.++.++|||||||++|+|++|+.||....+..+....+..+..+.......+
T Consensus 177 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 99987766666677899999999999988999999999999999999999999988888889888888888888888888
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++++||.+||. +|.+|||+.++|+||||+..
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999999998 89999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=414.66 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=193.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC--C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--K 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--~ 153 (719)
.|.+.+.+.||+|+||+||+|.+ +|+.||||+++... .....+..|+..+.+|+|||||++++++.+.+. .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 36788999999999999999976 69999999986432 122233456667788999999999999986543 3
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC------CCCeeeecCccceeEecCCCCcEEEeec
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~------~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
.+|+|||||++|+|.++++. ..+++..+..++.|++.||+|||++ .++||||||||+|||++.+ |.+||+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DF 152 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeC
Confidence 58999999999999999975 4689999999999999999999987 3459999999999999865 79999999
Q ss_pred chhhhccCCC------cccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCC----------C-
Q 005017 228 GLAIAMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSE----------C- 283 (719)
Q Consensus 228 GlA~~~~~~~------~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~----------~- 283 (719)
|+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||.. .
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9997664432 234579999999998864 378899999999999999999766532 1
Q ss_pred ---CCHHHHHHHHHcCCCCCccccC-----CChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 284 ---KNPAQIFKKVTSGIKPASLAKV-----NDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 284 ---~~~~~i~~~i~~g~~p~~~~~~-----~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....++.+.+......+.++.. ..+.+.+|+.+||. ||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1223444444443332222221 12468899999998 89999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.96 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=223.9
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
+.-..|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+++.+|+.+|++++||||+++++++... .
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~ 87 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--K 87 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--C
Confidence 334467889999999999999999999999999999975432 345667899999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEF 164 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGG
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceec
Confidence 68999999999999999998889999999999999999999999999 9999999999999855 79999999999766
Q ss_pred cCC-CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 QQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
... .....+||+.|+|||++.+. + +.++|||||||++|+|+||+.||.+ .+..++...+..+... .+...++++
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~ 241 (328)
T 3fe3_A 165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDC 241 (328)
T ss_dssp SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHH
Confidence 543 34567899999999988754 4 5789999999999999999999987 5677777777776543 344578999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++||.+||. ||.+|||+.++|+||||+...
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999998 899999999999999998644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=394.95 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=217.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+ .+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--EL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EE
Confidence 3456778999999999999999999999999999975542 23467889999999999999999999987654 58
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCceecCC
Confidence 8999999999999999764 6999999999999999999999999 9999999999999855 7999999999876654
Q ss_pred C--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||...............+......+...++.+++
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 3 2345689999999998864 589999999999999999999999987544444444444444444455667889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
||.+||. ||.+|||+.++|+||||+...
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 9999998 899999999999999998543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=404.67 Aligned_cols=258 Identities=22% Similarity=0.418 Sum_probs=224.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||+||+|.++.+|+.||+|+++...... ......+.+|+.+|+.++||||+++++++... ..++
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 81 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEE
Confidence 46788999999999999999999999999999997543222 23457788999999999999999999998765 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhcccC
Confidence 99999999999999998889999999999999999999999999 9999999999999855 7999999999975432
Q ss_pred -CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 236 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 236 -~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.. .++...++++++|
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 235 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 23456789999999998864 589999999999999999999999987 566777777766533 3455678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 314 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 314 I~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
|.+||. +|.+|| ++.++++||||+..++..
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~ 271 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999998 899999 999999999999776644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=404.47 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=224.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
....|.+.+.||+|+||+||+|.++.+|..||+|.++....... ....+.+.+|+.+|++++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-- 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--
Confidence 34568899999999999999999999999999999986543321 12357889999999999999999999998654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC---cEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G---~vKL~DFGl 229 (719)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+ .+||+|||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 468999999999999999998889999999999999999999999999 999999999999975532 799999999
Q ss_pred hhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccC
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKV 305 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~ 305 (719)
+...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+.+..+..+... ......
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccC
Confidence 9776543 3456789999999998875 689999999999999999999999987 5667777777766442 233456
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.++.+++||.+||. ||.+|||+.++|+||||+...
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 78899999999998 899999999999999998543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=408.60 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=220.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
-..|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|..+|+.+ +||||+++++++.+. ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence 346788999999999999999999999999999998543222 24457788999999998 799999999998655 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeecc
Confidence 8999999999999999999889999999999999999999999999 9999999999999855 799999999997543
Q ss_pred C--CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 Q--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 ~--~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
. ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+... ++...++.++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~ 252 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLHEDAT 252 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHH
Confidence 2 23456789999999998865 599999999999999999999999987 5677788888776432 3455788999
Q ss_pred HHHHHhcC-CCCCCCCH------HHHHcCccCccccCCC
Q 005017 312 GFIEKCLV-PASERLSA------KDLLKDPFLQVENQKE 343 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa------~eLL~hpf~~~~~~~~ 343 (719)
+||.+||. +|.+||++ .++++||||+..++..
T Consensus 253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 99999998 89999998 9999999999876654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=397.04 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=223.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~ 82 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 82 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEEE
Confidence 45788999999999999999999999999999997543221 23456788999999999999999999998654 4689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS-
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC-
Confidence 99999999999999998889999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+....+..+..+.. .++...+++++++|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 235 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHH
Confidence 3346789999999998864 589999999999999999999999987 566677777766543 244567889999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 316 KCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 316 kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
+||. +|.+|| +++++++||||+...+..
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 9998 899999 999999999999766543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.18 Aligned_cols=256 Identities=23% Similarity=0.425 Sum_probs=212.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC----------------------hhhHHHHHHHHHHHHh
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----------------------PGDLQKLYSEVHLLKS 134 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~----------------------~~~~~~~~~Ei~iL~~ 134 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++........ ....+.+.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 457889999999999999999999999999999976542211 1224678899999999
Q ss_pred CCCCCceeEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeE
Q 005017 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 214 (719)
Q Consensus 135 L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NIL 214 (719)
++||||+++++++.+.....+++||||+++|+|.+++. .+.+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 99999999999988766678999999999999998764 457999999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEeecchhhhccCCC--cccccCCCCCCCccccccc----cCccccchhhHHHHHHHhhccCCCCCCCCHHH
Q 005017 215 VNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 288 (719)
Q Consensus 215 l~~~~G~vKL~DFGlA~~~~~~~--~~~~~GT~~YmAPEvl~~~----~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~ 288 (719)
++.+ |.+||+|||++....... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.. .....
T Consensus 170 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~ 247 (298)
T 2zv2_A 170 VGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMC 247 (298)
T ss_dssp ECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHH
T ss_pred ECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHH
Confidence 9855 799999999997665432 3456799999999988643 47889999999999999999999987 45556
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
....+.....+.......++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6666665544433344567899999999998 899999999999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=401.29 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=225.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|.+.+.||+|+||.||+|.++.+|+.||+|++....... ....+.+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 116 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEE
Confidence 356888999999999999999999999999999997543322 23457788999999999999999999988754 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceeccC
Confidence 999999999999999998889999999999999999999999999 9999999999999855 7999999999986654
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
. ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.. .++...++.++++|
T Consensus 194 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 269 (350)
T 1rdq_E 194 R-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLL 269 (350)
T ss_dssp C-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHH
T ss_pred C-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 3 345689999999998764 589999999999999999999999987 567788888877643 34556789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHHcCccCccccCCC
Q 005017 315 EKCLV-PASERLS-----AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 315 ~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~ 343 (719)
.+||. +|.+||+ +.++++||||+..++..
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~ 304 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence 99998 8999998 99999999999776543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=408.46 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=220.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.-..|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|..+|.++ +|||||+++++|.+. .
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~ 126 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--S 126 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--C
Confidence 3456899999999999999999999999999999998654332 33446688999999887 899999999998755 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++||||+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeec
Confidence 68999999999999999998889999999999999999999999999 9999999999999855 79999999999753
Q ss_pred c--CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHHcCCCCCcc
Q 005017 234 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 234 ~--~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~ 302 (719)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....+++.+..... .+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RI 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CC
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CC
Confidence 2 234566789999999998865 5899999999999999999999999632 123345566655432 34
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCH------HHHHcCccCccccCCC
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQKE 343 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa------~eLL~hpf~~~~~~~~ 343 (719)
+...++++++||.+||. +|.+||++ .++++||||+..++..
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 55678999999999998 89999985 8999999999877654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=403.33 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=224.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
....|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||+++++++.+. .
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~ 91 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--E 91 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--S
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--C
Confidence 4466889999999999999999999999999999998643221 23456788899999876 999999999988655 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhc
Confidence 58999999999999999998889999999999999999999999999 9999999999999855 79999999999754
Q ss_pred c--CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~--~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..+.. .++...++++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEA 245 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHH
Confidence 3 234456789999999998865 589999999999999999999999987 567777777776543 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHH-HHHcCccCccccCCC
Q 005017 311 KGFIEKCLV-PASERLSAK-DLLKDPFLQVENQKE 343 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~-eLL~hpf~~~~~~~~ 343 (719)
++||.+||. +|.+||++. ++++||||+..++..
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~ 280 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 280 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHH
Confidence 999999998 899999998 999999999876644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=396.94 Aligned_cols=259 Identities=21% Similarity=0.341 Sum_probs=220.9
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
-..|++.++||+|+||.||+|.++.+|+.||+|+++..... .....+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CE
Confidence 34688999999999999999999999999999999865432 245567889999999998 899999999998654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence 8999999999999999998889999999999999999999999999 9999999999999855 799999999997543
Q ss_pred --CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC--------CCHHHHHHHHHcCCCCCccc
Q 005017 235 --QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 235 --~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--------~~~~~i~~~i~~g~~p~~~~ 303 (719)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||... .....++..+..... .++
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCC
Confidence 223456789999999998865 5899999999999999999999999642 223445556655432 345
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCH------HHHHcCccCccccCC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQK 342 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa------~eLL~hpf~~~~~~~ 342 (719)
...++++++||.+||. +|.+||++ .++++||||+...+.
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 5678999999999998 89999995 899999999876654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=390.39 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=220.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...+|.+.+.||+|+||+||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 86 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-- 86 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 34568899999999999999999999999999999986543221 12457899999999999999999999998654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC---CcEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~---G~vKL~DFGl 229 (719)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. ..+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 458999999999999999998888999999999999999999999999 99999999999997542 1799999999
Q ss_pred hhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccC
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKV 305 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~ 305 (719)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..... +......
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCcccccc
Confidence 9776533 3345679999999998864 589999999999999999999999987 455555555554432 2233456
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 68899999999998 899999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=391.75 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=216.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|++.+.||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREG--NIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeE
Confidence 34688999999999999999999999999999999754432 2346688999999999999999999988654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeeccceecc
Confidence 899999999999999998888999999999999999999999999 9999999999999855 6999999999976532
Q ss_pred C----CcccccCCCCCCCccccccc--cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 236 P----TARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 236 ~----~~~~~~GT~~YmAPEvl~~~--~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
. .....+||+.|+|||++.+. ++.++|||||||++|+|+||+.||.........+................++.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence 2 23456899999999988653 47789999999999999999999987555545555555544443444567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+++||.+||. +|.+|||+.|+++||||+...
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9999999998 899999999999999998543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=382.35 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=210.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+. ..+++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 78 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEE
Confidence 57888999999999999999999999999999986543 234567888999999999999999999998765 45899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+.++.+..+....+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCSCC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCCcc
Confidence 9999987545555555678999999999999999999999999 9999999999999855 79999999999766533
Q ss_pred -CcccccCCCCCCCcccccc-c-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCC------------
Q 005017 237 -TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP------------ 299 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p------------ 299 (719)
......||+.|+|||++.+ . ++.++|||||||++|+|+||..||....+.......+... ..+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2345678999999998754 3 7999999999999999999998876556666555554321 000
Q ss_pred -------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 300 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 300 -------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.......++.+++||.+||. ||.+|||+.|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 01112356889999999998 8999999999999999984
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=397.60 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=221.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||.||+|.++.+|..||+|++..... .....+.+.+|+.+|++|+||||+++++++.+. ..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 468899999999999999999999999999999986543 235567899999999999999999999988655 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++....
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999999998888999999999999999999999999 9999999999999753 2469999999997665
Q ss_pred CC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 310 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~l 310 (719)
.. .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+... .......++++
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 43 2345689999999998875 589999999999999999999999987 5566777777766442 22334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 999999998 89999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=399.53 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=224.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.-..|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||+++++++.+. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~ 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--D 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--S
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--C
Confidence 3456888999999999999999999999999999998653322 23457788999999988 899999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCccccc
Confidence 68999999999999999998889999999999999999999999999 9999999999999855 79999999999764
Q ss_pred c--CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 Q--QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~--~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+..+++..+..+.. .++...++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~ 248 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEA 248 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 3 233456789999999998864 689999999999999999999999987 567778888776543 2445678999
Q ss_pred HHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 311 KGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 311 ~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
++||.+||. +|.+|| ++.++++||||+..++..
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 999999998 899999 479999999999766543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=392.16 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=219.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+..+|..||+|.+.... .....+.+|+.+|+.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEE
Confidence 346788999999999999999999999999999987432 3456788999999999999999999998765 458
Q ss_pred eEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC-CCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~-~G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999999999997654 6999999999999999999999999 9999999999999852 479999999999876
Q ss_pred cCCC-cccccCCCCCCCccccccc-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCChH
Q 005017 234 QQPT-ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQ 309 (719)
Q Consensus 234 ~~~~-~~~~~GT~~YmAPEvl~~~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~ 309 (719)
.... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.. .+..++...+..+..... .....+++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 5432 3456799999999988754 79999999999999999999999987 556667777766544322 23456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999998 89999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=408.52 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=220.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+|++|+|||||++++++.+. ..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS--ARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH--HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEE
Confidence 4588899999999999999999999999999999865432 34567789999999999999999999988654 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. +.+.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999889999999999999999999999999 999999999999974 34689999999997665
Q ss_pred CCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChH
Q 005017 235 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 309 (719)
Q Consensus 235 ~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~ 309 (719)
... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......+++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 432 345689999999999875 599999999999999999999999987 5677777777776543 2233456899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++||.+||. ||.+|||+.++|+||||+..
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999998 89999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=410.55 Aligned_cols=263 Identities=20% Similarity=0.342 Sum_probs=220.5
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.....|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+++.++|||||+++++|.+. .
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 142 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--R 142 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--C
Confidence 34567899999999999999999999999999999997533211 12234578899999999999999999998754 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEee
Confidence 68999999999999999875 46999999999999999999999999 9999999999999855 79999999999776
Q ss_pred cCCC---cccccCCCCCCCccccccc-----cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccc
Q 005017 234 QQPT---ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLA 303 (719)
Q Consensus 234 ~~~~---~~~~~GT~~YmAPEvl~~~-----~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~ 303 (719)
.... ..+.+||+.|+|||++.+. |+.++|||||||++|||+||+.||.. .+....+..+..+.. .....
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTT
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCc
Confidence 5432 3467899999999988632 78999999999999999999999987 567777777765421 11122
Q ss_pred cCCChHHHHHHHHhcC-CCCC--CCCHHHHHcCccCccccCCCC
Q 005017 304 KVNDPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~--RpSa~eLL~hpf~~~~~~~~~ 344 (719)
...++++++||.+||. +|.+ ||++.|+++||||+..++...
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 3568899999999998 5777 999999999999998776543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=391.01 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=210.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
....|++.++||+|+||+||+|.+. .+|+.||+|+++.............+.+|+.+|++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG- 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-
Confidence 4467899999999999999999885 689999999998654333334556788999999999999999999988664
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~ 169 (327)
T 3a62_A 94 -GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCK 169 (327)
T ss_dssp -SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC-
T ss_pred -CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCccc
Confidence 458999999999999999998888999999999999999999999999 9999999999999855 799999999987
Q ss_pred hccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 232 AMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 232 ~~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+....+..+..+.. .++...++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~ 246 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQ 246 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCH
Confidence 54322 3345689999999998764 589999999999999999999999987 456666666665433 23455688
Q ss_pred HHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 309 QIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
++++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 99999999998 899999 89999999999876554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=375.19 Aligned_cols=255 Identities=22% Similarity=0.393 Sum_probs=220.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
.++|++.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDI 81 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeE
Confidence 4568999999999999999999999999999999875432 3457889999999999999999999998654 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ...+.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 899999999999999998888999999999999999999999999 99999999999992 24479999999999766
Q ss_pred cCC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCChHH
Q 005017 234 QQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQI 310 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~l 310 (719)
... ......||+.|+|||++.+.++.++||||||+++|+|+||+.||.. .+..+....+..+..... .....++.+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 543 3455679999999999988899999999999999999999999987 455666666666543322 223568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999998 89999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=402.99 Aligned_cols=262 Identities=21% Similarity=0.395 Sum_probs=223.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.++||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+. ..
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 89 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED 89 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence 4467899999999999999999999999999999997544322 23457889999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeecc
Confidence 8999999999999999998889999999999999999999999999 9999999999999855 799999999998764
Q ss_pred CC-CcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHHcCCCCCccccCCC
Q 005017 235 QP-TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~--~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.. .....+||+.|+|||++.. .|+.++|||||||++|||+||+.||... .....++..+.... ..++...+
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s 244 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWS 244 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSC
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCC
Confidence 43 3456789999999998852 4899999999999999999999999742 33455555555433 23445678
Q ss_pred hHHHHHHHHhcC-CCCCCCC-HHHHHcCccCccccCCCC
Q 005017 308 PQIKGFIEKCLV-PASERLS-AKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpS-a~eLL~hpf~~~~~~~~~ 344 (719)
+.+++||.+||. +|.+||+ +.++++||||+..++...
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 999999999998 8999998 999999999998776543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=409.59 Aligned_cols=259 Identities=23% Similarity=0.403 Sum_probs=213.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.++||+|+||.||+|.+..+|+.||+|+++..... .......+.+|+.+|+.++||||+++++++...+ .+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETT--EE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EE
Confidence 35689999999999999999999999999999999754322 2344567889999999999999999999987654 58
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+ ++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceecc
Confidence 9999999999999999988899999999999999999999998 88 9999999999999855 799999999997643
Q ss_pred CC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 QP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 ~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.. .+...++..+..... .++...+++++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~ 377 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAK 377 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 22 3456789999999998864 599999999999999999999999987 556667766665433 24456789999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 312 GFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 312 ~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
+||.+||. ||.+|| ++.++|+||||+...+..
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 99999998 899999 999999999999766543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=377.91 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=211.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.+..+|..||+|++..... ....+.+.+|+++|++++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEE
Confidence 467889999999999999999999999999999976542 23457889999999999999999999998654 4588
Q ss_pred EEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchh
Q 005017 157 MITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLA 230 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA 230 (719)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ..+.+||+|||++
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999999988643 67999999999999999999999999 999999999999953 2368999999999
Q ss_pred hhccCC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCCh
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDP 308 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~ 308 (719)
...... ......||+.|+|||++.+.++.++||||||+++|+|++|+.||.+ .+.......+....... ......++
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPLTP 253 (285)
T ss_dssp CC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred eecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcCCH
Confidence 765433 3345679999999999988899999999999999999999999987 44555555554433322 22233678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999998 8999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=409.48 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=226.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.++||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+|++++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 356889999999999999999999999999999997654332 34567899999999999999999999998654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~~~ 233 (719)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999999998889999999999999999999999999 99999999999995 23478999999999876
Q ss_pred cCC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCChHH
Q 005017 234 QQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQI 310 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~l 310 (719)
... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+..++...+..+..... .....++.+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 544 3345689999999999998999999999999999999999999987 567777777777654332 334568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++||.+||. +|.+|||+.++|+||||+...
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 999999998 899999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=377.10 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=217.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+..++..||+|++....... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEE
Confidence 356889999999999999999999999999999987543211 23356788999999999999999999998655 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCc
Confidence 899999999999999998889999999999999999999999999 9999999999999855 7999999999876655
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 238 (279)
T 3fdn_A 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLI 238 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHH
T ss_pred ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 55556789999999998865 478999999999999999999999987 456666666665432 23455778999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
.+||. +|.+|||+.++|+||||+.....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCccC
Confidence 99998 89999999999999999865543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=409.85 Aligned_cols=265 Identities=18% Similarity=0.339 Sum_probs=221.3
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
......|.+.++||+|+||+||+|.++.+|+.||+|+++...... ......+.+|+.++..++||||++++++|.+.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-- 146 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD-- 146 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--
Confidence 345567899999999999999999999999999999997533221 12234478899999999999999999998765
Q ss_pred CceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+|+||||+++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |.+||+|||+|+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhh
Confidence 458999999999999999987 467999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCC---cccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---CC
Q 005017 232 AMQQPT---ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KP 299 (719)
Q Consensus 232 ~~~~~~---~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~---~p 299 (719)
...... ....+||+.|+|||++. +.|+.++|||||||++|||+||+.||.. .+..+.+..+.... ..
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccC
Confidence 654432 23468999999999875 3589999999999999999999999987 56667776665421 11
Q ss_pred CccccCCChHHHHHHHHhcC-CCCC--CCCHHHHHcCccCccccCCCC
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~--RpSa~eLL~hpf~~~~~~~~~ 344 (719)
+......++++++||.+||. +|.+ |+++.|+++||||+..++...
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 22223468899999999997 5666 999999999999998877654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=405.88 Aligned_cols=264 Identities=20% Similarity=0.343 Sum_probs=220.7
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.....|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|..+|..++||||+++++++.+. .
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~ 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFAFQDE--N 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--S
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--C
Confidence 34567899999999999999999999999999999997533211 22345578899999999999999999998755 4
Q ss_pred ceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhhee
Confidence 6899999999999999998754 7999999999999999999999999 9999999999999855 7999999999977
Q ss_pred ccCCC---cccccCCCCCCCccccc--------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC---C
Q 005017 233 MQQPT---ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---K 298 (719)
Q Consensus 233 ~~~~~---~~~~~GT~~YmAPEvl~--------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~---~ 298 (719)
..... ....+||+.|+|||++. +.|+.++|||||||++|||+||+.||.. .+..+.+..+.... .
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcC
Confidence 65432 23468999999999886 3589999999999999999999999987 56666666665421 2
Q ss_pred CCccccCCChHHHHHHHHhcCCCCCC---CCHHHHHcCccCccccCCCC
Q 005017 299 PASLAKVNDPQIKGFIEKCLVPASER---LSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 299 p~~~~~~~~~~l~~lI~kcL~dP~~R---pSa~eLL~hpf~~~~~~~~~ 344 (719)
.+......++++++||.+||.+|.+| |++.++++||||+..++...
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 22233567899999999999988877 69999999999998877654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=391.67 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=216.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|++........ ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEE
Confidence 468899999999999999999999999999999975432221 12357789999999999999999999998765 458
Q ss_pred eEEEecccCCChhHHhhhcc----cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecch
Q 005017 156 NMITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGL 229 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~----~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGl 229 (719)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999998876532 4899999999999999999999999 9999999999999743 23599999999
Q ss_pred hhhccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccc
Q 005017 230 AIAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAK 304 (719)
Q Consensus 230 A~~~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~ 304 (719)
+....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. ....++..+..+..... ...
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccccc
Confidence 97765432 345689999999998865 589999999999999999999999986 35566666666543322 234
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..++++++||.+||. ||.+|||+.++|+||||+...
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 567899999999998 899999999999999998543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=407.85 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=223.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|++++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEEE
Confidence 4688899999999999999999999999999999754322 23457889999999999999999999988654 4689
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999999988889999999999999999999999999 999999999999963 33579999999998765
Q ss_pred CC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc--cccCCChHHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIK 311 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--~~~~~~~~l~ 311 (719)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|+.||.+ .+..++...+..+..+.. .....+++++
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 43 3345679999999999998999999999999999999999999987 566777777777655433 2345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+||.+||. +|.+|||+.++|+||||+....
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999998 8999999999999999986543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=372.22 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=221.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEE
Confidence 4567899999999999999999999999999999976543 245567889999999999999999999988654 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGlA~~~ 233 (719)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+.+||+|||++...
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 899999999999999998888999999999999999999999999 9999999999999743 235999999999766
Q ss_pred cCCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChH
Q 005017 234 QQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~ 309 (719)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+... .......+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHH
Confidence 5432 345679999999998865 589999999999999999999999987 4566666666665432 2233456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+++||.+||. +|.+|||+.++|+||||+....
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999998 8999999999999999985543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=398.84 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=216.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIVkl~~~~~~~~~~ 153 (719)
....|.+.++||+|+||+||+|.++.+|+.||+|+++...... ......+.+|..+ ++.++||||+++++++.+. .
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--D 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--C
Confidence 3457899999999999999999999999999999998665433 2344566777776 5778999999999998765 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCcccccc
Confidence 68999999999999999998889999999999999999999999999 9999999999999855 79999999999764
Q ss_pred cC--CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 234 QQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 234 ~~--~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.. ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+..+++..+..+.. .++...++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~ 266 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSA 266 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCC--CCCSSSCHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccc--CCCCCCCHHH
Confidence 32 34556789999999998865 589999999999999999999999987 567777777776532 3445678899
Q ss_pred HHHHHHhcC-CCCCCCCH----HHHHcCccCccccCCCC
Q 005017 311 KGFIEKCLV-PASERLSA----KDLLKDPFLQVENQKEP 344 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa----~eLL~hpf~~~~~~~~~ 344 (719)
++||.+||. +|.+||++ .++++||||+..++...
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 999999998 89999986 79999999998776543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=393.63 Aligned_cols=262 Identities=22% Similarity=0.394 Sum_probs=213.8
Q ss_pred CCCCCcEEEeEEEeee--CCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 73 DPSGRYVRYDEVLGKG--AFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G--~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.+.+..|++.++||+| +||+||+|.+..+|+.||+|+++.... .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 4567788999999999 999999999999999999999986543 245667888999999999999999999998765
Q ss_pred CCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
+ .+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 99 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~dfg 173 (389)
T 3gni_B 99 N--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLR 173 (389)
T ss_dssp T--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCGG
T ss_pred C--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccc
Confidence 4 589999999999999999875 67999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccC---------CCcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC
Q 005017 229 LAIAMQQ---------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296 (719)
Q Consensus 229 lA~~~~~---------~~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g 296 (719)
++..... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+..........+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 8854321 12234579999999998865 58999999999999999999999998754444333222111
Q ss_pred CC-------------------------------------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 297 IK-------------------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 297 ~~-------------------------------------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.. ........++.+++||.+||. ||.+|||+.|+|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 011334467889999999998 8999999999999
Q ss_pred CccCccccC
Q 005017 333 DPFLQVENQ 341 (719)
Q Consensus 333 hpf~~~~~~ 341 (719)
||||+....
T Consensus 334 hp~f~~~~~ 342 (389)
T 3gni_B 334 HSFFKQIKR 342 (389)
T ss_dssp SGGGGGC--
T ss_pred CHHHHHHhh
Confidence 999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=389.48 Aligned_cols=258 Identities=23% Similarity=0.373 Sum_probs=206.6
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
+.....|++.+.||+|+||+||+|.+..+++.||+|+++... ..+.+.+|+.+|++++||||+++++++...
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 120 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-- 120 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--
Confidence 334566899999999999999999999999999999987432 235678899999999999999999998654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLA 230 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA 230 (719)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 458899999999999999998888999999999999999999999999 999999999999973 3479999999999
Q ss_pred hhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCC
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVN 306 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~ 306 (719)
+..... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||........++..+..+... .......
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 766543 2345679999999998875 58999999999999999999999998866666677777665432 2233456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++++++||.+||. ||.+|||+.++|+||||+...
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 7899999999998 899999999999999998544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=376.18 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=203.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+ .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++... ..+++
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVL 77 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEE
Confidence 478889999999999999998 58999999999755422 22346788999999999999999999998755 45899
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.+ +|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIP 153 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccCcc
Confidence 9999975 899988764 67999999999999999999999999 9999999999999855 79999999999876533
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCC-C-----------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-P----------- 299 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~-p----------- 299 (719)
......||+.|+|||++.+ .++.++|||||||++|+|+||+.||........+...... +.. .
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 2344578999999998854 4899999999999999999999999875433333322211 100 0
Q ss_pred -------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 -------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.......++++++||.+||. ||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123457889999999998 89999999999999999853
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=386.91 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=205.9
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.-..|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+.+|+.+|++++||||+++++++.+. ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--TE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CE
Confidence 34568889999999999999999999999999999875432 223456778999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC----CCCcEEEeecchh
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLA 230 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~----~~G~vKL~DFGlA 230 (719)
+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 889999997 599999999889999999999999999999999999 999999999999952 3356999999999
Q ss_pred hhccCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCCCC-c---
Q 005017 231 IAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA-S--- 301 (719)
Q Consensus 231 ~~~~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~p~-~--- 301 (719)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...+.. +..+. .
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 876533 2345578999999998864 4899999999999999999999999875444443333221 11110 0
Q ss_pred ----------------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 302 ----------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 302 ----------------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+....++++++||.+||. ||.+|||+.|+|+||||+..++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 111256889999999998 89999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=390.64 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=204.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 90 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 90 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CE
Confidence 45567899999999999999999999999999999975432 225688999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC-CcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~-G~vKL~DFGlA~~~ 233 (719)
+++||||+.+|+|.+++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+. +.+||+|||+++..
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 8899999999999999998889999999999999999999999999 99999999999997542 35999999998754
Q ss_pred cC-CCcccccCCCCCCCcccccc-ccCcc-ccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHHHcCCCCCccccCCC
Q 005017 234 QQ-PTARSVIGTPEFMAPELYEE-EYNEL-VDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 234 ~~-~~~~~~~GT~~YmAPEvl~~-~~s~k-sDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.. ......+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||..... .......+.............+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 32 23345679999999998764 45544 8999999999999999999976432 2344455554433333334567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++++||.+||. +|.+|||+.++++||||...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 899999999998 89999999999999999643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=381.95 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=206.2
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.....|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 92 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--R 92 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--C
Confidence 34567888999999999999999986 699999999875432 234457788999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLARA 168 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcCcee
Confidence 68999999985 777777654 45999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH--cCCCCCcc----
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKPASL---- 302 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~--~g~~p~~~---- 302 (719)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..... ....+..+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6433 2344578999999998754 589999999999999999999999987554443332221 11111111
Q ss_pred ---------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 303 ---------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 303 ---------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
....++++++||.+||. ||.+|||+.|+|+||||+..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 12346789999999998 899999999999999998543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=387.71 Aligned_cols=257 Identities=23% Similarity=0.423 Sum_probs=217.3
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC--CCceeEEEeeecC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 150 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIVkl~~~~~~~ 150 (719)
...++.|++.+.||+|+||+||+|.+. +|..||+|++..... .....+.+.+|+.+|++++| |||+++++++...
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 346788999999999999999999885 789999999986542 34566789999999999987 9999999988754
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+++||| +.+|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ + |.+||+|||++
T Consensus 82 --~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~-~~~kl~DFG~a 154 (343)
T 3dbq_A 82 --QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIA 154 (343)
T ss_dssp --SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEECCCSSS
T ss_pred --CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-C-CcEEEeecccc
Confidence 46899999 568899999999889999999999999999999999999 99999999999997 3 68999999999
Q ss_pred hhccCCC----cccccCCCCCCCccccc------------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 005017 231 IAMQQPT----ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 231 ~~~~~~~----~~~~~GT~~YmAPEvl~------------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~ 294 (719)
+...... ....+||+.|+|||++. ..++.++|||||||++|||++|+.||....+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 7664332 23567999999999875 4588999999999999999999999987666666666666
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.......++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6555556667778899999999998 89999999999999999843
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=381.68 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=215.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+...+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+ .+++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEE
Confidence 4677789999999999999999999999999987543 234577889999999999999999999987654 5889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~ 195 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV 195 (321)
T ss_dssp EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCc
Confidence 9999999999999875 46999999999999999999999999 9999999999999855 79999999998766443
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCCChHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGF 313 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~~~~l~~l 313 (719)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+....+.....+. ......++.+++|
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 274 (321)
T 2c30_A 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274 (321)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHH
T ss_pred cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHH
Confidence 2345689999999998864 589999999999999999999999987 45666666666654432 2234467899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
|.+||. +|.+|||+.++|+||||+..
T Consensus 275 i~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcChhhccC
Confidence 999998 89999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=406.64 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=218.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++.+|..||+|++....... .....+.+|+.+|++++|||||+++++|.+. ..++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 36889999999999999999999999999999998654322 2346788999999999999999999998654 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+|+|.+++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++.. .+.+||+|||++....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999999998889999999999999999999999999 9999999999999743 3569999999997765
Q ss_pred CC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC--ccccCCChHHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIK 311 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~~~l~ 311 (719)
.. .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.. .+..++...+..+.... ......++.++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 43 3355689999999999988899999999999999999999999987 56677777777765433 23345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+||.+||. +|.+|||+.++|+||||+..
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999998 89999999999999999854
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=380.16 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=207.0
Q ss_pred cEEE-eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 78 YVRY-DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 78 ~~~l-~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
.|.+ .++||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+|.++ +||||+++++++.+. ..+
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~ 86 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRF 86 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEE
Confidence 3455 578999999999999999999999999987542 23457889999999995 799999999998765 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC--CcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~--G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+. +.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999999998888999999999999999999999999 99999999999998553 23999999998654
Q ss_pred cCC---------CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCC-------------
Q 005017 234 QQP---------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKN------------- 285 (719)
Q Consensus 234 ~~~---------~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~------------- 285 (719)
... .....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 321 122456999999999885 3489999999999999999999999976432
Q ss_pred -HHHHHHHHHcCCCCCc--cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 286 -PAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 286 -~~~i~~~i~~g~~p~~--~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...++..+..+..... .....++.+++||.+||. ||.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2345566665543221 224567899999999998 899999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=380.75 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=208.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
..|++.++||+|+||+||+|.+..+|+.||+|++..... ......+...|+..+.++ +||||++++++|.+. ..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~ 132 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GIL 132 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEE
Confidence 568899999999999999999999999999998764322 233444555666666555 999999999998754 458
Q ss_pred eEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+ +|+|.+++...+ .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecc
Confidence 9999999 679988887644 5999999999999999999999999 9999999999999855 799999999987665
Q ss_pred CCC-cccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 235 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 235 ~~~-~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
... .....||+.|+|||++.+.++.++|||||||++|||++|..|+.. ......+..+..+..+....++++++|
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHH
Confidence 432 344579999999999998999999999999999999999776654 234455666666666677788999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
|.+||. +|.+|||+.++|+||||+.
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 999998 8999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=382.25 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=207.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC-----
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----- 152 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~----- 152 (719)
.|++.+.||+|+||.||+|.++.+|+.||+|+++... .....+.+.+|+.+|++|+|||||+++++|.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4788899999999999999999999999999997543 23456789999999999999999999999876432
Q ss_pred --------------------------------------------------CceeEEEecccCCChhHHhhhccc---ccH
Q 005017 153 --------------------------------------------------KTVNMITELFTSGNLRQYRKKHKN---VDI 179 (719)
Q Consensus 153 --------------------------------------------------~~l~lV~Ey~~gGsL~~~L~~~~~---l~~ 179 (719)
..+++||||+++|+|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 237899999999999999987543 556
Q ss_pred HHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC--------------cccccCCC
Q 005017 180 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--------------ARSVIGTP 245 (719)
Q Consensus 180 ~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~--------------~~~~~GT~ 245 (719)
..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++...... ....+||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 678999999999999999999 9999999999999855 799999999997665431 23457999
Q ss_pred CCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCC
Q 005017 246 EFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASE 323 (719)
Q Consensus 246 ~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~ 323 (719)
.|+|||++.+ .++.++|||||||++|||++|..|+.. .......+.....+.. ....++.+++||.+||. +|.+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGGG
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCCc
Confidence 9999998865 589999999999999999998776532 3444455555544432 23345788999999998 8999
Q ss_pred CCCHHHHHcCccCcc
Q 005017 324 RLSAKDLLKDPFLQV 338 (719)
Q Consensus 324 RpSa~eLL~hpf~~~ 338 (719)
|||+.++|+||||+.
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=394.30 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=202.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l 155 (719)
+.|++.+.||+|+||+||+|.+..+|+.||+|++... .......+++.+|+.+|+++. ||||+++++++...+...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578899999999999999999999999999998633 233456678899999999997 9999999999987776789
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|+....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCcccccccc
Confidence 99999997 589998875 57899999999999999999999999 9999999999999865 7999999999975432
Q ss_pred -----------------------CCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHH
Q 005017 236 -----------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 290 (719)
Q Consensus 236 -----------------------~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~ 290 (719)
......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~ 240 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-L 240 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 11234579999999998854 589999999999999999999999987543333 3
Q ss_pred HHHHcC-CCCCc--------------------------------------------cccCCChHHHHHHHHhcC-CCCCC
Q 005017 291 KKVTSG-IKPAS--------------------------------------------LAKVNDPQIKGFIEKCLV-PASER 324 (719)
Q Consensus 291 ~~i~~g-~~p~~--------------------------------------------~~~~~~~~l~~lI~kcL~-dP~~R 324 (719)
..+... ..|.. .....++++++||.+||. ||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 333211 01100 011457899999999998 99999
Q ss_pred CCHHHHHcCccCccc
Q 005017 325 LSAKDLLKDPFLQVE 339 (719)
Q Consensus 325 pSa~eLL~hpf~~~~ 339 (719)
||+.|+|+||||+..
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=396.84 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=211.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++....... .....++.+|+.+|+.++||||+++++++... ..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 85 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIV 85 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEE
Confidence 34688999999999999999999999999999987543211 22346788999999999999999999998765 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceeccCC
Confidence 999999 7899999988889999999999999999999999999 9999999999999855 79999999999766543
Q ss_pred -CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.. ...+++.+..+ ....+...++.+++|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSC--VYVMPDFLSPGAQSL 238 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSS--CCCCCTTSCHHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcC--CCCCcccCCHHHHHH
Confidence 34566899999999998754 3 789999999999999999999997632 22222222222 123345578999999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
|.+||. ||.+|||+.|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999998 89999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=378.83 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=221.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
....|++.+.||+|+||.||+|.+..+|..||+|.++....... ....+.+.+|+.+|++++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-- 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 34578999999999999999999999999999999986543321 12457899999999999999999999988654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC---cEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G---~vKL~DFGl 229 (719)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.. .+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 458899999999999999998888999999999999999999999999 999999999999985532 799999999
Q ss_pred hhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccC
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKV 305 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~ 305 (719)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..+....+...... ......
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcc
Confidence 9766543 2345679999999998864 589999999999999999999999987 4556666666654432 233356
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 78899999999998 89999999999999999743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=395.54 Aligned_cols=255 Identities=23% Similarity=0.425 Sum_probs=217.7
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~~~~~~~~~ 152 (719)
.++.|++.+.||+|+||+||+|.+.. |..||+|++..... .....+.+.+|+.+|++|+ ||||+++++++...+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~- 129 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ- 129 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-
Confidence 46779999999999999999998874 99999999986543 2456688999999999997 599999999887654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||| +.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ + |.+||+|||+++.
T Consensus 130 -~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~-~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 -YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQ 203 (390)
T ss_dssp -EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-S-SCEEECCCSSSCC
T ss_pred -EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-C-CeEEEEecCcccc
Confidence 5899999 568899999998889999999999999999999999999 99999999999996 3 6899999999976
Q ss_pred ccCCC----cccccCCCCCCCcccccc------------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC
Q 005017 233 MQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296 (719)
Q Consensus 233 ~~~~~----~~~~~GT~~YmAPEvl~~------------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g 296 (719)
..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....+....+..+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 64332 245679999999998754 58899999999999999999999998766666666666666
Q ss_pred CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 297 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 297 ~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.....++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 55555666678899999999998 89999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=368.63 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=217.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEE
Confidence 357889999999999999999999999999999875442 24557889999999999999999999988654 4588
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCCC
Confidence 99999999999999998888999999999999999999999999 9999999999999855 79999999998755322
Q ss_pred ----CcccccCCCCCCCcccccc-c-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 ----TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 ----~~~~~~GT~~YmAPEvl~~-~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
......||+.|+|||++.+ . ++.++||||||+++|+|++|+.||.........+..+.............++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHH
Confidence 2345679999999998865 3 377899999999999999999999875554445555554433333344568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++||.+||. +|.+|||+.++++||||+...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999998 899999999999999998543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=406.21 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=222.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC---------hhhHHHHHHHHHHHHhCCCCCceeEEE
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL---------PGDLQKLYSEVHLLKSLKDDNVVKFYK 145 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~---------~~~~~~~~~Ei~iL~~L~HpNIVkl~~ 145 (719)
.+..|++.+.||+|+||+||+|.++.+|..||+|++........ ....+.+.+|+.+|++|+||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45668889999999999999999999999999999976442210 134577899999999999999999999
Q ss_pred eeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC--CcEE
Q 005017 146 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVK 223 (719)
Q Consensus 146 ~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~--G~vK 223 (719)
++.+. ..+++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+. ..+|
T Consensus 114 ~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECS--SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcC--CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 98654 468999999999999999998889999999999999999999999999 99999999999998543 2699
Q ss_pred EeecchhhhccCC-CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc-
Q 005017 224 IGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS- 301 (719)
Q Consensus 224 L~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~- 301 (719)
|+|||++...... .....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+.....
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCc
Confidence 9999999776543 3456689999999999998899999999999999999999999987 567778888877654332
Q ss_pred -cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 302 -LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 302 -~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.....++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 235568899999999998 899999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=378.23 Aligned_cols=261 Identities=29% Similarity=0.396 Sum_probs=206.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC-ChhhHHHHHHHHHHHHhC---CCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~-~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~~ 150 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|++....... .......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3456788999999999999999999999999999998644221 111224566777777766 499999999998765
Q ss_pred CCC---ceeEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 151 KKK---TVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 151 ~~~---~l~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
... .+++||||+. |+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEe
Confidence 422 5789999997 599999987654 999999999999999999999999 9999999999999855 799999
Q ss_pred ecchhhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCC-C
Q 005017 226 DLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-A 300 (719)
Q Consensus 226 DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p-~ 300 (719)
|||++...... .....+||+.|+|||++. ..++.++|||||||++|+|++|+.||... +.......+.. +..+ .
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN-SEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS-SHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChh
Confidence 99999876543 345678999999999875 46899999999999999999999999874 44444433322 1111 0
Q ss_pred c----------------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 301 S----------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 301 ~----------------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
. .....++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0 112456889999999998 899999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=391.84 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=218.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
..+|.+.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.+|++|+||||+++++++.+. ..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEE
Confidence 356889999999999999999999999999999987543 23456788999999999999999999998654 468
Q ss_pred eEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G~vKL~DFGlA~~~ 233 (719)
++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++...
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999999997654 6999999999999999999999999 999999999999974 3468999999999876
Q ss_pred cCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChH
Q 005017 234 QQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~ 309 (719)
... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||.. .+.......+..... +.......+++
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 543 2345679999999998865 589999999999999999999999987 455566666665433 22333456889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999998 899999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=384.31 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=211.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+.|++.+.||+|+||+||+|.+..++..||+|++....... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--QY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--Ce
Confidence 466899999999999999999999999999999997643221 235567899999999999999999999998654 46
Q ss_pred eeEEEecccCCChhHHhhh----------------------------------------cccccHHHHHHHHHHHHHHhh
Q 005017 155 VNMITELFTSGNLRQYRKK----------------------------------------HKNVDIKVIKNWARQILHGLV 194 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~----------------------------------------~~~l~~~~i~~i~~QIl~gL~ 194 (719)
+++||||+++|+|.+++.. ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 8999999999999999852 112467889999999999999
Q ss_pred hhhcCCCCeeeecCccceeEecCCC-CcEEEeecchhhhccCC------CcccccCCCCCCCccccc---cccCccccch
Q 005017 195 YLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQP------TARSVIGTPEFMAPELYE---EEYNELVDIY 264 (719)
Q Consensus 195 yLHs~~ppIIHrDLKp~NILl~~~~-G~vKL~DFGlA~~~~~~------~~~~~~GT~~YmAPEvl~---~~~s~ksDIw 264 (719)
|||+++ |+||||||+|||++.+. +.+||+|||++...... ......||+.|+|||++. ..++.++|||
T Consensus 183 ~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 183 YLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 999999 99999999999997442 28999999999754321 123567999999999885 4589999999
Q ss_pred hhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 265 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 265 SlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
||||++|||++|+.||... +..+....+...... .......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 261 slG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGV-NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHCCCCCCCC-ChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999874 444555555544332 22333468899999999998 899999999999999998544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=376.98 Aligned_cols=257 Identities=22% Similarity=0.376 Sum_probs=206.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++... ..+++
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l 79 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHL 79 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEE
Confidence 4788899999999999999999999999999886543 2234567788999999999999999999998765 45889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+.+++|.+++...+.+++..++.++.|++.||+|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc
Confidence 9999999999999988888999999999999999999999999 9999999999999855 79999999999766533
Q ss_pred -CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CC-------------
Q 005017 237 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GI------------- 297 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~------------- 297 (719)
......||+.|+|||++.+ .++.++||||||+++|+|+||+.||.......... .+.. ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhcccccccccccccccc
Confidence 2345679999999998864 58999999999999999999999998754333322 2211 00
Q ss_pred ----C-CC--c------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 298 ----K-PA--S------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 298 ----~-p~--~------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
. +. . .....++.+.+||.+||. +|.+|||+.++|+||||+.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 0 00 0 012356789999999998 89999999999999999865543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=388.05 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=215.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|++..... ...+|+++|.++ +||||+++++++.+. ..+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--KYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--SEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEE
Confidence 458889999999999999999999999999999975432 134688888887 799999999988654 568
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC---CcEEEeecchhhh
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIA 232 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~---G~vKL~DFGlA~~ 232 (719)
|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||+..+. +.+||+|||+++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999998888999999999999999999999999 99999999999985433 3599999999986
Q ss_pred ccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC--CCHHHHHHHHHcCCCCC--ccccC
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPA--SLAKV 305 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--~~~~~i~~~i~~g~~p~--~~~~~ 305 (719)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... ....+++..+..+..+. ..+..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 6443 3446689999999998875 4899999999999999999999999753 45677888887765432 23355
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.++++++||.+||. ||.+|||+.++|+||||...
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 78899999999998 89999999999999999653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.43 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=220.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.-..|.+.+.||+|+||.||+|.+..++..||+|++....... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KR 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CE
Confidence 3456889999999999999999999999999999987543221 22346789999999999999999999998754 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCc
Confidence 8899999999999999998888999999999999999999999999 9999999999999855 799999999997665
Q ss_pred CCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .........+..... .++...++.++++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 242 (284)
T 2vgo_A 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDL 242 (284)
T ss_dssp SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHH
T ss_pred ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHH
Confidence 555566789999999998865 589999999999999999999999987 445555555555432 2345568899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
|.+||. +|.+|||+.++++||||+...
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999998 899999999999999998543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=386.99 Aligned_cols=259 Identities=25% Similarity=0.458 Sum_probs=217.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+..+|..||+|++.... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CE
Confidence 3456889999999999999999999999999999987542 245567899999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++.+ |.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCccc
Confidence 889999999999999999888999999999999999999999985 8 9999999999999865 79999999999766
Q ss_pred cCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHH-----------------------
Q 005017 234 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI----------------------- 289 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i----------------------- 289 (719)
.........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +..++
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC------------------
T ss_pred ccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCC
Confidence 5444556789999999998865 5899999999999999999999999763 22222
Q ss_pred -------------------HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 290 -------------------FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 290 -------------------~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
...+.....+.......++++++||.+||. +|.+|||+.++|+||||+.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 222333333333344567899999999998 89999999999999999865543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=381.53 Aligned_cols=254 Identities=30% Similarity=0.513 Sum_probs=197.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|+++.... ....+.+.+|+.+|++++||||+++++++... ..++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEE
Confidence 456788999999999999999999999999999976542 23346788999999999999999999988654 4689
Q ss_pred EEEecccCCChhHHhhhc------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 157 MITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCccc
Confidence 9999998 5999998754 35899999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCC----
Q 005017 231 IAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPA---- 300 (719)
Q Consensus 231 ~~~~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~---- 300 (719)
...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||... +.......+.. +..+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT-NDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCSCCTTTCG
T ss_pred eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhHhh
Confidence 766432 2345679999999998864 5899999999999999999999999874 44444333321 11100
Q ss_pred --------------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 301 --------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 301 --------------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
......++++++||.+||. ||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0112457789999999998 899999999999999998544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=385.25 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=215.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+|++++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEE
Confidence 4578889999999999999999999999999999754322 234557889999999999999999999998765 4588
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCceecCC
Confidence 9999997 578887754 567999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CCcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 236 PTARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
....+||+.|+|||++. +.++.++|||||||++|||+||+.||... +.......+..+..+.......++.++
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 24567999999999873 46899999999999999999999999874 444444455555555555566788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+||.+||. +|.+|||+.++|+||||....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999998 899999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=398.15 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=210.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC----ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ----LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~----~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..|.+.+.||+|+||+||+|.+..+|+.||+|++....... .......+.+|+.+|++++||||+++++++..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--- 211 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 211 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 45788999999999999999999999999999998654321 11223357899999999999999999998743
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecchh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLA 230 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGlA 230 (719)
..+++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+.+||+|||++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccc
Confidence 237899999999999999998889999999999999999999999999 9999999999999743 236999999999
Q ss_pred hhccCC-CcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC--ccc
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLA 303 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~ 303 (719)
+..... .....+||+.|+|||++. ..|+.++|||||||++|+|+||+.||........+...+..+..+. ...
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 876543 335678999999999874 4588899999999999999999999987555555666666654432 233
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 4567899999999998 899999999999999998544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.02 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=217.8
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.+.||+|+||+||+|.+..+|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST--THY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEE
Confidence 4568899999999999999999999999999999985432 2335688999999999999999999988654 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. .+.+.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 899999999999999988888999999999999999999999999 99999999999992 24479999999999766
Q ss_pred cCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChHH
Q 005017 234 QQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQI 310 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~l 310 (719)
.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...+...+..+..+ .......++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 160 QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 5544556679999999998865 589999999999999999999999987 4566677777766432 23345567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 999999998 89999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=404.13 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=220.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+|+.++||||+++++++... ..++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~ 92 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIF 92 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 45788999999999999999999999999999997543221 23457889999999999999999999988655 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhcccc
Confidence 99999999999999998889999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred -CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+ .+...++..+..+... .+...++++++|
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~L 246 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISL 246 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHH
Confidence 34567899999999998764 4 7899999999999999999999987 4556677777776543 345568899999
Q ss_pred HHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 314 IEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
|.+||. ||.+|||+.++++||||+..
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999998 89999999999999999853
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=380.73 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=194.6
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.||+|+||+||+|.+..+|+.||+|++... ....+.+|+.+++.+. ||||+++++++.+. ..+++||||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEEc
Confidence 6799999999999999999999999998632 3466789999999997 99999999998654 458899999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC--CcEEEeecchhhhccCC--C
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQQP--T 237 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~--G~vKL~DFGlA~~~~~~--~ 237 (719)
+++|+|.+++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+. ..+||+|||+++..... .
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999999999889999999999999999999999999 99999999999997542 27999999999765433 2
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC------CCHHHHHHHHHcCCCCC--ccccCCCh
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPA--SLAKVNDP 308 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~------~~~~~i~~~i~~g~~p~--~~~~~~~~ 308 (719)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... ....++...+..+..+. ......++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 345678999999998865 5899999999999999999999999753 23355667776654432 22345688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++++||.+||. ||.+|||+.++++||||+...
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 99999999998 899999999999999998643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.26 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=219.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 467889999999999999999999999999999986543 235567899999999999999999999998876667899
Q ss_pred EEEecccCCChhHHhhhcc----cccHHHHHHHHHHHHHHhhhhhcCC---CCeeeecCccceeEecCCCCcEEEeecch
Q 005017 157 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~----~l~~~~i~~i~~QIl~gL~yLHs~~---ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ .+|+||||||+||+++.+ |.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCch
Confidence 9999999999999997643 3999999999999999999999987 359999999999999855 7999999999
Q ss_pred hhhccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 230 AIAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 230 A~~~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.. .+..++...+..+..+ .++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRY 240 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTS
T ss_pred heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCccc
Confidence 98765432 234579999999998865 589999999999999999999999987 4566677777766543 344567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++++++|.+||. +|.+|||+.+||+|+|+...
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 8899999999998 89999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=389.39 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=207.5
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC-
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK- 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~- 152 (719)
.....|.+.++||+|+||+||+|.+..+|+.||+|+++.. .......+++.+|+.+|++++||||+++++++.....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 3456788999999999999999999999999999998743 2334566889999999999999999999999876532
Q ss_pred --CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 153 --KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 153 --~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~-~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC-CCEEEccCCCc
Confidence 56899999986 599999998888999999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCC------------------------CcccccCCCCCCCcccc-c-cccCccccchhhHHHHHHHhhccCC-----
Q 005017 231 IAMQQP------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYP----- 279 (719)
Q Consensus 231 ~~~~~~------------------------~~~~~~GT~~YmAPEvl-~-~~~s~ksDIwSlGiil~EmlTG~~P----- 279 (719)
+..... .....+||+.|+|||++ . ..|+.++|||||||++|||++|..|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 765432 12456899999999975 3 4599999999999999999985333
Q ss_pred ------CCCCCC-----------------HHHH-----------------------HHHHHcCCC--CCc---cccCCCh
Q 005017 280 ------YSECKN-----------------PAQI-----------------------FKKVTSGIK--PAS---LAKVNDP 308 (719)
Q Consensus 280 ------f~~~~~-----------------~~~i-----------------------~~~i~~g~~--p~~---~~~~~~~ 308 (719)
|.+... ..++ ...+..... +.. .....++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 322110 1111 111111000 000 1134678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
++++||.+||. ||.+|||+.|+|+||||+.....
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999999998 99999999999999999875543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.59 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=209.1
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCceeEEEe
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----DDNVVKFYKS 146 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpNIVkl~~~ 146 (719)
.......|++.++||+|+||+||+|.+..+|+.||+|+++.. ....+.+..|+.+++.+. ||||++++++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 334456789999999999999999999999999999998632 344567788999999997 9999999999
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-------
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------- 217 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~------- 217 (719)
+...+ .+++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 105 ~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEE
T ss_pred eeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccc
Confidence 87654 588999999 999999998754 5999999999999999999999999 999999999999974
Q ss_pred -----------------CCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCC
Q 005017 218 -----------------NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYP 279 (719)
Q Consensus 218 -----------------~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~P 279 (719)
..+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 257899999999976443 2345689999999998764 699999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCC--CC------------------------------------------ccccCCChHHHHHHH
Q 005017 280 YSECKNPAQIFKKVTSGIK--PA------------------------------------------SLAKVNDPQIKGFIE 315 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~--p~------------------------------------------~~~~~~~~~l~~lI~ 315 (719)
|... +..+....+..... |. ......++.+.+||.
T Consensus 259 f~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 259 FRTH-EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CCCS-SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCC-cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9874 34443333322111 10 011122467889999
Q ss_pred HhcC-CCCCCCCHHHHHcCccCc
Q 005017 316 KCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+||. ||.+|||+.|+|+||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 9998 899999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=398.95 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=196.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---K 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---~ 152 (719)
...|++.++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|++|+|||||++++++.... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 35688999999999999999999999999999998643 233456688999999999999999999999986543 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+ +|+|.+++.....+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCBC
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeecccccchh
Confidence 5689999998 5799999998888999999999999999999999999 9999999999999865 7999999999976
Q ss_pred ccCC-----------------------------CcccccCCCCCCCcccc-c-cccCccccchhhHHHHHHHhh------
Q 005017 233 MQQP-----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT------ 275 (719)
Q Consensus 233 ~~~~-----------------------------~~~~~~GT~~YmAPEvl-~-~~~s~ksDIwSlGiil~EmlT------ 275 (719)
.... .....+||+.|+|||++ . ..|+.++|||||||++|||+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 5321 12345789999999975 3 459999999999999999999
Q ss_pred -----ccCCCCCCCC--------------------HHHHHHHHH--cCCCC---------------------------Cc
Q 005017 276 -----FEYPYSECKN--------------------PAQIFKKVT--SGIKP---------------------------AS 301 (719)
Q Consensus 276 -----G~~Pf~~~~~--------------------~~~i~~~i~--~g~~p---------------------------~~ 301 (719)
|+++|.+... ..++ ..+. .+..+ ..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHH-HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHH-HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6666654221 0111 1110 00000 11
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
.....++++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 123347899999999998 9999999999999999986554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=367.31 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=221.7
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
....+.|.+.+.||+|+||+||+|.+..+|+.||+|.+...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 87 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 87 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--
Confidence 34667889999999999999999999999999999998755432 245667889999999999999999999998654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~ 164 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATK 164 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCcee
Confidence 468899999999999999998888999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||.. ....+.+..+..+.. .++...++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (294)
T 2rku_A 165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPV 241 (294)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHH
T ss_pred cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHH
Confidence 5432 2345679999999998865 488999999999999999999999987 445555555555432 234567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++++|.+||. +|.+|||+.++++||||+..
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999998 89999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=382.22 Aligned_cols=255 Identities=22% Similarity=0.433 Sum_probs=217.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh----hhHHHHHHHHHHHHhC-CCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP----GDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~----~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~ 151 (719)
..|.+.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+.+|+.+++++ +||||++++++|...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS- 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-
Confidence 3578889999999999999999999999999998765422211 2246778999999999 899999999988654
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 173 -~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 -SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSC 248 (365)
T ss_dssp -SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred -CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCccc
Confidence 468899999999999999998888999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCC-CcccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-
Q 005017 232 AMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL- 302 (719)
Q Consensus 232 ~~~~~-~~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~- 302 (719)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+.......+..+......
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCc
Confidence 66543 3455789999999998753 488899999999999999999999987 4556666666665443322
Q ss_pred -ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 303 -AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 303 -~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
....++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 24567889999999998 899999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=368.69 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=203.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+..+...++.++||||+++++++.+. ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~~ 80 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--GD 80 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--CC
Confidence 44678899999999999999999999999999999875432 123334445555668889999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 155 VNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+||+++.+ +.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 156 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFGI 156 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC--
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecCC
Confidence 8899999974 88777653 56799999999999999999999998 8 9999999999999865 6999999999
Q ss_pred hhhccCCC-cccccCCCCCCCccccc-----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 230 AIAMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 230 A~~~~~~~-~~~~~GT~~YmAPEvl~-----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
+....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||..................+....
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 97665443 33457999999999862 3588999999999999999999999987666666666666555555555
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...++++++||.+||. +|.+|||+.++++||||+...
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 5678899999999998 899999999999999998544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=372.43 Aligned_cols=258 Identities=23% Similarity=0.433 Sum_probs=216.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|..||+|+++...........+.+.+|+.++++++||||+++++++.......++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 34678899999999999999999999999999998654333334567899999999999999999999998766667799
Q ss_pred EEEecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+| |.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeeccccccccC
Confidence 999999887 7777665 356999999999999999999999999 9999999999999855 799999999997654
Q ss_pred CC----CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 235 QP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 235 ~~----~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+.......+..+.. .++...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~ 237 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCG 237 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccC
Confidence 22 2234569999999998864 257899999999999999999999987 556667777766543 2345678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+.+.+||.+||. +|.+|||+.++++||||+....
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 899999999998 8999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=409.27 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=223.0
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.....|++.++||+|+||.||+|.++.+|+.||+|++....... ......+.+|+.+|++++|||||++++++.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--D 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--C
Confidence 34567899999999999999999999999999999997643322 23456788999999999999999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 154 TVNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+++||||+++|+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccce
Confidence 68999999999999999987543 999999999999999999999999 9999999999999855 799999999998
Q ss_pred hccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHHcCCCCCccccCC
Q 005017 232 AMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 232 ~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.... ....+...+... +..++...
T Consensus 335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~ 412 (576)
T 2acx_A 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERF 412 (576)
T ss_dssp ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTS
T ss_pred ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccC
Confidence 76543 3345689999999998865 59999999999999999999999997642 345566666553 33445667
Q ss_pred ChHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 307 DPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
++++++||.+||. ||.+|| ++.|+++||||+..++..
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~ 455 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR 455 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence 8999999999998 899999 899999999999776543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=387.78 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=209.7
Q ss_pred CcEEE--eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 77 RYVRY--DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 77 r~~~l--~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+|.+ .++||+|+||.||+|.+..+|..||+|+++... ....+.+.+|+.+|++|+||||+++++++... ..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--ND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CE
Confidence 44554 578999999999999999999999999997543 24567899999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec-CCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~-~~~G~vKL~DFGlA~~ 232 (719)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. .+.+.+||+|||+++.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 89999999999999988654 46999999999999999999999999 99999999999984 2446899999999987
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCCh
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDP 308 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~ 308 (719)
.... .....+||+.|+|||++.. .++.++|||||||++|||+||+.||.. .+....+..+..... +.......++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCChhhhccCCH
Confidence 6543 2345579999999998864 588999999999999999999999987 455555566555433 2223345688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++++||.+||. +|.+|||+.++|+||||+...
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 99999999998 899999999999999998543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=386.48 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=205.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC----
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD---- 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~---- 150 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+|+.++|||||+++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456789999999999999999999999999999998754321 23699999999999999999988653
Q ss_pred --------------------------------CCCceeEEEecccCCChhHHhh----hcccccHHHHHHHHHHHHHHhh
Q 005017 151 --------------------------------KKKTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLV 194 (719)
Q Consensus 151 --------------------------------~~~~l~lV~Ey~~gGsL~~~L~----~~~~l~~~~i~~i~~QIl~gL~ 194 (719)
+..++++||||+++ +|.+++. ..+.+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 23458899999985 7666554 4567999999999999999999
Q ss_pred hhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHH
Q 005017 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCIL 271 (719)
Q Consensus 195 yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~ 271 (719)
|||+++ |+||||||+|||++...|.+||+|||+|+..... ......||+.|+|||++.+ .++.++|||||||++|
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 999999 9999999999999866679999999999866433 3445678999999998764 4899999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHcCCCC--------------------------CccccCCChHHHHHHHHhcC-CCCCC
Q 005017 272 EMVTFEYPYSECKNPAQIFKKVTSGIKP--------------------------ASLAKVNDPQIKGFIEKCLV-PASER 324 (719)
Q Consensus 272 EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--------------------------~~~~~~~~~~l~~lI~kcL~-dP~~R 324 (719)
||++|+.||.+.....++...+.....| ..++...++++++||.+||. +|.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999998754444443333210000 01233467889999999998 89999
Q ss_pred CCHHHHHcCccCccc
Q 005017 325 LSAKDLLKDPFLQVE 339 (719)
Q Consensus 325 pSa~eLL~hpf~~~~ 339 (719)
||+.|+|+||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=377.77 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=210.8
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~ 154 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|+++.. ..+.+.+|+.+|++++ ||||+++++++.+.....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 45688999999999999999999999999999998632 2467889999999997 999999999998766677
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+++...
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 899999999999999885 4889999999999999999999999 99999999999998665589999999997655
Q ss_pred CC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-------------CC-
Q 005017 235 QP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------GI- 297 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-------------g~- 297 (719)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.. ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 33 3345679999999998764 5899999999999999999999999654444332222111 10
Q ss_pred ---------------------CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 ---------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 ---------------------~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+.......++++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0011122357899999999998 899999999999999998543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=378.94 Aligned_cols=263 Identities=21% Similarity=0.303 Sum_probs=213.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC--
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK-- 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~-- 153 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|+++.... .......++.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4567899999999999999999999999999999975432 2345567899999999999999999999988765432
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCcccc
Confidence 45899999999999999998889999999999999999999999999 9999999999999865 79999999999765
Q ss_pred cCC-----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC-ccccCC
Q 005017 234 QQP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVN 306 (719)
Q Consensus 234 ~~~-----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~-~~~~~~ 306 (719)
... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||............+.....+. ......
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 432 1234579999999998865 589999999999999999999999987443333344444433332 223456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
+++++++|.+||. +|.+||++.++|.|+|++.....
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 8899999999998 89999999999999999865443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=373.45 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=209.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.....|++.+.||+|+||+||+|.+ +|..||+|++..... .....+.+.+|+.+|++++||||+++++++...+
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 107 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-- 107 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--
Confidence 3456789999999999999999976 689999999875432 2455678999999999999999999999886554
Q ss_pred ceeEEEecccCCChhHHhhhccc---ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 154 TVNMITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~---l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
.+++||||+.+|+|.+++...+. +++..++.++.||+.||+|||+++++|+||||||+|||++.+ |.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCC
Confidence 58899999999999999987653 999999999999999999999999889999999999999855 79999999999
Q ss_pred hhccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 231 IAMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 231 ~~~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+..+....+.........+...+
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCC
Confidence 765433 2345679999999998865 589999999999999999999999987 456666666655555556667788
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc--CccCc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK--DPFLQ 337 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~--hpf~~ 337 (719)
+++++||.+||. +|.+|||+.++++ .++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999998 8999999999998 45554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.03 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=213.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l 155 (719)
+|+...+.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++.+. ||||+++++++... ..+
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~ 104 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEI 104 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeE
Confidence 444445899999999999999999999999999875432 2244678899999999995 69999999998654 458
Q ss_pred eEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhh
Q 005017 156 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAI 231 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~ 231 (719)
++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++. ..|.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 9999999999999998653 67999999999999999999999999 999999999999985 24799999999997
Q ss_pred hccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCC
Q 005017 232 AMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVND 307 (719)
Q Consensus 232 ~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~ 307 (719)
..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +....+..+..... +.......+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhcccC
Confidence 66543 2345679999999998864 5899999999999999999999999874 45555555544322 333345567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCCCC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 344 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~~ 344 (719)
+.+++||.+||. +|.+|||+.++|+||||+..++...
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 899999999998 8999999999999999997766543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=363.17 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=208.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l 155 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|+++..... ......+.+|+..+.++ +||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeE
Confidence 4578899999999999999999999999999998854322 34567888999999999 999999999998765 458
Q ss_pred eEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--------------
Q 005017 156 NMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-------------- 217 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-------------- 217 (719)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC---------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 8999999999999999865 56899999999999999999999999 999999999999973
Q ss_pred ----CCCcEEEeecchhhhccCCCcccccCCCCCCCccccccc--cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHH
Q 005017 218 ----NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 291 (719)
Q Consensus 218 ----~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~--~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~ 291 (719)
+.+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..|+... ....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~ 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWH 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHH
T ss_pred cccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHH
Confidence 2247999999999766543 234699999999988754 567999999999999999999877542 2344
Q ss_pred HHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 292 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 292 ~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+..+..+ .++...++.++++|.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHcCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 45555443 3455678999999999998 89999999999999999854
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.74 Aligned_cols=260 Identities=26% Similarity=0.487 Sum_probs=213.6
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeec
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD 149 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~ 149 (719)
+.......|++.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33345566789999999999999999999999999999987543 2346788999999999 89999999999876
Q ss_pred CC----CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 150 DK----KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 150 ~~----~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
.. ...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEE
Confidence 43 45789999999999999999864 46899999999999999999999999 9999999999999855 7999
Q ss_pred EeecchhhhccCC--CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc
Q 005017 224 IGDLGLAIAMQQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 224 L~DFGlA~~~~~~--~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~ 295 (719)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+||..||... +.......+..
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~ 248 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPR 248 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHH
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhc
Confidence 9999998765432 234567999999999874 35889999999999999999999999874 44444555555
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
...+.......++.+++||.+||. +|.+|||+.++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 555555556678999999999998 89999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=399.09 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=200.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++|||||++++++.... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 55788899999999999999999999999999997542 23456678999999999999999999999986543 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+.++ |.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC--
T ss_pred CeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeeee
Confidence 4679999999765 6666543 4899999999999999999999999 9999999999999865 7999999999987
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCC--------
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPA-------- 300 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~-------- 300 (719)
.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....+ +..+.. +..+.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSCH
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcch
Confidence 6544 3456789999999998764 699999999999999999999999987443333 333321 11100
Q ss_pred ---------------ccccC---------------CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 301 ---------------SLAKV---------------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 301 ---------------~~~~~---------------~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.++.. .++++++||.+||. ||.+|||+.|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000 14578999999998 9999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.45 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=212.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc----CChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL----QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~----~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||.||+|.+..+|+.||+|++...... ........+.+|+.+|++++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 4578899999999999999999999999999998754321 1112334678999999999999999999987543
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC--CcEEEeecchh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLA 230 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~--G~vKL~DFGlA 230 (719)
.+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||++
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 27899999999999999998889999999999999999999999999 99999999999997542 25999999999
Q ss_pred hhccCCC-cccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--Cccc
Q 005017 231 IAMQQPT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLA 303 (719)
Q Consensus 231 ~~~~~~~-~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~ 303 (719)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+... ....
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 7665432 23567999999999873 458899999999999999999999998755544455555554432 2233
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 4567899999999998 899999999999999998544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=376.30 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=211.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..+..|++.++||+|+||+||+|.+..+|+.||+|+++..... ...+.+.+|+++|++++||||+++++++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 4567789999999999999999999999999999998754322 3356788999999999999999999998877766
Q ss_pred ceeEEEecccCCChhHHhhhccc---ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe----cCCCCcEEEee
Q 005017 154 TVNMITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGD 226 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~---l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl----~~~~G~vKL~D 226 (719)
.+++||||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+ +. .+.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~-~~~~kL~D 159 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDG-QSVYKLTD 159 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTS-CEEEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCC-CceEEEcc
Confidence 88999999999999999987543 999999999999999999999999 9999999999998 53 36899999
Q ss_pred cchhhhccCC-CcccccCCCCCCCccccc---------cccCccccchhhHHHHHHHhhccCCCCCCCC---HHHHHHHH
Q 005017 227 LGLAIAMQQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKV 293 (719)
Q Consensus 227 FGlA~~~~~~-~~~~~~GT~~YmAPEvl~---------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---~~~i~~~i 293 (719)
||+++..... ......||+.|+|||++. ..++.++|||||||++|||+||+.||..... ...+...+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 9999776543 334567999999999874 4689999999999999999999999964332 23344444
Q ss_pred HcCCCCC-----------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 294 TSGIKPA-----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 294 ~~g~~p~-----------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
..+..+. .+....++.+.+||.+||. ||.+|||+.|+|+||
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 4333211 1112224578999999998 999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=367.77 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=221.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++... ..++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 97 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFY 97 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEE
Confidence 4678899999999999999999999999999999754432 24567899999999999999999999988654 4688
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFGlA~~~~ 234 (719)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ .+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999988888999999999999999999999999 9999999999999743 2479999999998765
Q ss_pred CCC-cccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc--ccCCChHHH
Q 005017 235 QPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIK 311 (719)
Q Consensus 235 ~~~-~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~--~~~~~~~l~ 311 (719)
... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+..++...+..+..+... ....+++++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 432 344568999999999988899999999999999999999999987 4566677777766544332 245678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+||.+||. +|.+|||+.++|+||||+...
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999998 899999999999999998543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.05 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=210.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS-LDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc-hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeE
Confidence 356788999999999999999999999999999997543211 23456889999999999999999999988654 468
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCC
Confidence 899999999999999998888999999999999999999999999 9999999999999855 7999999999977654
Q ss_pred C-CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 P-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~-~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
. ......||+.|+|||++.+. + +.++||||||+++|+|++|+.||.. .........+..+..+ .+...++.+++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVAT 240 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHH
Confidence 3 23456799999999998754 3 6899999999999999999999987 4566677777665432 34556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+|.+||. +|.+|||+.++++||||+.
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHccCChhhCCCHHHHHhChhhcc
Confidence 9999998 8999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=376.09 Aligned_cols=259 Identities=28% Similarity=0.421 Sum_probs=222.3
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
....+.|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 113 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-- 113 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 34567889999999999999999999999999999998755432 245667889999999999999999999998754
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATK 190 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCcee
Confidence 468999999999999999998888999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 233 MQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 233 ~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. ......+..+..+.. .++...++.
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~ 267 (335)
T 2owb_A 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPV 267 (335)
T ss_dssp CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHH
T ss_pred cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHH
Confidence 5432 2345679999999998865 588999999999999999999999987 445555555555432 234567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9999999998 899999999999999997543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=384.95 Aligned_cols=256 Identities=29% Similarity=0.426 Sum_probs=206.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC---
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--- 152 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+|++++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 456788999999999999999999999999999986432 234556788999999999999999999999866432
Q ss_pred -CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 -~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeeeccc
Confidence 3568999999 8899999876 57999999999999999999999999 9999999999999865 799999999997
Q ss_pred hccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCC--------
Q 005017 232 AMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-------- 299 (719)
Q Consensus 232 ~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p-------- 299 (719)
..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....+ +..+.. +..+
T Consensus 177 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCS
T ss_pred ccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhh
Confidence 65433 345689999999998764 589999999999999999999999987443333 322221 1111
Q ss_pred -------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 -------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 -------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......++.+++||.+||. ||.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11223457899999999998 999999999999999998543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=367.72 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=191.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+++.+|+.++++++||||+++++++.+. ..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 87 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYVY 87 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeEE
Confidence 45788999999999999999999999999999997543221 23457889999999999999999999998654 4688
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceeeccC
Confidence 999999999999999875 56999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred C--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+... ....+...++++++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVLA--DYEMPSFLSIEAKD 241 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHhhc--ccCCccccCHHHHH
Confidence 2 2335679999999998865 5889999999999999999999999764332 222222211 12334556889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+|.+||. +|.+|||+.++|+||||+...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999998 899999999999999998543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=369.44 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=210.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+..+|..||+|++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD--GK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--Ce
Confidence 3456788999999999999999999999999999987543 24467889999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCCCccc
Confidence 8899999999999999876 456999999999999999999999999 9999999999999855 79999999998543
Q ss_pred cC--CCcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-Ccccc
Q 005017 234 QQ--PTARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAK 304 (719)
Q Consensus 234 ~~--~~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~ 304 (719)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|+.||... +.......+.....+ ...+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCcc
Confidence 21 1223457999999999873 35889999999999999999999999874 444444455444333 23345
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..++.++++|.+||. +|.+|||+.++++||||+...
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 568899999999998 899999999999999998544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=364.61 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=217.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|.++....... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--Ce
Confidence 357889999999999999999999999999999986543321 12467899999999999999999999988754 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC---CcEEEeecchhh
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAI 231 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~---G~vKL~DFGlA~ 231 (719)
+++||||+++++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+. +.+||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 8899999999999999988888999999999999999999999999 99999999999997542 279999999997
Q ss_pred hccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCC
Q 005017 232 AMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVND 307 (719)
Q Consensus 232 ~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~ 307 (719)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+...... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCC
Confidence 65433 234557999999999886 4589999999999999999999999987 4555666666554332 22335567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 899999999998 8999999999999999986543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.17 Aligned_cols=251 Identities=31% Similarity=0.503 Sum_probs=206.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEecc
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 162 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~ 162 (719)
.+||+|+||+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence 38999999999999999999999999987543 24457789999999999999999999998755 4588999999
Q ss_pred cCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--C
Q 005017 163 TSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 237 (719)
Q Consensus 163 ~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~ 237 (719)
++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++...|.+||+|||++...... .
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999997652 4678999999999999999999999 9999999999999875679999999999765432 2
Q ss_pred cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
.....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.....................++...++++++||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 345679999999998864 37899999999999999999999997654444433333222233345566789999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
.+||. +|.+|||+.++|+||||+....
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99998 8999999999999999985543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.82 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=219.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCC-CCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLK-DDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-----~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~ 148 (719)
....|++.+.||+|+||.||+|.++.+|+.||+|++........ ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 34568899999999999999999999999999999976532111 133467889999999995 999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
.. ..+++||||+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||
T Consensus 95 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg 169 (298)
T 1phk_A 95 TN--TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFG 169 (298)
T ss_dssp CS--SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCT
T ss_pred cC--CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEeccc
Confidence 54 568999999999999999998888999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCC-CcccccCCCCCCCccccc-------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 229 LAIAMQQP-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 229 lA~~~~~~-~~~~~~GT~~YmAPEvl~-------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.. .+.......+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCccc
Confidence 99765543 334567999999999874 2478899999999999999999999987 45566666666554332
Q ss_pred c--cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 301 S--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 301 ~--~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
. .....++.++++|.+||. +|.+|||+.++|+||||+...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 2 224567899999999998 899999999999999998544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=416.08 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=225.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~ 154 (719)
-..|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..+|..+ +||||+++++++.+. ..
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CE
Confidence 345788999999999999999999999999999998543222 23456788999999988 799999999988654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||+.+|+|.+++...+.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+ |.+||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeeccc
Confidence 8999999999999999999889999999999999999999999999 9999999999999855 799999999997543
Q ss_pred --CCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 235 --QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 235 --~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+ .+..+++..+..+.. .++...+++++
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~ 570 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAV 570 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHH
Confidence 23455678999999999886 4699999999999999999999999987 677888888887543 34556789999
Q ss_pred HHHHHhcC-CCCCCCCH-----HHHHcCccCccccCCCC
Q 005017 312 GFIEKCLV-PASERLSA-----KDLLKDPFLQVENQKEP 344 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa-----~eLL~hpf~~~~~~~~~ 344 (719)
+||.+||. +|.+||++ .+|++||||+..++...
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 99999998 89999997 99999999998776543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=377.82 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=207.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC-----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----- 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 151 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|++++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4678889999999999999999999999999998755432 233456789999999999999999999987643
Q ss_pred -CCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 152 -KKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 152 -~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
...+++||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEccchh
Confidence 3468999999986 66666554 467999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCC------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CCC
Q 005017 230 AIAMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIK 298 (719)
Q Consensus 230 A~~~~~~------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~~ 298 (719)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+. +.......+.. ...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCC
Confidence 9765421 2234578999999998754 4899999999999999999999999874 44443333322 222
Q ss_pred CCccccC---------------------------CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 299 PASLAKV---------------------------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 299 p~~~~~~---------------------------~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+..++.. .++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 2211111 26789999999998 999999999999999998543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=377.98 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=200.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+|+.+|++++||||+++++++... ..+++
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 77 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTL 77 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEE
Confidence 478889999999999999999999999999998754321 1112345799999999999999999998655 45889
Q ss_pred EEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSIP 153 (324)
T ss_dssp EEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC---
T ss_pred Eecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCcccccccCC
Confidence 999997 58998887654 5999999999999999999999999 9999999999999865 79999999999765432
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CCCCCcc-------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPASL------- 302 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~~p~~~------- 302 (719)
......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+. +..+....+.. ...+..+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2344578999999998764 5899999999999999999999999874 44443333322 1111111
Q ss_pred ------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 303 ------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 303 ------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
....++++++||.+||. ||.+|||+.|+|+||||+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12346789999999998 89999999999999999866543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=387.08 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=201.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHH-HhCCCCCceeEEEeeec--CC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL-KSLKDDNVVKFYKSWVD--DK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkl~~~~~~--~~ 151 (719)
.+.|+...++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++ +.++||||+++++++.. .+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 345555568999999999999999999999999998622 3466888887 45589999999998754 33
Q ss_pred CCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DF 227 (719)
...+|+||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .|.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence 457899999999999999998754 5999999999999999999999999 9999999999999853 478999999
Q ss_pred chhhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCH---HHHHHHHHcCCC--CC
Q 005017 228 GLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIK--PA 300 (719)
Q Consensus 228 GlA~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~---~~i~~~i~~g~~--p~ 300 (719)
|+++..... .....+||+.|+|||++. ..|+.++|||||||++|||++|+.||...... ......+..+.. +.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 999765433 335678999999999886 46999999999999999999999999763321 113344444432 22
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......++++++||.+||. +|.+|||+.++|+||||...
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 2234568899999999998 89999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=402.52 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=221.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.++||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++||||++++++|... ..
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CE
Confidence 3457888999999999999999999999999999997544322 23456788999999999999999999988655 45
Q ss_pred eeEEEecccCCChhHHhhhc----ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 155 VNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~----~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeeccee
Confidence 89999999999999998764 36999999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHHcCCCCCcccc
Q 005017 231 IAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 231 ~~~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~~ 304 (719)
+...... ....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.... ....+...+..... .++.
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~ 414 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPD 414 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCT
T ss_pred eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCc
Confidence 8765432 345689999999998865 59999999999999999999999997642 34666666665432 3445
Q ss_pred CCChHHHHHHHHhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
..++.+++||.+||. +|.+||+ +.++++||||+..++.
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 678999999999998 8999995 5999999999976654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.22 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=214.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||+||+|.+. .+|+.||+|+++...........+.+.+|+.+|+++ +||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 131 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 131 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence 57899999999999999999884 589999999987544322223345677899999999 699999999988665
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKE 208 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCee
Confidence 458899999999999999998888999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC---CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCC---CCHHHHHHHHHcCCCCCccc
Q 005017 233 MQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 233 ~~~~---~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~---~~~~~i~~~i~~g~~p~~~~ 303 (719)
.... .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||... .....+...+..... .++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCC
Confidence 5322 2335679999999998864 4789999999999999999999999642 234455555554322 234
Q ss_pred cCCChHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 342 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~ 342 (719)
...++.+++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 5567899999999998 899999 99999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=379.72 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=209.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC----hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+|++++||||+++++++.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-- 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-- 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS--
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC--
Confidence 468889999999999999999999999999999986543221 11334577899999999999999999998654
Q ss_pred CceeEEEecccCC-ChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gG-sL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecccce
Confidence 4688999999777 99999999889999999999999999999999999 9999999999999865 799999999997
Q ss_pred hccCC-CcccccCCCCCCCccccccc-c-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 232 AMQQP-TARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 232 ~~~~~-~~~~~~GT~~YmAPEvl~~~-~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... .....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||..... ... .....+...++
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVSK 249 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCCH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccCH
Confidence 76543 33456799999999988653 4 7899999999999999999999975211 111 11223445688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
++++||.+||. +|.+|||+.++|+||||+.
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 99999999998 8999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=386.08 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=205.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC----C
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----K 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----~ 151 (719)
...|.+.++||+|+||+||+|.+..+|+.||+|++..... ...+|+++|++|+|||||++++++... +
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3468889999999999999999999999999999875432 123699999999999999999988643 2
Q ss_pred CCceeEEEecccCCChhHHhh----hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~----~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..++++||||+.+ +|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+||
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccc
Confidence 3357799999986 5555443 3567999999999999999999999999 9999999999999976668999999
Q ss_pred chhhhccCC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CC------
Q 005017 228 GLAIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI------ 297 (719)
Q Consensus 228 GlA~~~~~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~------ 297 (719)
|+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+.. +.
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999865433 3345689999999998754 5899999999999999999999999875444444333321 00
Q ss_pred -------CCCc------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 -------KPAS------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 -------~p~~------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.... +....++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 123457899999999998 899999999999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=369.19 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=191.1
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
......|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++...+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 86 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD- 86 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS-
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-
Confidence 3455678899999999999999999998999999998865432 234567889999999999999999999987654
Q ss_pred CceeEEEecccCCChhHHhhh--------cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 153 KTVNMITELFTSGNLRQYRKK--------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~--------~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||
T Consensus 87 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl 162 (303)
T 2vwi_A 87 -ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQI 162 (303)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred -CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEE
Confidence 58899999999999999874 356899999999999999999999999 9999999999999855 79999
Q ss_pred eecchhhhccCC-------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc
Q 005017 225 GDLGLAIAMQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 225 ~DFGlA~~~~~~-------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~ 295 (719)
+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|+||+.||............. .
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-Q 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-T
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-c
Confidence 999999765432 1234579999999998864 58999999999999999999999998754433333332 2
Q ss_pred CCCC--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCC
Q 005017 296 GIKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 342 (719)
Q Consensus 296 g~~p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~ 342 (719)
...+ .......++.++++|.+||. +|.+|||+.++++||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 2211 12234567899999999998 89999999999999999865543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=391.53 Aligned_cols=251 Identities=17% Similarity=0.192 Sum_probs=199.0
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHH---HHHHhCCCCCceeEE------
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV---HLLKSLKDDNVVKFY------ 144 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIVkl~------ 144 (719)
...+.|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+ ++|++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34678899999999999999999999999999999998654332 34668899999 556666899999998
Q ss_pred -EeeecCCC----------C-----ceeEEEecccCCChhHHhhhcccccH-------HHHHHHHHHHHHHhhhhhcCCC
Q 005017 145 -KSWVDDKK----------K-----TVNMITELFTSGNLRQYRKKHKNVDI-------KVIKNWARQILHGLVYLHSHNP 201 (719)
Q Consensus 145 -~~~~~~~~----------~-----~l~lV~Ey~~gGsL~~~L~~~~~l~~-------~~i~~i~~QIl~gL~yLHs~~p 201 (719)
+++.+.+. . ..++||||+ +|+|.+++...+.+++ ..++.|+.||+.||+|||+++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 226 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 226 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 44433211 1 378999999 6899999987655555 888899999999999999999
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc------------ccCccccchhhHHH
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMC 269 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~------------~~s~ksDIwSlGii 269 (719)
|+||||||+|||++.+ |.+||+|||+++.... .....+| +.|+|||++.+ .|+.++|||||||+
T Consensus 227 -ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp -EECSCCCGGGEEECTT-CCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCC-CCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999855 7999999999975433 3345678 99999998864 58999999999999
Q ss_pred HHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 270 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 270 l~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+|||+||+.||.... .......+.. .....++++++||.+||. ||.+|||+.++|+||||+.
T Consensus 303 l~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 303 IYWIWCADLPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHCCCCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999997632 1111111111 123557899999999998 8999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=367.23 Aligned_cols=254 Identities=30% Similarity=0.535 Sum_probs=209.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CE
Confidence 4556788999999999999999999999999999987532 236788999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccchhh
Confidence 8899999999999999873 567999999999999999999999999 9999999999999855 79999999999765
Q ss_pred cCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCCChH
Q 005017 234 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~~~ 309 (719)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+..... ....+...++.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPELWSDN 254 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCcccCCcccCCHH
Confidence 543 2345679999999998864 58999999999999999999999998744 3333333333322 22334556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
+++||.+||. +|.+|||+.++|+||||+...
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 9999999998 899999999999999998554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.28 Aligned_cols=252 Identities=34% Similarity=0.497 Sum_probs=206.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC------
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD------ 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~------ 150 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.++++++||||++++++|.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 3578889999999999999999999999999998643 34567889999999999999999999988653
Q ss_pred -----CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 151 -----KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 151 -----~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
....+++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEEE
Confidence 245788999999999999999854 35888999999999999999999999 9999999999999855 79999
Q ss_pred eecchhhhccCC----------------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCH
Q 005017 225 GDLGLAIAMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP 286 (719)
Q Consensus 225 ~DFGlA~~~~~~----------------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~ 286 (719)
+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 999998765321 1234579999999998864 58999999999999999998 66543344
Q ss_pred HHHHHHHHcCC--CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 287 AQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 287 ~~i~~~i~~g~--~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......+.... .+..+....++.++++|.+||. ||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 45555555432 2444555567789999999998 89999999999999999743
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.61 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=209.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 99 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRW 99 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEE
Confidence 346788999999999999999999999999999986543 2234556788999999999999999999998755 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+.+++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceeecC
Confidence 899999999999999887888999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred C--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CC-------------
Q 005017 236 P--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI------------- 297 (719)
Q Consensus 236 ~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~------------- 297 (719)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+.. +.
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 2345679999999998865 5899999999999999999999999875444433322211 00
Q ss_pred -----CCCc---------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 -----KPAS---------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 -----~p~~---------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
..+. .....++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0000 112357889999999998 899999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.29 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=208.7
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+..+|..||+|.+..... ......+++.+|+.++++++||||+++++++... ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~ 85 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DC 85 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--Ce
Confidence 34568899999999999999999999999999999875433 2345668899999999999999999999988654 46
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+++||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCccccc
Confidence 8999999999999999998889999999999999999999999999 9999999999999855 799999999997664
Q ss_pred CCC---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC---ccccCCC
Q 005017 235 QPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVND 307 (719)
Q Consensus 235 ~~~---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~---~~~~~~~ 307 (719)
... .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.+. +.............+. ......+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE-TAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS-CHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhhccCCCcchhcccCCC
Confidence 332 334679999999998865 5889999999999999999999999874 4444333333333332 2345567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+.+.++|.+||. +|.+||+..+.+.+.|..
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 899999999998 899999666666666554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=375.03 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=203.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--Cc
Confidence 4557788999999999999999999999999999875432211 11234678999999999999999999998654 45
Q ss_pred eeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+.+ +|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEecccceec
Confidence 8899999986 888888764 46899999999999999999999999 9999999999999855 79999999999876
Q ss_pred cCC--CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC-CCcc----
Q 005017 234 QQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK-PASL---- 302 (719)
Q Consensus 234 ~~~--~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~-p~~~---- 302 (719)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. +..+.+..+.. +.. +..+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHHcCCCChhhhhhhc
Confidence 433 2345679999999998854 4899999999999999999999999874 44444433332 111 1111
Q ss_pred -------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 303 -------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 303 -------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 13346789999999998 899999999999999998644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=374.23 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=218.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh-------------hhHHHHHHHHHHHHhCCCCCce
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-------------GDLQKLYSEVHLLKSLKDDNVV 141 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~-------------~~~~~~~~Ei~iL~~L~HpNIV 141 (719)
....|++.+.||+|+||.||+|.+ +|+.||+|++......... ...+.+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345688999999999999999988 8999999999865432211 1227899999999999999999
Q ss_pred eEEEeeecCCCCceeEEEecccCCChhHH------hhh--cccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccce
Q 005017 142 KFYKSWVDDKKKTVNMITELFTSGNLRQY------RKK--HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDN 212 (719)
Q Consensus 142 kl~~~~~~~~~~~l~lV~Ey~~gGsL~~~------L~~--~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~N 212 (719)
++++++.+. ..+++||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ ++ |+||||||+|
T Consensus 107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~N 182 (348)
T 2pml_X 107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182 (348)
T ss_dssp CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGG
T ss_pred eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHh
Confidence 999998765 468999999999999999 665 5679999999999999999999999 88 9999999999
Q ss_pred eEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCccccccc--cCc-cccchhhHHHHHHHhhccCCCCCCCCHHHH
Q 005017 213 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQI 289 (719)
Q Consensus 213 ILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~--~s~-ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i 289 (719)
|+++.+ |.+||+|||++............||+.|+|||++.+. ++. ++|||||||++|+|++|+.||.........
T Consensus 183 il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 183 ILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EEECTT-SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEEcCC-CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999855 7999999999987665555667899999999988754 555 999999999999999999999886665777
Q ss_pred HHHHHcCCCCCcc-----------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 290 FKKVTSGIKPASL-----------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 290 ~~~i~~g~~p~~~-----------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...+..+...... ....++.+++||.+||. +|.+|||+.++|+||||+..+
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 7777665432221 14567899999999998 899999999999999998544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.75 Aligned_cols=263 Identities=23% Similarity=0.416 Sum_probs=217.9
Q ss_pred CCCcccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEE
Q 005017 67 SDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFY 144 (719)
Q Consensus 67 ~~~~e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~ 144 (719)
..+......++.|++.+.||+|+||.||+|.+. +|..||+|++..... .....+.+.+|+.++++++ ||||++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 344555667888999999999999999999886 589999999976542 2456688999999999997 59999999
Q ss_pred EeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEE
Q 005017 145 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 224 (719)
Q Consensus 145 ~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL 224 (719)
+++... ..+++||| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ + |.+||
T Consensus 95 ~~~~~~--~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~-~~~kL 167 (313)
T 3cek_A 95 DYEITD--QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKL 167 (313)
T ss_dssp EEEECS--SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEE
T ss_pred EEeecC--CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-C-CeEEE
Confidence 988765 45889999 668899999998889999999999999999999999999 99999999999996 3 69999
Q ss_pred eecchhhhccCCC----cccccCCCCCCCcccccc------------ccCccccchhhHHHHHHHhhccCCCCCCCCHHH
Q 005017 225 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 288 (719)
Q Consensus 225 ~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~------------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~ 288 (719)
+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 9999997654332 234579999999998753 588899999999999999999999987666656
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
....+........++...++.++++|.+||. +|.+|||+.++|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 6666665555555566678899999999998 89999999999999999843
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=375.10 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=209.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--- 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~--- 151 (719)
.+..|++.+.||+|+||+||+|.+..+|..||+|++.... .....+++.+|+.+|++++||||+++++++....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3567899999999999999999999999999999987432 3455678899999999999999999999886543
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCcceE
Confidence 246889999997 599998875 46999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCC-----CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCCC----
Q 005017 232 AMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP---- 299 (719)
Q Consensus 232 ~~~~~-----~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~p---- 299 (719)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+......+...+.. +..+
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 65432 1244589999999997643 4899999999999999999999999875433333222110 0000
Q ss_pred -----------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 -----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 -----------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.......++++++||.+||. ||.+|||+.++|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01123457899999999998 89999999999999999854
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=381.28 Aligned_cols=255 Identities=29% Similarity=0.407 Sum_probs=192.2
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---- 151 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---- 151 (719)
...|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 356788899999999999999999999999999986432 23456678899999999999999999999886532
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...+++|+||+ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG~a~ 180 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLAR 180 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC-----
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeeccccc
Confidence 24578999999 7899998875 57999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCC--------
Q 005017 232 AMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-------- 299 (719)
Q Consensus 232 ~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p-------- 299 (719)
..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....+ +..+.. +..+
T Consensus 181 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHTTCC
T ss_pred ccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhh
Confidence 65433 345689999999998764 589999999999999999999999987443333 322221 1100
Q ss_pred ----------------C---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 ----------------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 ----------------~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
. ......++.+++||.+||. ||.+|||+.++|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 0 0112347889999999998 99999999999999999853
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.46 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=199.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+. |..||+|+++...........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cce
Confidence 456789999999999999999874 8999999987654433345567899999999999999999999988655 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCC-CeeeecCccceeEecCC-------CCcEEEeec
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVNGN-------HGEVKIGDL 227 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~p-pIIHrDLKp~NILl~~~-------~G~vKL~DF 227 (719)
++||||+++|+|.+++. .+.+++..++.++.|++.||.|||+++. +|+||||||+|||++.. .+.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 89999999999999986 4579999999999999999999999974 48999999999999752 468999999
Q ss_pred chhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 228 GLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 228 GlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
|++............||+.|+|||++.+ .++.++||||||+++|+|+||+.||... +.......+.........+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTC
T ss_pred CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCccc
Confidence 9998766655556789999999998865 5899999999999999999999999874 4455555555555555566777
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++.++++|.+||. +|.+|||+.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 8999999999998 89999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.67 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=217.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++... ..+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeE
Confidence 3457888999999999999999999999999999975542 24567899999999999999999999998765 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeecccceecCc
Confidence 899999999999999875 56999999999999999999999999 9999999999999855 7999999999976654
Q ss_pred CC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 236 PT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 236 ~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .........+..+.. ..+....++.+++
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 249 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKNNP-PTLEGNYSKPLKE 249 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-CCCCSSCCHHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcCCC-CCCccccCHHHHH
Confidence 32 345679999999998864 589999999999999999999999987 445555555555433 3455567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
||.+||. +|.+|||+.++++||||....
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999998 899999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.65 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=205.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC-----
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----- 150 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----- 150 (719)
+..|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 456788999999999999999999999999999987543 45667899999999999999999999987432
Q ss_pred -------CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 151 -------KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 151 -------~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
....+++||||+. |+|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 2356889999997 699999875 56899999999999999999999999 999999999999986667999
Q ss_pred EeecchhhhccCC-----CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC
Q 005017 224 IGDLGLAIAMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296 (719)
Q Consensus 224 L~DFGlA~~~~~~-----~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g 296 (719)
|+|||++...... ......||+.|+|||++. ..++.++|||||||++|||+||+.||.... .......+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~ 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILES 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHh
Confidence 9999999765422 223456899999999875 458999999999999999999999998743 33333333321
Q ss_pred CCC----------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 297 IKP----------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 297 ~~p----------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
... .......++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 110 01123467899999999998 899999999999999998543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=354.24 Aligned_cols=248 Identities=17% Similarity=0.272 Sum_probs=209.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+. |..||+|+++.... .....+.+.+|+.++++++||||+++++++.+.....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 346788899999999999999874 89999999876532 23556789999999999999999999999987766778
Q ss_pred eEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+++++|+||||||+||+++.+ |.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence 99999999999999998765 4899999999999999999999998899999999999999855 79999999887543
Q ss_pred cCCCcccccCCCCCCCccccccc-c---CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 234 QQPTARSVIGTPEFMAPELYEEE-Y---NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 234 ~~~~~~~~~GT~~YmAPEvl~~~-~---s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.. ....||+.|+|||++.+. + +.++|||||||++|||+||+.||... +.......+.........+...++.
T Consensus 164 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 164 QS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp SC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-CHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred cc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-ChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 22 345789999999988643 3 34799999999999999999999874 4455544554444444566677899
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++|.+||. +|.+|||+.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999998 8999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=368.05 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=208.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--- 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~--- 151 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|++.... ......++.+|+.+|++++||||+++++++....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc---cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 4567889999999999999999999999999999986432 2455677889999999999999999999876432
Q ss_pred CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEeccccc
Confidence 356899999997 589998875 56999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCC------------cccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-C
Q 005017 232 AMQQPT------------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G 296 (719)
Q Consensus 232 ~~~~~~------------~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g 296 (719)
...... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.+............. +
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 654221 12357899999999874 45899999999999999999999999874433322211110 1
Q ss_pred CCC----------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 297 IKP----------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 297 ~~p----------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
..+ .......++++++||.+||. ||.+|||+.++|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 000 01113467899999999998 8999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=382.99 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=205.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC------CCCCceeEEEee
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL------KDDNVVKFYKSW 147 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpNIVkl~~~~ 147 (719)
.....|++.++||+|+||+||+|.+..+|+.||+|+++.. ....+.+.+|+.+++.+ +|+||+++++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 3455689999999999999999999999999999998643 23456777888888877 577999999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc--EE
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VK 223 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~--vK 223 (719)
... ..+++||||+. |+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |. +|
T Consensus 169 ~~~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vk 242 (429)
T 3kvw_A 169 TFR--NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIK 242 (429)
T ss_dssp EET--TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEE
T ss_pred ccC--CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceE
Confidence 765 45899999996 69999987654 4999999999999999999999999 9999999999999865 45 99
Q ss_pred EeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCCCC-
Q 005017 224 IGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA- 300 (719)
Q Consensus 224 L~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~p~- 300 (719)
|+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|||+||..||........+...+.. +..+.
T Consensus 243 L~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 243 VIDFGSSCYEHQR-VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp ECCCTTCEETTCC-CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EeecccceecCCc-ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9999999665433 345689999999998765 5999999999999999999999999874433333222211 11100
Q ss_pred ------------------------------------------------------ccccCCChHHHHHHHHhcC-CCCCCC
Q 005017 301 ------------------------------------------------------SLAKVNDPQIKGFIEKCLV-PASERL 325 (719)
Q Consensus 301 ------------------------------------------------------~~~~~~~~~l~~lI~kcL~-dP~~Rp 325 (719)
.+....++.+++||.+||. ||.+||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0112236789999999998 999999
Q ss_pred CHHHHHcCccCcccc
Q 005017 326 SAKDLLKDPFLQVEN 340 (719)
Q Consensus 326 Sa~eLL~hpf~~~~~ 340 (719)
|+.|+|+||||+...
T Consensus 402 ta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 402 TPGQALRHPWLRRRL 416 (429)
T ss_dssp CHHHHHTSTTTC---
T ss_pred CHHHHhCChhhccCC
Confidence 999999999998543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=378.83 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=202.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
..|++.++||+|+||+||+|.+..++. ||+|++...... ..+|+++|+.++||||+++++++.... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 458889999999999999999886665 888888644321 236999999999999999999986543 2
Q ss_pred CceeEEEecccCCChhHH---hhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 153 KTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~---L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
.++++||||+.++.+... ......+++..++.|+.||+.||+|||+++ |+||||||+|||++...|.+||+|||+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 347899999987644433 233567999999999999999999999999 999999999999985568999999999
Q ss_pred hhhccCC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CCC-------
Q 005017 230 AIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK------- 298 (719)
Q Consensus 230 A~~~~~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~~------- 298 (719)
|+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+.. +..
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9766433 3446689999999998754 5899999999999999999999999885444444333221 000
Q ss_pred --------------CC----ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 299 --------------PA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 299 --------------p~----~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+. .+....++++++||.+||. +|.+|||+.++|+||||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 1123367899999999998 8999999999999999986543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=376.49 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=198.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---- 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---- 152 (719)
+.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 56788999999999999999999999999999987542 234556788999999999999999999999865432
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+ +|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC---
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecccc
Confidence 368999999975 7888875 45899999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---------
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--------- 301 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~--------- 301 (719)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. +....+..+......+.
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT-DHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 6543 2345689999999998765 5899999999999999999999999874 44444444433211100
Q ss_pred -----------c--------------c------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 302 -----------L--------------A------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 302 -----------~--------------~------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+ + ...++++++||.+||. ||.+|||+.++|+||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 0 0014578999999998 8999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=369.62 Aligned_cols=244 Identities=28% Similarity=0.395 Sum_probs=202.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|.+.++||+|+||+||+|.+..+|..||+|.+... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence 35678899999999999999999999999999988532 245678899999999999999999999998765 458
Q ss_pred eEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence 899999999999999987 567999999999999999999999999 9999999999999855 799999999997653
Q ss_pred CCCc----------------ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHH----HHHHH
Q 005017 235 QPTA----------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKKV 293 (719)
Q Consensus 235 ~~~~----------------~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~----i~~~i 293 (719)
.... ...+||+.|+|||++.+ .++.++||||||+++|||++|..||........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 3211 14679999999998875 589999999999999999999999865321110 01111
Q ss_pred HcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 294 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 294 ~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
... ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus 240 ~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1234467889999999998 8999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=355.77 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=209.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhH---HHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL---QKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~---~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
....|++.+.||+|+||+||+|.+..+++.||+|++............ +.+.+|+.++++++||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 456788999999999999999999999999999998765433322221 6789999999999999999999987543
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc-----EEEe
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIG 225 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~-----vKL~ 225 (719)
.++||||+.+|+|.+++... ..+++..++.++.|++.||+|||++++||+||||||+|||++.+ +. +||+
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVA 171 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEEC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeC
Confidence 25899999999999887654 46999999999999999999999998889999999999999754 34 9999
Q ss_pred ecchhhhccCCCcccccCCCCCCCccccc---cccCccccchhhHHHHHHHhhccCCCCCCCCHH-HHHHHHHcCCCCCc
Q 005017 226 DLGLAIAMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFKKVTSGIKPAS 301 (719)
Q Consensus 226 DFGlA~~~~~~~~~~~~GT~~YmAPEvl~---~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~-~i~~~i~~g~~p~~ 301 (719)
|||+++.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||....... .....+.....+..
T Consensus 172 Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 172 DFGLSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CCTTCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCCccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 9999975443 234567999999999883 347899999999999999999999998654333 33444444445555
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.+...++.++++|.+||. +|.+|||+.++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 667778999999999998 8999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.02 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=194.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC-----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----- 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 151 (719)
..|++.+.||+|+||+||+|.+..+|..||+|++..... ...+..++++.++.++||||+++++++....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 457889999999999999999999999999999865432 2245667888899999999999999986533
Q ss_pred CCceeEEEecccCCChh---HHhhhcccccHHHHHHHHHHHHHHhhhhh--cCCCCeeeecCccceeEecCCCCcEEEee
Q 005017 152 KKTVNMITELFTSGNLR---QYRKKHKNVDIKVIKNWARQILHGLVYLH--SHNPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~---~~L~~~~~l~~~~i~~i~~QIl~gL~yLH--s~~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
..++++||||+.++.+. .++.....+++..++.++.||+.||.||| +++ |+||||||+|||++...|.+||+|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECC
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEee
Confidence 22478999999875332 33345667999999999999999999999 777 999999999999986457999999
Q ss_pred cchhhhccCCC-cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCC--
Q 005017 227 LGLAIAMQQPT-ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP-- 299 (719)
Q Consensus 227 FGlA~~~~~~~-~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p-- 299 (719)
||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.... ....+..+... ..+
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-hHHHHHHHHHHcCCCCHH
Confidence 99998765432 345679999999998753 38999999999999999999999998743 44433333221 000
Q ss_pred --------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 300 --------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 300 --------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
.......++++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00011135689999999998 8999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=373.12 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=204.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC--
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK-- 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~-- 153 (719)
.+.|.+.+.||+|+||+||+|.+..+|+.||+|++.... ......+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 356788899999999999999999999999999987532 2345567889999999999999999999998765432
Q ss_pred --ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 154 --TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 154 --~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+++||||+. |+|.+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC-
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccc
Confidence 2489999997 68888874 35999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCC-------
Q 005017 232 AMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPA------- 300 (719)
Q Consensus 232 ~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~------- 300 (719)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.. ..+....+.. +..+.
T Consensus 193 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCcHHHHHHhh
Confidence 65443 345678999999998764 58999999999999999999999998743 3333333221 11100
Q ss_pred --------------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 --------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 --------------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 1123457899999999998 89999999999999999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.53 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=212.0
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEE-----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEee
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSW 147 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~-----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~ 147 (719)
.....|++.+.||+|+||.||+|. +..+|+.||+|+++... .....+.+.+|+.+|+++ +||||+++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 355678999999999999999998 56678999999987432 234567899999999999 789999999998
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhccc---------------------------------------------------
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHKN--------------------------------------------------- 176 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~--------------------------------------------------- 176 (719)
...+ ..+++||||+.+|+|.+++.....
T Consensus 96 ~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 96 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp CSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 7643 457899999999999999976543
Q ss_pred ---------------ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC----
Q 005017 177 ---------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---- 237 (719)
Q Consensus 177 ---------------l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~---- 237 (719)
+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeecccccchh
Confidence 899999999999999999999999 9999999999999855 799999999997653321
Q ss_pred cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
.....||+.|+|||++. ..++.++|||||||++|||+| |..||............+..+..+ ..+...++++.++|.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence 23456899999999876 468999999999999999998 999998866666666666655433 345567889999999
Q ss_pred HhcC-CCCCCCCHHHHHcC
Q 005017 316 KCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 316 kcL~-dP~~RpSa~eLL~h 333 (719)
+||. +|.+|||+.++++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9998 89999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.16 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=204.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---- 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~---- 152 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|++.... ......+++.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 45788899999999999999999999999999987532 234456788999999999999999999999876543
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+. |+|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCTTC
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeecccccC
Confidence 23589999997 589888753 5999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC----------
Q 005017 233 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK---------- 298 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~---------- 298 (719)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. .......+.. +..
T Consensus 176 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-HHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 5433 345678999999998764 58999999999999999999999998743 3333322221 000
Q ss_pred -----------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 299 -----------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 299 -----------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
........++.+++||.+||. ||.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011223457899999999998 89999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=361.63 Aligned_cols=260 Identities=29% Similarity=0.422 Sum_probs=207.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc-CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeec-
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE-FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVD- 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~-~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~- 149 (719)
....|++.+.||+|+||+||+|.+. .+|+.||+|+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3456889999999999999999995 678999999997654221 1123455677766665 89999999998863
Q ss_pred --CCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 150 --DKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 150 --~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
.....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEEe
Confidence 23456889999998 69999998754 4999999999999999999999999 9999999999999855 799999
Q ss_pred ecchhhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CC---
Q 005017 226 DLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK--- 298 (719)
Q Consensus 226 DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~--- 298 (719)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||.... .......+... ..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCcc
Confidence 99999765432 2345679999999998764 58999999999999999999999998744 33333333211 00
Q ss_pred --------------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 299 --------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 299 --------------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
...+....++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 011223467889999999998 8999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=379.84 Aligned_cols=258 Identities=13% Similarity=0.145 Sum_probs=189.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC--CCCCceeEEEee------
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSW------ 147 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkl~~~~------ 147 (719)
.+.|++.+.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++.| +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 455889999999999999999999999999999998754322 34556777885444444 699988866333
Q ss_pred -ecCCC---------------CceeEEEecccCCChhHHhhhcc-cccHHHH------HHHHHHHHHHhhhhhcCCCCee
Q 005017 148 -VDDKK---------------KTVNMITELFTSGNLRQYRKKHK-NVDIKVI------KNWARQILHGLVYLHSHNPPII 204 (719)
Q Consensus 148 -~~~~~---------------~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i------~~i~~QIl~gL~yLHs~~ppII 204 (719)
...+. ..+++||||+. |+|.+++...+ .+.+..+ ..++.||+.||+|||+++ |+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--iv 216 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LV 216 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Cc
Confidence 22221 34799999998 89999998743 3444455 677799999999999999 99
Q ss_pred eecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCC
Q 005017 205 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYS 281 (719)
Q Consensus 205 HrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~ 281 (719)
||||||+|||++.+ |.+||+|||+++...... ....||+.|+|||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 217 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 217 HGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp ETTCSGGGEEECTT-SCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCcCCHHHEEECCC-CCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999855 799999999998654332 24567799999998864 58999999999999999999999997
Q ss_pred CCCCHH-HHHHH---HHcC--CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 282 ECKNPA-QIFKK---VTSG--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 282 ~~~~~~-~i~~~---i~~g--~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
...... ..+.. .... ..........++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 642110 00000 0000 11111223568899999999998 89999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=372.50 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=209.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc-------CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEe
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKS 146 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~-------~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~ 146 (719)
....|.+.+.||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+|+++ +||||++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3467899999999999999999864 356789999987442 245667899999999999 89999999998
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
+... ..+|+||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||
T Consensus 156 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp 231 (370)
T 2psq_A 156 CTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 231 (370)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred EccC--CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 8654 45889999999999999998653 4789999999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECK 284 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~ 284 (719)
+|||++.+ |.+||+|||+++..... ......||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .
T Consensus 232 ~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~ 309 (370)
T 2psq_A 232 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 309 (370)
T ss_dssp GGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred hhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 99999855 79999999999765432 2234467889999998764 58999999999999999999 9999987 4
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...+++..+..+..+ ..+...+++++++|.+||. +|.+|||+.+++++
T Consensus 310 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566666777666543 3445678899999999998 89999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.48 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=194.9
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.....|++.+.||+|+||+||+|.+..++. .||+|+++..... ....+++.+|+.++++++||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA--SSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC--HHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345678899999999999999999887765 8999998754322 34568899999999999999999999998765
Q ss_pred CCC----ceeEEEecccCCChhHHhhhcc------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC
Q 005017 151 KKK----TVNMITELFTSGNLRQYRKKHK------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 220 (719)
Q Consensus 151 ~~~----~l~lV~Ey~~gGsL~~~L~~~~------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G 220 (719)
... ..++||||+.+|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~-~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED-M 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-S
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC-C
Confidence 432 2489999999999999987543 5899999999999999999999999 9999999999999855 7
Q ss_pred cEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHH
Q 005017 221 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~ 294 (719)
.+||+|||+++...... .....+|+.|+|||++.+ .++.++|||||||++|+|+| |..||.. .+...+...+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~ 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYLI 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc-cChHHHHHHHh
Confidence 99999999997654322 223457889999998865 58999999999999999999 8999987 44555666666
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCC-------HHHHHcCccCccccC
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLS-------AKDLLKDPFLQVENQ 341 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpS-------a~eLL~hpf~~~~~~ 341 (719)
.+..+. .+...++++++||.+||. +|.+||| .++++.|||+.....
T Consensus 254 ~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 254 GGNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred cCCCCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 554333 344567899999999998 8999999 788889999975443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=379.75 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=190.0
Q ss_pred EEE-eEEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 79 VRY-DEVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 79 ~~l-~e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
|.+ +++||+|+||+||+|.++ .++..||+|++.... ....+.+|+.+|++|+|||||++++++.......+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 444 568999999999999965 578999999986432 22467899999999999999999999987777789
Q ss_pred eEEEecccCCChhHHhhhcc---------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec---CCCCcEE
Q 005017 156 NMITELFTSGNLRQYRKKHK---------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVK 223 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~---------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~---~~~G~vK 223 (719)
++||||+. |+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||+. ...|.+|
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999996 48888775322 4899999999999999999999999 99999999999993 2447999
Q ss_pred EeecchhhhccCC-----CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCC---------HH
Q 005017 224 IGDLGLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN---------PA 287 (719)
Q Consensus 224 L~DFGlA~~~~~~-----~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~---------~~ 287 (719)
|+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||+.||..... ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999766432 2345689999999998864 489999999999999999999999975322 12
Q ss_pred HHHHHHHc-CCCCC-ccc---------------------------------cCCChHHHHHHHHhcC-CCCCCCCHHHHH
Q 005017 288 QIFKKVTS-GIKPA-SLA---------------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLL 331 (719)
Q Consensus 288 ~i~~~i~~-g~~p~-~~~---------------------------------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL 331 (719)
++...+.. +..+. .+. ...++.+.+||.+||. ||.+|||+.|+|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22211111 11111 010 0126789999999998 999999999999
Q ss_pred cCccCccccC
Q 005017 332 KDPFLQVENQ 341 (719)
Q Consensus 332 ~hpf~~~~~~ 341 (719)
+||||+....
T Consensus 333 ~hp~f~~~~~ 342 (405)
T 3rgf_A 333 QDPYFLEDPL 342 (405)
T ss_dssp TSGGGTSSSC
T ss_pred cChhhccCCC
Confidence 9999986543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.41 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=211.5
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEee
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 147 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~ 147 (719)
+...+.|.+.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+.+|++++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34567899999999999999999987 3456899999987432 345668899999999999999999999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhccc------------------------ccHHHHHHHHHHHHHHhhhhhcCCCCe
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHKN------------------------VDIKVIKNWARQILHGLVYLHSHNPPI 203 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~------------------------l~~~~i~~i~~QIl~gL~yLHs~~ppI 203 (719)
.+. ..+++||||+.+|+|.+++...+. +++..++.++.||+.||.|||+++ |
T Consensus 96 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i 171 (314)
T 2ivs_A 96 SQD--GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--L 171 (314)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ecC--CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 654 458899999999999999986543 899999999999999999999999 9
Q ss_pred eeecCccceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-cc
Q 005017 204 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FE 277 (719)
Q Consensus 204 IHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~ 277 (719)
+||||||+|||++.+ |.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|+| |.
T Consensus 172 vH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 172 VHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp ECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999855 799999999997654332 233457889999998764 58999999999999999999 99
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 278 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 278 ~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.||.. .....+...+..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 251 ~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 251 NPYPG-IPPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCC-CCHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99987 4556666666665433 3445678899999999998 89999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=362.29 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=205.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEE-cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC------ceeEEEee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFD-EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN------VVKFYKSW 147 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d-~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IVkl~~~~ 147 (719)
....|++.+.||+|+||+||+|.+ ..+|+.||+|+++.. ....+.+.+|+.+++.++|+| |+++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 445788999999999999999998 568999999998633 245577889999999987664 99999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC-------
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN------- 218 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~------- 218 (719)
... ..+++||||+ +++|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++..
T Consensus 87 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 87 EHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred ccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 655 4689999999 889999998765 6889999999999999999999999 9999999999999753
Q ss_pred -----------CCcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH
Q 005017 219 -----------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP 286 (719)
Q Consensus 219 -----------~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~ 286 (719)
.+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|||+||..||.... .
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~ 239 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD-S 239 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC-H
T ss_pred CccccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-h
Confidence 35799999999976443 2345679999999998865 58999999999999999999999998743 3
Q ss_pred HHHHHHHHc--CCCCCcc----------------------------------------ccCCChHHHHHHHHhcC-CCCC
Q 005017 287 AQIFKKVTS--GIKPASL----------------------------------------AKVNDPQIKGFIEKCLV-PASE 323 (719)
Q Consensus 287 ~~i~~~i~~--g~~p~~~----------------------------------------~~~~~~~l~~lI~kcL~-dP~~ 323 (719)
.+....+.. +..|..+ ....++.+++||.+||. ||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 332222211 1111100 01123578999999998 8999
Q ss_pred CCCHHHHHcCccCcccc
Q 005017 324 RLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 324 RpSa~eLL~hpf~~~~~ 340 (719)
|||+.|+|+||||+..+
T Consensus 320 Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 320 RITLREALKHPFFDLLK 336 (339)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred ccCHHHHhcCHHHHHHh
Confidence 99999999999998543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=366.93 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=182.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC--CC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~--~~ 152 (719)
.++|..+.++||+|+||+||+|.++.+|+.||+|++.... .........++.++||||+++++++... +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 3455444678999999999999999999999999986321 1122233446778999999999988652 24
Q ss_pred CceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEeecc
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLG 228 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~DFG 228 (719)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 46889999999999999998754 6999999999999999999999999 9999999999999743 3569999999
Q ss_pred hhhhccCCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHHcCC--CCCcc
Q 005017 229 LAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGI--KPASL 302 (719)
Q Consensus 229 lA~~~~~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~---i~~~i~~g~--~p~~~ 302 (719)
++............||+.|+|||++. ..++.++|||||||++|+|++|..||........ ....+..+. .+...
T Consensus 177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 99876665556678999999999885 4589999999999999999999999976322211 111222111 12223
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
....++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 34568899999999998 89999999999999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=357.26 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=204.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
...+.|++.+.||+|+||+||+|. +..+|+.||+|++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 356789999999999999999998 66789999999987432 4556789999999999999999999999877
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
.+...+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccCc
Confidence 66667899999999999999998755 4999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHH---------------
Q 005017 229 LAIAMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------------- 287 (719)
Q Consensus 229 lA~~~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~--------------- 287 (719)
++....... .....||+.|+|||++. ..++.++||||||+++|+|+||..||... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH--HHHHHHHHCTTCCTHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC--hHHHHhhhcCccccchh
Confidence 997664332 22345777899999886 45899999999999999999999998641 11
Q ss_pred --HHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 288 --QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 288 --~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.....+..+. ....+...++++.++|.+||. +|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222233332 223355678899999999998 8999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.76 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=204.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh--hhHHHHHHHHHHHHhC----CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSL----KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~--~~~~~~~~Ei~iL~~L----~HpNIVkl~~~~~ 148 (719)
....|++.+.||+|+||.||+|.+..+|+.||+|++......... .....+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 445678899999999999999999999999999998755432211 1223456799999998 8999999999886
Q ss_pred cCCCCceeEEEec-ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 149 DDKKKTVNMITEL-FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 149 ~~~~~~l~lV~Ey-~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
.. ...++|+|| +.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+.|.+||+||
T Consensus 109 ~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 109 TQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred cC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEc
Confidence 54 457889999 789999999998888999999999999999999999999 9999999999999855579999999
Q ss_pred chhhhccCCCcccccCCCCCCCcccccc-cc-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 228 GLAIAMQQPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 228 GlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
|++............||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||.. ...+ ... ...++..
T Consensus 185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~----~~~--~~~~~~~ 255 (312)
T 2iwi_A 185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEI----LEA--ELHFPAH 255 (312)
T ss_dssp SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHT--CCCCCTT
T ss_pred chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC---hHHH----hhh--ccCCccc
Confidence 9998776665666789999999998864 34 4589999999999999999999965 2222 221 1223455
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
.++.+++||.+||. +|.+|||+.++++||||+....
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 68899999999998 8999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.72 Aligned_cols=248 Identities=19% Similarity=0.327 Sum_probs=207.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
....|++.+.||+|+||+||+|.+..+|. .||+|+++... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 122 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG- 122 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-
Confidence 45678999999999999999999986554 59999987432 245567899999999999999999999998654
Q ss_pred CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+++||||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 198 (325)
T 3kul_A 123 -RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLS 198 (325)
T ss_dssp -GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSSC
T ss_pred -CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCcc
Confidence 4588999999999999999754 57999999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 231 IAMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 231 ~~~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
+...... .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 276 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRLP-AP 276 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCCC-CC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCCC-CC
Confidence 7664332 12234678899999887 468999999999999999999 9999987 45666777777664433 34
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
...++.+.++|.+||. +|.+|||+.++++
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5678899999999998 8999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.79 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=201.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--------CCCceeEEEee
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--------DDNVVKFYKSW 147 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpNIVkl~~~~ 147 (719)
...|++.++||+|+||+||+|.+..+|+.||+|+++.. ....+.+.+|+.+|++++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 35678999999999999999999999999999998633 345577889999999986 78899999988
Q ss_pred ecC--CCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCC---
Q 005017 148 VDD--KKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNH--- 219 (719)
Q Consensus 148 ~~~--~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~--- 219 (719)
... ....+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++ + |+||||||+|||++.+.
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence 632 345789999999 55666665543 5699999999999999999999998 8 99999999999998542
Q ss_pred ---------------------------------------------CcEEEeecchhhhccCCCcccccCCCCCCCccccc
Q 005017 220 ---------------------------------------------GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE 254 (719)
Q Consensus 220 ---------------------------------------------G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~ 254 (719)
..+||+|||++...... ....+||+.|+|||++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhc
Confidence 27999999999766543 34567999999999886
Q ss_pred c-ccCccccchhhHHHHHHHhhccCCCCCCCC-----HHHHHHHHH--cCCCCCc-------------------------
Q 005017 255 E-EYNELVDIYSFGMCILEMVTFEYPYSECKN-----PAQIFKKVT--SGIKPAS------------------------- 301 (719)
Q Consensus 255 ~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~-----~~~i~~~i~--~g~~p~~------------------------- 301 (719)
+ .|+.++|||||||++|||+||+.||..... .......+. .+..|..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 5 589999999999999999999999975332 111111111 1111100
Q ss_pred -------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 302 -------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 302 -------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+....++.+++||.+||. ||.+|||+.|+|+||||+
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011123568899999998 899999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.38 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=203.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CC-----CceeEEEeeec
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DD-----NVVKFYKSWVD 149 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----NIVkl~~~~~~ 149 (719)
...|++.+.||+|+||+||+|.+..+|+.||+|+++.. ......+..|+.+++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 45688999999999999999999999999999998743 244567788999998885 55 49999998876
Q ss_pred CCCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCCcEEEee
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGD 226 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G~vKL~D 226 (719)
. ..+++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|
T Consensus 128 ~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 R--NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp T--TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred C--CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 5 45899999996 5999998765 4699999999999999999999965444999999999999953 346899999
Q ss_pred cchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCCCCccc
Q 005017 227 LGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPASLA 303 (719)
Q Consensus 227 FGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~p~~~~ 303 (719)
||+++..... ....+||+.|+|||++.+ .++.++|||||||++|||+||+.||... +..+....+.. +..+....
T Consensus 205 FG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 205 FGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA-NEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCSCCHHHH
T ss_pred ccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHH
Confidence 9999776543 345689999999998865 5899999999999999999999999874 44444333332 11110000
Q ss_pred c------------------------------------------------------------CCChHHHHHHHHhcC-CCC
Q 005017 304 K------------------------------------------------------------VNDPQIKGFIEKCLV-PAS 322 (719)
Q Consensus 304 ~------------------------------------------------------------~~~~~l~~lI~kcL~-dP~ 322 (719)
. ...+++++||.+||. ||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0 001378999999998 999
Q ss_pred CCCCHHHHHcCccCccc
Q 005017 323 ERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 323 ~RpSa~eLL~hpf~~~~ 339 (719)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.75 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=213.0
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh--hhHHHHHHHHHHHHhCC--CCCceeEEEe
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLK--DDNVVKFYKS 146 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~--~~~~~~~~Ei~iL~~L~--HpNIVkl~~~ 146 (719)
+.++....|++.+.||+|+||+||+|.+..+|+.||+|++......... ...+++.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3455667789999999999999999999999999999999865432210 12245678999999996 5999999998
Q ss_pred eecCCCCceeEEEecccC-CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 147 WVDDKKKTVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~g-GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
+... ..+++|+|++.+ ++|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+.|.+||+
T Consensus 117 ~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 117 FERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence 8755 458899999986 899999998889999999999999999999999999 99999999999998556799999
Q ss_pred ecchhhhccCCCcccccCCCCCCCcccccc-c-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 226 DLGLAIAMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 226 DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
|||++............||+.|+|||++.+ . ++.++|||||||++|||+||+.||.. ... +..+. ..+.
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~~--~~~~ 263 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFR 263 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCS
T ss_pred eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhccc--cccc
Confidence 999998776665566789999999998864 3 36889999999999999999999965 222 22221 2234
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
...++++++||.+||. +|.+|||+.++++||||+..
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 5568899999999998 89999999999999999843
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.34 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=200.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-------CChhhHHHHHHHHHHHHhCCCCCceeEEEee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-------QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 147 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-------~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~ 147 (719)
....|++.+.||+|+||.||+|.+. +|..||+|++...... ......+++.+|+.+|++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3455788999999999999999886 4999999998654321 1223457899999999999999999999988
Q ss_pred ecC---CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 148 VDD---KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 148 ~~~---~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
... ....+++||||+. |+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~k 174 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDIT 174 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCEE
Confidence 653 3346899999998 5787777654 46999999999999999999999999 9999999999999855 6999
Q ss_pred EeecchhhhccCC-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC-CCC
Q 005017 224 IGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKP 299 (719)
Q Consensus 224 L~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g-~~p 299 (719)
|+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .......+... ..+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCC
Confidence 9999999754433 3345679999999998764 58999999999999999999999998743 33333333210 000
Q ss_pred -----------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 300 -----------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 300 -----------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.......++.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01123447889999999998 89999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.55 Aligned_cols=245 Identities=18% Similarity=0.382 Sum_probs=208.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 80 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 80 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cce
Confidence 356888999999999999999887 68889999987543 2336789999999999999999999988654 458
Q ss_pred eEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+++|+|.+++... +.+++..++.++.|++.||+|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBC
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEecccccccccc
Confidence 8999999999999999654 45899999999999999999999999 9999999999999755 799999999997664
Q ss_pred CC---CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.. ......||+.|+|||++. ..++.++||||||+++|+|+| |+.||.. ....+....+..+..+ ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 235 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHH
Confidence 43 223445778899999886 468999999999999999999 9999987 5667777777766443 334556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+.++|.+||. +|.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999998 89999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=370.96 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=212.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEE-----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~-----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
....|++.+.||+|+||+||+|. +..++..||+|+++.. ........+.+|+.++++++|||||++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 45678999999999999999998 5567889999998632 224556678999999999999999999998865
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc-------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CC
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HG 220 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~-------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G 220 (719)
. ...++||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ ..
T Consensus 146 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 S--LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp S--SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTC
T ss_pred C--CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCc
Confidence 4 45789999999999999998653 4899999999999999999999999 9999999999999833 23
Q ss_pred cEEEeecchhhhccC----CCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHH
Q 005017 221 EVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~----~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~ 294 (719)
.+||+|||+++.... .......||+.|+|||++. ..++.++|||||||++|||+| |..||.. ....++...+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~ 300 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVT 300 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 599999999975422 2234567899999999875 568999999999999999998 9999987 56677777777
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+..+. .+...++.+.+||.+||. +|.+|||+.+++++.++..
T Consensus 301 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 765433 345567899999999998 8999999999999987753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=363.81 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=199.7
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC--C
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--K 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~--~ 152 (719)
....|++.++||+|+||+||+|.+. |+.||+|++.... ........|+.+|++++|||||++++++.... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 4567899999999999999999765 8999999986442 33455667999999999999999999987654 3
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC----------CCCeeeecCccceeEecCCCCcE
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH----------NPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~----------~ppIIHrDLKp~NILl~~~~G~v 222 (719)
..+++||||+++|+|.+++... .+++..++.++.||+.||+|||++ + |+||||||+|||++.+ +.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CCE
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-CeE
Confidence 3578999999999999999764 599999999999999999999998 7 9999999999999855 799
Q ss_pred EEeecchhhhccCCC----cccccCCCCCCCcccccc------ccCccccchhhHHHHHHHhhccCCCCCCC--------
Q 005017 223 KIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECK-------- 284 (719)
Q Consensus 223 KL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-------- 284 (719)
||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|||+||+.||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999999997654322 234679999999998864 46788999999999999999999996532
Q ss_pred -------CHHHHHHHHHcCCCCCccccC-----CChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 285 -------NPAQIFKKVTSGIKPASLAKV-----NDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 285 -------~~~~i~~~i~~g~~p~~~~~~-----~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
....+...+......+.+... .++++.+||.+||. +|.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 223333333333332222221 12459999999998 8999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.05 Aligned_cols=248 Identities=21% Similarity=0.374 Sum_probs=207.4
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
......|++.+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 91 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-- 91 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--
Confidence 345667899999999999999999876 788899999875432 236788999999999999999999988654
Q ss_pred CceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~ 168 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSR 168 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTTGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEccccccc
Confidence 458899999999999999987 567999999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 232 AMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 232 ~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
...... .....+|+.|+|||++. ..++.++||||||+++|+|+| |+.||.. .+.......+..+..+ ..+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 246 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLA 246 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcC
Confidence 664432 22345678899999886 468999999999999999998 9999987 4566666677665433 334556
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++.++++|.+||. +|.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 7899999999998 89999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=345.12 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=207.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+. ++..||+|+++.... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 77 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YP 77 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--Cc
Confidence 4456889999999999999999776 677899999875432 336789999999999999999999988544 45
Q ss_pred eeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEEC
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceec
Confidence 889999999999999998754 5999999999999999999999999 9999999999999855 79999999999766
Q ss_pred cCCCc---ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 234 QQPTA---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 234 ~~~~~---~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
..... ....+|+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .........+..+..+ ..+...++
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVSQGHRL-YRPHLASD 232 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTSCH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHHcCCCC-CCCCcChH
Confidence 54432 23346678999998875 68999999999999999999 9999987 4555555666655433 33455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+.++|.+||. +|.+|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999998 89999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=359.58 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=210.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
....|++.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 4566788999999999999999987 456899999987432 24556789999999999999999999998865
Q ss_pred CCCCceeEEEecccCCChhHHhhhc------------------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeee
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIH 205 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~------------------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIH 205 (719)
. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 122 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 122 G--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp S--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred C--CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 4 4588999999999999999764 56899999999999999999999999 999
Q ss_pred ecCccceeEecCCCCcEEEeecchhhhccCC----CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCC
Q 005017 206 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYP 279 (719)
Q Consensus 206 rDLKp~NILl~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~P 279 (719)
|||||+|||++.+ |.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..|
T Consensus 198 ~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 198 RDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp SCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999855 79999999999765432 223456899999999876 468999999999999999999 9999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 280 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
|.. ....++...+..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 277 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 987 4566677777766543 3455678899999999998 89999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.63 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=203.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----------CCCceeE
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----------DDNVVKF 143 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIVkl 143 (719)
....|++.+.||+|+||+||+|.+..+|+.||+|++... ....+.+.+|+.++++++ ||||+++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 345688999999999999999999999999999998643 234567889999999886 8999999
Q ss_pred EEeeecCC--CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecC-
Q 005017 144 YKSWVDDK--KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNG- 217 (719)
Q Consensus 144 ~~~~~~~~--~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~- 217 (719)
++++...+ ...+++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99887643 33688999999 89999999863 4599999999999999999999998 9 999999999999952
Q ss_pred ----CCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC-----HH
Q 005017 218 ----NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-----PA 287 (719)
Q Consensus 218 ----~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~-----~~ 287 (719)
+.+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||+||+.||..... ..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3347999999999765543 344579999999998865 589999999999999999999999975321 11
Q ss_pred HHHHHHHc--CCCCC--------------------------------------ccccCCChHHHHHHHHhcC-CCCCCCC
Q 005017 288 QIFKKVTS--GIKPA--------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLS 326 (719)
Q Consensus 288 ~i~~~i~~--g~~p~--------------------------------------~~~~~~~~~l~~lI~kcL~-dP~~RpS 326 (719)
.....+.. +..|. .++...++++++||.+||. ||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111111 11111 0112234678999999998 8999999
Q ss_pred HHHHHcCccCcccc
Q 005017 327 AKDLLKDPFLQVEN 340 (719)
Q Consensus 327 a~eLL~hpf~~~~~ 340 (719)
+.++|+||||+...
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999998644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.79 Aligned_cols=257 Identities=21% Similarity=0.383 Sum_probs=195.8
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+..+..+++.++||||+++++++... ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcE
Confidence 34577889999999999999999999999999999754321 22333444555678889999999999998765 458
Q ss_pred eEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 156 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
++||||+ ++.+..+... ...+++..++.++.||+.||.|||+. + |+||||||+|||++.+ |.+||+|||++...
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGRL 175 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchhc
Confidence 9999999 5556555543 46799999999999999999999995 8 9999999999999855 79999999999765
Q ss_pred cCC-CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc-ccC
Q 005017 234 QQP-TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AKV 305 (719)
Q Consensus 234 ~~~-~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~-~~~ 305 (719)
... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+... ...
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 433 234557999999999874 358899999999999999999999998866777777776665443222 234
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.++.+++||.+||. +|.+|||+.++++||||+...
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 67899999999998 899999999999999998543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.49 Aligned_cols=245 Identities=20% Similarity=0.344 Sum_probs=202.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCC-------eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAG-------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 147 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g-------~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~ 147 (719)
....|.+.+.||+|+||+||+|.+..+| ..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3456889999999999999999998877 579999986432 34567899999999999999999999998
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhccc-ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc-----
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----- 221 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~-l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~----- 221 (719)
...+ ..++||||+.+|+|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 82 ~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~ 156 (289)
T 4fvq_A 82 VCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGN 156 (289)
T ss_dssp CCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTB
T ss_pred EeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-Ccccccc
Confidence 7654 57899999999999999987655 999999999999999999999999 9999999999999855 34
Q ss_pred ---EEEeecchhhhccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC
Q 005017 222 ---VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 296 (719)
Q Consensus 222 ---vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g 296 (719)
+||+|||++..... .....||+.|+|||++.+ .++.++|||||||++|||+||..|+................
T Consensus 157 ~~~~kl~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp CCEEEECCCCSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cceeeeccCcccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 99999999865433 234568999999998864 58999999999999999999655554435555544444332
Q ss_pred CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 297 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 297 ~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...+...+++++++|.+||. +|.+|||+.++++|
T Consensus 235 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22333446789999999998 89999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.54 Aligned_cols=259 Identities=23% Similarity=0.415 Sum_probs=189.2
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEeeecCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
.....|++.+.||+|+||.||+|.++.+|+.||+|+++... ......++..|+. +++.++||||+++++++...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-- 93 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-- 93 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--
Confidence 34566788899999999999999999999999999997542 2334455666666 77788999999999998765
Q ss_pred CceeEEEecccCCChhHHhhh-----cccccHHHHHHHHHHHHHHhhhhhcC-CCCeeeecCccceeEecCCCCcEEEee
Q 005017 153 KTVNMITELFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGD 226 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~-----~~~l~~~~i~~i~~QIl~gL~yLHs~-~ppIIHrDLKp~NILl~~~~G~vKL~D 226 (719)
..+++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++.+ |.+||+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~kl~D 169 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIKLCD 169 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEEECC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEEEcc
Confidence 458899999985 88877763 56789999999999999999999998 8 9999999999999855 7999999
Q ss_pred cchhhhccCCC-cccccCCCCCCCccccc-----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 227 LGLAIAMQQPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 227 FGlA~~~~~~~-~~~~~GT~~YmAPEvl~-----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||............+..+..+.
T Consensus 170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 99997664432 23447999999999873 3589999999999999999999999976433323322222322221
Q ss_pred ---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 301 ---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 301 ---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
......++.+++||.+||. +|.+|||+.++++||||.....
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 1223467899999999998 8999999999999999985543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=350.74 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=205.1
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
-..++|++.+.||+|+||.||+|. +..+|+.||+|+++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 346779999999999999999998 677899999999875432 3455788999999999999999999999988
Q ss_pred CCCCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
.+...+++||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEEECccc
Confidence 766778999999999999999955 456999999999999999999999999 9999999999999855 699999999
Q ss_pred hhhhccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCC--------------CCHHH
Q 005017 229 LAIAMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------------KNPAQ 288 (719)
Q Consensus 229 lA~~~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~--------------~~~~~ 288 (719)
++....... .....||+.|+|||++.+ .++.++||||||+++|+|+||..|+... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 997665432 234568889999998764 5889999999999999999999876321 11222
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
....+..+. ....+...++.+++||.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 333333333 333455678899999999998 8999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.58 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=208.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.+.||+|+||.||+|.+..+|+.||+|.++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CC
Confidence 3467899999999999999999999999999999886431 234556788999999999999999999988654 45
Q ss_pred eeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCceec
Confidence 889999999999999998754 5999999999999999999999999 9999999999999855 79999999999764
Q ss_pred cCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 234 QQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 234 ~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
..... ....+++.|+|||++. +.++.++|||||||++|||+| |..||.. ....+....+..+..+ ..+..++
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 341 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGGRL-PCPELCP 341 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT-SCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 43221 1223567899999886 468999999999999999998 9999987 4555666666665443 3455678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++.++|.+||. +|.+|||+.++++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999998 8999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.52 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=208.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~ 148 (719)
....|.+.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 456789999999999999999987 3467789999987432 123457889999999999 8999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcc-----------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeee
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIH 205 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~-----------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIH 205 (719)
.. ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+|
T Consensus 120 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 120 LS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp SS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred eC--CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 64 45889999999999999997653 2789999999999999999999999 999
Q ss_pred ecCccceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCC
Q 005017 206 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYP 279 (719)
Q Consensus 206 rDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~P 279 (719)
|||||+|||++.+ |.+||+|||++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |..|
T Consensus 196 ~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 196 RDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999855 799999999997654332 23446788999999875 468999999999999999998 9999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 280 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
|............+..+..+ ..+...++++.++|.+||. +|.+|||+.++++|..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 98866566666666555433 3445568899999999998 8999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=371.81 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=209.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..++.|++.++||+|+||+||+|.+..+|+.||+|+++.... ....+.+.+|+++|++++||||+++++++...+..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 456788999999999999999999999999999999875432 23356788999999999999999999999877766
Q ss_pred ceeEEEecccCCChhHHhhhccc---ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEe----cCCCCcEEEee
Q 005017 154 TVNMITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGD 226 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~---l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl----~~~~G~vKL~D 226 (719)
.+++||||+.+|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+ +. .+.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~-~~~~kL~D 159 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDG-QSVYKLTD 159 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTS-CEEEEECC
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCC-ceeEEEec
Confidence 78999999999999999987543 999999999999999999999999 9999999999998 53 35799999
Q ss_pred cchhhhccCCC-cccccCCCCCCCccccc---------cccCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHH
Q 005017 227 LGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKV 293 (719)
Q Consensus 227 FGlA~~~~~~~-~~~~~GT~~YmAPEvl~---------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i 293 (719)
||+++...... .....||+.|+|||++. ..++.++|||||||++|||+||+.||.... ...++...+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 99997665432 34567999999999875 357889999999999999999999996422 233445555
Q ss_pred HcCCCCCcc-----------------------ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 294 TSGIKPASL-----------------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 294 ~~g~~p~~~-----------------------~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+..+..+ ....++.++++|.+||. ||.+||++.+++++
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 544332111 11224578899999998 99999999998664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=359.61 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=200.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEV----AWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~V----AvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
....|++.++||+|+||+||+|.+..+|..+ |+|.++... .....+++.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4566889999999999999999998887755 666664322 234557899999999999999999999998754
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..++|+||+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~ 163 (327)
T 3poz_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGL 163 (327)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTH
T ss_pred ---CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEccCcc
Confidence 377899999999999999874 56999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 230 AIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 230 A~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
++...... .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.. .+...+...+..+..+. .+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~~-~~ 241 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QP 241 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCCC-CC
Confidence 98765432 223457889999998764 58999999999999999999 9999987 44555666666554332 34
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...++.+.+++.+||. +|.+|||+.+++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5567899999999998 89999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=350.76 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=201.2
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.+..+..|++.+.||+|+||+||+|.+. ..||+|+++.... .....+.+.+|+.+|++++||||++++++..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 90 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYST--- 90 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---
Confidence 3445677889999999999999999754 3599999875532 3456788999999999999999999999653
Q ss_pred CCceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
...+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-NTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-TEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-CCEEEccceec
Confidence 2347899999999999999964 456999999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCC----CcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 005017 231 IAMQQP----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 231 ~~~~~~----~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~ 302 (719)
...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||........+...+..+..+..+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 755421 223457999999999874 357889999999999999999999999877778877777776554433
Q ss_pred ---ccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 303 ---AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 303 ---~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
....++.+++||.+||. +|.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 34567899999999998 8999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=352.29 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=210.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~ 148 (719)
....|++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 456789999999999999999985 4578899999987442 234567899999999999 9999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcc------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
.. ...++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 98 IG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 55 45889999999999999998654 3899999999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCCCc----ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECK 284 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~~~----~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~ 284 (719)
+||+++.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|+| |..||....
T Consensus 174 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999855 7999999999976654322 2345788999999875 468999999999999999999 999998766
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
........+..+..+ ..+...++.++++|.+||. +|.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 556666555555433 3345567899999999998 89999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=359.65 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=202.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCC-eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC------ceeEEEee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN------VVKFYKSW 147 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g-~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------IVkl~~~~ 147 (719)
....|++.+.||+|+||+||+|.+..++ ..||+|+++.. ....+.+.+|+.++++++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 3467889999999999999999998777 78999998632 245577889999999998766 89999887
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--------
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-------- 217 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-------- 217 (719)
... ..+++||||+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 92 NFH--GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeC--CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 655 4688999999 66777777654 36999999999999999999999999 999999999999932
Q ss_pred ----------CCCcEEEeecchhhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH
Q 005017 218 ----------NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP 286 (719)
Q Consensus 218 ----------~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~ 286 (719)
..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||+||..||......
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3468999999999764432 345679999999998864 6899999999999999999999999874433
Q ss_pred HHHHHHHHc--CCCCCcc----------------------------------------ccCCChHHHHHHHHhcC-CCCC
Q 005017 287 AQIFKKVTS--GIKPASL----------------------------------------AKVNDPQIKGFIEKCLV-PASE 323 (719)
Q Consensus 287 ~~i~~~i~~--g~~p~~~----------------------------------------~~~~~~~l~~lI~kcL~-dP~~ 323 (719)
.. ...+.. +..|..+ ....++++++||.+||. ||.+
T Consensus 246 ~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 EH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 32 222211 1111100 00113478899999998 8999
Q ss_pred CCCHHHHHcCccCcccc
Q 005017 324 RLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 324 RpSa~eLL~hpf~~~~~ 340 (719)
|||+.++|+||||+...
T Consensus 325 Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 325 RITLAEALLHPFFAGLT 341 (355)
T ss_dssp SCCHHHHTTSGGGGGCC
T ss_pred CcCHHHHhcChhhcCCC
Confidence 99999999999998644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.29 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=202.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||.||+|.+..+|..||+|+++..... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN--E 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT--E
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--c
Confidence 345689999999999999999999999999999999754332 2456678999999999999999999999987654 5
Q ss_pred eeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 155 VNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccce
Confidence 8899999999999999875 356899999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCCC--cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHHHHHHHHHcCCCCCccccCC
Q 005017 231 IAMQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 231 ~~~~~~~--~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... +...+...+..+..+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 7654332 334579999999998764 58999999999999999999999997532 3455666666665555445667
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+++++++|.+||. ||.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8899999999998 89999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.41 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=198.2
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.....|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.++++++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-
Confidence 3556789999999999999999998653 567999987643 234556789999999999999999999998732
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 162 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGL 162 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC---
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECcccc
Confidence 35789999999999999998654 6999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 230 AIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 230 A~~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
+....... .....+|+.|+|||++. ..++.++||||||+++|||++ |..||... ...+....+..+..+ ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~ 240 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPP 240 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCC
Confidence 97664432 23345788999999886 468999999999999999997 99999874 445556666655433 3455
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..++.++++|.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678899999999998 89999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.42 Aligned_cols=249 Identities=28% Similarity=0.404 Sum_probs=211.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEe
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKS 146 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~ 146 (719)
....|.+.+.||+|+||+||+|.+.. .+..||+|+++... .....+++.+|+++++++ +|||||+++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 45678999999999999999998753 34689999987442 345668899999999999 99999999998
Q ss_pred eecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCcc
Q 005017 147 WVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 210 (719)
Q Consensus 147 ~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp 210 (719)
+... ..+++||||+.+|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||
T Consensus 144 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 219 (382)
T 3tt0_A 144 CTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 219 (382)
T ss_dssp ECSS--SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eccC--CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence 8654 45889999999999999998654 4899999999999999999999999 99999999
Q ss_pred ceeEecCCCCcEEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCC
Q 005017 211 DNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECK 284 (719)
Q Consensus 211 ~NILl~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~ 284 (719)
+|||++.+ |.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|+| |..||.. .
T Consensus 220 ~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~ 297 (382)
T 3tt0_A 220 RNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-V 297 (382)
T ss_dssp GGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred ceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Confidence 99999855 79999999999765432 2234467889999998764 58999999999999999999 9999987 5
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...++...+..+..+. .+...++++++||.+||. +|.+|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677777777765443 345678899999999998 89999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=356.52 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=209.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
..+.|++.+.||+|+||+||+|. +..+|..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG----PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 45788999999999999999998 57789999999987542 45567899999999999999999999998877
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+...+++||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEccccc
Confidence 777899999999999999999874 56999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC--------------HHHH
Q 005017 230 AIAMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--------------PAQI 289 (719)
Q Consensus 230 A~~~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--------------~~~i 289 (719)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 97664332 223468888999998864 589999999999999999999999854211 1223
Q ss_pred HHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 290 FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 290 ~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...+..+. ....+...++.+++||.+||. +|.+|||+.+++++
T Consensus 254 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 254 LELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333333 333455678899999999998 89999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=348.95 Aligned_cols=245 Identities=29% Similarity=0.479 Sum_probs=207.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec------
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD------ 149 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~------ 149 (719)
+..|++.+.||+|+||.||+|.+..+|+.||+|+++... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 456889999999999999999999999999999997542 346789999999999999999998754
Q ss_pred --------CCCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC
Q 005017 150 --------DKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219 (719)
Q Consensus 150 --------~~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~ 219 (719)
.....+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~- 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT- 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-
Confidence 2234588999999999999999754 56999999999999999999999999 9999999999999855
Q ss_pred CcEEEeecchhhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC
Q 005017 220 GEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 297 (719)
Q Consensus 220 G~vKL~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~ 297 (719)
+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~ 235 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI 235 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc
Confidence 69999999999766543 2345679999999998865 589999999999999999999988753 334444554443
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
. +...++.++++|.+||. +|.+|||+.++++|++.-.
T Consensus 236 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3 34567899999999998 8999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=353.11 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=211.9
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEee
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSW 147 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~ 147 (719)
.....|++.+.||+|+||+||+|.+ ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3456789999999999999999984 4577899999987432 234567889999999999 799999999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhccc----------------ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccc
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 211 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~----------------l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~ 211 (719)
...+ ..+++||||+++|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+
T Consensus 101 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~ 177 (316)
T 2xir_A 101 TKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 177 (316)
T ss_dssp CCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccc
Confidence 6543 468899999999999999987554 899999999999999999999999 999999999
Q ss_pred eeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCC
Q 005017 212 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKN 285 (719)
Q Consensus 212 NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~ 285 (719)
|||++.+ |.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||.....
T Consensus 178 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 178 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 9999855 799999999997654332 224568899999998764 58999999999999999998 9999988666
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.......+..+..+ ..+...++.++++|.+||. +|.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66666666665433 3445578899999999998 89999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=340.42 Aligned_cols=245 Identities=18% Similarity=0.395 Sum_probs=208.3
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 78 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--API 78 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCe
Confidence 456889999999999999999886 788999999875432 236789999999999999999999988654 458
Q ss_pred eEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 156 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBC
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEcccccccccc
Confidence 8999999999999999875 46899999999999999999999999 9999999999999855 799999999997654
Q ss_pred CC---CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 235 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
.. ......||+.|+|||++. ..++.++||||||+++|+|++ |+.||.. .+.......+..+..+ ..+...++.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 233 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTH 233 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHH
Confidence 32 123345788999999886 468999999999999999999 8999987 4566677777766443 334556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++++|.+||. +|.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 89999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=358.82 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=201.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.+..|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.++++| +||||+++++++... .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--K 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--T
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--C
Confidence 35678999999999999999999999999999999875432 23578999999999 999999999988764 4
Q ss_pred ceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc-----EEEeec
Q 005017 154 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDL 227 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~-----vKL~DF 227 (719)
..++||||+ +|+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |. +||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DF 154 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDF 154 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCC
T ss_pred ccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEc
Confidence 688999999 9999999986 367999999999999999999999999 9999999999999855 45 999999
Q ss_pred chhhhccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHc
Q 005017 228 GLAIAMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTS 295 (719)
Q Consensus 228 GlA~~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~ 295 (719)
|+++...... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9997654332 245689999999998875 58999999999999999999999997642 33444444433
Q ss_pred CCCCC---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 296 GIKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 296 g~~p~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
...+. ...... ++++++|..||. +|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22111 112223 499999999997 8999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.42 Aligned_cols=247 Identities=21% Similarity=0.327 Sum_probs=206.1
Q ss_pred CCcEEEeE-EEeeeCCeEEEEEE--EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDE-VLGKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e-~LG~G~fG~Vyka~--d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...|.+.+ .||+|+||+||+|. +..+++.||+|+++... ......+.+.+|+.++++++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~-- 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE-A-- 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S--
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C--
Confidence 45667777 99999999999994 45678999999987543 22345678999999999999999999999883 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCccee
Confidence 357899999999999999998888999999999999999999999999 9999999999999855 6999999999976
Q ss_pred ccCCCc-----ccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~~-----~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
...... ....||+.|+|||++.+ .++.++||||||+++|+|+| |+.||.. ....++...+..+..+ ..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 244 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAG 244 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 644321 22346789999998864 58999999999999999999 9999987 4566677777666543 34556
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.++.++++|.+||. +|.+|||+.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999998 8999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.60 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=212.1
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.......|++.+.||+|+||+||+|.+..++..||+|.+... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence 344667789999999999999999999999999999998643 24567899999999999999999999988654
Q ss_pred CCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||+
T Consensus 82 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~ 157 (288)
T 3kfa_A 82 -PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGL 157 (288)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCCG
T ss_pred -CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCcc
Confidence 4588999999999999999864 34999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 230 AIAMQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 230 A~~~~~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
+........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+..+....+.....+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~ 235 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPE 235 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCT
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCC
Confidence 987654432 2345788999999886 468999999999999999999 9999987 4555666666655433 3445
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..++.+++||.+||. +|.+|||+.++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 667899999999998 8999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.24 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=210.1
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEee
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 147 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~ 147 (719)
....+.|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345677899999999999999999876 467899999986432 234566789999999999999999999988
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhc----------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~----------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
.+. ..+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 98 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 98 SQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAE 173 (322)
T ss_dssp CSS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECT
T ss_pred ccC--CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcC
Confidence 654 4588999999999999998763 34689999999999999999999999 999999999999985
Q ss_pred CCCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 291 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~ 291 (719)
+ |.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .+..+...
T Consensus 174 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~ 251 (322)
T 1p4o_A 174 D-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLR 251 (322)
T ss_dssp T-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHH
T ss_pred C-CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHH
Confidence 5 799999999997654321 223467899999998864 58999999999999999999 8899987 45666667
Q ss_pred HHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 292 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 292 ~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+..+..+. .+...++.++++|.+||. +|.+|||+.++++|
T Consensus 252 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 666654432 345567899999999998 89999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.13 Aligned_cols=256 Identities=19% Similarity=0.325 Sum_probs=202.7
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEee
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 147 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~ 147 (719)
.....++.|.+.+.||+|+||+||+|.+.. ++..||+|.++.... .....+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 334567889999999999999999998765 566899999875432 245567899999999999999999999998
Q ss_pred ecCCCC---ceeEEEecccCCChhHHhh------hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC
Q 005017 148 VDDKKK---TVNMITELFTSGNLRQYRK------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 218 (719)
Q Consensus 148 ~~~~~~---~l~lV~Ey~~gGsL~~~L~------~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~ 218 (719)
...... ..++||||+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence 765432 4689999999999999984 3356999999999999999999999999 9999999999999855
Q ss_pred CCcEEEeecchhhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHH
Q 005017 219 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 292 (719)
Q Consensus 219 ~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~ 292 (719)
|.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .........
T Consensus 184 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~ 261 (313)
T 3brb_A 184 -MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDY 261 (313)
T ss_dssp -SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHH
T ss_pred -CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc-CCHHHHHHH
Confidence 799999999997654321 233457889999998864 58999999999999999999 8899977 445556666
Q ss_pred HHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 293 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 293 i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+..+..+ ..+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 262 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 262 LLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6665443 3345567899999999998 89999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.70 Aligned_cols=250 Identities=21% Similarity=0.238 Sum_probs=201.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
-..|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++++... ..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeE
Confidence 3457889999999999999999999999999999875432 2244567899999999999999999999988765 458
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCccccc
Confidence 899999999999999998888999999999999999999999999 9999999999999855 7999999999876544
Q ss_pred CC---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC-CCccccCCChHH
Q 005017 236 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQI 310 (719)
Q Consensus 236 ~~---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-p~~~~~~~~~~l 310 (719)
.. .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.. .+...+...+..... +.......++++
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCCHHH
Confidence 32 234579999999998864 589999999999999999999999986 333444444444332 223455678899
Q ss_pred HHHHHHhcC-CCCCCC-CHHHHHc
Q 005017 311 KGFIEKCLV-PASERL-SAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~Rp-Sa~eLL~ 332 (719)
+++|.+||. +|.+|| ++.++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 999999998 899999 8888876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.46 Aligned_cols=248 Identities=15% Similarity=0.211 Sum_probs=204.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.+..|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +|+||+++++++... .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 79 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 79 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--c
Confidence 4567899999999999999999999999999999986433 223577899999999 799999999987644 4
Q ss_pred ceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC----CcEEEeecc
Q 005017 154 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGDLG 228 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~----G~vKL~DFG 228 (719)
..++||||+ +++|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+. +.+||+|||
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 588999999 999999998754 5999999999999999999999999 99999999999997442 239999999
Q ss_pred hhhhccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHcC
Q 005017 229 LAIAMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSG 296 (719)
Q Consensus 229 lA~~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~g 296 (719)
++....... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ...+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 997654432 235579999999998865 58999999999999999999999997642 344444444332
Q ss_pred C---CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 297 I---KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 297 ~---~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
. .........+++++++|.+||. +|.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2 1222334567899999999997 89999999999773
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.39 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=189.5
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeec---
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVD--- 149 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~--- 149 (719)
..+..|++.++||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 35567899999999999999999999999999999986543 355678899999999996 9999999998853
Q ss_pred ---CCCCceeEEEecccCCChhHHhhh---cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEE
Q 005017 150 ---DKKKTVNMITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 150 ---~~~~~l~lV~Ey~~gGsL~~~L~~---~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
.....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++.+ |.+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~k 178 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIK 178 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEE
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEE
Confidence 33446889999996 799998865 456999999999999999999999998889999999999999855 7999
Q ss_pred EeecchhhhccCCCc--------------ccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCC
Q 005017 224 IGDLGLAIAMQQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKN 285 (719)
Q Consensus 224 L~DFGlA~~~~~~~~--------------~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~ 285 (719)
|+|||++........ ....||+.|+|||++. ..++.++|||||||++|+|+||+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999976543211 1446999999999873 3578999999999999999999999976322
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
.. +..+..........++.+++||.+||. +|.+|||+.++++|-.
T Consensus 259 -~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 259 -LR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred -HH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 21 222222223344556789999999998 8999999999999853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.03 Aligned_cols=245 Identities=28% Similarity=0.425 Sum_probs=194.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEeeecC--
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDD-- 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~~~~~~~-- 150 (719)
..+.|++.+.||+|+||+||+|.+ +|+.||+|++... ....+..|.+++.. ++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 456788999999999999999976 6999999998633 33556667777776 8999999999987653
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhh--------cCCCCeeeecCccceeEecCCCCcE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLH--------s~~ppIIHrDLKp~NILl~~~~G~v 222 (719)
....+++||||+++|+|.++++. ..+++..++.++.||+.||+||| +++ |+||||||+|||++.+ +.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~~ 152 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQC 152 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SCE
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CCE
Confidence 23468899999999999999964 57999999999999999999999 777 9999999999999855 799
Q ss_pred EEeecchhhhccCCC------cccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhc----------cCC
Q 005017 223 KIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTF----------EYP 279 (719)
Q Consensus 223 KL~DFGlA~~~~~~~------~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG----------~~P 279 (719)
||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|||+|| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997654332 223479999999998864 355799999999999999999 888
Q ss_pred CCCCCC----HHHHHHHHHcCCCCCccc-----cCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 280 YSECKN----PAQIFKKVTSGIKPASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 280 f~~~~~----~~~i~~~i~~g~~p~~~~-----~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
|..... .......+........++ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 865321 222333332222222222 1234679999999998 8999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.07 Aligned_cols=251 Identities=19% Similarity=0.233 Sum_probs=202.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC--CC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~--~~ 152 (719)
.++.|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4567899999999999999999999999999999987532 45667899999999999999999999988643 33
Q ss_pred CceeEEEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 153 KTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
..+++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEecC
Confidence 478899999999999999876 456999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCCC-----------cccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 005017 229 LAIAMQQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKK 292 (719)
Q Consensus 229 lA~~~~~~~-----------~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~-~~~i~~~ 292 (719)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 886543211 123458999999998853 378999999999999999999999953100 0112222
Q ss_pred HHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 293 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 293 i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+... .........++.++++|.+||. +|.+|||+.+++++
T Consensus 260 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQ-LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcc-CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2222 2222334567899999999998 89999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.48 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=209.3
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEc-------CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEE
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYK 145 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~-------~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~ 145 (719)
.....|++.+.||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 34577899999999999999999875 467889999987432 245667899999999999 8999999999
Q ss_pred eeecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCc
Q 005017 146 SWVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 209 (719)
Q Consensus 146 ~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLK 209 (719)
++... ..+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+|||||
T Consensus 109 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 109 ACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EECSS--SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEccC--CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 88654 45889999999999999998654 3899999999999999999999999 9999999
Q ss_pred cceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCC
Q 005017 210 CDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSEC 283 (719)
Q Consensus 210 p~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~ 283 (719)
|+|||++.+ |.+||+|||++....... .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||..
T Consensus 185 p~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~- 262 (334)
T 2pvf_A 185 ARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 262 (334)
T ss_dssp GGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred cceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-
Confidence 999999855 799999999997654432 23345788999999876 458999999999999999999 9999987
Q ss_pred CCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 284 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 284 ~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....++...+..+..+. .+...++.++++|.+||. +|.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 45667777776665433 445667899999999998 89999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.21 Aligned_cols=242 Identities=29% Similarity=0.486 Sum_probs=195.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
.+.|++.+.||+|+||+||+|.+ .++.||+|++... ...+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~ 74 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN----PV 74 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TT
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----Cc
Confidence 45688999999999999999976 4889999988532 345788999999999999999999997752 37
Q ss_pred eEEEecccCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhc---CCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 156 NMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHS---HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs---~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
++||||+++|+|.+++.... .+++..++.|+.||+.||+|||+ ++ |+||||||+|||++.+...+||+|||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccc
Confidence 89999999999999998654 37889999999999999999999 66 999999999999986533489999999
Q ss_pred hhhccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH-HHHHHHHHcCCCCCccccCCC
Q 005017 230 AIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 230 A~~~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~-~~i~~~i~~g~~p~~~~~~~~ 307 (719)
+...... .....||+.|+|||++.+ .++.++||||||+++|||+||+.||...... ..+...+..+..+ ......+
T Consensus 153 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (307)
T 2eva_A 153 ACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCC
T ss_pred ccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccC
Confidence 9765433 234569999999998865 5899999999999999999999999864433 3344444444433 3445668
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+.++++|.+||. +|.+|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 899999999998 89999999999884
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.46 Aligned_cols=248 Identities=19% Similarity=0.340 Sum_probs=207.1
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
++++.+.+.||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.++++++||||+++++++. . .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~--~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A--E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S--S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C--C
Confidence 445555569999999999999854 468889999987542 3456788999999999999999999999883 2 3
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECcccceee
Confidence 488999999999999999754 46999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
..... .....||+.|+|||++. ..++.++||||||+++|+|+| |+.||... ...++...+..+..+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~ 237 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPE 237 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCC
Confidence 64332 22345789999999886 468999999999999999998 99999874 455566666665443 34556
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
.++.++++|.+||. +|.+||++.+++++.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 78999999999998 899999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=357.61 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=203.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeE----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~----VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
....|++.++||+|+||+||+|.+..+|.. ||+|.+..... ....+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 345688999999999999999999888875 67776643321 2233457789999999999999999998742
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..+++||||+.+|+|.+++... +.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~ 161 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGV 161 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCSG
T ss_pred --CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCCc
Confidence 3588999999999999999875 57999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 230 AIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 230 A~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
++...... .....||+.|+|||++. +.++.++|||||||++|+|+| |..||... ....+...+..+..+ ..+
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~ 239 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQP 239 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCC
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCC
Confidence 98764432 23456888999999886 468999999999999999999 99999873 445555666655433 334
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...++.+.++|.+||. +|.+|||+.++++|
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4567789999999998 89999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.09 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=209.4
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEE-----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeee
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 148 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~-----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~ 148 (719)
...+.|++.+.||+|+||+||+|. +..+|..||+|.+.... ......++.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 355678999999999999999998 55688899999986322 2455678899999999999999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhcc-------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CC
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NH 219 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~~-------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~ 219 (719)
.. ..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. +.
T Consensus 104 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 104 QS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTT
T ss_pred CC--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCc
Confidence 54 45789999999999999998753 4899999999999999999999999 999999999999983 23
Q ss_pred CcEEEeecchhhhccCC----CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHH
Q 005017 220 GEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 293 (719)
Q Consensus 220 G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i 293 (719)
+.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|+| |..||.. .....+...+
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~ 258 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFV 258 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHH
Confidence 46999999999765332 223456899999999875 468999999999999999998 8999987 4566677777
Q ss_pred HcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 294 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 294 ~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
..+..+ ..+...++.++++|.+||. +|.+|||+.++++|.|+..
T Consensus 259 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 TSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 666443 3345668899999999998 8999999999999988753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.58 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=205.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.+|||++.+.||+|+||+||+|. +..+|+.||+|+++... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 56888999999999999997774 45589999999987542 345567899999999999999999999999887
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
+...+++||||+++|+|.+++... .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a 181 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFGLA 181 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCcccc
Confidence 667899999999999999999765 4999999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH--------------HHHH
Q 005017 231 IAMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIF 290 (719)
Q Consensus 231 ~~~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--------------~~i~ 290 (719)
....... .....||+.|+|||++.+ .++.++||||||+++|+|+||..||...... ..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 7765432 234468889999998865 5889999999999999999999998642111 0122
Q ss_pred HHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 291 ~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+ .....+...++++.+||.+||. +|.+|||+.++++
T Consensus 262 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERG-ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcc-cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 223333 2333455678899999999998 8999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.59 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=208.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCe-----EEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeee
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGI-----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWV 148 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~-----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~ 148 (719)
....|.+.+.||+|+||+||+|.+..+|. .||+|.++... .....+.+.+|+.+|+++ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 45678999999999999999999876664 79999886432 234567899999999999 8999999999886
Q ss_pred cCCCCceeEEEecccCCChhHHhhhc--------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeE
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKH--------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 214 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~--------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NIL 214 (719)
.. ..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 121 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 121 HG--GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp SS--SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred cC--CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 54 4588999999999999998753 34799999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHH
Q 005017 215 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 288 (719)
Q Consensus 215 l~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~ 288 (719)
++.+ +.+||+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+| |..||........
T Consensus 197 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 197 LTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred ECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9855 799999999997654332 22345788999999876 468999999999999999999 8999987655555
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....+..+..+ ..+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 276 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 55555554333 3445568899999999998 89999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=343.47 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=205.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|.+.++||+|+||+||+|.+..++. .||+|.+... ......+.+.+|+.++++++||||+++++++...+ .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-G 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-C
Confidence 345677999999999999998655444 7999988632 23456688999999999999999999999987554 3
Q ss_pred ceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++||||+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARD 173 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCccc
Confidence 44789999999999999976 456899999999999999999999999 9999999999999855 7999999999975
Q ss_pred ccCC------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
.... ......||+.|+|||.+.+ .++.++||||||+++|+|+||..|+....+.......+..+..+ ..+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCcc
Confidence 4322 2334568899999998865 58999999999999999999766665556677777777665543 33455
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.++.++++|.+||. +|.+|||+.++++.
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67899999999998 89999999999873
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.86 Aligned_cols=243 Identities=22% Similarity=0.386 Sum_probs=204.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||.||+|.+. |..||+|+++... ..+.+.+|+.+|++++|||||++++++.... ..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 261 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 261 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cc
Confidence 3467889999999999999999764 8899999987432 3467899999999999999999999887543 36
Q ss_pred eeEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+++|+|.+++...+. +++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCccc
Confidence 8899999999999999987654 799999999999999999999999 9999999999999855 7999999999975
Q ss_pred ccCCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 233 MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.... .....+++.|+|||++. ..++.++|||||||++|||+| |+.||... ...++...+..+..+ ..+..+++.+
T Consensus 339 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 415 (450)
T 1k9a_A 339 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAV 415 (450)
T ss_dssp CC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 4332 23346789999999886 458999999999999999998 99999874 445566677766543 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.++|.+||. +|.+|||+.+|++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999998 8999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=367.50 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=207.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+. .+..||+|+++... ...+.+.+|+.+|++|+|||||++++++. ...
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~ 256 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEP 256 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCc
Confidence 4567899999999999999999876 57889999987543 24578999999999999999999999874 245
Q ss_pred eeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCceE
Confidence 889999999999999998643 6899999999999999999999999 9999999999999855 7999999999987
Q ss_pred ccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
..... .....+|+.|+|||++. +.++.++|||||||++|||+| |+.||.+ .+..++...+..+.... .+..++
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-MSNPEVIRALERGYRMP-RPENCP 411 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCCC-CCTTSC
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 64321 22344678999999886 568999999999999999999 9999987 45666777777665433 345567
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++.++|.+||. +|.+|||+.+|++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 899999999998 8999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.92 Aligned_cols=248 Identities=21% Similarity=0.377 Sum_probs=197.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEc---CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~---~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
....|.+.++||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+|++++||||+++++++...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 118 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS- 118 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-
Confidence 4456788999999999999999876 467789999987532 245567899999999999999999999988654
Q ss_pred CCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 119 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 194 (373)
T 2qol_A 119 -KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLG 194 (373)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC---
T ss_pred -CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCccc
Confidence 45889999999999999998754 6999999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 231 IAMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 231 ~~~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
+...... .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.. .....+...+..+..+. .+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~ 272 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP-PP 272 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC-CC
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CC
Confidence 7664332 12234578899999886 468999999999999999998 9999987 45666666666654332 23
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
...++.+.++|.+||. +|.+||++.++++
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 4567899999999998 8999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=359.76 Aligned_cols=259 Identities=18% Similarity=0.223 Sum_probs=198.8
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCCh-------hhHHHHHHHHHHHHhCCCCCce
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLP-------GDLQKLYSEVHLLKSLKDDNVV 141 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~-------~~~~~~~~Ei~iL~~L~HpNIV 141 (719)
.+..+..|++.+.||+|+||+||+|.+.. ++..||+|++......... .....+.+|+..++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 45567788999999999999999999987 7889999998754311000 0113466788999999999999
Q ss_pred eEEEeeecC--CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC
Q 005017 142 KFYKSWVDD--KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 219 (719)
Q Consensus 142 kl~~~~~~~--~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~ 219 (719)
++++++... +...+++||||+ +++|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 999998762 245789999999 9999999998889999999999999999999999999 99999999999998542
Q ss_pred -CcEEEeecchhhhccCC---------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC-CHH
Q 005017 220 -GEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPA 287 (719)
Q Consensus 220 -G~vKL~DFGlA~~~~~~---------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~-~~~ 287 (719)
+.+||+|||+++.+... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||.... +..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 38999999999765321 1134579999999998875 48999999999999999999999995422 222
Q ss_pred HHHHHHH--cCCCCCccc-----cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 288 QIFKKVT--SGIKPASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 288 ~i~~~i~--~g~~p~~~~-----~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
....... ....+.... ...+++++++|.+||. +|.+|||+.+|++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 2221111 111121111 1567899999999998 89999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=342.17 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=201.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+..|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+.. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccC-CCCc
Confidence 35678899999999999999999999999999999875432 2357899999999999988777766544 3456
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhh
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 231 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~ 231 (719)
.++||||+ +++|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+.+.+||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 88999999 9999999974 457999999999999999999999999 99999999999994 244799999999997
Q ss_pred hccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcC---
Q 005017 232 AMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSG--- 296 (719)
Q Consensus 232 ~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g--- 296 (719)
...... .....||+.|+|||++.+ .++.++|||||||++|+|+||+.||..... ..+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 655432 245679999999998865 589999999999999999999999976322 11222222221
Q ss_pred CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 297 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 297 ~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..........++.+.++|.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11122334567899999999998 8999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.10 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=203.8
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.....|.+.+.||+|+||+||+|.+.. ++..||+|.+.... .....+++.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 355678999999999999999998653 34569999887442 245568899999999999999999999987532
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||+
T Consensus 86 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 ---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGL 159 (281)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCG
T ss_pred ---CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCC
Confidence 3678999999999999997754 5999999999999999999999999 9999999999999855 6999999999
Q ss_pred hhhccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccc
Q 005017 230 AIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAK 304 (719)
Q Consensus 230 A~~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~ 304 (719)
+....... .....+|+.|+|||++. ..++.++||||||+++|+|+| |+.||... ........+..+..+ ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 237 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDRL-PKPD 237 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCCC-CCCT
T ss_pred CcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCCC-CCCC
Confidence 97664432 23345788999999886 458999999999999999998 99999763 334445555554333 2344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 305 VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 305 ~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..++.++++|.+||. +|.+|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 568899999999998 89999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.15 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEE--EEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEV--AWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~V--AvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.+.||+|+||.||+|.+..+|..+ |+|.++... .....+.+.+|+.+|+++ +||||+++++++... .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--C
Confidence 56788999999999999999999899865 888886432 234456789999999999 999999999998665 4
Q ss_pred ceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 154 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
.+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence 5899999999999999997654 6899999999999999999999999 999999999999985
Q ss_pred CCCcEEEeecchhhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 294 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~ 294 (719)
+ |.+||+|||+++..... ......+++.|+|||++.+ .++.++|||||||++|+|+| |+.||.. .+...+...+.
T Consensus 178 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~ 255 (327)
T 1fvr_A 178 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 255 (327)
T ss_dssp G-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGG
T ss_pred C-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhh
Confidence 5 79999999998643322 2234457889999998864 58999999999999999998 9999987 56667777776
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+..+. .+...++.++++|.+||. +|.+|||+.+++++
T Consensus 256 ~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 664332 344567899999999998 89999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.99 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=206.4
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+|++++||||+++++++.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 81 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CC
Confidence 4567899999999999999999876 67789999987443 234678999999999999999999998753 34
Q ss_pred eeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCccccc
Confidence 789999999999999998654 6999999999999999999999999 9999999999999855 7999999999976
Q ss_pred ccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
..... .....+++.|+|||++. +.++.++||||||+++|+|+| |+.||.. .+..+....+..+..+ ..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 236 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCP 236 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCccccc
Confidence 65432 22345788999999886 468999999999999999999 8999987 4556666777665433 3345667
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++++++|.+||. +|.+|||+.++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 899999999998 8999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.78 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=200.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEV----AWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~V----AvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
....|++.++||+|+||+||+|.+..+|..| |+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 4566889999999999999999998888765 555554222 234567899999999999999999999998754
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..++|++|+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 90 ---~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL~DfG~ 163 (327)
T 3lzb_A 90 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGL 163 (327)
T ss_dssp ---SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCTTC
T ss_pred ---CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEEccCcc
Confidence 377899999999999999864 56999999999999999999999999 9999999999999855 7999999999
Q ss_pred hhhccCCC----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 005017 230 AIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 230 A~~~~~~~----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~ 303 (719)
++...... .....||+.|+|||++.+ .++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~ 241 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQP 241 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCC
Confidence 97664322 223457889999998764 58999999999999999999 9999987 4455566666555433 334
Q ss_pred cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
...++++.++|.+||. +|.+|||+.++++.
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5567899999999998 89999999999983
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.83 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=203.5
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeee
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 148 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~ 148 (719)
..+....|++.++||+|+||+||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 455667789999999999999999986543 345888887642 23456688999999999999999999999876
Q ss_pred cCCCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..+ ...++||||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+||+++.+ |.+||+||
T Consensus 97 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Df 172 (298)
T 3f66_A 97 RSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADF 172 (298)
T ss_dssp CSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSC
T ss_pred cCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEECcc
Confidence 543 4678999999999999999763 45899999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCC------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhc-cCCCCCCCCHHHHHHHHHcCCCC
Q 005017 228 GLAIAMQQP------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKP 299 (719)
Q Consensus 228 GlA~~~~~~------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG-~~Pf~~~~~~~~i~~~i~~g~~p 299 (719)
|++...... ......||+.|+|||++.+ .++.++||||||+++|+|++| .+||.. .+.......+..+..+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL 251 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC
Confidence 999765432 2234467889999998864 589999999999999999995 556655 4445555555555433
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+...++.++++|.+||. +|.+|||+.++++
T Consensus 252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3345567899999999998 8999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.54 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=197.8
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCC-----CeEEEEEEEeeccccCChhhH--------HHHHHHHHHHHhCCCCC
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDL--------QKLYSEVHLLKSLKDDN 139 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~-----g~~VAvK~i~~~~~~~~~~~~--------~~~~~Ei~iL~~L~HpN 139 (719)
+..+..|++.+.||+|+||+||+|.+..+ ++.||+|++....... .... ..+..|+..++.++|||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-FTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHH-HHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhH-HHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 45667889999999999999999998764 5889999987543100 0000 12345666778889999
Q ss_pred ceeEEEeeecCC--CCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec
Q 005017 140 VVKFYKSWVDDK--KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 216 (719)
Q Consensus 140 IVkl~~~~~~~~--~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~ 216 (719)
|+++++++.... ...+++||||+ +|+|.+++... +.+++..++.|+.||+.||+|||+++ |+||||||+|||++
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~ 186 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN 186 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence 999999987643 25689999999 99999999876 67999999999999999999999999 99999999999998
Q ss_pred C-CCCcEEEeecchhhhccCC---------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC
Q 005017 217 G-NHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN 285 (719)
Q Consensus 217 ~-~~G~vKL~DFGlA~~~~~~---------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~ 285 (719)
. +.+.+||+|||+++.+... .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 2 3379999999999654321 1134569999999998875 489999999999999999999999985333
Q ss_pred HHHHHHHHHcCCC---CC-----ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 286 PAQIFKKVTSGIK---PA-----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 286 ~~~i~~~i~~g~~---p~-----~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
............. +. ......++++.++|..||. +|.+||++.+|++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3322221111100 00 0013457899999999998 8999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.63 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=200.7
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcC-CC--eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEF-AG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~-~g--~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
.....|++.+.||+|+||+||+|.+.. ++ ..||+|+++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 346678999999999999999998643 33 36899988754322 235668899999999999999999999988654
Q ss_pred CCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
. .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||+
T Consensus 94 ~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~ 167 (291)
T 1u46_A 94 P---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGL 167 (291)
T ss_dssp S---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred C---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEccccc
Confidence 2 78999999999999999764 56999999999999999999999999 9999999999999855 6999999999
Q ss_pred hhhccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 005017 230 AIAMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 230 A~~~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 302 (719)
+....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..+....+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPR 246 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCC
Confidence 97664432 223457889999998864 58999999999999999999 9999987 4566677777665444445
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+...++.++++|.+||. +|.+|||+.+++++
T Consensus 247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 56678899999999998 89999999999973
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=358.50 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=201.1
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
.......|++.+.||+|+||+||+|.+. +|..||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 107 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER- 107 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-
Confidence 3445566788899999999999999865 78999999876442 34567899999999999999999999988654
Q ss_pred CCceeEEEecccCCChhHHhhhcc----cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~----~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+||
T Consensus 108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Df 183 (321)
T 2qkw_B 108 -NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDF 183 (321)
T ss_dssp -TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCC
T ss_pred -CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeec
Confidence 45889999999999999997643 5899999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCC----CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHH-----HH-HHHHHcC
Q 005017 228 GLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-----QI-FKKVTSG 296 (719)
Q Consensus 228 GlA~~~~~~----~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~-----~i-~~~i~~g 296 (719)
|++...... ......||+.|+|||++. +.++.++|||||||++|||+||+.||....... .. ......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 999754322 223456899999999875 568999999999999999999999996532111 11 1111111
Q ss_pred CCC--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 297 IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 297 ~~p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
... .......++.+.+++.+||. +|.+|||+.+++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 11111224578999999998 899999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=373.64 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=209.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|.+.+.||+|+||.||+|.++.++..||+|.++... ...+.+.+|+.+|++++|||||++++++... ..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 290 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 290 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--Cc
Confidence 3456889999999999999999999899999999987442 2357899999999999999999999998654 45
Q ss_pred eeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeeccccee
Confidence 88999999999999999864 45899999999999999999999999 9999999999999855 7999999999987
Q ss_pred ccCCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
...... ....+++.|+|||++. +.++.++|||||||++|||+| |..||.. .+..++...+..+... ..+..++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 445 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCP 445 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCC
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCC
Confidence 654322 2334678899999886 468999999999999999999 9999987 4455666666665443 3445678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.+++||.+||. +|.+|||+.+|++
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 899999999998 8999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.08 Aligned_cols=243 Identities=23% Similarity=0.387 Sum_probs=198.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+ +|..||+|.++.. ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 89 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GG 89 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-Cc
Confidence 456789999999999999999976 4899999998643 24577899999999999999999999876543 46
Q ss_pred eeEEEecccCCChhHHhhhccc--ccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~--l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+++|+|.+++...+. +++..++.++.|++.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeecccccc
Confidence 8899999999999999987544 899999999999999999999999 9999999999999855 7999999999876
Q ss_pred ccCCCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 233 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+| |+.||... +.......+..+..+ ..+...++.+
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l 243 (278)
T 1byg_A 167 ASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAV 243 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCC-CCCTTCCHHH
T ss_pred cccc-ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCC-CCcccCCHHH
Confidence 5433 234467899999998864 58999999999999999998 99999873 455566666655433 3455678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+++|.+||. +|.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 999999998 8999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.75 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=202.9
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCC----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
.....|.+.++||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.++++++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 35567888999999999999999876543 469999987432 23456678999999999999999999998855
Q ss_pred CCCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
. ..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 118 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg 192 (333)
T 1mqb_A 118 Y--KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFG 192 (333)
T ss_dssp S--SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCC
T ss_pred C--CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCC
Confidence 4 4688999999999999999764 57999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 005017 229 LAIAMQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 301 (719)
Q Consensus 229 lA~~~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 301 (719)
++....... .....+|+.|+|||++. ..++.++|||||||++|||+| |+.||.. ....++...+..+..+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~- 270 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP- 270 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-
Confidence 997664321 12234678999999886 458999999999999999999 9999987 45666777777664433
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+...++.++++|.+||. +|.+||++.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 334567899999999998 89999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.99 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=199.0
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
.++.||+|+||+||+|.+ +|..||+|++............+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 110 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYV 110 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEEE
Confidence 347899999999999975 68899999987554334445678899999999999999999999988654 45889999
Q ss_pred cccCCChhHHhhhc---ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 161 LFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 161 y~~gGsL~~~L~~~---~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeeccccccccccc
Confidence 99999999998743 45899999999999999999999999 9999999999999855 799999999987654322
Q ss_pred ----cccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHH---HHHHHHHcCCC---------CCc
Q 005017 238 ----ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK---------PAS 301 (719)
Q Consensus 238 ----~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~---~i~~~i~~g~~---------p~~ 301 (719)
.....||+.|+|||++.+.++.++||||||+++|+|+||..||....... .+...+..... ...
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 23457999999999998889999999999999999999999997643321 22222222111 011
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.....++.+.++|.+||. +|.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112234578999999998 89999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.85 Aligned_cols=248 Identities=27% Similarity=0.349 Sum_probs=190.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.++++...++||+|+||+||.+ ...+|+.||+|++... ..+.+.+|+.+|+++ +|||||++++++.+. .
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~ 82 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTD--R 82 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS--S
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecC--C
Confidence 4567778899999999999875 4568999999998643 235678899999876 899999999987654 5
Q ss_pred ceeEEEecccCCChhHHhhhccccc-------HHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--------
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVD-------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-------- 218 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~-------~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~-------- 218 (719)
.+++||||+. |+|.+++....... +..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence 6899999995 69999998754332 2345779999999999999999 9999999999999742
Q ss_pred ----CCcEEEeecchhhhccCCC------cccccCCCCCCCccccc--------cccCccccchhhHHHHHHHhh-ccCC
Q 005017 219 ----HGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-FEYP 279 (719)
Q Consensus 219 ----~G~vKL~DFGlA~~~~~~~------~~~~~GT~~YmAPEvl~--------~~~s~ksDIwSlGiil~EmlT-G~~P 279 (719)
.+.+||+|||+++...... ....+||+.|+|||++. ..++.++|||||||++|||+| |..|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 3489999999998765432 23457999999999875 358899999999999999999 9999
Q ss_pred CCCCCCHHHHHHHHHcCCC-CCcccc----CCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 280 YSECKNPAQIFKKVTSGIK-PASLAK----VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 280 f~~~~~~~~i~~~i~~g~~-p~~~~~----~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
|........ .+..+.. ...... ..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 240 f~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 240 FGDKYSRES---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TCSTTTHHH---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCchhhHH---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 976433321 2222222 111111 124689999999998 8999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.00 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=190.5
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHH--HHhCCCCCceeEEEeeec---
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL--LKSLKDDNVVKFYKSWVD--- 149 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~i--L~~L~HpNIVkl~~~~~~--- 149 (719)
.-..|++.+.||+|+||+||+|.+ +|+.||+|++.... ...+..|.++ +..++||||+++++.+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 446688999999999999999965 68999999987432 2334444444 556899999999975432
Q ss_pred CCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC---------CCCeeeecCccceeEecCCCC
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH---------NPPIIHRDLKCDNIFVNGNHG 220 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~---------~ppIIHrDLKp~NILl~~~~G 220 (719)
.+...+++||||+++|+|.+++.... .++..++.++.||+.||.|||++ + |+||||||+|||++.+ |
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-G 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-S
T ss_pred CCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-C
Confidence 33446789999999999999997654 58899999999999999999999 7 9999999999999855 7
Q ss_pred cEEEeecchhhhccCC----------CcccccCCCCCCCcccccc--------ccCccccchhhHHHHHHHhhccCCCCC
Q 005017 221 EVKIGDLGLAIAMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTFEYPYSE 282 (719)
Q Consensus 221 ~vKL~DFGlA~~~~~~----------~~~~~~GT~~YmAPEvl~~--------~~s~ksDIwSlGiil~EmlTG~~Pf~~ 282 (719)
.+||+|||+++.+... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999999999765422 1224579999999998864 467899999999999999999777643
Q ss_pred CCC-----------------HHHHHHHHHcCCCCCccccC------CChHHHHHHHHhcC-CCCCCCCHHHHH------c
Q 005017 283 CKN-----------------PAQIFKKVTSGIKPASLAKV------NDPQIKGFIEKCLV-PASERLSAKDLL------K 332 (719)
Q Consensus 283 ~~~-----------------~~~i~~~i~~g~~p~~~~~~------~~~~l~~lI~kcL~-dP~~RpSa~eLL------~ 332 (719)
... .......+........++.. .++.+++||.+||. +|.+|||+.+++ .
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 211 11222222222222222222 23479999999998 899999999994 4
Q ss_pred CccCcccc
Q 005017 333 DPFLQVEN 340 (719)
Q Consensus 333 hpf~~~~~ 340 (719)
++|.++.+
T Consensus 318 ~~~~~~~~ 325 (336)
T 3g2f_A 318 MIWERNKS 325 (336)
T ss_dssp HCCCC---
T ss_pred HHHHhccc
Confidence 67776544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.40 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=198.9
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
+....+..|++.+.||+|+||+||+|.+. +|+.||+|++...... .....+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 33445666788899999999999999754 7899999998754322 1223688999999999999999999998655
Q ss_pred CCCceeEEEecccCCChhHHhhhcc----cccHHHHHHHHHHHHHHhhhhhcC---CCCeeeecCccceeEecCCCCcEE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSH---NPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~----~l~~~~i~~i~~QIl~gL~yLHs~---~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
+ ..++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ + |+||||||+|||++.+ +.+|
T Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~k 174 (326)
T 3uim_A 100 T--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAV 174 (326)
T ss_dssp S--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEE
T ss_pred C--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEE
Confidence 4 5789999999999999998654 399999999999999999999998 7 9999999999999855 7999
Q ss_pred EeecchhhhccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCC----CCCHHHHHHHHHc
Q 005017 224 IGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSE----CKNPAQIFKKVTS 295 (719)
Q Consensus 224 L~DFGlA~~~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~----~~~~~~i~~~i~~ 295 (719)
|+|||++....... .....||+.|+|||++. ..++.++|||||||++|+|+||+.||.. ..........+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999997654322 23456999999999885 4689999999999999999999999952 0111111111211
Q ss_pred CCCCCc------------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCcc
Q 005017 296 GIKPAS------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 335 (719)
Q Consensus 296 g~~p~~------------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf 335 (719)
...... .....++.+.+++.+||. +|.+|||+.++++|-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111111 111112578999999998 8999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=347.88 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=204.9
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEE----EcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeee
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 148 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~----d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~ 148 (719)
....+.|++.+.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 3456789999999999999999998 5678999999998753 2456678999999999999999999999987
Q ss_pred cCCCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeec
Q 005017 149 DDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 227 (719)
Q Consensus 149 ~~~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DF 227 (719)
..+...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+||
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Df 189 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDF 189 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecC
Confidence 76666789999999999999999876 45999999999999999999999999 9999999999999855 79999999
Q ss_pred chhhhccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH---------------
Q 005017 228 GLAIAMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------- 286 (719)
Q Consensus 228 GlA~~~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--------------- 286 (719)
|++....... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 9997665432 223457788999998864 5899999999999999999999998531000
Q ss_pred HHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 287 ~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+...+..+..+ ..+...++++.++|.+||. +|.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122233333222 2345678899999999998 8999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.67 Aligned_cols=237 Identities=20% Similarity=0.308 Sum_probs=189.9
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHH-HhCCCCCceeEEEeeec--
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL-KSLKDDNVVKFYKSWVD-- 149 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIVkl~~~~~~-- 149 (719)
...++|+.+.++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 34566666678999999999999999999999999998632 3567888887 66799999999998865
Q ss_pred CCCCceeEEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC--CCcEEEe
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIG 225 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~--~G~vKL~ 225 (719)
.+...+++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+ .+.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEe
Confidence 33457899999999999999998754 6999999999999999999999999 9999999999999863 4689999
Q ss_pred ecchhhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC----C--C
Q 005017 226 DLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----K--P 299 (719)
Q Consensus 226 DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~----~--p 299 (719)
|||++.... ...++.++|||||||++|||+||+.||..... ........... . +
T Consensus 163 Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 163 DFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp CCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSC
T ss_pred ccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCC
Confidence 999885432 24578899999999999999999999976322 11111111111 1 1
Q ss_pred CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 ~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11114567899999999998 899999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.16 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=191.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC--CCCCceeEEEeeecCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIVkl~~~~~~~~~ 152 (719)
..+.|++.+.||+|+||.||+|.+. |+.||+|++... ....+..|.+++..+ +||||+++++++.....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3457889999999999999999775 999999998633 224455566666554 99999999999876643
Q ss_pred --CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC--------CCCeeeecCccceeEecCCCCcE
Q 005017 153 --KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH--------NPPIIHRDLKCDNIFVNGNHGEV 222 (719)
Q Consensus 153 --~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~--------~ppIIHrDLKp~NILl~~~~G~v 222 (719)
..+++||||+++|+|.++++.. .+++..++.++.|++.||+|||++ + |+||||||+|||++.+ |.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKN-GTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTT-SCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCC-CCE
Confidence 5689999999999999999754 699999999999999999999998 6 9999999999999855 799
Q ss_pred EEeecchhhhccCCC------cccccCCCCCCCccccccc-cCc------cccchhhHHHHHHHhhc----------cCC
Q 005017 223 KIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTF----------EYP 279 (719)
Q Consensus 223 KL~DFGlA~~~~~~~------~~~~~GT~~YmAPEvl~~~-~s~------ksDIwSlGiil~EmlTG----------~~P 279 (719)
||+|||++....... .....||+.|+|||++.+. ++. ++|||||||++|||+|| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654322 1245799999999988653 333 48999999999999999 777
Q ss_pred CCCCCC----HHHHHHHHHcCCCCCcccc-----CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 280 YSECKN----PAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 280 f~~~~~----~~~i~~~i~~g~~p~~~~~-----~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
|..... .......+........++. ..++++.+||.+||. +|.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 754321 2223333322222222222 234679999999998 89999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.08 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=196.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+..|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+.+|+.+++.++|++++..+..+... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCc
Confidence 345678999999999999999999999999999987654321 3477899999999999888877766543 356
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhh
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 231 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~ 231 (719)
.++||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+.+.+||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 88999999 9999999875 457999999999999999999999999 99999999999993 244799999999997
Q ss_pred hccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHHcC---
Q 005017 232 AMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSG--- 296 (719)
Q Consensus 232 ~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--~~i~~~i~~g--- 296 (719)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+.+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 654432 235579999999998865 5899999999999999999999999763321 1222222211
Q ss_pred CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 297 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 297 ~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..........++.++++|.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11112234567899999999998 8999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.33 Aligned_cols=249 Identities=18% Similarity=0.269 Sum_probs=200.6
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCC--------CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCcee
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFA--------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~--------g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVk 142 (719)
-.+..++.|++.+.||+|+||+||+|.+..+ |+.||+|.+... +.+.+|+.++++++||||++
T Consensus 36 i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp EECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHH
T ss_pred eecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhh
Confidence 3455678899999999999999999999874 889999998743 35779999999999999988
Q ss_pred ---------------EEEeeecCCCCceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeee
Q 005017 143 ---------------FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIH 205 (719)
Q Consensus 143 ---------------l~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIH 205 (719)
+++++.. ....+++||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH 182 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVH 182 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBC
T ss_pred hhhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccC
Confidence 5555554 245789999999 99999999876 67999999999999999999999999 999
Q ss_pred ecCccceeEecCCCC--cEEEeecchhhhccCC---------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHH
Q 005017 206 RDLKCDNIFVNGNHG--EVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEM 273 (719)
Q Consensus 206 rDLKp~NILl~~~~G--~vKL~DFGlA~~~~~~---------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~Em 273 (719)
|||||+|||++.+ + .+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|||
T Consensus 183 ~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 183 GNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp SCCCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 9999999999855 5 8999999999755322 1234579999999998875 689999999999999999
Q ss_pred hhccCCCCCCC-CHHHHHHHHHc-CCCCCccc------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 274 VTFEYPYSECK-NPAQIFKKVTS-GIKPASLA------KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 274 lTG~~Pf~~~~-~~~~i~~~i~~-g~~p~~~~------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+||+.||.... +...+...... ...+..+. ...++++++||.+||. +|.+|||+.++++.
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 99999998654 34433333221 00111111 2457899999999998 89999999999873
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=360.65 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=202.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||+||+|.+. .+..||+|+++... ...+.+.+|+.+|++|+||||+++++++.+ ..
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~ 252 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 252 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---Cc
Confidence 4567899999999999999999887 45679999987543 234678999999999999999999998754 45
Q ss_pred eeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCcccee
Confidence 88999999999999999753 45899999999999999999999999 9999999999999854 7999999999976
Q ss_pred ccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
..... .....+++.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+..+. .+..++
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 407 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECP 407 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTSC
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 64332 22345678999999876 568999999999999999999 9999987 45667777777765433 345667
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.+.++|.+||. +|.+|||+.+|++
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999998 8999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=366.42 Aligned_cols=250 Identities=27% Similarity=0.317 Sum_probs=191.0
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
.+..|.+.++||+|+||+||.. ...+|+.||+|++..... ..+.+|+++|+++ +|||||++++++.+. .
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~ 91 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--Q 91 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--T
T ss_pred ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--C
Confidence 4456888999999999996643 456899999999864322 2245799999999 799999999988654 4
Q ss_pred ceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC----CCcEEEeecc
Q 005017 154 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----HGEVKIGDLG 228 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~----~G~vKL~DFG 228 (719)
.+++||||+. |+|.+++.... .+.+..++.|+.||+.||.|||+++ |+||||||+|||++.+ ...+||+|||
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 5899999996 59999987654 3555567899999999999999999 9999999999999522 1258899999
Q ss_pred hhhhccCC-----CcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 005017 229 LAIAMQQP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 298 (719)
Q Consensus 229 lA~~~~~~-----~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~ 298 (719)
+++..... .....+||+.|+|||++. ..++.++|||||||++|||+| |..||.... ..+.. .+.....
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~~-~~~~~~~ 246 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQAN-ILLGACS 246 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHHH-HHTTCCC
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHHH-HHhccCC
Confidence 99765432 234567999999999885 347789999999999999999 899996532 22222 2222211
Q ss_pred CCc--cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 299 PAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 299 p~~--~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
... .....++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 111 112234568999999998 89999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.57 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=197.3
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 149 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~ 149 (719)
.+....|.+.++||+|+||+||+|.+..+ +..||+|.++.. ......+++.+|+.++++++||||+++++++..
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 34555678899999999999999987543 246888887632 234567889999999999999999999998765
Q ss_pred CCCCceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 150 DKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 150 ~~~~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
.+ ...++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||
T Consensus 162 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DFG 237 (373)
T 3c1x_A 162 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFG 237 (373)
T ss_dssp CS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred CC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeecc
Confidence 43 4578999999999999999765 45899999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCCC------cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 005017 229 LAIAMQQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 300 (719)
Q Consensus 229 lA~~~~~~~------~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~ 300 (719)
+++...... .....+|+.|+|||++. ..++.++|||||||++|||+| |.+||... +..++...+..+..+
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~- 315 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL- 315 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-
Confidence 997654321 12345788999999886 458999999999999999999 67777663 344445555555433
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345577899999999998 89999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=373.52 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=204.0
Q ss_pred EEE-eEEEeeeCCeEEEEEEE--cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 79 VRY-DEVLGKGAFKTVYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 79 ~~l-~e~LG~G~fG~Vyka~d--~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
+.+ .+.||+|+||+||+|.+ +.+++.||+|+++... ......+.+.+|+.+|++|+|||||++++++.. ..+
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCE
Confidence 444 34899999999999954 4567899999987543 223456889999999999999999999998843 247
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+.+|+|.+++...+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+++.+..
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCcccccc
Confidence 899999999999999998888999999999999999999999999 9999999999999855 6999999999987654
Q ss_pred CC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCCh
Q 005017 236 PT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 308 (719)
Q Consensus 236 ~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~ 308 (719)
.. .....||+.|+|||++.. .++.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+..+++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~ 599 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPR 599 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCH
Confidence 32 223357789999998875 69999999999999999998 9999987 5566777777776543 34456788
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 309 QIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 309 ~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.+||.+||. +|.+||++.+|++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999998 8999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=354.16 Aligned_cols=243 Identities=22% Similarity=0.302 Sum_probs=190.6
Q ss_pred CCCCCcEEEeEEEeeeCCeEEEEE-----EEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC---CCCceeEE
Q 005017 73 DPSGRYVRYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFY 144 (719)
Q Consensus 73 d~~gr~~~l~e~LG~G~fG~Vyka-----~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~ 144 (719)
...++.|.+.++||+|+||+||+| .+..+++.||+|+++.. ....+..|+++++.++ |+||++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 345678999999999999999999 46778999999998643 2356788888888887 99999999
Q ss_pred EeeecCCCCceeEEEecccCCChhHHhhh-----cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC-
Q 005017 145 KSWVDDKKKTVNMITELFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN- 218 (719)
Q Consensus 145 ~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~-----~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~- 218 (719)
+++...+ ..++||||+++|+|.+++.. .+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 134 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 134 SAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGG
T ss_pred eeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccc
Confidence 9987654 48899999999999999974 456999999999999999999999999 9999999999999751
Q ss_pred ---------CCcEEEeecchhhhccC----CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC
Q 005017 219 ---------HGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 284 (719)
Q Consensus 219 ---------~G~vKL~DFGlA~~~~~----~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~ 284 (719)
.+.+||+|||+|+.+.. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 47999999999965431 12345679999999998875 48999999999999999999999996422
Q ss_pred CHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 285 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 285 ~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
..... ...... ....++.+.+++..||. +|.+|++..+.|.+
T Consensus 290 ~~~~~----~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 290 GGECK----PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp TTEEE----ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCcee----echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 11000 000000 11235678999999998 78888654444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=343.41 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=199.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEeeecCCC-
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDDKK- 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIVkl~~~~~~~~~- 152 (719)
.+.|.+.+.||+|+||+||+|.+ +|+.||+|++... ....+.+|++++.. ++||||+++++++.....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 45688999999999999999987 5999999998632 34667889999888 799999999999876543
Q ss_pred -CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhh--------cCCCCeeeecCccceeEecCCCCcEE
Q 005017 153 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEVK 223 (719)
Q Consensus 153 -~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLH--------s~~ppIIHrDLKp~NILl~~~~G~vK 223 (719)
..+++||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +++ |+||||||+|||++.+ |.+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~k 187 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCC 187 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCEE
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCEE
Confidence 268899999999999999975 46899999999999999999999 777 9999999999999855 7999
Q ss_pred EeecchhhhccCCC------cccccCCCCCCCccccccc-------cCccccchhhHHHHHHHhhc----------cCCC
Q 005017 224 IGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTF----------EYPY 280 (719)
Q Consensus 224 L~DFGlA~~~~~~~------~~~~~GT~~YmAPEvl~~~-------~s~ksDIwSlGiil~EmlTG----------~~Pf 280 (719)
|+|||++....... .....||+.|+|||++.+. ++.++|||||||++|||+|| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997655432 2345799999999988653 34789999999999999999 7888
Q ss_pred CCCC----CHHHHHHHHHcCCCCCcccc-----CCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 281 SECK----NPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 281 ~~~~----~~~~i~~~i~~g~~p~~~~~-----~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.... ....+...+........++. ...+.++++|.+||. +|.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6532 23444454544333332222 123578999999998 89999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=346.03 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=206.7
Q ss_pred ccCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC
Q 005017 71 EKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 150 (719)
Q Consensus 71 e~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~ 150 (719)
+.......|++.+.||+|+||+||+|.+.. .||+|+++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC--CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC--HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 334456678999999999999999998753 4999998764322 23345677899999999999999999998765
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+ .+++||||+.+++|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++ + |.+||+|||+
T Consensus 102 ~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 P--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFGL 175 (319)
T ss_dssp S--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSC
T ss_pred C--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecCC
Confidence 4 5889999999999999998755 6999999999999999999999999 99999999999997 3 6899999999
Q ss_pred hhhccC-------CCcccccCCCCCCCcccccc----------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHH
Q 005017 230 AIAMQQ-------PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 292 (719)
Q Consensus 230 A~~~~~-------~~~~~~~GT~~YmAPEvl~~----------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~ 292 (719)
+..... .......||+.|+|||++.. .++.++|||||||++|||+||+.||.. .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~ 254 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQ 254 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHH
Confidence 865421 12234468999999998753 378899999999999999999999987 456667777
Q ss_pred HHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 293 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 293 i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+..+..+.......+++++++|.+||. +|.+|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 777766655555677899999999998 89999999999983
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=370.65 Aligned_cols=246 Identities=18% Similarity=0.346 Sum_probs=201.7
Q ss_pred EeEEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEE
Q 005017 81 YDEVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 158 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV 158 (719)
....||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+.+|++++|||||++++++.. ..+++|
T Consensus 340 ~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv 413 (613)
T 2ozo_A 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLV 413 (613)
T ss_dssp EEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEE
T ss_pred cCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEE
Confidence 3348999999999999775 356789999987542 23456889999999999999999999998864 348899
Q ss_pred EecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 159 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCC
Confidence 9999999999999754 45999999999999999999999999 9999999999999855 799999999998764321
Q ss_pred -----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 238 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 238 -----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....+|+.|+|||++. +.++.++|||||||++|||+| |+.||... +..++...+..+..+ ..+..+++++
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l 568 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPEL 568 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHH
Confidence 11234678999999886 569999999999999999998 99999884 455677777776543 3445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc---CccCc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK---DPFLQ 337 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~---hpf~~ 337 (719)
.++|.+||. +|.+||++.+|++ +.|+.
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999998 8999999999854 44443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=365.52 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=206.6
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
....|++.+.||+|+||.||+|.+. .+..||+|+++... ...+.+.+|+.+|++|+|||||++++++.+ ..
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~ 335 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EP 335 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---cc
Confidence 4567899999999999999999887 45679999987543 234678999999999999999999998754 45
Q ss_pred eeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 155 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
+++||||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEccccccee
Confidence 88999999999999999753 45899999999999999999999999 9999999999999855 6999999999976
Q ss_pred ccCCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
..... .....+++.|+|||++. +.++.++|||||||++|||+| |+.||.+ ....++...+..+.... .+..++
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 490 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRMP-CPPECP 490 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 64321 22345678999999876 468999999999999999999 8999987 45667777777665433 345667
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+.+.+||.+||. +|.+|||+.+|++
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 899999999998 8999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=349.91 Aligned_cols=248 Identities=19% Similarity=0.200 Sum_probs=194.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc----CChhhHHHHHHHHHHHHhCC---------CCCceeE
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL----QLPGDLQKLYSEVHLLKSLK---------DDNVVKF 143 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~----~~~~~~~~~~~Ei~iL~~L~---------HpNIVkl 143 (719)
..|++.+.||+|+||+||+|.+ +|+.||+|++...... ......+.+.+|+.+|+.|+ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4567789999999999999987 6899999999876432 12344578889999999886 7788777
Q ss_pred EEeeecC----------------------------CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhh
Q 005017 144 YKSWVDD----------------------------KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195 (719)
Q Consensus 144 ~~~~~~~----------------------------~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~y 195 (719)
++.+... +...+++||||+.+|++.+.+.+ +.+++..++.|+.||+.||+|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 7765321 14579999999999987776654 568999999999999999999
Q ss_pred hh-cCCCCeeeecCccceeEecCCCC--------------------cEEEeecchhhhccCCCcccccCCCCCCCccccc
Q 005017 196 LH-SHNPPIIHRDLKCDNIFVNGNHG--------------------EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE 254 (719)
Q Consensus 196 LH-s~~ppIIHrDLKp~NILl~~~~G--------------------~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~ 254 (719)
|| +++ |+||||||+|||++.+ | .+||+|||+|+..... ..+||+.|||||++.
T Consensus 177 lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 177 AEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGC
T ss_pred HHHhCC--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhc
Confidence 99 899 9999999999999855 4 8999999999876543 458999999999998
Q ss_pred cccCccccchhhHHH-HHHHhhccCCCCCCCCHHHHHHHHHcCC-----CCCccccCCChHHHHHHHHhcCCCCCCCCHH
Q 005017 255 EEYNELVDIYSFGMC-ILEMVTFEYPYSECKNPAQIFKKVTSGI-----KPASLAKVNDPQIKGFIEKCLVPASERLSAK 328 (719)
Q Consensus 255 ~~~s~ksDIwSlGii-l~EmlTG~~Pf~~~~~~~~i~~~i~~g~-----~p~~~~~~~~~~l~~lI~kcL~dP~~RpSa~ 328 (719)
+..+.++||||||++ .+++++|..||............+.... .+.......++++++||.+||..+ ||.
T Consensus 251 g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa~ 326 (336)
T 2vuw_A 251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SAT 326 (336)
T ss_dssp CCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SHH
T ss_pred CCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CHH
Confidence 877999999998777 7888999999854111122333333221 112223345688999999999832 999
Q ss_pred HHH-cCccCc
Q 005017 329 DLL-KDPFLQ 337 (719)
Q Consensus 329 eLL-~hpf~~ 337 (719)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=357.39 Aligned_cols=252 Identities=17% Similarity=0.209 Sum_probs=190.7
Q ss_pred CCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCcee----------
Q 005017 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVK---------- 142 (719)
Q Consensus 74 ~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVk---------- 142 (719)
...+.+++.++||+|+||+||+|.+..+|+.||+|+++...... ....+.+.+|+.+++.++| +|+..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 45567889999999999999999999999999999887443222 2345789999999999987 32211
Q ss_pred -----------EEEeeecCC---CCceeEEEecccCCChhHHhhh-------cccccHHHHHHHHHHHHHHhhhhhcCCC
Q 005017 143 -----------FYKSWVDDK---KKTVNMITELFTSGNLRQYRKK-------HKNVDIKVIKNWARQILHGLVYLHSHNP 201 (719)
Q Consensus 143 -----------l~~~~~~~~---~~~l~lV~Ey~~gGsL~~~L~~-------~~~l~~~~i~~i~~QIl~gL~yLHs~~p 201 (719)
++..+.... ...++++|+++ +++|.+++.. .+.+++..++.++.||+.||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 111111111 12355666655 6799998842 345888899999999999999999999
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhhccCCCcccccCCCCCCCcccc----------cc-ccCccccchhhHHHH
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCI 270 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl----------~~-~~s~ksDIwSlGiil 270 (719)
||||||||+|||++.+ |.+||+|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++
T Consensus 232 -iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp -EECSCCCGGGEEECTT-CCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred -cccCCcccceEEEecC-CeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999865 68999999998765443 345678 999999987 32 378899999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 271 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 271 ~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
|||+||+.||... +.......+... ....++.+++||.+||. +|.+||++.++++||||+..
T Consensus 308 ~elltg~~Pf~~~-~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 308 YWIWCADLPNTDD-AALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHSSCCCCTT-GGGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHCCCCCCCc-chhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999999763 222222211111 12457899999999998 89999999999999999743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=353.63 Aligned_cols=248 Identities=18% Similarity=0.289 Sum_probs=198.2
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+..|++.++||+|+||.||+|.+..+|+.||+|++...... ..+..|+.+++.|+|++++..+..+.. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~ 77 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDY 77 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCE
Confidence 356788999999999999999999999999999987754322 347789999999988555444433332 3356
Q ss_pred eeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEec--CCCCcEEEeecchhh
Q 005017 155 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 231 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~--~~~G~vKL~DFGlA~ 231 (719)
.++||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||+++ ||||||||+||||+ ...+.+||+|||+++
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 88999999 9999999975 457999999999999999999999999 99999999999994 244799999999997
Q ss_pred hccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCC--HHHHHHHHHcCC--
Q 005017 232 AMQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGI-- 297 (719)
Q Consensus 232 ~~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~--~~~i~~~i~~g~-- 297 (719)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+.+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 665432 125679999999998865 589999999999999999999999976433 333444333221
Q ss_pred -CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 298 -KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 298 -~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
....+....++++.+||.+||. +|.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1122335567899999999998 8999999998865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=363.84 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=204.4
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcC---CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~---~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...|.+.+.||+|+||+||+|.+.. .+..||+|.++.. ......+.+.+|+.+|++++||||+++++++.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3457889999999999999998864 3567999987643 234556789999999999999999999998743
Q ss_pred CceeEEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCCe
Confidence 34789999999999999998654 6899999999999999999999999 9999999999999855 799999999997
Q ss_pred hccCCC---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 232 AMQQPT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 232 ~~~~~~---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
...... .....||+.|+|||++.+ .++.++|||||||++|||++ |..||.+ ....+....+..+..+. .+...
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~ 617 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNC 617 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCCC-CCTTC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCCC-CCccc
Confidence 664432 223457889999998864 58999999999999999997 9999987 45666667776664433 44567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++.+.++|.+||. +|.+|||+.++++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8899999999998 89999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=375.56 Aligned_cols=258 Identities=27% Similarity=0.362 Sum_probs=204.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeec----CCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD----DKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~----~~~ 152 (719)
..|++.+.||+|+||+||+|.+..+|..||+|+++... .....+.+.+|+.+|++++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 45678899999999999999999999999999886432 34566789999999999999999999998654 224
Q ss_pred CceeEEEecccCCChhHHhhhcc---cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCC--cEEEeec
Q 005017 153 KTVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG--EVKIGDL 227 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~---~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G--~vKL~DF 227 (719)
...++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.+.+ .+||+||
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccc
Confidence 56789999999999999998754 5899999999999999999999999 999999999999985422 4899999
Q ss_pred chhhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHH-----------
Q 005017 228 GLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT----------- 294 (719)
Q Consensus 228 GlA~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~----------- 294 (719)
|++...... ......||+.|+|||++. ..++.++|||||||++|+|+||..||.....+.+....+.
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 999776543 334568999999999886 4689999999999999999999999976432222110000
Q ss_pred --cC--------CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 295 --SG--------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 295 --~g--------~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.+ ..+..+....++.+.+||.+||. ||.+|||+.++|+||||+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 00 00111223345789999999998 89999999999999999753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=368.31 Aligned_cols=244 Identities=17% Similarity=0.243 Sum_probs=199.9
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcC-CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~-~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
....|++.+.||+|+||+||+|.+.. +|+.||+|++.... .......+.+|+.+|++++|||||++++++...+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 34568899999999999999999976 79999999886432 245567889999999999999999999998765431
Q ss_pred ---ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 154 ---TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 154 ---~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
.+|+||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+|||++. +.+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccc
Confidence 26899999999999998765 7999999999999999999999999 999999999999985 38999999999
Q ss_pred hhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 231 IAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 231 ~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
+..... ...+||+.|+|||++.+.++.++|||||||++|+|++|..||..... ............++.+
T Consensus 229 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 229 SRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSY 297 (681)
T ss_dssp EETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHH
T ss_pred hhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHH
Confidence 766543 45679999999999988889999999999999999999988864210 0111111111235789
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.++|.+||. +|.+||++.+.+.|+|+..
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999998 8999999999999998853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=322.10 Aligned_cols=226 Identities=16% Similarity=0.108 Sum_probs=182.3
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+..|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--Cc
Confidence 34567888999999999999999999999999999875432 2245568899999999999999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||+++++|.++++.. .....+..|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~------- 173 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYP------- 173 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSC-------
T ss_pred EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEec-------
Confidence 89999999999999999653 355678889999999999999999 9999999999999855 79999743
Q ss_pred CCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHH---HHHHHcCCC-CCccccCCChHH
Q 005017 235 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI---FKKVTSGIK-PASLAKVNDPQI 310 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i---~~~i~~g~~-p~~~~~~~~~~l 310 (719)
.|++| ++.++|||||||++|||+||+.||.+......+ .+.+..... +.......++++
T Consensus 174 -----------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 174 -----------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 35554 789999999999999999999999864322111 001111111 112334567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+++|.+||. ||.+| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999998 89999 99999884
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-32 Score=312.18 Aligned_cols=188 Identities=13% Similarity=0.067 Sum_probs=136.0
Q ss_pred EeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC------ChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCCceeE
Q 005017 85 LGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ------LPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 85 LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~------~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.+.|++|.+..+.....|+.+|+|++....... .....++|.+|+++|+++ .|+||+++++++.++ ..+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEEEE
Confidence 677888888888888899999999997543221 123456799999999999 799999999998655 45999
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||++||+|.+++...+.+++. .++.||+.||+|||++| ||||||||+|||++.+ |.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCCCCC
Confidence 99999999999999998888875 47899999999999999 9999999999999855 79999999999876543
Q ss_pred -CcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCC
Q 005017 237 -TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPY 280 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf 280 (719)
...+.+||+.|||||++.+.+...+|+||+|+++++|.++..|+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 34567899999999999998999999999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=268.80 Aligned_cols=185 Identities=18% Similarity=0.194 Sum_probs=145.2
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC----hhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
...++||+|+||+||+| ...+..+++|+......... ....+++.+|+++|++++||||+++..++...+ ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 34678999999999999 45688999998765332211 112456899999999999999995444444443 46
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+++|+|.+++.. +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCC
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCC
Confidence 899999999999999986 5689999999999999999 999999999999985 899999999987654
Q ss_pred CC---------cccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCC
Q 005017 236 PT---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYS 281 (719)
Q Consensus 236 ~~---------~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~ 281 (719)
.. ....+||+.|||||++.. .|+..+|+||..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32 135689999999999874 58889999999999999999888875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=218.08 Aligned_cols=151 Identities=19% Similarity=0.179 Sum_probs=118.5
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----h---------hhHHHHHHHHHHHHhCCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-----P---------GDLQKLYSEVHLLKSLKDDNVV 141 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-----~---------~~~~~~~~Ei~iL~~L~HpNIV 141 (719)
+..|.+.+.||+|+||.||+|.+ .+|+.||+|.++....... . .....+.+|+.+|++++|+++.
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~ 167 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP 167 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcC
Confidence 55566779999999999999999 7899999999864321100 0 1356789999999999954444
Q ss_pred eEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc
Q 005017 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 221 (719)
Q Consensus 142 kl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~ 221 (719)
.+++ . ...++||||+++|+|.+ +.. .....++.||+.||.|||+++ |+||||||+|||++ .|.
T Consensus 168 ~~~~----~--~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~ 230 (282)
T 1zar_A 168 KVYA----W--EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEG 230 (282)
T ss_dssp CEEE----E--ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTE
T ss_pred eEEe----c--cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCc
Confidence 4432 2 34689999999999998 432 234579999999999999999 99999999999999 479
Q ss_pred EEEeecchhhhccCCCcccccCCCCCCCcccccc
Q 005017 222 VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE 255 (719)
Q Consensus 222 vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~~ 255 (719)
+||+|||+|+ .+..++|||++.+
T Consensus 231 vkl~DFG~a~-----------~~~~~~a~e~l~r 253 (282)
T 1zar_A 231 IWIIDFPQSV-----------EVGEEGWREILER 253 (282)
T ss_dssp EEECCCTTCE-----------ETTSTTHHHHHHH
T ss_pred EEEEECCCCe-----------ECCCCCHHHHHHH
Confidence 9999999985 3556899998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=194.16 Aligned_cols=143 Identities=17% Similarity=0.174 Sum_probs=109.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeE--EEEEEEeeccccCC--------------------hhhHHHHHHHHHHHHh
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIE--VAWSRVKIDDVLQL--------------------PGDLQKLYSEVHLLKS 134 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~--VAvK~i~~~~~~~~--------------------~~~~~~~~~Ei~iL~~ 134 (719)
..+.+.+.||+|+||.||+|.+..+|.. ||+|+++.....-. ......+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4577889999999999999998778999 99998764321100 0112467899999999
Q ss_pred CCCCCc--eeEEEeeecCCCCceeEEEecccC-C----ChhHHhhhcccccHHHHHHHHHHHHHHhhhhh-cCCCCeeee
Q 005017 135 LKDDNV--VKFYKSWVDDKKKTVNMITELFTS-G----NLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHR 206 (719)
Q Consensus 135 L~HpNI--Vkl~~~~~~~~~~~l~lV~Ey~~g-G----sL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLH-s~~ppIIHr 206 (719)
|.|+++ ..++.. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +++ |+||
T Consensus 127 l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 127 AKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred HHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 988864 444432 236789999942 4 67666432 335567889999999999999 999 9999
Q ss_pred cCccceeEecCCCCcEEEeecchhhhc
Q 005017 207 DLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 207 DLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS---SEEECCCTTCEET
T ss_pred CCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999985 7999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.1e-16 Score=171.01 Aligned_cols=139 Identities=14% Similarity=0.160 Sum_probs=99.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-----CC-----hhh------HH--HHHHHHHHHHhCCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-----QL-----PGD------LQ--KLYSEVHLLKSLKDDN 139 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-----~~-----~~~------~~--~~~~Ei~iL~~L~HpN 139 (719)
-|++...||+|+||.||+|.+. +|+.||+|+++..... .. ... .. ...+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3788999999999999999885 7999999987643210 00 000 01 1235777777775554
Q ss_pred ce--eEEEeeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 140 VV--KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 140 IV--kl~~~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
+. ..++ .. ..++||||+.|++|.++... .....++.||+.+|.|||++| ||||||||.|||++.
T Consensus 175 v~vp~p~~--~~----~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIA--QS----RHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEE--EE----TTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEE
T ss_pred CCCCeeee--cc----CceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeC
Confidence 42 2332 11 23689999999998765432 234568899999999999999 999999999999974
Q ss_pred CCC----------cEEEeecchhhh
Q 005017 218 NHG----------EVKIGDLGLAIA 232 (719)
Q Consensus 218 ~~G----------~vKL~DFGlA~~ 232 (719)
+ | .+.|+||+-+..
T Consensus 241 d-gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 E-KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp E-ECSSCTTSEEEEEEECCCTTCEE
T ss_pred C-CCcccccccccceEEEEeCCccc
Confidence 4 3 388999997654
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.2e-14 Score=121.55 Aligned_cols=60 Identities=25% Similarity=0.382 Sum_probs=58.3
Q ss_pred CceEEEEEeecCCCCccceeecccCCCCcHHHHHHHHHhccccCCCChHHHHHHHHHHHH
Q 005017 417 TSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIM 476 (719)
Q Consensus 417 ~~i~L~Lri~d~~~~~~~i~f~f~~~~Dta~~va~Emv~~~~i~~~d~~~iA~~i~~~i~ 476 (719)
++|+|+||++|+++++++|+|+|.++.|||++||+|||.+|+|++.|+..||++|+++|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 368999999999999999999999999999999999999999999999999999999997
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.2e-13 Score=119.50 Aligned_cols=64 Identities=31% Similarity=0.385 Sum_probs=59.1
Q ss_pred CCceEEEEEeecCC---CCcc---ceeecccCCCCcHHHHHHHHHhccccCCCChHHHHHHHHHHHHHhC
Q 005017 416 DTSVSLTLRIADSS---GRVR---NIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLL 479 (719)
Q Consensus 416 ~~~i~L~Lri~d~~---~~~~---~i~f~f~~~~Dta~~va~Emv~~~~i~~~d~~~iA~~i~~~i~~l~ 479 (719)
..+|+|+|||.|++ |+.+ +|+|+|++++|||++||+|||++|+++++|...||.+|+..|..+-
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 46899999999994 7888 9999999999999999999999999999999999999999876553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=3.2e-10 Score=116.06 Aligned_cols=139 Identities=17% Similarity=0.051 Sum_probs=103.2
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeE
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~l 157 (719)
|++...+|.|+.+.||++.. .|..+++|....... .....+.+|+.+|+.|. |.++.++++++... ...|+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l 87 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEE
Confidence 45667788899999999964 367899998764321 11235788999999985 67788888876543 45789
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCC-------------------------------------
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------- 200 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~------------------------------------- 200 (719)
||||++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999987632 11223467889999999999811
Q ss_pred --------------------CCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 201 --------------------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 201 --------------------ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+.++|+|++|.||+++.+ +.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 249999999999999743 356799998663
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=3.8e-09 Score=106.80 Aligned_cols=134 Identities=12% Similarity=0.014 Sum_probs=92.9
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC--ceeEEEeeecCCCCcee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IVkl~~~~~~~~~~~l~ 156 (719)
+.+..+.+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.+.+ +.+++++.... ...+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~ 91 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDW 91 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEE
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCE
Confidence 34433334566699999953 46778999986532 1134678999999886544 45677765443 3478
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCC------------------------------------
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------ 200 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~------------------------------------ 200 (719)
+||||++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999999884 211 12 1256777778888888643
Q ss_pred --------------------CCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 201 --------------------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 201 --------------------ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+.++|+|++|.||+++++ +.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 129999999999999754 456799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6.4e-09 Score=111.75 Aligned_cols=143 Identities=16% Similarity=0.185 Sum_probs=102.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEe--eccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEeeecCCC-CceeE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVK--IDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKK-KTVNM 157 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~--~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIVkl~~~~~~~~~-~~l~l 157 (719)
+.|+.|.++.||+.... +..+++|+.. ..... .....+.+|+.+|+.|. +.++.+++.++.+... ...++
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 66899999999998643 4577777664 32211 12346778999999997 4557888887654321 34778
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC--------------------------------------
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-------------------------------------- 199 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~-------------------------------------- 199 (719)
||||++|..+.+.. ...++......++.+++..|..||+.
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998885422 23467888888999999999999973
Q ss_pred ------------------CCCeeeecCccceeEecCCCC-cEEEeecchhhh
Q 005017 200 ------------------NPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAIA 232 (719)
Q Consensus 200 ------------------~ppIIHrDLKp~NILl~~~~G-~vKL~DFGlA~~ 232 (719)
.+.++|+|++|.||+++.+.+ .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999986532 368999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=7.9e-09 Score=108.56 Aligned_cols=183 Identities=19% Similarity=0.171 Sum_probs=119.4
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCC--ceeEEEeeecCCC-CceeEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDN--VVKFYKSWVDDKK-KTVNMI 158 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpN--IVkl~~~~~~~~~-~~l~lV 158 (719)
+.++.|....||+.. ..+++|.... ......+.+|+.+|+.+. +.. +.+++........ ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 458999999999972 4577776432 134567889999999883 333 3445443322221 234789
Q ss_pred EecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCC--------------------------------------
Q 005017 159 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-------------------------------------- 200 (719)
Q Consensus 159 ~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 200 (719)
|++++|.+|.+... ..++......++.|++..|..||+..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875332 34667777777888888888777511
Q ss_pred ------------------CCeeeecCccceeEecCC-CCcEEEeecchhhhccCCCcccccCCCCC---CCccccc---c
Q 005017 201 ------------------PPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQPTARSVIGTPEF---MAPELYE---E 255 (719)
Q Consensus 201 ------------------ppIIHrDLKp~NILl~~~-~G~vKL~DFGlA~~~~~~~~~~~~GT~~Y---mAPEvl~---~ 255 (719)
+.++|+|++|.||+++.+ .+.+.|+||+.+...... ........+ ..|+... .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHH
Confidence 248999999999999864 346889999987543221 011111111 2333221 1
Q ss_pred cc------------CccccchhhHHHHHHHhhccCCC
Q 005017 256 EY------------NELVDIYSFGMCILEMVTFEYPY 280 (719)
Q Consensus 256 ~~------------s~ksDIwSlGiil~EmlTG~~Pf 280 (719)
.| ....+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 12258899999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.1e-05 Score=82.33 Aligned_cols=134 Identities=16% Similarity=0.066 Sum_probs=88.4
Q ss_pred EEeeeCCe-EEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEEec
Q 005017 84 VLGKGAFK-TVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 84 ~LG~G~fG-~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey 161 (719)
.+..|..+ .||+......+..+++|+-.. .....+.+|...|+.|. +-.+.+++.++.+. ...++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEe
Confidence 45556555 699987776777888887652 23456888999999884 33356777766554 357889999
Q ss_pred ccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC------------------------------------------
Q 005017 162 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------------------------------------------ 199 (719)
Q Consensus 162 ~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~------------------------------------------ 199 (719)
++|.++.+...... .....++.++...|.-||..
T Consensus 102 l~G~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 102 IPGKTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CCSEEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred eCCccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 99988776543211 11223344444444444421
Q ss_pred --------------CCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 200 --------------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 200 --------------~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
.+.++|+|+.+.||+++.+ +.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccc
Confidence 1128999999999999854 466799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.5e-05 Score=83.92 Aligned_cols=136 Identities=19% Similarity=0.103 Sum_probs=88.3
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC---CceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.++.|....||+. |..+++|+.. .......+.+|..+|+.|.+. .+.+.+.+... .....++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEE
Confidence 45788999999998 4567777632 123457889999999999753 35566655532 234467999
Q ss_pred ecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC----------------------------------------
Q 005017 160 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH---------------------------------------- 199 (719)
Q Consensus 160 Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~---------------------------------------- 199 (719)
++++|..|....- ..++......++.|+...|..||+.
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988865211 1223333334444444444444432
Q ss_pred ------------------CCCeeeecCccceeEecC---CCCcEEEeecchhhh
Q 005017 200 ------------------NPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIA 232 (719)
Q Consensus 200 ------------------~ppIIHrDLKp~NILl~~---~~G~vKL~DFGlA~~ 232 (719)
.+.++|+|++|.||+++. +...+.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999986 222358999997754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3e-05 Score=84.19 Aligned_cols=79 Identities=14% Similarity=0.188 Sum_probs=48.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc-c--CChhhHHHHHHHHHHHHhCCC--CC-ceeEEEeeecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV-L--QLPGDLQKLYSEVHLLKSLKD--DN-VVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~-~--~~~~~~~~~~~Ei~iL~~L~H--pN-IVkl~~~~~~~~~~~l~ 156 (719)
+.||.|.++.||++.+...+..+++|....... . .......++..|.++|+.+.. |. +.+++.+ +.+ ..+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--MAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--TTE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--ccE
Confidence 579999999999997766678899998653211 0 001123456778888888742 33 4456643 232 356
Q ss_pred EEEecccCC
Q 005017 157 MITELFTSG 165 (719)
Q Consensus 157 lV~Ey~~gG 165 (719)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00084 Score=71.38 Aligned_cols=87 Identities=5% Similarity=-0.051 Sum_probs=52.8
Q ss_pred EeEEE-eeeCCeEEEEEEEcC------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEeeecC
Q 005017 81 YDEVL-GKGAFKTVYKAFDEF------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVDD 150 (719)
Q Consensus 81 l~e~L-G~G~fG~Vyka~d~~------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pNIVkl~~~~~~~ 150 (719)
..+.| +.|....+|+..... +|..+++|........... ....+.+|+.+|+.|.. -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-PTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-chhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 34668 888889999875431 2667888865432200000 01346678888888742 3567777765433
Q ss_pred C-CCceeEEEecccCCChh
Q 005017 151 K-KKTVNMITELFTSGNLR 168 (719)
Q Consensus 151 ~-~~~l~lV~Ey~~gGsL~ 168 (719)
. ....++||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 1 12456899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00034 Score=73.34 Aligned_cols=42 Identities=21% Similarity=0.216 Sum_probs=31.5
Q ss_pred HHHHhhhhhc-----------CCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 189 ILHGLVYLHS-----------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 189 Il~gL~yLHs-----------~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
+..++.+|+. ..+.++|+|+++.||+++.+ +.+.|+||+.+.
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 4445666653 23459999999999999644 589999998663
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0025 Score=69.73 Aligned_cols=76 Identities=11% Similarity=0.073 Sum_probs=43.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccc-cCC--h--hhHHHHHHHHHHHH-hCCCCCceeEEEeeecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDV-LQL--P--GDLQKLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~-~~~--~--~~~~~~~~Ei~iL~-~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.||.|....||++.. ++..+++|....... ... . .....+..|+..+. ......+.+++.+. . ...+
T Consensus 40 ~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~--~~~~ 113 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--R--TMAL 113 (420)
T ss_dssp EECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--T--TTTE
T ss_pred EEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CccE
Confidence 5689999999999943 567899995432111 000 0 12233333433322 22234567777654 2 3467
Q ss_pred EEEecc-cC
Q 005017 157 MITELF-TS 164 (719)
Q Consensus 157 lV~Ey~-~g 164 (719)
+||||+ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 899999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.004 Score=66.00 Aligned_cols=74 Identities=16% Similarity=0.046 Sum_probs=55.1
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC---CCCceeEEEeeecCCCCceeEEE
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.|. ...+.+.+...... ...++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence 5689999999999854 4677888876522 2466888999888884 35677787765443 4578999
Q ss_pred ecccCCCh
Q 005017 160 ELFTSGNL 167 (719)
Q Consensus 160 Ey~~gGsL 167 (719)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0042 Score=64.20 Aligned_cols=81 Identities=19% Similarity=0.050 Sum_probs=54.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pNIVkl~~~~~~~~~ 152 (719)
|+.+.-.+.+|.|..+.||+... .+|+.|.+|+-.... ......+..|...|+.|.- -.+.+.+.. +.
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~-- 84 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD-- 84 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence 44555567899999999999965 488999999754322 1122457789999998842 234555553 22
Q ss_pred CceeEEEecccCCCh
Q 005017 153 KTVNMITELFTSGNL 167 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL 167 (719)
-++||||+.++..
T Consensus 85 --~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 --RTLAMEWVDERPP 97 (288)
T ss_dssp --TEEEEECCCCCCC
T ss_pred --ceEEEEeecccCC
Confidence 3579999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.34 E-value=0.019 Score=57.85 Aligned_cols=122 Identities=17% Similarity=0.153 Sum_probs=79.6
Q ss_pred CChhHHhhhc-ccccHHHHHHHHHHHHHHhhhh-hcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCCccccc
Q 005017 165 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 242 (719)
Q Consensus 165 GsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yL-Hs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~~~~~~ 242 (719)
-||.+.|... .+++++++|.++.|.+.+|.-+ +...+ ..+=+.|..|++..+ |.|...+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~d-G~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRD-GAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETT-SCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecC-Cceeccc-cccc----------c
Confidence 3788888764 5799999999999999998765 22221 133346789999865 7877653 1110 1
Q ss_pred CCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcCC
Q 005017 243 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 320 (719)
Q Consensus 243 GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~d 320 (719)
....+.|||+.....+.+.=|||||+++|.-+--..| ..-....++.+..||..|..+
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHhc
Confidence 2334678888755566788899999999998864433 223445678899999888753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.014 Score=64.42 Aligned_cols=73 Identities=14% Similarity=0.107 Sum_probs=47.4
Q ss_pred EEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCc
Q 005017 83 EVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKT 154 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~ 154 (719)
+.|+.|....||++.... .+..+++|+.... . ....+..|..+++.|...++ .++++.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~---~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E---TESHLVAESVIFTLLSERHLGPKLYGIF--SG--- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C---CHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---C---cHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---
Confidence 568889899999996542 2577888876321 1 11345578888888854344 5677654 22
Q ss_pred eeEEEecccCCCh
Q 005017 155 VNMITELFTSGNL 167 (719)
Q Consensus 155 l~lV~Ey~~gGsL 167 (719)
.+|+||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 268999987444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.012 Score=61.92 Aligned_cols=31 Identities=23% Similarity=0.267 Sum_probs=25.7
Q ss_pred CeeeecCccceeEecCC---CCcEEEeecchhhh
Q 005017 202 PIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIA 232 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~---~G~vKL~DFGlA~~ 232 (719)
.++|||+.+.||+++.+ .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 59999999999999753 15789999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.18 E-value=0.011 Score=61.26 Aligned_cols=71 Identities=11% Similarity=0.036 Sum_probs=41.6
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCceeEEEe
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l~lV~E 160 (719)
.+.|+.|....+|+. ..+++|+...... ......+|+.+++.+...++ .+++.. +.+. -++|+|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~--~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-----EYINRANEAVAAREAAKAGVSPEVLHV--DPAT--GVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT--CCEEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCC--CEEEEe
Confidence 367899999999998 3577776653211 00112457777776643222 455553 2322 356999
Q ss_pred cc-cCCCh
Q 005017 161 LF-TSGNL 167 (719)
Q Consensus 161 y~-~gGsL 167 (719)
|+ +|.+|
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.08 E-value=0.021 Score=62.09 Aligned_cols=138 Identities=15% Similarity=0.174 Sum_probs=79.5
Q ss_pred EEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCCCCc
Q 005017 83 EVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKT 154 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~~~~ 154 (719)
+.|..|-...+|+..... ++..+++++... .. .....+.+|..+++.|.-.+ ..++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL---QGVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc---chHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 457778888899986532 356788886421 11 12345568999888874222 35666654 22
Q ss_pred eeEEEecccCCChhHH--------------hhh-c-------ccc--cHHHHHHHHHHHHHH------------------
Q 005017 155 VNMITELFTSGNLRQY--------------RKK-H-------KNV--DIKVIKNWARQILHG------------------ 192 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~--------------L~~-~-------~~l--~~~~i~~i~~QIl~g------------------ 192 (719)
.+||||++|.+|..- |.+ + +.. -+..+.+|..|+...
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 169999998665321 110 0 111 246677777665332
Q ss_pred -hhhh----hcC--CCCeeeecCccceeEecCC---CCcEEEeecchhh
Q 005017 193 -LVYL----HSH--NPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAI 231 (719)
Q Consensus 193 -L~yL----Hs~--~ppIIHrDLKp~NILl~~~---~G~vKL~DFGlA~ 231 (719)
+..| ... ...++|+|+.+.||+++.+ .+.+.|+||..+.
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2222 221 1259999999999999855 3589999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.042 Score=61.26 Aligned_cols=74 Identities=15% Similarity=0.107 Sum_probs=46.5
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCceeEEEec
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITEL 161 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey 161 (719)
+.|+.|-...+|+......+..+++|+..... .... ...+|..+++.|...++ .++++.+ .+ .+|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT----DEII-NREREKKISCILYNKNIAKKIYVFF--TN----GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C----CSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh----hhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEe
Confidence 56888999999999765435788888764221 0111 12578899998865555 5677655 22 149999
Q ss_pred ccCCCh
Q 005017 162 FTSGNL 167 (719)
Q Consensus 162 ~~gGsL 167 (719)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.025 Score=59.02 Aligned_cols=76 Identities=11% Similarity=0.006 Sum_probs=45.9
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEeeecC-----CCCce
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDD-----KKKTV 155 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~~~~-----~~~~l 155 (719)
..|+ |....||+... .+|..+++|....... ....+..|..++..|... .+++++.. ++ .....
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~ 102 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFY 102 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEE
Confidence 3466 88889998743 3566788898763211 234566788888777422 23444432 11 12345
Q ss_pred eEEEecccCCCh
Q 005017 156 NMITELFTSGNL 167 (719)
Q Consensus 156 ~lV~Ey~~gGsL 167 (719)
++||++++|..+
T Consensus 103 ~~l~~~i~G~~~ 114 (328)
T 1zyl_A 103 FAVFPSVGGRQF 114 (328)
T ss_dssp EEEEECCCCEEC
T ss_pred EEEEEecCCCCC
Confidence 679999987543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0089 Score=62.35 Aligned_cols=140 Identities=16% Similarity=0.142 Sum_probs=71.3
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC--ceeEEEee----ecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSW----VDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IVkl~~~~----~~~~~~~l~ 156 (719)
+.|+.|....||+.... .| .+++|...... ..+.+..|+.++..|...+ +.+++... ........+
T Consensus 28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 56788888999998543 34 67788775421 1134556777777664222 23333210 000113457
Q ss_pred EEEecccCCChhH-----H------h---hh----c--cc---ccHHHHHHHH---------------HHHHHHhhhhhc
Q 005017 157 MITELFTSGNLRQ-----Y------R---KK----H--KN---VDIKVIKNWA---------------RQILHGLVYLHS 198 (719)
Q Consensus 157 lV~Ey~~gGsL~~-----~------L---~~----~--~~---l~~~~i~~i~---------------~QIl~gL~yLHs 198 (719)
+|++|++|..+.. + + .. . .. .........+ ..+...+.+|+.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 8999999865421 0 0 00 0 00 0111111100 012333444432
Q ss_pred C-----CCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 199 H-----NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 199 ~-----~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
. .+.++|+|+.+.||+++++ +.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 1 1249999999999999854 345799998663
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.035 Score=59.27 Aligned_cols=74 Identities=12% Similarity=0.123 Sum_probs=41.6
Q ss_pred EEEeeeCCeEEEEEEEcC--------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCCCC
Q 005017 83 EVLGKGAFKTVYKAFDEF--------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKK 153 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~--------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~~~ 153 (719)
+.|+.|....+|+..... .+..+++|+..... ........|..+++.|...+ ..++++.. .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 457888888999986542 12578877654221 11112356888888775333 34666543 2
Q ss_pred ceeEEEecccCCCh
Q 005017 154 TVNMITELFTSGNL 167 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL 167 (719)
-++||||++|..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2469999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.10 E-value=0.15 Score=53.94 Aligned_cols=30 Identities=20% Similarity=0.348 Sum_probs=25.3
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 59999999999999744 5799999987643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=86.86 E-value=4.2 Score=44.59 Aligned_cols=74 Identities=11% Similarity=0.090 Sum_probs=44.5
Q ss_pred EEEeeeCCeEEEEEEEcCC-------CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEeeecCCCCc
Q 005017 83 EVLGKGAFKTVYKAFDEFA-------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKT 154 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~-------g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IVkl~~~~~~~~~~~ 154 (719)
+.|..|-...+|+...... +..+++++..... ...-...+|..+++.|.-.+ ..++++.+ .
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~---- 144 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF--P---- 144 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----
Confidence 5577788889999865421 5778887753221 11112346888887774322 34555533 2
Q ss_pred eeEEEecccCCCh
Q 005017 155 VNMITELFTSGNL 167 (719)
Q Consensus 155 l~lV~Ey~~gGsL 167 (719)
-++|+||++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2569999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.27 E-value=3.1 Score=44.91 Aligned_cols=29 Identities=17% Similarity=0.261 Sum_probs=23.5
Q ss_pred eeeecCccceeEec-----CCCCcEEEeecchhh
Q 005017 203 IIHRDLKCDNIFVN-----GNHGEVKIGDLGLAI 231 (719)
Q Consensus 203 IIHrDLKp~NILl~-----~~~G~vKL~DFGlA~ 231 (719)
++|+|+.+.|||+. .+.+.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57999999999993 234579999998774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 719 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-82 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-16 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 3e-82
Identities = 141/271 (52%), Positives = 186/271 (68%), Gaps = 5/271 (1%)
Query: 70 VEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV 129
V GR++++D +G+G+FKTVYK D +EVAW ++ D + Q+ E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEA 59
Query: 130 HLLKSLKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 187
+LK L+ N+V+FY SW KK + ++TEL TSG L+ Y K+ K + IKV+++W R
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 247
QIL GL +LH+ PPIIHRDLKCDNIF+ G G VKIGDLGLA + A++VIGTPEF
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 179
Query: 248 MAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
MAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPYSEC+N AQI+++VTSG+KPAS KV
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
P++K IE C+ ER S KDLL F Q
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 4e-59
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 15/303 (4%)
Query: 63 PDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDL 122
PD F + DP + +G G+F VY A D VA ++ Q
Sbjct: 2 PDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKW 59
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 182
Q + EV L+ L+ N +++ ++ + ++ E K + I
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 242
L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M A S +
Sbjct: 118 AAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--ANSFV 172
Query: 243 GTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 298
GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES 231
Query: 299 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 357
PA + + F++ CL +R +++ LLK F+ E I D ++ +++
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
Query: 358 MLR 360
L
Sbjct: 292 ELD 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 16/265 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+G G++ K + G + W + + + + Q L SEV+LL+ LK N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVR 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHS 198
+Y +D T+ ++ E G+L K+ + +D + + Q+ L H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 199 HN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELY 253
+ ++HRDLK N+F++G VK+GD GLA + T A++ +GTP +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 254 E-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
YNE DI+S G + E+ P+ + ++ K+ G K + ++
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNE 244
Query: 313 FIEKCLVP-ASERLSAKDLLKDPFL 336
I + L R S +++L++P +
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 7e-58
Identities = 82/288 (28%), Positives = 141/288 (48%), Gaps = 23/288 (7%)
Query: 65 ADSDFVEK--------DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL 116
+D + +EK DP +Y R+ E +G+GA TVY A D G EVA ++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-- 57
Query: 117 QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 176
+ + +E+ +++ K+ N+V + S++ + + ++ E G+L +
Sbjct: 58 --QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM 113
Query: 177 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQ 234
D I R+ L L +LHS+ +IHRD+K DNI + + G VK+ D G I +
Sbjct: 114 -DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169
Query: 235 QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
Q +++GTP +MAPE + + Y VDI+S G+ +EM+ E PY ++
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVEN 340
T+G + + F+ +CL +R SAK+LL+ FL++
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-57
Identities = 58/257 (22%), Positives = 119/257 (46%), Gaps = 11/257 (4%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LGKG F VY A ++ + +A + + + G +L EV + L+ N+++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILR 70
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
Y + D + V +I E G + + +K D + + ++ + L Y HS
Sbjct: 71 LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR-- 126
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELV 261
+IHRD+K +N+ + GE+KI D G ++ ++ GT +++ PE + ++E V
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 262 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP- 320
D++S G+ E + + P+ E + +K+++ + + I + L
Sbjct: 186 DLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHN 242
Query: 321 ASERLSAKDLLKDPFLQ 337
S+R +++L+ P++
Sbjct: 243 PSQRPMLREVLEHPWIT 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 25/295 (8%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
+P + LG GAF VYKA ++ + A + +L+ E+ +L
Sbjct: 9 NPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDIL 63
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILH 191
S N+VK ++ + + ++ E G + + + + I+ +Q L
Sbjct: 64 ASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMA 249
L YLH + IIHRDLK NI + G++K+ D G++ + R S IGTP +MA
Sbjct: 122 ALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 250 PELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
PE+ + Y+ D++S G+ ++EM E P+ E + K S +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 304 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 357
K F++KCL R + LL+ PF+ V++ K P++ I K
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK-----PIRELIAEAK 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 68/304 (22%), Positives = 125/304 (41%), Gaps = 50/304 (16%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G V+K + +G+ +A K+ + P ++ E+ +L +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
FY ++ D + +++ E G+L Q KK + +++ + ++ GL YL +
Sbjct: 69 FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-K 125
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELV 261
I+HRD+K NI VN GE+K+ D G++ + A S +GT +M+PE L Y+
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 262 DIYSFGMCILEMVTFEYPYS---------------------------------------- 281
DI+S G+ ++EM YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 282 -ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 339
++ + + P + V + + F+ KCL+ +ER K L+ F++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 340 NQKE 343
+ +E
Sbjct: 305 DAEE 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-53
Identities = 67/262 (25%), Positives = 116/262 (44%), Gaps = 15/262 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG+GA+ V A + VA VKI D+ + + + E+ + K L +NVVK
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
FY + + E + G L + + + + Q++ G+VYLH
Sbjct: 68 FYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPELYEEE-- 256
I HRD+K +N+ ++ +KI D GLA ++ + GT ++APEL +
Sbjct: 124 ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 257 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
+ E VD++S G+ + M+ E P+ + + Q + + K D + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 317 CLVP-ASERLSAKDLLKDPFLQ 337
LV S R++ D+ KD +
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 25/272 (9%)
Query: 74 PSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK 133
P G+ + +G G+F TVYK +VA + + P LQ +EV +L+
Sbjct: 6 PDGQI-TVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTA--PTPQQLQAFKNEVGVLR 59
Query: 134 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHG 192
+ N++ F + + ++T+ +L + ++ + + ARQ G
Sbjct: 60 KTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFM 248
+ YLH+ + IIHRDLK +NIF++ + VKIGD GLA + + + G+ +M
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 249 APELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 304
APE+ + Y+ D+Y+FG+ + E++T + PYS N QI V G L+K
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 305 VND---PQIKGFIEKCLVP-ASERLSAKDLLK 332
V +K + +CL ER +L
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 4e-50
Identities = 66/303 (21%), Positives = 125/303 (41%), Gaps = 20/303 (6%)
Query: 70 VEKDPSGRYVRYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYS 127
VE Y YD E LG GAF V++ ++ G + P D + +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKN 75
Query: 128 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 186
E+ ++ L ++ + ++ D + + +I E + G L + + + N+
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQP-TARSVIGT 244
RQ GL ++H H+ I+H D+K +NI VKI D GLA + + T
Sbjct: 134 RQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 245 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
EF APE+ + E D+++ G+ +++ P++ + + + A
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 304 KVN-DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 361
+ P+ K FI+ L +RL+ D L+ P+L+ ++ ++P +R
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL----TSRIPSSRYNKIRQ 307
Query: 362 PMS 364
+
Sbjct: 308 KIK 310
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 5e-50
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 21/290 (7%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
YD E LG GAF V++ + G A V D + + E+ + L+
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRH 82
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYL 196
+V + ++ DD + + MI E + G L + +H + + RQ+ GL ++
Sbjct: 83 PTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 197 HSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYE 254
H +N +H DLK +NI E+K+ D GL + + + + GT EF APE+ E
Sbjct: 141 HENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198
Query: 255 -EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIK 311
+ D++S G+ +++ P+ +N + + V S + + K
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 312 GFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 360
FI K L+ + R++ L+ P+L N ++P +R
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP---GRDSQIPSSRYTKIR 304
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 1e-49
Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 16/279 (5%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
+D Y + +VLG GAF V A D+ VA +K L G + +E+ +
Sbjct: 5 EDIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAV 60
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILH 191
L +K N+V + + +I +L + G L + + Q+L
Sbjct: 61 LHKIKHPNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFM 248
+ YLH I+HRDLK +N+ ++ I D GL+ + + GTP ++
Sbjct: 119 AVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 249 AP-ELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
AP L ++ Y++ VD +S G+ ++ P+ + +N A++F+++ +D
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDD 235
Query: 308 --PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 343
K FI + +R + + L+ P++ + +
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-49
Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 27/283 (9%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
++ ++LG+G+F TV A + E A ++ +++ + + E ++ L
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPF 69
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
VK Y ++ DD+K + +G L +Y +K + D + + +I+ L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYE 254
IIHRDLK +NI +N + ++I D G A + +Q A S +GT ++++PE L E
Sbjct: 128 G--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 255 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314
+ + D+++ G I ++V P+ N IF+K+ + P+ + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLV 241
Query: 315 EKCLVP-ASERLSAK------DLLKDPFLQ------VENQKEP 344
EK LV A++RL + L PF + + Q P
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (431), Expect = 1e-48
Identities = 60/277 (21%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-----QLPGDLQKLYSEVHLL 132
Y+ E+LG+G V + + E A + + ++ + EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 133 KSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILH 191
+ + N+++ ++ + ++ +L G L Y + + K + R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAP 250
+ LH N I+HRDLK +NI ++ + +K+ D G + + R V GTP ++AP
Sbjct: 122 VICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 251 ELYEEE-------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 303
E+ E Y + VD++S G+ + ++ P+ + + + + SG
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSP 237
Query: 304 KVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ +D +K + + LV +R +A++ L PF Q
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 60/306 (19%), Positives = 133/306 (43%), Gaps = 20/306 (6%)
Query: 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL 131
K+ +Y E LG+G F V++ + + VK+ D + E+ +
Sbjct: 1 KELYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISI 54
Query: 132 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQIL 190
L + N++ ++S+ ++ + MI E + ++ + ++ + I ++ Q+
Sbjct: 55 LNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFV-NGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFM 248
L +LHSHN I H D++ +NI +KI + G A ++ R + PE+
Sbjct: 113 EALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170
Query: 249 APELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKV 305
APE+++ + + D++S G + +++ P+ + QI + + + K
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 306 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLP 362
+ F+++ LV R++A + L+ P+L+ +E + LK +++
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289
Query: 363 MSGPSS 368
++ S
Sbjct: 290 LNMVVS 295
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-47
Identities = 70/294 (23%), Positives = 133/294 (45%), Gaps = 16/294 (5%)
Query: 69 FVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLY 126
F +++ Y E LG G F V K ++ G++ A +K + + +
Sbjct: 3 FRQENVDDYY-DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
EV +LK ++ NV+ ++ + + V +I EL G L + + +++ + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQPTARS-VI 242
+QIL+G+ YLHS I H DLK +NI + N +KI D GLA + +
Sbjct: 120 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 301
GTPEF+APE+ E D++S G+ +++ P+ + V++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFE 236
Query: 302 LAKVND--PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLP 352
++ K FI + LV +R++ +D L+ P+++ ++ ++ + P
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (418), Expect = 2e-46
Identities = 52/293 (17%), Positives = 105/293 (35%), Gaps = 19/293 (6%)
Query: 60 AEPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP 119
+P +A +F ++ + ++V+G G F V + G + +K
Sbjct: 10 EDPNEAVREFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 120 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVD 178
+ SE ++ NV+ V +ITE +G+L + R+
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFT 126
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
+ + R I G+ YL N +HRDL NI VN N K+ D GL+ ++ T+
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTS 183
Query: 239 RSV-------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 290
+ APE + ++ D++S+G+ + E++++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK--DPFLQVEN 340
+ + + + C + R ++ D ++ N
Sbjct: 244 NAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 51/269 (18%), Positives = 111/269 (41%), Gaps = 20/269 (7%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLK 133
+Y + +LG G F +VY + VA V+ D + + ++ EV LLK
Sbjct: 4 SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 134 SLKDD--NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILH 191
+ V++ W + V ++ +L + + + ++ +++ Q+L
Sbjct: 63 KVSSGFSGVIRLL-DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE 251
+ + H+ ++HRD+K +NI ++ N GE+K+ D G ++ GT + PE
Sbjct: 122 AVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 179
Query: 252 LYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
+ ++S G+ + +MV + P+ + + + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSE 230
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ I CL S+R + +++ P++Q
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-46
Identities = 56/254 (22%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ +GKG F V ++ G +VA VK ++ Q +E ++ L+ N+V+
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
V++K + ++TE G+L Y + + + ++ + + YL +N
Sbjct: 65 LLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNE 259
+HRDL N+ V+ + K+ D GL T + ++ APE L E++++
Sbjct: 124 --FVHRDLAARNVLVSED-NVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFST 179
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319
D++SFG+ + E+ +F + +V G K + P + ++ C
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWH 238
Query: 320 P-ASERLSAKDLLK 332
A+ R S L +
Sbjct: 239 LDAAMRPSFLQLRE 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 2e-45
Identities = 60/276 (21%), Positives = 106/276 (38%), Gaps = 15/276 (5%)
Query: 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
S RY E+LG G V+ A D +VA ++ D + + P + E +
Sbjct: 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAA 63
Query: 135 LKDDNVVKFYKSWVDDKK--KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
L +V Y + + ++ E LR + K
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEF 247
L + H + IIHRD+K NI ++ + VK+ D G+A A+ +VIGT ++
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 248 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306
++PE + + D+YS G + E++T E P++ + ++ V P S
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 307 -DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVEN 340
+ + K L R ++ ++V N
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 23/270 (8%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
+ E LG G F V+ + +VA +K + +E +L+K L+
Sbjct: 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQR 69
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLH 197
+V+ Y + + +ITE +G+L + K + I + + A QI G+ ++
Sbjct: 70 LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAP-ELY 253
N IHRDL+ NI V+ + KI D GLA + + ++ AP +
Sbjct: 127 ERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313
+ D++SFG+ + E+VT ++ + + G + ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQL 242
Query: 314 IEKCLVP-ASERLSAKDL---LKDPFLQVE 339
+ C +R + L L+D F E
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-44
Identities = 54/274 (19%), Positives = 111/274 (40%), Gaps = 21/274 (7%)
Query: 82 DEVLGKGAFKTVYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
D+ LG G F TV K + + VA +K + P +L +E ++++ L +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPY 69
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 199
+V+ + ++ E+ G L +Y +++++V K I Q+ G+ YL
Sbjct: 70 IVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 200 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LY 253
N +HRDL N+ + KI D GL+ A++ ++ APE +
Sbjct: 127 N--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313
+++ D++SFG+ + E ++ +++ + G + A ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDL 242
Query: 314 IEKCLVP-ASERLSAKDL---LKDPFLQVENQKE 343
+ C R + L++ + V N+
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 20/279 (7%)
Query: 66 DSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFD---EFAGIEVAWSRVKIDDVLQLPGDL 122
V PS V ++EV+G+G F VY + I A VK + + G++
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRITDIGEV 72
Query: 123 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK-KHKNVDIKV 181
+ +E ++K NV+ + + + ++ G+LR + + + N +K
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 182 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS- 240
+ + Q+ G+ + +HRDL N ++ VK+ D GLA M S
Sbjct: 132 LIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSV 188
Query: 241 -----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294
++MA E L +++ D++SFG+ + E++T P N I +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 295 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
G + DP + + KC P A R S +L+
Sbjct: 249 QGRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 59/275 (21%), Positives = 112/275 (40%), Gaps = 23/275 (8%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
R + LG+G F V+ VA +K + + E ++K L+ +
Sbjct: 20 RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEK 73
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLH 197
+V+ Y ++ + ++TE + G+L + + K + + + + A QI G+ Y+
Sbjct: 74 LVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPE-LY 253
N +HRDL+ NI V N K+ D GLA ++ + ++ APE
Sbjct: 131 RMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313
+ D++SFG+ + E+ T ++ +V G + + +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDL 246
Query: 314 IEKCLVP-ASERLSAKDL---LKDPFLQVENQKEP 344
+ +C ER + + L L+D F E Q +P
Sbjct: 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 2e-43
Identities = 62/262 (23%), Positives = 124/262 (47%), Gaps = 17/262 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
LG G+F V+ G A +K + V++ ++ E +L + +++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIR 68
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ ++ D ++ + MI + G L +K + V K +A ++ L YLHS +
Sbjct: 69 MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELV 261
II+RDLK +NI ++ N G +KI D G A + T ++ GTP+++APE + + YN+ +
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 262 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-- 319
D +SFG+ I EM+ P+ + N + ++K+ + + +K + + +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRD 239
Query: 320 ----PASERLSAKDLLKDPFLQ 337
+ + +D+ P+ +
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-43
Identities = 67/304 (22%), Positives = 115/304 (37%), Gaps = 39/304 (12%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVV 141
+ LG+G F TVYKA D+ VA ++K+ + G + E+ LL+ L N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
++ ++++ + + + + IK + L GL YLH H
Sbjct: 64 GLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELY--EEEY 257
I+HRDLK +N+ ++ N G +K+ D GLA + P + T + APEL Y
Sbjct: 121 -ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 258 NELVDIYSFGMCILEMVTFEYPYS-------------------------ECKNPAQIFKK 292
VD+++ G + E++ C P + K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 293 VTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKL 351
GI + + I+ + R++A LK + P C L
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ---L 295
Query: 352 PIQS 355
P +
Sbjct: 296 PRPN 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 59/332 (17%), Positives = 132/332 (39%), Gaps = 31/332 (9%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKS 134
Y +VLG G V + F++ + A ++ D K EV ++
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRA 61
Query: 135 LKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQIL 190
+ ++V+ + + +K + ++ E G L + + + + I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 191 HGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEF 247
+ YLHS N I HRD+K +N+ + +K+ D G A + + TP +
Sbjct: 122 EAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 179
Query: 248 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------PA 300
+APE+ E+Y++ D++S G+ + ++ P+ + I + + I+ P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPN 238
Query: 301 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLK 357
++K I L ++R++ + + P++ + + P+ L +
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298
Query: 358 MLRLPMSGPSSM-DIDSDYKQLSLSTCTESNN 388
+ S++ + DY+Q+ + +++N
Sbjct: 299 WEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 45/266 (16%), Positives = 103/266 (38%), Gaps = 20/266 (7%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
DPS + + +G G F V+ + +VA ++ + + + E ++
Sbjct: 3 DPS-EL-TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE-----EDFIEEAEVM 54
Query: 133 KSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILH 191
L +V+ Y ++ + ++ E G L Y R + + + +
Sbjct: 55 MKLSHPKLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 192 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFM 248
G+ YL +IHRDL N V + +K+ D G+ + ++
Sbjct: 113 GMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307
+PE Y+ D++SFG+ + E+ + E ++ +++ + +++G + ++
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLAS 228
Query: 308 PQIKGFIEKCLVP-ASERLSAKDLLK 332
+ + C +R + LL+
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-43
Identities = 48/289 (16%), Positives = 116/289 (40%), Gaps = 26/289 (8%)
Query: 69 FVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLY 126
F+++D + D LG G F +V + I+VA +K+ D +++
Sbjct: 4 FLKRD---NLLIADIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMM 57
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 185
E ++ L + +V+ + + ++ E+ G L ++ K + + + +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-----QQPTARS 240
Q+ G+ YL N +HRDL N+ + KI D GL+ A+ +
Sbjct: 115 LHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSA 171
Query: 241 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299
++ APE + +++ D++S+G+ + E +++ + ++ + G +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL---LKDPFLQVENQKEP 344
+ P++ + C + +R + ++ + + ++ E
Sbjct: 232 ECPPEC-PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-42
Identities = 57/265 (21%), Positives = 107/265 (40%), Gaps = 21/265 (7%)
Query: 80 RYD--EVLGKGAFKTVYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
R + +G+G F V++ E + VA +K +K E ++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR-KKHKNVDIKVIKNWARQILHGL 193
++VK ++ V +I EL T G LR + + ++D+ + +A Q+ L
Sbjct: 65 FDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 194 VYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAP 250
YL S +HRD+ N+ V+ + VK+GD GL+ M+ T ++MAP
Sbjct: 122 AYLESKR--FVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 251 E-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
E + + D++ FG+C+ E++ + + ++ +G + P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPT 237
Query: 310 IKGFIEKCLVP-ASERLSAKDLLKD 333
+ + KC S R +L
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 57/280 (20%), Positives = 125/280 (44%), Gaps = 18/280 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
++LGKG F V ++ G A ++ + ++ ++ +E +L++ + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
++ + + + E G L + + + + + + +I+ L YLHS +
Sbjct: 70 LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 125
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNE 259
+++RD+K +N+ ++ G +KI D GL T ++ GTPE++APE+ E +Y
Sbjct: 126 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319
VD + G+ + EM+ P+ ++ ++F+ + + P+ K + L
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLK 241
Query: 320 P-ASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPI 353
+RL AK++++ F N ++ + L P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 281
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 64/260 (24%), Positives = 120/260 (46%), Gaps = 13/260 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
++LGKG+F V+ A + A +K D VL + + L + + +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 202
+ ++ + M E G+L + + D+ +A +I+ GL +LHS
Sbjct: 68 MFCTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG-- 123
Query: 203 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNE 259
I++RDLK DNI ++ G +KI D G+ A+ + GTP+++APE L ++YN
Sbjct: 124 IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 260 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 319
VD +SFG+ + EM+ + P+ ++ ++F + + + + K + K V
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFV 239
Query: 320 P-ASERLSAK-DLLKDPFLQ 337
+RL + D+ + P +
Sbjct: 240 REPEKRLGVRGDIRQHPLFR 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-41
Identities = 52/257 (20%), Positives = 102/257 (39%), Gaps = 18/257 (7%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+ LG G F V +VA +K + + + E ++ +L + +V+
Sbjct: 10 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQ 63
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
Y + + +ITE +G L Y R+ + + + + + YL S
Sbjct: 64 LYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---VIGTPEFMAPELYE-EEY 257
+HRDL N VN + G VK+ D GL+ + S + PE+ ++
Sbjct: 121 -FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 317
+ DI++FG+ + E+ + E ++ + + G++ + ++ + C
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSC 237
Query: 318 LVP-ASERLSAKDLLKD 333
A ER + K LL +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 15/259 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSR-VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 141
+VLG GAF TVYK G +V +K P +++ E +++ S+ + +V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHN 200
+ + TV +IT+L G L Y ++HK N+ + + NW QI G+ YL
Sbjct: 75 RLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEE 255
++HRDL N+ V VKI D GLA + ++ A ++MA E +
Sbjct: 132 --LVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 256 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315
Y D++S+G+ + E++TF + ++I + G + + +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMV 247
Query: 316 KCLVP-ASERLSAKDLLKD 333
KC + A R ++L+ +
Sbjct: 248 KCWMIDADSRPKFRELIIE 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 2e-41
Identities = 61/294 (20%), Positives = 117/294 (39%), Gaps = 22/294 (7%)
Query: 61 EPPDADSDFVEKDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPG 120
+P + D E + + LG G + VY+ + + VA +K D
Sbjct: 3 DPSSPNYDKWEMERT-DI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TM 55
Query: 121 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVD 178
++++ E ++K +K N+V+ + + E T GNL Y + V
Sbjct: 56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT--EFMTYGNLLDYLRECNRQEVS 113
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 238
V+ A QI + YL N IHRDL N V N VK+ D GL+ M T
Sbjct: 114 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 170
Query: 239 RSVIGT---PEFMAP-ELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294
+ G ++ AP L +++ D+++FG+ + E+ T+ + +Q+++ +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
Query: 295 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK--DPFLQVENQKEPI 345
+ ++ + C S+R S ++ + + Q + + +
Sbjct: 231 KDYRMERPEGC-PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 63/286 (22%), Positives = 110/286 (38%), Gaps = 45/286 (15%)
Query: 83 EVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+VLG GAF V A I+VA VK+ + + L SE+ ++ L
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMMTQLGS 99
Query: 138 -DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-------------------- 176
+N+V + + +I E G+L Y + +
Sbjct: 100 HENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 177 ---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233
+ + + +A Q+ G+ +L + +HRDL N+ V VKI D GLA +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDI 214
Query: 234 QQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPA 287
+ ++MAPE L+E Y D++S+G+ + E+ + PY A
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 288 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
+K + +G K +I ++ C + +R S +L
Sbjct: 275 NFYKLIQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 54/322 (16%)
Query: 73 DPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL 132
D +Y +G+G F V+KA G +VA +V +++ + G E+ +L
Sbjct: 7 DEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKIL 63
Query: 133 KSLKDDNVVKFYKSWVDDK------KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 186
+ LK +NVV + K ++ ++ + + IK
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 187 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RS 240
+ +L+GL Y+H + I+HRD+K N+ + + G +K+ D GLA A +
Sbjct: 124 QMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 241 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYS----------------- 281
+ T + PE L E +Y +D++ G + EM T
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 282 ------------ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 328
E ++ K +K A V DP I+K LV ++R+ +
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 329 DLLKDPFLQVENQKEPICDPLK 350
D L F +P+ LK
Sbjct: 301 DALNHDFF----WSDPMPSDLK 318
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-40
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 25/291 (8%)
Query: 71 EKDPSGRYVRYDEVLGKGAFKTVYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLY 126
E PS R +V+G G F VYK + VA +K
Sbjct: 3 EIHPS-CVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFL 57
Query: 127 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 185
E ++ N+++ K + +ITE +G L ++ R+K + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 186 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARS 240
R I G + N +HRDL NI VN N K+ D GL+ ++ T
Sbjct: 116 LRGIAAG--MKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 241 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 299
+ APE + ++ D++SFG+ + E++T+ + ++ K + G +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 300 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK--DPFLQVENQKEPICD 347
+ I + +C + R D++ D ++ + + + D
Sbjct: 233 PTPMDC-PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (380), Expect = 1e-40
Identities = 58/265 (21%), Positives = 117/265 (44%), Gaps = 15/265 (5%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL--YSEVHLLKSLKDDNV 140
++G+G F VY G A + + G+ L + L+ + +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 141 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN 200
V ++ K ++ I +L G+L + +H ++ +A +I+ GL ++H+
Sbjct: 70 VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 201 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YN 258
+++RDLK NI ++ HG V+I DLGLA + + +GT +MAPE+ ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 318
D +S G + +++ P+ + K + + L P+++ +E L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 319 VP-ASERLS-----AKDLLKDPFLQ 337
+ RL A+++ + PF +
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 18/261 (6%)
Query: 83 EVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN 139
E LG G+F V + + + VA +K D + Q P + EV+ + SL N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRN 72
Query: 140 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHS 198
+++ Y + + M+TEL G+L +KH+ + + +A Q+ G+ YL S
Sbjct: 73 LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-L 252
IHRDL N+ + VKIGD GL A+ Q + APE L
Sbjct: 130 KR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 253 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312
++ D + FG+ + EM T+ N +QI K+ + + I
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 313 FIEKCLVP-ASERLSAKDLLK 332
+ +C +R + L
Sbjct: 247 VMVQCWAHKPEDRPTFVALRD 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 56/273 (20%), Positives = 108/273 (39%), Gaps = 27/273 (9%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-D 138
++ +V+G+G F V KA + G+ + + +K D + E+ +L L
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----------------KNVDIKVI 182
N++ + + + E GNL + +K + + +
Sbjct: 72 NIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 183 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 242
++A + G+ YL IHRDL NI V N+ KI D GL+ + +++
Sbjct: 130 LHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG 186
Query: 243 -GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 300
+MA E L Y D++S+G+ + E+V+ A++++K+ G +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 301 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
D ++ + +C ER S +L
Sbjct: 247 KPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 81/302 (26%), Positives = 128/302 (42%), Gaps = 43/302 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFD-EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 136
+Y+ +G+GA+ V+KA D + G VA RV++ + G EV +L+ L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLE 65
Query: 137 D---DNVVKFYKSWVD---DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQI 189
NVV+ + D++ + ++ E + V + IK+ Q+
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 190 LHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFM 248
L GL +LHSH ++HRDLK NI V + G++K+ D GLA I Q SV+ T +
Sbjct: 126 LRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 249 APE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS------ 301
APE L + Y VD++S G EM + + + Q+ K + P
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 302 ------------------LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ-VENQ 341
D K + KCL ++R+SA L P+ Q +E
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302
Query: 342 KE 343
KE
Sbjct: 303 KE 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (371), Expect = 2e-39
Identities = 61/267 (22%), Positives = 120/267 (44%), Gaps = 19/267 (7%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
++D + LG G+F V + +G A + V++ ++ +E +L+++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNF 100
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
+VK S+ D+ + M+ E G + + ++ + +A QI+ YLH
Sbjct: 101 PFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEE 256
S + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE +APE + +
Sbjct: 159 SLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKG 214
Query: 257 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316
YN+ VD ++ G+ I EM P+ P QI++K+ SG +K +
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRN 271
Query: 317 CLV------PASERLSAKDLLKDPFLQ 337
L + + D+ +
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 72/333 (21%), Positives = 125/333 (37%), Gaps = 58/333 (17%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY +G+GA+ V A+D + VA +K + Q+ E+ +L
Sbjct: 8 PRY-TNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRF 63
Query: 136 KDDNVVKFYKSWVDD---KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
+ +N++ + K V ++T L + + + +H + I + QIL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRG 121
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEF 247
L Y+HS N ++HRDLK N+ +N ++KI D GLA + T +
Sbjct: 122 LKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 248 MAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------ 299
APE+ Y + +DI+S G + EM++ + Q+ + P
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 300 ----------------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 336
L D + ++K L +R+ + L P+L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
Query: 337 Q--VENQKEPICDPL--------KLPIQSLKML 359
+ + EPI + LP + LK L
Sbjct: 299 EQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 47/292 (16%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
+V+G G+F VY+A +G VA +V D + E+ +++ L N+V+
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVR 77
Query: 143 ----FYKSWVDDKKKTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVY 195
FY S + +N++ + R Y + + + + +K + Q+ L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY- 253
+HS I HRD+K N+ ++ + +K+ D G A + + S I + + APEL
Sbjct: 138 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS----------- 301
+Y +D++S G + E++ + + Q+ + + P
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 302 ---------------LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
P+ + L + RL+ + F
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-39
Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 39/294 (13%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 142
E +G+G + VYKA ++ G VA ++++D + G E+ LLK L N+VK
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 143 FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNP 201
+ K + ++ E + + + +IK++ Q+L GL + HSH
Sbjct: 66 LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEY 257
++HRDLK N+ +N G +K+ D GLA A P + T + APE+ + Y
Sbjct: 123 -VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 258 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN----------- 306
+ VDI+S G EMVT + Q+F+ + P +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 307 ---------------DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 344
D + + + L ++R+SAK L PF Q + P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 4e-39
Identities = 51/283 (18%), Positives = 105/283 (37%), Gaps = 31/283 (10%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY R +G G+F +Y D AG EVA +K+ + +L+ E + K +
Sbjct: 7 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMM 59
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+ + + W + M+ EL + + +K + A Q++ + Y
Sbjct: 60 QGGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 196 LHSHNPPIIHRDLKCDNIFV--NGNHGEVKIGDLGLAIAMQQP---------TARSVIGT 244
+HS N IHRD+K DN + V I D GLA + +++ GT
Sbjct: 119 IHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 245 PEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPAS 301
+ + + E + D+ S G ++ + + Q +++++
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 302 LAKVND---PQIKGFIEKCLVP-ASERLSA---KDLLKDPFLQ 337
+ + + ++ C ++ + L ++ F +
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 4e-39
Identities = 68/291 (23%), Positives = 119/291 (40%), Gaps = 41/291 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y E +G+G + VYKA + + G A +++++ + G E+ +LK LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKH 59
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
N+VK Y K+ + ++ E + ++ K++ Q+L+G+ Y H
Sbjct: 60 SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEE 255
++HRDLK N+ +N GE+KI D GLA A P + I T + AP++
Sbjct: 118 DRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 256 E--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK---------------------- 291
Y+ +DI+S G EMV + Q+ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 292 ----KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
V + S K D + K L ++R++AK L+ + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 66/292 (22%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
+Y+ E +G+G + TV+KA + VA RV++DD G E+ LLK LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 197
N+V+ + DKK ++ E + + + ++D +++K++ Q+L GL + H
Sbjct: 61 KNIVRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 198 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPELY-- 253
S N ++HRDLK N+ +N +GE+K+ + GLA A P + T + P++
Sbjct: 119 SRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---------------- 297
+ Y+ +D++S G E+ P + K++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 298 -----------KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
++ + + ++ L +R+SA++ L+ P+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 50/298 (16%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
R + E +GKG F V++ G EVA VKI + ++ +E++ L
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVA---VKIFSSREERSWFRE--AEIYQTVML 54
Query: 136 KDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGL 193
+ +N++ F + D + +++ G+L Y ++ V ++ + A GL
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 113
Query: 194 VYLHS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSV 241
+LH P I HRDLK NI V N G I DLGLA+ T
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 242 IGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 294
+GT +MAPE+ ++ E + DIY+ G+ E+ ++ + +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 295 SG------IKPASLAKVNDPQIKG-------------FIEKCLVP-ASERLSAKDLLK 332
++ + P I + +C + RL+A + K
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 58/283 (20%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 80 RYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
+ + LG GAF V +A A + VA VK+ + + L SE+ +L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSY 82
Query: 135 LKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN----------------- 176
L + N+V + +ITE G+L + ++ ++
Sbjct: 83 LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 177 -VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235
+D++ + +++ Q+ G+ +L S N IHRDL NI + KI D GLA ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKN 197
Query: 236 PTARSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 290
+ V ++MAPE ++ Y D++S+G+ + E+ + F
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 291 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
K+ + ++ ++ C +R + K +++
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (353), Expect = 3e-37
Identities = 53/295 (17%), Positives = 115/295 (38%), Gaps = 52/295 (17%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVV 141
LG+G + V++A + +V +K P +K+ E+ +L++L+ N++
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93
Query: 142 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 201
D +T ++ E + + +Q ++ + I+ + +IL L Y HS
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE--YN 258
I+HRD+K N+ ++ H ++++ D GLA + + F PEL + Y+
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 259 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT------------------------ 294
+D++S G + M+ + P+ + ++
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 295 -----------SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 337
+ + P+ F++K L RL+A++ ++ P+
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 6e-37
Identities = 52/288 (18%), Positives = 95/288 (32%), Gaps = 44/288 (15%)
Query: 80 RYDEVLGKGAFKTVYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS 134
Y +G+GAF V++A VA VK+ E L+
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMAE 72
Query: 135 LKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN------------------ 176
+ N+VK K + ++ E G+L ++ +
Sbjct: 73 FDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 177 ------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230
+ ARQ+ G+ YL +HRDL N V N VKI D GL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGEN-MVVKIADFGLS 187
Query: 231 IAMQQPTAR----SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKN 285
+ + +M PE ++ Y D++++G+ + E+ ++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
++ V G A ++ + C ++R S + +
Sbjct: 248 HEEVIYYVRDGNILACPENC-PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 8e-37
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 39/281 (13%)
Query: 83 EVLGKGAFKTVYKAFD-------EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
+ LG+GAF V A +VA VK+ DL L SE+ ++K +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA---VKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 136 KD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVD 178
N++ + D + +I E + GNLR+Y + + +
Sbjct: 76 GKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 179 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 236
K + + A Q+ G+ YL S IHRDL N+ V + +KI D GLA +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 237 --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 293
+ ++MAPE L++ Y D++SFG+ + E+ T ++FK +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 294 TSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 333
G + + ++ + C S+R + K L++D
Sbjct: 251 KEGHRMDKPSNC-TNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 74/307 (24%), Positives = 121/307 (39%), Gaps = 43/307 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD 137
Y + +G GA+ V A D G +VA ++ Q ++ Y E+ LLK ++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRH 76
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTS--GNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+NV+ + D+ L G KH+ + I+ Q+L GL Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 196 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY-- 253
+H+ HRDLK N+ VN + E+KI D GLA + T + APE+
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADSEM-TGYVVTRWYRAPEVILN 192
Query: 254 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-------------- 299
Y + VDI+S G + EM+T + + + Q+ + + P
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 300 --------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQK 342
AS+ P +EK LV A +R++A + L P+ + + +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 343 EPICDPL 349
EP
Sbjct: 313 EPQVQKY 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 62/291 (21%), Positives = 129/291 (44%), Gaps = 26/291 (8%)
Query: 83 EVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-D 138
+VLG GA+ V+ G A +K ++Q + +E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 139 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 198
+V + ++ + K + + + G L + + + ++ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 199 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY-- 253
II+RD+K +NI ++ N G V + D GL+ +A + A GT E+MAP++
Sbjct: 148 LG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVNDPQ 309
+ +++ VD +S G+ + E++T P+ E + A+I +++ P +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSAL 262
Query: 310 IKGFIEKCLVP-ASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 354
K I++ L+ +RL A ++ + F Q N + + P +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 313
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 28/283 (9%)
Query: 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRV--KIDDVLQLPGDLQKLYSEVHLLKSLKD 137
LG+G+F VY+ + + +RV K + + + +E ++K
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 138 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV----------DIKVIKNWAR 187
+VV+ + +I EL T G+L+ Y + + + + A
Sbjct: 83 HHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 188 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIG 243
+I G+ YL+++ +HRDL N V + VKIGD G+ + + +
Sbjct: 141 EIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 244 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 302
+M+PE L + + D++SFG+ + E+ T + + Q+ + V G
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 303 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 344
+ + C R S +++ ++ + EP
Sbjct: 258 DNC-PDMLFELMRMCWQYNPKMRPSFLEIIS----SIKEEMEP 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 36/287 (12%)
Query: 74 PSGRYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSE 128
P R + + LG+GAF V +A VA VK+ + + L SE
Sbjct: 11 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSE 66
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN------------ 176
+ +L + V + +I E GNL Y + +N
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 177 ----VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232
+ ++ + ++ Q+ G+ +L S IHRDL NI ++ VKI D GLA
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARD 183
Query: 233 MQQP----TARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 286
+ + ++MA +++ Y D++SFG+ + E+ + PY K
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 332
+ +++ G + P++ + C S+R + +L++
Sbjct: 244 EEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 132 bits (333), Expect = 4e-35
Identities = 36/262 (13%), Positives = 93/262 (35%), Gaps = 29/262 (11%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
Y + +G+G+F +++ + +VA +K D +L E K L
Sbjct: 5 VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVA---IKF---EPRRSDAPQLRDEYRTYKLL 57
Query: 136 KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVY 195
+ + + V ++ +L + +K + A+Q+L +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 196 LHSHNPPIIHRDLKCDNIFVN----GNHGEVKIGDLGLAIAMQQP---------TARSVI 242
+H + +++RD+K DN + N + + D G+ + P +++
Sbjct: 117 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 243 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKP 299
GT +M+ + E + D+ + G + + + + Q ++++ +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 300 ASLAKVND---PQIKGFIEKCL 318
L ++ + ++
Sbjct: 235 TPLRELCAGFPEEFYKYMHYAR 256
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 80/319 (25%), Positives = 128/319 (40%), Gaps = 45/319 (14%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLK 136
RY +G GA+ +V AFD G+ VA VK + Q ++ Y E+ LLK +K
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 137 DDNVVKFYKSWVDDKKKT--VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLV 194
+NV+ + + ++ G K + + ++ QIL GL
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 195 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY- 253
Y+HS + IIHRDLK N+ VN E+KI D GLA + T + APE+
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIML 191
Query: 254 -EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------- 299
YN+ VDI+S G + E++T + + Q+ + P
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 300 ---------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQ 341
A++ +P +EK LV + +R++A L + +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
Query: 342 KEPICDPLKLPIQSLKMLR 360
EP+ DP +S +L
Sbjct: 312 DEPVADPYDQSFESRDLLI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 74/334 (22%), Positives = 125/334 (37%), Gaps = 59/334 (17%)
Query: 80 RYD--EVLGKGAFKTVYKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLK 136
RY + +G GA V A+D VA +K + Q ++ Y E+ L+K +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 137 DDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHG 192
N++ + K + V ++ EL + + + + D + + Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCG 131
Query: 193 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPE 251
+ +LHS IHRDLK NI V + +KI D GLA + + T + APE
Sbjct: 132 IKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 252 -LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------- 299
+ Y E VDI+S G + EMV + + Q K + P
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 300 ----------------------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 330
+ K+ Q + + K LV ++R+S D
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 331 LKDPFLQVE-NQKEPICDPLKLPIQSLKMLRLPM 363
L+ P++ V + E P ++ + L +
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTI 342
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 3e-27
Identities = 71/339 (20%), Positives = 120/339 (35%), Gaps = 74/339 (21%)
Query: 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL 135
RY LG G F TV+ A D VA V+ D V + E+ LL+ +
Sbjct: 13 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRV 66
Query: 136 KDDNVVK--------------FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 181
D + K + + V + L + + +H+ + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 182 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-----GNHGEVKIGDLGLAIAMQQP 236
+K ++Q+L GL Y+H IIH D+K +N+ + N ++KI DLG A +
Sbjct: 127 VKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 237 TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY------SECKNPAQI 289
+ I T E+ +PE L + DI+S I E++T ++ + S K+ I
Sbjct: 186 Y-TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 290 FKKVTSGIKPAS---------------------------------------LAKVNDPQI 310
+ + + S +K +I
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304
Query: 311 KGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 348
F+ L +R A L+ P+L+ E I P
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.4 bits (182), Expect = 6e-16
Identities = 33/204 (16%), Positives = 67/204 (32%), Gaps = 32/204 (15%)
Query: 83 EVLGKGAFKTVYKAFDEFAGIEVA--------------WSRVKIDDVLQLPGDLQKLYSE 128
+++G+G V+ + E E + D+ ++ +E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 129 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 188
L+ L+ V K Y + ++ EL + L + R ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA------VLMELIDAKELYRVRVEN-------PDEVLDM 111
Query: 189 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 248
IL + + I+H DL N+ V+ + I D ++ + + R ++
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 249 APELYEEEYNELVDIYSFGMCILE 272
+ Y DI S IL+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 719 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 86.03 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=490.87 Aligned_cols=264 Identities=53% Similarity=0.961 Sum_probs=242.2
Q ss_pred cCCCCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC-
Q 005017 72 KDPSGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD- 150 (719)
Q Consensus 72 ~d~~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~- 150 (719)
....|||+++.+.||+|+||+||+|.++.+|..||+|++..... .....+.+.+|+++|++|+|||||+++++|.+.
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 35678999999999999999999999999999999999876543 245567899999999999999999999998653
Q ss_pred -CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 -KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 -~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
+...+|+||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++++||||||||+|||++.+.|.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 3456899999999999999999989999999999999999999999999888999999999999986668999999999
Q ss_pred hhhccCCCcccccCCCCCCCccccccccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChH
Q 005017 230 AIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 309 (719)
Q Consensus 230 A~~~~~~~~~~~~GT~~YmAPEvl~~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~ 309 (719)
|+..........+||+.|||||++.+.|+.++|||||||++|||+||+.||.+..+..++++.+..+..|..+....+++
T Consensus 162 a~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 162 ATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 98877666778899999999999999999999999999999999999999998888889999999988888888888999
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHHcCccCc
Q 005017 310 IKGFIEKCLV-PASERLSAKDLLKDPFLQ 337 (719)
Q Consensus 310 l~~lI~kcL~-dP~~RpSa~eLL~hpf~~ 337 (719)
+++||.+||. +|.+|||+.|+|+||||+
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999998 899999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=458.72 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=217.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|+++.... ....+.+.+|+++|++|+|||||++++++.+. ..+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeE
Confidence 358899999999999999999999999999999976543 23346788999999999999999999999765 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeeccC
Confidence 99999999999999998889999999999999999999999999 9999999999999855 79999999999865432
Q ss_pred ----CcccccCCCCCCCcccccc-cc-CccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 237 ----TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 237 ----~~~~~~GT~~YmAPEvl~~-~~-s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.....+||+.|||||++.+ .+ +.++|||||||++|||+||++||.........+..+.............++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 2346789999999999865 34 67899999999999999999999876555566666665554444455668999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
++||.+||. ||.+|||++|+|+||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999998 8999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=456.44 Aligned_cols=252 Identities=23% Similarity=0.411 Sum_probs=224.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|++++|||||++++++.+. ..+|+
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~i 83 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYL 83 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEE
Confidence 4788999999999999999999999999999997543322 23457789999999999999999999998765 45899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCCCc
Confidence 9999999999999999899999999999999999999999999 9999999999999855 799999999998777666
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++++||.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISR 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHH
Confidence 677889999999999876 489999999999999999999999976 667778888776543 3456678999999999
Q ss_pred hcC-CCCCCCCHHHHHcCccCcc
Q 005017 317 CLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 317 cL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
||. ||.+|||+.|+|+||||+.
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 998 8999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=452.79 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=210.4
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++|++++|||||++++++.+.....+|+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47888999999999999999999999999999976543 2455678999999999999999999999998776677999
Q ss_pred EEecccCCChhHHhhh----cccccHHHHHHHHHHHHHHhhhhhcCC---CCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 158 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~----~~~l~~~~i~~i~~QIl~gL~yLHs~~---ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
||||+++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+||||||||+|||++.+ |.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccce
Confidence 9999999999999864 356999999999999999999999865 259999999999999865 79999999999
Q ss_pred hhccCC--CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 231 IAMQQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 231 ~~~~~~--~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.. .+..++...+..+..+ .++...+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s 239 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYS 239 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccC
Confidence 887543 3456789999999999865 599999999999999999999999987 5677888888877554 3455678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFL 336 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~ 336 (719)
+++++||.+||. ||.+|||+.|||+|||+
T Consensus 240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999998 89999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=456.83 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=218.3
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
+|++.+.||+|+||+||+|.++.+|+.||+|+++.... ...+.+.+|+.+|++++|||||+++++|.+.+ .+|+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~i 94 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 94 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEE
Confidence 45777899999999999999999999999999986542 23567899999999999999999999997654 5899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++.+ +.+++..++.|++||+.||+|||++| ||||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchhheeecccc
Confidence 9999999999998765 56999999999999999999999999 9999999999999855 79999999999876433
Q ss_pred -CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHH
Q 005017 237 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 314 (719)
Q Consensus 237 -~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI 314 (719)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+......+...+..+..+...+...++++++||
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 250 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence 3456689999999998875 58999999999999999999999998855445555555555555555667789999999
Q ss_pred HHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 315 EKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 315 ~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.+||. ||.+|||+.|+|+||||+.
T Consensus 251 ~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 251 NRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHccCChhHCcCHHHHhcCHhhCC
Confidence 99998 8999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=460.75 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=215.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|+++... .....+++.+|+.+|++++|||||+++++|.+.+ .+|
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 80 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EIS 80 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--EEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEE
Confidence 45788899999999999999999999999999997543 2345678999999999999999999999997654 589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+ |.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCccccCC
Confidence 999999999999999998899999999999999999999997 58 9999999999999855 7999999999987766
Q ss_pred CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHH--------------------------
Q 005017 236 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ-------------------------- 288 (719)
Q Consensus 236 ~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~-------------------------- 288 (719)
....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||........
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 55667899999999998875 699999999999999999999999976332211
Q ss_pred ---------------HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 289 ---------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 289 ---------------i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
....+.....+.......++++++||.+||. ||.+||||+|+|+||||+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111122222222233457899999999998 9999999999999999986543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=451.60 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=216.5
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+++|++|+|||||++++++.+.+ .+++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~l 86 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWI 86 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEE
Confidence 4688899999999999999999999999999987543 345577889999999999999999999987654 5899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|+.....
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechhhhccCCC
Confidence 9999999999999765 456999999999999999999999999 9999999999999855 79999999999654332
Q ss_pred --CcccccCCCCCCCccccc------cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC-CccccCCC
Q 005017 237 --TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVND 307 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~------~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p-~~~~~~~~ 307 (719)
.....+||+.|||||++. ..|+.++|||||||++|||+||+.||.+. +..+++..+..+..+ ...+...+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCccccCC
Confidence 234568999999999873 34899999999999999999999999874 555666666655433 33455678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+++++||.+||+ ||.+|||+.|+|+||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999998 89999999999999999743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=454.46 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=222.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|+..+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|++|+|||||++++++.+. ..+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEE
Confidence 34777889999999999999999999999999998654322 34567899999999999999999999998765 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+|||||.+|+|..++...+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeecccccccCC-
Confidence 99999999999988888889999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred CcccccCCCCCCCccccc----cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 237 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~----~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
....+||+.|||||++. +.|+.++|||||||++|||++|+.||.+ .+..+.+..+..+..+.......++++++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 34568999999999874 3589999999999999999999999987 45556666666666665556677899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 313 FIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
||.+||. ||.+|||+.|+|+||||+..
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999998 89999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=446.16 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=224.7
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..+|++.+.||+|+||+||+|.++.+|+.||+|+++...... .....+.+.+|+++|++|+|||||+++++|.+. .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--T 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--C
Confidence 356899999999999999999999999999999998654322 223467899999999999999999999998765 4
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCC---CcEEEeecchh
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLA 230 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~---G~vKL~DFGlA 230 (719)
.+|+|||||++|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+. +.+||+|||+|
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 68999999999999999998889999999999999999999999999 99999999999997542 25999999999
Q ss_pred hhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCC
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVN 306 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~ 306 (719)
...... ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+... .......
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCC
Confidence 876543 3456789999999999875 599999999999999999999999987 5677777777776443 3344567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccccCCC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~~~ 343 (719)
++++++||.+||. ||.+|||+.|+|+||||+..++..
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 8899999999998 899999999999999998655443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=449.42 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=223.1
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+++|++|+|||||++++++.+. ..+|+
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 85 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYF 85 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEE
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEE
Confidence 4899999999999999999999999999999997544322 23457899999999999999999999998755 45899
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC-
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~- 236 (719)
||||+++|+|.+++...+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCC
Confidence 9999999999999999999999999999999999999999999 9999999999999855 79999999999876432
Q ss_pred ---CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 237 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 237 ---~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.. .+..+++..+..+.. .++...++++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARD 239 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHH
Confidence 2345689999999999875 589999999999999999999999987 677888888877643 345567899999
Q ss_pred HHHHhcC-CCCCCCCHHH------HHcCccCccccCCC
Q 005017 313 FIEKCLV-PASERLSAKD------LLKDPFLQVENQKE 343 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~e------LL~hpf~~~~~~~~ 343 (719)
||.+||. ||.+|||++| +++||||+..++..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 9999998 8999999987 68899998877654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-53 Score=449.23 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=205.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||+||+|.++.+|+.||+|++...... ...+.+.+|+.+|++|+|||||++++++.+. ..+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--SEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 4588999999999999999999999999999999765432 2345688999999999999999999998655 4589
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~~~ 234 (719)
+||||++||+|.+++...+.+++..++.++.||+.||+|||+++ ||||||||+|||+.. +.|.+||+|||+|+...
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999998889999999999999999999999999 999999999999953 35799999999998765
Q ss_pred CC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC--ccccCCChHH
Q 005017 235 QP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQI 310 (719)
Q Consensus 235 ~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~--~~~~~~~~~l 310 (719)
.. ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..++...+..+..+. ......++++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 43 3456789999999998875 599999999999999999999999987 56677777777665432 3345578999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
++||.+||. ||.+|||+.|+|+||||+..
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999998 89999999999999999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=452.59 Aligned_cols=258 Identities=22% Similarity=0.418 Sum_probs=227.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|++++|||||+++++|.+. ..+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--cccc
Confidence 35888999999999999999999999999999998654322 24567889999999999999999999998765 4599
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccC
Confidence 99999999999999999999999999999999999999999999 9999999999999865 7999999999986543
Q ss_pred -CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 236 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 236 -~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......+||+.|||||++.+ .|+.++|||||||++|||+||++||.+ .+..++++.+..+.. .++...++++++|
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 235 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSL 235 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHH
Confidence 23456789999999999874 599999999999999999999999987 677888888877643 3456788999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHHcCccCccccCCC
Q 005017 314 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKE 343 (719)
Q Consensus 314 I~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~~ 343 (719)
|.+||+ ||.+|++ +.++++||||+..++..
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence 999998 8999994 99999999998765543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-52 Score=446.52 Aligned_cols=257 Identities=25% Similarity=0.427 Sum_probs=225.6
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|++++|||||++++++.+. ..+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeC--Ceee
Confidence 35889999999999999999999999999999997543222 24467899999999999999999999998765 4699
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
+||||+.||+|..++.....+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSSC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEeccc
Confidence 99999999999999999999999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHH
Q 005017 237 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 315 (719)
Q Consensus 237 ~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~ 315 (719)
..+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...+++++++|.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLS 233 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence 346789999999999876 599999999999999999999999987 677788888877643 344567899999999
Q ss_pred HhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 316 KCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 316 kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
+||. +|.+|+ |++++|+||||+..++..
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~ 267 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence 9998 899986 999999999999876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-52 Score=449.69 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=221.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|++|+|||||++++++.+. ..+|+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~i 100 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVM 100 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEE
Confidence 5788999999999999999999999999999987543 34567889999999999999999999998765 45899
Q ss_pred EEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G~vKL~DFGlA~~~~~ 235 (719)
|||||++|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ ||||||||+|||++. ..|.+||+|||+|+.+..
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999999854 567999999999999999999999999 999999999999964 347899999999987665
Q ss_pred C-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHHH
Q 005017 236 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIK 311 (719)
Q Consensus 236 ~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l~ 311 (719)
. ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. +.......+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 4 3456789999999999875 589999999999999999999999986 567777777776543 3334455788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccccC
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 341 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~~ 341 (719)
+||.+||. ||.+|||+.|+|+||||+..+.
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999998 8999999999999999986543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.9e-52 Score=447.02 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=221.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.+|++.+.||+|+||+||+|.++.+|+.||+|+++... ....+.+.+|+.+|++|+|||||+++++|.++ ..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 35889999999999999999999999999999987543 23456788999999999999999999998755 4689
Q ss_pred EEEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC-CCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~-~~G~vKL~DFGlA~~~~ 234 (719)
+|||||++|+|.+++...+ .+++..++.|+.||+.||+|||+++ ||||||||+|||++. ..|.+||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999999999876654 6999999999999999999999999 999999999999973 45799999999998776
Q ss_pred CCC-cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CCccccCCChHH
Q 005017 235 QPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 310 (719)
Q Consensus 235 ~~~-~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~~~~~~~~~~l 310 (719)
... .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+.. +.......++++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 543 456789999999998875 599999999999999999999999987 456666777766543 333445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
++||.+||. ||.+|||+.|+|+||||+...
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999998 899999999999999998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-52 Score=451.55 Aligned_cols=259 Identities=21% Similarity=0.349 Sum_probs=216.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~--~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
..|++.++||+|+||+||+|.++.+|+.||+|++....... ......+...|+.+++.++|||||+++++|.+. ..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CE
Confidence 35889999999999999999999999999999987543211 111222334457788888999999999998765 45
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||+++|+|.+++.+...+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 8999999999999999999999999999999999999999999999 9999999999999855 799999999998877
Q ss_pred CCCcccccCCCCCCCccccc-c-ccCccccchhhHHHHHHHhhccCCCCCCCCH--HHHHHHHHcCCCCCccccCCChHH
Q 005017 235 QPTARSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~-~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~--~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.......+||+.|||||++. + .|+.++|||||||++|||+||+.||...... ..+...+ ...+..++...++++
T Consensus 159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPEL 236 (364)
T ss_dssp SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCCCCSSSCHHH
T ss_pred CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCCCCHHH
Confidence 76667788999999999885 3 4899999999999999999999999764322 2232222 223444556678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHHcCccCccccCC
Q 005017 311 KGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQK 342 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpS-----a~eLL~hpf~~~~~~~ 342 (719)
++||.+||. ||.+||| |+|+++||||+..++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 999999998 8999999 8999999999976654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-52 Score=448.14 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=225.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+++|++++|||||++++++.+. ..+++
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~ 118 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccc--ccccc
Confidence 5788899999999999999999999999999997543322 34567889999999999999999999998765 45889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |.+||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeecccc-
Confidence 9999999999999999899999999999999999999999999 9999999999999855 79999999999876543
Q ss_pred cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHH
Q 005017 238 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 316 (719)
Q Consensus 238 ~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~k 316 (719)
....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+...++..+..+... .+...++++++||.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRN 271 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHHHHHH
Confidence 346789999999998875 589999999999999999999999987 5777888888776433 345678999999999
Q ss_pred hcC-CCCCC-----CCHHHHHcCccCccccCCC
Q 005017 317 CLV-PASER-----LSAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 317 cL~-dP~~R-----pSa~eLL~hpf~~~~~~~~ 343 (719)
||. ||.+| ||+++|++||||+..++..
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~ 304 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred HhhhCHHhccccccccHHHHHcCccccCCCHHH
Confidence 998 89988 4999999999999876544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=433.36 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=204.8
Q ss_pred eEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh-hhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeEEEe
Q 005017 82 DEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 82 ~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~-~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~lV~E 160 (719)
.++||+|+||+||+|.++.+|+.||+|+++........ ...+.+.+|+.+|++++|||||++++++...+ .+|+|||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehhh
Confidence 37899999999999999999999999999765432211 22356889999999999999999999987654 5899999
Q ss_pred cccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC--Cc
Q 005017 161 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 238 (719)
Q Consensus 161 y~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~--~~ 238 (719)
|+.++++..+......+++..++.|++||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|+..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence 9999988888877788999999999999999999999999 9999999999999855 79999999999776543 33
Q ss_pred ccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCC---------------
Q 005017 239 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP--------------- 299 (719)
Q Consensus 239 ~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p--------------- 299 (719)
...+||+.|||||++.. .|+.++|||||||++|||+||.+||.+.. ..+....+... ..+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-HHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 45689999999998753 48999999999999999999999998744 44443333221 000
Q ss_pred ---------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 300 ---------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 300 ---------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.......++++++||.+||+ ||.+||||.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00112347899999999998 899999999999999998544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-50 Score=424.85 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=220.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCC-CCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~-----~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~ 150 (719)
..|.+.+.||+|+||+||+|.++.+|+.||+|+++....... ....+++.+|+.+|++|+ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 357899999999999999999999999999999986543321 123456889999999997 99999999998754
Q ss_pred CCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
..+|+||||+++|+|.++++..+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 83 --~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a 157 (277)
T d1phka_ 83 --TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFS 157 (277)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred --cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchhe
Confidence 569999999999999999999999999999999999999999999999 9999999999999855 79999999999
Q ss_pred hhccCC-CcccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--CC
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA 300 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~--p~ 300 (719)
+..... .....+||+.|+|||++.+ .++.++||||+||++|||+||+.||.+ .+.....+.+..+.. +.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 876543 3455789999999998752 378899999999999999999999987 566677777776543 23
Q ss_pred ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 301 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 301 ~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 3344678999999999998 8999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=437.78 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=221.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHH-hCCCCCceeEEEeeecCCCCcee
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
.|.+.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|..++. .++|||||++++++.+. ..+|
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 4788999999999999999999999999999997543222 234566777777765 68999999999998765 4599
Q ss_pred EEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC-
Q 005017 157 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~- 235 (719)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhcccc
Confidence 99999999999999999999999999999999999999999999 9999999999999855 7999999999976543
Q ss_pred -CCcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHHH
Q 005017 236 -PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 313 (719)
Q Consensus 236 -~~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~l 313 (719)
......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+.. .++...++++++|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 233 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDL 233 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHH
Confidence 23445689999999998875 699999999999999999999999987 577888888876643 4456678999999
Q ss_pred HHHhcC-CCCCCCCHH-HHHcCccCccccC
Q 005017 314 IEKCLV-PASERLSAK-DLLKDPFLQVENQ 341 (719)
Q Consensus 314 I~kcL~-dP~~RpSa~-eLL~hpf~~~~~~ 341 (719)
|.+||. +|.+|||+. +|++||||+..++
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 999998 899999995 8999999987554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=427.30 Aligned_cols=251 Identities=20% Similarity=0.348 Sum_probs=212.8
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCCh--hhHHHHHHHHHHHHhCC--CCCceeEEEeeecC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDD 150 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~--~~~~~~~~Ei~iL~~L~--HpNIVkl~~~~~~~ 150 (719)
....|++.++||+|+||+||+|.++.+|+.||+|+++........ ....++.+|+.+|++++ |||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 345689999999999999999999999999999999865432211 12234678999999997 89999999998765
Q ss_pred CCCceeEEEecccC-CChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecch
Q 005017 151 KKKTVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 229 (719)
Q Consensus 151 ~~~~l~lV~Ey~~g-GsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGl 229 (719)
..+++||||+.+ +++.+++.+...+++..++.|+.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+
T Consensus 82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 458899999976 688899988889999999999999999999999999 999999999999987767999999999
Q ss_pred hhhccCCCcccccCCCCCCCcccccc-c-cCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 230 AIAMQQPTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 230 A~~~~~~~~~~~~GT~~YmAPEvl~~-~-~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
|+..........+||+.|||||++.+ . ++.++|||||||++|||+||+.||.. ... +..+. ..++...+
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~----i~~~~--~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---chH----Hhhcc--cCCCCCCC
Confidence 98776666677889999999998864 3 46789999999999999999999975 222 23322 23445678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
+++++||.+||. ||.+|||++|+|+||||+.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999998 8999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-51 Score=433.84 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=219.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|.++.+|+.||+|+++... .....+.+|+++|++++|||||+++++|.+. ..+|+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~l 78 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EELVM 78 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEE
Confidence 3688899999999999999999999999999997543 3345688999999999999999999998765 45999
Q ss_pred EEecccCCChhHHhhhcc-cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCC-CCcEEEeecchhhhccC
Q 005017 158 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~-~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~-~G~vKL~DFGlA~~~~~ 235 (719)
|||||+||+|.+++...+ .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ .+.+||+|||+++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999998765 6999999999999999999999999 9999999999999743 35899999999987654
Q ss_pred C-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCC--CccccCCChHHH
Q 005017 236 P-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIK 311 (719)
Q Consensus 236 ~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p--~~~~~~~~~~l~ 311 (719)
. ......||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.. .+..+++..+..+... .......+++++
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 3 3456689999999998764 589999999999999999999999987 5677778887766442 233345788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 312 GFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+||.+||. ||.+|||+.|+|+||||+..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999998 89999999999999999743
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=432.71 Aligned_cols=253 Identities=20% Similarity=0.312 Sum_probs=206.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHh-CCCCCceeEEEeeec--CCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVD--DKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIVkl~~~~~~--~~~ 152 (719)
++|..+.++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++.+ ++|||||+++++|.+ ...
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 44544567899999999999999999999999998632 456789998655 589999999998865 334
Q ss_pred CceeEEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecc
Q 005017 153 KTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLG 228 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFG 228 (719)
..+|+|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++. +.+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 6789999999999999999864 46999999999999999999999999 999999999999974 34679999999
Q ss_pred hhhhccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHH---HHHHHHcCC--CCCc
Q 005017 229 LAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGI--KPAS 301 (719)
Q Consensus 229 lA~~~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~---i~~~i~~g~--~p~~ 301 (719)
+|+..... .....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+...... +...+..+. .|..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 99866543 3456789999999999875 599999999999999999999999976332221 222222221 1222
Q ss_pred cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 302 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 302 ~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
.....++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 223467899999999998 89999999999999999743
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=417.25 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=209.4
Q ss_pred CcEEEe-EEEeeeCCeEEEEEEEc--CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYD-EVLGKGAFKTVYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~-e~LG~G~fG~Vyka~d~--~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
+.+.+. +.||+|+||+||+|.+. .+++.||+|+++... ..+...+++.+|+.+|++|+|||||++++++..+
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~--- 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE--- 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---
Confidence 345555 46999999999999754 456789999986443 2245567899999999999999999999988532
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
.+++||||+++|+|.+++.+...+++..+..|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhc
Confidence 36899999999999999999899999999999999999999999999 9999999999999855 79999999999866
Q ss_pred cCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 234 QQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 234 ~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
.... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+. .+..+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccc
Confidence 4332 22456899999999876 468999999999999999998 8999987 56777888888776543 45567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHH---HcCccCc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDL---LKDPFLQ 337 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eL---L~hpf~~ 337 (719)
++++++||.+||. +|.+|||+.++ |+|+|++
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8999999999998 89999999998 5677765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=418.38 Aligned_cols=245 Identities=29% Similarity=0.435 Sum_probs=205.7
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|.+.+.||+|+||+||+|... ..||||+++.... .....+.|.+|+.+|++++|||||++++++.. ..+++
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 4567889999999999999643 3699999875433 24567889999999999999999999997643 34789
Q ss_pred EEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence 99999999999999754 56999999999999999999999999 9999999999999865 79999999999765432
Q ss_pred ----CcccccCCCCCCCcccccc----ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCc---cccC
Q 005017 237 ----TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKV 305 (719)
Q Consensus 237 ----~~~~~~GT~~YmAPEvl~~----~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~---~~~~ 305 (719)
......||+.|||||++.. .|+.++|||||||++|||+||+.||.+.....++...+..+..++. ....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2345689999999998852 4899999999999999999999999987777777777777765543 3445
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+++++++||.+||. +|.+|||+.+|+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 67899999999998 89999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=412.95 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=212.7
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++.+ ..++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~ 83 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIY 83 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeE
Confidence 57899999999999999999876 67899999986432 234679999999999999999999998743 2478
Q ss_pred EEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++|+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEcc
Confidence 9999999999999876543 5999999999999999999999999 9999999999999865 799999999998765
Q ss_pred CCC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 235 QPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 235 ~~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
... .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l 239 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEEL 239 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHH
Confidence 432 23457899999999886 4699999999999999999997766655577888888888776554 345678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc--CccCc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK--DPFLQ 337 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~--hpf~~ 337 (719)
++||.+||. +|.+|||++++++ |+||.
T Consensus 240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999998 8999999999998 78875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-49 Score=416.62 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=213.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|+++... ...+++.+|+++|++|+|||||+++++|.+. ..++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ 89 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 89 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeE
Confidence 46889999999999999999999999999999986432 3457799999999999999999999998755 4588
Q ss_pred EEEecccCCChhHHhhhc--ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~--~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccceeecC
Confidence 999999999999998754 56899999999999999999999999 9999999999999855 799999999998765
Q ss_pred CCCc---ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 235 QPTA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 235 ~~~~---~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.... ....||+.|||||++. +.|+.++|||||||++|||+||..||....+..++++.+..+..+ ..+...++++
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l 245 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKV 245 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHH
Confidence 5432 2345899999999876 569999999999999999999888877667788888888776554 3455678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++||.+||. ||.+|||+.++++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999998 8999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=415.46 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=204.6
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.+..+|+.||+|+++..... ....+++.+|+++|++++|||||+++++|.+.+ .+|+
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~i 78 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYL 78 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeE
Confidence 477889999999999999999999999999999754322 234578899999999999999999999997654 5899
Q ss_pred EEecccCCChhHHhh-hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCC
Q 005017 158 ITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 236 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~-~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~ 236 (719)
||||+.++.+..... ..+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccCC
Confidence 999997654443333 3456999999999999999999999999 9999999999999865 69999999999877543
Q ss_pred --CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCC------------
Q 005017 237 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA------------ 300 (719)
Q Consensus 237 --~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~------------ 300 (719)
......||+.|+|||++.. .++.++|||||||++|+|++|+.||.+......+.+.......+.
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3445689999999998654 368899999999999999999999987544444443332110000
Q ss_pred --------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 --------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 --------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......++++++||.+||. ||.+|||+.|||+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0012346789999999998 89999999999999999744
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=409.19 Aligned_cols=245 Identities=17% Similarity=0.343 Sum_probs=201.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.+. ++..||||+++... ...+++.+|++++++++|||||++++++...+ .++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCC--ceE
Confidence 35788999999999999999876 67889999987432 23467999999999999999999999987654 588
Q ss_pred EEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+++|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC-------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccC
Confidence 999999999999998754 56899999999999999999999999 9999999999999855 7999999999987654
Q ss_pred CC---cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHH
Q 005017 236 PT---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 311 (719)
Q Consensus 236 ~~---~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~ 311 (719)
.. .....||+.|||||++.+ .|+.++|||||||++|||+|+..|+....+..++...+..+..+. .+...++++.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 232 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVY 232 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCHHHH
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHH
Confidence 32 234578999999998874 699999999999999999996555555577788888888775543 4566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHHcC
Q 005017 312 GFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 312 ~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+||.+||. +|.+|||++++++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999998 89999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-49 Score=415.60 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=200.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCe---EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 152 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~---~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~ 152 (719)
...|++.++||+|+||+||+|.++.+|. .||+|.+.... .....+.|.+|+++|++|+|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-- 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-- 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence 3568999999999999999999887765 57888765332 345667899999999999999999999998655
Q ss_pred CceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
..+++|||||++|+|.+++... +.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccce
Confidence 4588999999999999988774 46999999999999999999999999 9999999999999865 799999999998
Q ss_pred hccCCCc-------ccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 005017 232 AMQQPTA-------RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 302 (719)
Q Consensus 232 ~~~~~~~-------~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~ 302 (719)
....... ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..++ .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~ 254 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-P 254 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-C
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-C
Confidence 7643321 1245799999999886 469999999999999999998 8999987 46677888887776544 3
Q ss_pred ccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 303 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 303 ~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+...++++++||.+||. +|.+|||+.+|+++
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45578899999999998 89999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8e-49 Score=410.24 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=207.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
+|.+.++||+|+||+||+|.++ +|+.||+|+++..... ....+++.+|+.+|++++|||||+++++|...+ .+++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i 77 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVL 77 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEE
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeE
Confidence 4678899999999999999986 8899999999765432 234578999999999999999999999997664 4889
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
++||+.++.+..+....+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|.......
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC--
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceecccCc
Confidence 9999999888888888889999999999999999999999999 9999999999999865 799999999998765432
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc--CCC-------------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK------------- 298 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--g~~------------- 298 (719)
.....|++.|+|||.+.+ .++.++|||||||++|||++|+.||.+.. ..+....+.. +..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 345579999999998753 47999999999999999999999998744 3333333221 000
Q ss_pred ------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 299 ------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 299 ------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011223457889999999998 8999999999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-49 Score=409.59 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=207.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC--Cc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KT 154 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--~~ 154 (719)
..|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+++.+|+++|++++|||||++++++...+. ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 347889999999999999999999999999999976443 335566789999999999999999999999876543 35
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.++|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhhhc
Confidence 8899999999999999999999999999999999999999999999 9999999999999865 699999999886543
Q ss_pred CC-----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHH-HcCCCCC-ccccCC
Q 005017 235 QP-----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV-TSGIKPA-SLAKVN 306 (719)
Q Consensus 235 ~~-----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i-~~g~~p~-~~~~~~ 306 (719)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+ .+..+....+ .....+. ......
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC-cCHHHHHHHHHhcCCCCCchhccCC
Confidence 22 2345689999999999875 589999999999999999999999987 4455554444 4433332 334567
Q ss_pred ChHHHHHHHHhcC-CCCCCC-CHHHHHcCccCc
Q 005017 307 DPQIKGFIEKCLV-PASERL-SAKDLLKDPFLQ 337 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~Rp-Sa~eLL~hpf~~ 337 (719)
++++++||.+||. ||.+|| |++++ .|+|++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 8999999999998 899999 55555 566664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=419.21 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=207.0
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCC-----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g-----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|++.++||+|+||+||+|.+..++ ..||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 46889999999999999999886554 3799998864332 23456789999999998 899999999998765
Q ss_pred CCCceeEEEecccCCChhHHhhhcc-----------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeec
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 207 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~-----------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrD 207 (719)
+ .+++|||||++|+|.+++...+ .+++..++.++.||+.||+|||+++ |||||
T Consensus 114 ~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD 189 (325)
T d1rjba_ 114 G--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD 189 (325)
T ss_dssp S--SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred C--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 4 5899999999999999997542 4889999999999999999999999 99999
Q ss_pred CccceeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCC
Q 005017 208 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYS 281 (719)
Q Consensus 208 LKp~NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~ 281 (719)
|||+|||++.+ |.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.
T Consensus 190 lKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999865 799999999997654432 23456899999999875 569999999999999999998 899998
Q ss_pred CCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 282 ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 282 ~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+......+.+.+..+..+ ..+...++++++||.+||. +|.+|||++||++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 866666666666665443 4556678999999999998 89999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.03 Aligned_cols=251 Identities=18% Similarity=0.369 Sum_probs=211.7
Q ss_pred CcEEEeEE-EeeeCCeEEEEEEEcC--CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEV-LGKGAFKTVYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~-LG~G~fG~Vyka~d~~--~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..+.+.++ ||+|+||+||+|.++. ++..||||+++... .....+++.+|+++|++++|||||++++++..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---
Confidence 35677775 9999999999997754 45689999987432 345678899999999999999999999987542
Q ss_pred ceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+|+||||+++|+|.+++.. .+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKA 158 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhc
Confidence 47899999999999999765 457999999999999999999999999 9999999999999865 7999999999987
Q ss_pred ccCCC-----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~-----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
+.... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~ 236 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPE 236 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCc
Confidence 65332 23456899999999886 569999999999999999998 89999874 4567778888776554 4556
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHH---HcCccCcc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDL---LKDPFLQV 338 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eL---L~hpf~~~ 338 (719)
.++++.+||.+||. +|.+|||+.++ |+|+|+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 78999999999998 89999999888 67888753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=410.98 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=204.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC-CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC---CCCCceeEEEeeecC--
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD-- 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~-g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIVkl~~~~~~~-- 150 (719)
..|++.+.||+|+||+||+|.+..+ ++.||+|+++...... .....+.+|+.+|+.| +|||||+++++|...
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4678889999999999999999765 6779999997654322 1223455677766655 899999999988642
Q ss_pred -CCCceeEEEecccCCChhHHhh-hcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 151 -KKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 151 -~~~~l~lV~Ey~~gGsL~~~L~-~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
....++++|||+.+|++..... ....+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecchh
Confidence 3357899999999987765544 3456999999999999999999999999 9999999999999855 799999999
Q ss_pred hhhhccCC-CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CC------
Q 005017 229 LAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK------ 298 (719)
Q Consensus 229 lA~~~~~~-~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~------ 298 (719)
+++..... .....+||+.|||||++. ..|+.++|||||||++|||+||++||.+. +..+....+... ..
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhccc
Confidence 98765432 345678999999999875 46999999999999999999999999874 444444433210 00
Q ss_pred -----------------CCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 299 -----------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 299 -----------------p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
...+....++.+++||.+||. ||.+||||.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 011233457889999999998 899999999999999998543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-48 Score=411.00 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=210.9
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCce
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l 155 (719)
..|++.++||+|+||+||+|.++.+|+.||+|+++.. ..+++.+|+++|++++ ||||++++++|.......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 4689999999999999999999999999999998633 2467889999999995 9999999999987767789
Q ss_pred eEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 156 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
++||||+.+|+|..+. +.+++..++.+++||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999998764 46999999999999999999999999 999999999999987666799999999987654
Q ss_pred C-CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-------------C-C-
Q 005017 236 P-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------G-I- 297 (719)
Q Consensus 236 ~-~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-------------g-~- 297 (719)
. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....+.......+.. . .
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 3 3456789999999998754 4899999999999999999999999875554432222110 0 0
Q ss_pred --------------------CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 --------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 --------------------~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.+.......++++++||++||. ||.+||||+|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0111123357889999999998 999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=401.12 Aligned_cols=244 Identities=21% Similarity=0.381 Sum_probs=210.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
+.|++.+.||+|+||+||+|.++ ++..||||+++.... ..+.+.+|+.++++++|||||++++++.+. ..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceE
Confidence 34567889999999999999985 888999999985432 346799999999999999999999998755 4589
Q ss_pred EEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccC
Q 005017 157 MITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 235 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~ 235 (719)
+||||+.+|+|.+++.. ...+++..++.|+.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSS
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccC
Confidence 99999999999998655 456899999999999999999999999 9999999999999855 7999999999976544
Q ss_pred CC---cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 236 PT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 236 ~~---~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.. .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.. .+..++...+..+..+ ..+...++++
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l 230 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKV 230 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC-CCHHHHHHHHHhCCCC-CCcccccHHH
Confidence 32 22456899999999886 469999999999999999998 8999987 4577788888887654 3556778999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 311 KGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++||.+||. +|.+|||+.++|+|
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999998 89999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=401.31 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=203.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCC----eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g----~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.|.+.++||+|+||+||+|.++.++ ..||||+++... .......|.+|+.+|++|+|||||++++++.+. .
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~ 82 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--K 82 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--C
Confidence 4788899999999999999877654 479999986432 244567799999999999999999999998755 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+.+|+|.+++... +.+++..+..|+.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRV 159 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC---
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEcccchhhc
Confidence 588999999999999987654 57999999999999999999999999 9999999999999865 7999999999987
Q ss_pred ccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 233 MQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 233 ~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....||+.|||||++.+ .|+.++|||||||++|||+||..||....+..+++..+..+..++ .+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-Cchhh
Confidence 64321 223468999999998864 699999999999999999998777666677888888888876654 34556
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
++.++++|.+||. +|.+|||+.++++
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 7899999999998 8999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=399.63 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=215.9
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCceeE
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 157 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~l 157 (719)
.|++.+.||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|++++|||||+++++|.+.. .+++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~i 78 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTL 78 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--ceeE
Confidence 57888999999999999999999999999999976542 2356788999999999999999999999987654 5888
Q ss_pred EEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhccCCC
Q 005017 158 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 237 (719)
Q Consensus 158 V~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~~~~ 237 (719)
|++++.+++|..++...+.+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||.|+......
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSCC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccCCC
Confidence 9999999999999998999999999999999999999999999 9999999999999865 699999999998765432
Q ss_pred --cccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCC----------------
Q 005017 238 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---------------- 297 (719)
Q Consensus 238 --~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~---------------- 297 (719)
.....+++.|+|||++.. .++.++|||||||++|||++|+.||....+..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 334567889999998764 378999999999999999999999876677666665543210
Q ss_pred -----------CCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 298 -----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 298 -----------~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111223346789999999998 8999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=413.58 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=204.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC----CCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----~~~ 153 (719)
.|+..++||+|+||+||+|.++.+|+.||+|+++..... +.+|+++|++|+|||||+++++|... +..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 577788999999999999999999999999999754322 23699999999999999999988653 344
Q ss_pred ceeEEEecccCCChhHH---hhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 154 TVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~---L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
++++||||+++|.+... ......+++..++.|++||+.||+|||+++ |+||||||+|||++.+...+||+|||++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccch
Confidence 68899999987644333 334567999999999999999999999999 9999999999999876558999999999
Q ss_pred hhccCC-CcccccCCCCCCCccccc--cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-C----------
Q 005017 231 IAMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G---------- 296 (719)
Q Consensus 231 ~~~~~~-~~~~~~GT~~YmAPEvl~--~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g---------- 296 (719)
+..... ...+.+||+.|+|||++. ..|+.++|||||||++|||++|+.||.......++...+.. +
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 776543 345678999999999764 35899999999999999999999999875443333322210 0
Q ss_pred -------CCC--------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 297 -------IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 297 -------~~p--------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
..+ .......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 01123357899999999998 99999999999999999854
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=407.53 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=205.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC-----
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----- 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----- 151 (719)
.+|++.+.||+|+||+||+|.++.+|+.||||++...... ....+++.+|+.+|++++||||+++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3457889999999999999999999999999998765432 234577889999999999999999999886532
Q ss_pred -CCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchh
Q 005017 152 -KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 230 (719)
Q Consensus 152 -~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA 230 (719)
...+++||||+.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEeeeccee
Confidence 3468899999999888877777788999999999999999999999999 9999999999999865 79999999999
Q ss_pred hhccCC------CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---CCCC
Q 005017 231 IAMQQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKP 299 (719)
Q Consensus 231 ~~~~~~------~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~---g~~p 299 (719)
+..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+ .+.......+.. ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~-~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG-NTEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHHHCCCCT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC-CCHHHHHHHHHHhcCCCCh
Confidence 655422 2334579999999998753 589999999999999999999999986 344443333322 1111
Q ss_pred Cccc---------------------------cCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 300 ASLA---------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 300 ~~~~---------------------------~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
.... ...++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1100 1136788999999998 9999999999999999984
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=410.48 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=203.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC----C
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----K 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~----~ 152 (719)
..|++.+.||+|+||+||+|.++.+|+.||+|+++... ......+++.+|+++|++|+|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 45678899999999999999999999999999987432 23456678999999999999999999999987654 2
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+ +++|..+.+ ++.+++..++.+++||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-cccccccccceec
Confidence 3578999999 567777654 567999999999999999999999999 9999999999999865 7999999999987
Q ss_pred ccCCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc-CC------------
Q 005017 233 MQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI------------ 297 (719)
Q Consensus 233 ~~~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~-g~------------ 297 (719)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+...... +.
T Consensus 171 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 171 ADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 6543 345689999999998754 4789999999999999999999999874333322221110 00
Q ss_pred ------------CC---CccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcccc
Q 005017 298 ------------KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 340 (719)
Q Consensus 298 ------------~p---~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~~ 340 (719)
.. .......++.+++||.+||. ||.+||||.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 11223457899999999998 999999999999999998543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=398.92 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=208.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.+.||+|+||+||+|.++ ++.+||+|+++... ...+.|.+|+.+|++++|||||++++++.+ ..++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~ 87 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 87 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeE
Confidence 46899999999999999999887 45679999987443 234679999999999999999999998743 2478
Q ss_pred EEEecccCCChhHHhhh--cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~--~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++|+|..++.. .+.+++..++.++.||+.||+|||+++ |+||||||+||||+.+ |.+||+|||+|+...
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIE 164 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC---
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhcc
Confidence 99999999999998765 346999999999999999999999999 9999999999999855 799999999997654
Q ss_pred CC---CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHH
Q 005017 235 QP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 310 (719)
Q Consensus 235 ~~---~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l 310 (719)
.. ......||+.|+|||++. +.++.++|||||||++|||+||..||.......+++..+..+..++ .+...++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHH
Confidence 32 223457999999999876 4699999999999999999998777766677888888888776544 456678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHHc--CccCcc
Q 005017 311 KGFIEKCLV-PASERLSAKDLLK--DPFLQV 338 (719)
Q Consensus 311 ~~lI~kcL~-dP~~RpSa~eLL~--hpf~~~ 338 (719)
++||.+||. +|.+|||+++++. ++||..
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999998 8999999999988 888864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=406.81 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=203.9
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC--
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK-- 153 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~-- 153 (719)
+.+|++.+.||+|+||+||+|.++.+|+.||||++.... .....+++.+|+.+|++|+|||||++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 345789999999999999999999999999999987433 345667899999999999999999999998654321
Q ss_pred ceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 154 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
..+++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||+++ ||||||||+|||++.+ |.+||+|||+|+..
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVA 159 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred ceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccCceeec
Confidence 23345566779999999975 46999999999999999999999999 9999999999999855 79999999999754
Q ss_pred cCC-----CcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCC--------
Q 005017 234 QQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-------- 298 (719)
Q Consensus 234 ~~~-----~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~-------- 298 (719)
... .....+||+.|+|||++.. .|+.++||||+||++|+|++|+.||.......+....+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 322 2345679999999998743 4789999999999999999999999874433332222111000
Q ss_pred -----------------CC---ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 299 -----------------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 299 -----------------p~---~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
+. ......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 1123456789999999998 99999999999999999743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=403.19 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=203.2
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCe----EEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~----~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
.|++.++||+|+||+||+|.+..+|+ +||+|+++... .....+.+.+|+.+|++++|||||+++++|.+.
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 47889999999999999999988876 57888775332 234567899999999999999999999998754
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..++++||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla~~ 160 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKL 160 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHHHH
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeecccccee
Confidence 367899999999999887664 57999999999999999999999999 9999999999999865 6999999999987
Q ss_pred ccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 233 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 233 ~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
..... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..++ .+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~ 238 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPIC 238 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTB
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccc
Confidence 65432 23446899999999876 469999999999999999999 7888876 45667777777776553 34567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcCc
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKDP 334 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~hp 334 (719)
++.+++||.+||. +|.+|||+.+|++|.
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8899999999998 899999999999983
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=395.52 Aligned_cols=246 Identities=23% Similarity=0.401 Sum_probs=199.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCC---CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~---g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.+.||+|+||+||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++|||||++++++.+ .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 3689999999999999999988654 456888877532 234556789999999999999999999998843 3
Q ss_pred ceeEEEecccCCChhHHhhh-cccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~-~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+||+++.+ +.+||+|||+|+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhhee
Confidence 58899999999999998765 456999999999999999999999999 9999999999999855 6999999999987
Q ss_pred ccCC---CcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCC
Q 005017 233 MQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 307 (719)
Q Consensus 233 ~~~~---~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~ 307 (719)
.... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..++ .+...+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~ 235 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MPPNCP 235 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CCTTCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCC
Confidence 6433 234457899999999886 469999999999999999998 8889877 56677788888776553 455678
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 308 PQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 308 ~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+++++||.+||. +|.+|||+.+|++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999998 89999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=412.75 Aligned_cols=260 Identities=22% Similarity=0.355 Sum_probs=215.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE---cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEeeecCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d---~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~~~~~~~~~ 152 (719)
..|++.+.||+|+||+||+|.+ +.+|+.||+|+++...........+.+.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 4589999999999999999987 447999999998765433323345678899999999977 89999999886654
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+.+|+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |.+||+|||+|+.
T Consensus 103 -~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 -KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKE 178 (322)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEE
T ss_pred -ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchhh
Confidence 58899999999999999999999999999999999999999999999 9999999999999865 7999999999976
Q ss_pred ccCC---CcccccCCCCCCCcccccc---ccCccccchhhHHHHHHHhhccCCCCCCC---CHHHHHHHHHcCCCCCccc
Q 005017 233 MQQP---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLA 303 (719)
Q Consensus 233 ~~~~---~~~~~~GT~~YmAPEvl~~---~~s~ksDIwSlGiil~EmlTG~~Pf~~~~---~~~~i~~~i~~g~~p~~~~ 303 (719)
+... ......|++.|+|||.+.+ .++.++|||||||++|||+||+.||.... ....+.+...... ..++
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~~ 256 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYP 256 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCCc
Confidence 5432 2345679999999998753 47889999999999999999999996532 2333444443332 2345
Q ss_pred cCCChHHHHHHHHhcC-CCCCCC-----CHHHHHcCccCccccCCC
Q 005017 304 KVNDPQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 343 (719)
Q Consensus 304 ~~~~~~l~~lI~kcL~-dP~~Rp-----Sa~eLL~hpf~~~~~~~~ 343 (719)
...++++++||.+||. +|.+|| ||+|+|+||||+..++..
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 5678999999999998 899999 589999999998766543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=397.57 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=201.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-----CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-----~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|++.+.||+|+||+||+|.+.. +++.||+|+++... .....+.+.+|..++.++ +|+|||.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 468999999999999999998654 45789999987432 234567788888888887 689999999987654
Q ss_pred CCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeE
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 214 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NIL 214 (719)
+ ..+++|||||++|+|.+++...+ .+++..++.++.||+.||+|||+++ ||||||||+|||
T Consensus 90 ~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NIL 166 (299)
T d1ywna1 90 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNIL 166 (299)
T ss_dssp T-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred C-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcccee
Confidence 3 46889999999999999987532 4889999999999999999999999 999999999999
Q ss_pred ecCCCCcEEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhc-cCCCCCCCCHHH
Q 005017 215 VNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 288 (719)
Q Consensus 215 l~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG-~~Pf~~~~~~~~ 288 (719)
++.+ |.+||+|||+|+..... ......||+.|||||++.+ .|+.++|||||||++|||+|| ..||........
T Consensus 167 l~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9855 79999999999865433 2335679999999998864 589999999999999999997 567877666677
Q ss_pred HHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 289 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 289 i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
+...+..+..+. .+...++++++||.+||. ||.+|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777777776553 455678999999999998 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=391.13 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=197.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcC-C--CeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEF-A--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~-~--g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~ 153 (719)
+.|++.+.||+|+||+||+|.+.. + +..||||+++..... .....+++.+|+.+|++++|||||++++++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 568999999999999999997643 3 347899998755432 345668899999999999999999999988542
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
.+++||||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhh
Confidence 478999999999999877654 56999999999999999999999999 9999999999999866 6999999999987
Q ss_pred ccCCC-----cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccC
Q 005017 233 MQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKV 305 (719)
Q Consensus 233 ~~~~~-----~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~ 305 (719)
..... .....|++.|+|||++.+ .++.++|||||||++|||+| |+.||.+ .+..++...+.........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCccc
Confidence 64432 234467889999998865 58999999999999999998 8999987 5666777777655444445566
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 306 NDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 306 ~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
.++.+++||.+||. ||.+|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78899999999998 8999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=390.25 Aligned_cols=242 Identities=22% Similarity=0.384 Sum_probs=200.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCcee
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l~ 156 (719)
..|++.++||+|+||+||+|.+ .|..||+|+++.. ...+.+.+|+++|++++|||||++++++.+.+ ..++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~ 77 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 77 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEE
Confidence 3578899999999999999987 4889999998643 23467899999999999999999999887543 3478
Q ss_pred EEEecccCCChhHHhhhcc--cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 157 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 157 lV~Ey~~gGsL~~~L~~~~--~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
+||||+++|+|.+++.+.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecC
Confidence 9999999999999997643 5899999999999999999999998 9999999999999865 799999999998654
Q ss_pred CCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCHHHHHHHHHcCCCCCccccCCChHHHH
Q 005017 235 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 312 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~ 312 (719)
.. .....+|+.|+|||++. +.++.++|||||||++|||+| |++||.. .+..++...+..+..+. .+...++++++
T Consensus 155 ~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (262)
T d1byga_ 155 ST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYE 231 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHH
T ss_pred CC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHH
Confidence 33 34567899999999875 569999999999999999998 6777765 56778888888776665 45567899999
Q ss_pred HHHHhcC-CCCCCCCHHHHHcC
Q 005017 313 FIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 313 lI~kcL~-dP~~RpSa~eLL~h 333 (719)
||.+||. ||.+|||+.+|+++
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHH
Confidence 9999998 89999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=393.37 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=207.8
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..|.+.+.||+|+||+||+|.++ .++..||||+++... .....+++.+|+.+|++++||||++++++|...
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~- 88 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG- 88 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-
Confidence 35788999999999999999865 356899999986432 245567899999999999999999999998765
Q ss_pred CCceeEEEecccCCChhHHhhhcc------------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeec
Q 005017 152 KKTVNMITELFTSGNLRQYRKKHK------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 207 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~~------------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrD 207 (719)
..+++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |||||
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrD 165 (301)
T d1lufa_ 89 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 165 (301)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred -CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeE
Confidence 45888999999999999986432 3788999999999999999999999 99999
Q ss_pred CccceeEecCCCCcEEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhcc-CCCC
Q 005017 208 LKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFE-YPYS 281 (719)
Q Consensus 208 LKp~NILl~~~~G~vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~-~Pf~ 281 (719)
|||+|||++.+ +.+||+|||+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||++|. +||.
T Consensus 166 lKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 166 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999865 79999999999865432 2235678999999998875 6999999999999999999996 5666
Q ss_pred CCCCHHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 282 ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 282 ~~~~~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.||++
T Consensus 245 ~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 G-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp T-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5 67788888888876543 455678899999999998 8999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=396.79 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=205.3
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeE--EEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecCCCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 153 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~--VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~~~~ 153 (719)
..|++.++||+|+||+||+|.++.+|.. ||||+++... .....+.+.+|+++|+++ +|||||++++++.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 4578899999999999999999888875 6667664322 234557799999999999 7999999999998654
Q ss_pred ceeEEEecccCCChhHHhhhc----------------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC
Q 005017 154 TVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 217 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~----------------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~ 217 (719)
.+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 589999999999999998654 46899999999999999999999999 999999999999986
Q ss_pred CCCcEEEeecchhhhccCCC-cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccC-CCCCCCCHHHHHHHHH
Q 005017 218 NHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVT 294 (719)
Q Consensus 218 ~~G~vKL~DFGlA~~~~~~~-~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~-Pf~~~~~~~~i~~~i~ 294 (719)
+ +.+||+|||+|+...... .....||+.|+|||.+. +.|+.++|||||||++|||++|.. ||.+ .+..+++..+.
T Consensus 163 ~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~ 240 (309)
T d1fvra_ 163 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLP 240 (309)
T ss_dssp G-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGG
T ss_pred C-CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHH
Confidence 5 699999999997654332 33557999999999886 469999999999999999999765 5654 67888888888
Q ss_pred cCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 295 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 295 ~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.+..+. .+...++++++||.+||. +|.+|||+.++++|
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 876554 445567899999999998 89999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=400.14 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=204.0
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC---CCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~---~~~ 154 (719)
+|++.+.||+|+||+||+|.++.+|+.||||+++... ......+++.+|+++|++|+|||||++++++.... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4788899999999999999999999999999987543 23455678899999999999999999999886432 223
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhcc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 234 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~~ 234 (719)
.++|++|+.+|+|.+++.. +++++..++.+++||+.||+|||+++ |+||||||+|||++.+ |.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhcccC
Confidence 4567788889999999864 57999999999999999999999999 9999999999999865 799999999997654
Q ss_pred CCCcccccCCCCCCCcccccc--ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcC--CCCC----------
Q 005017 235 QPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA---------- 300 (719)
Q Consensus 235 ~~~~~~~~GT~~YmAPEvl~~--~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g--~~p~---------- 300 (719)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|++||.+. +.......+... ..+.
T Consensus 173 ~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 DE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp GG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred cc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 32 345678999999997654 3689999999999999999999999874 333333333211 0000
Q ss_pred -----------------ccccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCccc
Q 005017 301 -----------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 339 (719)
Q Consensus 301 -----------------~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~~ 339 (719)
......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0112457899999999998 99999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=402.00 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=195.4
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecC----CC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KK 152 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~----~~ 152 (719)
..|++.++||+|+||+||+|.++.+|+.||||+++.... ......++.+|+.+|++++|||||+++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 358888999999999999999999999999999975432 345667899999999999999999999998654 33
Q ss_pred CceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhh
Q 005017 153 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 232 (719)
Q Consensus 153 ~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~ 232 (719)
..+|+||||+.++.+.. + ...+++..++.+++||+.||+|||++| |+||||||+|||++.+ +.+|++|||+++.
T Consensus 95 ~~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC---
T ss_pred ceeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhhc
Confidence 67899999997765554 3 346899999999999999999999999 9999999999999865 6899999999876
Q ss_pred ccCC-CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHc---------------
Q 005017 233 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--------------- 295 (719)
Q Consensus 233 ~~~~-~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~--------------- 295 (719)
.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.. .......+..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhhh
Confidence 6543 3455689999999998864 58999999999999999999999998743 3333222211
Q ss_pred -------CCCCC-----------c-------cccCCChHHHHHHHHhcC-CCCCCCCHHHHHcCccCcc
Q 005017 296 -------GIKPA-----------S-------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 338 (719)
Q Consensus 296 -------g~~p~-----------~-------~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~hpf~~~ 338 (719)
...+. . .....++++++||.+||. ||++||||+|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 00000 0 001124578999999998 9999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=392.10 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=204.8
Q ss_pred cEEEeEEEeeeCCeEEEEEEEcCCC---eEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCc
Q 005017 78 YVRYDEVLGKGAFKTVYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 154 (719)
Q Consensus 78 ~~~l~e~LG~G~fG~Vyka~d~~~g---~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~ 154 (719)
.+.++++||+|+||+||+|.+..++ ..||||+++.. ......++|.+|+++|++|+|||||++++++...+ ..
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~ 103 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GS 103 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-Cc
Confidence 3455889999999999999886543 46899988632 23566788999999999999999999999987543 35
Q ss_pred eeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEeecchhhhc
Q 005017 155 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 233 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~DFGlA~~~ 233 (719)
+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDM 180 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEecccchhhc
Confidence 88999999999999988754 45788899999999999999999999 9999999999999855 69999999999765
Q ss_pred cCCC------cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCHHHHHHHHHcCCCCCccccCC
Q 005017 234 QQPT------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 306 (719)
Q Consensus 234 ~~~~------~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i~~~i~~g~~p~~~~~~~ 306 (719)
.... .....||+.|+|||++. +.++.++|||||||++|||+||+.||....+..++...+..+..+. .+...
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~ 259 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYC 259 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccC
Confidence 4321 22356899999999876 5699999999999999999999888877666777778888876554 45567
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 307 DPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 307 ~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
++++.+||.+||. ||.+|||+.|+++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8899999999998 89999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=387.75 Aligned_cols=247 Identities=28% Similarity=0.401 Sum_probs=205.0
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCC-------eEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEee
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAG-------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSW 147 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g-------~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~ 147 (719)
...|.+.+.||+|+||.||+|.+..++ ..||+|+++... .......+.+|+..+.++ +|||||+++++|
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 356888999999999999999876544 479999986432 245567889999999888 899999999999
Q ss_pred ecCCCCceeEEEecccCCChhHHhhhcc----------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccc
Q 005017 148 VDDKKKTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 211 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~L~~~~----------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~ 211 (719)
.++ ..+++||||+++|+|.+++.... .+++..++.|+.||+.||+|||+++ ||||||||+
T Consensus 89 ~~~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 89 TQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp CSS--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ccC--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 765 45889999999999999997543 4899999999999999999999999 999999999
Q ss_pred eeEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCC
Q 005017 212 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 285 (719)
Q Consensus 212 NILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~ 285 (719)
|||++.+ |.+||+|||+++...... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+ .+
T Consensus 165 NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~ 242 (299)
T d1fgka_ 165 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 242 (299)
T ss_dssp GEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred ceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CC
Confidence 9999865 799999999997664332 33467899999999875 569999999999999999998 6778866 66
Q ss_pred HHHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 286 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 286 ~~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+++..+..+..+. .+...++.+++||.+||+ +|.+|||+.|+++
T Consensus 243 ~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 778888888776554 456678899999999998 8999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=387.07 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=206.5
Q ss_pred CcEEEeEEEeeeCCeEEEEEEE-----cCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEeeecC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD 150 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d-----~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIVkl~~~~~~~ 150 (719)
..|.+.++||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+++++ +|||||++++++.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4688899999999999999975 3467899999997543 245567899999999999 699999999998655
Q ss_pred CCCceeEEEecccCCChhHHhhhcc------------------cccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccce
Q 005017 151 KKKTVNMITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 212 (719)
Q Consensus 151 ~~~~l~lV~Ey~~gGsL~~~L~~~~------------------~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~N 212 (719)
+ .+++||||+++|+|.+++.+.. .+++..++.|+.||+.||+|||+++ ||||||||+|
T Consensus 100 ~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~N 175 (311)
T d1t46a_ 100 G--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARN 175 (311)
T ss_dssp S--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred C--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccc
Confidence 4 5889999999999999987543 5899999999999999999999999 9999999999
Q ss_pred eEecCCCCcEEEeecchhhhccCCC----cccccCCCCCCCccccc-cccCccccchhhHHHHHHHhh-ccCCCCCCCCH
Q 005017 213 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNP 286 (719)
Q Consensus 213 ILl~~~~G~vKL~DFGlA~~~~~~~----~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlT-G~~Pf~~~~~~ 286 (719)
|+++.+ +.+||+|||+++...... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||......
T Consensus 176 Il~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999865 799999999998765432 23457899999999886 468999999999999999999 45556554444
Q ss_pred HHHHHHHHcCCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 287 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 287 ~~i~~~i~~g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+.+.+..+..+ ..+...++.+++||.+||. ||.+|||+.+|++
T Consensus 255 ~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5555556565544 4456678999999999998 8999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=385.73 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=208.2
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEc-----CCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCC
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 151 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~-----~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~ 151 (719)
..+.+.+.||+|+||+||+|.+. .++..||||+++... .......+.+|+.++++++|||||++++.+....
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 57889999999999999999875 246789999986432 3455677999999999999999999999886554
Q ss_pred CCceeEEEecccCCChhHHhhhc----------ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCc
Q 005017 152 KKTVNMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 221 (719)
Q Consensus 152 ~~~l~lV~Ey~~gGsL~~~L~~~----------~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~ 221 (719)
.+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.
T Consensus 97 --~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~-~~ 171 (308)
T d1p4oa_ 97 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FT 171 (308)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT-CC
T ss_pred --ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC-ce
Confidence 588999999999999998643 23688899999999999999999999 9999999999999865 69
Q ss_pred EEEeecchhhhccCC----CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhcc-CCCCCCCCHHHHHHHHHc
Q 005017 222 VKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTS 295 (719)
Q Consensus 222 vKL~DFGlA~~~~~~----~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~-~Pf~~~~~~~~i~~~i~~ 295 (719)
+||+|||+|+..... ......||+.|+|||.+.+ .++.++|||||||++|||+||. .||.+ .+..+++..+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHh
Confidence 999999999765432 2234468999999998764 5899999999999999999995 66665 677888888887
Q ss_pred CCCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 296 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 296 g~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
+..+. .+...++.+.++|.+||. +|.+|||+.+|++
T Consensus 251 ~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 251 GGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 76544 345677899999999998 8999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=380.40 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=191.1
Q ss_pred CcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCC--Cc
Q 005017 77 RYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KT 154 (719)
Q Consensus 77 r~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~--~~ 154 (719)
|.+.+.+.||+|+||+||+|.+ +|+.||+|+++... ........|+..+++++|||||++++++.+.+. ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 5688999999999999999975 69999999986432 122223345666678899999999999987653 36
Q ss_pred eeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcC------CCCeeeecCccceeEecCCCCcEEEeecc
Q 005017 155 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLG 228 (719)
Q Consensus 155 l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~------~ppIIHrDLKp~NILl~~~~G~vKL~DFG 228 (719)
+++||||+++|+|.+++++. .+++..+..++.|++.||+|||+. .++||||||||+||||+.+ |.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecC
Confidence 88999999999999999864 689999999999999999999974 2349999999999999865 799999999
Q ss_pred hhhhccCC------CcccccCCCCCCCcccccc-------ccCccccchhhHHHHHHHhhccCCCCCC------------
Q 005017 229 LAIAMQQP------TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSEC------------ 283 (719)
Q Consensus 229 lA~~~~~~------~~~~~~GT~~YmAPEvl~~-------~~s~ksDIwSlGiil~EmlTG~~Pf~~~------------ 283 (719)
+++..... .....+||+.|||||++.. .++.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99766432 2235679999999998764 2678999999999999999998776321
Q ss_pred --CCHHHHHHHHHcCCCCCccccC-----CChHHHHHHHHhcC-CCCCCCCHHHHHcC
Q 005017 284 --KNPAQIFKKVTSGIKPASLAKV-----NDPQIKGFIEKCLV-PASERLSAKDLLKD 333 (719)
Q Consensus 284 --~~~~~i~~~i~~g~~p~~~~~~-----~~~~l~~lI~kcL~-dP~~RpSa~eLL~h 333 (719)
.....+...+......+.++.. ....+.+++.+||+ ||.+|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1223333333333322222211 12358899999998 89999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=372.33 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=195.6
Q ss_pred CCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEeeecCCCCce
Q 005017 76 GRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 155 (719)
Q Consensus 76 gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIVkl~~~~~~~~~~~l 155 (719)
|..|++.+.||+|+||+||+|.+..+|+.||+|++..... .+++..|++++++++|+|+|..+..+... ....
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEec-CCEE
Confidence 4568999999999999999999999999999998875432 13477899999999988776665554433 3468
Q ss_pred eEEEecccCCChhHHh-hhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC--CCCcEEEeecchhhh
Q 005017 156 NMITELFTSGNLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIA 232 (719)
Q Consensus 156 ~lV~Ey~~gGsL~~~L-~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~--~~G~vKL~DFGlA~~ 232 (719)
++||||+.+ +|.+++ ...+.+++..+..++.|++.||+|||+++ ||||||||+|||++. ....+||+|||+|+.
T Consensus 79 ~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 79 VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 899999955 555544 44567999999999999999999999999 999999999999853 334799999999987
Q ss_pred ccCCC---------cccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCCCHHHH--HHHHHc---CC
Q 005017 233 MQQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--FKKVTS---GI 297 (719)
Q Consensus 233 ~~~~~---------~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~~~i--~~~i~~---g~ 297 (719)
+.... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||......... +..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 64321 235679999999998875 4899999999999999999999999764332221 111111 11
Q ss_pred CCCccccCCChHHHHHHHHhcC-CCCCCCCHHH---HHcCccCc
Q 005017 298 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKD---LLKDPFLQ 337 (719)
Q Consensus 298 ~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~e---LL~hpf~~ 337 (719)
.+.......++++.+||.+||. +|.+||++.+ +|+|+|.+
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 2223345678899999999997 8999999874 57777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-42 Score=362.46 Aligned_cols=247 Identities=15% Similarity=0.223 Sum_probs=200.1
Q ss_pred CCCcEEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEeeecCCCC
Q 005017 75 SGRYVRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKK 153 (719)
Q Consensus 75 ~gr~~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIVkl~~~~~~~~~~ 153 (719)
.|..|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+|++.++.|+| +||+.+++++... .
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~ 74 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--L 74 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--T
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--C
Confidence 35678999999999999999999999999999998764321 2346789999999976 8999999987654 4
Q ss_pred ceeEEEecccCCChhHHhhhc-ccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecC----CCCcEEEeecc
Q 005017 154 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLG 228 (719)
Q Consensus 154 ~l~lV~Ey~~gGsL~~~L~~~-~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~----~~G~vKL~DFG 228 (719)
..++||||+ +|+|.+++... ..+++..+..++.|++.||+|||+++ ||||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 588999999 68999988765 46999999999999999999999999 999999999999963 24689999999
Q ss_pred hhhhccCC---------CcccccCCCCCCCcccccc-ccCccccchhhHHHHHHHhhccCCCCCCC--CHHHHHHHHHcC
Q 005017 229 LAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSG 296 (719)
Q Consensus 229 lA~~~~~~---------~~~~~~GT~~YmAPEvl~~-~~s~ksDIwSlGiil~EmlTG~~Pf~~~~--~~~~i~~~i~~g 296 (719)
+|+..... .....+||+.|||||++.+ .++.++|||||||++|||+||+.||.... +....+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99765432 1235679999999998875 49999999999999999999999997532 333444433322
Q ss_pred ---CCCCccccCCChHHHHHHHHhcC-CCCCCCCHHHHHc
Q 005017 297 ---IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 332 (719)
Q Consensus 297 ---~~p~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL~ 332 (719)
..+..+....++++.+++..|+. +|.+||+++.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22233445567899999999997 8999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-41 Score=364.52 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=193.3
Q ss_pred EEEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----------CCCceeEEEee
Q 005017 79 VRYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----------DDNVVKFYKSW 147 (719)
Q Consensus 79 ~~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpNIVkl~~~~ 147 (719)
|++.++||+|+||+||+|.++.+|+.||||+++... ...+.+.+|+.+|+.++ |+|||++++++
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 789999999999999999999999999999997442 33467788999988875 57899999988
Q ss_pred ecCCCCceeEEEecccCCChhHH---hhhcccccHHHHHHHHHHHHHHhhhhhc-CCCCeeeecCccceeEecCCC----
Q 005017 148 VDDKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH---- 219 (719)
Q Consensus 148 ~~~~~~~l~lV~Ey~~gGsL~~~---L~~~~~l~~~~i~~i~~QIl~gL~yLHs-~~ppIIHrDLKp~NILl~~~~---- 219 (719)
........+++++++..+..... ......+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 76665667777777765543332 2334578999999999999999999997 78 99999999999997432
Q ss_pred -CcEEEeecchhhhccCCCcccccCCCCCCCccccc-cccCccccchhhHHHHHHHhhccCCCCCCCCH------HHHHH
Q 005017 220 -GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP------AQIFK 291 (719)
Q Consensus 220 -G~vKL~DFGlA~~~~~~~~~~~~GT~~YmAPEvl~-~~~s~ksDIwSlGiil~EmlTG~~Pf~~~~~~------~~i~~ 291 (719)
..+|++|||.|..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..+..
T Consensus 168 ~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred cceeeEeeccccccccc-ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 1499999999876543 335678999999999876 46999999999999999999999999643211 11111
Q ss_pred HHH-cCCCC--------------------------------------CccccCCChHHHHHHHHhcC-CCCCCCCHHHHH
Q 005017 292 KVT-SGIKP--------------------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 331 (719)
Q Consensus 292 ~i~-~g~~p--------------------------------------~~~~~~~~~~l~~lI~kcL~-dP~~RpSa~eLL 331 (719)
.+. -+..+ .......++++++||.+||. ||.+||||+|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 00000 00111224679999999998 999999999999
Q ss_pred cCccCccc
Q 005017 332 KDPFLQVE 339 (719)
Q Consensus 332 ~hpf~~~~ 339 (719)
+||||+..
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred cCcccCCC
Confidence 99999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6e-24 Score=207.99 Aligned_cols=171 Identities=18% Similarity=0.193 Sum_probs=123.8
Q ss_pred EEeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc-----C---------ChhhHHHHHHHHHHHHhCCCCCceeEEE
Q 005017 80 RYDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL-----Q---------LPGDLQKLYSEVHLLKSLKDDNVVKFYK 145 (719)
Q Consensus 80 ~l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~-----~---------~~~~~~~~~~Ei~iL~~L~HpNIVkl~~ 145 (719)
.++++||+|+||+||+|.+. +|+.||+|+++..... . ..........|+..+.++.|+++++.++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999885 7999999987642210 0 0011234457899999999999999887
Q ss_pred eeecCCCCceeEEEecccCCChhHHhhhcccccHHHHHHHHHHHHHHhhhhhcCCCCeeeecCccceeEecCCCCcEEEe
Q 005017 146 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 225 (719)
Q Consensus 146 ~~~~~~~~~l~lV~Ey~~gGsL~~~L~~~~~l~~~~i~~i~~QIl~gL~yLHs~~ppIIHrDLKp~NILl~~~~G~vKL~ 225 (719)
+. . .+++|||++++.+.+ ++...+..++.|++.+|+|||+++ |+||||||+|||++.+ .++|+
T Consensus 82 ~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~li 144 (191)
T d1zara2 82 WE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWII 144 (191)
T ss_dssp EE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEEC
T ss_pred ec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEE
Confidence 42 1 357999999866543 344556789999999999999999 9999999999999843 59999
Q ss_pred ecchhhhccCCCcccccC-CCCCCCccccccccCccccchhhHHH
Q 005017 226 DLGLAIAMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGMC 269 (719)
Q Consensus 226 DFGlA~~~~~~~~~~~~G-T~~YmAPEvl~~~~s~ksDIwSlGii 269 (719)
|||+|.....+....... ... .-.+.+.+.|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHHH
Confidence 999997655443222110 000 0013455679999999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.79 E-value=3.2e-05 Score=76.10 Aligned_cols=82 Identities=11% Similarity=-0.121 Sum_probs=50.7
Q ss_pred EeEEEeeeCCeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEeeecCCCCceeEEE
Q 005017 81 YDEVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 159 (719)
Q Consensus 81 l~e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIVkl~~~~~~~~~~~l~lV~ 159 (719)
..+..+.++.+.||+.. ..+..+++|+....... ....+.+|...|..|. +--+.+++.+.... ...++||
T Consensus 18 ~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~ 89 (263)
T d1j7la_ 18 CVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM 89 (263)
T ss_dssp EEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred EEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc----chhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEE
Confidence 33433444557899874 45666778876543221 2234677888887774 33345666654433 4578899
Q ss_pred ecccCCChhHH
Q 005017 160 ELFTSGNLRQY 170 (719)
Q Consensus 160 Ey~~gGsL~~~ 170 (719)
++++|.++...
T Consensus 90 ~~l~G~~~~~~ 100 (263)
T d1j7la_ 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred Eeccccccccc
Confidence 99999887654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=0.00011 Score=77.82 Aligned_cols=81 Identities=14% Similarity=0.176 Sum_probs=50.0
Q ss_pred EEEeeeCCeEEEEEEEcCCCeEEEEEEEeecccc---CChhhHHHHHHHHHHHHhCC-C--CCceeEEEeeecCCCCcee
Q 005017 83 EVLGKGAFKTVYKAFDEFAGIEVAWSRVKIDDVL---QLPGDLQKLYSEVHLLKSLK-D--DNVVKFYKSWVDDKKKTVN 156 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~~g~~VAvK~i~~~~~~---~~~~~~~~~~~Ei~iL~~L~-H--pNIVkl~~~~~~~~~~~l~ 156 (719)
+.||.|....||+..+...|+.|++|+-...-.. ..+....+...|.+.|+.+. + ..+.+++.+ +.. ..+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~--~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--MAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--TTE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC--CCE
Confidence 4589999999999988777889999975432111 11223455667888887662 2 345666653 333 345
Q ss_pred EEEecccCCCh
Q 005017 157 MITELFTSGNL 167 (719)
Q Consensus 157 lV~Ey~~gGsL 167 (719)
+|||++.+..+
T Consensus 108 lvmE~L~~~~~ 118 (392)
T d2pula1 108 TVMEDLSHLKI 118 (392)
T ss_dssp EEECCCTTSEE
T ss_pred EEEeccCCccc
Confidence 79999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.40 E-value=0.00039 Score=67.61 Aligned_cols=75 Identities=11% Similarity=-0.016 Sum_probs=47.7
Q ss_pred EEeeeCC-eEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEeeecCCCCceeEEEe
Q 005017 84 VLGKGAF-KTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDDKKKTVNMITE 160 (719)
Q Consensus 84 ~LG~G~f-G~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIVkl~~~~~~~~~~~l~lV~E 160 (719)
.+..|.. +.||+... ..|..+++|...... ...+..|...|+.|... .+.+++....+. ...++||+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEE
Confidence 4455553 68899864 356667888654332 12366788888777432 356667655443 45788999
Q ss_pred cccCCChh
Q 005017 161 LFTSGNLR 168 (719)
Q Consensus 161 y~~gGsL~ 168 (719)
+++|.++.
T Consensus 87 ~i~G~~~~ 94 (255)
T d1nd4a_ 87 EVPGQDLL 94 (255)
T ss_dssp CCSSEETT
T ss_pred eeeccccc
Confidence 99887664
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.61 E-value=0.009 Score=60.60 Aligned_cols=71 Identities=10% Similarity=-0.018 Sum_probs=41.6
Q ss_pred CeEEEEEEEcCCCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc--eeEEE---eeecCCCCceeEEEecccC
Q 005017 90 FKTVYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV--VKFYK---SWVDDKKKTVNMITELFTS 164 (719)
Q Consensus 90 fG~Vyka~d~~~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI--Vkl~~---~~~~~~~~~l~lV~Ey~~g 164 (719)
--.||++.. .+|..|++|+.+... ...+++..|...+..|....+ +.... --........+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~-----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC-----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999965 478889999876432 123567788888888753322 11111 0000112346778898876
Q ss_pred CC
Q 005017 165 GN 166 (719)
Q Consensus 165 Gs 166 (719)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.48 E-value=0.077 Score=54.84 Aligned_cols=74 Identities=14% Similarity=0.137 Sum_probs=46.6
Q ss_pred EEEeeeCCeEEEEEEEcC-------CCeEEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEeeecCCCCc
Q 005017 83 EVLGKGAFKTVYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKT 154 (719)
Q Consensus 83 e~LG~G~fG~Vyka~d~~-------~g~~VAvK~i~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-Vkl~~~~~~~~~~~ 154 (719)
+.|+.|-.=.+|++.... .+..|.+++.- .. ... ....+|..+++.+.-.++ .++++++ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~--- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP----ETE-SHLVAESVIFTLLSERHLGPKLYGIF--SG--- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC---
Confidence 568888889999987542 23556655543 11 112 345578888888853344 5777765 22
Q ss_pred eeEEEecccCCChh
Q 005017 155 VNMITELFTSGNLR 168 (719)
Q Consensus 155 l~lV~Ey~~gGsL~ 168 (719)
.+|+||++|..|.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -ceEEEEeccccCC
Confidence 3589999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=86.03 E-value=0.24 Score=48.81 Aligned_cols=29 Identities=34% Similarity=0.426 Sum_probs=24.3
Q ss_pred CeeeecCccceeEecCCCCcEEEeecchhh
Q 005017 202 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 231 (719)
Q Consensus 202 pIIHrDLKp~NILl~~~~G~vKL~DFGlA~ 231 (719)
++||+|+.++||+++++ +..-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccc-cceeEecccccc
Confidence 49999999999999865 356799999763
|